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Dear Minister
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Preface
Welcome to the seventh edition of AustraliaÕs Health, the two-yearly summary of
information on health in Australia. AustraliaÕs Health 2000 is a special edition because it
summarises AustraliaÕs health record at the end of the twentieth century. Yet, like its
predecessors, it provides a contemporary view of health and will be of maximum use
over the next 2 years. As always, it contains a mass of factual and objective data to
inform community discussion and policy debate on health issues. These include health
status (including new information summarising the burden of disease and injury),
service provision and performance.
AustraliaÕs Health 2000 follows a more ordered structure than in the past and includes
some other special features. Chapter 3 focuses on health determinants, in line with the
interest in population health planning from work being undertaken under the auspices
of the National Public Health Partnership. Chapter 6 brings together information on
health service strategies and performance, reflecting the interest of AHMAC in
monitoring the performance of the overall health system. As chapter 7 points out, these
are both areas where more information development is needed to complete the picture.
Chapter 8 examines changes in AustraliaÕs disease profile in the twentieth century. It
draws on work by JHL Cumpston, the first and longest serving head of the
Commonwealth Department of Health (from 1921 to 1945) and the most important
figure in public health in Australia this century, and of HO Lancaster, who examined in
detail the Australian mortality experience in the early part of the century. It also draws,
directly and indirectly, on a range of contemporary sources illustrating the depth of
knowledge of mortality in Australia right through the century.
The range of contributors is large and many have worked long and hard to produce this
book. But special mention must go to Diana Hetzel for her work on chapter 8, to Geoff
Sims for his coordinating effort, and to the editor Tony Wood (as in 1998).
The Institute hopes that AustraliaÕs Health 2000 will find a place on many bookshelves
for many years to come. On behalf of all the authors I wish readers an enjoyable and
rewarding experience.
Richard Madden
Director
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Introduction
 
 
The twentieth century has seen great changes in the health of Australians. There has
been a 20-year gain in life expectancy at birth, and a dramatic fall in the toll of
infectious disease, offset to an extent by an increase in chronic diseases associated with
age. Although most Australians enjoy good health today, some groups in the
population continue to suffer poor health, in particular Aboriginal and Torres Strait
Islander peoples.
This report is the seventh in the series of biennial reports on health in Australia
produced by the Australian Institute of Health and Welfare (AIHW). It is broadly
structured along the lines of the conceptual framework for health shown in Figure 1.1.
This shows health and wellbeing as the outcome of many causes modified by
intervention activities that are supported by human and material resources.
This first chapter discusses what health is, what determines it, and the need for good
information on the causes and patterns of health and illness in the community. It also
includes an overview of the Australian health system. Chapter 2 reports on the health
status of Australians and describes the major diseases and conditions that have an
impact on their health. It includes results from the InstituteÕs Australian Burden of
Disease and Injury Study conducted in 1999. Chapter 3 focuses on the environmental
and individual factors that determine health. Chapter 4 discusses the health of particular
population groups. Chapter 5 examines the cost of health services, employment in the
health industry and the provision and use of health services. Chapter 6 looks at
strategies for improving the health of Australians and performance in health service
delivery. Chapter 7 outlines requirements for health information for a better
understanding of current and emerging health issues. Chapter 8 uses mortality data to
document the changes in the disease profile of Australians during the twentieth century.
A wide range of statistical tables is included after chapter 8. These tables include data
on population and fertility as well as health-related information. They include
indicators that have been agreed for reporting under the National Health Priority Areas
initiative of governments, covering cardiovascular health, cancer control, injury
prevention and control, mental health, diabetes mellitus and asthma. Many of the tables
provide time series information, as well as comparing Australia with other countries.
Tables have also been included for some of the figures in the report, for the benefit of
readers who may wish to examine the data in more detail. 
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1.1 Health and its determinants
 
What is health?
 
Health has several important aspects, and our notions of it continue to develop. This
means it cannot be described simply; it needs a range of measures, and it is still difficult
to measure fully.
 
The
 
 
 
Macquarie Dictionary
 
 describes health as Ôthe general condition of the body or mind
with reference to soundness and vigourÕ (Macquarie 1997). In 1946 the World Health
Organization (WHO) defined health as Ôa state of complete physical, mental and social
well-being and not merely the absence of disease or infirmityÕ (WHO 1946). 
The WHO description applies to an ideal standard of health and can be seen as a goal
as much as a definition. However, it remains widely used and along with the Macquarie
version it helps to convey the ideas that: 
¥ health is an important part of wellbeing, of how people feel and function, and also
contributes to social and economic wellbeing;
¥ health is not simply the absence of illness or injury and there are degrees of good
health as well as of bad health;
 
Box 1.1: Australia at a glance
 
¥ 19 million people, including about 400,000 Indigenous persons (2% of total)
¥ Average life expectancy at birth 81 years for women, 76 for men
¥ Fertility rate below replacement level but at higher end for developed countries
¥ 50,000 years of Aboriginal settlement, 212 of European and other
¥ 6th largest land mass in world, almost same as USA (excluding Alaska)
¥ Lowest population density among developed countriesÑ2 persons per km
 
2
 
¥ Climate varied but mainly continental and dry
¥ Highly urbanised, most people living in south-east seaboard region
¥ Many cultural backgrounds, 23% of residents born overseas
¥ Christianity main religion (71%), no religion 17%, Buddhism 1.1%, Islam 1.1%
¥ 76% of 15Ð19-year-olds are at school or other educational institution
¥ Per capita income high, gross domestic product (GDP) 8th among 17 OECD countries
¥ Manufacturing main contributor to GDP (13.2%)
¥ Unemployment under 7% in late 1999
¥ Health expenditure 8.3% of GDP in 1997Ð98
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¥ for example, the better the health, the better a personÕs energy, reserves, resilience
and capacity to stay that way for a longer life; also, many damaging processes in the
body occur long before symptoms arise; and
¥ health should be seen in a broad social context.
In short, healthy people feel and function well in body and mind and are in condition to
keep doing so for as long as possible.
Information on health must try to take account of the many factors that improve or
reduce health and wellbeing, the processes and features of disease, and the
management of illness and disability. Concepts and measures of health vary with the
interests of those using them, such as researchers, clinical health professionals,
administrators, social scientists, health economists and policy makers. Biomedical
concepts are concerned with the biological processes of health and ill health. Clinical
and epidemiological approaches consider mainly causes, disease, disability, death, life
expectancy and years of healthy life. The social sciences focus more on social, emotional
and material wellbeing as well as the quality of life. Health economists and policy
makers are interested in information about the efficient and cost-effective use of limited
resources as well as in health outcomes.
Some of these concepts are difficult to measure because they are hard to define clearly
or because the measurement is expensive or technically difficult. For these reasons,
much of this report relies on traditional or clinical measures such as death, disease,
disability, certain risk factors or life expectancy. These measures either are clear-cut or
have been developed over many years, and some have arisen from the daily activities
of the health system. Concepts such as ÔwellbeingÕ and Ôquality of lifeÕ are much more
challenging.
 
What determines and influences health?
 
Many things determine and influence health. Ideas about the causes of good health and
disease have developed significantly over the past two centuries. Although ill health
was linked to industrial and urban living in the nineteenth century, the single-cause
germ theory of disease came to dominate health sciences well into the twentieth
century. However, in the twentieth century the rise of chronic diseases, such as
cardiovascular disease and several cancers, led to a wider ÔmulticausalÕ view. Research
on populations showed the importance of ÔlifestyleÕ factors such as diet, physical
activity and cigarette smoking. Disease and health came to be seen as the result of the
interaction of human biology, lifestyle and environmental factors, modified by health
care (Lalonde 1974). As a further step, there has been increasing attention on the health
of groups, particularly inequalities between groups. This in turn has been linked to the
broad social and economic influences on health and lifestyle. 
Figure 1.1 (page 4) shows some current concepts in simplified form. Health, disease and
disability can be seen as the result of a complex interplay of many factors described as
individual or environmental. These causes and effects can be modified to various
degrees by prevention and health promotion or by treatment and rehabilitation. Such
interventions are supported by human and material resources, including essential
information via research, monitoring and evaluation.
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ÔIndividualÕ factors shown in the box at the left of Figure 1.1 are those that can be
measured in an individualÑalthough they can also be applied to groups and often, as
previously mentioned, reflect environmental influences. The environmental factors can
be physical, as in landscape and climate; biological, as in vegetation, the food supply,
infectious agents and other animal life; and socioeconomic, as in politics, culture,
standards of living and the economy. Environmental factors in turn overlap one another
in many ways and are also influenced by the actions of individuals. 
The nature and scale of all these influences carry important implications for what and
how much can be done to improve health. Broad socioeconomic influences can affect all
people to some extent, but they often act to the further disadvantage of groups with
lower education and income. The effects include peopleÕs health risks, knowledge,
attitudes, opportunities and behaviour. In more detail they include:
¥ the varying exposure of individuals to risks;
¥ the understanding and attitudes of individuals in relation to prevention, and to ill
health and its treatment;
¥ the willingness and ability of those individuals to look after their own health and also
to obtain and follow professional help when needed; and 
¥ the quality of that professional help and the ease of access to it.
These features will also vary according to factors such as age, sex, occupation and
location. Other factors include marital status and social support or isolation. Age and
sex are the largest single determinants of health but all factors have social and
psychological aspects. 
 
Figure 1.1: A conceptual framework for health
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1.2 Implications for improving health
 
Despite AustraliaÕs generally good health and major improvements over the twentieth
century, there is still great scope for further gains. This can be seen from the previous
discussion and from information in later chapters of this book:
¥ large and rapid improvements have already been shown to occur and in some areas
seem likely to continueÑfor example, falling death rates from heart attack and
stroke, two of the greatest killers;
¥ awareness of the numerous biological, behavioural, social and economic factors that
increase the risk of ill health that can be prevented or modified, and that are presently
at high levels among many individuals and groups;
¥ the example of some countries that much lower levels of some diseases are possible,
suggesting what Australia can aim to achieve, for example in the area of death rates
from heart attack and several cancers;
¥ the relatively poor health (and therefore scope to improve) of those at a socio-
economic disadvantage, most notably Aboriginal and Torres Strait Islander peoples;
¥ growing recognition of the contribution to the burden of disease of morbidity as well as
mortality, and the identification of major sources of morbidity such as depression; and
¥ constant advances in health research and technology, producing better diagnosis and
treatment.
Health interventions can occur at many levels. These can range from clinical and
preventive attention to individuals through to efforts to improve the physical, social and
economic environment for special groups or the community as a whole. As well as
seeking to reduce peopleÕs exposure to risks, some strategies aim to help individuals
develop personal skills to exercise more control over their own health and environments
and to make healthy choices. 
Given the great range of influences on health, many major improvements require a
strong partnership between public health and clinical care and also that the health
sector work with other sectors to make the best use of limited resources. This further
requires that other sectors take into account the possible health impact of their
decisions. Improvements in health technology and an ageing and more health-
conscious population have also led to growing demands on health and treatment
services. Expectations are also increasing in other areas of peopleÕs lives, so there are
competing interests both within the health sector and between it and other sectors.
Much of this further gain can be achieved under present social and economic conditions.
Improvements have occurred among all the major Australian socioeconomic groups,
even though there are continuing large inequalities between them in their levels of
health. However, to achieve the full scope of improvement also requires significant social
changes such as reducing educational and economic disadvantage. These changes can be
seen as one of the great aims of society for reasons that include not only health (in its
narrower sense), but also other benefits. They are already the subject of much action;
they clearly extend far wider than the activities of the health sector and they require
major and sustained effort from many areas of society.
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The information on the great potential for improvement and how it might be achieved
gives scope for a strategic approach in Australia towards sustainable gains. However,
the major issues involved always require value judgments, and often include political
processes because of competing interests. Along with limited resources, the situation
involves choices, priority setting and trade-offs between the health sector and other
sectors, between prevention and treatment services, and between the short term and
longer term.
 
1.3 The role of health information
 
Valid and reliable health information is fundamental to developing effective health
policies and programs, for general health-system development and to further the broad
research and development effort (WHO 1996). The information needs to cover the
patterns and trends of health and illness in Australia, the determinants of health and ill
health, population health activities and clinical medical care (including primary health
care). It is also required for a range of population groups.
Even where health care is delivered by private rather than by government providers,
there are often public policy issues to do with funding (e.g. Medicare) or with managing
the relationship between care systems. Health care management uses information about
patients and their diagnoses or problems. It is also concerned with the nature of
services provided and their cost, quality and effectiveness. Employment and training
information supports health labour force planning. There is increasing focus on the
interaction of care settings, particularly where different services are accessed by the
same patient as part of a complete episode of care. The latter information is less well
developed at present.
In the area of public health, information is required for:
¥ monitoring trends in the health and wellbeing of the community;
¥ similarly monitoring the determinants of that health and wellbeing;
¥ helping to determine priorities for public health interventions;
¥ identifying emerging issues that may require interventions;
¥ contributing to the design (or redesign) and management of interventions; and
¥ monitoring the effects of public health interventions.
Analysing disease prevalence and other data to estimate the burden of disease
(reported in this edition of 
 
AustraliaÕs Health
 
 for the first time) and cost-effectiveness of
interventions helps to shape decisions about priorities for interventions and for
research, as does information about the equity of distribution of health and access to
health services.
Increasing attention is being given to structuring and coordinating health information to
support decision making. The National Health Information Agreement, made in 1993
between Commonwealth, State and Territory health agencies, the Australian Bureau of
Statistics and the Australian Institute of Health and Welfare, now includes the Health
 
01 AH2000 body  Page 6  Thursday, June 1, 2000  3:06 PM
 1
 
 Introduction  
 
7
 
TRIM SIZE 175 mm Wide x 250 mm Deep
Insurance Commission. A major product of this agreement is the 
 
National Health Data
Dictionary
 
 (AIHW 1999) which is updated annually to provide standards for national
health information and to be a guide for health data gathering generally. 
The agreement also provides mechanisms for extending the range of information
available into areas of high priority. In this regard 
 
The Aboriginal and Torres Strait Islander
Health Information PlanÉThis Time LetÕs Make It Happen
 
 (AHMAC & AIHW 1998) is an
important example of a commitment to use health information to focus attention on
important health needs.
The role of health information does not stop at informing decision makers in policy,
administrative or service provider roles. Regular wide dissemination of new health
information enables people to be informed about the issues behind public debate about
health and health services and to make judgments about health and their own
wellbeing.
 
1.4 The Australian health system
 
Individual Australians and families and health care professionals are partners in
seeking good health and high-quality treatment. PeopleÕs decisions about lifestyle, self-
care, and seeking and acting on professional help, and their participation in the
development of public policy at many levels, all contribute to shaping the Australian
health system. Increasingly, detailed information is available to and accessed by
individuals, especially via the Internet.
The Australian health system is complex, with many types and providers of services and
a range of funding and regulatory mechanisms. Those who provide services include
medical practitioners, other health professionals, hospitals, and other government and
non-government agencies. Funding is provided by the Commonwealth (Federal)
Government, State and Territory Governments, health insurers, individual Australians
and a range of other sources.
The CommonwealthÕs funding includes two national subsidy schemes, Medicare and
the Pharmaceutical Benefits Scheme. These schemes cover all Australians and subsidise
their payments for medical services and for a high proportion of prescription
medications bought from pharmacies. The Commonwealth and State Governments also
jointly fund public hospital services so they are provided free of charge to patients.
Between them, these three funding provisions aim to give all Australians, regardless of
their personal circumstances, access to adequate health care at an affordable cost or no
cost. These arrangements have become a central feature of AustraliaÕs health system
during the last 25 years.
Many patientsÕ first contact with the health system is through a general medical
practitioner (GP). Patients can choose their own GP and are reimbursed for all or part of
the GPÕs fee by Medicare, depending on the GPÕs billing arrangements. 
 
AustraliaÕs Health
 
now reports on reasons for the attendances and actions arising from them. For specialised
care, patients can be referred to specialist medical practitioners, other health
professionals, hospitals or community-based healthcare organisations. These community-
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based services, some of which can also be accessed directly by patients, provide mental
health, family planning and other specialised care and treatment, usually funded through
Medicare or other government programs. 
Australians also visit dentists and other private sector health professionals of their
choice. Charges are met by the patients themselves, or with support of private health
insurance, which Australians may purchase for these or hospital services.
Patients can access public hospitals through emergency departments, where they may
present on their own initiative, or via the ambulance services, or after referral from a
medical practitioner. Admitted patients are charged nothing for their treatment, food or
accommodation, unless they choose private treatment. Emergency department and
outpatient services are free.
Australians may also choose to be Ôprivate patientsÕ in hospital, if they use a private
hospital, or choose to be treated as a private patient in a public hospital. Private patients
can choose their own doctor, but the hospitalÕs services, which include accommodation
and food, must be paid for by the patient, with or without the support of private health
insurance, or through other arrangements such as compensation. Medicare subsidises
the fees charged by doctors for services provided to private patients in hospitals, and
private health insurance funds also contribute towards medical fees for insured
patients. No-gap or known-gap arrangements are increasingly being agreed on between
hospitals and insurers.
The health service system is regulated in various ways. Private hospitals are licensed by
State and Territory Governments. Medical practitioners and other health professionals
are registered for practice in each State and Territory. The CommonwealthÕs regulatory
roles include overseeing the safety and quality of pharmaceutical and therapeutic
goods and appliances, and regulating the private health insurance industry.
In addition to the services outlined above, the Commonwealth, State and Territory
Governments and local governments provide public health services, community health
services and ambulance services. Public health services include activities to ensure food
quality, immunisation services and other communicable disease control, public health
education campaigns, environmental monitoring and control, and screening programs
for diseases such as breast cancer. 
Essential support to the health service system is given by many other agencies.
Research and statistical agencies provide the information needed for prevention,
detection, diagnosis, treatment, care and associated policy. Consumer and advocacy
groups contribute to public discussion and policy. Professional associations for medical
practitioners and other health professionals help set professional standards and clinical
guidelines. Universities and hospitals undertake training of undergraduate and
postgraduate health professionals. Voluntary agencies contribute in various ways,
including raising funds for research, running education and health promotion
programs, and coordinating voluntary care. 
Although they are not seen as part of the health system, many other government and
non-government organisations play a role because of their influence on health.
Departments of transport and the environment, the media and the food industry are
just a few examples. 
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2
 
The health of 
Australians
 
International comparisons show that Australians enjoy good health, and that the
underlying health trends are broadly in step with health improvements occurring
elsewhere, particularly in other developed countries (AIHW: de Looper & Bhatia 1998).
However, there are significant interpopulation differences in health outcomes within
Australia.
This chapter reports on the health status of Australians towards the end of the twentieth
century, and the diseases and conditions affecting them. 
There are five broad sections: 
 
2.1 Dimensions and components of health
 
 describes health using indicators such as
life expectancy, self-rated health status, fitness, sexual health, oral health and
immunological health. 
 
2.2
 
B
 
urden of disease and injury
 
 outlines aspects of morbidity, disability and
mortality in the Australian population. Results from the Australian Burden of
Disease and Injury study have been included to describe the contributions made by
various diseases and conditions to ill health, disability and premature mortality.
 
2.3 National Health Priority Area (NHPA) diseases and conditions
 
 reviews the
burden of diseases and conditions that have been accorded priority status for
action by Australian Health Ministers. The diseases and conditions covered are
cardiovascular diseases, cancers, injuries, mental disorders, diabetes and asthma. 
 
2.4 Other major chronic diseases and conditions
 
 details those chronic, non-
communicable diseases that are not currently the focus of the NHPA initiative, but
are large contributors to morbidity, disability and mortality in Australia. Some of
these diseases and conditions are likely to emerge as major health and wellbeing
concerns with the ageing of the population. 
 
2.5 Communicable diseases 
 
provides data on various infectious diseases including
gastrointestinal illness, HIV/AIDS, sexually transmitted diseases, blood-borne
infection, vaccine-preventable diseases and other infections in Australia. 
Determinants of health are not discussed in detail here, but are covered in chapter 3.
Similarly, the health of various population subgroups in Australia is described in
chapter 4.
 
2.1 Dimensions and components of health
 
The instinct for survival is the most basic of human traits, and therefore central to any
discussion of health. However, a view of health in terms of freedom from disease, with
a greater emphasis on body functions and structure, the ability to perform core
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activities and participate in society, is likely to provide further insight into variation in
health outcomes. This section provides brief overviews of various aspects of health, its
dimensions and components. 
As well as providing an assessment of life expectancy, there is an overview of health
status as rated by Australians themselves. The section also describes various
components of health in a modern settingÑphysical fitness, sexual health, oral health
and immunological health.
 
Life expectancy and longevity
 
Long life is a cherished goal for most people. For many Australians this goal is highly
achievable. Most Australians can now expect to live an average of 80 years, a large
proportion of these as healthy years. 
Significant increases in life expectancy have occurred throughout the twentieth century.
Reductions in infant and child mortality have been the most significant contributors to
the increase in life expectancy at birth over the period (ABS 1998c). However, more
recently, significant gains in life expectancy occurred following reductions in death
rates among the elderly, especially for diseases of the circulatory system, such as heart
disease and stroke. These trends have important consequences. Not only do they
increase the proportion of the population reaching an advanced age, but they also
influence the health, disease and disability patterns in a population. 
Longevity is much more valuable if it is accompanied by freedom from suffering, pain or
disability. The growing prevalence of chronic diseases and disabilities has brought into
focus the need to seek a balance between the length and quality of life (WHO 1997).
 
Life expectancy in Australia
 
Most Australians can expect to live relatively long and healthy lives. An Australian boy
born between 1996 and 1998 can expect to live, on average, 75.9 years, and a girl born in
the same period can expect to live 81.5 years (ABS 1999a). These estimates assume that,
over the lifetime of these individuals, the death rates at various ages will not deviate
from the rates obtained in 1996Ð98. However, if the age-specific death rates decrease
further, then the life expectancy achieved by these individuals will be more than that
estimated from current life tables.
A corollary to the above observation is that at higher ages total life expectancies are
greater than those obtained at birth. Surviving early years of life adds years to the
balance of life expectancy (Insel & Roth 1988). For example, for males aged 65 in
1996Ð98, the expected number of remaining years of life is 16.3, a total life expectancy of
81.3 years. For females aged 65 in 1996Ð98, this figure is 20.0 years or a total of
85.0 years (ABS 1999a). 
Life expectancy is not uniform across population groups. Some groups in the
population, such as those who are socioeconomically disadvantaged and Aboriginal
and Torres Strait Islander peoples, have lower life expectancy than the national average.
The most socioeconomically disadvantaged in society, for example, are expected to live
about 3 years less than those most advantaged (AIHW: Mathers et al. 1999a). But the
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greatest difference is in relation to the life expectancy for Aboriginal and Torres Strait
Islander peoples. Indigenous persons born in 1996Ð98 are expected to live about
20 years less than the rest of the Australian population (ABS & AIHW 1999).
Life expectancy also shows regional variation. Based on 1996Ð98 data, life expectancy at
birth in the Northern Territory was the lowest for both sexes, considerably lower than
the overall Australian levelsÑ5.3 years lower for males and 6.5 years lower for females
(Table S11, page 371). These differences largely reflect the higher death rates in the
Indigenous populations, which constitute a large proportion (29%) of the population in
the Northern Territory (ABS 1999a). In other States of Australia, male life expectancy
ranges from 75.1 years in Tasmania to 77.5 years in the Australian Capital Territory, and
female life expectancy ranges from 80.4 years in Tasmania to 81.9 years in Western
Australia. 
Life expectancy for both males and females has increased considerably over the last 100
years. Since 1901, life expectancy at birth increased by 38% (from 55.2 years) for
Australian males and by 39% (from 58.8 years) for Australian females. Trends in life
expectancy are discussed in more detail in chapter 8.
 
International comparisons
 
Australians enjoy some of the highest life expectancies in the world. In 1995, the highest
male life expectancies at birth were recorded in Iceland (76.5 years) and Japan
(76.4 years), and the highest female life expectancies were recorded in Japan (82.9 years)
and France (82.6 years). Australian life expectancy at birth is similar to that estimated
for countries such as Canada, Norway, Spain, New Zealand, the United Kingdom and
the United States (Figure 2.1). 
The countries compared in Figure 2.1 are all from more developed regions of the world.
The life expectancies of less developed countries are considerably lower. Regions
defined by the United Nations as being made up of less developed countries
(i.e. countries outside Europe, North America, Australia, Japan and New Zealand) have
an overall life expectancy of 64 years, compared with 75 years for developed regions.
The African continent has the lowest life expectancy at birth of 52 years (Population
Reference Bureau 1999).
 
Self-reported health
 
PeopleÕs perception of their own health has been shown to be a powerful, independent
predictor of their survival in several populations (see, for example, Mossey & Shapiro
1982, Kaplan & Camacho 1990, and Idler et al. 1990). Although some inconsistency
between the results of different studies suggests that this is not equally true of all
populations, Australian studies have demonstrated the link between self-reported health
and subsequent health outcomes, at least for older Australians (McCallum et al. 1994).
This section discusses how Australians rate their own health and wellbeing, based on
self-assessed health status and the physical and mental health component summary
(PCS and MCS) scores derived from the SF-12 questionnaire (Ware et al. 1996Ñsee
Box 2.1, page 14). These summary scores were originally developed from the longer
SF-36 health survey questionnaire and are intended to represent independent measures
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of mental and physical health, with higher scores indicating better health. There is some
evidence that results relating to physical health may affect the MCS score and vice versa
(see Box 2.1, page 14). 
The results presented here are based on data from the 1997 National Survey of Mental
Health and Wellbeing of adults (persons aged 18 years and over), conducted by the
Australian Bureau of Statistics (ABS).
 
(a) Philippines 1991; Ireland, Italy 1993; France, Iceland, Norway, Spain, USA 1994; Singapore 1996; 
Lebanon 1990–95; Malaysia 1990–96; New Zealand 1992–94; Switzerland 1994–95; Australia 1995–97.
 
Sources:
 
 ABS 1998c; UN 1998; WHO 1998.
 
Figure 2.1: Life expectancy at birth, selected countries, 1995
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Self-assessed health status
 
Just over half (57%) of people aged 18 years and over reported their overall health as
excellent or very good, and a further 28% reported that they were in good health.
Proportions were similar for the two sexes. The remaining 15% rated their health as
either fair or poor. In interpreting, these findings, note that some of those in poorer
health were excluded from the surveyÑfor example, people living in institutions such
as hospitals and nursing homes were not included.
Self-assessed health status is strongly related to age. The proportions reporting excellent
or very good, good, and fair or poor health remained relatively unchanged up to the
age group 35Ð44 years. At ages over 44 years, the proportion reporting excellent or very
good health declined with increasing age, from 66% at ages 35Ð44 to 37% at ages 75 and
over, while the corresponding proportion reporting fair or poor health increased from
10% to 33% (Figure 2.2). 
 
PCS and MCS scores
 
The PCS score declines steadily with age for both males and females, whereas the MCS
score is higher at older ages than at younger ages (Figure 2.3). These patterns suggest
that whereas self-assessed physical health declines with age, self-assessed mental health
shows improvement. However, these findings should be interpreted with caution since
respondents with cognitive problems such as dementia, which mainly occur at older
ages, were excluded from completion of the SF-12 questionnaire. 
 
Box 2.1: SF-12 questionnaire and self-assessed health
 
The SF-12 questionnaire is a standard international instrument developed by the Medical
Outcomes Trust, Boston, USA (Ware et al. 1998). It contains 12 questions that provide a
generic measure of self-reported health status. 
The responses to various questions can be combined into a physical component summary
(PCS) score and a mental component summary (MCS) score. The PCS is taken as repre-
senting limitations in physical functioning, role limitations due to physical health prob-
lems, bodily pain and general health. The MCS focuses mainly on role limitations due to
emotional problems, social functioning, mental health and vitality (Ware et al. 1996). 
These summary scores were originally developed from the longer SF-36 health survey
questionnaire (Ware et al. 1994). The SF-12 questionnaire was designed as a shorter form
of the SF-36 questionnaire; nonetheless it closely reproduces the MCS and PCS scores.
Each score has a mean value in the general population of around 50, with a higher score
indicating better self-reported health and wellbeing. 
There is some evidence that the state of physical health may affect the MCS scores and vice
versa, probably because mental and physical health are to some extent interrelated (Simon
et al. 1998). However, they still provide useful summaries of self-reported physical and
mental health status (Ware et al. 1996). 
Self-assessed health was recorded with a question that asked respondents to rate their
health according to a 5-point Likert scale (excellent, very good, good, fair, poor). 
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Source:
 
 AIHW analysis of National Survey of Mental Health and Wellbeing data.
 
Figure 2.2: Self-assessed health status by age, 1997
 
Source:
 
 AIHW analysis of National Survey of Mental Health and Wellbeing data.
 
Figure 2.3: Mean physical and mental component scores by age and sex, 1997
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Variation in self-reported health status
 
The link between health status and socioeconomic status has been clearly demonstrated
in studies both in Australia and overseas (Wilkinson & Marmot 1998), with lower
socioeconomic status being associated with poorer health. The Australian Burden of
Disease and Injury Study shows a clear gradient in the total mortality burden with
socioeconomic disadvantage as defined by the ABSÕs Index of Relative Socioeconomic
Disadvantage (IRSD) at the statistical local area level (AIHW: Mathers et al. 1999a). The
study also shows a similar marked gradient in the disability burden of mental
disorders.
As expected, the proportion of people who reported their health as either excellent or
very good shows a marked trend across the socioeconomic disadvantage quintiles. It
rises from 49% for males and 53% for females in the first quintile (the most
disadvantaged) to 63% for males and 65% for females in the fifth quintile (the least
disadvantaged) (Figure 2.4). The pattern of poorer self-assessed health status with
increasing disadvantage is also reflected in the mean PCS scores and to a lesser extent in
the mean MCS scores (Figure 2.5). 
 
 
 
Note: 
 
Age standardised to the Australian population at 30 June 1991.
 
Source:
 
 AIHW analysis of National Survey of Mental Health and Wellbeing data.
 
Figure 2.4: Proportion of people reporting their health as excellent or very good by sex 
and socioeconomic status, 1997
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Fitness
 
Fitness can be broadly defined as the matching of an individual to his or her physical
and social environment. Through a combination of heredity and modifiable lifestyle
factors, an individual may acquire the attributes to carry out physical tasks with vigour
and alertness, and without undue fatigue in a specified physical, social and
psychological environment. This implies that fitness has both physical and mental
components that are largely modifiable. 
Traditionally, definitions of physical fitness have related only to the physical attributes
that are necessary for optimal sport or work performance in terms of an individualÕs
ability in an athletic competition, a performance test or occupation (Pate 1988; Gledhill
1990). Muscular strength, motor skills, power, endurance, body composition, body size,
motivation and nutritional status are thus important components of performance-
related fitness (Bouchard & Shephard 1994). In recent years, there has been an
increasing interest in the health-related aspects of fitness (Bouchard et al. 1997).
Mental fitness involves stimulating the mind through education, work and leisure, and
enables people to solve many of the challenges confronted throughout life
(Gringold 1999).
 
Note: 
 
Age standardised to the Australian population at 30 June 1991.
 
Source:
 
 AIHW analysis of National Survey of Mental Health and Wellbeing data.
 
Figure 2.5: Mean physical and mental component scores by sex and 
socioeconomic status, 1997
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Health-related fitness
 
Health-related fitness has been defined as a state characterised by (a) an ability to
perform daily tasks with vigour and (b) traits and capacities associated with a low risk
of development of diseases or conditions, where these diseases or conditions are related
to a sedentary lifestyle (Bouchard & Shephard 1994). 
The relationships between health-related fitness, participation in physical activity and
health are complex. Not only does physical activity influence health, but health status
also influences participation in physical activity and therefore level of fitness (Bouchard
& Shephard 1994). Further, a personÕs natural (genetic) level of fitness will influence
participation, and there is variation among people in their response to the same levels
of physical activity (Bouchard et al. 1997). In the general population, both performance-
related fitness and health-related fitness decline with increasing age, especially after
about age 35 (Smith & Gilligan 1989). 
Bouchard and Shephard (1994) have identified several components of health-related
fitness: morphological, muscular, motor, cardiorespiratory and metabolic fitnesses
(Box 2.2). 
 
Health-related fitness of Australians
 
Quantitative information on the health-related fitness of Australians is sporadic. A
National Health and Fitness Survey was conducted in 1985 on Australian school
children aged 7Ð15 years (Pyke 1987). More recently, a comparable survey was carried
out among New South Wales school children (Booth et al. 1997). The latter study shows
that about 25% of boys in Year 6, and around 30% of Year 8 and Year 10 boys, have low
aerobic capacity. 
Several components of health-related fitness were measured in adults from Adelaide in
the Pilot Survey of the Fitness of Australians (DASET 1992). The survey found higher
levels of cardiorespiratory fitness, better lung function, and better flexibility and muscle
 
Box 2.2: Components of health-related fitness
 
Sources: 
 
Bouchard & Shephard 1994; Bouchard et al. 1997.
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strength among those who were physically more active. Information on components of
health-related fitness has also been collected in the Risk Factor Prevalence Surveys
(conducted in 1980, 1985 and 1989) and the 1995 National Nutrition Survey. 
Data on the participation of Australian adults in physical activity were collected by the
ABS in 1998Ð99 (ABS 1999f). Although not a measure of fitness, around 15% of adult
Australians reported that they had participated in aerobics or fitness activities
sometime during the 12-month period prior to interview. Participation of Australians in
physical activity for health benefits is discussed further in chapter 3.
 
Oral health
 
Oral health refers to the health of a number of different tissues in the mouth, including
mucous membrane, connective tissue, blood vessels, nerves, muscles, bone, teeth and
periodontal structures. It also covers immunological, physiological, sensory and
digestive system aspects of human health. However, the term is used overwhelmingly
in relation to two specialised tissues of the mouth, namely the teeth and the periodontal
structures or gums.
Many different factors affect the oral health of a population and individual variation
therein, prominent among which are age, exposure to fluorides, dietary patterns,
preventive dental behaviours, smoking, alcohol consumption, stress, infection and
immunity, access to and use of preventive and dental restorative services, and attitudes
towards treatment preferences. The oral health of children in developed countries has
improved dramatically over the last several decades. Factors such as changes in
exposure to fluoride and disease control and management have contributed to this
improvement (AIHW: de Looper & Bhatia 1998).
The preservation or loss of teeth and periodontal structures starts early in life, and is a
life-long, cumulative process. Early improvements contribute to better outcomes later in
life. The loss of all teeth, or edentulism, increases with age, but has been decreasing
over time. The numbers of missing teeth in individuals with some natural teeth have
also been decreasing. For the individual, the loss of natural teeth is usually associated
with chewing difficulties, higher levels of discomfort during eating, personal
embarrassment, social isolation and the need for assistance. Decayed teeth are also the
cause of much morbidity and pain. 
 
Measurement of oral health
 
Indicators of oral health may be designed in terms of personal hygiene, dental
preservation and/or oral wellbeing, However, the outcomes are usually measured in
terms of dental morbidity and mortality such as the number of decayed, missing or
filled teeth (DMFT) or edentulism. Because of the highly pervasive nature of dental
caries and periodontal (gum) disease, it is necessary to measure not only the prevalence
but also the extent and severity of oral diseases.
An increasing proportion of Australian adults are retaining their natural teeth, with
recent significant falls in both adult DMFT scores and edentulism, due mainly to
effective preventive strategies and changes in disease management. However, both
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DMFT scores and the proportion of the population that are edentulous are
comparatively high for Australians when compared with other OECD countries
(AIHW: de Looper & Bhatia 1998).
 
Child oral health
 
The oral health of primary and secondary school children in Australia continues to
improve. Oral health in children is most often assessed by their dental decay experience
(or extent), expressed as a count of the number of teeth currently decayed, teeth
extracted as a result of having been decayed and teeth with fillings. The average
number of decayed, missing or filled teeth (dmft) in the deciduous dentition (ÔbabyÕ or
primary teeth) for children aged between 5 and 10 years declined markedly between
1989 and 1996 (Table S26, page 390). Reductions were greatest for the youngest age
groups. The average dmft of 5-year-old children reduced by 39.1%, from 2.07 to 1.26,
while for 10-year-old children the dmft score fell by 21.8%, from 1.88 to 1.47.
Disease experience in the permanent dentition (ÔadultÕ teeth) also declined between
1989 and 1996 (Table S27, page 390). By 1996, the DMFT score for 12-year-old children
had reduced by 42.3%, from 1.56 to 0.90. This is a considerable improvement on the
average score of 4.79 for 12-year-olds in 1977. 
Appreciable differences in disease in the deciduous and permanent dentition exist
across AustraliaÕs States and Territories, despite the general reduction in the level of
disease (Table S28, page 391). The average dmft score for 6-year-old children in 1996
was lowest in New South Wales (0.94) and the Australian Capital Territory (0.89) and
highest in Queensland (2.25). In the permanent dentition, average DMFT was lowest in
South Australia (0.47) and the Australian Capital Territory (0.56) and again highest in
Queensland (1.30). State and Territory differences may be a result of differences in
patterns of exposure to preventive factors such as water fluoridation, delivery system
organisation, the targeting of oral care and even the methodology used for collecting
oral health information. It is notable that, of the major cities in Queensland, only
Townsville has fluoridated drinking water (AIHW 1998a).
 
The changing pattern of children’s oral health
 
Over the last two decades, there has been a considerable increase in the proportion of
children with no caries (tooth decay). Between 1989 and 1996, there was an increase in
the percentage of 6-year-old children with no decayed, missing or filled teeth from
48.8% to 59.8%, and the percentage of 12-year-olds with no caries increased from 35.0%
to 51.4% in the same period (Figure 2.6). These figures represent an increase of 20.5%
and 46.9%, respectively, in the number of 6-year-olds and 12-year-olds without any
dental caries at each age. 
The burden of oral disease is increasingly concentrated in a minority of children. In
particular, there remains a significant proportion of children who present with a
considerable history of dental caries (Figure 2.7). The percentage of these high-risk
children has decreased only slightly in recent years. For example, the proportion of
6-year-old children with four or more decayed, missing or filled teeth reduced by only
3.7% between 1989 and 1996. 
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Source: AIHW Dental Statistics and Research Unit Child Dental Health Surveys.
Figure 2.6: Proportion of children with no decayed, missing or filled teeth by age, 
1989 to 1996
Source: AIHW Dental Statistics and Research Unit Child Dental Health Surveys.
Figure 2.7: Proportion of children with four or more decayed, missing or filled teeth 
by age, 1989 to 1996
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Children with the largest burden of oral disease are more likely to be of lower
socioeconomic status, reside in a rural area or be of Indigenous origin (Davies et al.
1997; Spencer et al. 1998; Gaughwin et al. 1999). In the Northern Territory in 1996,
Indigenous 6-year-old children had three times the number of clinically detectable
decayed teeth (2.10 on average) than non-Indigenous children (0.73 on average).
Therefore, although the caries experience of the general population of children has
improved significantly, there remain pockets of at-risk children who require further
targeting through oral health initiatives (AIHW DSRU: Armfield et al. 1999).
Oral health of young adults
Gains in oral health made in childhood need to be carried into adult years to continue
the improvement of oral health in the general population. Young adulthood may be a
period of greater risk of oral diseases as it is a time of change when people move into
new accommodation arrangements, relationships become established and economic
independence is attained (Young 1996). These changes may alter patterns of preventive
health behaviours and treatment service use by young adults. In addition, this age
group is noted for its risk-taking behaviours. 
The Adult Dental Programs Survey (AIHW DSRU: Brennan et al. 1995) indicated that
publicly funded patients in the 18Ð24 age group have the highest rates of oral surgery
(15% of visits), an average of slightly more than two decayed teeth and the highest rates
of temporary restorations (12% of visits), suggesting a strong presence of emergency
treatment. Brennan (2000) also found that in private practice extraction rates for dental
caries, infections of the tooth root or gum-related diseases were highest in patients aged
18Ð24 years.
A study in Adelaide in 1999 by Roberts-Thomson and Stewart examined 644 young
adults who were selected from the electoral roll. Figure 2.8 shows the distribution of the
number of decayed, missing and filled teeth (DMFT) due to dental caries from that
study. More than one in five adults (22%) had no clinical evidence of caries. The
distribution was positively skewed with a mean DMFT score of 3.66, and a median of
3.0 teeth with caries experience. 
However, over 10% of these young adults had a DMFT score of 8 or more. Persons with
the highest levels of tooth decay were more likely to be those who were disadvantaged
such as concession card holders, those who use public dental clinics, and those who had
not visited a dental professional in the previous 2 years. 
The mean DMFT of 3.66 was made up of 75% filled teeth, 19% of teeth with untreated
decay and 6% of teeth missing due to dental caries. About 29% of the young adults had
untreated decayed teeth, with an additional 31% with signs of early decay. Those with
untreated decay were more likely to be young adults who usually visit only for a
problem, who have not made a dental visit in the last 2 years and who are regular
smokers.
Note that the results presented here are from urban Adelaide with access to water
fluoridation, and would therefore tend to be an underestimation of national figures. For
the majority of young adults, the gains in oral health made in childhood are carried into
later years. However, for a minority, oral diseases remain a significant problem.
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Oral health of nursing home residents
Demographic changes and changing patterns of oral health are resulting in larger
numbers of older Australians who are increasingly dentate (have some of their own
natural teeth). To provide a better understanding of their oral health, a baseline study of
the oral health of nursing home residents was carried out in Adelaide in 1998 (Chalmers
et al. 1999). The mean age of participating residents was 83.2 years. Oral inspections were
completed for 224 residents. 
Two-thirds (66%) of participating residents were edentulous. Edentulous residents had
significant oral problems and treatment needsÑthey had lost a higher percentage of
body weight, they could eat fewer foods, their last visit to a dentist was more likely to
have been for a problem, and they were less likely to think they needed dental
treatment. Denture-related conditions of the mouth were prevalent, such as
inflammation of areas of the mouth covered by the denture (16.8%) and inflammation
of the corners of the mouth (18.5%). Up to 20% of residents owned dentures that were
not worn.
Dentate residents had an average of 11.9 teeth remaining, 18.9 missing teeth, and
1.1 retained roots (0.8 decayed and 0.3 sound retained roots). They had a mean of
1.1 decayed teeth and 3.8 filled teeth, for an average DMFT score of 23.7. 
Source: Adelaide Dental Study of Young Adults.
Figure 2.8: Distribution of dental decay in young adults aged 20Ð24 years, 1999
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Residents with a government concession card had significantly more missing teeth.
Residents without a government card, those taking 8 or more medications and those
who could eat most foods had significantly more filled teeth (Figure 2.9). Residents who
had been living at the nursing home for more than 3 years had significantly more
retained roots. Males had significantly more retained roots and decayed crowns
(Figure 2.10). Significantly more plaque/debris-covered surfaces were found in
residents who could not eat many foods. Residents with severe cognitive impairment
had more decayed teeth, more missing teeth, fewer filled teeth and many more plaque/
debris-covered surfaces. 
The prevalence of caries in the crown of the tooth and in the root was high in residents
of nursing homes. The mean number of decayed coronal surfaces (1.7) was greater than
the number of decayed teeth (1.1), indicating that multiple surfaces were affected on
some teeth. The mean number of filled coronal surfaces was 8.7, decayed root surfaces
was 1.5, and filled root surfaces was 1.1. Males had significantly more decayed coronal
and root surfaces; they also had more decayed root surfaces and significantly higher
new caries in crowns and roots. Residents who could not eat many foods had more
decayed coronal surfaces, less filled coronal and root surfaces and many more plaque/
debris-covered surfaces. More severely cognitively impaired residents had much higher
numbers of decayed coronal surfaces. 
Source: Chalmers et al. 1999.
Figure 2.9: Nursing home residents: tooth status by residentsÕ characteristics, 1998
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Plaque and tartar (calculus) accumulation was very high on residentsÕ teeth and
dentures. Over 25% of dentate and edentulous residents who wore dentures had
staining/debris accumulation on more than one-third of the denture surface. Residents
with significantly more plaque accumulation were those who could not eat many foods
and those who had been admitted to the nursing home more than 12 months
previously. Other residents with more plaque were those with a diagnosed dementia
and/or severe cognitive impairment, concession card holders, males, younger
residents, and the more functionally dependent. Tartar accumulation was highÑ63% of
sites assessed for loss of periodontal attachment had tartar present on probing.
Prevalence of mild to moderately deep gum pockets was common, but severe
periodontal disease was evident only in a small percentage (4.4%) of residents. 
Dentate residents had high treatment needs as determined by a dentist (Table 2.1,
page 26). They required a mean of 2.9 surfaces for restoration per resident. Normative
need for extractions was highÑ0.9 teeth per dentate resident. However, less than 25%
of residents perceived a need for dental treatment. 
Over 30% of dentate residents had unstable and/or unretentive upper dentures and
40% of edentulous residents had unstable and/or unretentive lower dentures. Over
20% of dentate residents had defects with their upper partial dentures. However,
residentsÕ perceived need for denture treatment was much lower than the normative
Source: Chalmers et al. 1999.
Figure 2.10: Nursing home residents: retained roots and decayed crowns by 
residentsÕ characteristics, 1998
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need. For example, based on clinical criteria, 68% of residents who required a new full
denture did not want it and 50% of residents who required a denture reline did not
want it.
Sexual health 
Sexuality is integral to physical and mental health. In addition to its reproductive
function, it influences a broad range of attitudes and social values. Sexual health,
therefore, refers not only to the health of reproductive organs but also to the
psychological, emotional and relationship aspects of sexual behaviour. 
Attitudes to sexuality, in particular to the reproductive purpose of sexual behaviour,
have changed considerably over the last several decades. Two major factors
contributing to this change are improved methods of, and greater access to,
contraception. Social and economic factors have also influenced the association between
sexual activity and reproduction.
For most people, sex is a positive and normal aspect of life. It is a means of
reproduction, as well as providing intimacy in relationships. For others, who experience
sexual dysfunction, sexual intimacy can be difficult and lead to emotional and relational
problems. There is also the problem of sexually transmitted diseases (STDs) or
unwanted pregnancy that can result from unsafe sex practices.
This section provides an overview of the sexual health of Australians, relating to
reproduction and contraception, sexual health status, sexual dysfunction and STDs. The
section on communicable diseases later in this chapter provides additional information
on STDs. Chapter 3 describes sexual health practices in Australia and associated risk
factors. The section on mothers and babies in chapter 4 covers the issues of pregnancy,
multiple births, abortion and perinatal deaths in greater detail. Information on
healthcare services in relation to sexual health in general, and reproduction in
particular, is included in chapter 5.
Table 2.1: Nursing home residents: dentate residentsÑ
treatment needs determined by dentist, 1998
Type of treatment
Mean number of teeth
requiring treatment
Restorations
For 1 surface 0.97
For 2 surfaces 0.41
For 3 surfaces 0.30
For 4 surfaces 0.04
Extractions 0.87
Preventive 0.33
Source: Chalmers et al. 1999.
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Reproduction
An important goal for many people is to have a family. However, the timing of starting
a family and the size of the family has changed substantially over the last 100 years. A
wide variety of contraceptive methods makes it possible for couples and individuals to
plan the number and timing of children. 
In 1998, around 246,000 women gave birth in Australia, with almost 250,000 live births
registered (the difference takes into account multiple births). The outcome of some
pregnancies is the birth of a stillborn child. A total of 1,336 stillbirths were registered in
1998 (ABS 1999c, 1999d). Crude birth rates have declined from 21.7 per 1,000 people in
1971 to 13.3 per 1,000 in 1998.
Medical assistance such as in-vitro fertilisation (IVF) and gamete intrafallopian transfer
(GIFT) have made it possible for people with fertility problems to have children. In
1997, almost 3,500 births were the result of assisted conception. This was an increase of
9.3% over the number of assisted-conception births in 1996 (AIHW NPSU: Hurst et al.
1999). 
Fertility
The average number of births per woman (the total fertility rate) has been declining in
Australia since the peak in 1961 (3.6 babies per woman). This is likely to be due to the
greater control women and men now have over reproduction. By 1998, the total fertility
rate had dropped to 1.76, below the replacement level of 2.1 babies per woman
(Figure 2.11). 
Source: ABS Cat. No. 3301.0 (various years).
Figure 2.11: Total fertility rate, Australia, 1921 to 1998
0
1
2
3
4
1920 1930 1940 1950 1960 1970 1980 1990 2000
Number of children per woman
Year
01 AH2000 body  Page 27  Thursday, June 1, 2000  3:06 PM
28  AustraliaÕs Health 2000
TRIM SIZE 175 mm Wide x 250 mm Deep
As well, child-bearing is being delayed until later in life. Major declines in the fertility
rate over the period 1978 to 1998 occurred among younger women. Births to teenage
mothers decreased by 38% over the period, to a rate of 18 births per 1,000 women aged
15Ð19 years. Over the two decades the fertility rate for women aged 20Ð24 years
declined by 48%, and for women aged 25Ð29 years by 23%. Conversely, between 1978
and 1998, the fertility rate for women aged 30Ð34 years increased by 46%, and for
women aged 35Ð39 years by 94% (ABS 1999c). 
Changes in fertility are a result of the interaction of many social and economic factors,
as well as health factors. These issues are beyond the scope of this report, but are
discussed in AustraliaÕs Welfare 1997 (AIHW 1997).
Contraception
Contraception is recognised as a preventive health measure because it offers protection
against unwanted pregnancy. 
Contraception methods are many and varied, and can be classified as non-surgical or
surgical. Non-surgical methods include withdrawal or periodic abstinence (rhythm or
natural method), condoms, the contraceptive pill, diaphragm, spermicides, douche, and
intra-uterine devices (IUD). Surgical methods are tubal ligation or hysterectomy in
women and vasectomy in men. Although the number of vasectomies has remained
steady over the past decade, the number of tubal ligations has dropped (Figure 2.12). 
The 1995 National Health Survey found that almost 40% of women aged 18Ð49 years
used the oral contraceptive pill, 19% used sterilisation and another 18% used condoms
for contraception (ABS 1998d). 
Not all contraception methods are infallible. Sterilisation has the lowest failure rate
(0.3%), followed by modern reversible methods such as IUD (4.4%) and traditional
methods such as periodic abstinence, withdrawal, diaphragm and condoms (16.4%)
(Handelsman 1995). 
Sexual health status
Sexual health status refers to the health of reproductive organs and problems relating to
pregnancy, the prevalence of sexual dysfunction and STDs. 
Health of reproductive organs and pregnancy
In 1998Ð99, the Bettering the Evaluation And Care of Health (BEACH) survey found
that female genital system problems accounted for 4.3% of the total number of health
issues managed by general practitioners (GPs). Most of these visits were for genital
check-ups or Pap smears (28%) and menopausal complaints (24%). Consultations
relating to pregnancy and family planning accounted for 2.8% of all health issues
managed. Such problems include pre/postnatal check-ups and consultations relating to
oral contraception. Male genital system problems accounted for 1% of all health issues
managed by GPs.
Statistics on hospital separations provide some information on morbidity related to
reproductive organs (both male and female), as well as complications of pregnancy.
There were 185,183 separations for diseases or disorders of the female pelvic organs and
genital tract (3.3% of all separations), with an average length of stay of about 2 days, in
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1997Ð98. There were 213,378 separations related to labour and delivery, 135,589
separations due to complications of pregnancy, 9,154 for complications of the
puerperium and 76,013 separations for pregnancy with an abortive outcome during
that period. Diseases of male genital organs accounted for 45,166 separations and an
average length of stay of about 3 days (AIHW 1999b). 
Sexually transmitted diseases
Many STDs are notifiable on a national basis, which means that any diagnosis of the
disease must be reported to the relevant State/Territory authorities. These reports are
then provided to the Commonwealth through the National Notifiable Diseases
Surveillance System (NNDSS). The diseases classified as sexually transmissible for
surveillance in the NNDSS are chancroid, chlamydial infection, donovanosis,
gonococcal infection, lymphogranuloma venereum and syphilis. Trends in the annual
number of notifications for chlamydia, gonococcal infection and syphilis are shown in
Figure 2.13, page 30. Trends in HIV infection and AIDS are discussed in section 2.5. 
Chlamydia is the highest reported STD, and is among the top five notifiable diseases in
Australia. In 1998, a total of 11,405 notifications were received for chlamydial infection,
a rate of about 88 cases per 100,000 population. The highest prevalence was recorded in
the age group 20Ð24 years, with 60% more notifications for females than males. The
Source: Commonwealth Department of Health and Aged Care, unpublished data.
Figure 2.12: Contraceptive medical procedures, 1985 to 1998
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incidence of chlamydia has been increasing over time, with an 80% increase in the rate
between 1991 and 1998. However, this increase may reflect increased rates of testing
and notification rather than any actual rise in prevalence. 
Notifications of gonococcal infection have also increased over this period. In 1998, there
were 5,428 notifications of gonococcal infection to NNDSS. The notification rate of
29 per 100,000 was higher than in recent years but still far below the rates recorded in
the 1970s and early 1980s (Thomson et al. 1999). Notification rates were the highest
among the age groups 15Ð19 and 20Ð24 years, and there were 50% more notifications for
males than for females.
A total of 1,689 notifications of syphilis were received in 1998, a rate of 9 per 100,000
population. This is a 29% increase in the rate compared with 1997, and a reversal of the
underlying trend since 1992. 
Other important diseases that are commonly or usually spread by sexual contact
include genital herpes, genital warts, trichomaniasis and parasitic infestations such as
pubic lice. However, these diseases are not subject to national notification. No
information on their incidence is available. 
Sources: Herceg et al. 1996; Thomson et al. 1999.
Figure 2.13: Trends in STD notifications, 1991 to 1998
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Knowledge 
Knowledge about the importance of contraception and protection against STDs is
perhaps most important for young adults, because this is the stage when most people
become sexually active and some have children. However, note that although having
the knowledge is necessary, it does not ensure that an individual will engage in safer
sexual practices.
Information on the knowledge that young people have about STDs is available from a
nationally representative sample survey of 3,550 students (Year 10 and Year 12)
conducted in 1997 by the Centre for the Study of Sexually Transmissible Diseases at La
Trobe University. Earlier, in 1992, the National Centre in HIV Social Research had
conducted a survey on the issue. The 1997 study found that there has been a shift over
the 5 years towards safer sexual practices, with significantly more young people using
condoms and having sex with fewer partners than in 1992. The survey also found that
condoms were the most common method, but substantial numbers of students were
using the pill, with some falsely believing that the pill also protects them against STDs
(Lindsay et al. 1997).
Education programs have been successful to the extent that young people are highly
informed about the transmission of HIV/AIDS. However, knowledge about other STDs
and blood-borne viruses is low. A most disturbing observation is that many students do
not see themselves at risk of becoming infected with an STD. A substantial minority of
young people continue to engage in high-risk practices such as having unprotected sex
with casual partners; it is estimated that 4% never use condoms with casual partners
and 28% use them only sometimes (Lindsay et al. 1997).
Immunological health
The immunological health of an individual depends on the bodyÕs ability to recognise
and effectively counter infection. People cannot survive without a functioning immune
system. The immunological mechanisms also contribute to or control a range of other
health outcomes. Several primary prevention strategies take advantage of these
mechanisms to improve immunological health, both at an individual level and at a
population level. 
Of the many defences that the human body has against infections, the most basic are
those that prevent the entry of micro-organisms into the body. These include the skin
and mucous membranes, and the secretions they produce which contain antimicrobial
proteins. Despite this, some micro-organisms manage to enter the body either directly
through wounds, sexual intercourse, breastfeeding, the placenta and blood transfusion,
or indirectly through contaminated food and water, infected insects and animal contact.
Following contact with an infectious micro-organism, the immune system protects the
body with an array of defences (see Box 2.3, page 32). The immunity developed
following recovery from an infection is known as naturally acquired immunity. This is
also known as active immunity, because it depends on an active response by the bodyÕs
own immune system. 
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Box 2.3: Development of immunity
The body protects itself against the entry of microscopic organisms with the skin, and with
chemicals exuded by the skin and by mucous membranes. If an infectious agent gets past
these barriers, it then encounters two cooperative defence mechanisms, non-specific and
specific immunity.
Non-specific immunity
Non-specific immunity depends mainly on white cells such as neutrophils and macro-
phages which are involved in phagocytosis (cell eating), and on natural killer cells which
are particularly important in the defence against viruses. The body also possesses a variety
of proteins capable of antimicrobial activity such as complements and interferons which
assist in the defence process.
Non-specific immune responses often involve an inflammation. An injury to tissue causes
chemical signals resulting in an increased flow of blood to the area and increased perme-
ability of the blood vessels, thus allowing phagocytes to leave the blood and enter the
infected area. The area around the injury becomes inflamed (hot and red). The pus that is
often seen in an infected injury is mainly dead cells and fluid leaked from small blood ves-
sels. An inflammatory response can involve the whole body. In severe infections injured
cells emit chemicals which cause the body to produce large numbers of white blood cells.
Some white blood cells produce pyrogens, molecules that raise the bodyÕs temperature. A
moderate fever inhibits the growth of some infectious organisms and speeds up the phago-
cytic processes described above. However, a very high fever may cause complications.
Specific immunity
The immune system learns how to distinguish between self and non-self early in its devel-
opment. Each kind of micro-organism, be it a virus, a bacterium, a fungus or a parasite,
contains macromolecules known as antigens. The body responds to these antigens in two
ways. 
The first way is by what is called cellular immunity, in which white blood cells known as
T lymphocytes destroy organisms carrying that particular antigen. The second way is by
humoral immunity, in which white blood cells known as B lymphocytes produce anti-
bodies. These antibodies bind to the antigen, and neutralise or inactivate the infectious
micro-organism. This mechanism also makes it easier for phagocytes (see above) to ingest
them. Antibodies defend the body against toxins and free bacteria and viruses found in
body fluids, whereas T lymphocytes defend the body against bacteria and viruses living
inside human cells as well as against fungi and parasites (Campbell 1993). 
Each antigen stimulates the production of a unique, appropriate immune response. In
addition, the immune system has a great diversity of lymphocytes and this enables it to
respond rapidly to many different types of micro-organisms. Furthermore, as people grow
older and over the years become exposed to a wider range of infectious micro-organisms,
the immune system develops memory. If the body encounters the same infectious organism
again, it is able to produce a quicker and stronger immune response to that antigen. The
individual will then suffer only a mild illness or have no symptoms at all. A person who
experienced an infection with a certain pathogen but shows no clinical symptoms on
renewed exposure to this pathogen is said to be naturally immune to that infection.
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Disease protection
The health outcome of an infection is influenced by many factors. These include the
ability of the micro-organism to produce disease among those exposed, the level of
severity of the disease it causes, the actual number of micro-organisms the person is
exposed to, and the level of natural or induced immunity in the host (Beaglehole et al.
1998). An infection does not necessarily lead to illness. The great majority of micro-
organisms to which people are exposed cause only mild symptoms or discomfort. There
is, however, a minority of organisms, such as those causing measles or cholera, which
can lead to severe illness and death if introduced into the body. 
The problem with natural immunity as a protection strategy against certain infections is
that some or many people will die of the disease caused by the infection. Only those
who survive the illness (mild or severe) would have acquired natural immunity.
Immunity, however, can be acquired artificially by the use of vaccines made from killed,
weakened or only small parts of the microbes that cause infection (Box 2.4, page 34). In
this way, a person can become immune to disease-causing micro-organisms without
having to suffer illness. 
Vaccination, however, is not without its risks. Although rare, some people may have a
severe reaction to a vaccination. However, at a population level, the risks of severe and
debilitating illness or death from the disease itself if people are not vaccinated are much
higher than the risk of an adverse reaction to a vaccine. For example, it is known from
experience that 1 in 25 children infected with measles will develop pneumonia and 1 in
2,000 will develop encephalitis (brain inflammation) (NHMRC 1997b). Of the children
who develop encephalitis, 10% will die and 40% will suffer permanent brain damage. In
addition, about 1 in 25,000 will develop subacute sclerosing panencephalitis (SSPE,
brain degeneration), a rare late complication of measles infection that is fatal (Elliott
et al. 1999). But for every million children vaccinated against measles, only one child
may develop encephalitis as an adverse reaction to the vaccination (NHMRC 1997b).
Immunity in the form of antibodies can also be transferred from one individual to
another, and this mechanism is known as passive immunity. This occurs naturally when
antibodies pass through the placenta from the mother to the foetus. Although these
antibodies last only for a few months, they nevertheless protect the infant against
diseases that the mother has been exposed to and possesses antibodies against. This
source of antibodies, together with antibodies in breast milk, is important in protecting
the infant from infections during the early months of life. 
Herd immunity
If a large proportion of individuals in the population is immune to a particular
infectious disease, then the general level of immunity in the population becomes
sufficiently high to minimise the spread of infections. Even if a small proportion of the
population is not immuneÑi.e. they remain susceptible to the diseaseÑtheir risk of
infection is much reduced because they are less likely to be exposed to the organism
and less able to pass it on to others. This outcome is called herd immunity. 
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If everyone or almost everyone in a population is immune or protected against disease,
it is possible to eradicate the disease completely. For example, as a result of a large and
extensive campaign of vaccination throughout the world, the infectious agent causing
smallpox was completely eradicated. An immunisation coverage of 90% to 95% is,
however, required to interrupt transmission of highly infectious diseases (Lister et al.
1999).
Herd immunity can be lost if an increasing proportion of the population does not
become immune. If a large pool of unprotected individuals exists, they can transmit the
infection and an outbreak or epidemic can occur as a result. Since some people either
cannot be vaccinated because of their medical condition or decline immunisation
perhaps because of their beliefs, it is important that as many people as possible are
vaccinated so that the herd immunity is maintained (Box 2.5). 
Box 2.4: Vaccination
Vaccines are either whole preparations of the infectious or toxic agents that have been
killed or modified (attenuated) so that they will not cause the disease, or antigen prepar-
ations from an infectious agent that have been purified (subunit vaccines). The immune
system may respond to this modified material resulting in immunological memory of that
particular organism. This immunity will protect the body on a subsequent encounter with
that infectious agent. Active immunisation has contributed to the control of nine major
infectious diseases which previously killed large numbers of children and adults: smallpox
(completely eradicated), diphtheria, tetanus, yellow fever, pertussis (whooping cough),
polio, measles, mumps and rubella (Moxon 1990). 
A way of urgently but temporarily protecting against disease is through passive immun-
isation. Antibodies can be transferred artificially from an individual or animal that has
been already vaccinated against the disease to a person who is in danger after being
infected. Tetanus in humans can be treated in this way because the infection can develop
rapidly and protection from a normal vaccination would take too long. The protection pro-
duced by passive immunisation is immediate but lasts only a few weeks. 
The protection offered by a vaccine (vaccine efficacy) is measured in clinical trials where
one group is given the real vaccine and another group (the control group) is left unvacci-
nated. Vaccine efficacy is the percentage reduction of the incidence of the disease among the
vaccinated compared with the unvaccinated or control group (Giesecke 1994). The term
ÔvaccinatedÕ refers to those who are injected with the vaccine, whereas ÔimmunisedÕ refers
to those in whom the vaccine actually brought about an immune response (NHMRC
1997b).
It has been possible to develop effective vaccines against many important microbial dis-
eases. Difficulties are encountered in the development of vaccines against several diseases
caused by parasites. Some of the obstacles are due to the complex life cycles of protozoan
parasites, and others are related to evasion mechanisms of the infectious microbes. These
include genetic variability of the organism and variability in the structure of its antigens
that would be targets of immune response mechanisms (influenza and HIV). In addition,
some parasites mimic host tissues to evade destruction by the immune system. 
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Monitoring immunisation levels
The herd immunity of a population can be monitored in several different ways. The most
useful indicator is an assay for antibody levels. This type of information is not currently
collected in Australia nationally. Another indicator of herd immunity is the extent of the
immunisation coverage. Although Australia has had a childhood immunisation program
since the 1920s, information on coverage was less than satisfactory until the
establishment of the National Notifiable Disease Surveillance Scheme (NNDSS) in 1991
and the Australian Childhood Immunisation Register (ACIR) in 1996 (Lister et al. 1999).
Box 2.5: Immunisation strategies
A knowledge of vaccine potency (efficacy), the duration of its effectiveness, factors influ-
encing the spread of infectious agents within a population and herd immunity all influence
immunisation strategies used against different diseases. Strategic issues include the pro-
portion of the population to be vaccinated and the age at which they should be vaccinated.
In general, the higher the infectivity of a micro-organism (reproductive potential), the
greater the degree of coverage needed to generate and maintain herd immunity. 
Other factors taken into account in developing immunisation strategies include the costs
and benefits of immunising people and an assessment of the risks if a person becomes
infected. For example, diphtheria and pertussis (whooping cough) cause high mortality
and serious consequences and only people vaccinated against them are protected. Vaccines
against diphtheria and pertussis are safe, highly effective and produce long-lasting immu-
nity. Thus the immunisation strategy for the two diseases is that everyone should be
immunised. 
In contrast, vaccines against cholera offer only short-term and incomplete protection.
Cholera is a serious disease, but in healthy people is rarely fatal, although it can kill children
and old people. Cholera is spread by poor sanitation and water supply, uncommon problems
in Australia. Cholera immunisation is therefore not routinely recommended in Australia. 
Many other diseases present risk to only certain individuals or groups in the population. In
Australia, these include meningococcal disease, pneumonia, influenza, hepatitis A, Q fever
and tuberculosis (NHMRC 1997b). Vaccination is recommended only for aged people,
healthcare workers, people with malfunctioning immune systems and those chronically ill,
i.e. people at increased risk of becoming infected or of suffering severe illness if they do.
Other vaccines are used to protect travellers against diseases that they are only likely to
come into contact with outside of Australia. These include vaccines against cholera, Japa-
nese encephalitis, typhoid, yellow fever, rabies and bat lyssavirus infections. When Aus-
tralian travellers are protected against infection, the Australian resident population is also
protected because vaccinated travellers are less likely to bring the infections back into the
country where they could spread further.
Vaccines used in the standard schedule of immunisation in Australia are diphtheria, tet-
anus, pertussis, measles, mumps and rubella, polio, Haemophilus influenzae type B
(Hib) and hepatitis B (NHMRC 1997b). All these vaccines are highly effective (range 84%
to 100%) (Hall 1998).
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Before the establishment of ACIR, which collects information directly from providers,
the ABS collected information on immunisation coverage by asking parents whether
their children had been vaccinated. The most recent ABS data suggest that only 52% of
children aged 0Ð6 years are fully immunised for their age, excluding Haemophilus
influenzae type B (Hib), 46% are partially immunised and the remaining 2% are either not
immunised or their immunisation status is unknown (ABS 1996a). Vaccination coverage
also varied by type of vaccine, age, State, socioeconomic status and country of origin. 
Reliable ACIR data will not be available until 2001 but preliminary analysis indicates
that the ABS surveys probably overestimate the degree of vaccination coverage
(McIntyre et al. 1998). 
Allergies, auto-immunity and immunodeficiency
High-quality immunological health requires fine regulation of the bodyÕs immune
system. In certain circumstances, however, the immune system may overreact to certain
antigens giving rise to allergies such as asthma. In other cases, and for reasons not yet
well understood, the immune system may fail to recognise the difference between the
body and the foreign agent, i.e. self and non-self, and react against the body cells
leading to a variety of auto-immune diseases. Examples include Type 1 diabetes and
rheumatoid arthritis. Lack of effective immune functioning also results from a variety of
immunodeficiencies such as AIDS.
There is a growing body of evidence that physical and emotional stress, including
depression, can reduce natural immunity (Olff 1999). This can happen either through
direct transmission of signals from the nervous system to the immune system, or
through hormones produced during stress and during pregnancy which can adversely
affect the immune system. It would appear that a sense of wellbeing and security,
including good mental health, mediated through the immune system, has beneficial
effects for health in general. 
Allergies
Allergic reactions can occur to such things as wasp and bee venom, particular drugs,
certain foods, plants, dust mites and pets or other animals. These substances are called
allergens. For example, hay fever occurs when the immune system reacts to pollen
allergens and becomes sensitised. Later exposure to the same allergen will cause a rapid
and vigorous immune response that includes the release of histamines and other
chemicals. The bodyÕs reaction to histamines causes the symptoms of the allergy,
sneezing, a runny nose and tears. If a reaction occurs in the tissues of the respiratory
tract, it can cause smooth muscle contraction leading to breathing difficulties (Kay &
Lessof 1992).
Allergies are also believed to be involved in the development of asthma, an increasingly
serious disease in Australia (Robertson et al. 1991). It is possible that allergens play an
important role in the sensitisation and persistence of T cell subsets responsible for
causing and maintaining the asthmatic condition. These cells occur in the lungs, and
continued exposure to allergens results in an immune response that causes the
obstruction of airflow in the lungs during an asthma attack (Kay 1997). 
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The rapid increase in asthma in developed countries has led some experts to suggest
that the absence of infections in childhood, due to improved hygiene and effective
childhood immunisation, is responsible for the persistence of an early life, immature
immune response. This is particularly the case in genetically susceptible individuals
(Abramson & Walters 2000). 
Auto-immunity
The failure of the immune system to distinguish between self and non-self leads to a
variety of auto-immune diseases, including:
¥ systemic lupus erythmatosus, in which people develop immunity against nucleic
acids released by the breakdown of normal cells (Bach & Koutouzov 1997); 
¥ rheumatoid arthritis, a crippling disease in which the immune system attacks the
cartilage and bone of joints; 
¥ Type 1 diabetes, which results from the destruction of the insulin-producing cells of
the pancreas; 
¥ rheumatic fever, where antibodies against streptococcus also react with heart muscle,
damaging heart valves; and 
¥ multiple sclerosis, believed to be caused by auto-immune responses to certain
components of the nervous system. 
The incidence, prevalence, morbidity and mortality associated with auto-immune
diseases are difficult to establish. These diseases may share a common aetiology, but are
expressed in a diverse range of illnesses and outcomes. A wide range of information is
collected on epidemiological aspects of these diseases, but the degree to which they are
classified as auto-immune in administrative collections varies. No consistent
categorisation of auto-immune diseases occurs, and this may underestimate their
burden on the community. 
Auto-immune diseases are responsible for significant illness, disability and activity
restriction in Australia. A major impact of these diseases is disability rather than
premature mortality. With the exception of Type 1 diabetes, auto-immune diseases are
more highly prevalent among females than males (Figure 2.14, page 38), and this
difference is reflected in hospital separation and mortality statistics (Table 2.2). 
Table 2.2: Hospital separations (1997Ð98) and deaths (1998) for selected diseases and 
conditions with large auto-immune components
Condition ICD-9 code(s)
Hospital separations Mortality
Males Females Males Females
Type 1 diabetes* 250 5,974 5,628 — —
Rheumatic heart disease 390–398 764 1,308 87 171
Rheumatoid arthritis 714 1,603 4,080 29 106
Multiple sclerosis 340 771 2,224 31 63
Systemic lupus 710.0 208 873 10 44
* Type 1 diabetes is not coded separately in mortality collections. 
Sources: AIHW National Morbidity Database and AIHW National Mortality Database.
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ImmunodeÞciency
Immunodeficiency arises through a variety of mechanisms. Some people are born with
defective immune systems. In other cases, cancerous cells may suppress or damage the
immune system. Some micro-organisms attack the immune system itself, leaving it
unable to protect the body against other micro-organisms. A good example of the latter
is infection with HIV, which causes weakness of the immune system leading to AIDS.
When damage to the immune system reaches a certain point, cellular immunity
collapses and opportunistic infections and diseases such as KaposiÕs sarcoma and
pneumocystis pneumonia can kill the host.
2.2 Burden of disease and injury 
The burden of disease refers to the impact on ÔhealthyÕ life of illness, injury, disability
and premature mortality. Illnesses and conditions present in Australia are described,
including estimates of their incidence and prevalence, using a range of data sources.
The section on mortality describes trends in death rates by cause of death and identifies
the contributions made by major diseases. A further section presents the results of the
Australian Burden of Disease and Injury Study which combined information from
various aspects of disease and injury into a single measure, disability-adjusted life years
(DALYs). 
Sources: AIHW National Morbidity Database; AIHW: Mathers et al. 1999a.
Figure 2.14: Prevalence of selected auto-immune conditions, 1996
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Mortality
This section describes the patterns of mortality in the Australian population in terms of
rate and cause of death, by age and sex. Trends in death rates over the period 1921 to
1998 are also described. Mortality differentials by socioeconomic status, country of
birth, ethnicity and remoteness are discussed in chapter 4. 
Mortality patterns
In 1998, there were 127,194 deaths recorded in Australia, consisting of 67,066 male
deaths (758 per 100,000) and 60,128 female deaths (468 per 100,000). Deaths of persons
aged 70 years and over accounted for 70% of all deaths, 20% occurred at ages
50Ð69 years, 8% at ages 20Ð49 years, and 2% at ages less than 20 years. 
Major causes of death by life stage
The major causes of death in various age groups in 1998 were as follows:
¥ The main underlying causes of deaths in infants (those aged less than 1 year) were
congenital anomalies, respiratory conditions and sudden infant death syndrome
(SIDS) (also see section 4.1). 
Box 2.6: Comparing death rates
Statistics relating to deaths are easily presented as crude death rates, i.e. the number of
deaths in a year divided by the number of individuals in the corresponding population. For
example, the crude death rate in Australia in 1998 was 680 deaths per 100,000 population.
However, since the risk of dying varies greatly with age and sex, even minor variations in
the age and sex structure of a population may affect crude death rates. This makes compar-
isons between different populations and analysis of time trends in the same population
erroneous. One way around this difficulty is to compare age-specific death rates, i.e. mor-
tality at particular ages for each sex, but this entails a separate comparison or analysis for
each age group. Interpopulation or temporal variations in age structure, however, can be
adjusted by a simple statistical procedure called age standardisation. 
In this report, unless otherwise specified, death rates have been directly age standardised to
the Australian population as at 30 June 1991 (ABS 1993b). Both AIHW and ABS have
agreed to adopt this as the national standard until population estimates for 30 June 2001
become available. The population at 30 June 1991 was the standard used in the 1996 and
1998 editions of AustraliaÕs Health, whereas the 1992 and 1994 editions used the popul-
ation at 30 June 1988 as the standard. For this reason, age-standardised death rates in this
publication cannot be directly compared with those in the 1992 and 1994 editions.
The major causes of death are typically coded according to the International Classification
of Diseases (ICD) system, Version 9 (WHO 1977). The ICD-9 classification categorises
diseases into sixteen broad groupings or chapters on the basis of type of condition or body
system. Causes of death can be further disaggregated either on the basis of similar disease
aetiology (e.g. infectious diseases or cancers), or into specific disease entities (e.g. tubercu-
losis, breast cancer or AIDS). 
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¥ In children aged between 1 and 14 years, motor vehicle traffic accidents, congenital
abnormalities, leukaemia and drowning were the most frequent underlying causes
of death. 
¥ Among those aged 15Ð24 years, deaths from motor vehicle accidents, suicide and
drug dependence were the most common. 
¥ Suicide, motor vehicle accidents, ischaemic heart disease (IHD), deaths due to the use
and abuse of drugs of dependence, and breast cancer (in females) were the major
causes of death among those aged 25Ð44 years. 
¥ Among those aged 50 years and over, the most common causes of death were
generally the same as for the total populationÑIHD, cerebrovascular disease or
stroke, lung cancer, bowel cancer, cancer of the breast (females) and chronic
obstructive pulmonary disease (COPD). 
Trends in major causes of death, 1921 to 1998
In 1998, seven major causes of death stood out when ranked by the number of deaths.
These were: IHD, cerebrovascular disease or stroke, lung cancer, colorectal cancer,
COPD, and breast and prostate cancers (Table 2.3). Trends in death rates for these major
underlying causes over the period 1921 to 1998 are shown in Figures 2.15 and 2.16,
page 41.  
Table 2.3: Leading causes of death by number of deaths and sex, 1998 
Males Females
Cause of death No. Cause of death No.
1 Ischaemic heart disease (410–414) 15,021 1 Ischaemic heart disease (410–414) 12,801
2 Lung cancer (162) 4,821 2 Cerebrovascular disease (430–438) 7,170
3 Cerebrovascular disease (430–438) 4,812 3 Dementia and related disorders 
(290, 294.1, 331)(a)
2,579
4 Chronic obstructive pulmonary disease 
(416.0, .8, .9, 490–492, 495–496)
3,325 4 Breast cancer (174) 2,542
5 Colorectal cancer (153, 154) 2,579 5 Colorectal cancer (153, 154) 2,165
6 Prostate cancer (185) 2,530 6 Lung cancer (162) 2,053
7 Suicide (950–959) 2,150 7 Chronic obstructive pulmonary disease 
(416.0, .8, .9, 490–492, 495–496)
2,026
8 Cancer of lymphatic tissue (200–208) 1,870 8 Cancer of lymphatic tissue (200–208) 1,600
9 Diabetes (250) 1,424 9 Diabetes (250) 1,327
10 Dementia and related disorders 
(290, 294.1, 331)(a)
1,294 10 Pneumonia (480–486)(a) 937
(a) Data are for 1996, as data for 1997 and 1998 are not comparable with previous years following the introduction of 
automatic coding by the Australian Bureau of Statistics in 1997.
Note: Codes refer to the International Classification of Diseases, 9th revision (ICD-9).
Source: AIHW National Mortality Database.
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Ischaemic heart disease is the biggest cause of death in Australia. In 1998, there were
171 deaths per 100,000 males and 93 deaths per 100,000 females with IHD as the
underlying cause of death. 
IHD death rates climbed steadily from 1940 to 1968 (AIHW: dÕEspaignet 1993). Since
then, the rates have declined steadily, by 3.6% in males and 3.0% in females per annum.
The decline has been steeper over the past 5 years (1994 to 1998), with death rates
declining annually by 5.4% in males and 5.5% in females. 
The reduction in IHD death rates is believed to be due mainly to prevention, notably:
¥ reduction in the prevalence of smoking 
¥ control of blood pressure 
¥ reduction of saturated fats in the diet
¥ improved management of the disease including the use of anti-hypertensive drugs
and medical interventions. 
Notes
1. The time series for ischaemic heart disease begins in 1968 due to coding changes between the ICD-8 and 
previous versions of the ICD.
2. The time series for chronic obstructive pulmonary disease (COPD) breaks at 1979 due to coding changes 
between the ICD-9 and previous versions of the ICD.
Source: AIHW National Mortality Database.
Figure 2.15: Trends in major causes of death, males, 1921 to 1998
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Cerebrovascular disease or stroke is the second biggest underlying cause of death, with
56 deaths per 100,000 males and 51 deaths per 100,000 females in 1998. 
Death rates for stroke increased over the first half of the century, but began to slow
down between 1950 and 1970. The rate peaked in the early 1950s in females, and in the
late 1960s in males. Since 1970, death rates for stroke have declined annually by over
4.6% in males and 4.9% in females. As with IHD, changes in lifestyle and improvements
in the management of the disease are considered to have contributed to the decline in
these death rates. 
Lung cancer is the leading cause of cancer deaths in Australia, with 53 deaths per 100,000
males and 19 deaths per 100,000 females in 1998. 
Between 1940 (when lung cancer was identified as a specific cause of death) and 1982,
the death rate for lung cancer in males increased steadily. The rate has since declined,
1.7% annually, with a more rapid decline over the 5-year period commencing in 1993.
The death rate for lung cancer in females also increased during 1940 to 1967, but at a
rate lower than that in males. But, unlike males, the overall death rate for lung cancer in
Notes
1. The time series for ischaemic heart disease begins in 1968 due to coding changes between the ICD-8 and 
previous versions of the ICD.
2. The time series for chronic obstructive pulmonary disease (COPD) breaks at 1979 due to coding changes 
between the ICD-9 and previous versions of the ICD.
Source: AIHW National Mortality Database.
Figure 2.16: Trends in major causes of death, females, 1921 to 1998
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females has continued to rise, more steeply in the period 1967 to 1993. However, since
1993, the death rate for lung cancer in females has been relatively stable, albeit
decreasing slowly at a rate of 0.3% per annum. 
The main risk factor for lung cancer is tobacco smoking, which is considered to be
responsible for over 85% of lung cancer deaths (DHFS & AIHW 1998a). Lung cancer can
take up to 20 years to develop, and given this timelag, the overall trend in lung cancer
death rates in Australia follows the trend in tobacco smoking 20 years earlier. There has
been a definite decline in the prevalence of tobacco smoking since the mid-1970s
(AIHW: Waters & Bennett 1995). This decline has been more substantial in males than in
females, but the underlying trend may now be plateauing (Hill et al. 1998). 
Colorectal cancer is the second most common cause of cancer deaths, with rates of 29 per
100,000 males and 20 per 100,000 females in 1998. 
Colorectal cancer death rates have fluctuated over the last several decades. The rates
increased slightly, in both sexes, from 1921 until the early 1940s. However, the death
rate in males decreased from 1940 until the mid-1960s, before increasing again until the
early 1980s. During the period 1942 to 1998, the death rate decreased by 0.8% per
annum for males, and by 0.7% per annum for females. However, since 1993, the death
rate for colorectal cancer has been decreasing at faster rates, 2.5% per annum in males
and 1.8% in females. 
The decrease in colorectal cancer death rates has resulted from a combination of factors:
reductions in disease risk through improved diet (less fat, more cereals and vegetables,
reduced alcohol consumption), more timely diagnosis (faecal occult blood tests and
colonoscopy) and improved clinical management (Ireland & Giles 1993). 
Breast cancer is the fourth leading cause of cancer deaths, and the most common cause of
cancer deaths among females. In 1998, there were about 23 deaths per 100,000 females.
The death rate for breast cancer peaked in the early 1940s, having increased slowly since
1921. Between 1940 and 1950 the rate decreased, but between the 1950s and mid-1980s it
remained relatively stable. From 1985 to 1998, the overall rate declined by 1.0% per
annum. Since 1993, the decline has been more pronounced, at 3.3% per annum. The
death rate for breast cancer is expected to continue declining over the next 10 to 20 years.
Prostate cancer is a major cause of death in older men, with 83% of the prostate cancer
deaths occurring in males over the age of 70. In 1998, the death rate for prostate cancer
was 29 per 100,000 males.
Since 1921, the death rate for prostate cancer has been increasing slowly. The early 1990s
saw a high rise in the death rate for prostate cancer, with some of this increase
attributed to improved diagnosis. However, over the past 5 years to 1998 the rate has
been decreasing by 4.5% per annum.
Chronic obstructive pulmonary disease is a major cause of death, reflecting long-term
damage to the respiratory system. Chronic bronchitis and emphysema are the two main
diseases included in this group, usually caused by, or related to, smoking. In 1998, there
were about 38 deaths per 100,000 males and 17 deaths per 100,000 females with COPD
as the underlying cause. 
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Death rates for COPD have followed a pattern similar to those for deaths from lung
cancer in both males and females. COPD death rates in males increased steadily from
the early 1950s, peaking in 1970. In the period 1970 to 1998, the male death rate declined
by 1.9% per annum, and since 1993 the decline has been 6.0% per annum. In females,
the overall COPD death rate increased between 1960 and 1998, at almost 4.5% per
annum. Since 1996, however, there has been little decline in the COPD death rate
among females.  
Multiple causes of death 
Use of mortality data in understanding disease processes has been limited until recently
by having information on only the single underlying cause of death. However, since
1997 the ABS has been coding multiple causes of death information from death
certificates. In 1998, more than one cause of death was listed on 71.5% of death
certificates. In more than a half of these deaths, at least three causes of death were listed.
This additional information is potentially very useful for understanding, through
disease-association and co-morbidity studies, the role of various factors contributing to
death. For example, of the 15,024 male deaths in 1998 with IHD as the stated underlying
cause of death, IHD was recorded as the sole cause of death in only 13% of cases. Heart
failure was listed as an additional cause of death in 16.5% of cases with IHD as the
underlying cause of death and hypertensive disease in 14.1% of cases. Another common
cause of death associated with IHD deaths was diabetes (9.1%). There were similar
associations for IHD deaths in females (Table 2.4). 
Illness, morbidity and health conditions
This section provides a brief overview of the incidence and prevalence of the most
common illnesses (morbidity) and health conditions in Australia. Information from
several different sources, including population surveys, GP visits and hospital
separations, can be used to generate a profile of the extent of illness in the community.
The prevalence of illness in the population, as determined by the National Health
Table 2.4: Additional causes of death associated with ischaemic heart disease as the 
underlying cause of death, 1998
Cause of death Additional cause of death
Males Females
Number Per cent Number Per cent
Reported alone  1,958  13.03  1,239  9.68
Reported with Cancer  1,035  6.89  538  4.20
Diabetes  1,366  9.09  1,130  8.83
Hypertensive disease  2,117  14.09  2,342  18.30
Heart failure  2,480  16.51  2,927  22.87
Cerebrovascular disease  1,097  7.30  1,184  9.25
Diseases of blood vessels  1,543  10.27  1,234  9.64
Pneumonia and influenza   573  3.81   541  4.23
Chronic obstructive pulmonary disease  1,716  11.42  1,037  8.10
Nephritis  1,018  6.78   798  6.23
Total deaths  15,024  12,801
Source: ABS 1999a.
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Surveys (NHS), is briefly described below. Profiles of illness and morbidity, based on
general practitioner (GP) visits and hospital separations, are described in chapter 5. For
more details on actions taken in response to ill health, based on 1995 NHS data, see
AustraliaÕs Health 1998.
The scale of the problem
About 85% of Australians report having an illness or condition either as a recent illness
in the previous 2 weeks or as a long-term condition. Three out of four persons also take
some form of health action in relation to their health in any 2-week period, with about
60% taking some form of medication other than vitamins and minerals and
approximately one out of five consulting a doctor (ABS 1997b). In addition, some 9% of
the employed population report taking days off work due to illness, most commonly
for respiratory illnesses such as influenza, in any 2-week period (ABS 1997b). 
These figures may suggest that a large proportion of the Australian population does not
enjoy Ôfull healthÕ at all times. However, while many chronic or more serious conditions
are reported, these figures also include minor and temporary conditions, as well as
conditions under control. 
Recent and long-term conditions
According to the 1995 NHS, 65% of males and 73% of females reported experiencing
one or more recent illnesses. Diseases of the respiratory system were the most common
recent illnesses, reported by 22% of the population in 1995. The most frequently
reported respiratory conditions were asthma, the common cold and influenza. Other
commonly reported recent illnesses were headaches (13%), diseases of the circulatory
system (12%), and diseases of the digestive system (11%).
Around three-quarters of the population (73% of males, 76% of females) reported
having one or more long-term health conditions (conditions experienced for 6 months
or more). Sight conditions were the most common long-term conditions reported; for
example, 21% were far-sighted, 20% were short-sighted, and 14% had other sight
disorders of refraction and accommodation. Other commonly reported long-term
conditions were arthritis (15%), hay fever (14%), asthma (11%) and hypertension (10%).
Disease incidence and prevalence
The Australian Burden of Disease and Injury Study has produced comprehensive
estimates of incidence, prevalence and average duration for a large number of diseases
and injuries and their disabling effects for Australians in 1996 (AIHW: Mathers et al.
1999a). The estimates synthesise the available information from the most appropriate
sources for each condition.  
Table 2.5 (page 46) contains estimates of the total number of prevalent cases of the most
common diseases and injuries in Australia for 1996. Dental caries (tooth decay) was
estimated to be the most common health problem in Australia, with an average of
almost one decayed tooth per person at any one point of time. The next most common
problem was hearing loss; nearly 17% of the population are estimated to have hearing
loss of a level sufficient to cause problems in conversations with more than one person.
Edentulism or total tooth loss (nearly 8% of the population) and asthma (with a
prevalence of nearly 7%) were the other major problems. 
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Table 2.5: Most prevalent health conditions, 1996
Condition(a)
Prevalence(b)
Prevalence (%)Persons Males Females
1 Dental caries(c) 19,014,000 9,567,000 9,447,000 —
2 Hearing loss 3,088,300 2,245,800 842,500 16.9
3 Edentulism 1,396,700 392,400 1,004,300 7.6
4 Asthma 1,206,100 533,900 672,200 6.6
5 Periodontal disease(d) 1,027,200 494,700 532,500 5.6
6 Iron-deficiency anaemia 769,400 275,800 493,600 4.2
7 Alcohol dependence & harmful use 727,800 538,500 189,300 4.0
8 Osteoarthritis 625,000 241,500 383,500 3.4
9 Chronic back pain 585,800 300,500 285,300 3.2
10 Depression(e) 538,000 163,900 374,100 2.9
11 Type 2 diabetes 469,400 247,400 222,000 2.6
12 Slipped disc(f) 340,100 214,000 126,100 1.9
13 Urinary incontinence(g) 307,200 50,200 257,000 1.7
14 Chronic obstructive pulmonary disease 296,600 177,100 119,500 1.6
15 Social phobia(h) 291,100 130,000 161,100 1.6
16 Generalised anxiety disorder(h) 285,600 106,100 179,500 1.6
17 Fires/burns/scalds(i) 231,200 154,000 77,200 1.3
18 Benign prostatic hypertrophy(j) 195,400 195,400 — 1.1
19 Peptic ulcer disease 174,100 78,700 95,400 1.0
20 Attention-deficit disorder 173,200 125,200 48,000 0.9
21 Cannabis dependence/abuse 171,000 128,700 42,300 0.9
22 Cataracts 168,800 48,400 120,400 0.9
23 Angina pectoris 168,100 90,500 77,600 0.9
24 Osteoporosis 155,200 29,100 126,100 0.8
25 Bipolar affective disorder 133,400 67,900 65,500 0.7
(a) Prevalence has not been estimated for infectious diseases (apart from HIV/AIDS) or for cancers, congenital anomalies 
and maternal conditions related to pregnancy and childbirth. These diseases are not included in the rankings, but 
would not appear in the top 25 prevalent conditions.
(b) Prevalent cases of disease or injury, except where otherwise specified. Some prevalence estimates are derived from 
modelling of incidence and duration and assume a stationary population with no trends in incidence rates or average 
duration. All prevalence estimates rounded to nearest 100.
(c) Prevalence estimates relate to total decayed teeth (excluding missing and filled teeth), not to people with decayed 
teeth.
(d) Periodontal disease with pockets 6 mm or more deep.
(e) Prevalence estimates relate to people with dysthymia or experiencing a major depressive episode in the 12-month 
period of 1996.
(f) Prevalence refers to number of people with chronic conditions.
(g) Moderate and severe urinary incontinence (leaking urine occurring ‘often’) not due to neurological disorders, stroke, 
prostate problems or other diseases or injury.
(h) People experiencing symptomatic episodes in the 12-month period of 1996.
(i) Prevalence estimates include only people with long-term effects of injuries.
(j) Symptomatic benign prostate enlargement resulting in treatment.
Source: Australian Burden of Disease and Injury Study.
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Table 2.6 contains estimates of the total number of new cases of the most common
diseases and injuries occurring in Australia in 1996. The condition with the highest
incidence was upper respiratory tract infection (colds, acute sinusitis, tonsillitis, etc.).
Table 2.6: Most common new health conditions, 1996
Condition(a)
Incidence(b) Incidence per
1,000 populationPersons Males Females
1 Upper respiratory tract infections 43,399,200 20,794,600 22,604,600 2,370
2 Dental caries(c) 10,877,800 5,432,300 5,445,500 594
3 Chronic back pain 6,035,300 3,141,100 2,894,200 330
4 Diarrhoeal diseases 3,754,200 1,863,400 1,890,800 205
5 Lower respiratory tract infections 3,480,200 1,589,100 1,891,100 190
6 Otitis media 1,018,500 478,200 540,300 56
7 Periodontal disease(d) 399,700 195,300 204,400 22
8 Depression(e) 376,700 115,400 261,300 21
9 Falls(f) 359,141 175,070 184,071 20
10 Non-melanoma skin cancers 282,825 167,751 115,074 15
11 Alcohol dependence & harmful use 161,482 120,162 41,320 9
12 Peptic ulcer disease 156,045 73,199 82,846 9
13 Slipped disc(g) 143,489 83,769 59,720 8
14 Hearing loss 111,484 70,212 41,272 6
15 Menstrual problems(h) 106,952 — 106,952 6
16 Road traffic accidents(f) 88,139 54,711 33,428 5
17 Diverticulitis(i) 77,117 34,676 42,441 4
18 Separation anxiety disorder 73,199 37,505 35,694 4
19 Sports injuries(f) 70,732 52,157 18,575 4
20 Asthma 69,434 32,048 37,386 4
21 Gall bladder and bile duct disease(i) 66,132 21,309 44,823 4
22 Stroke 57,244 26,488 30,756 3
23 Benign prostatic hypertrophy(j) 53,752 53,752 — 3
24 Interpersonal violence(f) 47,585 36,343 11,242 3
25 Angina pectoris 44,548 28,468 16,080 2
(a) Incidence of iron-deficiency anaemia has not been estimated.
(b) Incident (new) cases of disease or injury occurring in Australia in 1996, except where otherwise specified. Some 
incidence estimates are derived from modelling of prevalence, case-fatality and remission rates and assume a 
stationary population with no trends in incidence, remission and case-fatality rates. Incidence estimates rounded to 
nearest 100.
(c) Incidence estimates relate to decayed teeth (excluding missing and filled teeth), not to people with decayed teeth.
(d) Periodontal disease with pockets 6 mm or more deep.
(e) Incidence estimates relate to number of major depressive episodes in the 12-month period of 1996, together with 
number of new cases of dysthymia (not resulting in a major depressive episode in 1996).
(f) New cases of injury requiring hospitalisation or attendance at a hospital emergency department.
(g) Total episodes of intervertebral disc disorders in 1996.
(h) Based on self-reported episodes of menstrual problems in the 1995 National Health Survey.
(i) Incidence estimated from hospitalisation data for Australia.
(j) Symptomatic benign prostate enlargement resulting in treatment.
Source: Australian Burden of Disease and Injury Study.
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This was followed by dental caries and then chronic back pain, with an estimated
6 million new episodes per year. There were around 3.8 million new episodes of
diarrhoeal disease per year, or around one for every five Australians. 
Disability 
Disability is defined by the ABS as the presence of one or more of 17 Ôrestrictions,
limitations or impairmentsÕ (Box 2.7). According to the ABS Survey of Disability, Ageing
and Carers, about 3.6 million people reported disability in 1998, a prevalence rate of
19.3% (Table 2.7). Almost 80% of people with a disability, or over 2.8 million people,
reported core activity restrictions in 1998 (ABS 1999b). The extent of disability is
described in AustraliaÕs Welfare 1999 (AIHW 1999a).
Expected years of life with disability and core activity restriction
Based on 1998 mortality data, the life expectancy is 75.9 years for Australian males and
81.5 years for Australian females. Only 57.5 (76%) and 63.3 (78%) of those years are
expected to be disability-free. In terms of profound and severe core activity restriction,
it is estimated that 5.2 male life years and 7.6 female life years will be affected (AIHW
unpublished data).  
Australian Burden of Disease and Injury Study
So far, this chapter has looked at mortality, morbidity and disability in Australia, using
death rates, indicators of disease incidence and prevalence, and core activity
restrictions, each presented separately. This section presents a means of bringing these
isolated indicators together to present a summary view of the Ôburden of diseaseÕ.
The Global Burden of Disease Study has developed a new summary measure of
population health, the disability-adjusted life year or DALY, that combines information
on the impact of premature death and of disability and other non-fatal health outcomes
(Murray & Lopez 1996) (see Box 2.8, page 50). This measure was used to provide a
comprehensive assessment of the global burden of disease and injury for the World
Table 2.7: Prevalence of disability (numbers and rates), by disability status, severity of core 
activity restriction and sex, 1998
Profound
core
activity
restriction
Severe
core
activity
restriction
Moderate
core
activity
restriction
Mild core
activity
restriction
School-
ing or
employ-
ment
restriction
only
Total with
specific
restrictions
Without
specific
restrictions
Total
with
disability
Number (’000)
Males 218.8 286.6 338.6 534.3 188.4 1,566.7 254.4 1,821.1
Females 318.9 311.6 321.7 497.5 139.5 1,589.2 200.0 1,789.2
Persons 537.7 598.2 660.3 1,031.8 327.9 3,155.9 454.4 3,610.3
Percentage
Males 2.4 3.1 3.6 5.8 2.3 16.9 2.7 19.6
Females 3.4 3.3 3.4 5.3 1.7 16.9 2.2 19.1
Persons 2.9 3.2 3.5 5.5 2.0 16.9 2.4 19.3
Sources: ABS 1999b:14; AIHW 1999a.
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Bank (World Bank 1993), and to provide a basis for global priority-setting for health
research (Ad Hoc Committee on Health Research Relating to Future Intervention
Options 1996). The method has subsequently been adopted by the World Health
Organization as a tool to assist global health planning.  
Box 2.7: Defining disability
According to the 1998 Survey of Disability, Ageing and Carers (ABS 1999b), a person is
classified as having a disability if he or she reports any of the following limitations, restric-
tions or impairments that have lasted or are likely to last for 6 months or more:
¥ loss of sight, not corrected by glasses or contact lenses
¥ loss of hearing, with difficulty communicating or use of aids
¥ loss of speech
¥ chronic or recurring pain that restricts everyday activities
¥ shortness of breath or breathing difficulties that restrict everyday activities
¥ blackouts, fits, or loss of consciousness
¥ difficulty learning or understanding
¥ incomplete use of arms or fingers
¥ difficulty gripping or holding things
¥ incomplete use of feet or legs
¥ a nervous or emotional condition that restricts everyday activities
¥ restriction in physical activities or physical work
¥ disfigurement or deformity
¥ head injury, stroke or any other brain damage with long-term effects that restrict 
everyday activities
¥ needing help or supervision because of a mental illness or condition
¥ treatment or medication for any other long-term condition or ailment and still restricted
¥ any other long-term condition that restricts everyday activities.
The 1998 survey identified five Ôspecific restrictionsÕ: restrictions in the three ÔcoreÕ activi-
ties of daily living (self-care, mobility and communication), and restrictions in schooling
and employment.
Severity of core activity restriction was classified into four levels: mild (no difficulty per-
forming a core activity but using aids or equipment), moderate (not needing assistance,
but having difficulty), severe (sometimes needing assistance to perform a core activity) and
profound (unable to perform a core activity or always needing assistance).
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The AIHW has carried out a comprehensive study of the burden of disease in Australia
for the reference year 1996. This study adapted the DALY measure for the Australian
context and calculated the disease burden for a comprehensive set of 176 disease and
injury categories.
This section provides an overview of the burden of disease and injury in Australia
using this statistic. More detailed results are given in two AIHW reports on the
Australian Burden of Disease and Injury Study (AIHW: Mathers et al. 1999a, 1999b).
Box 2.8: Disability-adjusted life year (DALY)
The DALY is a summary measure of population health that combines information on mor-
tality and non-fatal health outcomes. It was originally developed as part of the 1990 World
Health Organization and World Bank Global Burden of Disease Study and has been
adapted by the Australian Institute of Health and Welfare for the Australian context. In
common with most summary health measures, the DALY uses time as a common Ôcur-
rencyÕ. It is a measure of the years of healthy life lost due to illness or injuryÑone DALY
is one lost year of ÔhealthyÕ life. 
DALYs are calculated as the sum of years of life lost due to premature mortality (YLL) and
the equivalent years of ÔhealthyÕ life lost due to poor health or disability (YLD). YLL are cal-
culated for each death as the average life expectancy of a person of the same age as the
person who died. Thus, unlike most measures of potential years of life lost, YLL do not
exclude deaths above a specified age or years of life lost above that age. The YLL quoted in
this report are based on the projected average life expectancies for Australians alive in 1996.
YLD are calculated for a given condition by estimating the number of new cases of that
condition in a specified time. For each new case, the YLD is obtained by multiplying the
average duration of the condition (to remission or death) by a severity weight that quanti-
fies the equivalent loss of healthy years of life due to living with the condition. The DALY
value is then the sum of the YLL and the YLD.
The severity weights are derived to quantify societal preferences for health states. There are
no comprehensive Australian measurements of such weights. The YLD quoted in this
report are based on weights from a combination of sources. Where possible, the weights are
taken from a Dutch study of selected diseases of public health importance (Stouthard et al.
1997). Where the Dutch weights are not available, the weights are taken from the 1990
Global Burden of Disease Study. Where these are not available, provisional weights were
estimated using regression analysis based on the Dutch study results. The weights used in
this study should be regarded as provisional pending the development of internationally
accepted standard weights or suitable Australian weights. 
An annual discount rate of 3% is applied in calculating both the YLL and YLD. With this
discount rate, a year of healthy life gained in 10 years time is worth 24% less than one
gained now. For example, a male infant death would result in 81 YLL without dis-
counting, because this is the average male life expectancy at that age. The same death
would result in 30 YLL with discounting. All YLL, YLD and DALY figures presented in
this report are based on new cases of disease and injury and deaths occurring in the cal-
endar year 1996 and include discounting.
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The burden of disease associated with each of the National Health Priority Areas is
described in section 2.3. The disease and injury burden in Australia attributable to
major risk factors is described in chapter 3. Socioeconomic differentials and sex
differentials in disease and injury burden are described in chapter 4. 
The burden of premature mortality—YLL
In 1996, premature mortality was responsible for 1.35 million years of life lost (YLL)
(discounted at 3% per annum) in Australia. Males lost 26% more years of life than
females. If male YLL are calculated using the cohort life expectancies for females (so
that there is no maleÐfemale difference in years of life lost due to a death at a given age),
then the male excess mortality burden is 43%. 
Cardiovascular diseases, cancers and injury were responsible for 72% of the total YLL in
both males and females. In people aged 75 years and over, cardiovascular diseases
accounted for more than half the YLL, whereas cancers were a more important cause
than cardiovascular diseases for all ages below 75. Injuries were the main cause of lost
years of life in young adults and children aged 5Ð14 years, and neonatal conditions the
main cause in children aged under 5.
Ischaemic heart disease (IHD) was by far the largest cause of YLL in Australia in 1996
(see Figure 2.17). IHD was followed by stroke and breast cancer in females, and by lung
cancer and suicide in males. Heroin overdose deaths were in the top 20 causes of YLL
for males, resulting in almost as many years of life lost as HIV/AIDS or leukaemia. 
Source: Australian Burden of Disease and Injury Study.
Figure 2.17: Distribution of mortality burden (YLL) and deaths for leading causes, 1996
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Because YLL give greater weight to deaths at younger ages, causes such as breast
cancer, suicide and road traffic accidents claim a higher proportion of the premature
mortality burden than of the total number of deaths (Figure 2.17). 
Trends in mortality burden, 1981 to 1996
There have been substantial declines in the mortality burden of cardiovascular diseases,
road traffic accidents, low birthweight, and stomach cancer, for both males and females,
over the last two decades. Overall, the age-adjusted mortality burden in Australia has
declined by 27% in the 15 years between 1981 and 1996 alone. 
The burden of smoking-related diseases has decreased in males but increased
substantially in females. Between 1981 and 1996, the per person mortality burden for
lung cancer and chronic obstructive pulmonary disease (COPD) decreased by 15% and
16% respectively for males, but increased by 62% and 70% respectively for females.
The largest increases in YLL have occurred for HIV/AIDS, suicide and prostate cancer
in males, for senile dementias and heroin dependence and abuse in both sexes, and for
lung cancer and COPD in females. HIV/AIDS mortality peaked in 1989, and has
dropped dramatically since. The large apparent increase in YLL for dementia is likely to
be partly due to changes in coding practice that have led to increased identification of
dementia as an underlying cause of death. 
Leading causes of the disability burden—YLD
The non-fatal component of the disease burden presents a substantially different picture
from that provided by traditional mortality statistics. Figure 2.18 shows the
contributions for the major disease groups and injury to the total non-fatal burden of
disease and injury in Australia in 1996. 
Mental disorders were the leading cause of years of ÔhealthyÕ life lost due to disability
(YLD) in 1996, accounting for nearly 30% of the total YLD in Australia. Nervous system
disorders were responsible for 16% of YLD. The latter category was dominated by
dementia and hearing loss. 
In contrast to the mortality burden (YLL), the size of the overall disability burden (YLD)
was almost identical for males and females. The YLD for nervous system disorders,
mental disorders and musculoskeletal disorders were all higher for females than for
males. The male burden was higher for cardiovascular diseases, diabetes, chronic
respiratory diseases and cancers.
Depression was the leading cause of YLD in Australia, causing 8% of the total YLD in
1996. Hearing loss and alcohol dependence and harmful use were the second and third
leading contributors to the YLD for males. Dementia and osteoarthritis were the second
and third leading contributors for females (AIHW: Mathers et al. 1999a).
Total burden of disease and injury—DALYs
The total burden of disease and injury in Australia in 1996 was estimated to be
2.5 million DALYs. The male burden (in total DALYs) was 13% higher than the female
burden. Non-fatal outcomes (YLD) were responsible for 43% of the male burden and
49% of the female burden. 
01 AH2000 body  Page 52  Thursday, June 1, 2000  3:06 PM
2 The health of Australians  53
TRIM SIZE 175 mm Wide x 250 mm Deep
Note: Acute respiratory infections are included with the infectious diseases category in this figure.
Source: Australian Burden of Disease and Injury Study.
Figure 2.18: Non-fatal burden of disease (YLD) for major disease groups, 1996
Source: Australian Burden of Disease and Injury Study.
Figure 2.19: Burden of disease (YLL, YLD and total DALYs) for major disease groups, 1996
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Figure 2.19 shows the YLL and YLD contributions to total DALYs for the major disease
groups and injury. Inclusion of non-fatal health outcomes provides a substantially
different picture from that provided separately by traditional mortality or disability
statistics: mental disorders were the third leading cause of overall burden (14% of total)
after cardiovascular diseases (20%) and cancers (19%). Central nervous system and
chronic respiratory conditions were almost as large a contributor to total burden as
injuries.
The 15 leading causes of the burden of disease in Australia are shown in Table 2.8.
Together, these 15 causes accounted for about 50% of the 1996 total disease burden in
Australia. Among these top 15 causes are 4 non-fatal or low-fatality diseases:
depression, asthma, osteoarthritis and hearing loss. The burdens of mental illnesses
such as depression and alcohol dependence, and of non-fatal diseases such as
osteoarthritis and hearing loss, have been seriously underestimated by traditional
approaches that take into account only deaths and not disability.
The leading causes of death differ between the sexes. IHD and stroke are the two
leading causes of burden of disease in both sexes. Depression, dementia and breast
cancer are the next three leading causes in females; in contrast, lung cancer, COPD and
suicide are respectively the third, fourth and fifth leading causes of burden of disease
among males (AIHW: Mathers et al. 1999a). 
Table 2.8: The 15 leading causes of burden of disease, 1996
Per cent of
DALYs
1 Ischaemic heart disease 12.4
2 Stroke 5.4
3 Chronic obstructive pulmonary disease(a) 3.7
4 Depression 3.7
5 Lung cancer 3.6
6 Dementia 3.5
7 Diabetes mellitus 3.0
8 Colorectal cancer 2.7
9 Asthma 2.6
10 Osteoarthritis 2.2
11 Suicide and self-inflicted injuries 2.2
12 Road traffic accidents 2.2
13 Breast cancer 2.2
14 Hearing loss 1.9
15 Alcohol dependence and harmful use 1.8
(a) Chronic bronchitis and emphysema.
Source: AIHW: Mathers et al. 1999a.
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The figures in Table 2.8 take into account only the actual condition with which someone
has been diagnosed. However, some conditions are also risk factors for other
conditions. For example, people with diabetes are also at higher risk of cardiovascular
disease. The data in Table 2.8 can be modified to take into account a broader
attributable burden in the following way:
¥ If the burden of suicide and self-inflicted injury attributable to depression is included
with the disability burden of depression, the total burden of depression rises to 4.9%,
making it the third leading cause of burden of disease in Australia, after IHD and
stroke.
¥ If the burden of cardiovascular diseases attributable to diabetes is included with
diabetes, its total attributable burden rises to 4.9%, making it the equal third leading
cause of disease burden with depression.
¥ If the burden of diseases and injuries caused by alcohol use is included with its direct
burden in terms of mental health, the attributable burden of alcohol use rises to 2.2%. 
2.3 NHPA diseases and conditions
The preceding section outlined the contribution of various diseases and conditions to
the burden of disease in Australia. About 70% of the total burden has been attributed to
cardiovascular problems, cancers, injuries, mental problems, diabetes mellitus and
asthma, identified by Australian Health Ministers for priority action under the National
Health Priority Areas (NHPA) initiative.
The NHPA initiative is a collaborative effort involving Commonwealth, State and
Territory governments. It seeks to focus public attention and health policy on those
areas that are known to contribute significantly to the burden of disease in Australia,
and for which there is potential for health gain. The NHPA initiative recognises that in
order to reduce the burden of disease, strategies need to be holistic, and to encompass
the continuum of care from prevention through to treatment and management (AIHW
& DHFS 1997). 
This section gives an overview of the six NHPAs, providing information on their
incidence, prevalence, risk factors, illness, complications, disability and mortality. A set
of indicators has been developed for each priority area to monitor progress towards
national health targets. The AIHW has undertaken to report progress in each of the
priority areas biennially in AustraliaÕs Health. The latest information for each of the
NHPA indicators is contained in Tables S52Ð57, pages 415Ð425. Further information on
the framework within which NHPA indicators have been developed can be found in
chapter 6. 
Cardiovascular disease
Cardiovascular disease comprises all diseases and conditions involving the heart and
blood vessels including coronary heart disease, stroke, peripheral vascular disease and
heart failure. The main underlying problem in cardiovascular disease is atherosclerosis,
a process that clogs blood vessels with deposits of fat, cholesterol and other substances.
It is most serious when it affects the blood supply to the heart (causing angina, heart
attack or sudden death) or to the brain (which can lead to a stroke).
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Cardiovascular disease is AustraliaÕs greatest health problem. It kills more people than
any other disease (accounting for 40% of all deaths) and its health and economic burden
exceeds that of any other disease. In 1993Ð94, cardiovascular disease accounted for the
largest proportion of health system costs in Australia, $3.7 billion or 12% of total health
system costs (AIHW: Mathers & Penm 1999a). Cardiovascular disease accounted for
22% of disease burden in Australia in 1996, 33.1% of premature mortality (YLL) and
8.8% of years of equivalent ÔhealthyÕ life lost through disease, impairment and disability
(YLD) (AIHW: Mathers et al. 1999a).
Based on the National Health Survey, an estimated 2.8 million Australians, or 16% of
the population, had cardiovascular conditions in 1995. High blood pressure was the
most common condition for both males and females (AIHW 1999c).
Much of the death, disability and illness caused by cardiovascular disease is
preventable. Many Australians remain at higher risk of the disease through smoking,
being physically inactive, eating a diet high in saturated fats and/or being overweight.
Many Australians have blood pressure and/or blood cholesterol above recommended
levels; there has been little improvement in physical activity participation, and the
proportion of overweight and obese Australians is on the increase.
Incidence 
Coronary heart disease
There are no national data on the incidence of coronary heart disease in Australia.
However, the Universities of Newcastle and Western Australia and the Queensland
Department of Health have developed a method to estimate the rate of coronary events
among people aged 35Ð69. Using this method, it is estimated that there were 19,910
coronary events (mainly heart attacks) among people aged 35Ð69 in 1995Ð96. Non-fatal
heart attacks represented almost two-thirds (12,955 cases) of these events. Non-fatal
heart attacks were three times more common among males than females in the
35Ð69 age group. Over the period 1984 to 1993, rates of non-fatal heart attacks fell by
about 3% per year (AIHW 1998a).
Stroke
Each year, around 40,000 Australians have a stroke, with 70% of these first-ever strokes.
Stroke is the cause of nearly 25% of all chronic disability in Australia (NHMRC 1997c).
It is more common among older Australians, with around 50% of all strokes occurring
in those aged 75 and over. The incidence of stroke is higher in males than in females
under the age of 85. For 45-year-olds, the risk of having a stroke before age 85 is 1 in 4
for males and 1 in 5 for females (AIHW 1999c).
Rheumatic fever and rheumatic heart disease
Although this disease is rare among the Australian population overall, its prevalence
among Indigenous Australians is one of the highest in the world. The high rates of
rheumatic fever among Indigenous peoples are likely to reflect high levels of exposure
to group A streptococci, with overcrowding and poor living conditions as major risk
factors (Carapetis & Currie 1998).
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A register of people with known or suspected rheumatic fever and rheumatic heart
disease has been established in the Top End of the Northern Territory. In 1998, there
were 19 cases of acute rheumatic fever among Aboriginal children aged 5Ð14 in the Top
End of the Northern Territory (216 per 100,000), whereas among non-Indigenous
children in the area there were 2 cases (12.8 per 100,000). Over the last decade or so,
there has been little change in the incidence of acute rheumatic fever among Aboriginal
children (AIHW 1999c).
Rheumatic heart disease is the damage done to the heart muscle and heart valves by an
attack of acute rheumatic fever. In 1998, Aboriginal people accounted for 95% of all cases
of rheumatic heart disease in the Top End of the Northern Territory (426 cases), with a
prevalence rate of 1,180 per 100,000. In contrast, there were 25 cases (24 per 100,000)
among non-Indigenous Australians living in the Top End (AIHW 1999c).
Health services
General practice
A survey of general practice activity found that in 1998Ð99 cardiovascular problems
represented 11% of all problems managed by general practitioners (GPs) (AIHW
GPSCU: Britt et al. 1999). Hypertension was the most common cardiovascular problem
managed and was the most frequent problem seen in general practice overall,
accounting for 5.7% of all problems. Other common cardiovascular problems managed
were cardiac check-up (0.9% of problems), coronary heart disease without angina (0.8%)
and heart failure (0.6%). Lipid disorder, although not strictly a cardiovascular problem,
rated high as well, accounting for 1.7% of problems managed.
Several classes of antihypertensive drugs and blood-lipid reducers were among the top
30 drug groups prescribed by GPs, reflecting the large number of hypertensive and
lipid disorder problems managed. Lipids accounted for the highest number of
chemistry pathology tests ordered, and represented 9.4% of all pathology tests ordered
by GPs.
Comparison of 1998Ð99 results with those of a similar study conducted in 1990Ð91
showed that although hypertension remained the most common problem managed by
GPs, the rate per 100 encounters fell from 9.5 to 8.4. In contrast, the management rate
for lipid disorders increased in frequency from 1.8 to 2.5 per 100 encounters, probably
because of raised awareness among both GPs and the public of the need to measure and
control cholesterol level (Sullivan 2000).
Hospitalisation
In 1997Ð98, cardiovascular disease accounted for 434,748 hospital separations from all
public acute and private hospitals in Australia. Of these, 37% were attributed to coronary
heart disease, 12% to stroke, 10% to heart failure, 10% to cardiac dysrhythmias, 8% to
haemorrhoids, 5% to varicose veins of lower extremities and 3% to peripheral vascular
disease.
Across all age groups, males were more likely to be hospitalised for cardiovascular
disease than females. The sex differential was particularly marked for coronary heart
disease and peripheral vascular disease, where males were twice as likely to be
hospitalised for these diseases than females. Hospitalisations associated with stroke and
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heart failure were similar for the two sexes, but for hypertensive disease and rheumatic
fever and rheumatic heart disease, females were significantly more likely to be
hospitalised than males (Table 2.9). 
Hospitalisation for cardiovascular disease increases rapidly with age (Table 2.9).
Although those aged 55 years and over represent only 21% of the total population, they
accounted for about three-quarters of hospital separations for cardiovascular disease. In
the case of stroke, peripheral vascular disease and heart failure, over 89% of
hospitalisations were of those aged 55 years and over. 
The average length of stay in hospital for cardiovascular disease declined from 7.6 days
in 1993Ð94 to 5.7 days in 1997Ð98. Over this period, there was an increase in the
proportion of same-day patients, particularly for coronary heart disease (67%), largely
reflecting the much greater use of investigations in recent years. On average, those
hospitalised for stroke in 1997Ð98 tended to stay the longest (10.3 days), followed by
heart failure (8.4 days), peripheral vascular disease (8.2 days), rheumatic fever and
rheumatic heart disease (7.5 days), and hypertensive disease (4.7 days). Those
hospitalised for coronary heart disease tended to stay for a shorter period (on average
4.6 days) than those hospitalised for other major cardiovascular diseases, diabetes, most
cancers and mental disorders. The average length of stay for non-cardiovascular
diseases was 3.9 days. 
Table 2.9: Hospital separations(a) for cardiovascular diseases, 1997Ð98
Sex by disease (ICD-9-CM code)
Age group (years)
All ages<15 15–34 35–54 55–74 75+
Males
Coronary heart disease (410–414) 0.3 24.3 865.5 4,240.0 5,615.0 1,131.2
Stroke (430–438) 5.6 16.5 101.8 889.2 2,981.9 291.3
Peripheral vascular disease (441–444) 0.6 3.7 25.4 351.5 924.6 99.5
Heart failure (428) 2.8 5.0 47.8 596.7 2,980.3 226.7
Hypertensive disease (401–405) 4.5 7.0 31.2 84.9 172.4 32.0
Rheumatic fever and rheumatic heart disease 
(390–398) 3.3 3.2 6.3 22.6 31.8 8.2
All cardiovascular diseases (390–459) 63.3 303.4 1,890.8 8,562.7 17,112.5 2,647.3
Females
Coronary heart disease (410–414) 0.4 7.9 242.4 1,840.3 3,572.0 586.7
Stroke (430–438) 4.9 16.1 80.1 554.8 2,384.7 267.0
Peripheral vascular disease (441–444) 0.1 3.9 14.0 129.6 371.9 49.1
Heart failure (428) 3.3 1.7 23.1 364.4 2,452.6 220.8
Hypertensive disease (401–405) 2.8 7.6 36.6 129.6 273.1 50.8
Rheumatic fever and rheumatic heart disease 
(390–398) 3.9 5.6 10.2 41.7 33.1 14.0
All cardiovascular diseases (390–459) 46.5 288.3 1,220.4 4,938.3 12,517.0 2,009.1
(a) Age-specific separations per 100,000 population.
Source: AIHW National Hospital Morbidity Database.
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Although males were more likely than females to be hospitalised for cardiovascular
disease, females tended to stay in hospital longer (5.8 days compared with 5.3 days).
Length of stay in hospital for cardiovascular disease increased with age after age 30,
with those aged 85 and over staying in hospital for 9.9 days on average compared with
3.1 days for those aged 30Ð34 in 1997Ð98. 
Cardiovascular procedures
The most common heart operation in Australia is coronary artery bypass grafting. This
procedure was developed in the 1960s and its use has increased steadily since that time.
In 1995, there were 17,150 coronary artery bypass graft operations, with 7% of these re-
operations (AIHW: Senes & Davies 1999a). The death rate for coronary artery bypass
graft operations was 2.3%. 
Other revascularisation procedures include coronary angioplasty and coronary stenting.
Coronary angioplasty, a less invasive technique than coronary artery bypass grafting (it
does not require the opening of a patientÕs chest), was introduced in the 1980s and its use
has grown dramatically since then. During 1996, there were 13,854 coronary angioplasty
procedures performed in Australia, an increase of 22% from the previous year (AIHW:
Senes & Davies 1999b). Coronary stenting, widespread since 1995 in Australia, was used
in 54% of coronary angioplasty patients in 1996, an increase of 106% over its use in the
previous year (Figure 2.20). The main cardiovascular procedures are explained in Box 2.9
(page 60).
In addition, during 1997Ð98 there were 76,362 coronary angiograms conducted and
24,855 CT brain scans performed for the diagnosis of stroke.  
Note: Coronary angioplasty includes procedures with or without stents.
Source: AIHW/NHF National Cardiac Surgery and Coronary Angioplasty Registers.
Figure 2.20: Trends in coronary revascularisation procedures, 1970 to 1996
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Mortality
Cardiovascular disease was the leading cause of death among Australians in 1998,
accounting for 50,797 deaths or 40% of all deaths. Coronary heart disease was the major
cardiovascular cause of death accounting for 55% of all such deaths, followed by stroke
(24%), heart failure (5%) and peripheral vascular disease (4%). Cardiovascular mortality
is higher among Indigenous Australians, in rural areas of the country, and among
socioeconomically disadvantaged groups (DHAC & AIHW 1999b) (see chapter 4).
Over the last three decades there has been a considerable decline (around 66%) in cardio-
vascular death rates. These declines are substantial, especially when compared with a
decline of around 22% in the death rate for non-cardiovascular diseases. During the
period 1987 to 1998, death rates for cardiovascular diseases fell 3.9% per year for males
and 3.7% per year for females, faster than for all causes overall (Table 2.10). Coronary
heart disease death rates have been declining faster than death rates from stroke. 
Declines in death rates for coronary heart disease and stroke have been influenced by
improvements in some risk factors (levels of blood pressure, tobacco smoking and
saturated fat) and in medical interventions such as counselling, drug use, emergency
care, medical and surgical treatment, and follow-up care. These gains have been
achieved despite there being a significant increase in the prevalence of overweight and
little change in physical activity levels.  
Box 2.9: Cardiovascular procedures
There is a range of procedures to diagnose and treat cardiovascular diseases. Some of the
major procedures are:
Coronary artery bypass grafting (CABG) entails opening a patientÕs chest and using
blood vessel grafts to bypass blockages in the coronary arteries and restore adequate blood
supply to the heart muscle. CABG is not a cure for coronary artery disease, and there is a
risk of recurrence. 
Coronary angioplasty involves inserting a catheter with a balloon into a major artery
via the skin. The catheter is threaded through the circulation back towards the heart and
into the coronary arteries to the area of the vessel blockage. The balloon is then inflated
against the blocked area to create a wider passage for blood flow.
Coronary stenting involves expanding metal mesh tubes within the artery to form a sup-
porting structure to hold the artery open at the point where there is narrowing. The devel-
opment of this catheter-based technique was due to the risk of early acute closure of the
coronary artery and a high rate of reblockage from coronary angioplasty. 
Coronary angiography gives a picture of the heartÕs arteries. The procedure is used to
diagnose coronary heart disease and is essential before either coronary artery bypass sur-
gery or coronary angioplasty.
Computerised tomographic (CT) scan of the brain is used to guide treatment in acute
stroke by distinguishing between major stroke types (either blocked blood supply to the
brain, or bleeding within the brain or on its surface). The test is also done to confirm a
clinical diagnosis of stroke.
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Table 2.10: Deaths from cardiovascular diseases, 1998
Cause of death 
(ICD-9 code)
Males Females
Number
(1998)
Rate(a)
(1998)
Annual rate
of change(b)
(per cent)
Number
(1998)
Rate(a)
(1998)
Annual rate
of change(b)
(per cent)
All cardiovascular diseases 
(390–459)  24,746 284.7 –3.9  26,051 188.0 –3.7
Coronary heart disease 
(410–414) 15,024 171.3 Ð4.3 12,801 93.3 –4.1
Stroke (430–438)  4,812 56.4 –3.4  7,170 50.9 –3.6
Heart failure (428)   988 12.0 –4.3  1,567 10.3 –4.4
Peripheral vascular 
disease(441–444)  1,171 13.5 –2.9  916 6.8 –1.2
Hypertensive disease 
(401–405)  410 4.7 –3.2  730 5.2 –2.8
Rheumatic fever and 
rheumatic heart disease 
(390–398)  87 1.0 –5.2  171 1.5 –4.8
All causes of death 
(001–999)  67,073 759.9 –2.3  60,129 470.2 –1.9
(a) Age-standardised rate per 100,000 population. 
(b) Annual change in the age-standardised death rate over the period 1987 to 1998.
Source: AIHW National Mortality Database.
Source: AIHW National Mortality Database.
Figure 2.21: Death rates for major cardiovascular diseases, 55 years and over, 1998
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Males were more likely to die from cardiovascular disease than females across almost
all age groups, with death rates among males aged 25Ð74 two to three times those of
females in 1998. For coronary heart disease, the sex differentials were more marked
than for cardiovascular disease overall, particularly in the 25Ð64 age group where death
rates among males were 3Ð4 times those of females. For stroke, the sex differentials
were not as large as for coronary heart disease, with death rates across most age groups
marginally higher for males than females (Figure 2.21). 
Death rates for cardiovascular disease increased dramatically with age, with 82% of all
such deaths occurring among those aged 70 and over, compared with less than 5% for
those aged under 55. 
Note: Death rates have been age standardised to the World Standard Population.
Source: WHO 1996, 1998.
Figure 2.22: Death rates for cardiovascular disease, selected countries, 1994
Hong Kong
Japan
France
Spain
Canada
Chile
Italy
Australia
Netherlands
Singapore
Israel
Greece
Sweden
Norway
USA
England and Wales
New Zealand
Germany
Finland
Northern Ireland
Scotland
Switzerland
Poland
Russian Federation
0 200 400 600 800 1,000 1,200
Deaths per 100,000 population
Males
Females
01 AH2000 body  Page 62  Thursday, June 1, 2000  3:06 PM
2 The health of Australians  63
TRIM SIZE 175 mm Wide x 250 mm Deep
Cardiovascular disease death rates in Australia have declined by about 60% over the
period 1960Ð64 to 1994. There have been similar large declines in other countries. Japan
(for both males and females) and Canada (for females) are the only countries to exceed
AustraliaÕs decline in cardiovascular disease death rates. Rates of decline in Canada (for
males), the United States, France, Switzerland and Finland have also been substantial
(WHO 1998).
Despite marked declines, AustraliaÕs cardiovascular disease death rates still compare
unfavourably with those of some other developed countries. Of the 24 countries
compared, Australia had the eighth and tenth lowest death rates for cardiovascular
disease for males and females respectively in 1994. The Australian death rates, although
one-third the rates in the Russian Federation and half the rates in Poland, were 72% and
50% higher for males and females than the rates observed in Hong Kong. Australian
death rates were also significantly higher than rates in Japan and France (Figure 2.22). 
The relative ranking of Australian death rates varies for the major components of
cardiovascular disease. For coronary heart disease, Australian death rates ranked
towards the middle of those compared, whereas for stroke Australian death rates were
among the lowest of those compared. 
Cancers 
Cancer is a diverse group of diseases characterised by the proliferation and spread of
abnormal cells in the body. These abnormal cells invade and destroy surrounding tissue
and can spread (metastasise) to distant parts of the body. Cancer can develop in most
types of cells, and each cancer has its own pattern of local behaviour and metastasis.
Although some cancers share risk factors, most cancers have a unique set of risk factors
that may be responsible for their onset. In Australia, information on cancers is collected
by State and Territory cancer registries, and compiled by the AIHW in the National
Cancer Statistics Clearing House (see Box 2.10, page 64). 
It is estimated that 30% of cancers can be attributed to active smoking, 30% to dietary
influences, 2% to radiation exposure, 5Ð15% to infectious agents, and the remainder to
other risk factors (Trichopoulos et al. 1996). Some of these risk factors are modifiable
through lifestyle changes, and others are inherited. Although some risk factors are
unavoidable, risks of particular cancers may be reduced through clinical monitoring of
a person and their risk factors and treating newly diagnosed cases early in their
development.
Each year, approximately 345,000 new cancer cases are diagnosed in Australia. A large
proportion of these, approximately 270,000, are non-melanocytic skin cancers (NMSC)
which, if treated early, are far less life-threatening than most other cancers. Cancer
currently accounts for 29% of male deaths and 25% of female deaths.
Cancer control is a National Health Priority Area. Eight cancers have been targeted for
priority action: lung cancer, melanoma, NMSC, colorectal cancer, non-HodgkinÕs
lymphoma, prostate cancer in males and cancers of the cervix and breast in females.
These cancers have a significant impact on the health status of the Australian
population and are of concern in all States and Territories.
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Cancer incidence
Excluding NMSC, there were 42,733 new cancers in males and 34,933 new cancers in
females in 1996, with age-standardised incidence rates of 489 per 100,000 males and
339 per 100,000 females. In the same year, there were 19,196 male deaths due to cancer
with an age-standardised death rate of 226 per 100,000, and 14,893 female deaths due to
cancer at the rate of 137 per 100,000 (AIHW & AACR 1999). 
Details of NMSC are not recorded by all cancer registries as most are not histologically
confirmed or reported. These skin cancers are often self-detected and are usually
removed in doctorsÕ surgeries. Staples et al. (1998) estimated, using survey methods,
that the national age-standardised incidence rates (standardised to the World Standard
Population) for treated NMSC in 1995 were 1,374 per 100,000 for males and 857 per
100,000 for females. 
The incidence of the other most common cancers is presented in Figure 2.23. Prostate
cancer is the most common cancer accounting for 23.5% of all cancers in males. Between
1989 and 1994, there was a dramatic rise in the number of new cases of prostate cancer
registered. Incidence rates have fallen substantially since then, although not to pre-1989
levels. The rise and then fall in the prostate cancer incidence rate has been attributed to
early detection through increased investigation, particularly following the introduction of
prostate-specific antigen (PSA) testing around 1990. PSA tests are specifically designed to
identify cancers before the onset of clinical symptoms. Many of these prevalent cancers
may not show any symptoms, and therefore would not be detected except for PSA
testing. The recent decline in the incidence rate indicates a return towards the underlying
Box 2.10: Cancer surveillance and monitoring in Australia
The registration of cancer is required by law in each of the States and Territories, usually
under the Public Health Acts, where the data are collated by cancer registries. These regis-
tries collect clinical and demographic information about people with newly diagnosed
cancer. This information is obtained from hospitals, pathologists, radiation oncologists,
cancer treatment centres and nursing homes. Generally, operational guidelines for each of
the registries are similar and coincide with the objectives of the International Association
of Cancer Registries. Although some registries operate under different coding systems for
site, morphology and other variables, the bulk of information is directly comparable and
has been reconciled for this publication. 
Registrars of Births, Deaths and Marriages collect information related to deaths from
cancer. By combining information from these sources, the State and Territory cancer regis-
tries produce statistics of cancer incidence and mortality. Data from these population-based
registries enable monitoring of cancer incidence and mortality and have disclosed high-risk
groups and emerging incidence trends that warrant a public health response.
A national collection of cancer data is maintained by the National Cancer Statistics
Clearing House at the Australian Institute of Health and Welfare, where data for incidence
are currently available to 1996 and for mortality to 1998 (AIHW & AACR 1999).
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rate, removing the effect of these previously undetected cases. The incidence rate is also
declining as the number of PSA tests conducted falls, reducing the number of prevalent
cases detected (Smith et al. 1998; Threlfall et al. 1998). 
Note: NHL = Non-Hodgkin’s lymphoma.
Source: AIHW & AACR 1999.
Figure 2.23: New cases and number of deaths from most frequently occurring cancers 
(excluding non-melanocytic skin cancer), by sex, 1996
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The incidence of cancer is lowest in late childhood, but increases with age. Figure 2.24
presents age-specific incidence rates for all cancers. Males have a higher incidence than
females beyond 55 years of age. However, females have a higher incidence than males
between ages 30 and 54 years because cancers of the cervix, uterus, ovary and breast
have an incidence almost seven times that of cancers specific to males in this age range.
Between 1990 and 1996, age-standardised incidence rates for all cancers combined
(excluding NMSC) rose for both males and females by an average of 2.1% and 1.4% per
year respectively. Trends in incidence rates for individual cancers for this period have
varied. Among males, incidence of melanoma showed increases of approximately 3.6%
per annum. The incidence of prostate cancer increased steadily until 1989 but has
shown a large average annual increase of 8% since then, despite the recent falls. Other
cancers to show average annual increases from 1990 to 1996 include: colorectal (1.0%),
bladder (1.6%), kidney (1.6%), brain (1.1%), non-HodgkinÕs lymphoma (0.7%) and testis
(3.4%). Lung cancer has shown a consistent decline since 1983 and an average annual
decline from 1990 to 1996 of 2%. The following cancers also recorded a decline: larynx
(Ð3.4%), stomach (Ð2.1%), unknown primary (Ð1.9%), leukaemia (Ð1.1%) and pancreas
(Ð0.7%). 
Source: AIHW & AACR 1999.
Figure 2.24: Age-specific incidence and death rates for malignant neoplasms 
(excluding non-melanocytic skin cancer), by sex, 1996
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Among females, the four most common cancers all showed average annual increases in
the age-standardised rate for the period 1990 to 1996, although the increases were much
more substantial for breast cancer (3%), melanoma (2.3%) and lung cancer (1.6%) than
for colorectal cancer (0.2%). Cancers of the pancreas (0.5%), uterus (1.5%), bladder (1.2%)
and kidney (1.2%), leukaemias (0.6%) and non-HodgkinÕs lymphoma (2.7%) all showed
an increase during this period. Cervical cancer showed one of the largest average annual
declines in age-standardised incidence rate (Ð4.1%), but cancers of the larynx (Ð2.2%),
brain (Ð0.8%) and unknown primary (Ð1.9%) also declined from 1990 to 1996.
Increases or decreases in the incidence of these cancers are due to variations in exposure
to a range of risk factors such as UV radiation exposure, smoking, alcohol and other
dietary components (Trichopoulos et al. 1996). Improvements in detection of cancers
through the introduction and more widespread use of medical technologies has also
increased the number of cancers reported, and improved the accuracy of determining
their site of origin. 
Survival following cancer
Survival from cancer depends on the type of cancer, its behaviour (i.e. slow- or fast-
growing) and its metastasising characteristics; the stage at diagnosis; the availability of
appropriate treatment; and the general health of the person and his or her capacity to
handle treatment.
Relative survival analysis uses the ratio of the survival of a person diagnosed with a
disease, in this case cancer, to that of a person from the general population matched on
age and sex. The South Australian and New South Wales cancer registries have
published survival estimates for their respective jurisdictions where the 5-year relative
survival ratio for all cancers is approximately 46% for males and 57% for females. 
Survival ratios decline with age at diagnosis for most cancers. For all cancers in South
Australia in 1986Ð94, the relative survival ratios were 72% for those under 55 years,
54% at 55Ð64 years, 48% at 65Ð74 years and 43% at 75 years and over (South Australian
Cancer Registry 1996).
The NSW Cancer Registry has noted significant improvements in survival from most
cancers. For example, the 5-year survival ratio for cancer of the cervix improved from
69% in 1980Ð85 to 75% in 1990Ð95. For other cancers, the improvement in survival was:
61% to 83% for prostate cancer; 51% to 61% for colorectal cancer; 48% to 59% for kidney
cancer; and 9% to 16% for cancer of the oesophagus (Supramaniam et al. 1999).
Mortality from cancer
In 1998, lung cancer accounted for 25% of cancer deaths among males, and prostate
cancer and colorectal cancer both accounted for 13%. The major causes of cancer death
in females were breast cancer (17% of all cancer deaths), colorectal cancer (14%) and
lung cancer (14%).
From the age of 15 years, death rates for cancer increase with age (Figure 2.24). Further, an
ageing population has meant that older people constitute a higher proportion of those
dying from cancer. For example, in 1983, approximately 30% of all cancer deaths occurred
in persons aged 75 years and over, but by 1998 this proportion had risen to around 40%.
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Males have higher death rates than females before age 35 and from age 50 onwards. The
higher death rates among females aged 35Ð49 years reflect the impact of the female-
only cancers on the rates. However, the differential between the male and female rates
in this age group is not as large as that observed for incidence.
Specific cancers
The following sections provide information about breast cancer, lung cancer and
melanoma. These cancers are among the most commonly diagnosed cancers and have a
significant impact on morbidity, mortality and health service use. Other common
cancers, such as prostate and colorectal cancers, have been the focus of discussion in
previous editions of AustraliaÕs Health.
Breast cancer
Apart from non-melanocytic skin cancers, breast cancer is the most common cancer
detected in Australian females, where the lifetime risk of a female developing this
disease before age 75 is 1 in 12. In 1997, 10,144 new cases of breast cancer were
diagnosed in Australia. Breast cancer is also the most common cause of death from
cancer in females with 2,602 deaths in 1997 and 2,542 in 1998. The incidence of breast
cancer has been on the rise since the early 1980s (Figure 2.25). The death rate for breast
cancer has remained relatively stable over this period, declining marginally from
24.9 deaths per 100,000 in 1980 to 23.0 deaths per 100,000 in 1998. The total health
system cost for female breast cancer was estimated to be $184 million in 1993Ð94
(AIHW: Mathers et al. 1998b).
Established risk factors for breast cancer are age (breast cancer rates typically increase
progressively with age from the third decade) and a family history of the disease. Other
factors associated with increased risk are a previous history of breast cancer or benign
breast disease, a larger body size, reproductive factors including late age at first birth,
nulliparity (never borne a child), early start to menstruation and late age at menopause,
use of oral contraceptives at young ages, use of hormone replacement therapy and
exposure of breast tissue to ionising radiation (particularly before 20 years of age) (see,
for example, McMichael & Armstrong 1988; Higginson et al. 1992; Kelsey 1993). More
recently, a role for physical activity in decreasing risk of breast cancer has been
proposed (Friedenreich & Rohan 1995). Diet, especially one rich in fat and animal
protein, and consumption of alcohol are other potential risk factors. Prevention of some
deaths from breast cancer is currently achievable mainly by earlier detection,
principally by way of mammography in organised screening programs (such as that set
up by BreastScreen Australia). Improvements in treatment have also contributed to
increased survival. 
The 5-year relative survival ratio for females diagnosed with breast cancer from 1982 to
1994 was 77%. The ratio has increased over time, with those diagnosed in the 1990s
showing a better 5-year relative survival ratio (79%) than those diagnosed in the 1980s
(74%). Females diagnosed with breast cancer in their 40s had the best relative survival,
whereas those aged in their 80s and 90s had the worst survival (AIHW, AACR &
NHMRC 1998). 
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Lung cancer
National incidence data indicate that in 1996 there were 5,228 new cases diagnosed in
males (60.1 new cases per 100,000 population) and 2,393 new cases diagnosed in
females (23.0 new cases per 100,000). In the same year, there were 4,773 deaths (55.4 per
100,000) for males and 2,054 for females (19.4 per 100,000) with only a slight rise in 1998.
Lung cancer currently accounts for 12.2% of all new cancer registrations in males and
6.9% in females, but 24.7% of all male cancer deaths and 13.6% of all female cancer
deaths. Lung cancer is the leading cause of cancer death in Australia. South Australian
and New South Wales studies estimate a 5-year survival ratio of approximately 11%
(South Australian Cancer Registry 1996; Supramaniam et al. 1999). The 1993Ð94 health
system cost for lung cancer was $107 million (AIHW: Mathers et al. 1998b). 
Smoking is responsible for approximately 80% of lung cancers (English et al. 1995).
Twenty-five years ago, smoking rates in men were almost double those in women.
However, this is no longer the case, with the latest estimates indicating that 25% of men
and 20% of women aged 14 years or over currently smoke (AIHW 1999d). Current
patterns of incidence probably reflect smoking behaviour approximately 20 years ago,
due to the timelag between exposure to carcinogens in tobacco smoke and the diagnosis
of cancer. The changing behaviour in smoking between males and females is reflected in
the trends for lung cancer incidence and mortality. Between 1990 and 1996, the incidence
and mortality of lung cancer among males fell by an average of 2.0% per year. In contrast,
Source: AIHW & AACR 1999; AIHW National Mortality Database.
Figure 2.25: Age-standardised incidence and death rates for female breast cancer, 
1983 to 1998
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lung cancer incidence among females increased at an average rate of 1.6% per year. The
increase in lung cancer incidence is predominantly in females aged 65 years and over,
whereas the rate in younger females has generally remained stable or fallen. Despite these
patterns, the male rate is still more than 2.5 times greater than the female rate. 
Melanoma
Melanoma is the fourth most common cancer in males and the third most common
cancer in females. There has been a strong upward trend in melanoma mortality since
the early 1950s. Since 1990, the death rates for both sexes have been relatively stable
(Figure 2.27) although males have a rate twice that of females. 
Incidence rates for melanoma have increased markedly since 1983, especially for males.
The largest increase occurred in those aged 60 years and over. Melanoma cost the health
system $66 million in 1993Ð94 (AIHW: Mathers et al. 1998b). 
AustraliaÕs melanoma rates are among the highest in the world. A comparison between
Australia and England and Wales shows a tenfold difference in incidence, and it is
known that incidence in Australia is up to 150 times higher than in some other
countries. International differences in death rates are substantially less than incidence
rates (AIHW: Giles et al. 1995). 
Source: AIHW & AACR 1999; AIHW National Mortality Database.
Figure 2.26: Age-standardised incidence and death rates for lung cancer, by sex, 
1983 to 1998
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Melanoma risk is related to UV radiation exposure. Melanoma incidence is higher in
people with fair, sun-sensitive skin, those with many moles, and those who have
intermittent high recreational exposure or frequent sunburns. Exposure in childhood
may be particularly important (DHFS & AIHW 1998a).
In 1996, there were 4,313 new cases diagnosed in males (48.0 new cases per 100,000
population) and 3,448 new cases diagnosed in females (35.0 new cases per 100,000
population). There were 635 male deaths (6.9 per 100,000) and 345 female deaths
(3.1 per 100,000) in 1998. Melanoma currently accounts for approximately 10% of all
new cancer registrations, and 3.0% of all cancer deaths in males and 2.2% in females.
Survival studies show that male 5-year relative survival ratios vary between 86% and
89% and female ratios vary between 92% and 95% (South Australian Cancer Registry
1996; Supramaniam et al. 1999). 
Injuries
Injury contributes significantly to mortality and morbidity in Australia. It is the leading
cause of death among young people. Injury is also the cause of a range of disabling
conditions, often persisting, that affect the quality of life of injured people and their
families. The total health system costs of injury in 1993Ð94 have been estimated at
$2.6 billion (AIHW: Mathers & Penm 1999b). Health Ministers have identified injury
prevention and control as a priority area.
Source: AIHW & AACR 1999; AIHW National Mortality Database.
Figure 2.27: Age-standardised incidence and death rates for melanoma, by sex, 
1983 to 1998
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Deaths
In 1998, a total of 7,946 deaths (5,614 males and 2,332 females) were the result of an
external cause of injury (used here to mean injury and poisoning), representing 6% of
all deaths that year. Injury was the leading cause of death for persons aged under
45 years, accounting for 43% of all deaths among people in that age group. Almost one-
quarter of people dying from injury were young males aged 20Ð34 years.
Despite a large reduction in rates since 1970, road crashes remain a common cause of
injury-related deaths. However, suicide accounted for the largest proportion of injury
deaths in 1998, followed by deaths due to road crashes. Unintentional falls, mostly by
older people, ranked third among commonly reported causes of injury death. 
For nearly all types of injury, death rates in 1998 were higher among males than
females. (One exception was falls by older people, for which male and female rates
were similar.) Overall, injury death rates were the highest among young males, and in
both males and females in old age. 
Trends in injury-related deaths
The death rate for injury declined during the second half of the twentieth century,
broadly in step with the decline in the all-causes death rate. Throughout this period,
injury was responsible for 7Ð8% of male deaths and for 4Ð5% of female deaths. During
the middle and late 1990s, however, injury death rates remained more or less static,
whereas all-causes death rates continued to decline 1Ð2% annually. 
Note: Age standardised to the Australian population at 30 June 1991.
Source: AIHW National Injury Surveillance Unit using mortality and population data from the ABS.
Figure 2.28: Injury mortality by sex and external cause, 1924 to 1998
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Trends over time in injury deaths vary greatly for major types of external cause
(Figure 2.28). No sustained underlying trend is evident in the all-ages suicide rate over
the long term, although the age-specific rate has shown a differing trend. An increase in
the suicide rate occurred in the 1960s, when the rate of suicide using pharmaceutical
substances (especially barbiturates) increased. Death rates for motor vehicle crashes
also rose with the emergence of this mode of transport in the first half of the twentieth
century, but dipped with the reduced use of motor vehicles during the Great
Depression and the Second World War. However, despite continued increases in vehicle
numbers and the distance travelled, case numbers and the population-based road
injury death rate have declined sharply since the early 1970s, due mainly to the success
of road safety initiatives (DHFS & AIHW 1998b). 
Suicides and opiate-related deaths
Two categories of injuries have shown upward trends in death rates in recent years.
These are suicide among males and deaths related to opiate drugs. 
At about 23 deaths per 100,000 population, the male suicide rates in 1997 and 1998 were
the highest since the 1960s. The female suicide rate, on the other hand, has remained
close to 5 per 100,000 population for two decades, but the rate is rising among young
females. Further information about suicide can be found in the section on mental
problems and disorders (see page 79). 
Notes 
1. Age standardised to the Australian population at 30 June 1991.
2. Includes underlying cause of death codes E850.0, E858.8, 304.0, 304.7 and 305.5.
Source: AIHW National Injury Surveillance Unit analysis of ABS mortality data.
Figure 2.29: Opiate mortality, 1979 to 1998
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The rate for opiate-related deaths has risen dramatically since the early 1980s, especially
among young adults (Figure 2.29). The rate has risen in both sexes, although the
increases are much higher among males than females. The rate for suicide by opiates
has also risen, though less rapidly, from about 0.5 deaths per 100,000 in the early 1980s
to about 1.0 in the late 1990s.
Hospital care
Injuries are a prominent reason for hospitalisation. Injury was the principal diagnosis
recorded for 403,386 separations from hospitals in Australia during 1997Ð98 (7% of all
hospital separations). 
Although records for 68,631 separations (1% of all separations) specified complications
of care as the principal diagnosis, 255,120 (5% of all separations) had mention of
complications, misadventure, abnormal reaction or adverse effect of treatment in the
record. The occurrence of adverse events and other undesired outcomes of health care is
discussed further in chapter 6.
Injury from causes other than complications of surgical and medical care was the
principal diagnosis for 334,755 separations in 1997Ð98 (6% of all separations). These
separations accounted for about 1.3 million patient bed-days, with an average length of
stay of 4.0 days. The following discussion relates to these hospital separations.
Falls was the leading single cause of injury-related hospital care in Australia in 1997Ð98,
accounting for 36% of all hospital separations for injury. Transport-related incidents (15%)
and unintentional poisoning (5%) were the other common causes of hospitalisation. 
Unintentional injuries accounted for 88% of separations from hospital due to injuries.
Interpersonal violence and intentional self-harm each accounted for about half of the
remaining 12%.
A fracture was the main diagnosis in 41% of the injury separations. Open wounds
(17%), poisoning and toxic effects (11%), sprains, strains and dislocations (8%) and
intracranial injuries (6%) were other common conditions. 
Lower limb fractures to persons aged 65 years and over accounted for 7% of all hospital
separations due to injury and for 21% of the bed-days. The average length of stay for
these separations was 12.2 days, more than three times longer than for injury cases
overall.
Prevention strategies
A range of strategies, developed by various sectors, has contributed to the sustained
decline in death rates for injuries (National Injury Prevention Advisory Council 1999).
The diverse nature of the issues constituting ÔinjuryÕ is reflected in the degree and
variety of institutional responses to the problem (NHMRC 1999). In particular, road
injury, occupational injury, drug-related harm and suicide are subjects of specific
policies and programs. The first two of these causes of injury are largely the province of
agencies outside the health sector; the response to suicide is largely from a mental
health perspective.
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The risk of injury is particularly high for some sections of the population. Two groups
well known to experience high rates of injury are people who live in rural and remote
areas compared with urban-dwellers, and Indigenous peoples compared with non-
Indigenous Australians (AIHW NISU: Moller 1996; AIHW 1998b). 
At the national level, the health sector (in addition to efforts through the National
Mental Health Strategy to tackle suicide prevention) is focusing attention on aspects of
injury that are not covered by well-established institutions and programs. The draft
National Injury Prevention Action Plan nominates four priority areas for immediate
action by the health sector in the period 2000 to 2002 (DHAC 1999): 
¥ injury due to falls among persons aged 65 years and older; 
¥ falls among children under 15 years of age; 
¥ drowning and near drowning; and 
¥ poisoning of infants and children less than 5 years of age. 
Table 2.11 presents summary information on these four types of injury. 
Table 2.11: Injury prevention priority areas for 2000Ð2002: summary data 
Indicator
Falls at ages 65
years and over
Falls at ages
0–14 years Drowning
Poisoning at
ages 0–4 years
Mortality (1998)
Cases Males 397 2 215 2
Females 617 1 58 1
Persons 1,014 3 273 3
Deaths per 100,000 
population Males 39.7 0.1 2.3 0.3
Females 48.1 0.1 0.6 0.2
Persons 44.4 0.1 1.5 0.2
Hospital separations (1997–98)
Cases Males 12,557 15,189 467 1,974
Females 36,863 9,706 224 1,622
Persons 49,420 24,895 691 3,596
Separations per 
100,000 population Males 1,268.9 755.9 5.0 298.7
Females 2,895.3 508.1 2.4 258.9
Persons 2,184.0 635.1 3.7 279.3
Notes 
1. ICD-9 codes: falls E880–888; drowning: E830, E832, E910; poisoning: E850–869.
2. Hospital separations are limited to cases where the principal diagnosis is in the range ICD-9-CM 800–999. 
3. Mortality is by year of registration. Episodes of hospital care are by year of separation from hospital.
Source: AIHW National Injury Surveillance Unit.
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Mental problems and disorders
Mental problems and disorders relate to emotions, thoughts and behaviours which can
manifest as anxiety and depression or more serious disorders such as schizophrenia. The
1995 National Health Survey estimates that about one million Australians suffer from a
mental problem or disorder. More than 50% of these are affected long term. However,
only 40% of these will seek help or have their problem diagnosed (ABS 1997b). 
Mental health has been identified as a National Health Priority Area (NHPA) (AIHW &
DHFS 1997). Depression is the most common mental disorder reported, and has been
identified as the first priority for action (DHAC & AIHW 1999a).
Mental problems and disorders are responsible for a large number of hospitalisations,
although the number of deaths from these causes is low compared with other NHPAs.
This is particularly the case among those in the age group 25Ð44 years. Mental problems
also account for much disability, incur high health system costs, and impose a heavy
burden of human suffering including stigmatisation of people with mental disorders
and their families. 
Interventions able to impact on mental problems and disorders occur at many levels of
the community, and across the spectrum of disease prevention, management and
maintenance. In particular, prevention and early intervention activities are able to focus
on recognition and early management of risk factors that increase peopleÕs vulnerability
to mental problems and disorders.
Prevalence
The prevalence and types of mental disorders are known to vary with age, sex and across
population groups. Almost 1 out of 5 children and adolescents are reported to suffer from
a mental problem or disorder within any 6-month period (Zubrick et al. 1995).
Furthermore, the 1997 ABS Survey of Mental Health and Wellbeing found that
approximately 18% of adults in the community suffer from a mental disorder (ABS 1998b). 
The onset of most mental disorders occurs in mid-to-late adolescenceÑand tends to
become chronicÑaffecting future psychosocial development. A comparative picture of
prevalence of mental problems between children and adults is given in Figure 2.30. This
shows considerable morbidity in childhood with a steady increase in prevalence to
early adulthood but a gradual decline in the older years. 
Although the overall prevalence rates are similar in both sexes, females are more likely
to experience anxiety and affective disorders whereas males are more likely to
experience substance use disorders (ABS 1998b). Further information on the prevalence
of mental problems and disorders in Australia is contained in AustraliaÕs Health 1998
(AIHW 1998a). 
GP consultations
People with mental problems and disorders are cared for in various settings, ranging
from community settings to general practice, outpatient departments, day hospital
facilities and psychiatric admissions. However, the rates of attendance vary
considerably for different levels of psychiatric care. Other than community support,
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GPs are usually the first point of healthcare contact by people with mental problems in
Australia. The number of GP consultations for mental problems and disorders is more
than twice the total contacts for other forms of professional care. 
According to the BEACH (Bettering the Evaluation And Care of Health) Survey,
psychological problems accounted for 7.2% of all problems managed by GPs in 1998Ð99,
at a rate of 105 every 1,000 encounters (AIHW GPSCU: Britt et al. 1999). In 1996, there
were approximately 1,230 primary care providers in Australia specialising in
counselling and psychotherapy (DHAC & AIHW 1999a). 
Hospitalisation 
In 1997Ð98, mental disorders accounted for 235,477 hospital separations, or 4.2% of total
hospital separations (Table 2.12, page 78), an average of 12.6 separations and 169
patient-days per 1,000 population (AIHW 1999b).
Persons diagnosed with major depressive disorder or schizophrenia accounted for the
highest proportion of separations for mental disorders in 1997Ð98, 18.6% and 14.7%
respectively (AIHW 1999b).
Note: Data for this figure come from two different sources: 1993 Western Australian Child Health Survey (children; 
dark grey bars) and 1997 National Survey of Mental Health and Wellbeing (adults; light blue bars). The data are 
presented here to show age-specific changes in the prevalence rates and have been interpreted broadly.
Sources: Silburn et al. 1996; ABS 1998b.
Figure 2.30: Prevalence of mental problems and disorders by age
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Co-morbidity
Co-morbidity refers to the occurrence of more than one disorder at the same time, and
is commonly found among people with mental disorders. The 1997 Survey of Mental
Health and Wellbeing found that nearly 1 in 3 persons with an anxiety disorder also
had an affective disorder, and 1 in 5 also had a substance use disorder. Of those who
had an anxiety disorder, 8.7% also had both affective and substance use disorders. Also,
those with mental disorders are more likely to have physical conditions. Almost 43% of
persons with a mental disorder had one or more physical conditions such as a heart
problem, diabetes or cancer. This coexistence of a physical condition and a mental
disorder was reported much more commonly among females (ABS 1998b).
Disability 
According to the 1998 Survey of Disability, Ageing and Carers, about 529,000 people
had a disability related to a mental disorder (ABS 1999b). Females were more likely to
report psychiatric disability than males. Disability was more common (62.9%) among
those with both a physical condition and a mental disorder (ABS 1999b). 
Table 2.12: Hospital separations(a) for mental disorders, all hospitals(b), 1997Ð98
ICD-9-CM code Principal diagnosis
Hospital separations
Total Per cent Rate(c)
290, 294.1, 331.0 Dementia 7,836 3.3 0.4
291–294 Other organic psychotic conditions(d) 16,572 7.0 0.9
295 Schizophrenic disorders 34,552 14.7 1.9
296 Other affective psychoses(e) 16,229 6.9 0.9
298–299 Other psychoses 4,555 1.9 0.2
296.2–296.3 Major depressive disorder 43,869 18.6 2.4
311 Depressive disorder, nec 8,987 3.8 0.5
297 Paranoid states 2,164 0.9 0.1
300 Neurotic disorders 22,660 9.6 1.2
301 Personality disorders 8,247 3.6 0.4
302 Sexual deviations and disorders 284 0.1 <0.1
303 Alcohol dependence syndrome 14,211 6.0 0.8
304 Drug dependence 6,826 2.9 0.4
305 Non-dependent drug use disorder 6,399 2.7 0.3
306–310, 312–316 Other non-psychotic mental disorders 41,729 17.7 2.2
V71.0 Observation for suspected mental condition 253 0.1 <0.1
Other codes Other factors influencing health status, services 
contact 104 0.04 <0.1
Total 235,477 100.00 12.6
(a) Includes same-day separations.
(b) Includes public psychiatric hospitals.
(c) Separations per 1,000 population.
(d) Excludes dementia in conditions classified elsewhere (294.1).
(e) Excludes major depressive disorder (296.2–296.3).
Source: AIHW National Hospital Morbidity Database.
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Mortality
In 1998, a total of 3,268 deaths occurred where a mental disorder was listed as the
underlying cause of death. This figure does not include suicide, which is described
separately in this section. 
Death rates for mental disorders increased between 1985 and 1998 (Figure 2.31). Among
males, the age-standardised rate increased from 13.4 deaths per 100,000 in 1985 to
15.4 deaths in 1989, rising to 17.9 deaths in 1998. Female death rates for mental disorders
also increased from 9.3 deaths per 100,000 in 1985 to 11.2 deaths in 1989, rising to
12.2 deaths in 1998. 
Suicides 
Suicide is a leading cause of death in Australia, responsible for 2,683 deaths
(2,150 males, 533 females) in 1998. The male suicide rate was higher than the female rate
across all age groups. Whereas the rate for adult females varied little by age, the male
rate peaked between ages 20 and 39 years and (to a lesser extent) at ages 80 and over
(Figure 2.32, page 80). 
Suicide became a matter of national public health concern in Australia during the 1990s
(DHAC 1998). A focus on youth suicide was prompted by the observation that the rate
for young males (i.e. ages 15Ð24 years) had risen about threefold during the 30 years to
1990, and rates at older ages had tended to decline. During the 1990s, the rate did not
rise further for males aged 15Ð19 years, but it continued to increase for males aged
20Ð39 years (Figure 2.33, page 80). 
Note: Mental disorders defined as ICD-9 codes 290–319.
Source: AIHW National Mortality Database.
Figure 2.31: Trends in death rates for mental disorders, 1985 to 1998
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Note: Age standardised to the Australian population at 30 June 1991.
Source: AIHW National Mortality Database.
Figure 2.32: Age-specific suicide rates, 1998
Note: Rates for ages 20–39 years and 40 years and over are age standardised to the June 1991 Australian 
population. Includes deaths with underlying cause of death codes E950–E959.
Source: AIHW National Injury Surveillance Unit analysis of ABS mortality data.
Figure 2.33: Suicide rates for selected male age groups, 1979 to 1998
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Hanging has become the predominant method of suicide in Australia, and its use is
accelerating (Figure 2.34). The 1,217 suicide deaths by hanging, strangulation and
suffocation in 1998 were 15% of all deaths from external causes, up from 2% in 1980.
Hanging has been the most common method of suicide for males since the early 1990s
and for females since 1997. The dramatic increase in hanging more than accounts for the
total increase in the suicide rate in recent years. Suicide by hanging, strangulation and
suffocation rose from 13% of all suicides in 1980 to 45% in 1998. Rates remain much
higher for males than females, but are increasing for both sexes.
The other marked changes in the method of suicide are a reduction by more than half in
the rate of suicide by shooting since the late 1980s, and an increase of about 20% in
suicide by motor vehicle exhaust gas over the same period. Males often use more
violent means, which result in a greater number of deaths than among females. On the
other hand, females have higher rates of hospital separations for suicide and self-harm
attempts (DHAC 1998). 
Notes 
1. Age standardised to the Australian population at 30 June 1991.
2. Categories: hanging, suffocation E953; motor vehicle exhaust gas E952.0; firearms E955.0; drugs, medications 
E950.0–950.5; other means, rest of E950–959.
Source: AIHW National Injury Surveillance Unit analysis of ABS mortality data.
Figure 2.34: Suicide mortality, 1979 to 1998
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Approximately one-third of persons who die by suicide, and 40% of those who attempt
suicide, were receiving psychiatric treatment before the episode (DHAC 1998). Between
60% and 90% of young people who attempt suicide are considered to be depressed
(NHMRC 1997a). 
Male psychiatric patients are more likely to commit suicide than female patients.
Younger patients are at higher risk than older patients, and patients with extended
periods of in-patient treatment are at twice the risk of suicide compared with short-stay
patients (Lawrence et al. 1999). 
Suicide and self-harm accounted for 20,131 hospital separations during 1997Ð98, more
than 53,000 patient-days in total. These figures include people who died in hospital
following the suicide attempt. 
Burden of mental disorders
Mental disorders were responsible for 13.3% of the total disease burden and for about
30% of the non-fatal burden in 1996 (AIHW: Mathers et al. 1999a). Depression was the
leading cause of non-fatal disease burden, responsible for 8% of the total years of
ÔhealthyÕ life lost due to disability (YLD). 
In males, substance use disorders accounted for 33% of the burden of disease due to
mental problems and disorders in 1996 (Figure 2.35). In females, affective disorders
accounted for 39% of the burden. The burden of disease for affective disorders among
females was due almost entirely (87%) to depression.
Note: 1 DALY (disability-adjusted life year) = 1 lost year of equivalent ‘healthy’ life. 
Source: AIHW: Mathers et al. 1999a.
Figure 2.35: The burden of mental illness by sex and major category of mental disorder, 
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Health system costs 
The institutional and non-institutional costs of mental disorders have been estimated at
$2.58 billion or 8.3% of the total health system costs in 1993Ð94. Intentional self-inflicted
injuries cost a further $69 million (AIHW: Mathers & Penm 1999b). Hospitals and
nursing homes accounted for almost 64% of these costs (AIHW: Mathers & Penm 1999b). 
In addition, there are numerous indirect costs to the community resulting from
absenteeism, lost productivity, burden on carers and family, legal costs and lost quality
of life which are difficult to quantify (DHAC & AIHW 1999a). 
Major mental disorders
Two mental disorders, depression and schizophrenia, are discussed further in this
section because of their large overall burden in the Australian population.
Depression
A mental problem is classified as ÔdepressionÕ when at least five of the nine symptoms
listed in Box 2.11 are present (DHAC & AIHW 1999a). The severity of depression ranges
from minor melancholy and stress to debilitating levels requiring professional help and
medication. Depression as defined here includes depressive neurosis and postnatal or
reactive depression.
Depression was the most common mental disorder reported by adults in the 1997
Survey of Mental Health and Wellbeing, with 3.4% of males and 6.8% of females
reporting the condition (ABS 1998b). 
Depression was the fourth most common problem managed by general practitioners in
1998Ð99 as revealed by the BEACH survey, at a rate of 35 per 1,000 encounters (AIHW
GPSCU: Britt et al. 1999). The majority of patients were females (68%), and between the
ages of 25 and 64 years (72%). However, there is evidence that depression is
underdiagnosed, and undertreated in primary care settings (NHMRC 1997a). 
Box 2.11: Major depressive symptoms
¥ Depressed mood most of the day.
¥ Loss of interest or pleasure (in all or most activities, most of the day).
¥ Large increases or decreases in appetite (significant weight loss or gain).
¥ Insomnia or excessive sleeping (hypersomnia).
¥ Restlessness as evident by hand wringing and similar other activities (psychomotor 
agitation) or slowness of movement (psychomotor retardation).
¥ Fatigue or loss of energy.
¥ Feelings of worthlessness, or excessive and inappropriate guilt.
¥ Diminished ability to concentrate, or indecisiveness.
¥ Recurrent thoughts of death or suicide.
Source: APA 1996.
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Depression and coexisting disease
Depression frequently occurs in combination with anxiety disorders, substance-related
disorders, conduct disorders, eating disorders, attention deficit/hyperactivity disorder
and chronic conditions such as heart disease, cancer and diabetes. 
The 1997 Survey of Mental Health and Wellbeing found that approximately 50% of
people who have an affective or depressive disorder also have a related physical
problem. Recent studies indicate that persons treated for depression have 2.3 times the
risk of having a heart attack than those without it (Musselman et al. 1998). Depression is
also associated with an increased risk of developing diabetes and poorer diabetic
control (Goodnick 1997). Furthermore, approximately half the people being treated for
cancer have a psychiatric disorder, usually with depressive symptoms. 
According to the BEACH survey, most of the co-morbidities presenting with depression-
related GP encounters were for chronic conditions such as hypertension (67 per 1,000
depression-related encounters), back complaints (31 per 1,000), menopausal complaints
(27 per 1,000) and diabetes (22 per 1,000). Sleep disturbance, including insomnia,
managed at a rate of 21 per 1,000 depression encounters, was the only other psychological
problem co-managed with depression. 
People with depression may also indulge in more risky health behaviours. There is
evidence that 35% of people with mental disorders smoke; the effect is age specific,
being more prevalent in younger adults (Jorm 1999).
Schizophrenia
Schizophrenia, bipolar affective disorders and delusional disorders are generally
known as psychotic disorders. Schizophrenia accounts for over 60% of the psychotic
disorders, with males and females equally affected but with differing degrees of
severity (Jablensky et al. 1999). 
There are approximately 160,000 sufferers of schizophrenia in Australia, and the figure
increases by at least 2,000 each year (NISAD 1998). Schizophrenia can lead to lifelong
disability, affecting 1 in every 100 persons, often between the ages of 16 and 25 years. 
For males, the incidence of schizophrenia is highest in those aged 15Ð24 years and for
females in those aged 25Ð34 years. The disorder can also appear later in adulthood,
although onset is less common after age 30 and rare after 40. 
One in ten persons suffering from schizophrenia commits suicide and four out of ten
are known to have attempted suicide. Most people who commit suicide do so within
the first 10 years of their illness (DHAC & AIHW 1999a). 
Diabetes
Diabetes is a long-term (chronic) condition in which blood glucose levels remain high
because the body produces little or no insulin or cannot use insulin properly. Insulin is
a hormone produced by the pancreas that helps the body to use glucose. 
Diabetes is the seventh leading cause of death in Australia (ABS 1999d), and contributes
to significant illness, disability, poor quality of life and premature mortality. Over the
course of the disease, diabetes can lead to a variety of conditions and complications
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including heart disease, stroke, blindness, kidney failure and neurological problems.
Diabetes also contributes to many pregnancy-related complications for the mother and
the unborn child. 
Types of diabetes
Because the common feature of diabetes is high blood glucose, it is often mistakenly
thought to be a single disease. There are several types of diabetes, with different causal
mechanisms. There are three major types:
Type 1 diabetes is marked by a complete lack of insulin. People with this form of
diabetes require insulin therapy to survive. It is the most common cause of childhood
diabetes. 
Type 2 diabetes is marked by reduced levels of insulin, or the inability of the body to
use insulin properly. The disease is common among people aged 40 years and over.
Many people with this form of diabetes eventually need insulin therapy to control their
blood glucose levels.
Gestational diabetes occurs during pregnancy in about 4Ð6% of females not previously
diagnosed with diabetes. Gestational diabetes is a marker of greater risk of developing
Type 2 diabetes later in life. 
Both genetic and environmental factors contribute to the onset of diabetes. Type 1
diabetes is believed to be caused by particular biological interactions and exposure to
environmental triggers. In addition to ageing and genetic predisposition, the risk of
developing Type 2 diabetes increases with body fatness. Regular physical activity, on
the other hand, plays a protective role against the development of Type 2 diabetes
(Manson et al. 1992; Perry et al. 1995). 
Poor nutrition in foetal and early infant life is also considered to predispose a person to
the development of Type 2 diabetes (Storlien et al. 1997; Hales & Barker 1992). Low
birthweight, therefore, is considered a useful marker of the lifetime risk for Type 2
diabetes (Leger et al. 1997). The risk factors for gestational diabetes are mostly similar to
those for Type 2 diabetes.
Incidence and prevalence 
There are no national estimates of the incidence or prevalence of diabetes, based on
measured blood glucose levels. According to the 1995 National Health Survey (NHS),
over 430,700 persons (2.4% of the total population) reported that they had been
diagnosed with diabetes at some point in their lives. Of those, 82% reported that they
currently have diabetes (ABS 1997d).
The true prevalence of diabetes is higher than the figures given above suggest because
a large proportion of diabetes, especially Type 2 diabetes, remains undiagnosed in the
community. It has been estimated that for every person in the population diagnosed
with diabetes, there is one undiagnosed person (DHAC & AIHW 1999c). It is therefore
estimated that there were about 700,000 persons with diabetes in Australia in 1995
(Amos et al. 1997). 
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Among the 1995 NHS respondents reporting diabetes, 18% had Type 1 diabetes, 42%
had Type 2 diabetes, and 6% had gestational diabetes. Among the remaining 33%,
i.e. those who did not report the type of diabetes, the majority were determined to have
Type 2 diabetes (ABS 1997d). Estimates based on various data sources suggest that the
prevalence of gestational diabetes is between 5.5% and 8.8% of all pregnancies (Stone &
Halliday 1996; Moses & Colaguiri 1997). 
The prevalence of diabetes increases with age, from 0.1% among people aged less than
15 years to 8.9% among those aged 75 years and over (ABS 1997d). There is also a
marked difference in the age profile of people with various types of diabetes. Type 1
diabetes is more common among children and young adults because of its early onset;
Type 2 diabetes is the predominant form among middle-aged and elderly persons on
account of a rapid increase in its prevalence after the age of 45. 
The prevalence of diabetes, particularly Type 2 and gestational diabetes, is higher in
certain population groups, including Aboriginal and Torres Strait Islander peoples and
people of Chinese, Vietnamese, Indian and Arab origin (Dowse et al. 1990; FECCA
1997). On the other hand, Type 1 diabetes is more common among populations of
European origin.
Estimates from regional studies indicate that the incidence (new cases) of Type 1 diabetes
is between 12 and 15 per 100,000 among persons aged less than 15 years (McCarty et al.
1996). In New South Wales, the incidence of Type 1 diabetes among children under the
age of 15 years was reported to be about 22 per 100,000 in 1996. It has been suggested
that the incidence of Type 1 diabetes in Australia is on the rise, increasing annually by
3% between 1992 and 1996 (Handelsman & Jackson 1999). 
Efforts are being made to generate reliable estimates of the incidence and prevalence of
diabetes in Australia. The AIHW has recently established the National Diabetes Register
to assemble and maintain a national database of persons diagnosed with insulin-treated
diabetes (see Box 2.12). The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)
is also currently in progress to determine the prevalence of diabetes using the oral
glucose tolerance test. Plans to conduct a national biomedical risk factor survey, which
would include testing for diabetes, are also being developed. 
Diabetes-related complications
Diabetes, if uncontrolled, can lead to a range of complications including diseases of the
small blood vessels (microvascular disease) such as kidney disease, nerve damage and
loss of vision, and diseases of the large blood vessels (macrovascular disease) such as
coronary heart disease, stroke and peripheral vascular disease. The risk of
microvascular complications is similar in both Type 1 and Type 2 diabetes, but
macrovascular complications are more common in persons with Type 2 diabetes. 
All types of diabetes are known to be associated with obstetric and neonatal
complications. Poorly managed diabetes in pregnancy can lead to spontaneous
abortions, stillbirths or difficult births.
A range of factors is known to lead to, or contribute to, the risk of developing
complications in diabetes. In addition to uncontrolled glucose levels and duration of
disease, these risk factors include age, genetic predisposition, obesity, high blood
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pressure, high cholesterol and tobacco smoking. The avoidance or reduction of risk-
increasing behaviours and conditions can delay the onset or slow the progression of
complications associated with diabetes.
According to the 1995 NHS, the proportion of people with diabetes who also reported
hypertension (44.1%) was more than four times that of people without diabetes (10.0%).
Similarly, the proportion of people with diabetes who reported heart disease (14.9%)
was more than six times that of people without diabetes (2.5%), and the proportion of
people with diabetes who had kidney disease (6.8%) was over four times that of people
without diabetes (1.5%). For eye disorders, 6% of people with diabetes reported
blindness, 10% reported cataracts and 3% reported glaucoma, all complications at much
higher rates than reported by people without diabetes (ABS 1997d). 
A study in South Australia has estimated that among people with Type 2 diabetes, two
out of three persons had at least one microvascular complication and more than one out
of two persons had at least one macrovascular complication (Phillips et al. 1998).
Common complications found were nerve damage, coronary heart disease and
circulatory problems in lower limbs and feet. More males than females reported
diabetes-related complications. 
Data from the 1999 National Association of Diabetes Centres (NADC) survey have also
shown that persons attending specialist diabetes services (diabetes centres and specialist
endocrinologists in private practice) have had a wide range of complications including
erectile dysfunction, nerve damage, kidney problems, eye damage, circulatory problems
in the limbs, myocardial infarction and stroke (Table 2.13, page 88). 
Further evidence of renal complications caused by diabetes is found in the Australia
and New Zealand Dialysis and Transplant Registry, a register of people requiring
kidney dialysis or a kidney transplant. About one in five registrants during 1995Ð97
were persons with diabetes (Disney et al. 1998a).
Box 2.12: National Diabetes Register
The National Diabetes Register was established in 1999 as part of the National Diabetes
Strategy to collect information about Australians who have insulin-treated diabetes. The
Register is operated by AIHW using data from Diabetes Australia and the Australasian
Paediatric Endocrine Group.
The Register is currently collecting information about people who have been diagnosed
with insulin-treated diabetes since 1 January 1999.
Information contained in the register will assist in monitoring the incidence of insulin-
treated diabetes in Australia (including Type 1, Type 2 and gestational diabetes).
Researchers will also be able to use the Register for their studies on diabetes. In particular,
it is expected that the Register will become an important source of information for clinical
and epidemiological studies of the causes, complications and even prevention of diabetes.
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Health services use
People with diabetes are more than twice as likely as those without diabetes to consult
health professionals or use hospital services (ABS 1997d). This higher rate is related to
treatment for blood glucose control, as well as for complications associated with diabetes. 
GP consultations
In 1998Ð99, according to the BEACH survey, diabetes was managed at 3.2% of all GP
encounters with males and 2.1% of encounters with females (AIHW GPSCU: Britt et al.
1999). For persons with diabetes, high blood pressure and lipid disorders were the other
main problems managed (Table 2.14). Ischaemic heart disease without angina and heart
failure were also common problems managed for males, whereas osteoarthritis and
depression were commonly managed for females with diabetes. 
Hospital separations
In 1997Ð98, diabetes was the principal diagnosis in 23,855 hospital separations or 0.4%
of all hospital separations for that period. Diabetes is often not reported as the principal
diagnosis because the condition responsible for the hospitalisation, rather than the
diabetes, is recorded as the principal diagnosis even when it is a complication of
diabetes. Diabetes is often reported as an additional diagnosis, in particular in
Table 2.13: Presence of complications among people with diabetes, 1999
Current condition Per cent Condition(a) Per cent
Erectile dysfunction 26.4 Severe hypoglycaemia 4.5
Peripheral neuropathy 23.0 Myocardial infarction 2.3
Peripheral vascular disease 12.2 Stroke 2.1
Previous foot ulcer 5.0 New blindness 1.4
Active foot lesion 3.7 Lower limb amputation 0.9
Current foot ulcer 2.4 End-stage renal disease 0.8
Total sample 7,110 Total sample 7,110
(a) Condition seen in the last 12 months.
Source: NADC ANDIAB (Australian National Diabetes Information Audit & Benchmarking) Collection. 
Table 2.14: GP consultations: top five ÔotherÕ problems managed at encounters where diabetes 
was managed, 1998Ð99
Males Per cent(a) Females Per cent(a)
Hypertension 19.0 Hypertension 20.1
Lipid disorder 7.3 Lipid disorder 5.3
IHD(b) without angina 3.9 Immunisation(c) 5.1
Immunisation(c) 3.7 Osteoarthritis 3.0
Heart failure 2.7 Depression 2.9
Total number of complications 1,544 Total number of complications 1,543
(a) Listed condition as a proportion of all complications.
(b) Ischaemic heart disease.
(c) Includes preventive immunisation medication for hepatitis, tetanus, influenza and other non-specific conditions.
Source: AIHW GPSCU: Britt et al. 1999.
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association with primary diagnoses of coronary heart disease, stroke and kidney
disease. When separations for diabetes as the principal diagnosis and as an additional
diagnosis are combined, the total number of such separations rises to 300,181 or 5.4% of
all hospital separations (AIHW 1999b). This high number gives some insight into the
extent of diabetes-related morbidity in the population, and the need to manage it in a
hospital setting. 
The impact of diabetes on the health system is further increased by the long periods
that patients with diabetes spend in hospital. The average length of stay in hospital for
persons with diabetes as the principal diagnosis was 7 days (8.1 days when same-day
separations were excluded). In comparison, the average length of stay for all persons
without diabetes as the primary diagnosis was 4.0 days (AIHW 1999b).
Diabetes also contributes to extended hospital stays for other related or non-related
conditions. When separations for diabetes as an additional diagnosis were included in
the analysis, the average length of hospital stay increased to 7.9 days. 
Mortality
Diabetes was the underlying cause of 2,751 deaths, or 2.2% of all deaths in 1998. In
addition, diabetes was listed as an associated cause of 6,703 deaths (ABS 1999d).
Diabetes is rarely listed alone as the cause of death. Of the deaths in 1998 where
diabetes was given as the underlying cause of death, in less than 2% of cases it was
listed as the only cause. Listed in association with diabetes (as an underlying cause of
death) were conditions such as ischaemic heart disease (54.0%), hypertensive disease
(22.6%), stroke (20.8%) and kidney-related diseases (19.7%). 
Of the deaths in 1998 where diabetes was listed as an associated cause of death,
ischaemic heart disease was recorded as the underlying cause of death in 26.4% of
cases. Other prominent underlying causes of death with which diabetes was associated
included cancer (13.8%) and stroke (8.3%). 
The death rate for diabetes (as an underlying cause of death) has shown a consistent
increase in recent years, with average annual increases of 1.7% and 0.4% for males and
females respectively between 1986 and 1997. 
Burden of diabetes
In terms of premature mortality, diabetes was responsible for almost 70,000 years of life
lost (YLL) in 1996, almost 5.3% of the estimated YLL in Australia that year for all causes.
Diabetes and its complications were also responsible for much disability in 1996, with
more than 53,000 years of equivalent ÔhealthyÕ life lost to disability (YLD), or 4.6% of all
YLDs estimated for 1996. Although the impact of diabetes in terms of premature
mortality was similar in both sexes, YLD was much higher among males than females
(AIHW: Mathers et al. 1999a).
As a result of the high impact of the disease, a substantial proportion of healthcare
expenditure goes on diabetes and its complications. The direct costs of diabetes and its
complications in 1993Ð94 have been estimated at $681 million, or 2.2% of total health
system costs (AIHW: Mathers & Penm 1999a). 
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Asthma
Asthma is a chronic inflammatory disorder of the airways that results in variable
airflow obstruction in response to certain triggers. The disease affects all age groups but
particularly young people, and ranges in severity from intermittent mild symptoms to a
severe, incapacitating and life-threatening disorder. 
People with asthma experience reduced quality of life and require a range of health
services, from consultations in primary care to emergency room visits to hospital
inpatient care. The symptoms are reversible, either spontaneously or with treatment;
however, death may result if the asthmatic episode is not managed properly
(NHLBI 1992). 
Asthma is highly prevalent in Australia. Although asthma mortality has declined in the
past decade, Australia has the highest death rate for asthma among its young people in
comparison to other developed countries (Peat et al. 1994). 
Asthma became the sixth National Health Priority Area in 1999. 
Prevalence 
The prevalence of asthma in Australia is one of the highest in the world, with more than
2 million Australians estimated to be affected by the disease. According to the National
Health Survey (NHS), the self-reported prevalence of asthma has increased from 85 per
1,000 persons in 1989Ð90 to 113 per 1,000 persons in 1995 (ABS 1997c). Most of these had
asthma of mild to moderate severity, and were not at high risk of death from the disease. 
Asthma is more prevalent in young people. In the 1995 NHS, it was more commonly
reported as a recent or long-term condition by those aged less than 25 years (149 per 1,000
persons). It was reported most often in those aged 5Ð14 years (192 persons per 1,000).
Among those aged less than 15 years, asthma was reported more often by males, but in
older age groups the condition was more common in females (Figure 2.36).
There is some regional/latitudinal variation in the prevalence of asthma in Australia.
According to the 1995 NHS, Queensland had the highest (134 per 1,000 persons) and
Tasmania the lowest (103 per 1,000 persons) prevalence of asthma. Symptoms of asthma
do not vary much with season, although autumn has been reported as the time when
asthma attacks increase in number and severity (ABS 1997c). 
Risk factors
The symptoms of asthma can be triggered by a wide variety of agents in the
environment, acting either alone or in conjunction with other irritants. The irritants that
cause episodes of airway narrowing and other asthma symptoms are specific to each
individual. The known irritants include allergens, exercise, viral infections, exposure to
tobacco smoke, food chemicals, cold air and weather changes. 
Allergens. Known asthma allergens include house dust mites, pollens and animal fur
(usually cats and dogs). A high proportion of asthmatics (about 80%) are allergic to the
house dust mite (Newton et al. 1998). Australian houses are reported to have some of
the highest levels of house dust mite. This is mainly due to environmental factors such
as the location of housing in temperate coastal climates, which provide ideal conditions
for mite proliferation. 
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Smoking. Tobacco smoking has been identified as another risk factor for asthma.
According to the 1995 NHS, asthma prevalence was higher among smokers (11%) and
ex-smokers (11%) than those who have never smoked (9%). Furthermore, the prevalence
of asthma in young children living in households with one or more smokers was higher
than in non-smoking households. Of children aged 0Ð4 years, 13% living in households
with one or more smokers had asthma compared with 9% in non-smoking households.
Similarly, of children aged 5Ð9 years, 22% living in households with one or more
smokers had asthma compared with 18% in non-smoking households (ABS 1997c). 
Drugs. Traditional, prescription or non-prescription drugs can also trigger asthmatic
episodes. The medications that may cause or exacerbate asthma symptoms include
beta-adrenergic blocking agents and aspirin. Some herbal preparations, such as ÔRoyal
JellyÕ which has concentrated bee-pollen, can also trigger asthma. Allergic reactions and
exacerbation of asthma have been reported with the use of herbs such as echinacea
(Newton et al. 1998). 
Other irritants. Exposure to sensitising agents in the workplace can also cause asthma,
generally referred to as occupational asthma. Known agents include wood dust, flour,
laboratory animals, industrial chemicals (isocyanates and epoxy resins) and metal salts.
Extended exposure to these agents may also increase the severity of asthma symptoms
(Newton et al. 1998).
Source: ABS 1997c.
Figure 2.36: Age-specific prevalence of asthma, 1995
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Immunogenetic susceptibilities. Asthma often coexists with other respiratory and allergic
conditions such as eczema, seasonal allergic rhinoconjunctivitis (hay fever), chronic
obstructive pulmonary disease, emphysema and bronchitis, several of which are
immunogenetic in origin. 
Asthma management
Asthma can be controlled by effective education, regular use of peak flow meters,
identification of trigger factors, coordinating self-management with written action
plans, and regular medical consultations. Studies have shown that self-management
education reduces hospitalisations, emergency room visits, unscheduled visits to the
doctor, days off work and nocturnal asthma (Gibson et al. 1999). 
Persons who have had a hospital admission related to asthma within the last 12 months
of their consultation or who require three or more medications for control of their
asthma are at an increased risk of dying from the disease. These persons need tailored
management plans developed by their GP and close consultation with their provider
(Ruffin & Southcott 1997). 
General practitioner consultations
According to the BEACH survey, asthma is the sixth most frequently managed problem
(32 per 1,000 encounters) by GPs, accounting for 2.2% of problems managed in 1998Ð99
(AIHW GPSCU: Britt et al. 1999). 
Hospital separations 
Asthma is in the top five problems referred to hospital by GPs (AIHW GPSCU: Britt et al.
1999). During 1997Ð98, asthma was the principal diagnosis in 60,280 hospital separations
or 1.08% of all hospital separations, with an average stay of 3.5 days (AIHW 1999b).
Asthma is often reported as an additional diagnosis in hospital separations, in
particular with principal diagnoses of pneumonia, cataract and heart conditions such as
angina. When separations for asthma as the principal diagnosis and as an additional
diagnosis are combined, the number rises to 251,472 or 4.52% of all hospital separations
(AIHW 1999b). This figure gives some insight into the extent of hospital use associated
with asthma. 
Emergency department admissions
Asthma is one of the most common reasons for emergency department admissions. The
clinical presentation encompasses the whole spectrum of disease severity from chronic
cough or mild wheeze to respiratory arrest. Misdiagnosis, undertreatment or poor
asthma control of persons with asthma in the community and possibly in hospitals
often lead to re-admissions either in the course of the same attack or with subsequent
attacks of asthma. 
A cross-sectional survey in Adelaide in 1994 found that 62% of 272 patients aged under
15 years and 40% of 165 patients aged 15 years and over had attended hospital two or
more times during the preceding year. Among adults, repeat attendance was related to
asthma severity but among children re-admissions were associated with parental
attitudinal variables relating to appraisal of their childÕs asthma severity, management
of asthma attacks and parental worry (Wakefield et al. 1997).
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Disability
Asthma is a cause of significant disability in the community. According to the 1998
Disability, Ageing and Carers Survey (ABS 1999b), more than 171,000 people in
Australia reported asthma as a disabling condition. The disability is mainly in the form
of restriction of daily activities, including work and school participation. Furthermore,
131,400 Australians reported experiencing specific activity limitation in regard to self-
care, mobility and communication due to their asthma (ABS 1999b). 
Mortality
Asthma was the underlying cause of 685 deaths in 1998, compared with 543 in 1980 and
964 in 1989 (the peak year of asthma deaths). The death rates were generally similar for
both sexes from 1980 to 1998, although the rate among females was slightly higher than
the rate among males between 1993 and 1998. The declining death rates since 1990
(Figure 2.37) suggest improved treatment and management of the disease. 
Burden of disease
As indicated above, asthma is a major cause of disability rather than premature
mortality. In 1996, asthma was responsible for 2.6% of the total burden of disease in
Australia. However, most of the burden of disease was more in the form of YLD (over
86%) than YLL (AIHW: Mathers et al. 1999a). 
Note: Age standardised to the Australian population at 30 June 1991.
Source: AIHW National Mortality Database.
Figure 2.37: Trends in death rates for asthma, 1980 to 1998
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The majority of cases of asthma are diagnosed before the age of 15. These cases
contribute 70% of the total asthma burden. The average duration of childhood/
adolescent asthma is around 17 years and the average duration for asthma diagnosed in
adulthood is around 30 years. As a result, the majority of asthma cases diagnosed in
childhood will continue into adulthood. This means that at any point in time the
majority of existing (prevalent) cases of asthma will be in adults, with around 67% of
the disability burden associated with prevalent cases at ages 15 and over and 34%
associated with prevalent cases at ages 25 and over.
Health system costs
The health system costs for asthma are estimated to be $478 million in 1993Ð94, more
than 19% of the total costs for all respiratory conditions in that period. These include
costs that relate to prevention, diagnosis and treatment of asthma.
Pharmaceuticals constitute a large proportion of asthma-related costs ($199 million, or
42% of the total costs). This is in contrast to the pattern of costs for other diseases, for
which 45% of all costs are in the hospital sector (inpatients and outpatients), and only
13% of the costs are towards pharmaceuticals. Hospital sector expenditure accounts for
only 28% of direct costs for asthma (Figure 2.38) (AIHW: Mathers & Penm 1998). 
2.4 Other major chronic diseases and conditions
Although more than 80% of the years of life lost due to premature mortality (YLL) have
been attributed to the six National Health Priority Areas (NHPAs), a large proportion of
years of equivalent ÔhealthyÕ life lost to disability (YLD) result from a variety of other
chronic diseases and conditions. Prominent among the non-NHPA chronic diseases and
conditions described in this section are chronic obstructive pulmonary diseases
Source: AIHW: Mathers & Penm 1998.
Figure 2.38: Health system costs for asthma, 1993Ð94
Hospital inpatients (20%)
Nursing homes (1%)
GPs and specialists (21%)
Other health professionals (3%)
Pharmaceuticals (42%)
Out-patients (8%)
Other (4%) Research (1%)
01 AH2000 body  Page 94  Thursday, June 1, 2000  3:06 PM
2 The health of Australians  95
TRIM SIZE 175 mm Wide x 250 mm Deep
(COPD), musculoskeletal diseases and conditions, nervous system disorders, kidney
problems and cirrhosis of the liver. This section outlines morbidity, disability and
mortality associated with these diseases and conditions. 
Chronic obstructive pulmonary disease 
COPD, also referred to as chronic obstructive airways disease, is a term used to describe
a combination of several different but related diseases. COPD is a progressive and
irreversible disabling disorder characterised by diminished breathing capacity of the
lungs. Several factors have been identified as contributors to COPD. Cigarette smoking
is the most common risk factor; other risk factors include exposure to pollution (in the
workplace or elsewhere) and/or infection. 
Chronic bronchitis and emphysema are the two prominent COPD diseases. Unspecified
bronchitis, extrinsic allergic aleolitis and primary pulmonary heart disease (excluding
kyphoscoliotic heart disease) are also categorised as COPD. 
It is estimated that there were almost 300,000 persons with COPD in 1996, with more
than 20,000 new cases every year (AIHW: Mathers et al. 1999a). A large proportion of
these cases were males. 
Mortality. Although much less prevalent in the population than asthma, COPD is
responsible for more deaths. In 1998, COPD was responsible for 5,352 deaths, the fourth
most common cause of death among males (3,326 deaths) and sixth most common
cause of death among females (2,026 deaths). 
The male death rate for COPD decreased from a peak of 75 per 100,000 in 1982 to a low
of 38 per 100,000 in 1998. In contrast, the female death rate increased slightly from
11 per 100,000 in 1979 to 17 per 100,000 in 1998 (Figure 2.39, page 96).
Reductions in male mortality from COPD are considered to follow the decline in
smoking rates and, to a lesser extent, better management of the disease. The increase in
the female death rate could be the delayed effect of an increase in the proportion of
female smokers, from the late 1970s to mid-1980s. 
Hospitalisation. In 1997Ð98, there were almost 40,000 hospital separations with the
principal diagnosis of COPD, with an average length of stay of 5.3 days.
Hospitalisations for COPD occur principally among the elderly. 
Hospital separation rates for COPD were higher for males than for females. Male hospital
separations rates increased sharply from 140 per 100,000 in the age group 50Ð54 years to a
peak of 4,300 per 100,000 in the age group 85 years and over. The increase in female rates
with age was not as pronounced, rising from 170 per 100,000 in the age group 50Ð54 years
to a peak of 1,450 per 100,000 in those aged 80Ð84 years (Figure 2.40). 
Disability. COPD is a major cause of disability. It occurs more commonly among older
individuals who often have multiple chronic conditions that contribute to overall
disability. A prospective study of COPD suggests that disability in persons suffering
from COPD progresses gradually. However, within 7 to 8 years of initial diagnosis, most
persons with COPD are no longer capable of productive work (Goldring et al. 1993).
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Source: AIHW National Mortality Database.
Figure 2.39: Trends in death rates for chronic obstructive pulmonary disease, 
1979 to 1998
Source: AIHW National Hospital Morbidity Database.
Figure 2.40: Age-specific hospital separations with COPD as the principal diagnosis, 
1997Ð98
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Burden of disease. The burden of COPD includes both premature mortality and
significant disability. In 1996, COPD was the largest contributor to the burden of disease
associated with all respiratory diseases and conditions (including asthma), three times
the burden of acute respiratory infections and more than four times the burden of other
chronic respiratory diseases (Figure 2.41).
The burden of COPD was greater among males than females. In 1996, it was the fourth
leading cause of disease burden among males, accounting for 4.2% of their total disease
burden, and the sixth leading cause for females, 3.2% of their total disease burden
(AIHW: Mathers et al. 1999a:66). 
The burden due to COPD increases with age, to peak in the age groups 55Ð74 years for
males and 75 years and over for females. Among those aged 65 years and over, COPD
ranks as the fourth leading cause of burden for both males and females, accounting for
5.8% and 4.0% respectively of the total burden (AIHW: Mathers et al. 1999a:73). 
Arthritis and other musculoskeletal disorders
Arthritis and other diseases of the musculoskeletal system and connective tissue are a
diverse group of diseases and conditions that includes problems, conditions and
disorders such as chronic back pain, gout, osteoporosis, osteoarthritis, rheumatoid
arthritis and juvenile arthritis. They are responsible for considerable illness, morbidity
and disability, compromising the quality of life, but have relatively low mortality when
compared with other disease groups. The impact of these diseases and conditions is
described below.
Source: AIHW unpublished data.
Figure 2.41: The burden of chronic obstructive pulmonary disease and other 
respiratory diseases, 1996
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The scale of the problem
Incidence and prevalence. In 1995, almost 5 million Australians (26% of the total
population) self-reported one or more musculoskeletal diseases or conditions (ABS
1997b:21). A majority of these respondents, 17% of the total population, reported their
problem or condition as being long term (one that had lasted or was expected to last for
6 months or more). Arthritis and back problems (disorders of the intervertebral disc and
unspecified back problems) were reported most commonly, by 15% and 6% of the total
population respectively (ABS 1997b:20,21).
Hospital separations and visits to GPs are other useful indicators of the extent of illness
caused by these diseases and conditions (Table 2.15). In 1997Ð98, hospital separations
for diseases of the musculoskeletal system and connective tissue represented 5.6% of all
hospitalisations, with an average length of stay of 4.1 days. There were slightly more
separations among males (52%) than females (48%). Musculoskeletal diseases and
conditions also accounted for 11.7% of problems managed by GPs in 1998Ð99, with back
complaints and osteoarthritis being the most common (AIHW GPSCU: Britt et al.
1999:41). 
Estimates of the incidence and prevalence of various musculoskeletal diseases and
conditions, based on a range of data sources, have been recently generated (AIHW:
Mathers et al. 1999a). Back pain is the most common of these diseases and conditions,
with a prevalence rate of 51 per 1,000 population, followed by osteoarthritis with a rate
of 34 per 1,000 population (Table 2.15). 
Disability. Musculoskeletal diseases and conditions are responsible for much disability
in the population. In 1998, about 1.2 million Australians were reported to have a
disability due to arthritis and other musculoskeletal disorders (AIHW 1999a:219). This
represents about one-third (34.4%) of people with a disability. 
Of those reporting arthritis or other musculoskeletal disorders as their disabling
condition, more than 90% had restrictions in one or more of their core activities of self-
care, mobility and communication, and/or restrictions in schooling or employment.
People who were unable to perform core activities, or who always needed assistance,
together with those who sometimes needed assistance, represented 29% of people
reporting a musculoskeletal disability (ABS 1999b:23). Old age, accident and injury
were described as the major causes of disability attributed to arthritis and other
musculoskeletal disorders, each accounting for 27% of the reported cases. Working
conditions, work and overwork were reported as responsible in 21% of the cases of
musculoskeletal disability (ABS 1999b:24).
Mortality. Compared with other major disease groups, deaths attributed to arthritis and
other diseases of the musculoskeletal system as the underlying cause are relatively
uncommon. In 1998, death rates for diseases of the musculoskeletal system and
connective tissue were 2.3 per 100,000 males and 3.7 per 100,000 females. 
Disease burden. In 1996, musculoskeletal diseases and conditions represented 4.7% of the
total disease burden among females and 2.6% of the total burden among males (AIHW:
Mathers et al. 1999a:69). Years of ÔhealthyÕ life lost due to disability represented 94% of
the total burden among males and 91% among females. 
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Health system costs. Musculoskeletal disorders and conditions accounted for about
$3 billion in health system costs in 1993Ð94, the third highest in the list of disease
groups that are responsible for most health system expenditure. Back problems were a
major component, accounting for 23% of the total expenditure on musculoskeletal
disorders (Table 2.15). Osteoarthritis accounted for 21% of the costs, rheumatoid
arthritis for 4% and osteoporosis for 2% (AIHW: Mathers & Penm 1999b:19).  
Table 2.15: Selected musculoskeletal diseases and conditions: estimated incidence (1996), 
prevalence (1996), hospitalisations (1997Ð98) and health system costs (1993Ð94)
Disease or condition
Incidence
per 1,000
Prevalence
per 1,000
Hospital-
isations
Total costs
($’000)
Back pain 337.4 50.6 44,402 700
Osteoporosis 0.8 8.5 17,130 60
Osteoarthritis 2.3 34.1 51,306 624
Rheumatoid arthritis 0.2 3.0 5,683 129
All musculoskeletal diseases and 
conditions 480.5 131.1 312,383 3,002
Sources: AIHW National Morbidity Database; AIHW: Mathers et al. 1999a; AIHW: Mathers & Penm 1999b.
Source: AIHW National Hospital Morbidity Database.
Figure 2.42: Age-specific hospital separations with principal diagnoses of chronic back 
pain or slipped disc, 1997Ð98
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Back pain
Back pain encompasses both chronic back pain and slipped disc. It can be caused by the
displacement of an intervertebral disc, bone growth, and ligament and/or muscle
strain. Most back problems and complaints are transitory and short term, but in some
cases they can become chronic. 
In 1996, the prevalence rate for back pain was 51 per 1,000 persons (Table 2.15, page 99),
higher in males (57 per 1,000) than females (45 per 1,000). The incidence rate for back
pain has been estimated as 354 per 1,000 males and 321 per 1,000 females (AIHW:
Mathers et al. 1999a:209).
Back complaints were the most frequent musculoskeletal disease or condition managed
by GPs (AIHW GPSCU: Britt et al. 1999:41). Overall, back complaints were the seventh
most frequent problem managed by GPs in 1998Ð99, accounting for 1.8% of the total
problems managed. 
Considerable hospitalisation occurs for back pain. In 1997Ð98, there were about 44,000
hospital separations with back pain as the principal diagnosis (Table 2.15). The rates
were slightly higher for females (245 per 100,000) than males (240 per 100,000), although
the separation rates were higher among males in the age groups between 20Ð24 years
and 40Ð44 years (Figure 2.42, page 99). 
Osteoporosis
Osteoporosis is a condition in which reduction in bone mass over time increases risk of
fractures, back pain and a curving of the spine. The occurrence of the condition
increases with age and is common among older people. 
Females are more susceptible to osteoporosis because of the reduction in bone density
that begins around the age of 40 and accelerates in the years after menopause. For
example, it is estimated that the proportion of females with osteoporosis increases from
15% among those aged 60 to 64 years to 71% among those over 80 years of age (AIHW:
Mathers et al. 1999a:74,209). The prevalence of osteoporosis among females (13.7 per
1,000) was more than four times that among males (3.2 per 1,000) in 1996. 
A similar picture emerges for hospital separations. In 1997Ð98, hospital separation rates
for osteoporosis were 109 per 100,000 females and 89 per 100,000 males. The separation
rates increase with age, most rapidly from age 60Ð64 years to peak in the age group
85 years and over (Figure 2.43). 
Osteoarthritis
Osteoarthritis is a degenerative joint disease affecting primarily the hands, spine and
weight-bearing joints such as hips, knees and ankles. The disease begins in cartilage
overlying the ends of joint bones, and is caused and accelerated by mechanical forces,
disrupting the normal function of the joint. Pain is initially experienced in the joints
during and after activity, but as degeneration progresses it may occur with only
minimal movement or even during rest. Obesity, overuse of a joint during recreational
or work-related activities, meniscus tears and other forms of arthritis are associated
with the development of osteoarthritis, as are genetic factors. 
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Osteoarthritis is the second most prevalent musculoskeletal disease, after back pain, with
a rate of 34 per 1,000 persons in 1996 (Table 2.15, page 99). It is more prevalent among
females (42 per 1,000) than males (27 per 1,000) (AIHW: Mathers et al. 1999a:209). It was
the tenth most frequently managed problem in general practice, representing 1.5% of all
problems managed in 1998Ð99 (AIHW GPSCU: Britt et al. 1999:41). 
Hospitalisation for osteoarthritis is mostly concentrated in the older age groups
(Figure 2.43). In 1997Ð98, the hospital separation rate for females (311 per 100,000) was
slightly higher than the rate for males (283 per 100,000).
Osteoarthritis ranked as the tenth leading cause of total disease burden, ranking higher
among females (9th) than males (15th) (AIHW: Mathers et al. 1999a:66). It accounted for
63% of the total burden of musculoskeletal diseases and conditions in 1996. The burden
of osteoarthritis is almost entirely (99%) composed of years of equivalent ÔhealthyÕ life
lost due to disability.
Rheumatoid arthritis
Rheumatoid arthritis (which includes juvenile rheumatoid arthritis) is the most
disabling form of arthritis as it involves more than one joint and can ultimately lead to
joint destruction. The disease commences as an inflammation of the joint lining or
synovium that progresses to other parts of the joint and leads to destruction of the bone.
Source: AIHW National Hospital Morbidity Database.
Figure 2.43: Age-specific hospital separations with principal diagnoses of osteoporosis 
and osteoarthritis, 1997Ð98
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It is most common in joints of the fingers, toes, wrists, knees, elbows and ankle.
However, rheumatoid arthritis can also cause inflammation in the heart, blood vessels
and other body tissues.
Rheumatoid arthritis is more common among females. The prevalence rate in 1996 was
4.1 per 1,000 females compared with 1.9 per 1,000 males (AIHW: Mathers et al.
1999a:209). The hospital separation rate among females (42.8 per 100,000) was 2.5 times
the rate among males (17.4 per 100,000). There was a similar difference in hospital
separation rates for juvenile rheumatoid arthritis, 3.7 per 100,000 females compared
with 1.4 per 100,000 males.
Hospital separation rates for rheumatoid arthritis increased rapidly from the age group
40Ð44, reaching a peak in the age group 75Ð79 years. The juvenile form of the disease
was concentrated in the younger age groups, particularly among those aged 0Ð14 years
(Figure 2.44). 
Gout
Gout is a form of arthritis in which joint inflammation is caused by a deposit of sodium
urate crystals in the synovium. It occurs mostly in toes, ankles, knees, elbows, wrists
and hands, and more frequently in older males. 
Source: AIHW National Hospital Morbidity Database.
Figure 2.44: Age-specific hospital separations with principal diagnoses of juvenile 
chronic arthritis and rheumatoid arthritis, 1997Ð98
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Gout is a major cause of hospitalisation, particularly among males. In 1997Ð98, hospital
separation rates for gout were 24 per 100,000 males and 8 per 100,000 females.
Hospital separation rates for gout increase markedly with age. For males, it increased
from 8 per 100,000 in the age group 30Ð34 years to 53 per 100,000 in the age group
65Ð69 years, then increased sharply to 310 per 100,000 in the age group 85 years and
over. For females, the hospital separation rate was comparatively lower in all age
groups, nonetheless increasing from 11 per 100,000 in the age group 65Ð69 years to
140 per 100,000 in the age group 85 years and over in 1997Ð98. 
Nervous system disorders 
Nervous system disorders account for 9% of the total disease burden in Australia,
mostly in the form of disability. They are also responsible for significant lost
productivity and healthcare costs. Several of these disorders, such as dementia
(including AlzheimerÕs disease) and ParkinsonÕs disease, are highly age-associated and
are important causes of death and disability among older persons. Epilepsy and
multiple sclerosis are other important nervous system disorders that contribute
significantly to the burden of disease. 
Dementia
Dementia is the sixth leading cause of disease burden in Australia, accounting for 3.5%
of the total burden. The main symptoms are progressive loss of memory and other
cognitive functions, with both incidence and prevalence rising sharply after age 50.
AlzheimerÕs disease is the principal type of dementia, accounting for approximately
50% to 60% of known cases of dementia in persons over 50 years of age. 
In Australia, death rates for dementia rose steadily up to 1995 due probably to increased
awareness of the disease (Figure 2.45, page 104). This pattern is largely influenced by
trends in death rates for AlzheimerÕs disease. A large number of deaths due to
AlzheimerÕs disease have been coded to pneumonia since 1997, creating a break in the
time series. This largely explains the apparent fall in the death rate for dementia and
related deaths in recent years (Figure 2.45). 
Table 2.16: Selected nervous system disorders: estimated incidence (1996), prevalence (1996), 
mortality (1996), hospitalisations (1997Ð98) and health system costs (1993Ð94)
Nervous system 
disorder
Incidence per
100,000
Prevalence
per 100,000
Mortality per
100,000
Hospital-
isations
Total costs
($’000)
Dementia(a) 130 680 21 9,281 113,829
Epilepsy 30 340 1 17,255 157,419
Parkinson's disease 40 200 4 3,132 148,715
Multiple sclerosis 2 39 1 2,995 21,589
(a) ICD-9 codes 290, 330–331 used for incidence, prevalence, mortality, and hospitalisations; ICD-9 codes 331.0 and 
331.2 used for costs. 
Sources: AIHW National Morbidity Database; AIHW: Mathers et al. 1999a:208,214.
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Epilepsy
Epilepsy, a condition characterised by recurrent (two or more), unprovoked seizures,
affects over 62,000 Australians, with estimated prevalence rates in 1996 of 360 per 100,000
males and 320 per 100,000 females. Relatively few deaths (1 per 100,000) are attributable
to epilepsy, but there were 17,255 hospitalisations in 1997Ð98 alone (Table 2.16). The health
system costs for epilepsy are considerable, over $157 million in 1993Ð94. 
Age-specific incidence follows a U-shaped pattern, with higher rates in the youngest
and oldest age groups. Several risk factors that lead to the development of epilepsy
have been identified, and these are known to vary with age. In addition to family
history, the major risk factors for epilepsy are: anoxia (oxygen starvation); congenital
malformations and structural brain abnormalities among the newborn; cerebral palsy,
mental retardation and central nervous system infections such as bacterial meningitis
and viral encephalitis among children; and moderate to severe brain injury among
young adults. Cerebrovascular disease (stroke) and AlzheimerÕs disease are the major
risk factors for epilepsy among the elderly. 
Parkinson’s disease 
ParkinsonÕs disease is a progressive, incurable neurological disease that affects an
estimated 36,000 persons (AIHW: Mathers et al. 1999a). It mainly afflicts people over
the age of 50, with only 10% of the cases occurring at an earlier age. 
Source: AIHW National Mortality Database.
Figure 2.45: Death rates for dementia and AlzheimerÕs disease, 1979 to 1998
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The disease affects the brain (basal ganglia), leading to a progressive loss of motor skills
involving sequential movements, and impacts on cognition, behaviour and mood. It is
marked by increasing rigidity of the limbs, trunk and face, and by regular tremors,
particularly when the body is at rest. At advanced stages, swallowing and speech
become affected and the patient eventually is confined to a wheelchair or bed. Without
effective treatment and support, people with ParkinsonÕs disease become increasingly
dependent on institutional care.
Prevalence is higher among females (260 per 100,000 in 1996) than males (130 per
100,000), although death rates are higher among males (4 per 100,000 compared with
2 per 100,000 females). Health system costs were $149 million in 1993Ð94 (Table 2.16,
page 103), predominantly for nursing home care. 
Multiple sclerosis
Multiple sclerosis (MS) affects mainly adults between the ages of 20 and 50 years, with
average age of onset in the early 30s. The disease affects the myelin sheaths of the
nerves and often involves progressive impairment of vision, speech, muscle
coordination and bladder dysfunction. 
The estimated prevalence rate for MS in Australia in 1996 was 39 per 100,000, with
prevalence among females more than twice that among males (AIHW: Mathers et al.
1999a). Recorded death rates in 1998 were 0.6 per 100,000 females and 0.3 per 100,000
males, but most persons with MS die from other causes. Hospital separations for MS
have recently increased by nearly 50%, from 2,018 in 1993Ð94 to 2,995 in 1997Ð98.
Nearly three-quarters of hospital separations for MS are among females. Health system
costs for MS as a primary cause were about $22 million in 1993Ð94 (Table 2.16). 
As in several other countries, in Australia the prevalence of multiple sclerosis is
positively correlated with latitude, with Tasmania having about seven times the
prevalence rate of tropical Queensland. Because of this geographical variation, several
studies have focused on the potential role of infective agents in multiple sclerosis
(McLeod et al. 1994).
End-stage renal (kidney) disease
A variety of diseases and malfunctions affect the kidneys, including primary renal
disease (nephritis and nephrosis) and conditions such as cancer, hypertension, diabetes,
congenital malformations, infectious diseases and some injuries. The most serious
consequence of these diseases is end-stage renal failure, a condition that is fatal within
a few weeks if untreated.
The Australian and New Zealand Dialysis and Transplant Registry (ANZDATA)
monitors the incidence and prevalence of end-stage renal disease, and outcomes of
dialysis and transplantation, in Australia. According to ANZDATA, incidence of renal
failure in Australia is about 8 per 100,000 persons, with more males (59%) than females
(41%) reported to develop renal failure (Disney et al. 1999:1,13). 
The most common cause of end-stage renal disease is glomerulonephritis, an illness that
includes a variety of conditions affecting the glomerular portion of the nephron and
inhibiting the ultrafiltration of blood (Table 2.17, page 106). In 1998, glomerulonephritis
represented 32% of new cases of end-stage renal disease notified to the Registry. Long-
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term complications associated with diabetes also cause nephropathy, the second most
common cause of end-stage renal disease. Another major cause, analgesic nephropathy,
is attributed to the long-term use of various analgesic compounds and related agents,
and is potentially preventable and partially reversible. Hypertension is also a major
cause of renal failure. 
The proportion of new cases of renal failure resulting from diabetic nephropathy
increased from 16% in 1993 to 22% in 1998 (Table 2.17). Renal failure attributed to
hypertension also increased over that period, from 9% to 12% of new cases. On the
other hand, analgesic nephropathy dropped to 6% of all cases in 1998, by almost half of
the proportion in 1993. This decline may be attributed to restrictions placed on the use
of certain analgesics (NHMRC 1992:2).
Dialysis and kidney transplantation
There are two major treatment options to sustain life for people with renal failureÑ
dialysis and transplantation. Dialysis is a method of removing waste products from the
blood when the kidneys are unable to function effectively. Transplantation involves the
surgical replacement of a patientÕs kidney with one from a donor. Over the last three
decades, these treatments have been increasingly refined.
The number of people on dialysis and those with functioning transplants is increasing
(Figure 2.46), but for very different reasons. The increase in the number of people on
dialysis is mainly due to older patients being accepted on the program. In 1998, 38% of
new patients were aged 65 years and over compared with 7% in 1979 (Disney et al.
1999). Stagnancy in the availability of new donor or cadaver kidneys during the 1990s
has also contributed to the increase in dialysis patients (Disney et al. 1999). 
The increase in the number of people with functional transplants is due mainly to a
marked improvement in the survival of kidney transplants. Of people who had a
cadaveric kidney transplant in 1983, 58% had a functioning transplant 5 years later,
increasing to 73% of those who had a transplant in 1993 (Disney et al. 1998b, 1999).
Consequently, the rate for functioning kidney transplants has increased, from 9 per
Table 2.17: Causes of renal failure, 1993 and 1998
Cause
1993 1998
Number Per cent Number Per cent
Glomerulonephritis 380 33 507 32
Diabetic nephropathy 181 16 350 22
Analgesic nephropathy 124 11 97 6
Hypertension 105 9 191 12
Other 370 32 444 28
Total 1,160 100 1,589 100
Note: The data reported here have been supplied by the Australia and New Zealand Dialysis and Transplant Registry 
(ANZDATA). The interpretation and reporting of these data are the responsibility of the authors and in no way should be 
seen as an official policy or interpretation of the Australia and New Zealand Dialysis and Transplant Registry.
Source: Disney et al. 1998b, 1999.
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100,000 in 1979 to 25 per 100,000 in 1998 (Figure 2.46). There were 517 kidney transplant
operations in 1998, 85% of which were for primary recipients (first kidney transplant),
meeting less than one-third of the waiting list (Disney et al. 1999).
Dialysis procedures are the most common reason for admission to public hospitals
(378,466 separations in 1997Ð98) and the fifth most common in private hospitals
(44,640 separations in 1997Ð98) (AIHW 1999b). People requiring haemodialysis are
likely to use it at least twice a week, with about 100 separations from a hospital in any
one year. However, due to the large number of people receiving dialysis at home or in a
satellite centre, hospital separations represent only about 30% of all dialysis procedures
occurring in Australia (Disney et al. 1998b:84). As at 31 December 1998, there were
5,523 Australians dependent on dialysis. 
Deaths
In 1998, there were 789 male and 903 female deaths for which nephritis, nephrotic
syndrome or nephrosis were recorded as the underlying cause, with age-standardised
death rates of 9.3 and 6.5 per 100,000 respectively (ABS 1999d:23). An additional
9,370 deaths (5,162 males, 4,208 females) listed nephritis, nephrotic syndrome and
nephrosis as a contributing cause of death (ABS 1999d:46). There has been little change
in the underlying cause of death rate over the past 20 years. Improvements in treatment
technology are likely to have offset any increase in incidence.
Note: Age standardised to the Australian population at 30 June 1991.
Source: Disney et al. 1998b, 1999.
Figure 2.46: Kidney disease: new cases and treatments, 1979 to 1998
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Kidney disease among Aboriginal and Torres Strait Islander peoples
Indigenous people constitute an increasing and disproportionately large proportion of
new patients commencing renal treatment, increasing from 5% in 1990 to 8% in 1998
(Disney et al. 1999:13). In contrast, the proportion of persons with functioning
transplants remained the same (Disney et al. 1998b, 1999). 
Diabetes is the major cause of kidney disease among Aboriginal and Torres Strait
Islander peoples. In 1998, diabetic nephropathy contributed 42% of the Indigenous
dialysis group, compared with 22% among the total dialysis group (Disney et al. 1999).
In 1994Ð98, there were 90 Indigenous deaths (42 males and 48 females) attributed to
renal failure in Western Australia, South Australia and the Northern Territory alone
(identification of Indigenous peoples in death records in other jurisdictions is not of
sufficient quality to allow for reporting). Indigenous deaths from renal failure also
occur at relatively younger ages than non-Indigenous deaths (ABS 1999e).
Cirrhosis and other chronic liver diseases 
Cirrhosis results from damage to the liver, where the liver cells are destroyed and
replaced by scarred tissue. As the disease develops, the liver shrinks since there are
progressively fewer healthy cells. 
There are four main categories of liver disease, namely alcoholic fatty liver, hepatitis,
cirrhosis, and other or unspecified forms of liver disease. Some of these forms are
preventable or reversible. Almost all heavy drinkers have alcoholic fatty liver, but it is
partly reversible with abstinence from alcohol. Generally benign, alcoholic fatty liver
may cause death through liver failure or the formation of lung or brain blood clots.
Hepatitis is inflammation of the liver, which can cause widespread liver cell loss.
Chronic active hepatitis can progress to cirrhosis and liver cancer. Cirrhosis contributes
significantly to the burden of disease in Australia, both in terms of premature mortality
and health system costs. 
Determining the incidence and prevalence of cirrhosis and other chronic liver diseases
is difficult because most cases show no signs or symptoms until late. In 1996, it was
estimated that there were more than 1,000 new cases of cirrhosis and chronic liver
disease in Australia. The prevalence was estimated at about 70 per 100,000 males and
50 per 100,000 females (AIHW: Mathers et al. 1999a:208). Cases are concentrated among
those aged 35 years and over. 
In 1998, cirrhosis of the liver was the underlying cause of 1,018 deaths (725 males and
293 females) and the contributing or associated cause for another 876 deaths. The death
rate among males was higher than among females in all age groups, in particular
between the ages of 55 and 79 years. The disease was also the major reason for 9,836
hospitalisations in 1997Ð98. Again, the age-standardised hospitalisation rate for males
(71 per 100,000) was higher than that for females (42 per 100,000). In 1997Ð98, the average
length of hospital stay for a person with a principal diagnosis of cirrhosis was 9 days.
The death rate for cirrhosis and other chronic diseases of the liver is declining. After
rising consistently for several decades, the rate peaked in the late 1970s (Figure 2.47).
Since then, the age-standardised death rates have declined from 13 per 100,000 males
and 4.5 per 100,000 females in 1979 to 8 and 3 per 100,000, respectively, in 1998.
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2.5 Communicable diseases
Communicable or infectious diseases are illnesses due to specific infectious agents or
their toxic products. Bacteria cause diseases such as pertussis (whooping cough) and
tuberculosis; viruses cause diseases such as measles, influenza and Ross River virus
infection; fungi are responsible for conditions such as tinea; protozoan parasites cause
diseases including malaria; and bacterial toxins are responsible for conditions such as
some forms of food poisoning. Infestations of larger parasites such as head lice are also
regarded as communicable diseases. 
This section provides an overview of communicable diseases in Australia, including
notifications and deaths, and discusses the associated burden of disease, hospitalisation
and health system costs. Information on communicable diseases in general, including
pneumonia, influenza and meningitis, is presented first, followed by notifiable diseases
such as blood-borne diseases, gastrointestinal diseases, sexually transmitted diseases,
vector-borne diseases, tuberculosis and vaccine-preventable diseases. 
Information on the occurrence of communicable diseases in this section is derived
mainly from disease notifications, hospital separations and deaths data. Self-reports
from the National Health Surveys, data on visits to general practitioners, data from the
Australian Paediatric Surveillance Unit, laboratory investigations and special surveys
are other sources of information useful for the surveillance of communicable diseases in
Australia. 
Source: AIHW National Mortality Database.
Figure 2.47: Death rates for cirrhosis of the liver, 1970 to 1998
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Communicable diseases were responsible for considerable morbidity and mortality in
Australia in the early part of the twentieth century. However, the incidence and death
rates for communicable diseases have been much reduced, with improvements in
hygiene (building on advances begun in the nineteenth century), the introduction of
antibiotics and mass immunisations making major contributions (see chapter 8 for an
overview of changing patterns of disease in Australia over the twentieth century).
In 1998, there were 85,096 notifications of communicable diseases to the National
Notifiable Diseases Surveillance System, representing a slight decrease from the 89,576
notifications in 1997 (Thomson et al. 1999). The most commonly notified diseases were
blood-borne diseases, followed by gastrointestinal and sexually transmitted diseases. For
a brief description of communicable disease notifications in Australia, see Box 2.13.
In 1997Ð98, there were 79,156 hospital separations with a principal diagnosis of
infectious and parasitic diseases. In addition, there were 67,683 hospital separations for
pneumonia and influenza, and 924 hospital separations for meningitis (AIHW 1999b). 
There is much variation in the epidemiology, distribution and mortality associated with
various communicable diseases. Management of these diseases and the approaches
available to control them also vary considerably. The following provides brief
overviews of the epidemiology of some of the high profile communicable diseases in
terms of notifications, hospital separations and deaths. 
Acute respiratory infections 
Acute respiratory infections (ARI) are usually divided into upper respiratory tract
infections (URTI) and lower respiratory tract infections (LRTI). These infections are
responsible for much morbidity and mortality. It is estimated that in 1996 there were
43 million new cases of URTI, and 7 million cases of LRTI. 
Box 2.13: Disease notification 
A disease may be made notifiable to State and Territory health authorities if there is poten-
tial for its control. Information on more than forty notifiable communicable diseases is
available from the National Notifiable Diseases Surveillance System. 
Surveillance of communicable diseases varies between jurisdictions, as each State/Territory
has specific requirements under their public health legislation for notification by medical
practitioners, laboratories and hospitals. The notifiable diseases and the case definitions
may also vary between jurisdictions. However, Australia is working towards a model
public health legislation that will standardise the approach to communicable disease sur-
veillance. 
Newly diagnosed HIV infection and AIDS are notifiable conditions in every State and Terri-
tory. The National Centre in HIV Epidemiology and Clinical Research compiles HIV/AIDS
notifications.
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Mortality. ARIs contribute significantly to mortality. Pneumonia alone was responsible
for 4,459 deaths (2,000 males and 2,459 females) in 1998, the third largest cause of death
among females and the eighth largest cause of death among males. Deaths are
concentrated among males and females aged 70 years and over.
Both male and female death rates for ARI decreased over the period 1979 to 1996.
However, the male death rate was consistently higher than the female rate. The male
death rate fell from 25 per 100,000 in 1979 to 10 per 100,000 in 1996. For females, the
death rate decreased from 15 per 100,000 in 1979 to 8 per 100,000 in 1996 (Figure 2.48). 
Hospitalisations. In 1997Ð98, there were 155,960 hospital separations with the principal
diagnosis of ARI. Of the three groups of respiratory conditions considered in this report
(asthma, COPD and ARI), ARI had the highest rate of hospitalisation but the shortest
average length of stay (1.4 days).
Hospitalisations are concentrated among the elderly and the young. Again, rates are
higher for males than females. In the age group 0Ð4 years, hospital separation rates in
1997Ð98 were 5,700 per 100,000 for males and 3,900 per 100,000 for females. From age
group 50Ð54 years onwards the rates rose sharply from around 400 per 100,000 to peak
in the age group 85 years and over with rates of 8,100 per 100,000 males and 4,400 per
100,000 females (Figure 2.49). 
Note: Data for 1997 and 1998 are not included as they are not comparable with previous years following the 
introduction of automatic coding of deaths data in 1997.
Source: AIHW National Mortality Database.
Figure 2.48: Trends in death rates for acute respiratory infections, 1979 to 1996
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Burden of disease. The burden from ARI is almost equally divided between premature
mortality (YLL) and years of equivalent ÔhealthyÕ life lost due to disability (YLD). As
with the other major respiratory categories, the burden is similar for both the sexes but
is higher among the young and the elderly.
Blood-borne diseases
Blood-borne diseases are diseases spread via blood, blood products and body fluids,
although there are other modes of transmission, including sexual contact. They include
HIV infection, hepatitis B, hepatitis C and hepatitis D. Initial HIV infection may cause a
transitory illness similar to glandular fever. The infection goes on to damage the immune
system with AIDS developing as the patientÕs susceptibility to infections and cancers
increases. Hepatitis B, hepatitis C and hepatitis D are viral infections characterised by
inflammation of the liver, jaundice, anorexia, vague abdominal discomfort, nausea and
vomiting and/or fever. Severity can range from unapparent cases, detectable only
through laboratory tests, to fatal cases. Some people may become persistently infected
and develop chronic hepatitis, and/or cirrhosis and/or liver cancer. 
HIV/AIDS. At the end of 1998, there were around 11,800 people living with HIV. By then,
the cumulative number of HIV infections in Australia was estimated to be about 17,600.
Most cases of HIV infection (85%) were transmitted by sexual contact between males,
with relatively little transmission through other sources of exposure (NCHECR 1999). 
Source: AIHW National Hospital Morbidity Database.
Figure 2.49: Age-specific hospital separations with a principal diagnosis of acute 
respiratory infection, 1997Ð98
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The number of HIV diagnoses in Australia has declined, from a peak of over 2,500 in
1985 to just over 660 in 1998 (Figure 2.50). These include both newly acquired (and
diagnosed) infections and new diagnoses of infections acquired some time in the past
(Box 2.14, page 114). Around 20Ð25% of the total HIV diagnoses recorded each year
since 1993 have been in persons who are considered to have newly acquired the disease. 
New diagnoses of AIDS in Australia, after adjustment for reporting delay, peaked in
1994 with an estimated 950 diagnoses. The number is estimated to have declined to 348
new diagnoses in 1998 (Figure 2.50). This decrease in the number of AIDS diagnoses, in
addition to reductions in new infections, is due to the use of effective drug therapies for
the treatment of HIV infection. It is estimated that there were 1,090 fewer AIDS
diagnoses between 1995 and 1998 than would have been expected if the use of these
therapies had not delayed the progression from HIV to AIDS. A total of 2,430 persons
were estimated to be living with AIDS in 1998 (NCHECR 1999).  
Comparison of HIV/AIDS hospital separations over time is made difficult by the
change in coding practice for HIV/AIDS from ICD-9-CM (US version) to ICD-9-CM
(Australian version) in July 1995. Therefore, only data since 1995Ð96 are reported here.
Over the period 1995Ð96 to 1997Ð98, there were 904 hospital separations with the
Note: Age standardised to the Australian population at 30 June 1991.
Source: AIHW National Mortality Database.
Figure 2.50: Diagnoses of HIV infection and AIDS, 1980 to 1998
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principal diagnosis of HIV/AIDS and 36,116 separations with HIV/AIDS as an
additional diagnosis. Most of the separations were of males (95%), and the majority
(63%) were of persons in the age group 30Ð44 years.
There has also been a considerable reduction in the number of AIDS-related deaths in
recent years. There were 170 AIDS-related deaths in 1998, almost one-fifth of the 735
deaths recorded in 1994 (NCHECR 1999). 
Hepatitis B. The number of notifications of incident (new) cases of hepatitis B has
remained fairly consistent since 1994. The National Notifiable Diseases Surveillance
System received notification of 247 cases in 1997 (1.3 per 100,000) and 261 in 1998 (1.4
per 100,000). 
Over the period 1993Ð94 to 1997Ð98, there were 2,247 hospital separations with the
principal diagnosis of acute or chronic hepatitis B and 16,314 separations with hepatitis B
as an additional diagnosis. Hospital separations for hepatitis B were more common
among males (64%) than females (36%), and the majority (62%) were of persons in the
age group 25Ð49 years. 
Over the past two decades, the number of deaths from hepatitis B has been rising.
Between 1979 and 1998, there were 653 deaths with an underlying cause of hepatitis B,
rising from 11 deaths in 1979 to 55 deaths in 1998 (Figure 2.51). 
Hepatitis C. The numbers of hepatitis C cases notified (incident and unspecified) in 1997
and in 1998 were similar, 19,770 and 19,604 respectively. However, notifications of
incident cases of hepatitis C increased from 81 in 1997 (0.5 per 100,000) to 343 in 1998
(2.0 per 100,000). This change may be due mainly to surveillance efforts to distinguish
between new and old infections. 
Box 2.14: HIV and AIDS diagnosis
Newly diagnosed HIV: Total number of cases of HIV infection newly diagnosed in a par-
ticular year. Includes both newly acquired HIV and older cases of HIV that have only just
been diagnosed. 
Newly acquired HIV: Newly diagnosed HIV infection with a negative or indeterminate
HIV antibody test result, or a diagnosis of HIV seroconversion illness, within 1 year of
HIV diagnosis.
Seroconversion illness: Characteristic clinical findings that reflect the first interaction of
HIV with the host immune system (i.e. primary HIV infection). 
HIV antibody test: The test detects the presence of HIV antibodies that are produced by
the immune system in response to infection by the virus. Antibodies to HIV are usually
detected within the first 2 to 6 weeks of illness. 
AIDS: AIDS diagnosis is based on a positive HIV antibody test along with the presence of
any one of the conditions associated with severe immune deficiency. 
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Over the period 1993Ð94 to 1997Ð98, there were 8,485 hospital separations with the
principal diagnosis of acute or chronic hepatitis C and 45,367 separations with hepatitis C
as an additional diagnosis. Hospital separations for hepatitis C were more common
among males (61%) than females (39%), and the majority (65%) were of persons in the age
group 25Ð44 years.
Hepatitis D. There were 13 notifications of hepatitis D in 1997 and 14 in 1998. 
Gastrointestinal infections
The diseases currently classified as gastrointestinal for the National Notifiable Disease
Surveillance System include hepatitis A, salmonellosis, campylobacteriosis, yersiniosis,
listeriosis, shigellosis, botulism, typhoid and paratyphoid (Table S20, page 384).
Haemolytic uraemic syndrome (HUS) became nationally notifiable in late 1998. 
Campylobacteriosis. Campylobacteriosis accounts for more than 50% of all
gastrointestinal notifications in Australia. The infection is transmitted mainly by food or
by drinking untreated or poorly treated water. It usually causes diarrhoea for a few
days, including abdominal pain, malaise, fever, nausea and vomiting. There were 11,848
notifications of campylobacteriosis in 1997 (96.7 per 100,000) and 13,439 in 1998
(108.3 per 100,000). Since 1991, campylobacteriosis notifications have trended upwards
(Figure 2.52, page 116). The disease shows a seasonal pattern, with peak notifications in
the spring and summer months. 
Source: AIHW National Mortality Database.
Figure 2.51: Hepatitis B deaths, 1979 to 1998
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Haemolytic uraemic syndrome. HUS is a potential complication of gastrointestinal
infection with shiga-toxin-producing Escherichia coli. Acute renal failure and death are
potential consequences of infection. The Australian Paediatric Surveillance Unit has
reported 108 confirmed cases of HUS for the period July 1994 to December 1998,
including 20 from the outbreak in South Australia in 1995 that was attributed to a type
of smallgood (APSU 1999). 
Over the period 1994Ð95 to 1997Ð98, there were 332 hospital separations with the
principal diagnosis of HUS, an annual average of 83 hospital separations. The number
increased from 84 in 1994Ð95 to 122 in 1997Ð98. The majority of hospital separations
(60%) were of children aged 0Ð4 years. 
Sexually transmitted diseases
Chancroid, chlamydial infection (not elsewhere classified), donovanosis, gonococcal
infection, lymphogranuloma venereum and syphilis are the sexually transmitted
diseases (STDs) monitored by the National Notifiable Diseases Surveillance System.
There were 15,165 STD notifications in 1997 and 18,554 STD notifications in 1998. 
Chlamydial infection. Chlamydial notifications have increased in the 1990s. There were
9,126 notifications of chlamydial infection in 1997 (74.5 per 100,000) and 11,405
notifications in 1998 (87.7 per 100,000). 
Source: National Notifiable Diseases Surveillance System.
Figure 2.52: Notifications of campylobacteriosis, by month of onset, 1991 to 1998
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Gonococcal infection. NNDSS received 4,689 notifications of gonococcal infection in 1997
(25.3 per 100,000) and 5,428 notifications in 1998 (29.0 per 100,000). Notifications for
gonococcal infection increased by more than 98% between 1991 and 1998. However, this
increase may reflect improved diagnosis rather than any real increase in incidence. 
Notifications of chancroid, lymphogranuloma venereum and syphilis have remained
steady in recent years, whereas notifications of donovanosis have decreased. 
Vector-borne diseases
The nationally notifiable vector-borne diseases include several mosquito-borne viral
diseases and malaria. The viral diseases include infections caused by Barmah Forest
virus and Ross River virus, which cause epidemic polyarthritis. Also included are
Australian encephalitis (caused by Murray Valley encephalitis and Kunjin viruses),
Japanese encephalitis and dengue fever.
Ross River virus. The Ross River virus infection was the most commonly notified vector-
borne disease in Australia in 1998, with 3,094 cases (16.5 per 100,000). The infection
shows a seasonal pattern, with peak notifications in the wet season or summer months
(Figure 2.53). 
Source: National Notifiable Diseases Surveillance System.
Figure 2.53: Notifications of Ross River virus infection, by month of onset, 1992 to 1998
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Barmah Forest virus. Notifications of Barmah Forest virus infection have decreased in
recent years. There were 558 notifications in 1998 (3.0 per 100,000), down from the 704
notifications in 1997 (3.8 per 100,000). 
Dengue fever. Only a small number of cases of dengue fever were notified between 1993
and 1996. However, outbreaks of locally acquired disease in far north Queensland
resulted in a large number of cases in 1997 and 1998. In 1997, 210 cases were notified
(1.1 per 100,000), but 557 cases were notified in 1998 (3.0 per 100,000). Over 80% of these
notifications were from Queensland. 
Over the period 1993Ð94 to 1997Ð98, there were 205 hospital separations with the
principal diagnosis of dengue fever. The numbers have increased consistently from 24
in 1993Ð94 to 68 separations in 1997Ð98. The majority of hospital separations (58%) were
of persons between the ages of 15 and 34 years, and there was a greater proportion of
males (62%) than females (38%). Almost 40% of the hospital separations were in
Queensland. No deaths have been attributed to dengue fever as the underlying cause of
death since 1967. 
Japanese encephalitis. Following outbreaks in the Torres Strait in 1995, the first case of
Japanese encephalitis acquired on the Australian mainland was reported in Queensland
in March 1998. Around the same time, a further case of Japanese encephalitis was
confirmed in the Torres Strait.
Malaria. Australia has been certified malaria-free since 1981. Recent cases are all
importsÑtravellers returning from endemic areas. Malaria notifications remained
stable in the period 1994 to 1998. 
Over the period 1993Ð94 to 1997Ð98, there were 2,515 hospital separations with the
principal diagnosis of malaria, 37% of which occurred in Queensland. This corresponds
to an average of 503 hospitalisations per year. The majority of hospital separations
(52%) were of persons between the ages of 15 and 34 years, and 71% were males. 
During the period 1979 to 1998, there were 22 deaths from malaria, on average about
one death every year. The number of malaria deaths has shown little change over the
past 20 years. There were no malaria deaths reported in 1998.
Tuberculosis 
Australia has one of the lowest rates for tuberculosis notification internationally, with
little change in the number of notifications over the last 10 years. From 1986 to 1997,
between 863 and 996 new tuberculosis cases (5.2 to 5.7 per 100,000) have been notified
annually.
In 1997, a total of 954 new cases (5.2 per 100,000) were notified. Most of the cases were
in the older age groups, and were slightly more common among males (5.5 per 100,000)
than females (4.8 per 100,000). The majority of notified new cases (71%) were of those
born overseas (Gilroy et al. 1999).
Over the period 1993Ð94 to 1997Ð98, there were 4,689 hospital separations with the
principal diagnosis of tuberculosis, an annual average of 938 hospital separations. There
were more hospital separations for males (54%) than females (46%). 
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A total of 1,807 tuberculosis deaths were recorded between 1979 and 1998. The number
decreased from 95 in 1979 to 62 in 1998, with a high of 118 in 1981. Tuberculosis deaths
occurred more frequently in the older ages, with 1,547 deaths (86%) of persons aged
55 years or more.
Vaccine-preventable diseases 
Vaccine-preventable diseases are the communicable diseases for which the National
Health and Medical Research Council schedule recommends routine vaccination/
immunisation for children in Australia. These are pertussis (whooping cough), tetanus,
diphtheria, poliomyelitis, invasive Haemophilus influenzae type b (Hib) disease, measles,
mumps and rubella. There have been a number of important changes to the
vaccination/immunisation schedule in the last few years, which are outlined in
Box 2.15.
Despite a reduction in their incidence, vaccine-preventable diseases remain a problem
in Australia. Table 2.18 (page 122) shows recent notifications, hospital separations and
deaths for these diseases. 
Pertussis. Pertussis remains the most frequently reported vaccine-preventable disease,
and cyclic epidemics of pertussis continue to occur. The most recent peak occurred in
1997 with 10,668 notifications (57.6 per 100,000). In 1998, there were a total of 6,432
notifications (34.3 per 100,000), with the highest number of cases in children under 1 year
of age. A large number of cases also occurred in children aged 5Ð9 years and 10Ð14 years. 
Over the period 1993Ð94 to 1997Ð98, there were 4,031 hospital separations with the
principal diagnosis of pertussis, an average of 806 hospital separations per year. The
majority of hospital separations (60%) were of children aged less than 1 year of age. 
Box 2.15: Recent changes to the vaccination/immunisation schedule
Recent changes to the vaccination schedule are: 
¥ a fifth dose of diphtheria, tetanus, pertussis (DTP) vaccine for children aged 4Ð5 years
in 1994; 
¥ the introduction in 1994Ð95 of the second dose of measles, mumps, rubella (MMR) vac-
cine for both sexes at age 10Ð16 years, and subsequent change in 1998 for this dose to be
given between age 4 and 5 years; 
¥ from 1 May 2000, the second dose of MMR and fifth dose of DTP was scheduled for
4 years;
¥ the introduction of Haemophilus influenzae type b vaccination in 1993; and 
¥ the introduction of acellular pertussis vaccine, replacing whole-cell pertussis vaccine, as
boosters in 1997 and for the primary schedule in 1999. 
The full immunisation schedule is contained in the NHMRC Australian Immunisation
Handbook (NHMRC 1997b). 
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During the period from 1979 to 1998, there were 26 deaths with pertussis as the
underlying cause of death. In 1997, there were 6 pertussis deaths, reflecting the 1997
outbreak, but there were no deaths from pertussis recorded in 1998.
Tetanus. Tetanus cases remain rare in Australia. Only 7 notifications of tetanus were
received in 1998. 
Over the period 1993Ð94 to 1997Ð98, there were 101 hospital separations with the
principal diagnosis of tetanus, an annual average of 20 separations. The majority of
hospital separations (56%) were of persons aged 60 and older, and there was a greater
proportion of females (59%) than males (41%). There were an additional 3 hospital
separations for cases of tetanus among newborns over this period. 
Although uncommon, tetanus deaths continue to occur. During the period from 1979 to
1998, there were 42 deaths with an underlying cause of tetanus, an average of about
2 deaths every year. There has been little change in the numbers of tetanus deaths over
the past 20 years. 
Diphtheria. No cases of diphtheria have been notified since 1993. Over the period 1979 to
1998, there were only 3 deaths with an underlying cause of diphtheria. 
Polio. There have been no notifications of community-acquired (wild-type) polio since
1978 but a few possible cases of vaccine-related polio have been reported, the last one in
1995 (Burgess & McIntyre 1999). As a necessary part of the process for Australia to be
declared polio-free, an enhanced polio surveillance has been undertaken over the past
few years to supplement the notification system for this disease. No cases have been
detected through these surveillance activities, which have included the active
surveillance program for acute flaccid paralysis by the Australian Paediatric
Surveillance Unit (APSU 1999).
Haemophilus influenzae type b (Hib). The number of reported cases of invasive infections
likely to be due to Hib has declined following the introduction in April 1993 of a free
Hib vaccine for children under 5 years of age. There were 35 cases (0.2 per 100,000)
reported in 1998, the lowest annual number of notifications since national surveillance
began in 1991. Most cases were of children under 5 years of age, in particular children
under 2 years of age. 
Hib is the agent most likely to cause Haemophilus influenzae meningitis and acute
epiglottitis. Virtually all cases of epiglottitis in young children are caused by
Haemophilus influenzae type b. From 1993Ð94 to 1997Ð98, there were 1,309 hospital
separations with the principal diagnosis of acute epiglottitis or Haemophilus influenzae
meningitis, an average of 262 hospital separations every year. The number decreased
consistently over the period, from 436 in 1993Ð94 to 201 in 1997Ð98. There was a greater
proportion of hospital separations for males (58%), and 54% of these separations were
of children under the age of 10. Acute epiglottitis accounted for 72% of separations and
Haemophilus influenzae meningitis for 28%. 
Deaths from acute epiglottitis and Haemophilus influenzae meningitis have also been
falling. During the period from 1979 to 1998, there were 251 deaths with these
underlying causes, decreasing from 14 in 1979 to 3 in 1998. There was a high of 21
deaths in 1987.
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Measles. There were 306 measles notifications in 1998, at a rate of 1.6 per 100,000
population. This was the lowest annual rate since national surveillance began in 1991.
The highest notification rate in 1998 was in the age group 0Ð4 years (15.6 per 100,000),
and there were slightly more notifications for males than females. 
Over the period 1993Ð94 to 1997Ð98, there were 1,863 hospital separations with the
principal diagnosis of measles, an annual average of 373 hospital separations. There
was an 85% decrease in the number of measles hospital separations over this period,
from 917 in 1993Ð94 to 133 in 1997Ð98. More than half of the hospital separations were
in Queensland. Over half of the hospital separations were of children under the age of
10 years (55%), and a further 16% of children aged 10Ð14 years. 
During the period from 1979 to 1998, there were 74 deaths attributed to measles. The
trend shows a decrease from 11 in 1979 to none in 1995 through to 1998. Measles,
including the impact of the Measles Control Campaign, is discussed further in the
section on vaccination status (chapter 3, page 157).
Subacute sclerosing panencephalitis. Subacute sclerosing panencephalitis (SSPE) is a late
complication of measles causing progressive brain damage and finally death, usually 10
to 15 years after the initial measles episode (NHMRC 1997b). In the period from 1995 to
1998, there were six cases of SSPE, with an incidence rate of 0.02 per 100,000 (APSU
1999). 
Over the period 1993Ð94 to 1997Ð98, there were 55 hospital separations with the
principal diagnosis of SSPE. The number of SSPE hospital separations declined
consistently over this period from 19 in 1993Ð94 to 3 in 1997Ð98. Males (83%) were more
likely to be hospitalised than females (17%), and the majority of hospital separations
(74%) were of those in the age group 10Ð19 years. 
During the period from 1979 to 1998, there were 79 deaths with an underlying cause of
SSPE, an average of about 4 per year. There has been a general decrease in mortality
due to SSPE over the period, from 3 in 1979 to none in 1998. There was a high of
9 deaths in 1981, with the last two deaths occurring in 1996.
Mumps. Annual notifications of mumps have remained stable since it became notifiable
in all States and Territories in July 1996. In 1998, a total of 183 cases (1.0 per 100,000)
were reported, with the highest notification rates in the age groups 5Ð9 years (3.1 per
100,000) and 0Ð4 years (2.6 per 100,000). 
Over the period 1993Ð94 to 1997Ð98, there were 190 hospital separations with the
principal diagnosis of mumps, an annual average of 38 hospital separations. A large
proportion of the hospital separations (42%) were of children under the age of 14 years. 
During the period from 1979 to 1998, there were 10 deaths from mumps, with an
average of less than 1 per year. No mumps deaths have been reported since 1995.
Rubella. Notification rates for rubella have fallen from 4,380 notifications in 1995
(24.2 per 100,000) to a low of 772 cases (4.1 per 100,000) in 1998. Males aged 15Ð19 years
continue to have the highest notification rate (15.8 per 100,000 in 1998), although this
rate has declined since 1994Ð95 when the second dose of the measles, mumps and
rubella vaccine was introduced for both sexes at age 10Ð16 years. 
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Over the period 1993Ð94 to 1997Ð98, there were 305 hospital separations with the
principal diagnosis of rubella, decreasing from 73 in 1993Ð94 to 29 in 1997Ð98. There
were more hospital separations of males (63%) than females (37%), and 50% were of
children under the age of 5 years. The last recorded rubella death was in 1988, the only
death from rubella during the 20-year period from 1979 to 1998. 
The major burden of rubella on the community is children born with congenital
abnormalities due to maternal rubella during pregnancy. In the period between May
1993 and December 1997, 26 children were born with congenital rubella infection
(APSU 1999). Anomalies were identified in 21 children, with 17 having multiple defects.
No cases were identified among children born in 1998. 
Burden of communicable diseases 
Despite major reductions in mortality, and the overall success of vaccination,
communicable diseases are responsible for considerable burden of disease and health
system costs. In 1996, infectious and parasitic diseases, along with acute respiratory
infections including pneumonia and influenza, represented 3% of the total disease
burden in Australia. HIV/AIDS represented about one-fifth of the total burden of
communicable diseases in 1996 (AIHW: Mathers et al. 1999a). The burden of
communicable diseases was 30% higher among males than females. This difference was
largely due to the greater burden of HIV/AIDS among males and its consequent
premature mortality.
Infectious and parasitic diseases accounted for 2.7% ($849 million) of the total health
system costs in 1993Ð94 (AIHW: Mathers et al. 1998a). 
Issues and problems
Over the last few years, there has been a re-emergence of some of the infectious diseases
previously thought to have been conquered, and the emergence of ÔnewÕ diseases.
These have been associated with the increase in international travel, the development of
resistance to antimicrobials and changes in the environment, and the way in which the
Table 2.18: Notifications, hospital separations and deaths for the main vaccine-preventable 
diseases
Disease
ICD-9/ICD-9-CM 
codes
Notifications
(1998)
Hospital
separations
(1997–98)
Deaths
(1998)
Pertussis 033 6,432 989 0
Tetanus 037, 771.3 7 20 2
Haemophilus influenzae type b(a) 320.0, 464.3 35 201 3
Measles 055 306 133 0
Mumps 072 183 36 0
Rubella 056, 771.0 772 29 0
(a) Haemophilus influenzae cases were classified using the codes 320.0 (Haemophilus influenzae meningitis) and 464.3 
(acute epiglottitis) as Haemophilus influenzae by type is not specified in the ICD-9 coding system. 
Sources: National Notifiable Diseases Surveillance System; AIHW National Hospital Morbidity Database; AIHW National 
Mortality Database.
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population interacts with new infections. In addition, better understanding of disease
epidemiology and new diagnostic methods have led to the recognition of ÔnewÕ
communicable diseases.
Recently recognised emerging diseases include bat paramyxovirus, which causes
respiratory disease in humans and horses, in Queensland (Selvey & Sheridan 1994), and
a lyssavirus that causes neurological symptoms in humans (Allworth et al. 1996).
Factors that may contribute to the emergence of new agents of disease are medical and
animal husbandry practices and population movements. In addition, existing diseases
such as dengue fever and Japanese encephalitis have spread more widely, as well as
increased in incidence in the northern regions of Australia. These problems emphasise
the need for continued control and active surveillance of these diseases. 
The emergence of antibiotic-resistant bacteria has been recognised as an important
indicator of inappropriate use of antibiotics in human medicine and in food-producing
animals. Infections with multiresistant Staphylococcus aureus and more recently
vancomycin-resistant enterococci pose an increasing threat to health, particularly in the
hospital setting. Strategies to encourage prudent use of antimicrobials and better
infection control are important in reducing the incidence of resistance (Turnidge et al.
1996; McAlister et al. 1999).
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3 Determinants of health
 
As discussed briefly in chapter 1, the health of individuals and populations is
determined by many factors acting alone or together, often in complex interplay.
Information on the determinants of health is particularly important because it can help
explain trends in health and why some groups have better or worse health than others.
This knowledge can then guide the nature and focus of preventive activities. Prevention
can occur through the efforts of individuals acting on their own behalf, through health
professionals, and through governments and other agencies. 
The health determinants outlined in this chapter comprise: 
¥ Environmental factors. These include physical, chemical, biological, social, economic,
cultural and political factors. Socioeconomic factors such as education and
employment can affect an individualÕs ability and opportunity to make healthy
choices. Physical, chemical and biological factors affect the quality and safety of air,
water, soil and food by, for example, chemical pollution and waste disposal methods.
Larger scale environmental disruptions, such as human-induced climate change and
ozone depletion, can have major health implications. 
¥ Genetic factors. Some diseases, such as muscular dystrophy, result entirely from an
individualÕs genetic make-up whereas many others reflect the interaction between
that make-up and environmental factors.
¥ Attitudes and beliefs. Attitudes, beliefs and knowledge influence individualsÕ
lifestyle and behaviours and so affect health. 
¥ Lifestyle and behaviour. Patterns of eating and drinking, use of tobacco and other
drugs, physical activity, sexual practice, and other behaviours can all contribute
strongly to a personÕs health (Box 3.1, page 134). Along with genetic factors, lifestyle
and behaviour influence biomedical factors that affect health.
¥ Biomedical factors. Blood pressure, blood cholesterol and bodyweight are among the
important biomedical factors that affect health (Box 3.1). The levels of these factors in
an individual are the result of lifestyle, behaviour and genetic predisposition. 
3.1 Environmental factors
AustraliaÕs present social, economic and physical environment generally provides
access to good-quality food and water, housing and places for recreation as well as
education and employment. These contribute to an overall standard of living and
health that compares well with other developed countries (enHEALTH 1999; AIHW:
de Looper & Bhatia 1998; AIHW: Lester 1994). 
01 AH2000 body  Page 133  Thursday, June 1, 2000  3:06 PM
134  AustraliaÕs Health 2000
TRIM SIZE 175 mm Wide x 250 mm Deep
Despite this, some Australians such as Indigenous peoples have generally poor social
and economic conditions and poor health. In addition, significant changes to AustraliaÕs
physical environment since European settlement have been at considerable cost to
resources such as soil, rivers and aquifers, and biodiversity (State of the Environment
Advisory Council 1996; CSIRO 1998a). Also, material released into AustraliaÕs
atmosphere and the oceans contributes to environmental issues that could have
significant population health impacts in Australia and worldwide (Epstein 1999;
McMichael 1993; McMichael & Powles 1999). 
These changes to the physical environment are relevant to AustraliaÕs long-term ability
to supply basic human needs and may also pose more direct threats to health.
Unfortunately, although environmental factors are increasingly seen as important, there
are presently insufficient data to monitor nationally the levels and changes in many of
these factors or to accurately estimate their effect on current or future health.
Box 3.1: Some behavioural and biomedical risk factors associated 
with major causes of morbidity, disability and mortality 
Risk factors Cause of ill health, disability and mortality
Behavioural
Poor diet and 
nutrition
Coronary heart disease, stroke, breast and digestive system cancers, type 2 
diabetes, gallstones, osteoporosis, malnutrition, dental conditions
Excess alcohol 
consumption
Coronary heart disease, liver and pancreatic disease, stroke, high blood 
pressure, cancers of the digestive system, accidents, mental illness, violence
Smoking Coronary heart disease, several cancers including lung, mouth and cervical 
cancers, stroke, chronic lung disease
Other drug abuse HIV/AIDS, hepatitis, renal failure, mental illness, suicide, violence, accidents
Inadequate physical 
activity
Coronary heart disease, stroke, type 2 diabetes, colon cancer, osteoporosis, 
bone fractures, falls, mental illness, obesity
Excessive sun 
exposure
Melanoma and other skin cancers, premature ageing of the skin
Not vaccinated Measles, diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus 
influenzae type b
Unprotected sexual 
activity
HIV/AIDS, hepatitis, cervical cancer, infertility, pelvic infection, venereal 
disease
Biomedical
Overweight and 
obesity
Coronary heart disease, type 2 diabetes, breast cancer, gallstones, 
degenerative joint disease, obstructive sleep apnoea
High blood pressure Coronary heart disease, stroke
Raised blood 
cholesterol level 
Coronary heart disease, stroke
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Social, economic, cultural and political determinants
The strong association between health and social and economic factors has become
increasingly recognised and documented. However, the mechanisms behind that
association are less clear (Yen & Syme 1999). Much of the research on the social and
economic bases of health focuses on the observation that people in poor circumstances
have worse health than those in more advantaged conditions. Social and economic
disadvantages (e.g. poor education, unemployment and few assets) tend to occur
together, and magnify the negative effects on health (WHO 1998). Social and economic
circumstances can also cause anxiety, low self-esteem and social isolation which in turn
can influence health-related behaviours and health itself.
In Australia, men and women with lower socioeconomic status (as measured by
education level, occupation, family income and areas of socioeconomic disadvantage),
including many Indigenous peoples, bear a higher burden of disease (see chapter 4).
Social, economic and cultural determinants of health are closely related. Social
circumstances affect behaviour, and socioeconomically disadvantaged people may be
influenced by economic and cultural reasons in their choice of behaviours that affect
health. People in lower socioeconomic groups are more likely to exhibit behaviours,
such as smoking and heavy use of alcohol, that place them at higher risk (DHAC &
AIHW 1999). Unhealthy behaviour may be driven partly by a lack of knowledge, partly
by more fatalistic attitudes and feelings of hopelessness, and partly by desire for
immediate gratification in the absence of other rewards. 
Cultural factors may influence health because of traditions, attitudes and beliefs, and
customs. Family life, parental support and social exclusion are other factors that cross
the social and cultural boundaries and may affect health in various ways. There are also
related issues of Ôsocial capitalÕ, a concept developed to explain the apparent benefits
that social ties within communities have by making resources, advantages and
opportunities available to individuals. Migrants, minority groups and refugees may be
susceptible to ill health due to social isolation and often have few social support
networks (Kawachi et al. 1996; Wilkinson & Marmot 1998). Despite this, overseas-born
Australians, especially those born in southern Europe, generally have lower death rates
than those born in Australia (Powles & Gifford 1990).
Physical, chemical and biological determinants 
Over the past decade there has been growing concern about the links between health
and the damage that humans are doing to the physical environment (McMichael 1993).
Humans now have a large and growing capacity to affect the life support systems of
this planet such as water, agricultural land and climate. 
Australia currently has no system of monitoring to provide regular national data about
issues such as the quality of drinking water, food, sewerage, soil health and
biodiversity.
In the absence of agreed national indicators, the following provides an overview of
some significant environmental issues relating to the environment and health.
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Australian climate
The atmosphere and its expression through the weather affect the economic and social
health of the country (CSIRO 1998b). Average annual temperatures have gradually
increased to be about 1°  Celsius higher in the year 2000 than they were in 1900, with
many of the warmest years on record having occurred in the 1980s and 1990s (Bureau of
Meteorology 1999a). Although average annual rainfall in north-west and south-east
Australia has increased since 1910, rainfall in the other quadrants shows little or no
change (Bureau of Meteorology 1999b). Depending on location within Australia and the
severity of global warming, temperatures are estimated to rise by between 0.6°  and 3.8°
Celsius within 70 years, and winter rainfall over most of Australia may fall by up to 20%
(CSIRO 1998a). 
Global climate is changing and the factors causing this are of both natural and human
origin (enHEALTH 1999). Although the timing and size of future changes are difficult
to predict, the consequences upon health are likely to be significant (enHEALTH 1999).
Health impacts could include increases in vector-borne diseases such as dengue fever,
water- and sewerage-related diseases, and respiratory problems related to urban
pollution. There could also be indirect health impacts resulting from impairment of
agriculture and water resources as well as damage to buildings and roads (Watson et al.
1997; enHEALTH 1999).
Some interesting environmental indicators are:
¥ a steady increase in atmospheric carbon dioxide concentrations from 330 parts per
million (ppm) in 1976 to over 360 ppm in 1998 (CSIRO 1999);
¥ per capita carbon dioxide emissions from energy use of 16.6 tonnes, which is lower
than those of the United States (20.4) but higher than those of the Organisation for
Economic Co-operation and Development (OECD) average (11.1) (OECD 1997) and
much higher than those for developing nations;
¥ estimated falling net greenhouse gas emissions from land clearing, from 103 million
tonnes of carbon dioxide equivalents in 1990 to 65 million tonnes in 1997;
¥ an 11% increase in net emissions from all other sources (related mainly to energy and
agriculture) between 1990 and 1997, from 389 to 431 million tonnes of carbon dioxide
equivalents (Australian Greenhouse Office 1997);
¥ 3% of AustraliaÕs energy production occurring through renewable methods,
compared with 11% in Canada, 17% in Japan, 1% in the Netherlands and 7% in the
United States (ABS 1999b); and
¥ 79% of Australians driving to work, 7% being driven to work as car passengers, 16%
travelling by bus or train and 9% walking or cycling (ABS 1996a).
Stratospheric ozone
The stratospheric ozone layer filters cancer-causing ultraviolet radiation from sunlight
before it reaches the EarthÕs surface. This helps protect against skin cancer, cataracts and
perhaps some suppression of the immune system (UNEP 1998). Human production and
release of chlorofluorocarbons (CFCs) and similar compounds into the atmosphere has
caused a decrease in the concentration of stratospheric ozone, especially evident over
Antarctica in spring. Through international agreement, the release of CFCs into the
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atmosphere has slowed. However, since many CFCs persist in the stratosphere for
years, the concentration of the main CFCs has remained unchanged or is still increasing
slightly (CSIRO 1999). The concentration of ozone over Antarctica in October has
halved since the 1950s (Fraser 1999). The Commonwealth Scientific and Industrial
Research Organisation (CSIRO) estimates that the ozone layer may recover between the
years 2050 and 2070 (Fraser 1999). However, fair-skinned populations at mid-latitudes
are predicted to experience a 5Ð10% increase in skin cancer incidence during the middle
decades of the twenty-first century as a result of current higher ultraviolet light
exposure (Slaper et al. 1996).
Human health indicators of environmental effects
Although the importance of the environment is increasingly being recognised, its
contribution to health is often likely to be indirect, subtle, complex and delayed. It is
therefore very difficult to estimate the full range and size of the health effects that can
ultimately be traced to the environment, and so to plan accordingly. AustraliaÕs ability
to report on health-related environmental issues is poorly developed, as elsewhere. The
reporting that is currently possible relies mainly on measures of ill health rather than
Ôgood healthÕ. Three environment-related human health issues for which data exist are
vector-borne diseases, skin cancer and low-level lead exposure of children. 
A number of communicable diseases are influenced by environmental conditions or are
kept in check by the efforts of environmental and other health workers. These diseases
include Ross River virus, Murray Valley encephalitis, Japanese encephalitis, dengue
fever, Barmah Forest virus, food poisoning diseases and legionellosis. The prevalence of
diseases influenced by environmental conditions fluctuates considerably with changes
in the weather and the prevalence of insect vectors. Surveillance of arboviruses and
their vectors is important for the detection and management of these diseases, and
climate and environmental changes associated with global warming are likely to result
in higher numbers and wider geographic distribution of vector-borne diseases within
Australia. The first case of Japanese encephalitis (a potentially fatal virus transmitted by
mosquitoes) on the Australian mainland was diagnosed in March 1998 (Thomson et al.
1998). In recent years, Japanese encephalitis has also been diagnosed in the Torres Strait
Islands. 
Development of melanoma and other skin cancers is related to exposure to ultraviolet
radiation in sunshine. Although the death rate from melanoma has remained relatively
unchanged, the incidence of new cases is growing steadily (AIHW 1999b) (see
section 2.2, page 70).
Industrial use of lead, especially in the manufacture of paint and as an additive in petrol,
has resulted in the widespread distribution of lead in the environment where it is
available for people, and especially children, to swallow or inhale. Community concern
over the past decade about the health effects of lead, especially its effects on young
children, has stimulated action to solve the problem. There has been only one systematic
national study of blood lead concentration in children. This was conducted in 1995, and
found that less than 1 in 12 children aged 1Ð4 years had blood lead concentrations
greater than or equal to the 1993 National Health and Medical Research Council
(NHMRC) goal for all Australians (AIHW: Donovan 1996). From many individual
Australian studies there appears to be a general trend for blood lead concentrations in
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children to have decreased over time. It appears likely that this decrease is in response to
the introduction of legislation encouraging the use of unleaded petrol, the general
lowering of paint-lead concentration over the decades and community awareness. 
3.2 Genetic factors
Genetic factors play an important role in human health and disease. An individualÕs
genetic make-up (genome) sets the main features and boundaries within which life is to
be experienced. It also provides the blueprint for how the human body interacts with
the environment. In addition, the genome is programmed to protect its own molecular
structure and to repair any damage caused to it by environmental agents.
Human health also depends on the genetics of other life forms, especially organisms
that infect humans. Therefore, human health should be seen as the result of our
environment (including the genetics of other life forms), our genes, and the interaction
between the two.
The spectrum of genetic diseases
Genetic factors contribute to diseases at various levels and in many different ways
(Khoury 1996). A study in British Columbia, Canada, suggests that prior to age 25, more
than 5% of all live-born individuals will be affected by a disease that primarily has a
genetic component (Baird et al. 1988). Separate estimates put the proportion at about
10% when measured for recurrent genetic diseases over the whole lifetime (UNEP &
ICPEMC 1992).
Broadly, three major types of genetic diseases/disorders are identified. (For explanation
of various genetic terms and a description of the organisation of the human genetic
material, see Box 3.2.) These are: 
¥ single gene (monogenic) disorders, genetic defects that result from an alteration or a
change (mutation) in the structure of the gene and can be traced through families and
clearly defined;
¥ chromosomal abnormalities, caused by structural changes in the chromosomes or the
gain or loss of whole chromosomes (or parts of chromosomes), some of which can be
related to specific clinical syndromes; and 
¥ multifactorial diseases, which seem to have a strong genetic component but are
expressed following interaction of genes with environmental factors such as diet,
chemical exposure and lifestyle.
About 2% of the population will have a monogenic problem or condition, with some of
the problems showing up at birth and others showing up later in life. Common
examples of monogenic disorders are muscular dystrophy, cystic fibrosis and
haemophilia. Limited data are available to generate reliable estimates of the prevalence
of these problems in Australia.  
The incidence of chromosomal abnormalities or malformations among live-born infants is
estimated to be at least 0.5%. In addition to well-defined clinical syndromes, e.g. Down
syndrome, chromosomal abnormalities also account for more than 20% of spontaneous
abortions (Riccardi 1977). Chromosomal abnormalities represented 13% of all notified
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Box 3.2: Human genetic organisation
It is estimated that each human cell has at least 70,000 different types of genes. Genes,
whose main function is to code for various proteins, are regions of deoxyribonucleic acid
(DNA) that operate as units of heredity. The total set of genes and its organisation is called
a genome.
The genetic information is stored in the ordered sequence of four types of nucleotides
(building blocks of nucleic acids) that are linked together to form DNA molecules. There
are some 6 billion nucleotides in each human cell. This extensive information system is
packaged up into 46 chromosomes (23 pairs) within the nucleus of the cell, with genes sit-
uated at specific sites or loci on the chromosomes. 
For every pair of chromosomes, one chromosome comes from one parent and the second
from the other parent. These paired chromosomes are separated again at the time of forma-
tion of sperm and ova. 
While broadly similar in underlying structure, i.e. the ordered sequence of their nucle-
otides, individual genes on each member of a pair of chromosomes may exist in alternative
forms, called alleles. Examples of this variation are alleles of the ABO gene, located on
Chromosome 9, that lead to the formation of A, B and O blood groups. 
This existence of many different forms of the same gene in the populationÑalthough an
individual may carry no more than two alleles for any one geneÑin concert with various
chromosomal combinations (possible from a set of 23 pairs of chromosomes) is the source of
much genetic variation. In addition, maternally inherited genetic information contained in
mitochondria, components of cells that are important in various cellular activities, adds to
the genetic complexity.
An international effort, the Human Genome Project, is currently under way to map the
location of each gene on the chromosomes along with their nucleotide sequence in order to
understand the function of various genes (Box 3.3, page 140). 
Genetic terms
Cell: Cells are basic structural units of organisms, made up of various membranes,
organelles and cytoplasm. The genetic material (DNA) is contained within the nucleus of
the cell as well as its mitochondria.
Chromosome: A very long strand of DNA supported by proteins. In each human cell,
except the egg and sperm cells, there are 46 chromosomes (arranged in 23 pairs, with one
member of a pair inherited from one parent) that vary in size and structure.
Chromosomal abnormalities: An anomaly resulting from a change in the number or
structure of the chromosomes. Chromosomal anomalies may occur either during the pro-
duction of the egg or sperm, or at conception, and may even transmit (or be inherited) over
generations. 
DNA (deoxyribonucleic acid): The molecule in which genetic information is stored; com-
posed of two complementary chains of nucleotides (its basic unit) wound in a double helix.
Gene: The basic unit of heredity; a sequence of nucleotides that codes for a peptide chain
(assembled into proteins), along with other intermediary genetic molecules such as ribonu-
cleic acid (RNA).
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congenital malformations in Australia in 1996, with an incidence rate of about 228 per
100,000 live births (Table 3.1) (AIHW NPSU: Hurst et al. 1999). In addition to chromo-
somal abnormalities, genetic contribution to congenital malformations such as spina
bifida, congenital heart disease, and cleft lip/cleft palate is also high (Weatherall 1993).
The health impact of various genetic disorders mentioned above is small compared
with their role in common diseases, several of which are multifactorial in origin. High
blood pressure, asthma, diabetes and schizophrenia, common chronic diseases whose
population impacts are known to be linked to environmental and lifestyle factors, also
have large genetic components (Schull & Hanis 1990). However, the involvement of
many genes in these diseases, each with an additive effect, makes it difficult to quantify
the extent of the genetic contribution (Nora et al. 1991).
In addition to the diseases that result from the abnormal functioning of the genes that
people have inherited from their parents, many genetic diseases result from
abnormalities of the genetic machinery of cells that manages genetic and cellular
processes (UNEP & ICPEMC 1992). Many forms of cancer which result from acquired
abnormalities of the genetic machinery in body cells are prime examples of such
changes. With the exception of a few rare childhood forms, cancer is now considered to
result from mutations acquired during the lifetime. These changes affect only the body
Box 3.3: The Human Genome Project
Initiated in the United States in 1988Ñthe project is now an international research
effortÑthe Human Genome Project (HGP) plans to generate genetic maps of all human
chromosomes by 2005 (Trent 1999). This includes the location of various genes on the
chromosomes and determination of their ordered nucleotide sequence. 
Several useful outcomes with relevance to human health are expected from the project,
including:
¥ knowledge about the structure of various genes and their function; 
¥ improved diagnosis and predictive testing for genetic disorders; and
¥ new treatments for genetic disorders, including gene therapy. 
Before the advent of HGP, only 4Ð6% of all human genes had been identified and their
function partially described. These genes could at best be used as markers of various dis-
eases. Availability of new molecular techniques, and a concerted international effort, has
now ensured that the full sequence of the human genome, covering more than 70,000
genes, will soon become available (Foote 1999). 
There have been many spin-offs from the HGP already, including the development of: 
¥ new technologies for microtesting, e.g. automated DNA testing of relatively small samples
of tissue or blood, with a variety of forensic, diagnostic, screening and biological applica-
tions; and
¥ sophisticated methods to link vast arrays of data, originally developed to determine loca-
tional relationships between different genes, which may prove highly suitable for linking
various administrative collections.
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cells, and are not passed on unless they affect the DNA of the egg or sperm. However,
it appears that we may inherit genes that make us more likely to develop a particular
cancer following their mutation in body cells (Weatherall 1993). 
Genetic resistance to disease
Examples of genetic diseases given above reflect mutational changes in the genome that
can damage health. However, not all mutations are harmful. Generally, along with other
mechanisms, mutations lead to the generation of significant genetic diversity that is
essential to our survival as a species. 
The wide range of human leukocyte antigens (HLA), sentries that help differentiate self
from non-self (see immunological health in chapter 2 for immune mechanisms), are
good examples of this type of variation. The HLA diversity ensures that there is enough
variation among individuals in a population to resist new diseases. 
Other forms of genetic resistance to disease include our innate ability to counter various
infections and environmental hazards. Genetic traits such as sickle cell haemoglobin
and ovalocytosis, which resist infection by the malarial parasite Plasmodium or stunt its
growth inside the cell, are good examples of innate genetic resistance. However,
individuals differ markedly in their ability to resist infection (Wakelin 1988), and this
changes with age (Anderson & May 1991). Other environmental hazards are also
handled variously by individuals using many different genetic mechanisms. 
The genetic preparedness of the human host to resist disease is also influenced by the
genetic ability of the invading organism to bypass the resistance mechanisms. Quite
often, human parasites evolve in step with the disease-resistance mechanisms of the
host. HostÐparasite interactions therefore present a fascinating example of how
environmental interactions between species influence health and disease processes.
Undoubtedly, many of the genetic traits we observe today, in either host or parasite, are
results of this co-evolution. 
Table 3.1: Notifications of chromosomal malformations, 1996
ICD-9 code Chromosomal abnormality Number
Incidence
(per 100,000
births)
758.0 Trisomy 21 (Down syndrome) 312 121
758.1 Trisomy 13 (Patau’s syndrome) 25 10
758.2 Trisomy 18 (Edward’s syndrome) 56 22
758.3 Autosomal deletion 46 18
758.5 Other autosomal anomalies 76 30
758.6 Turner’s syndrome 28 11
758.7 Klinefelter’s syndrome 17 07
758.8 Sex chromosome anomalies 25 10
758.9 Unspecified 2 1
758 Total 587 228
Note: All States and Territories notify foetuses and infants with major congenital malformations, including chromosomal 
abnormalities, to the AIHW National Perinatal Statistics Unit which provides a national monitoring system.
Source: AIHW NPSU: Hurst et al. 1999.
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A variety of determinants, however, may influence our inherent resistance to disease
(Table 3.2). These include age, nutrition and socioeconomic factors. Variation in the
capacity and mechanism for DNA repair may also lead to differences in the survival of
harmful mutations. The genetic complexity of the invading organisms, as mentioned
earlier, is another important factor.
However, this variation in response to infectious and other environmental agents
depends on the degree of exposure. If the exposure is high, such as a highly virulent
strain of a virus, then a large proportion of the population may be overwhelmed by the
exposure irrespective of genetic resistance. 
Prevention of genetic diseases
A common perception is that, since the genetic inheritance of an individual or a
population is unchangeable, its outcomes cannot be significantly altered. However, the
latest advances in genetic testing may remedy this problem partly through disease
prevention. A series of tests for prenatal screening of chromosomal abnormalities and
some single-gene disorders is now available. A variety of gene therapy techniques has
also been developed to manipulate naturally occurring genes and introduce them into
the body to combat disease. Also, given the role of genetic factors in influencing an
individualÕs response to various diseases, gene technology has the potential to
contribute to the prevention of these diseases by identifying those most at risk.
Table 3.2: Factors influencing genetic susceptibility to disease
Factor Mechanisms and outcomes
Age Older people are more vulnerable to disease than younger people because of 
the decline in their ability to handle environmental damage to DNA and the 
accumulation of harmful mutations over time.
Nutrition Diet can have a major inßuence on DNA mutation and cancer promotion. Some 
dietary factors may lead to certain genetic changes that in turn lead to cancers.
Socioeconomic factors No direct relationship has been identiÞed between socioeconomic factors and 
increases in genetic risks. However, poor diet, inadequate health care, infec-
tious diseases, and exposure to environmental agents such as tobacco smoke 
can increase an individualÕs susceptibility to agents that cause genetic change.
Genetic complexity of 
parasites
Several parasitic organisms have evolved to circumvent the defence mecha-
nisms of the human host, e.g. drug resistance, the ability to mutate at a faster 
rate, increased virulence and other evading mechanisms. 
Degree of exposure There is an upper limit to the ability of organisms to survive in a hostile environ-
ment. For example, extensive exposure to agents such as sunlight increases 
risks of skin cancer and may override all DNA repair capacities.
DNA repair mechanisms Damaged capacity to repair DNA may allow new mutations to survive. This 
repair capacity varies between individuals and between different tissues of the 
same individual.
Evolutionary maladaptations Several genetic traits such as sickle cell haemoglobin and thalassemias have 
evolved to help individuals and populations adapt to their environment. How-
ever, when the affected individuals live in other environments, the disadvan-
tages may outweigh any special advantage.
Note: Based on list given in UNEP & ICPEMC (1992).
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3.3 Attitudes and beliefs
PeopleÕs attitudes, beliefs and knowledge are among the many influences on health-
related behaviour, and therefore on health itself. Documenting and tracking these so-
called cognitive factors among Australians may help to explain overall health levels and
trends. It may also help shed light on the differences in the lifestyles and health of
different groups in the population.
Available data indicate that health is an important issue for Australians. For example,
Tasmanian adults rated ÔhealthÕ over factors such as Ôability to perform activities of
daily livingÕ, Ôrelationship with partnerÕ, Ôpersonal safetyÕ and Ôrelationship with
childrenÕ as the most important factor for quality of life (DHHST 1999).
Attitudes and beliefs on specific health issues
Data on AustraliansÕ attitudes, beliefs and knowledge are available for major health
issues such as diet, alcohol, illicit drug use and childhood immunisation. For example,
most Australian adults believe that fat, sodium and sugar contributed to the
development of disease and ill health (Crawford & Baghurst 1990). Despite the well-
documented and widely promoted adverse effects of tobacco use, the 1998 National
Drug Strategy Household Survey found that regular use of tobacco by adults is
considered acceptable by 40% of Australians (Table 3.3, page 144). 
Around 25% of Australians consider the regular use of cannabis/marijuana acceptable.
For other drugs (except tobacco and alcohol), less than 10% of Australians believe that
regular use by adults is acceptable. The legalisation of cannabis/marijuana is supported
by around 30% of Australians, and about 10% support the legalisation of heroin,
cocaine and amphetamines (AIHW 1999a). About 96% of Tasmanian adults believe that
immunisation is Ôvery effectiveÕ or ÔeffectiveÕ in preventing childhood diseases such as
measles, mumps, polio, diphtheria and tetanus (DHHST 1999). 
Sex and age differences
Although Australian data are limited, differences in attitudes and beliefs relating to
health are also evident between males and females, and between younger and older age
groups. For example, men believe that increasing physical activity is an important
healthy behaviour, whereas women focus more on social, environmental and dietary
changes (Welsh et al. 1998). Further, older Australian men are more likely to highlight
the importance of Ôkeeping busyÕ and Ôhaving some purpose in lifeÕ. In contrast, older
women appear to share the hope of Ôslowing down moreÕ after being busy with the
multiple roles of paid work, household duties, children and grandchildren. Women are
more likely to see Ôrest and relaxationÕ as important for good health (Brown et al. 1999).
Men are also more likely than women to consider regular use of cannabis/marijuana
and alcohol to be acceptable (AIHW 1999a).
Younger people are more aware than older people of the importance of fibre in a
healthy diet, and the role of fat and salt in relation to heart disease (Crawford &
Baghurst 1990). 
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3.4 Lifestyle and behaviour
Dietary behaviour
AustraliaÕs Food and Nutrition (AIHW: Lester 1994) described a strong association
between dietary behaviour and many chronic diseases.  The major causes of death,
illness and disability in which diet and nutrition play an important role include coronary
heart disease, stroke, hypertension, atherosclerosis, some forms of cancer, type 2
diabetes, osteoporosis, dental caries, gall bladder disease and nutritional anaemias.
Ill health generally cannot be attributed to any one dietary component alone (Ashwell
1997). Diseases associated with diet are also associated with environmental,
behavioural, biological and genetic factors. The complex relationships between diet,
other risk factors and disease make it difficult to assess the contribution of diet to ill
health (AIHW: Lester 1994).
In an optimal diet, the supply of required nutrients is adequate for tissue maintenance,
repair and growth. The vitamins, minerals and proteins required to maintain the human
body in good health can be met only through the intake of a well-balanced, wide
variety of food.
The dietary guidelines for Australians recommend consumption of a wide variety of
nutritious food. Essential nutrients for good health are found in varying amounts
throughout many different food groups. Variety in a diet maximises the possibility of
obtaining enough of these essential nutrients.
Table 3.3: Proportion of people who find regular drug use by adults acceptable, 1998 (per cent)
Drug Males Females Persons
Tobacco 41.8 38.6 40.2
Alcohol 67.7 55.1 61.3
Cannabis/marijuana 30.4 20.9 25.6
Pain killers/analgesics(a) 10.3 8.8 9.5
Tranquillisers/sleeping pills(a) 7.2 3.8 5.5
Steroids(a) 3.9 0.9 2.4
Barbiturates(a) 2.7 0.7 1.6
Inhalants 1.7 0.3 1.0
Heroin 2.8 0.8 1.8
Methadone(b) 2.8 0.8 1.8
Amphetamines 4.7 1.7 3.1
Cocaine 3.8 1.1 2.4
Naturally occurring hallucinogens 6.4 2.2 4.3
LSD/synthetic hallucinogens 4.4 1.5 2.9
Ecstasy/designer drugs 5.1 1.5 3.3
(a) Non-medical use.
(b) Non-maintenance.
Source: 1998 National Drug Strategy Household Survey.
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Food variety can be defined as the consumption of foods that are biologically diverse or
nutritionally distinct from each other. Data from the 1995 National Nutrition Survey
showed that the variety of food consumed in Australia increased significantly during
the 14 years since the previous survey.
More than 90% of Australians reported consuming foods from the Ôcereal and grainsÕ
and Ômilk productÕ food groups in 1995 (ABS & DHFS 1997). However, over half of the
males aged 12Ð44 years and approximately one-third of children aged 4Ð11 years had
not eaten fruit on the day before the interview.
There is increasing evidence that fresh fruit and vegetable consumption offers protection
against cancer, coronary heart disease and stroke (Ness & Powles 1997; NHMRC 1992a;
Rimm et al. 1996; Steinmetz & Potter 1996). Previously, five serves of fruit and vegetables
were recommended daily, but in recent years this has been increased to seven serves per
day to obtain the best health benefits (Cashel & Jeffreson 1995).
In 1995, the proportion of people aged over 25 years who consumed less than five
serves of fruit or vegetables per day ranged from a low of 46% for women aged 55Ð64 to
a high of 70% for men aged 35Ð44 (ABS & DHFS 1997).
It is estimated that inadequate fruit and vegetable consumption (less than five serves)
was responsible for 3% of the total burden of disease and 11% of total cancer burden in
Australia in 1996 (AIHW: Mathers et al. 1999). By comparison, the net harm associated
with alcohol consumption in 1996 was around 2.2% of the total burden of disease. The
effects of alcohol consumption on health are discussed elsewhere in this chapter. 
Source: 1995 ABS National Nutrition Survey.
Figure 3.1: Saturated fat as a proportion of total energy intake, 1995
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High intakes of fat, especially saturated fats, are associated with elevated blood
cholesterol levels, overweight and increased death from cardiovascular disease in
populations where levels of physical activity are low (AIHW 1999c). Total fat (including
saturated, mono-unsaturated and polyunsaturated) accounts for about 33% of the total
energy intake of Australian adults. Although total dietary fat intake appears to have
decreased from about 37% in the 1980s, the current level is still above the NHMRCÕs
recommended level of 30% (NHMRC 1991). 
Among Australian adults, saturated fat accounts for around 13% of total energy intake
(Figure 3.1), higher than the recommended maximum level of 10% (AIHW 1999c). The
major sources of saturated fatty acids in the adult diet are cheese, butter and margarine,
pastries, milk and meat (ABS & DHAC 1998). 
High salt consumption in some people is associated with an increase in blood pressure
and possibly cardiovascular illness and death. No national data exist to assess levels of
salt consumption among Australians. However, in one study conducted in Hobart, only
6% of men and 36% of women were below the recommended maximum intake of
100 mmol/day (Beard et al. 1997).
The recommended dietary intake (RDI) is a level of consumption for each nutrient
considered to be adequate to maintain good health and prevent deficiency diseases
(NHMRC 1991). AustraliaÕs mean nutrient intake from food and beverages, reported
from the 1995 National Nutrition Survey, was very close to or exceeded the RDI for
most vitamins and minerals in all age groups. The exceptions were calcium for females
in most age groups and for boys aged 12Ð15 years, zinc for females aged over 12 years,
and magnesium for girls aged 16Ð18 years (ABS & DHFS 1997). Calcium is important
for bone and tooth development and insufficient dietary calcium increases the risk of
developing low bone density and osteoporosis (NHMRC 1999). Zinc and magnesium
are important for immune function, wound healing and muscle growth (Mann &
Truswell 1998). 
The evidence linking diet with preventable disease is recognised in Australia and
internationally to provide sufficient reason for including improved nutrition as a major
component of public health initiatives (AIHW: Lester 1994). The Strategic
Intergovernmental Nutrition Alliance (SIGNAL) was established in 1997 as part of a
strategic plan to further the implementation of the National Food and Nutrition Policy
(DHCS 1992).  
Alcohol consumption
Alcohol consumption is associated with considerable mortality and morbidity in the
Australian community, accounting for an estimated 3,700 deaths in 1997 and almost
96,000 hospital episodes in 1996Ð97 (AIHW: Higgins et al. 2000).
It has been estimated that the harm caused by alcohol consumption accounts for 4.9% of
the total disease burden (AIHW: Mathers et al. 1999). Conditions associated with
hazardous and harmful alcohol use include some cancers, liver disease, pancreatitis,
diabetes and epilepsy. Alcohol is a significant factor in motor vehicle fatalities and
injuries, and is associated with falls, drowning, burns, suicide and occupational injuries
(English et al. 1995).
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However, low to moderate levels of alcohol consumption can protect against
hypertension, ischaemic heart disease, stroke and gallstones. The net harm associated
with alcohol consumption, after taking into account these benefits, is around 2.2% of the
total disease burden. The distribution of harm and benefit varies with age. For both
males and females, the harmful burden of disease is highest in the 15Ð24 years age
group, and the greatest protective effect is realised in persons over 75 years of age.
There are also social costs to the excessive use of alcohol. In 1998, over one-third of
adult Australians reported being either verbally or physically abused by someone
under the influence of alcohol (AIHW 1999a). About 1 in 10 persons reported being the
victims of alcohol-related property damage or theft.
Based on results from the 1998 National Drug Strategy Household Survey, about 9 in 10
Australians aged 14 years or more had tried an alcoholic drink at some time in their
lives, and around 8 in 10 persons reported drinking in the past 12 months (AIHW 1999a).
Drinking status has remained largely unchanged over the last decade (Figure 3.2), with
around 50% of the population aged 14 years and over drinking regularly, i.e. on at least
one day per week. A further 30% drank on only a few occasions each month, and the
remainder either no longer drank alcohol or had never consumed a full glass of alcohol. 
Source: National Drug Strategy Household Survey series.
Figure 3.2: Alcohol drinking status, persons aged 14 years and over, 1991 to 1998
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Although the drinking status pattern has remained fairly constant, overall levels of
alcohol consumption have decreased. Using apparent consumption data published by
the Australian Bureau of Statistics (ABS), consumption of pure alcohol decreased
markedly from 9.7 litres per person in 1981 to 8.2 litres in 1991, and then more slowly to
7.6 litres in 1997 (ABS 1998a).
The 1998 National Drug Strategy Household Survey showed that among recent
drinkers (in the last 12 months), 14% of males and 6% of females typically consumed
alcohol every day of the week (Table 3.4). Based on NHMRC recommendations
regarding responsible drinking behaviour (NHMRC 1992b), at least 8% of adult male
drinkers and 4% of females usually drank at levels considered to be hazardous or
harmful to health (AIHW: Higgins et al. 2000).
Internationally, Australia ranked 19th in 1997Ð98 for per capita consumption of alcohol
(total pure alcohol), at 7.6 litres per person (Productschap voor Gedistilleerde Dranken
1999). This figure is made up from 94.5 litres of beer per person (for which Australia
ranked 9th), 19.7 litres of wine per person (ranked 18th) and 1.3 litres per person of pure
alcohol from spirits (ranked 35th). 
Tobacco smoking
Of all risk factors for disease, tobacco smoking is responsible for the greatest burden on
the health of Australians. It is estimated that in 1996 tobacco smoking was responsible
for about 12% of the total burden of disease in males and 7% in females (AIHW:
Mathers et al. 1999).
Table 3.4: Alcohol consumption patterns, recent drinkers aged 14 years and over, 1998 
(per cent)
Frequency
Quantity (standard drinks)
1–2 3–4 5–6 7 or more Total
Males
Every day 4 5 3 2 14
4–6 days/week 5 6 3 3 17
2–3 days/week 6 7 4 6 23
1 day/week 3 6 3 4 16
Less often 17 6 2 3 30
Total 36 31 15 18 100
Females
Every day 4 2 1 — 6
4–6 days/week 6 3 — — 10
2–3 days/week 9 4 1 2 16
1 day/week 8 4 2 2 17
Less often 35 9 3 2 50
Total 62 22 8 7 100
Note: ‘Recent’ refers to the last 12 months.
Source: National Drug Strategy Household Survey 1998.
01 AH2000 body  Page 148  Thursday, June 1, 2000  3:06 PM
3 Determinants of health  149
TRIM SIZE 175 mm Wide x 250 mm Deep
Tobacco smoking increases the risk of coronary heart disease, stroke and peripheral
vascular disease as well as a range of cancers and other diseases and conditions. It is
responsible for around 85% of new cases of lung cancer annually (DHFS & AIHW 1998).
Approximately 13% of deaths from cardiovascular disease and 21% of deaths from
cancer are due to smoking tobacco (AIHW 1996). It is estimated that smoking tobacco
was associated with almost 150,000 hospitalisations in Australia in 1998 (AIHW 1999a). 
From data collected in the 1995 National Health Survey it is estimated that almost
3.2 million adult Australians were at risk of developing heart disease and other chronic
conditions from smoking tobacco products (AIHW 1999c). About 27% of men and 20%
of women aged 18 years and over were smokers. Highest rates of smoking were found
among men (34%) and women (28%) aged 25Ð34 years. After 34 years of age, the rate of
smoking declined with increasing age to be lowest among men and women aged
75 years and over (Figure 3.3). 
In 1995, the proportion of ex-smokers in Australia was 32% for men and 23% for
women. The proportion of people reporting to have never smoked was 40% for men
and 57% for women (AIHW 1999c).
Source: ABS National Health Survey 1995.
Figure 3.3: Proportion of adults who are current smokers, 1995
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Male adult smoking rates have been declining since the 1960s, while among women
smoking rates began to decline in the late 1970s. However, national surveys by the Anti-
Cancer Council of Victoria show that the rate of decline of current smokers has slowed
in more recent years (Hill, White & Scollo 1998) (Figure 3.4). 
From data collected in a national survey of secondary students, it is estimated that more
than 276,000 aged 12Ð17 years were current smokers in 1996. It has been estimated that
approximately 70,000 take up smoking each year (Hill, White & Letcher 1999). The
smoking rate for those aged 12Ð15 years in 1996 was 16% for both boys and girls, with
the rate rising to 28% among boys aged 16Ð17 years and 32% among girls aged
16Ð17 years (Figure 3.5).
There was a decline in current smoking rates for students aged 12Ð17 years from 1984
through to 1990, but this decline has since ceased.
The 1998 National Drug Strategy Household Survey (AIHW 1999a) measured tobacco
consumption patterns among Australians. The average number of cigarettes smoked
per week by adult male and female smokers was 101 and 100 respectively. 
The average number of cigarettes smoked per week by teenagers (aged between 14 and
19 years) was 60 for males and 57 for females (AIHW 1999a).
Source: Hill, White & Gray 1988, 1991; Hill & White 1995; Hill, White & Scollo 1998.
Figure 3.4: Proportion of adults who are current smokers, 1974 to 1995
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Quality of life is a subjective assessment made by individuals and relates to their
functioning across a number of physical and mental health dimensions. Heavy smokers
(more than 25 cigarettes per day) have lower quality of life than do light (less than 15
cigarettes per day) or moderate (15Ð24 cigarettes per day) smokers. Further, all types of
smokers have lower quality of life than those who had never smoked and ex-smokers
(Wilson et al. 1999). 
Use of illicit drugs
Illicit drug use refers to the use of illegal drugs and the illicit use of drugs and volatile
substances, including the non-medical use of prescription drugs. Illicit drug use is,
directly and indirectly, a significant cause of death and ill health.  Conditions associated
with illicit drug use include overdose, HIV/AIDS, hepatitis C, low birthweight,
infective endocarditis, poisoning, suicide and self-inflicted injury. 
Approximately 2% of the total burden of disease in Australia can be attributed to illicit
drug use (AIHW: Mathers et al. 1999), with the age-specific burden peaking in the age
group 25Ð34 years.
Data from the 1998 National Drug Strategy Household Survey show that, defined in the
above terms, an estimated 3.3 million Australians aged 14 years or more have used an
illicit drug in the past 12 months. Most of this use is associated with marijuana/
Source: Hill, White & Letcher 1999.
Figure 3.5: Proportion of adolescents (12Ð17 years) who are current smokers, 1984 to 1996
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cannabis (around 2.7 million persons). It is estimated that in 1997, over 800 people died
from illicit drug-related causes, and in 1996Ð97 there were over 11,000 hospital episodes
related to the use of illicit drugs (AIHW 1999a).
Although estimates of low-prevalence behaviours are subject to high relative standard
errors, it appears that illicit drug use is generally increasing (Table 3.5). An exception is
the non-medical use of barbiturates, which is declining, due apparently to increased
restrictions on access to this class of drugs. As noted above, marijuana/cannabis use
continues to dominate among the drugs surveyed: in 1998 almost two-fifths of the
population aged 14 years and over had tried using marijuana/cannabis at some time in
their life, and almost one-fifth had used the drug in the past 12 months. Use of this drug
in 1998 increased from previous years, and there was an associated increase in
community acceptance of its regular use by adults (AIHW 1999a). 
In 1998, with the exception of tranquillisers, recent use by males exceeded that of females
for all the substances included in the survey (Figure 3.6), and this reflected the pattern
for lifetime use. However, between 1995 and 1998, illicit drug use among young females
(aged 14Ð19) increased markedly (particularly for marijuana/cannabis), and use of illicit
drugs among young males remained relatively stable.  This has led to a convergence in
the overall prevalence of illicit drug use between young males and females. 
Injection of illicit drugs and non-prescribed pharmaceuticals can have significant
adverse health effects, including drug overdose, acquiring of blood-borne infections
(such as with HIV or hepatitis C virus (HCV)), and other illnesses from the injection of
contaminants or impure substances. It is estimated that there were around 108,000
injecting drugs users in 1998 (AIHW 1999a).
Table 3.5: Summary of illicit drug use, persons aged 14 years and over, 1991Ð98 (per cent)
Substance
Ever used Recently used(a)
1991 1993 1995 1998 1991 1993 1995 1998
Amphetamines(b) 8 8 6 9 3 2 2 4
Barbiturates(b) (c) 4 1 2 (c) — — —
Cocaine 3 2 3 4 1 1 1 1
Ecstasy 2 3 2 5 1 1 1 2
Hallucinogens 7 7 7 10 2 1 2 3
Heroin 2 2 1 2 1 — — 1
Inhalants 3 4 2 4 1 1 — 1
Injected drugs 2 2 1 2 1 1 1 1
Marijuana/cannabis 32 34 31 39 13 13 13 18
Pain killers(b) (c) 3 12 12 (c) 2 3 5
Steroids(b) n.a. 3 1 1 n.a. — — —
Tranquillisers (c) 3 3 6 (c) 1 1 3
(a) Used in the last 12 months.
(b) For non-medical purposes.
(c) Data for 1991 not comparable to other years.
Sources: National Campaign Against Drug Abuse Household Survey 1991; National Drug Strategy Household Survey 1993, 
1995, 1998.
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In a 1998 survey of injecting drug users who visited needle and syringe exchanges,
2% tested positive for HIV antibodies and 49% of the surveyed users tested positive to
the HCV antibody. Prevalence of the antibodies is highly correlated with the length of
injecting drug-use history (Table 3.6). 
(a) For non-medical purposes.
(b) Non-maintenance.
Note: ‘Recent use’ = use within the last 12 months.
Source: 1998 National Drug Strategy Household Survey.
Figure 3.6: Recent use of selected illicit drugs, persons aged 14 years and over, 1998
Table 3.6: Prevalence of HIV and HCV antibodies among injecting drug users(a), 1998 
(per cent)
History of injecting drug 
use
Tested positive to HIV antibody Tested positive to HCV antibody
Males Females Persons Males Females Persons
Less than 3 years 1 1 1 15 20 17
3 to 5 years 2 — 1 25 34 29
6 or more years 2 1 2 63 73 66
Not reported 3 — 2 49 55 52
Total 2 1 2 47 53 49
(a) Survey of users attending 32 needle and syringe program sites.
Source: NCHECR 1999.
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Using data from the National HIV Database, approximately 8% of HIV diagnoses in
Australia have been in people with a history of injecting drug use, of whom half were
men who also reported homosexual contact (NCHECR 1999).
Physical inactivity
Physical inactivity is a major determinant of ill health and the effects of physical activity
on reducing the risk of mortality from all causes are well documented for people at all
life stages (Mensink et al. 1999). According to recent estimates, physical inactivity is
responsible for about 7% of the total burden of disease in Australia (AIHW: Mathers
et al. 1999).
Studies show that participation in physical activity is associated with the prevention of
cardiovascular disease. People who do not participate in regular moderate physical
activity are about twice as likely to suffer a cardiovascular condition compared with
those who participate (Blair et al. 1996).
Physical inactivity is associated with other risk factors for cardiovascular disease such
as overweight, high blood pressure and high blood cholesterol. People who increase
their levels of physical activity will reduce their levels of these risk factors (Bauman &
Owen 1999; United States Department of Health and Human Services 1996).
Participation in physical activity reduces the risk of developing colon cancer (Martinez
et al. 1997), and emerging evidence suggests it provides a protective effect for breast
cancer, especially among postmenopausal women (Sesso et al. 1997), and for lung
cancer (Lee et al. 1999).
Participation in physical activity is associated with a reduced risk of developing
diabetes (Hu et al. 1999) and improvements in musculoskeletal health. Further, studies
have shown the benefits of physical activity on mental health (Chen & Millar 1999).
Currently, no nationally accepted uniform procedures exist for the collection and
analysis of data on physical activity in Australia. The development of an appropriate tool
to measure the physical activity among populations is a challenging task. Physical
activity (any bodily movement produced by skeletal muscles that results in energy
expenditure) for health benefit comprises several components (e.g. intensity, frequency,
duration) that can be carried out in different settings (e.g. leisure time, occupational,
transport). Measurement is further complicated because there are several dimensions of
physical activity related to health such as energy expenditure, aerobic intensity, strength
and flexibility. For example, physical activity for the prevention of cardiovascular disease
is different from that required for prevention of musculoskeletal problems. 
The 1997 Active Australia National Physical Activity Survey indicated that 50% of men
and 49% of women aged 18Ð75 years undertook physical activity at a level which was
beneficial to health. This level was defined as participation in at least 150 minutes
activity of at least moderate intensity, spread over five sessions per week. In general,
physical activity levels decline with increasing age (Figure 3.7). 
The National Health Survey shows that the proportion of people doing no physical
activity during their leisure time decreased only slightly between 1989Ð90 and 1995
from 36% to 34%. This decline was due mainly to an increase in physical activity among
people aged 35Ð54 years (AIHW 1999c).
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Walking increased in popularity during the 1990s with 45% of men and 53% of women
walking for recreation or exercise in 1995, compared with 41% and 49%, respectively, in
1989Ð90. Despite this increase, the overall proportions of people undertaking physical
activity at moderate intensities did not change between 1989Ð90 and 1995, suggesting that
walking may have replaced other forms of moderate physical activity (Armstrong 1998).
In an effort to increase physical activity participation rates, a national participation
strategy, Active Australia, has been established. Active Australia represents the interests
of Commonwealth and State government agencies, including the sport, health and
fitness sectors. The sports and physical activities that attracted most participants in
1998Ð99 were walking (23%), swimming (15%), aerobics (11%), golf (9%) and tennis
(6%). Participation in organised sport and physical activity has increased from around
27% in 1996Ð97 to 30% in 1998Ð99 (ABS 1999a).
Sun exposure
Australia has the highest incidence of skin cancer in the world (DHFS & AIHW 1998).
Skin cancer is the most common cancer in Australia and can largely be prevented by
taking simple measures such as wearing protective clothing, applying sunscreens or
avoiding the sun. Childhood exposure to sunlight has been shown to be an important
cause of skin cancer (NHMRC 1996).
Source: 1997 Active Australia National Physical Activity Survey 1997.
Figure 3.7: People who are sufficiently active for health, 1997
18–29 30–44 45–59 60–75 18–75
0
10
20
30
40
50
60
70
Per cent
Age group (years)
Males Females
01 AH2000 body  Page 155  Thursday, June 1, 2000  3:06 PM
156  AustraliaÕs Health 2000
TRIM SIZE 175 mm Wide x 250 mm Deep
The 1995 National Health Survey found that 77% of the population were protected from
exposure to the sun, by always or usually taking some sun protection measure, or by
not going out in the sun (Figure 3.8). The most protected group were young children, of
whom 96% aged under 2 years and 92% of those aged 2Ð4 years were protected or not
exposed to the sun. Only 69% of persons aged 15Ð24 years used sun protection or were
not exposed to the sun. Overall, 23% of the population never, seldom or only sometimes
used any protection from exposure to the sun.
Some issues that can influence the accuracy of the survey results are discussed in Box 3.4.
In general, the type of sun protection used varied with age (Table 3.7). Hats followed by
sunscreen and clothing were the most common types of protection used by children
0Ð14 years. For people aged 15Ð54 years, the most common type of protection was
sunglasses followed by hats and sunscreen. Those aged 55 years and over tended to
prefer hats, with sunglasses and sunscreen as the next most frequently mentioned
protection measure taken. 
Although there are no national trend data, results from surveys in Victoria and New
South Wales suggest that the use of sun protective measures has been rising. Data from
a series of sun behaviour surveys in Victoria show a rise in the use of sunscreen in
people exposed to the sun between 11 a.m. and 3 p.m. on Sundays in the summer
months, from 19% in 1988 to 34% in 1995 (Hill & Boulter 1996). Further, the proportion
Note: See Box 3.4 for comment on the accuracy of the estimates. 
Source: 1995 National Health Survey.
Figure 3.8: Use of sun protection measures, 1995
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of people who wore a brimmed hat between 11 a.m. and 3 p.m. on the previous Sunday
rose from 9% in 1988 to 20% in 1995. A similar trend was observed in New South Wales:
in a survey of high school adolescents the percentage using high-level sun protection,
measured by a score based on protection by a hat, clothing or SPF 15+ sunscreen,
increased from 39% in 1991Ð92 to 57% in 1994Ð95 (Armstrong 1996). Over this period
there was an associated decline in attitudinal and normative beliefs favourable to
getting suntanned: the percentage of people who believed that a suntanned person is
more healthy declined from 17% in 1988 to 8% in 1995. 
Vaccination status
Immunisation is the administration of vaccine(s) to prevent disease and so reduce death
and serious illnesses, particularly in infants and children but also in adults. The potential
risks of immunisation are much lower than the risks or complications from these
diseases. Immunisation is recognised as a key cost-effective public health program
(Freeman & Robbins 1994).
Table 3.7: Type of sun protection used, by age group, 1995 (per cent)
Age group Sunscreen Umbrella Hat Clothing Sunglasses Avoid sun Other
0–1 49 9 63 49 8 39 3
2–4 69 6 84 55 22 31 1
5–14 65 3 81 48 22 20 —
15–24 46 2 48 42 56 21 —
25–34 46 4 51 40 67 27 1
35–44 44 5 54 34 67 27 1
45–54 37 5 55 29 59 22 1
55–64 32 5 57 24 49 19 —
65–74 31 8 60 22 39 20 1
75 and over 22 8 57 17 30 19 1
Total 45 5 59 36 49 23 1
Source: 1995 National Health Survey.
Box 3.4: Accuracy of sun protection estimates
Respondents in the 1995 National Health Survey were asked what protective measures they
deliberately take when they go out in the sun. Such questions can result in over-estimates of
actual behaviour as respondents tend to report what they like to do rather than what they
actually did (Borland 1996).
It was not possible to conduct personal interviews with persons in some age groups: a parent
or a responsible adult was interviewed on behalf of all children aged 0Ð14 years and those
children aged 15Ð17 years where permission to interview them personally was not given.
The question listed various sun protective items, but it implied the use of hats, clothing or
sunglasses to be for sun protection.
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The effectiveness of immunisation was first demonstrated by Dr Edward Jenner some
200 years ago with his experiments with vaccination against smallpox. Since then, the
number of vaccines has grown and the role of immunisation has expanded significantly.
In the early 1970s the World Health Organization (WHO) Expanded Programme on
Immunization set as a goal the universal immunisation of children against diphtheria,
pertussis, tetanus, tuberculosis, poliomyelitis and measles. Goals were also set for the
eradication through immunisation of smallpox (achieved in 1977), poliomyelitis
(currently under way) and measles (a future possibility) (Plotkin & Orstein 1999).
In Australia, vaccine-preventable diseases are still responsible for serious illness and
occasional death (Carnie 1997). The schedule of age-appropriate immunisations is set
out in the Australian Immunisation Handbook (NHMRC 1997, 2000). 
There have been a number of government strategies and programs to improve
immunisation coverage in Australia. These include the National Immunisation Strategy
released in 1993 (NHMRC 1993), the Immunise Australia: Seven Point Plan announced
in February 1997, including the GP Immunisation Incentives Program from mid-1998,
the Australian Childhood Immunisation Register (ACIR) begun in 1996 (National
Childhood Immunisation Committee 1996), and most recently the Measles Control
Campaign (MCC). The effectiveness of these programs will ultimately be measured by
the extent of immunisation coverage and the number of new cases (incidence) of
vaccine-preventable diseases. 
Immunisation coverage
Immunisation coverage in Australia has been estimated in a number of ways including
special surveys through the State and Territory Public Health Departments, academic
organisations, ABS and other organisations (Lister et al. 1999). More recently the
implementation of the ACIR has provided a means of measuring immunisation
coverage at a national level for vaccines on the standard national childhood vaccination
schedule. There is an ongoing use of surveys for vaccine-preventable diseases for other
age groups and checks of validity of the ACIR data.
The ACIR was set up as a part of the National Childhood Immunisation Program to
collect immunisation-coverage information for Australian children under 7 years of age
registered with Medicare since January 1996.  The ACIR performs a number of
functions, including the collection of information from providers, provision of
immunisation information for parents, and administration of a recall or reminder
system for parents. The ACIR also provides regular reports on immunisation coverage
at national, State/Territory or local level for public health authorities (National
Childhood Immunisation Committee 1996). 
Since 1997 and as part of the Immunise Australia program, a number of initiatives have
been introduced to improve both immunisation uptake and notification of encounters.
Schemes to encourage parent compliance with the Australian Standard Vaccination
Schedule have included the linkage of immunisation status to the Commonwealth
Child Care Rebate scheme (with the accompanying history form), the Childcare
Assistance scheme, and the Maternity Immunisation Allowance. The General Practice
Immunisation Incentives scheme encourages participation by general practitioners in
the delivery of immunisation and reporting to ACIR of immunisation-encounter details. 
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ACIR coverage results are reported for birth cohorts at 1 and 2 years of age and
expressed as the percentage of children immunised (OÕBrien et al. 1998). The first
coverage estimates for children at age 1 year were published in March 1998 for the
cohort born between 1 January 1996 and 31 March 1996 (OÕBrien et al. 1998).
Subsequent reports have been published on a quarterly basis and have shown a
progressive increase in coverage. The most recent report of immunisation coverage
found that for those aged 1 year (cohort born between 1 July 1998 and 30 September
1998) 87% were fully immunised (Table 3.8) and for those aged 2 (cohort born in the
3-month period between 1 July 1997 and 30 September 1997) 74.9% were fully
immunised (Table 3.9) (Communicable Diseases Network 2000).   
Table 3.8: Proportion of children immunised at 1 year of age, preliminary results by disease 
and State for the birth cohort 1 July to 30 September 1998
NSW Vic Qld WA SA Tas ACT NT Aust
Number of children 22,272 15,770 12,347 6,311 4,730 1,661 1,065 848 65,004
Diphtheria, tetanus and 
pertussis (%) 86.5 89.1 90.5 87.3 89.0 89.3 90.0 86.9 88.3
Poliomyelitis (%) 86.6 89.1 90.5 87.3 89.0 89.3 90.0 86.9 88.3
Haemophilus influenzae 
type b (%) 85.7 88.6 90.6 86.9 88.6 88.7 90.2 88.9 87.9
Fully immunised (%) 84.7 88.0 89.9 85.9 88.0 88.2 89.8 83.8 87.0
Change in fully immunised 
since last quarter (%) +0.5 +0.3 +1.5 –0.3 –1.0 +1.2 +0.8 +0.9 +0.5
Source: Australian Childhood Immunisation Register.
Table 3.9: Proportion of children immunised at 2 years of age, preliminary results(a) by disease 
and State for the birth cohort 1 July to 30 September 1997
NSW Vic Qld WA SA Tas ACT NT Aust
Number of children 22,876 15,840 12,688 6,516 4,778 1,605 1,073 924 66,300
Diphtheria, tetanus and 
pertussis (%) 81.4 83.5 84.9 81.2 84.6 82.1 87.2 75.9 82.8
Poliomyelitis (%) 81.4 83.6 84.9 81.2 84.6 82.1 87.2 75.9 82.8
Haemophilus influenzae 
type b (%) 80.5 83.2 85.3 80.9 83.9 80.4 86.8 81.2 82.4
Measles, mumps and
rubella (%) 87.2 90.5 90.2 87.5 91.0 88.8 91.1 86.3 89.0
Fully immunised (%) 71.0 76.8 79.4 73.0 77.8 74.0 82.9 69.6 74.9
Change in fully immunised 
since last quarter (%) –1.2 –0.5 –1.7 –0.4 +1.0 –3.1 –0.9 +2.5 –1.0
(a) The proportions shown as ‘fully immunised’ appear low when compared with the proportions for individual vaccines.  
This is at least partly due to poor identification of children on immunisation encounter forms.
Source: Australian Childhood Immunisation Register.
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Measles as an example of the effectiveness of immunisation
Measles is often a severe disease, sometimes complicated by otitis media (2.5% of cases)
and bronchopneumonia (4%). Acute encephalitis occurs in a small number of reported
cases and has a mortality of 10Ð15%, and 15Ð40% of survivors have permanent brain
damage. Subacute sclerosing panencephalitis is a late complication of measles (occurring
in about 1 in 25,000 cases) that causes progressive brain damage and is always fatal
(NHMRC 1997). 
The measles vaccine was first licensed in Australia in 1968 and was in routine use by the
early 1970s, but coverage estimates from this time are not available. The introduction of
the measles vaccine resulted in a decrease in the number of measles cases, the number of
admissions to hospital for measles and the number of deaths due to measles (Figure 3.9).
However, measles epidemics continued to occur. In 1993 and 1994, a large epidemic of
measles affected Australia with over 9,000 notified cases (Figure 3.10) and a peak in the
number of hospitalisations at about 1,100 (MEAC 2000a). A second dose of measles
vaccination for those aged 10Ð16 years was implemented in 1994 by States and
Territories but coverage estimates from this time are not available.  Since then, the
number of notified cases has decreased (Figure 3.10). Measles is now a notifiable disease
in all States and Territories.  
Source: AIHW National Mortality Database.
Figure 3.9: Deaths due to measles, 1964 to 1998
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A further epidemic of measles was predicted for 1998 from serological surveys in New
South Wales and South Australia that showed gaps in levels of immunity (Forrest et al.
1998).  A set of recommendations was developed to prevent the predicted epidemic.
The NHMRC recommended in 1998 that the second dose of the measles, mumps and
rubella vaccine should be given to children when aged 4Ð5 years rather than at age
10Ð16 years.  The change in scheduling was to minimise the susceptible population by
shortening the interval between the first and second dose from 10 years to 3 years. More
recently, the recommendation for the second dose has been updated to 4 years. The
MCC followed this decision to ensure that all school children aged 5Ð12 years received
their second dose.  
The MCC was conducted from August to November 1998 with primary school children
the main target for measles immunisation. About 96% (1.7 million) of all primary school
children were vaccinated, with about 1.3 million vaccinated in the school program
(MEAC 2000b). Overall, the MCC resulted in increased protection against measles. A
serosurvey conducted after the MCC showed that 94% of children aged 6Ð12 years were
serologically immune compared to 84% before the MCC (MEAC 2000b). The impact of
the MCC on notifications of measles cases is shown in Figure 3.10. It was estimated that
17,500 cases of measles were averted (MEAC 2000b). The national immunisation coverage
for measles, mumps and rubella vaccine measured by ACIR has increased from 82.5% for
the first 2-year cohort of children born between 1 January 1996 and 31 March 1996
(Communicable Diseases Network 1998) to 89% for the 2-year cohort for children born
between 1 July 1996 and 30 September 1996 (Communicable Diseases Network 2000). 
Source: National Notifiable Diseases Surveillance System.
Figure 3.10: Measles notifications, by month, January 1991 to January 2000
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Sexual practice
Sexual activity can carry health risks such as sexually transmitted diseases (STDs) and
cancer of the cervix. It can also lead to unwanted pregnancy. The risks are mainly due to
Ôunsafe sexÕ, where precautions are not taken against transmitting infections or against
unintended pregnancy. ÔSafe sexÕ does not guarantee absolute protection against STDs,
and condoms may not prevent the transmission of genital herpes and warts. 
Unsafe sex can lead to infections such as gonorrhoea, chlamydia, syphilis, hepatitis and
HIV/AIDS, and can have serious and long-term health effects. Also, 90% of cases of
cancer of the cervix are due to the sexually transmitted human papilloma virus.
Unwanted pregnancy can lead to economic and social problems. 
A study of the burden of disease and injury in Australia attributed 97% of the male
burden and 71% of the female burden for HIV/AIDS to unsafe sex (AIHW: Mathers
et al. 1999). All of the burden of other sexually transmitted diseases was attributed to
unsafe sex. Table 3.10 shows the contribution of these diseases to the estimated total
attributable burden of unsafe sex in Australia in 1996. HIV/AIDs accounts for 61% of the
total, followed by cervical cancer (24%) and other sexually transmitted diseases (8%). In
total, unsafe sex contributes about 1% to the burden of disease in Australia (1.1% for
males and 0.7% for females). The burden of unsafe sex is of a similar magnitude to the
burden of falls or melanoma. 
Use of contraceptives
Although conclusions about sexual behaviours, including unsafe sex, cannot be drawn
from contraceptive use, it does provide a context in which to consider sexual practices
as a risk factor.
The 1995 National Health Survey collected information on contraceptive use by women
aged 18Ð49 years (Table 3.11). The contraceptive pill is the most commonly used method
of contraception among Australian women, used by 40% of women. Sterilisation and
use of condoms were the next most frequently used contraceptive methods. There is
Table 3.10: The attributable burden of unsafe sex by condition, 1996
Cause Deaths YLL(a) YLD(b) DALYs(c)
Per cent of
total DALYs
HIV/AIDS 506 11,541 2,361 13,901 0.55
Other sexually transmitted diseases(d) 5 82 1,823 1,904 0.08
Hepatitis B 51 820 143 964 0.03
Hepatitis C 19 226 27 253 0.01
Abortion 1 22 299 321 0.01
Other maternal conditions 1 37 223 260 0.01
Cervical cancer 292 4,533 907 5,441 0.22
Total 875 17,261 5,698 22,959 0.91
(a) Years of life lost due to mortality.
(b) Years of ‘healthy’ life lost due to disability.
(c) Disability-adjusted life year.
(d) Gonorrhoea, syphilis, chlamydia and pelvic inflammatory disease. 
Source: AIHW: Mathers et al. 1999.
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variation in contraceptive use across age groups. Among younger women, the
contraceptive pill and condoms were most commonly used, but use of these diminished
with age. Sterilisation was the most frequently reported method of contraception
among women aged over 40 years.  
Table 3.11: Type of contraception used by women aged 18Ð49 years, 1995 (per cent)
Method
Age of users (years)
18–19 20–24 25–29 30–34 35–39 40–44 45–49 Total
Contraceptive pill 66.3 71.1 59.2 43.0 31.3 16.9 10.1 40.0
Condom 32.2 21.6 27.0 21.2 13.9 10.5 7.2 17.6
IUD — 2.1 — 2.8 3.1 6.1 2.8 3.0
Periodic abstinence — — 3.6 4.2 3.9 3.0 2.4 3.0
Other temporary method — 2.6 2.4 3.9 3.7 2.1 — 2.6
Female sterilisation — — 3.6 10.7 21.6 36.1 49.9 19.2
Male sterilisation — — 2.8 14.2 22.4 25.3 25.8 14.5
Number using contraception 111,300 441,100 428,600 453,700 476,500 448,200 392,600 2,757,900
Users as a proportion of all 
women 49.7 65.7 64.5 65.4 71.6 71.8 67.4 66.7
Source: ABS 1998b. 
Source: ABS 1998b.
Figure 3.11: Use of the contraceptive pill, 1983, 1989 and 1995
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Data on the use of the pill can be compared for 1983, 1989 and 1995 (Figure 3.11,
page 163). The proportion of women aged 18Ð49 years using the pill increased from 24%
in 1983 to 28% in 1989 but changed little to 1995 (27%). The highest usage continues to
be in the age group 20Ð24 years. 
It is estimated that over 85% of all HIV infection in Australia has been transmitted by
unsafe sexual contact between men (NCHECR 1999). Of men who have sex with men,
the percentage engaging in unprotected anal intercourse is the principal indicator of
unsafe sexual behaviour. Surveys in Sydney during the 1990s found that, of men who
have sex with men, around 30% reported unprotected anal sex with regular partners in
the previous 6 months. Around 15% reported unprotected anal sex with casual partners
in the previous 6 months. Surveys carried out in other capital cities show similar levels
of unsafe sexual behaviour (NCHECR 1999).   
3.5 Biomedical factors
Body weight
The association between overweight or obesity and health problems such as coronary
heart disease, stroke, heart failure, type 2 diabetes, osteoarthritis, sleep apnoea, gallstones,
and reproductive problems among women is well documented (NHLBI 1998).
Overweight and obesity accounted for over 4% of the total burden of disease in Australia
in 1996 (AIHW: Mathers et al. 1999). 
Being underweight is also associated with poor health, including conditions such as
osteoporosis, ulcers, mental conditions such as depression and eating disorders
(Gilmore 1999). 
Inappropriate body weight is due mainly to an imbalance between energy intake (diet)
and energy expenditure (physical activity). Other factors, including genetics and
environment, also play a role (Pi-Sunyer 1993).
Among those who are overweight, weight loss reduces the incidence and severity of
high blood pressure, high blood cholesterol, diabetes and osteoarthritis (NHLBI 1998).
Body mass index (BMI) is used to estimate the prevalence of underweight, normal
weight, overweight and obesity in a population. 
In 1995, just over 7.4 million adult Australians (56% of those aged 18 years and over)
were overweight or obese (BMI ‡  25). Of these, over 2.4 million (or 19% of the adult
population) were obese (BMI ‡  30). Men were more likely to be overweight or obese
than were women, 64% compared with 49%. The proportion of overweight or obese
people increased with age and peaked in the age groups 45Ð54 and 55Ð64 years for men
(76%) and 55Ð64 years for women (67%) (Figure 3.12) (AIHW 1999c).  
In 1995, the proportion of overweight or obese children and adolescents aged
2Ð17 years was 21% for boys and 23% for girls.
In 1995, the proportion of underweight (BMI < 18.5) women aged 18 years and over
was almost 3%. However, among women aged 18Ð24 years the prevalence was over 6%.
The proportion of underweight men aged 18 years and over was less than 1%. The
proportion of underweight children and adolescents aged 2Ð17 years was 6% for boys
and 5% for girls. 
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Source: AIHW analysis of the 1995 National Nutrition Survey.
Figure 3.12: Proportion of overweight or obese adults, 1995
Note: Capital cities only.
Sources: NHF Risk Factor Prevalence Surveys; ABS National Nutrition Survey.
Figure 3.13: Proportion of overweight or obese adults, 25Ð64 years, 1980 to 1995
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There have been significant increases in the proportions of overweight and obese
Australians over the last 15 years. Trend data from the Risk Factor Prevalence Surveys
and the National Nutrition Survey show that the proportion of overweight or obese
women aged between 25 and 64 years (living in Australian capital cities only) has
increased from 27% in 1980 to 43% in 1995. Similarly, the proportion of overweight or
obese men increased from 48% to 63% over this period (Figure 3.13). The proportion of
obese men has increased dramatically from 8% in 1980 to 18% in 1995 and the proportion
of obese women has increased from 7% to 16%. On average, women in 1995 weighed
4.8 kg more than their counterparts in 1980, and men 3.6 kg more (AIHW 1999c). 
Although BMI is used as the main classification of overweight and obesity, the waist-to-
hip ratio (WHR) and waist circumference are also useful measures of increased disease
risk due to overweight and obesity (NHLBI 1998; WHO 1997). 
Fat located in the abdominal region is associated with greater risk of diabetes, coronary
heart disease and high blood pressure, independent of BMI (Albu et al. 1997; Bjrntorp
1992; Lemieux et al. 1996). A high WHR (WHR > 0.9 in men and 0.8 in women) is used
to identify those individuals at increased risk of cardiovascular disease. In 1995, 53% of
adult men and 35% of adult women could be regarded as at increased risk from
cardiovascular disease due to a high WHR (ABS 1996b). For both men and women,
WHR increased with age (Figure 3.14). 
Source: AIHW analysis of the ABS 1995 National Nutrition Survey.
Figure 3.14: Proportion of adults with waist-to-hip ratio >0.9 for men and 
>0.8 for women, 1995
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Changes in waist circumference reflect changes in risk for chronic disease, although
populations differ in the level of risk associated with a particular waist circumference
cut-off (Dowling & Pi-Sunyer 1993; Han et al. 1997). Although there are currently no
standard cut-offs for waist circumferences that indicate increased risk, the WHO
suggests that waist circumferences greater than 94 cm in men and greater than 80 cm in
women indicate increased risk (WHO 1997). Waist circumferences greater than 102 cm
and 88 cm for men and women respectively indicate substantially increased risk. Note
that these waist circumference measures are for Caucasians. Risk cut-offs for other
populations have not yet been developed. In 1995, 35% of men had a waist
circumference greater than 94 cm and 37% of women had a waist circumference greater
than 80 cm. Almost 19% of men had a waist circumference greater than 102 cm and 23%
of women had a waist circumference greater than 88 cm. For both men and women,
waist circumferences generally increased with age. 
Blood pressure
High blood pressure is a major risk factor for coronary heart disease, stroke, heart
failure, peripheral vascular disease and renal failure. The risk of disease increases as the
level of blood pressure increases. When high blood pressure is controlled by
medication, the risk of disease is reduced, but not to the levels of unaffected people
(Kannel 1991). It is estimated that in 1996 high blood pressure was responsible for over
5% of the total burden of disease among Australians (AIHW: Mathers et al. 1999). 
Source: ABS National Nutrition Survey, 1995.
Figure 3.15: Proportion of adults with high blood pressure, 1995
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In terms of predicting ill health, both systolic (SBP) and diastolic blood pressures (DBP)
are predictors of cardiovascular disease. Each reduction of 10Ð14 mmHg in SBP and
5Ð6 mmHg in DBP reduces the occurrence of stroke by two-fifths, of coronary heart
disease by one-sixth, and of cardiovascular disease by one-third (Chalmers 1999).
The 1995 National Nutrition Survey reported that around 2.2 million Australians aged
18 years and over had high blood pressureÑ17% of men and 15% of women. The
proportion of men and women with high blood pressure increases with age
(Figure 3.15, page 167).
Along with the decline in the proportion of people with high blood pressure and/or
receiving treatment since the 1980s, there has also been a significant decline in average
blood pressure levels during the same period (Figure 3.16). This decline occurred
equally among those not on medication for high blood pressure as among those on
medication (AIHW 1999c; Bennett & Magnus 1994). 
High blood pressure was the most common problem managed by general practitioners
in 1998Ð99, accounting for about 6% of all conditions managed (AIHW GPSCU: Britt
et al. 1999).
Note: Capital cities only.
Sources: NHF Risk Factor Prevalence Surveys; ABS National Nutrition Survey.
Figure 3.16: Proportion of persons aged 25Ð64 years with high blood pressure, 
1980 to 1995
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Biomedical and lifestyle factors that are major causes of high blood pressure include
excess body fat, alcohol consumption, physical inactivity, dietary salt intake and
complex dietary patterns with a low intake of fruit and vegetables and high saturated
fat (Puddey et al. 1987; Cutler et al. 1997; Appel et al. 1997). Stress raises blood pressure
transiently but in the long term may have indirect effects by influencing eating,
drinking, smoking and physical activity patterns (Beilin 1997). Cigarette smoking
increases the risk of heart attack and stroke threefold in hypertensive individuals. 
Blood cholesterol
High blood cholesterol is a major risk factor for coronary heart disease and possibly for
some types of stroke. It is one of the main causes of the process by which the blood
vessels that supply the heart and other parts of the body become clogged. High blood
cholesterol causes nearly 3% of the total burden of disease of Australians (AIHW:
Mathers et al. 1999).
For most people, saturated fat in the diet is regarded as the main factor that raises blood
cholesterol levels. Cholesterol in foods can also raise blood cholesterol levels, but less
than saturated fat does. Genetic factors can affect blood cholesterolÑsome people have
high cholesterol levels regardless of their saturated fat and cholesterol dietary intake
and are at increased risk from coronary heart disease (Bouchard et al. 1997). 
The risk of heart disease increases steadily in a curvilinear manner from a low base with
increasing blood cholesterol levels. Total blood cholesterol levels above 5.5 mmol/L are
an indication of a greatly increased risk of developing coronary heart disease. Levels
above 6.5 mmol/L are considered to indicate extremely high risk (NHF 1987). 
Box 3.5: High blood pressure 
Blood pressure is the force exerted by blood on the walls of the arteries and is written as
systolic/diastolic (e.g. 120/80 mmHg, stated as Ô120 over 80Õ).
The continuous relationship between blood pressure levels and cardiovascular disease risk,
and the ÔarbitraryÕ nature of the definition of high blood pressure, have contributed to the
variation in the definitions issued by various national and international authorities for
population surveys and clinical guidelines. 
For use in Australian surveys, high blood pressure has been defined as:
¥ systolic blood pressure (SBP) greater than or equal to 160 mmHg and/or 
¥ diastolic blood pressure (DBP) greater than or equal to 95 mmHg and/or,
¥ receiving medication for high blood pressure.
New classifications for the clinical management of high blood pressure have recently been
released by the World Health Organization (1999). These guidelines define hypertension
as an SBP of 140 mmHg or greater and/or a DBP of 90 mmHg or greater in subjects who
are not receiving medication for high blood pressure. 
A review of the classifications of high blood pressure used in Australia will begin in 2000
to establish national standards for population surveys.
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The last national survey to measure blood cholesterol levels in Australia was conducted
by the National Heart Foundation in 1989. It was estimated that over 4.5 million
Australian adults (aged 20Ð69 years) had high-risk cholesterol levels. Over 47% of men
and 39% of women had blood cholesterol levels above 5.5 mmol/L (Bennett & Magnus
1994). In men, there was a rapid increase in the prevalence of elevated total cholesterol
after age 34. In women, the increase occurred a decade later, after age 44, and the level
exceeded that of men after the age of 55 (Figure 3.17). In terms of those at very high risk
of cardiovascular disease, over 15% of men and women aged 20Ð69 years had blood
cholesterol levels of 6.5 mmol/L or more. 
There was little change during the 1980s in Australia in average blood cholesterol levels
or in the proportion of people with levels of 6.5 mmol/L or more (Bennett & Magnus
1994). There are no recent data for Australia. New Zealand reported a fall in average
levels between 1989 and 1997, and a fall in the proportion of people with levels of
6.5 mmol/L or more (Russell et al. 1999). 
A recent Australian study, the Long-term Intervention with Pravastatin in Ischaemic
Disease (LIPID) trial, showed that the cholesterol-lowering drug treatment pravastatin
reduces the risk of death from coronary heart disease by around 24% in people with
established coronary heart disease (LIPID Study Group 1998). This and other
international studies have clearly shown that lipid-lowering drugs are of benefit to
prevent events both in people with coronary heart disease and in those without clinical
manifestations of coronary heart disease. 
Note: Capital cities only.
Source: 1989 NHF Risk Factor Prevalence Study.
Figure 3.17: Proportion of persons aged 20Ð69 years with raised blood cholesterol, 1989
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4 Health and determinants 
in population groups
This chapter presents the major health and illness issues for a number of population
groups, with an emphasis on the health status and the factors affecting the health of
specific populations. These issues are generally reported using such standard measures
as morbidity, mortality, hospitalisations and the impact of socioeconomic status on
levels of health. An important aspect of such a report is the inclusion of underlying
determinants of ill health, although the reporting of a number of the social and
behavioural factors is limited by the lack of reliable national data.
The section on the health of men and women aged 25 and over draws heavily on recent
work in estimating the burden of disease and injury, as measured by years of life lost
due to premature mortality and the equivalent years of healthy life that are lost due to
disability. The burden of disease project is discussed in chapter 2.
4.1 Mothers and babies
Fertility
There were 249,616 live births registered in Australia in 1998 (ABS 1999d), 0.9% fewer
than in 1997, and 9.7% fewer than the peak annual registration of 276,362 live births in
1972. After declining to 223,129 in 1979, the annual number of births gradually
increased to 264,151 in 1992 and has since declined again each year.
The crude birth rate relates the number of live births in any one year to the total
population size. This rate declined from 21.7 per 1,000 people in 1971 to 14.9 per 1,000
in 1991, and then to 13.3 per 1,000 in 1998.
Age-specific birth rates express the number of women in selected 5-year age groups
giving birth in a year as a proportion of the number of women of the same age group in
the population. Recent trends in these rates have differed with age. For teenagers of
15Ð19 years, the birth rate increased slightly each year from 20.3 live births per 1,000
women in 1988 to 22.1 live births per 1,000 in 1991 and then decreased annually to
18.5 per 1,000 women in 1998, an historical low. The birth rates for women in their
twenties declined to their lowest levels ever in 1998, down to 60.0 per 1,000 for women
aged 20Ð24 years and 111.2 per 1,000 for women aged 25Ð29 years. Age-specific birth
rates for older women have generally increased in recent years, reflecting the trend for
some women to defer child-bearing until their thirties, or even later. Women aged 30Ð34
years had their lowest birth rates in the mid-1970s, those aged 35Ð39 in the late 1970s,
and those aged 40Ð44 in the mid-1980s (Table S2, page 366). Since then, the birth rates of
women aged 35Ð39 years and 40Ð44 years steadily increased to 45.7 and 8.0 per 1,000
women, respectively, in 1998.
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Multiple births
Twin confinements have increased since the mid-1970s, and reached their highest rate
ever in Australia in 1998 when there were 14.6 twin confinements per 1,000. In 1998,
there were 3,592 twin confinements among a total of 245,898 confinements (Figure 4.1).
There were 98 confinements of triplets and higher order multiple births in 1998. Because
multiple births increase with advancing maternal age up to the late thirties, rates of
multiple births are influenced by changes in maternal age distribution. The increasing
use of assisted conception (in-vitro fertilisation and related techniques) to treat infertile
couples has also contributed to the higher rates of multiple births since the early 1980s. 
In 1997, assisted conception accounted for 14% of twin confinements in Australia and
36% of triplets. Among the more than 22,000 pregnancies resulting in births using
assisted conception since it began in Australia in 1979, twins occurred in 18.6%, triplets
in 2.4%, and other multiple births in 0.1%. These multiple births usually follow transfer
of more than one embryo into the uterus, or more than one egg into the fallopian tube,
in the course of the various treatment procedures. In the past decade, the policy of
reducing the number of embryos or eggs transferred during assisted conception has
been partly effective in reducing the incidence of multiple births (Figure 4.2) (AIHW
NPSU & Fertility Society of Australia 1999). An unknown proportion of other multiple
births occurs after fertility drugs are used independently of assisted conception. 
Source: AIHW NPSU, derived from ABS data.
Figure 4.1: Twin confinement rates, 1969 to 1998
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Termination of pregnancy
National information on fertility patterns and induced abortions is lacking because only
South Australia and the Northern Territory (and Western Australia since mid-1998)
collect population-based data on induced abortions. In South Australia in 1997, there
were 5,605 induced abortions and 18,394 confinements; thus almost 1 in 4 (23.4%) of the
23,999 pregnancies (excluding miscarriages) resulted in abortions (Chan et al. 1999).
More than half (54.4%) of all teenage pregnancies were terminated.
Maternal mortality
Maternal deaths occur infrequently in Australia. In the early 1990s, maternal mortality
was reported to have declined to 10.9 per 100,000 confinements, the lowest level ever
recorded (NHMRC 1998). Deaths from pregnancy complications accounted for about
one-third of all maternal deaths, deaths from other pre-existing diseases for 1 in 4
maternal deaths, and other pregnancy-related deaths, where the pregnancy was
unlikely to have contributed significantly to the death, accounted for about 4 in 10
maternal deaths. The main causes of maternal death include pulmonary embolism,
amniotic fluid embolism, complications associated with hypertension in pregnancy,
cardiovascular disease, and motor vehicle accidents.
Source: AIHW NPSU: Day et al. 1999a.
Figure 4.2: Multiple pregnancies of at least 20 weeksÕ gestation after assisted conception, 
Australia and New Zealand, 1979 to 1997
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Perinatal mortality
The perinatal death rate declined markedly in the last two decades, decreasing to
8.3 deaths per 1,000 total births in 1998, the lowest rate ever achieved (ABS 1999e)
(Figure 4.3). Foetal deaths (5.3 per 1,000 total births) accounted for 63.9% of perinatal
deaths, and neonatal deaths (3.0 per 1,000 live births) for 36.1%. The perinatal death rate
for males (8.9 per 1,000 total births) was higher than for females (7.8 per 1,000 total births). 
Birthweight
A key indicator of the health of babies born in Australia is the proportion having a
birthweight of less than 2,500 grams. These low-birthweight babies have a greater risk
of dying, require a longer period of hospitalisation after birth, and are more likely to
develop significant disabilities. In 1997, there were 16,800 babies of low birthweight,
6.6% of all births (AIHW NPSU: Day et al. 1999a), an increase on the 6.3% of babies with
low birthweight in the early 1990s. This change is at least partly attributable to an
increase in the number of multiple births. Low birthweight is more common in the
Northern Territory due to the relatively high proportion of Indigenous births. Of
8,151 births to Indigenous mothers nationally in 1997, 13.1% were low birthweight.
(a) Per 1,000 total births for foetal deaths and perinatal deaths. Per 1,000 live births for neonatal deaths.
Note: Perinatal deaths comprise stillbirths (foetal deaths) and deaths of infants within the first 28 days of life 
(neonatal deaths). They include infants and foetuses weighing at least 400 grams or having a gestational age of 
at least 20 weeks.
Source: AIHW NPSU, derived from ABS data.
Figure 4.3: Foetal, neonatal and perinatal death rates, 1973 to 1998
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Type of delivery
Obstetric intervention may be needed if complications arise during pregnancy or labour,
although there is debate about the most appropriate rate of intervention. Caesarean birth
rates have increased markedly in the last few decades (AIHW NPSU 1993). In 1997,
20.3% of deliveries were by caesarean section, the highest proportion ever recorded in
Australia (Table 4.1) (AIHW NPSU: Day et al. 1999a), slightly higher than the proportion
recorded in 1996 (19.5%). In 1997, South Australia (23.5%) had the highest proportion of
deliveries by caesarean section and New South Wales (18.2%) had the lowest. Indigenous
mothers had a slightly lower proportion of deliveries by caesarean section (18.2%) than
all mothers. There was also considerable variation among the States and Territories in
the rates of forceps deliveries and the use of vacuum extraction (Table 4.1). 
Congenital malformations
All States and Territories notify foetuses and infants with major congenital
malformations to a national monitoring system (AIHW NPSU: Hurst et al. 1999). In 1996,
the malformation rate was highest in the musculoskeletal system (47.1 per 10,000 births),
malformations of the heart and circulatory system (48.4), genital malformations (26.6),
and chromosomal abnormalities (22.8). The major individual congenital malformations
are shown in Table 4.2 (page 184). 
Anencephalus, spina bifida and encephalocele are serious malformations of the brain
and spine, known collectively as neural tube defects, which often result in death or
major disability and handicap. In 1996, the reported malformation rate for neural tube
defects among births and terminations of pregnancy was 10.6 per 10,000 births,
although this may be an understatement. A randomised controlled trial by the Medical
Research Council in the United Kingdom has shown that supplements of the vitamin
folic acid are effective in preventing recurrence of these neural tube defects (Medical
Research Council Vitamin Study Research Group 1991). Other studies indicate that
supplements of folic acid also prevent many first occurrences of neural tube defects,
and possibly some other birth defects. The National Health and Medical Research
Council has recommended folic acid supplementation for women likely to become
Table 4.1: Type of delivery, States and Territories, 1997
NSW Vic Qld WA SA Tas(a) ACT NT Aust
(number)
Total confinements 86,920 61,311 47,278 24,856 18,394 5,378 4,708 3,525 252,370
(per cent)
Spontaneous vertex 70.4 66.3 68.1 63.3 62.5 68.3 65.4 73.1 67.6
Forceps 5.8 9.7 4.9 4.8 9.3 7.3 7.9 4.7 6.8
Vacuum extraction 4.5 2.9 4.4 9.4 4.0 2.9 5.0 — 4.5
Vaginal breech 1.1 0.9 0.6 0.5 0.7 0.6 1.0 1.4 0.8
Caesarean section 18.2 20.2 22.0 22.0 23.5 20.9 20.2 20.8 20.3
Other/unknown — — 0.1 — — — 0.4 — —
(a) Data for Tasmania incomplete.
Source: AIHW NPSU: Day et al. 1999a.
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pregnant and for those with a close family history of neural tube defects, stressing the
importance of commencing the supplementation before conception and continuing it
for the first 3 months of pregnancy (NHMRC 1993). 
4.2 Children and young people
The majority of children and young people in Australia are healthy. They have low rates
of death, hospitalisation and reported illness compared with other age groups.
However, some groups of young Australians do not share this good health, most
notably Aboriginal and Torres Strait Islander peoples. Also, many young Australians
have to face important health issues during this period of life including injury, mental
health problems and asthma. In addition, factors such as diet, physical activity and
drug use will affect the health of the young person not only in childhood, adolescence
and young adulthood, but also later in life.
For the purposes of monitoring the health and wellbeing of this age group, recent
national work in relation to child and youth health has defined children as those aged
0Ð14 years and young people as those aged 12Ð24 years. The overlap is intentional,
reflecting the fact that the transition from childhood to adulthood is a gradual process,
which does not occur at the same age for all individuals. 
The overview of child and youth health given here is based on a comprehensive
analysis using currently available data. However, it is important to note that there are
gaps and deficiencies in the data which require attention.
Table 4.2: Selected congenital malformations, Australia, 1996
ICD-9 
code Congenital malformation Number
Rate per
10,000 births
740 Anencephalus 42 1.6
741 Spina bifida 77 3.0
742.3 Hydrocephalus 84 3.3
745.1 Transposition of great vessels 94 3.7
745.4 Ventricular septal defect 480 18.7
749 Cleft lip and/or cleft palate 382 14.9
750.3 Tracheo-oesophageal fistula, oesophageal atresia and 
stenosis 64 2.5
751.2 Atresia and stenosis of large intestine, rectum and anus 82 3.2
752.6 Hypospadias 604 23.5
753.0 Renal agenesis and dysgenesis 106 4.1
754.3 Congenital dislocation of hip 469 18.2
756.6 Diaphragmatic hernia 76 3.0
758.0 Down syndrome 312 12.1
Source: AIHW NPSU: Hurst et al. 1999.
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Children
Most of this information has been drawn from the AIHW report AustraliaÕs Children:
Their Health and Wellbeing 1998 (AIHW: Moon et al. 1998), with some updates using
more recent data. 
Compared with children in many other parts of the world, Australian children are
healthy. They have infant and child mortality rates (deaths in the first year of life and
under five years respectively) well below average (UNICEF 1999:84). In 1996, the infant
mortality rate in Australia was around the average for OECD countries, and lower than
the rate found in the United States, New Zealand, the United Kingdom and Canada
(OECD 1999). Australian children also compare well in dental health, having the lowest
decay rates among OECD countries (AIHW: de Looper & Bhatia 1998). 
One area in which Australian children have not compared so well internationally is in
relation to vaccine-preventable diseases: Australian rates for cases of both measles and
pertussis (whooping cough) (as measured by compulsory notifications) were among the
highest for OECD countries in the mid-1990s. Using recent data, it has been shown that
there are an average of nearly 5,000 disease notifications, nearly 1,000 hospitalisations
and just over 5 deaths per year among Australian children for diseases that are
preventable by vaccines. In addition, the childhood immunisation rates in Australia
have tended to be lower than in many of the OECD countries (AIHW: de Looper &
Bhatia 1998).
There are some indications of improvements in the proportion of children fully
immunised for diphtheria, tetanus, pertussis, polio and Haemophilus influenzae type b
(Hib) since 1997. The Australian Childhood Immunisation Register shows a rate of full
immunisation of 86.5% in late 1999 (AIHW: de Looper & Bhatia 2000).
There have been substantial declines in childhood death rates in recent years. During
the period 1979 to 1998, infant mortality rates more than halved for both males and
females (Figure 4.4, page 186). The male infant mortality rate has remained 20Ð30%
higher than the female rate over this period. 
Although infant mortality rates include all deaths to children under the age of 1 year,
the majority of these deaths occur at very young agesÑin 1998, one-third of infant
deaths occurred within the first day of life, more than half in the first week of life and
around two-thirds of the deaths in the first 4 weeks of life (ABS 1999b:52). 
The decrease in the infant mortality rate shown in Figure 4.4 has occurred fairly equally
between the neonatal period (the first 4 weeks of life) and the post-neonatal period
(4 weeks to 1 year). Between 1979 and 1998, neonatal mortality decreased by 55% and
post-neonatal mortality decreased by 58%.
One reason for the decline in post-neonatal mortality has been the decline in deaths
from sudden infant death syndrome (SIDS). In 1998, the SIDS rate for males was less
than a quarter of the 1987 rate and less than a third of the 1979 rate. For females, the
1998 rate was about one-third the 1987 rate (Figure 4.5, page 186). The decline in SIDS
accounts for 57% of the fall in the male post-neonatal mortality rate and 52% of the fall
in the female post-neonatal mortality rate over the period 1979 to 1998. The role played
by the national prevention campaign begun in the early 1990s has been stressed by
many as a likely contributor to this decline. 
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Source: ABS, Deaths Australia (ABS Cat. No. 3302.0 for 1998 and previous years).
Figure 4.4: Infant mortality rate, 1979 to 1998
Source: AIHW National Mortality Database.
Figure 4.5: Mortality rate from SIDS for infants under 1 year, 1979 to 1998
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There have also been large decreases in the mortality rates for children aged 1Ð14 years
in the period 1979 to 1998, by 45% for males and 44% for females. However, the rate
plateaued somewhat in the second half of the 1990s at around 25 deaths per 100,000 for
males and 19 per 100,000 for females (Figure 4.6). 
Injury remains the leading cause of death among Australian children aged 0Ð14 years.
This is despite a large fall (59%) in childhood injury deaths for both males and females
(Figure 4.7, page 188). The rate for boys remains 1.6 times higher than that for girls. 
Drowning replaced motor vehicle accidents as the leading cause of childhood deaths
from injury in 1997, and remained so in 1998 (AIHW Mortality Database). The main
causes of injury deaths to children in 1998 were drowning (20% of injury deaths), motor
vehicle accidents (17%) and pedestrian deaths (14%). 
As well as being the leading cause of death in children, injury also accounts for a large
proportion of the childhood hospitalisationsÑ9% of hospitalisations of children in
1997Ð98. Injury (which includes poisoning) was the third most common reason children
were hospitalised in that year, after respiratory conditions and conditions originating in
the perinatal period. Within injury, accidental falls were the most common cause
requiring hospitalisation. 
Although injury causes the most deaths to children, asthma is the most common
chronic condition. In 1995, 16% of children aged 0Ð14 years were reported to have
asthma as a long-term condition. Asthma was also the most common reason for
Source: AIHW National Mortality Database.
Figure 4.6: Mortality rate for children aged 1Ð14 years, 1979 to 1998
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hospitalisation among children in 1997Ð98, with a hospitalisation rate of 8.6 per 1,000
for boys and 5.1 per 1,000 for girls. As discussed in chapter 2, asthma is also the leading
contributor to the burden of disease among Australian children.
Determinants of health
As well as monitoring the health status of Australian children, it is also important to
monitor determinants of health, some of which may not affect health status until later in
life. In relation to children, information on determinants of health is less developed than
health status measures. National information available in late 1998 is contained in
AustraliaÕs Children: Their Health and Wellbeing 1998, including information on physical
activity, weight, diet and sun protection measures. In 1995, around 86% of 0Ð3-year-olds
had been breastfed, although the proportion that had been breastfed differed by socio-
economic group, with higher proportions breastfed in the higher socioeconomic groups. 
As well as these behavioural and biological determinants, the family and social
environment is also a major determinant of childrenÕs health, both within childhood and
later in life (Centre for Community Child Health 2000). Some of the risk factors for poor
health outcomes, particularly in the preschool years, include difficult temperament,
harsh parenting, abuse or neglect, parental mental illness or substance abuse, family
conflict, low socioeconomic status, and poor links with the community.
Source: AIHW National Mortality Database.
Figure 4.7: Injury mortality rates for children aged 0Ð14 years, 1979 to 1998
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Health differentials 
Many of the health concerns discussed above affect particular groups of children more
than others. Infant mortality among Indigenous babies was found to be 3Ð4 times
higher than among non-Indigenous babies (see section 4.6). Similar mortality
differentials exist for children aged 1Ð14 years (ABS & AIHW 1999:132). Children from
lower socioeconomic backgrounds also have a health disadvantage, generally having
more long-term conditions, lower rates of breastfeeding, and higher rates of some
conditions including asthma.
Young people
Most of this information has been drawn from the AIHW report AustraliaÕs Young People:
Their Health and Wellbeing 1999 (AIHW: Moon et al. 1999). 
There are divergent views about the health and wellbeing of those aged 12Ð24 years in
Australia. One opinion is that young people have better health than their older
counterparts; another is that this age group is particularly vulnerable to some of the ill-
effects of modern society. The evidence suggests that the actual situation is somewhere
between these two opinions.
There is evidence that Australian young people are in good health. Two-thirds of young
people aged 15Ð24 years rated their health as ÔexcellentÕ or Ôvery goodÕ. Further, young
people compare well in relation to other age groups. Mortality rates among people aged
15Ð24 years are lower than most other age groups, with the exception of children aged
1Ð14 years (ABS 1999b:40). Disability rates are also low in this age group: 8% of people
aged 15Ð19 years and 9% of people aged 20Ð24 years self-reported as having a disability,
the lowest of all age groups. In relation to weight, 67% of people aged 15Ð24 years were
classified as being of Ôacceptable weightÕ (compared with only 38% of those aged
25 years and over), 27% were overweight or obese and 6% were underweight.
There is also evidence that the health of young people is getting better. Notably, death
rates for people aged 12Ð24 years have fallen over time (a 29% decline between 1979
and 1992), although there has been some levelling off in recent years (Figure 4.8,
page 190). Part of the decline in death rates is due to a decline in motor vehicle accident
deaths, which have fallen from 40 to 15 per 100,000 for males and 16 to 6 per 100,000 for
females over the period 1979 to 1998. 
There have also been reductions in both new HIV diagnoses among young people and
teenage fertility rates. Among people aged 12Ð24 years, new HIV diagnoses in males
fell from 11 per 100,000 in 1991 to 3 per 100,000 in 1998. The female rate remained
consistently much lower at about 1 per 100,000. Teenage fertility rates fell from 55 births
per 1,000 women in 1971 to 20 in 1997 (ABS 1977, 1998b).
Despite these improvements in youth health, there are some areas of concern. Mental
health disorders (including drug dependence disorders) are the major burden of disease
for this age group (AIHW: Mathers et al. 1999:71). Alcohol dependence and its harmful
use, and motor vehicle accidents are the two leading specific causes of disease and
injury burden in people aged 15Ð24 years. Of people aged 18Ð24 years, 27% were found
to have a mental disorder in 1997 (ABS 1998c:19). 
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Injury is the leading cause of death for people aged 12Ð24 years, with two-thirds of all
deaths attributed to some form of injury, including accidents and suicide. 
Suicide has not followed the declines seen for most other causes of death in this age
group. Over the period 1979 to 1998, the suicide rate rose by 40% (Figure 4.9). The male
rate remains around 4 times higher than the female rate. 
Drug dependence accounted for 7.4% of youth deaths in 1998, and has risen sharply in
recent years (Figure 4.9). The death rate from drug dependence among young people in
1998 was almost 5 times the 1979 rate.
One in 5 males and 1 in 10 females in the age group 18Ð24 years were found to have
Ôsubstance use disordersÕ (Ôharmful useÕ or ÔdependenceÕ on drugs and/or alcohol).
Alcohol dependence was more prevalent than drug dependence, with 12% of males
having alcohol dependence compared with 9% dependent on marijuana/cannabis and/
or opioids. Further, in 1998, 25% of young persons aged 14Ð19 years and 39% of those
aged 20Ð24 years were regular or occasional smokers. 
Chlamydia is the main sexually transmitted disease among young people: notifications
for this infection increased from 105 to 292 per 100,000 over the period 1991 to 1998.
Notifications for gonococcal infection also rose during the period, to 65 per 100,000, but
notifications for syphilis decreased. 
Source: AIHW National Mortality Database.
Figure 4.8: Death rates for people aged 12Ð24 years, 1979 to 1998
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Determinants of health 
There are some areas of concern in relation to determinants of health among young
people. Social and economic disadvantages (e.g. poor education and unemployment)
and issues such as lack of social ÔconnectednessÕ have been shown to have negative
effects on health (Resnick et al. 1997). Of concern is that 40% of year 8 students in an
Australian study did not feel they had anyone who knew them well (Glover et al. 1998).
In 1995, 20% of unemployed youth assessed their health status as being fair or poor,
compared with 9% of employed youth and 8% of students.
The proportions of young people who reported in 1995 exercising at a ÔvigorousÕ or
ÔmoderateÕ level for sport or recreation declined with age, for males from about 61% of
those aged 15Ð17 years to about 44% of those aged 20Ð24 years, and for females from
41% of those aged 15Ð17 years to 31% of those aged 20Ð24 years. Similarly, the
proportion of young people who reported that they ate cereals and the proportion
eating fruit on the previous day decreased with age (ABS & DHAC 1999:38).
Source: AIHW National Mortality Database.
Figure 4.9: Suicide and drug dependency mortality rates for people aged 12Ð24 years, 
1979 to 1998
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Health differentials 
There are differences in health between young males and young females. Among young
Australians, there are nearly 3 male deaths to every 1 female death (ABS 1999b:38).
Across all ages, the difference in death rates between males and females is highest for the
age group 20Ð24 years (ABS 1999b:29). Higher death rates for young males from
accidents and suicide account for most of this difference. For some groups of males, the
comparative situation is getting worse: the gap in death rates between the lowest and
highest socioeconomic status groups widened between 1985Ð87 and 1995Ð97 for males
but narrowed for females. 
There are also some areas where females do worse than males; for example, rates of
depressive disorders are three times higher for young females than for males. The
female hospitalisation rate for parasuicide (self-harm not resulting in death) was greater
at all ages, despite the higher suicide rate in males.
Among young people, some groups are comparatively worse off. Using data for the
period 1995Ð97, death rates for young Aboriginal and Torres Strait Islander peoples
were found to be 2.8 times higher for males and 2.0 times higher for females than their
non-Indigenous counterparts (ABS & AIHW 1999:132). The 20% of males in the lowest
socioeconomic group were 1.7 times more likely to die and 1.4 times more likely to be
hospitalised than the 20% of males in the highest socioeconomic group; for females,
these ratios were 1.4 and 1.2 respectively. 
4.3 Men and women aged 25 and over
Aspects of the health of males and females are discussed throughout this report, in
particular in reviewing the major disease areas (see chapter 2). Comparisons are made
where appropriate. This section provides an overview of the health of adult males and
females drawing on the results of the AIHW 1996 Australian Burden of Disease and
Injury Study (AIHW: Mathers et al. 1999). Disease burden includes both premature
mortality (years of life lost due to premature mortality: YLL) and the impact of disability
(equivalent ÔhealthyÕ years of life lost due to disability: YLD). The sum of YLL and YLD
equals the total disability-adjusted life years (DALYs), a measure of total burden. One
DALY is the equivalent of one lost year of ÔhealthyÕ life (see section 2.2).
Men
The overall disease and injury burden for men aged 25 years and over is largely
attributable to mortality, with 61.6% of the total burden (DALYs) due to YLL (Table 4.3).
The burden due to YLL increases with increasing age, from 47.1% for younger men
(ages 25Ð44) to 70.8% for older men (aged 65 and over). Although most deaths occur at
ages 65 and over, the total burden of disease at ages 25Ð64 is slightly higher than that at
ages 65 and over. 
Men aged 25–44 years
The disease and injury burden for men aged 25Ð44 years is dominated by mental
disorders (Figure 4.10), which make up 27.3% of the total burden for this age group.
Mental disorder is dominated by substance abuse disorders (alcohol and illicit drugs)
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and depression, which make up 37.6% and 27.3% respectively of the burden of mental
disorder. They contribute to the burden of disease mainly through disability rather than
mortality. 
Unintentional and intentional injuries are the second and third leading causes of
disease and injury burden in this age group, accounting for 15.5% and 12.1%
respectively of the total disease burden. Almost half of the unintentional injury burden
comes from road traffic accidents (42.8%), and the majority of intentional injury burden
comes from suicide and self-inflicted injury (85.2%). These conditions contribute mainly
through mortality rather than disability. 
Table 4.3: The total burden of disease and injury in men aged 25 years and over, 1996
Age
YLD YLL
DALYsValue
Per cent of
DALYs Value
Per cent of
DALYs
25–44 119,507 52.9 106,366 47.1 225,873
45–64 148,322 43.0 196,773 57.0 345,095
65 and over 152,995 29.2 370,779 70.8 523,774
Total 25 and over 420,824 38.4 673,918 61.6 1,094,743
Source: Australian Burden of Disease and Injury Study.
Source: Australian Burden of Disease and Injury Study.
Figure 4.10: Leading causes of burden of disease and injury in men aged 25Ð44 years, 
1996
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The largest single cause of disease and injury burden in younger men is suicide and
self-inflicted injury, which contributes 10.3% of the burden for this age group
(Table 4.4). The other leading individual causes are depression (7.4%), road traffic
accidents (6.6%), alcohol dependence and harmful use (5.8%), and HIV/AIDS (4.5%). 
Men aged 45–64 years
The two leading causes of disease and injury burden in men aged 45Ð64 are
cardiovascular disease and cancer (malignant neoplasms) (Figure 4.11), which
contribute 26.1% and 25.3% respectively of the total disease burden for this age group.
The cardiovascular disease group is dominated by ischaemic heart disease (63.9%) and
stroke (16.8%). The biggest contributors to the cancer group are lung cancer (25.8%) and
colorectal cancer (16.0%). Both cardiovascular disease and cancer contribute mainly
through mortality rather than disability. 
The largest single cause of disease and injury burden in men aged 45Ð64 is ischaemic
heart disease, which contributes 16.7% of the total disease burden for this age group
(Table 4.4). The other leading individual causes of the disease burden are lung cancer
(6.5%), chronic obstructive pulmonary disease (4.9%), hearing loss (4.6%) and diabetes
(4.6%).
Table 4.4: Leading single causes of burden of disease and injury in men by age, 1996
Condition DALYs Per cent of total
25–44 years
Suicide and self-inflicted injuries 23,296 10.3
Depression 16,827 7.4
Road traffic accidents 14,929 6.6
Alcohol dependence and harmful use 13,026 5.8
HIV/AIDS 10,250 4.5
All causes total 225,873
45–64 years
Ischaemic heart disease 57,521 16.7
Lung cancer 22,509 6.5
Chronic obstructive pulmonary disease 16,999 4.9
Hearing loss 15,861 4.6
Diabetes mellitus 15,711 4.6
All causes total 345,095
65 years and over
Ischaemic heart disease 113,681 21.7
Stroke 45,111 8.6
Lung cancer 36,206 6.9
Chronic obstructive pulmonary disease 30,348 5.8
Alzheimer’s disease and other dementias 27,804 5.3
All causes total 523,774
Source: Australian Burden of Disease and Injury Study.
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Men aged 65 years and over
Cardiovascular disease and cancer are also the two leading causes of disease and injury
burden in older men (Figure 4.12, page 196), contributing 36.1% and 27.1% respectively
of the total burden for this age group. Once again, the cardiovascular disease group is
dominated by ischaemic heart disease (60.2%) and stroke (23.9%). The cancer group is
dominated by three cancersÑlung cancer (25.5%), prostate cancer (18.8%) and
colorectal cancer (14.0%). Again, the contribution of cardiovascular disease and cancer
is mainly through mortality rather than disability. 
The largest single cause of disease and injury burden in older men is ischaemic heart
disease, which contributes 21.7% of the total disease burden for this age group
(Table 4.4). The other leading individual causes are stroke (8.6%), lung cancer (6.9%),
chronic obstructive pulmonary disease (5.8%), and AlzheimerÕs disease and other
dementias (5.3%).
Women
Disability is a somewhat higher contributor to the overall disease and injury burden for
adult women, with only 56.2% of the total disease burden due to YLL (Table 4.5). As with
men, the burden due to YLL increases with increasing age, from 26.4% for younger
women (ages 25Ð44) to 68.9% for older women (aged 65 and over). 
Source: Australian Burden of Disease and Injury Study.
Figure 4.11: Leading causes of burden of disease and injury in men aged 45Ð64 years, 
1996
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Women aged 25–44 years
The disease and injury burden for younger women, as for younger men, is dominated
by mental disorders (Figure 4.13), which make up 33.8% of the total burden for this age
group. The principal mental disorders are depression and anxiety disorders, which
make up 37.6% and 33.3% respectively of the burden of mental disorder. They
contribute mainly through disability rather than mortality. Cancer is the second leading
cause of disease and injury burden in this age group, accounting for 13.1% of the total
burden. The biggest individual cancer is breast cancer, which makes up 37.1% of the
cancer burden. Cancers contribute mainly through mortality rather than disability. 
Source: Australian Burden of Disease and Injury Study.
Figure 4.12: Leading causes of burden of disease and injury in men aged 65 years and 
over, 1996
Table 4.5: The total burden of disease and injury in women aged 25 years and over, 1996
Age
YLD YLL
DALYsValue
Per cent of
DALYs Value
Per cent of
DALYs
25–44 136,401 73.6 48,918 26.4 185,318
45–64 125,881 49.7 127,633 50.3 253,514
65 and over 170,730 31.1 378,498 68.9 549,228
Total 25 and over 433,012 43.8 555,049 56.2 988,060
Source: Australian Burden of Disease and Injury Study.
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The largest single cause of disease and injury burden in younger women is depression,
which contributes 12.7% of the total burden for this age group (Table 4.6, page 199). The
other leading individual causes are generalised anxiety disorder (6.2%), breast cancer
(4.9%), genito-urinary disease (4.2%) and asthma (3.5%).  
Women aged 45–64 years
The leading cause of disease and injury burden in women aged 45Ð64 is cancer
(Figure 4.14, page 198), which contributes 33.1% of the total disease burden for this age
group. The three largest cancers in this age group are breast cancer, lung cancer and
colorectal cancer, which contribute 30.3%, 14.3% and 13.0% respectively to the cancer
burden. The second and third largest causes are cardiovascular disease and mental
disorders, which account for 13.7% and 10.1% respectively of the total disease burden
for this age group. Cardiovascular disease is dominated by ischaemic heart disease
(47.0%) and stroke (28.7%) and mental disorders are dominated by depression (51.5%)
and anxiety disorders (32.7%). Cancer and cardiovascular disease contribute mainly
through mortality, and mental disorders contribute mainly through disability.
The largest single cause of disease and injury burden in women aged 45Ð64 is breast
cancer, which contributes 10.0% of the total burden for this age group (Table 4.6). The
other leading individual causes are osteoarthritis (6.6%), ischaemic heart disease (6.5%),
diabetes (5.6%) and depression (5.2%). 
Source: Australian Burden of Disease and Injury Study.
Figure 4.13: Leading causes of burden of disease and injury in women aged 25Ð44 years, 
1996
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Source: Australian Burden of Disease and Injury Study.
Figure 4.14: Leading causes of burden of disease and injury in women aged 45Ð64 years, 
1996
Source: Australian Burden of Disease and Injury Study.
Figure 4.15: Leading causes of burden of disease and injury in women aged 65 years and 
over, 1996
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Women aged 65 years and over
The three leading causes of disease and injury burden in older women are cardio-
vascular disease, cancer, and nervous system and sense organ disorders (Figure 4.15),
which contribute 37.2%, 20.8% and 17.9% respectively to the total burden for this age
group. Cardiovascular disease is dominated by ischaemic heart disease (54.4%) and
stroke (28.8%). The three largest cancers are breast cancer (15.1%), colorectal cancer
(16.4%) and lung cancer (15.1%). In the nervous system and sense organ disorders
group, the leading causes are AlzheimerÕs disease and other dementias (49.7%), hearing
and vision disorders (32.1%) and ParkinsonÕs disease (12.2%). Cardiovascular disease
and cancer contribute mainly through mortality, and nervous system and sense organ
disorders contribute mainly through disability. 
The largest single cause of disease and injury burden in older women is ischaemic heart
disease, which contributes 20.3% of the total burden for this age group (Table 4.6). The
other leading individual causes are stroke (10.7%), AlzheimerÕs disease and other
dementias (8.9%), chronic obstructive pulmonary disease (4.0%) and breast cancer (3.6%).
Table 4.6: Leading single causes of burden of disease and injury in women by age, 1996
Condition DALYs Per cent of total
25–44 years
Depression 23,546 12.7
Generalised anxiety disorder 11,529 6.2
Breast cancer 9,025 4.9
Other genito-urinary diseases 7,836 4.2
Asthma 6,548 3.5
All causes total 185,318
45–64 years
Breast cancer 25,451 10.0
Osteoarthritis 16,665 6.6
Ischaemic heart disease 16,381 6.5
Diabetes mellitus 14,232 5.6
Depression 13,237 5.2
All causes total 253,514
65 years and over
Ischaemic heart disease 111,267 20.3
Stroke 58,894 10.7
Alzheimer’s disease and other dementias 48,946 8.9
Chronic obstructive pulmonary disease 21,838 4.0
Breast cancer 19,627 3.6
All causes total 549,228
Source: Australian Burden of Disease and Injury Study.
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4.4 Older people
Healthy ageing was one of the primary themes identified by the National Strategy for
an Ageing Australia as part of the work undertaken in Australia for the International
Year of Older Persons (1999). Declining mortality rates and increased life expectancy
have led to an extended period of life which is spent in Ôold ageÕ, and a growing
recognition of the many different activities, opportunities and contributions which can
characterise this phase of the life cycle. The National Strategy for an Ageing Australia
identified a number of key areas in promoting healthy ageing and preventing illness.
These include maintaining physical and mental health, engaging in physical activity,
preventing falls and injury, maintaining adequate nutrition, detecting sensory loss early,
managing incontinence, and evaluating alcohol and other drug usage (Bishop 1999:23).
Broader social factors are also an important contributor to good health in old age. A
lifetime of higher education, higher income, supportive personal and social
environments, good medical care and good superannuation entitlements all contribute
to better life chances in old age, and thus to a higher likelihood of maintaining good
health at advanced ages.
Life expectancy at age 65
Life expectancy has increased for both men and women. Whereas most of the gains
earlier in the twentieth century resulted from a reduction in death rates at younger
ages, the latter decades saw an increase in life expectancy at older ages. Life expectancy
for men at age 65 increased by only a single year between 1911 and 1963, and for
women by less than 3 years over the same period (CBCS 1965:147). Between 1977 and
1997, life expectancy for men at age 65 increased from 13 years to 16 years, and for
women from 17 to 20 years. Just under half of the life years remaining after age 65 will
be spent free of disability (41% for men and 45% for women). 
Disability levels
The proportion of persons with a ÔdisabilityÕ is relatively high among the population
aged 65 and over (Table 4.7). However, it is important to understand the meaning of
disability as used in the 1998 Survey of Disability, Ageing and Carers. Disability is
defined in this survey by the ABS as having one or more of 17 limitations, restrictions or
impairments (see Box 2.7, page 49). These range from conditions such as Ôloss of speechÕ
to ÔanyÉlong-term condition that restricts everyday activityÕ. Having a ÔdisabilityÕ does
not, therefore, imply a need for assistance. The proportion of the population with a
profound or severe core activity restriction is a better indicator of need for assistance, as
it includes those who sometimes or always require assistance with self-care, mobility or
communication. These proportions are quite low in the aged population until age 75.
For those aged 65Ð69 years, for example, only 7.8% of men and 9.2% of women have a
profound or severe core activity restriction. The proportions rise quite markedly after
age 75, so that by ages 75Ð79, 19% of men and 25% of women reported a profound or
severe core activity restriction, and at ages 80Ð84 the proportions had risen to 24% and
36% respectively. By age 85 and over, more than half the population reported a severe
or profound core activity restriction. At these advanced ages, the degree of difference
between the sexes lessens somewhat, although the proportions for women are still
substantially higher than those for men (69% for women and 56% for men). 
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Main disabling condition 
The main disabling conditions of those aged 65Ð79 and those aged 80 and over were
related to physical conditions (80.1% and 67.7% respectively). Within this category,
arthritis, problems relating to the circulatory system and other musculoskeletal
conditions were the major problems. Sensory problems (diseases of the eye or ear) were
the second most disabling set of conditions, affecting 14.2% of those aged 65Ð79 and
17.4% of those aged 80 and over. Mental and behavioural problems were the main cause
of disability for only 5.8% of those aged 65Ð79, but 14.9% of those aged 80 and over.
Dementia and AltzheimerÕs disease were reported as the main disabling condition by
2.6% of those aged 65Ð79, and 12.0% of those aged 80 and over.
Main reasons for hospitalisation
There are many reasons patients are admitted to hospitals. The data presented in
Tables 4.8 and 4.9 (page 202) report on the principal diagnosis and the main procedure
performed on the patient while in hospital care. In 1997Ð98, the most common diagnosis
for older Australians was dialysis (9.7% of separations), followed by cataract (5.4%).
Diagnoses associated with heart disease totalled 8%. The most commonly reported
procedures for older Australians during hospitalisation were other operations on vessels
(including haemodialysis) (9.7%), followed by injection or infusion of other therapeutic or
prophylatic substance (including chemotherapy) (5.4%) and extraction of eye lens (4.5%).  
Main causes of death
The main causes of death for both men and women aged 65 and over were diseases of
the circulatory system, malignant neoplasms and diseases of the respiratory system.
Together, these three categories accounted for well over three-quarters of deaths among
people aged 65 and over. The leading cause of death in 1998 among men aged 65Ð74
was malignant neoplasms (40% of all deaths) closely followed by diseases of the
circulatory system (37%), and then diseases of the respiratory system (9%). Over the
1990s, age-specific death rates from circulatory diseases, previously the leading cause of
death, fell markedly in this age group, whereas those for malignant neoplasms
increased (Figure 4.16, page 203). Among men aged 75 and over, diseases of the
circulatory system accounted for 43% of deaths, followed by malignant neoplasms
Table 4.7: Persons aged 65 years and over: disability status, by sex and age group, 1998 
(per cent)
Core activity 
restriction
Males Females
65–69 70–74 75–79 80–84 85+ 65–69 70–74 75–79 80–84 85+
Profound or 
severe 7.8 11.8 19.0 24.2 56.0 9.2 15.1 24.9 35.5 68.8
Moderate 10.8 10.3 15.3 *7.8 *10.4 8.9 10.4 10.2 6.9 6.9
Mild 16.0 21.6 20.3 24.8 16.9 14.8 16.5 18.3 22.6 7.5
All with specific 
restrictions 34.6 43.7 54.6 56.9 83.3 32.8 41.9 53.3 65.0 83.2
All with disability 43.4 51.1 60.9 63.4 84.3 37.6 47.3 56.6 66.8 84.2
* Subject to a relative standard error greater than 25%.
Source: ABS 1999c:15.
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(29%) and diseases of the respiratory system (12%). Among these men, age-specific
death rates for diseases of the circulatory system also fell substantially over the decade,
whereas those for malignant neoplasms increased (Figure 4.17).
In 1998, for women aged 65Ð74, malignant neoplasms were the leading cause of death
(39%), followed by diseases of the circulatory system (34%) and diseases of the
respiratory system (9%) (Figure 4.16). This represents a change from the pattern a
decade earlier, when circulatory diseases were the major cause of death. For women
aged 75 and over, circulatory diseases continued to be the leading cause of death in
1998 (49%), although to a lesser extent than that reported a decade earlier (59%).
Malignant neoplasms (21%) and diseases of the respiratory system (11%), were the next
most common causes (Figure 4.17). For both age groups, the age-specific death rates for
diseases of the circulatory system fell during the decade.  
Table 4.8: Patients aged 65 and over: separations for the most frequently occurring principal 
diagnoses, 1997Ð98
Principal diagnosis Separations Per cent
Encounter for dialysis 166,822 9.7
Cataract 92,752 5.4
Other and unspecified procedures and aftercare 79,332 4.6
Care involving use of rehabilitation procedures 62,755 3.6
Heart failure 35,908 2.1
Other acute and subacute forms of ischaemic heart disease 34,530 2.0
Other malignant neoplasm of skin 34,150 2.0
Diseases of oesophagus 28,319 1.6
Osteoarthritis and allied disorders 27,978 1.6
Cardiac dysrhythmias 25,693 1.5
Follow-up examination 25,665 1.5
Pneumonia, organism unspecified 23,137 1.3
Angina pectoris 22,075 1.3
Source: Australian National Hospital Morbidity Database.
Table 4.9: Patients aged 65 and over: separations for the most frequently occurring principal 
procedures, 1997Ð98
Principal diagnosis Separations Per cent
Other operations on vessels  167,601 9.7
Injection or infusion of other therapeutic or prophylactic 
substance  92,759 5.4
Extracapsular extraction of lens by fragmentation & aspiration 
techniques 77,415 4.5
Diagnostic procedures on small intestine 74,203 4.3
Diagnostic procedures on large intestine 59,218 3.4
Diagnostic physical therapy 40,620 2.4
Transfusion of blood & blood components 33,754 2.0
Soft tissue X-ray of face, head and neck 32,072 1.9
Joint replacement of lower extremity 28,464 1.7
Source: Australian National Hospital Morbidity Database.
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Source: ABS 1990, 1999b.
Figure 4.16: Deaths by major cause: men and women aged 65Ð74 years, 
1988 and 1998 (per cent)
Source: ABS 1990, 1999b.
Figure 4.17: Deaths by major cause: men and women aged 75 years and over, 
1988 and 1998 (per cent)
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4.5 Overseas-born
Australia is an ethnically diverse nation. The 1998 ABS population estimates show that
about 23% of Australians were born overseas. More than half of these Australian
residents were born in a non-English-speaking country.
A heterogenous mix, migrants bring to Australia their own unique health profiles. The
stringent health requirements for immigration ensure that most migrants enjoy good, if
not better, health than the Australian-born population. This is known as the Ôhealthy
migrant effectÕ. Immigrants have lower death rates and hospitalisation rates, as well as
lower prevalence of certain lifestyle-related risk factors. There are also variations in the
health status of migrants according to birthplace, age, socioeconomic status, fluency in
the English language and satisfaction with their job and life in Australia (Kliewer &
Jones 1998). Illness and disability among migrant groups, however, increases with
length of residence in Australia (Young 1992).
For purposes of health comparison, immigrants may be grouped into four broad
regional groups: the United Kingdom and Ireland, Other Europe, Asia and Other
(Box 4.1). These regional groups exhibit significant variation in their age structures,
depending on the recency of their arrival. Migrants from Asia and Other regions, for
example, are mainly young, with large numbers aged between 20 and 44 years, whereas
migrants from the United Kingdom and Ireland and Other Europe have median ages
around 50 years. To enable meaningful comparisons to be made, variation in the health
status among these populations due to different age structures has been removed by
age standardisation. 
Mortality
Table 4.10 compares the death rates for the overseas-born with the Australian-born for
the period 1996Ð98 using standardised mortality ratios (SMRs). The SMRs for all causes
are lower for both males and females in all four birthplace categories. Death rates
among migrants from the United Kingdom and Ireland were closest to the rates for
Box 4.1: Country of birth categories
Countries classified according to the Australian Standard Classification of Countries for
Social Statistics are grouped here into four birthplace groups: 
United Kingdom and Ireland: Form a distinct category that is not easily separated in
population statistics. 
Other Europe: Continental Europe including Eastern Europe, former USSR and
Baltic States.
Asia:  North-East, South-East and Southern Asia.
Other:  Middle East, Northern and Southern Africa, the Americas, New Zealand and the
Pacific region. New Zealand is the largest source country, constituting around 30% of this
group. 
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Australian-born persons. In comparison, migrants from the Asian region have much
lower SMRs, with death rates 46% lower among Asian-born males and 38% lower
among Asian-born females than their Australian-born counterparts. 
Mortality by cause of death shows significant variation between overseas-born
population groups. Table 4.10 shows that migrant groups in Australia have lower levels
of cardiovascular mortality compared with the Australian-born population. However,
studies show that rates tend to increase after the migrantsÕ first 10 years of residence in
Australia (NHF 1996). Research also indicates that physical inactivity, a risk factor for
cardiovascular disease, is more common among people from southern, northern and
Table 4.10: Mortality differentials by birthplace, cause of death and sex, persons aged 15 years 
and over, 1996Ð98
ICD-9-CM
Males Females
Total
Standardised mortality ratio(a)
(Australian-born = 1.0)
Total
Standardised mortality ratio(a)
(Australian-born = 1.0)
UK and
Ireland
Other
Europe Asia Other
UK and
Ireland
Other
Europe Asia Other
Infectious 2,558 *0.79 1.01 *1.39 *1.39 1,742 *0.84 *1.36 *1.52 *1.24
AIDS(b) 1,005 *0.84 *0.76 *0.49 *1.44 95 0.95 *0.58 1.32 1.61
Cancers 58,685 *0.94 *0.90 *0.64 *0.84 45,508 *1.05 *0.85 *0.71 *0.94
Lung 14,092 *1.16 *1.07 *0.68 *0.91 6,139 *1.49 *0.66 *0.83 0.95
Skin 2,489 *0.42 *0.34 *0.10 *0.45 1,326 *0.63 *0.40 *0.10 *0.68
Prostate 7,592 *0.80 *0.64 *0.42 *0.83 n.a. n.a. n.a. n.a. n.a.
Breast n.a. n.a. n.a. n.a. n.a. 7,731 *1.09 *0.86 *0.61 *1.05
Cervix n.a. n.a. n.a. n.a. n.a. 861 1.03 *0.87 *1.23 *1.19
Diabetes mellitus 4,340 *0.83 *1.27 *1.18 *1.27 4,183 *0.76 *1.74 *1.54 *1.56
Cardiovascular 76,319 *0.88 *0.86 *0.61 *0.90 79,851 *0.87 *0.84 *0.70 *0.95
Ischaemic 46,251 *0.89 *0.88 *0.58 *0.92 39,287 *0.89 *0.85 *0.65 *0.94
Stroke 14,759 *0.84 *0.83 *0.71 *0.85 21,889 *0.85 *0.80 *0.88 *0.94
Respiratory 18,980 *0.95 *0.64 *0.58 *0.67 16,462 *1.03 *0.56 *0.58 *0.83
Digestive 5,892 *0.86 *0.84 *0.63 *0.71 5,719 0.99 *0.74 *0.65 *0.86
Injury and 
poisoning 15,631 *0.89 *0.84 *0.58 *0.90 6,393 1.05 0.96 0.94 1.04
Motor vehicle 3,663 *0.79 *0.79 *0.69 0.99 1,495 1.10 *1.21 *1.20 *1.16
Suicide 6,155 *0.93 *0.74 *0.40 *0.79 1,544 0.95 0.92 *0.83 0.97
Homicide 603 *0.79 *1.53 *1.44 *1.63 286 1.08 1.31 0.98 0.83
All causes 195,135 *0.88 *0.82 *0.54 *0.79 176,626 *0.93 *0.81 *0.62 *0.86
* Significantly different from 1.00 at the 5% level.
(a) The standardised mortality ratio (SMR) is a measure of death from a specific condition in the overseas-born population 
relative to the Australian-born population. The ratio for Australian-born is 1.00, and ratios that exceed 1.00 indicate a 
relatively greater mortality in that population than for the Australian-born. Likewise, ratios less than 1.00 indicate a 
lower death rate for a given cause of death than for the Australian-born.
(b) All deaths where AIDS is mentioned on the death certificate, regardless of whether it is identified as the primary 
cause of death.
Note: Age standardised to the Australian population at 30 June 1991.
Source: AIHW National Mortality Database.
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eastern Europe, Asia, the Middle East and North Africa in comparison with their
Australian-born counterparts. Exercise levels are reported to increase with length of
stay in Australia (NHF 1996).
Deaths from cancers also show variation. Death rates from lung cancer for both males
and females born in the United Kingdom and Ireland, and for males born in Other
Europe were higher than for males and females born in Australia. Females born in the
United Kingdom and Ireland had higher death rates for breast and cervical cancer.
Cervical cancer death rates among women born in Asia and Other countries were
higher than among Australian-born women. However, Australian-born males had
higher death rates for prostate cancer across all birthplace groups. Immigrants from all
regions have much lower death rates for skin cancer compared with Australian-born
persons. Smoking, diet, sun exposure, alcohol consumption, and utilisation of health-
care services such as screening programs all play a role in creating the differentials
related to cancer risk. Culturally appropriate models of preventive health care delivery
are currently being developed to overcome access and equity concerns regarding the
health of overseas-born persons (DHFS & AIHW 1998).
SMRs for diseases of the respiratory system and diseases of the digestive system among
persons born overseas are lower than in the Australian-born population across all
regions, except for females born in the United Kingdom and Ireland. Mortality rates for
diabetes are higher for those born in Other Europe, Asia and Other countries relative to
the Australian-born population. The prevalence of diabetes is high for certain
immigrant groups compared with the Australian-born group, particularly among
persons of European, Pacific Islander and Asian origin (DHAC & AIHW 1999a). It has
been suggested that there is a need to provide information and education for effective
self-management of diabetes, since poor glycaemic control is common and more
marked among migrant groups (FECCA 1997).
Motor vehicle accident and suicide death rates are higher among Australian-born males.
Note, though, that in 1992 approximately 25% of all suicide deaths were among migrants,
with 40% of these among persons from English-speaking countries (DHAC 1998).
Hospitalisation
Hospitalisation rates for 1997Ð98 for overseas-born persons generally reflect the
corresponding mortality patterns and indicate lower morbidity in comparison to
Australian-born persons for both males and females (Table 4.11).
Asian-born migrants had the lowest hospitalisation rates in 1997Ð98. However, the
hospitalisation rates for tuberculosis among Asian-born migrants were much higher
than for other population groups. The hospitalisation rates for cancer of the cervix
among females from Asia and Other countries were also higher than for the Australian-
born females. Lung cancer among females born in the United Kingdom and Ireland was
the only other principal diagnosis among immigrant groups having a significantly
higher rate than the Australian-born population. 
One of the most notable differences was for melanoma, for which the hospitalisation
rate for the Australian-born population was more than double that for the overseas-
born. Risk factors for melanoma include increased exposure to sun early in life, fair
complexion, freckles and ease of sunburn.
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4.6 Aboriginal and Torres Strait Islander peoples
AustraliaÕs Aboriginal and Torres Strait Islander peoples continue to experience much
poorer health than the general Australian population (see ABS & AIHW 1999 for a more
detailed report). Despite the relative lack of good-quality national health statistics for
AustraliaÕs Indigenous population, evidence from those jurisdictions and collections
where the data are considered to be of reasonable quality indicates large differences
between the health of Indigenous and non-Indigenous populations across a range of
health status measures. This health disadvantage begins at an early age and continues
throughout the life cycle. It reflects the broader social and economic disadvantages
faced by Aboriginal and Torres Strait Islander Australians.
Table 4.11: Standardised hospital separation ratios by principal diagnosis, birthplace and sex, 
persons aged 15 years and over, 1997Ð98
ICD-9-CM
Males Females
Total
Standardised hospital 
separation ratio(a)
(Australian-born = 1.0)
Total
Standardised hospital 
separation ratio(a)
(Australian-born = 1.0)
UK and
Ireland
Other
Europe Asia Other
UK and
Ireland
Other
Europe Asia Other
Infectious 21,339 *0.72 *0.74 1.00 *0.92 22,027 *0.86 *0.75 *0.80 *0.83
Tuberculosis 419 1.01 *1.65 *14.89 *2.68 372 *0.64 1.18 *21.50 *2.39
Cancers 178,688 *0.70 *0.69 *0.44 *0.69 188,233 *0.79 *0.76 *0.61 *0.83
Skin 3,764 *0.40 *0.31 *0.10 *0.45 3,158 *0.56 *0.44 *0.09 *0.42
Lung 11,636 0.99 *1.04 *0.68 *0.77 5,252 *1.20 *0.64 *0.50 *0.78
Prostate 11,682 *0.70 *0.59 *0.39 *0.71 n.a. n.a. n.a. n.a. n.a.
Breast n.a. n.a. n.a. n.a. n.a. 17,730 *0.96 *0.79 *0.59 *0.91
Cervix n.a. n.a. n.a. n.a. n.a. 1,994 0.95 *0.79 *1.24 *1.52
Diabetes mellitus 11,809 *0.68 *0.81 *0.49 *0.66 10,150 *0.67 *0.92 *0.58 *0.78
Mental 104,173 *0.68 *0.68 *0.33 *0.67 119,847 *0.79 *0.59 *0.31 *0.81
Cardiovascular 244,185 *0.77 *0.88 *0.58 *0.92 187,274 *0.81 *0.92 *0.60 *0.94
Ischaemic 104,882 *0.78 *0.86 *0.64 1.00 54,944 *0.82 *0.86 *0.64 *0.97
Stroke 26,894 *0.69 *0.81 *0.58 *0.82 24,909 *0.74 *0.77 *0.78 *0.88
Respiratory 111,499 *0.72 *0.71 *0.52 *0.79 108,301 *0.81 *0.59 *0.45 *0.78
Asthma 11,253 *0.71 *0.51 *0.54 *0.93 21,948 *0.79 *0.38 *0.43 *0.80
Digestive 297,254 *0.76 *0.79 *0.56 *0.80 318,327 *0.79 *0.81 *0.54 *0.79
Injury and 
poisoning 190,734 *0.72 *0.62 *0.38 *0.74 144,288 *0.83 *0.71 *0.47 *0.77
All causes 2,231,442 *0.74 *0.82 *0.60 *0.84 2,778,141 *0.79 *0.83 *0.66 *0.91
* Significantly different from 1.00 at the 5% level.
(a) The standardised hospital separation ratio is a relative measure of hospital use between the overseas-born and 
Australian-born populations. The ratio for Australian-born is 1.00, and ratios that exceed 1.00 indicate relatively greater 
hospital use in that population than for the Australian-born. Likewise, ratios less than 1.00 indicate less hospital use 
due to a given cause than for the Australian-born population.
Note: Age standardised to the Australian population at 30 June 1991.
Source: AIHW National Morbidity Database.
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It is difficult at present to measure precisely the magnitude of this health disadvantage
and the changes over time. The main factors limiting the quality and availability of data
include incomplete identification of Aboriginal and Torres Strait Islander peoples in
administrative data collections (such as death registrations, hospital records, cancer
registries and communicable disease notifications); uncertainties in estimating the size
and composition of the Indigenous population; and a relative lack of high-quality survey
data about this comparatively small population group (ABS & AIHW 1999). A number of
recent initiatives in information development, such as the National Aboriginal and
Torres Strait Islander Health Information Plan (ATSIHWIU 1997), may result in some
improvements to the quality and availability of data in the future. Some data-quality
problems may take a great deal of time to overcome, if indeed they are solvable.
Life expectancy
Life expectancy at birth for Indigenous Australians in the period 1991Ð96 was estimated
to be 56.9 years for males and 61.7 years for females, considerably lower than the all-
Australian estimates of 75.2 years for males and 81.1 years for females (ABS & AIHW
1999). The figures for the Australian Indigenous population are similar to those for
Australians born at the beginning of the twentieth century, when life expectancy was
55 years for Australian males and 59 years for Australian females. 
Mortality
Information on mortality comes from deaths that occurred among usual residents of the
Northern Territory, Western Australia and South Australia during calendar years
1995Ð97 and were registered by the end of 1998. Despite efforts to improve data quality,
the level of completeness of identification of Indigenous deaths in other jurisdictions
was not considered adequate during this time period to allow for reporting (ABS 1998a;
ABS & AIHW 1999; Cunningham & Paradies 2000), although Queensland was
considered to have adequate data quality for 1998 (ABS 1999b). Even in the three
jurisdictions reported here, however, there may be underestimation of Indigenous
deaths due to incomplete identification on death certificates.
Overall mortality
In 1995Ð97, in Western Australia, Northern Territory and South Australia combined,
there were about three times as many deaths among Indigenous people as there would
have been if the Indigenous population had the same age-specific death rates as the
total Australian population (Cunningham & Paradies 2000). The death rates for
Indigenous people exceeded those for all Australians in every age group (Figure 4.18),
but the differences were greatest, in relative terms, among those aged 35Ð54 years.
There are no reliable data at present to determine whether and to what extent the death
rates for the Indigenous population have been changing in recent years. 
Age at death
The higher age-specific death rates and the lower life expectancy at birth for Aboriginal
and Torres Strait Islander peoples are reflected in the younger age distribution of
Indigenous deaths. In 1995Ð97, more than half (53%) of the deaths of Indigenous males
and 41% of the deaths of Indigenous females were of people aged less than 50 years.
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This is in stark contrast to the age distribution for all Australian deaths, with the vast
majority (72% of male deaths and 83% of females deaths) occurring among people aged
65 years or more (Figure 4.19, page 210). 
Causes of death
The major causes of deaths among Indigenous people were cardiovascular diseases,
injury, respiratory diseases, cancer (neoplasms), and endocrine diseases (such as
diabetes), which together accounted for about three-quarters of all Indigenous deaths
(Cunningham & Paradies 2000). While these same causes were also the most important
for the Australian population overall, deaths from these and most other causes occurred
at greater rates in the Indigenous population than among other Australians (Figure 4.20,
page 211). 
Birth outcomes for Indigenous mothers
Despite reductions in infant and maternal mortality among Indigenous Australians
over the past 30 years (see, for example, Thomson 1991), there are still considerable
differences in birth outcomes between the Indigenous and non-Indigenous populations.
Low-birthweight babies, stillbirths and neonatal deaths (those occurring in the first
28 days of life) are all about twice as common among births to Indigenous mothers than
among births to other mothers. In 1994Ð96, about 12% of babies born to Indigenous
Note: Data are for deaths which occurred in 1995–97 and were registered by the end of 1998. Indigenous data are for 
usual residents of Western Australia, South Australia and the Northern Territory combined.
Source: Cunningham & Paradies 2000.
Figure 4.18: Age-specific death rates, 1995Ð97
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mothers were below 2,500 grams at birth, compared with about 6% of other babies. The
perinatal mortality rate (stillbirths and neonatal deaths) in the same period was almost
22 per 1,000 births for babies born to Indigenous mothers, compared with just under
10 per 1,000 for other babies (AIHW NPSU: Day et al. 1999b)(Figure 4.21). 
Infant mortality (death in the first year of life) was also higher for Indigenous children
than for other children. In 1995Ð97, in the Northern Territory, Western Australia and South
Australia combined, the infant death rates were 3.1 times as high for Indigenous males
(1,873 per 100,000) as for all Australian males (605) and 3.5 times as high for Indigenous
females (1,731) as for all Australian females (495) (Cunningham & Paradies 2000).
Morbidity
Hospitalisation
As with mortality and many other types of data, the rates of hospitalisation among
Indigenous people are underestimated to the extent that the identification of
Indigenous people in hospital records is incomplete. The level of under-identification is
likely to vary from hospital to hospital and from State to State. Although the quality of
identification has been assessed in a small number of hospitals, where coverage ranged
from 55% to 100% (ATSIHWIU 1999), this has not yet occurred at a national or
jurisdictional level, except in the Northern Territory (Condon et al. 1998).
Note: Indigenous data are for deaths of usual residents of Western Australia, South Australia and Northern Territory 
combined.
Source: Cunningham & Paradies 2000.
Figure 4.19: Age at death, 1995Ð97
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Note: Data are for deaths of usual residents of Western Australia, South Australia and Northern Territory which 
occurred in 1995–97 and were registered by the end of 1998. Rates are age standardised to the Australian population 
at 30 June 1991. 
Source: Cunningham & Paradies 2000.
Figure 4.20: Age-standardised death rates for selected causes, 1995Ð97
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In 1997Ð98, the age-standardised rate of hospitalisation for the total Australian
population was 291 per 1,000. The age-standardised rate of hospitalisation for patients
identified as Indigenous was almost twice as high, at 540 per 1,000 for all States and
Territories combined (AIHW 1999). Thus a large difference was apparent despite
significant undercounting of Indigenous people in hospital records because of the
identification issues mentioned previously.
The rates of hospitalisation were much higher among Indigenous people than among
all Australians in every age group (Figure 4.22). 
Among Indigenous males, the most common causes of admission to hospital were
kidney dialysis (25%), injury (13%) and respiratory diseases (12%). Among Indigenous
females, the leading causes of hospitalisation were dialysis (25%), pregnancy and
childbirth (17%), respiratory diseases (9%) and injury (8%) (Cunningham & Beneforti
2000). Most of the admissions for dialysis occurred as part of ongoing treatment of
people with end-stage kidney failure, with individual patients accounting for as many
as three admissions per week. 
For most types of conditions and diseases, there were between 1.3 and 3 times as many
hospitalisations as there would have been if the Indigenous population had
experienced the same age-specific rates as the total Australian population (Cunningham
& Beneforti 2000).
(a) Australian figures include Tasmania and Australian Capital Territory.
Note: Data for Tasmania and Australian Capital Territory are not presented due to small numbers and data quality 
concerns. Perinatal deaths include stillbirths and deaths within the first 28 days of life.
Source: AIHW NPSU: Day et al.1999a; ABS & AIHW 1999.
Figure 4.21: Perinatal death rates, 1994Ð96
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Dialysis accounted for over 40% of all procedures performed in hospital on patients
identified as Indigenous (44% among Indigenous males and 41% among Indigenous
females), compared with about 9% of procedures on other patients (12% among other
males and 7% among other females) (Cunningham & Beneforti 2000).
Use of general practitioners
Not all health problems are treated in hospital, but there is little national information
about the use of other health care services by Indigenous people. The Bettering the
Evaluation And Care of Health (BEACH) survey provides the first opportunity to
examine the use of general medical practitioners (GPs) by Aboriginal and Torres Strait
Islander Australians. 
About 1.2% of the encounters recorded in the first year of the survey (1998Ð99) were with
patients identified as Indigenous. As 2.1% of the population is Indigenous, this shows
clearly the relative under-utilisation of GPs in private practice by Indigenous peoples.
The most commonly managed problems for Indigenous patients were upper respiratory
tract infections (9% of encounters), acute bronchitis/bronchiolitis (5%), diabetes (5%),
acute otitis media/myringitis (5%), asthma (5%) and hypertension (4%). In contrast, the
most commonly managed problems among patients overall were hypertension (8% of
encounters), upper respiratory tract infections (7%), immunisation/vaccination (5%) and
depression (4%) (AIHW GPSCU: Britt et al. 1999).
Note: Data from public and private hospitals, except in the Northern Territory (public hospitals only). 
Source: Cunningham & Beneforti 2000.
Figure 4.22: Hospital separation rates, all causes excluding dialysis, 1997Ð98
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No comparable information is available about the use of other primary health care
providers, such as Aboriginal health workers and nurses, or about GP-like interactions
in which they are involved.
Ill health in the community
The use of health services does not necessarily indicate the prevalence or incidence of
illnesses and conditions in the Indigenous population, but sources of more exact
indicators of incidence or prevalence at the national level are limited.
Some information was collected about self-reported illnesses and conditions as part of
the ABS National Health Survey, which in 1995 included an enhanced sample of
Aboriginal and Torres Strait Islander peoples. Although information was collected from
Indigenous people living in urban, rural and remote areas, there were concerns about
the quality of some data for some groups of Indigenous people, especially those living
in remote areas and/or who spoke a language other than English at home (ABS 1999a).
People living in remote areas are excluded from the following analysis.
After adjusting for age differences, Indigenous people were more likely than non-
Indigenous people to report a range of chronic diseases and conditions, such as asthma
(Figure 4.23) and diabetes (Figure 4.24) (ABS 1999a). 
Note: Excludes persons living in remote areas. 
Source: ABS 1999a.
Figure 4.23: Reported asthma, 1995
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The reported use of medications for asthma and diabetes was correspondingly high
(ABS & AIHW 1999), but the most commonly reported type of medication, for both
Indigenous and non-Indigenous people, was pain relievers (ABS 1999a).
Health risk factors
Some of the differences in health status can be explained by differences in the health
risk factors to which people are exposed, such as low socioeconomic status, poor living
conditions, poor nutrition, the use of harmful substances, and violence. As a group,
Indigenous people are more likely than other Australians to be exposed to such health
risk factors.
Social and economic factors
Compared with other Australians, Indigenous people are less likely to be employed and
less likely to have post-school educational qualifications. They also have lower personal
and household incomes. At the time of the 1996 Census, the unemployment rate for
those aged 15 years or more was about 23% for Indigenous people, compared with
about 9% for other Australians. About 2% of Indigenous people aged 15 years or more
reported a Bachelor degree or higher in 1996, compared with 11% of other Australians.
The median weekly personal income of Indigenous people in 1996 was $218, below the
Note: Excludes persons living in remote areas. 
Source: ABS 1999a.
Figure 4.24: Reported diabetes, 1995
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median weekly income recorded for the total population ($294). Median weekly
household income was also lower for Indigenous households ($540) than for other
households ($632), despite the larger size of Indigenous households (ABS 1998a). 
Housing and living conditions
Indigenous people are much less likely than other Australians to live in a home that is
owned or being purchased by its occupants, which is generally taken as indicative of
security of tenure. In the 1996 Census, about 31% of Indigenous households owned or
were purchasing their home, compared with 71% of other households (ABS 1998a).
Among households renting their dwelling, the majority of Indigenous households
(53%) rented their home from either a government agency or a community/cooperative
housing agency, whereas most other renter households (67%) rented from a private
owner (ABS 1998a). 
Indigenous households in the 1996 Census were larger than other households
(3.7 versus 2.7 people on average) and were much more likely to live in crowded
dwellings. About 2% of all Indigenous households (and almost 7% of Indigenous
people) lived in dwellings with 10 or more people, compared with only 0.04% of other
households (and 0.14% of other people). Almost half (49%) of all private dwellings in
Australia with 10 or more people living in them were occupied by Indigenous
households. Among large households (that is, with 10 or more people), Indigenous
households were more likely than other households to live in smaller dwellings. The
majority (70%) of large Indigenous households lived in dwellings with three or fewer
bedrooms. In contrast, there were five or more bedrooms in almost half (46%) of the
dwellings occupied by other large households (ABS 1998a; ABS & AIHW 1999).
Indigenous households counted in the Census were more likely than other households
to live in improvised dwellings, such as sheds, humpies or other rough
accommodation. Almost a third (31%) of all households counted in improvised
dwellings were Indigenous households (ABS & AIHW 1999), even though Indigenous
households account for less than 2% of all Australian households (ABS 1998a).
Indigenous people were also more likely than other Australians to use the Supported
Accommodation Assistance Program, which provides services to people who are
homeless or at risk of being homeless (AIHW 1997).
Nutritional status
Adequate consumption of nutritious foods is important for good health, but little
information is currently available at the national level about the food intake of Indigenous
people. However, it is likely that the economic and geographic disadvantages faced by
the Indigenous population are reflected in nutritional disadvantages as well.
One aspect of nutritional status for which national information does exist is relative
weight. Indigenous people are more likely than other Australians to be classified as
obese based on their body mass index (BMI). Among Indigenous adults aged 18 years
or more who were measured in the 1994 National Aboriginal and Torres Strait Islander
Survey, about 28% of females and 25% of males were classified as obese (BMI greater
than 30). This compares unfavourably with figures for all Australians from the 1995
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National Nutrition Survey, in which 19% of females and the same proportion of males
aged 19 years and over were classified as obese, based on BMI derived from measured
height and weight (Cunningham & Mackerras 1998). 
Drugs and other harmful substances
Indigenous adults are about twice as likely to smoke cigarettes as non-Indigenous
adults (Figure 4.25), which puts them at increased risk of heart disease, cancer,
respiratory disease and other conditions. Although Indigenous people are more likely
than non-Indigenous people to abstain from alcohol, those who do drink are more
likely to drink at unsafe levels. The use of illicit drugs and other harmful substances
(such as leaded petrol) is also of concern among the Indigenous population (ABS &
AIHW 1999). For example, a recent study in Western Australia highlighted the rapid
increase in first-time hospital admission rates for Indigenous people for illicit-drug
problems, especially cannabis and amphetamines, during the first half of the 1990s
(Patterson et al. 1999). 
Exposure to violence
Although it is difficult to quantify precisely the extent of the impact of violence on the
health and wellbeing of Indigenous Australians, there is strong evidence that
Indigenous people as a group are at increased risk of being exposed to violence. 
Note: Excludes people living in remote areas. 
Source: ABS 1999a.
Figure 4.25: Smoking prevalence by age group, 1995
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Deaths from intentional injury are more common for Indigenous people than for other
Australians. In 1995Ð97 in the Northern Territory, Western Australia and South
Australia combined, there were about seven times as many deaths among Indigenous
females and almost eight times as many deaths among Indigenous males as would have
been expected if the all-Australian rates had applied (Cunningham & Paradies 2000). In
the period 1989 to 1996, it was estimated that about 20% of victims and 22% of
offenders in intimate-partner homicides were Indigenous (Carcach & James 1998).
Indigenous females are grossly overrepresented in hospitalisations recorded as being
due to intentional injury. Of all hospitalisations among females in 1997Ð98, almost half
(46%) of those classified as being due to intentional injury were among females
identified as Indigenous. It is possible that some intentional injuries to non-Indigenous
females were coded as another type of injury, such as Ôaccidental fallsÕ, but this cannot
completely explain the disparity between the two groups because the rates of
hospitalisation were higher for Indigenous females than for non-Indigenous females for
almost every type of injury. Indigenous males were also at much greater risk of
hospitalisation for intentional injury compared with their non-Indigenous counterparts,
but the differences were not as extreme (Cunningham & Beneforti 2000).
Although death registrations and hospital statistics on intentional injury point to a
heavy burden of violence among Indigenous people, they do not tell the whole story.
Not all victims of violence are admitted to hospital or killed, and not all the results of
violence are physical. However, there is little good statistical information about other
aspects of violence, such as those relating to mental and emotional wellbeing.
Health services and expenditure
Appropriate health services are necessary help reduce disparities in health status
between population groups. According to an analysis of health expenditure in the
financial year 1995Ð96, about $2,320 per person was spent on health services to
Indigenous people, compared with $2,163 for services to non-Indigenous people
(Deeble et al. 1998). This difference in expenditure (8%) is much smaller than the
differences for many of the health status measures shown above. 
Aboriginal and Torres Strait Islander peoples appear to have a different pattern of
service use from that for the rest of the population (Figure 4.26), with higher estimated
per person expenditure for Indigenous people for public hospital services and
community health services, and lower per person expenditure for Medicare, the
Pharmaceutical Benefits Scheme, nursing homes, dental and other professional services,
and private hospitals (Deeble et al. 1998). 
4.7 Socioeconomically disadvantaged
There has been considerable focus in Australia and overseas on the association between
socioeconomic disadvantage and health. The relationship between increasing mortality
and morbidity with decreasing socioeconomic status has been well demonstrated (Turrell
et al. 1999). Similarly, many of the differences in health between groups, such as between
men and women, between Indigenous people and non-Indigenous persons, and between
urban and rural residents, also show a relationship with socioeconomic factors (AIHW:
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Mathers 1994a). However, the reason for the relationship is not clear and requires further
work. A range of risk factors, as well as the social and economic elements, affect health.
Health inequalities are caused by a complex interplay of these factors. 
There are a number of elements that contribute to socioeconomic status, including
income, level of education, employment status and occupation. These elements by
themselves, however, do not provide an ideal measure, and their use often depends on
the age group being analysed. Health information by socioeconomically graded areas of
residence provides a useful way to analyse information for children, retired people and,
in some cases, women, where data on occupation, education and income are not always
available or not relevant (AIHW: Mathers 1994a). The most common measure of
socioeconomic status by area of residence is the Index of Relative Socioeconomic
Disadvantage (IRSD), derived by the Australian Bureau of Statistics from population
census data (Box 4.2, page 220). 
Analyses of inequalities in health were conducted in the first half of the 1990s by the
National Health Strategy (1992) and the Australian Institute of Health and Welfare
using mortality data for 1985 to 1987, data from the 1988 Survey of Disabled and Aged
Persons, the 1989Ð90 National Health Survey, and the 1989 National Heart Foundation
Risk Factor Prevalence Survey. These studies found that people of a low socioeconomic
status generally have higher rates of mortality and are most likely to suffer from
(a) Includes inpatient and outpatient.
Source: Deeble et al. 1998.
Figure 4.26: Estimated per person health expenditure by type of service, 1995Ð96
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disability, to have serious chronic illnesses or suffer recent illnesses, and to report being
in only fair or poor health as opposed to good or excellent health. The analysis
conducted by the AIHW demonstrated substantial inequalities in health by all measures
of socioeconomic status (education level, employment status, occupation, occupational
prestige, family income and areas of socioeconomic disadvantage) and for all age
groups. People with lower socioeconomic status had higher death rates and reported
higher levels of illness and reduced activity due to illness (AIHW: Mathers 1994a,
1994b, 1995, 1996). 
These analyses also demonstrated that the socioeconomically disadvantaged make
greater use of primary and secondary health services such as doctors, hospitals and
outpatient clinics, but are less likely to use preventive health services such as dentists,
immunisation and cancer screening tests (e.g. mammograms and Pap smears). 
More recently, mortality and morbidity data and data from the 1995 National Health
Survey have been analysed with regard to socioeconomic status. The findings are
reported in the following paragraphs. 
Box 4.2: Measures of inequality
Index of Relative Socioeconomic Disadvantage (IRSD). The IRSD is one of a group
of measures developed by the Australian Bureau of Statistics to categorise small geo-
graphic areas according to their social and economic characteristics (ABS 1998d). This
measure was used to group people into quintiles of socioeconomic disadvantage according
to the IRSD for their statistical local area of usual residence, with the first quintile corre-
sponding to the group with the highest socioeconomic status and the fifth quintile the
lowest. 
YLL and YLD rate ratios. These are the age-standardised YLL (years of life lost due to
premature mortality) or YLD (years of life lost due to disability) rate per 1,000 population
for the least socioeconomically disadvantaged quintile divided by the corresponding age-
standardised rate for the most socioeconomically disadvantaged quintile. This provides a
measure of the excess mortality or disability among the most disadvantaged which is inde-
pendent of variations in age and sex distribution between groups with different
socioeconomic status. Rate ratios greater than 1 indicate higher mortality or disability for
the most disadvantaged.
Gini coefficient. This is a summary measure of the degree of inequality in some charac-
teristic within the population (Wagstaff et al. 1991). In this case the coefficient is calcu-
lated for cause-specific YLL and YLD. Its values range from 0 (perfect equality) to 1
(perfect inequality) and measure the degree of mortality or disability inequality across the
quintiles of socioeconomic disadvantage as measured by the IRSD.
Excess burden. This measure identifies the burden of mortality or disability which may
be attributed to socioeconomic disadvantage (Kunst 1997). It is presented as the per-
centage of YLL or YLD which could potentially be avoided if all quintiles had the same
age-standardised YLL or YLD rate as the least disadvantaged quintile.
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Mortality
The most complete data on socioeconomic status and the burden of disease and injury
is available for mortality. Variability in the mortality burden with socioeconomic status
can be examined using three measures: the YLL rate ratio, the Gini coefficient and the
excess mortality burden (see Box 4.2). 
For all deaths registered for the years 1995Ð97, classified into quintiles of socioeconomic
disadvantage according to the IRSD (see Box 4.2) for their statistical local area of usual
residence (AIHW: Mathers et al. 1999), there is a marked gradient in the mortality
burden across these quintiles. The YLL rate ratio shows that the burden in the most
disadvantaged group is 41% higher for males and 26% higher for females (Table 4.12,
page 222). Looking at specific causes of death, the differentials in mortality burden are
smaller for infectious diseases and cancers but larger for cardiovascular disease, chronic
respiratory conditions, digestive system diseases and injuries.
The Gini coefficient indicates that the overall mortality burden for males is 50% higher
than females (with Gini coefficients of 0.06 and 0.04 respectively). A similar difference
between males and females is shown in the excess mortality burden, with 19% of the
mortality burden for males associated with socioeconomic status compared with 12% of
the burden for females.
This inequality in mortality burden is also reflected in the age-specific probability of
death, which is higher at all ages for people in the most disadvantaged quintile
compared with the least disadvantaged quintile.
Analysis of mortality for 1997 and 1998 found that males in the most disadvantaged
quintile had 12% higher mortality than the average Australian male, and 30% higher
than males in the least disadvantaged quintile. For females, those in the most
disadvantaged quintile had a 16% higher level of mortality than those in the least
disadvantaged quintile (ABS 1999b).
Consistent with these results, analysis of 1995Ð97 mortality data by AIHW found that
among those aged 15Ð24 years death rates of males in the most disadvantaged quintile
were 70% higher than males in the least disadvantaged quintile, with death rates of 112
and 65 per 100,000 population, respectively. Similarly, females in the most disadvantaged
quintile had death rates 40% higher than those in the least disadvantaged quintile
(35 compared with 26 per 100,000 population) (AIHW: Moon et al. 1999).
This analysis also found that there is a 3.6-year gap in life expectancy at birth for males
between the top and bottom quintiles of socioeconomic disadvantage, and a 1.9-year
gap for females. That is, the most socioeconomically disadvantaged in society have
lower life expectancies than the least socioeconomically disadvantaged, losing 35%
more years of life in 1996 (AIHW: Mathers et al. 1999).
In interpreting these results, it should be borne in mind that the IRSD relates to the
average disadvantage of all people living in a geographic area. Hence any variability
between groups based on the IRSD will probably be smaller than if the variability had
been measured between individuals. In other words, these measures of inequality will
in most cases understate the level of inequality in mortality burden by socioeconomic
disadvantage between individuals. 
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Disability
There are no data to measure socioeconomic inequality in YLD for the whole
population, but this inequality can be examined for mental disorders. The 1997
National Survey of Mental Health and Wellbeing collected data on mental disorders
among the Australian population aged 18 years and over. Survey respondents were
classified into quintiles of socioeconomic disadvantage using the IRSD to classify place
of usual residence.
The YLD burden due to mental disorders in the most disadvantaged quintile is 45%
higher for males and 41% higher for females than the burden in the least disadvantaged
quintile. The Gini coefficients show similar levels of inequality for both males and
females (with coefficients for the burden of mental disorders of 0.07 and 0.06
respectively). The excess disability burden from mental disorders is slightly larger for
women, with 20.0% of the disability burden for mental disorders among women
associated with socioeconomic status compared with 17.5% of the burden among men
(AIHW: Mathers et al. 1999).
Total disease burden
The lack of data on the burden of disability means that a comprehensive analysis of the
total disease burden associated with inequalities in socioeconomic status cannot be
completed. However, modelling techniques can be used to derive provisional total
burden estimates (Figure 4.27).
The total burden (DALY) for the most disadvantaged is 37% higher for males and 27%
higher for females than the total burden for the least disadvantaged (Table 4.12). The
proportion of total burden associated with inequalities in socioeconomic disadvantage
is 18.7% for males and 15.4% for females.
Findings from the 1995 National Health Survey reveal that a greater proportion of both
males and females in the areas of greatest disadvantage rated their health as fair or poor
(rather than good, very good or excellent) than did those from other areas. There was a
clear gradient of more negative assessment of health with greater disadvantage of area.
Table 4.12: Differentials in the burden of disease and injury between top and bottom quintiles 
of socioeconomic disadvantage, age-standardised YLL, YLD and DALYs per 1,000 population, 
1996
Males Females Persons
YLL ratio(a) 1.41  (1.38–1.45) 1.26  (1.22–1.29) 1.35  (1.32–1.37)
YLD ratio(a) 1.32  (1.13–1.46) 1.29  (1.05–1.53) 1.30  (1.09–1.44)
DALY ratio(a) 1.37  (1.28–1.43) 1.27  (1.14–1.41) 1.32  (1.22–1.39)
Excess burden (per cent)(b) 18.7  (15.1–21.5) 15.4    (9.3–19.6) 17.1  (13.7–19.4)
(a) Ratio of age-standardised rate per 1,000 population for bottom (5th) quintile of IRSD to the age-standardised rate per 
1,000 population for the top (1st) quintile. Range given in brackets is the estimated 95% confidence or uncertainty 
interval.
(b) Percentage of total burden (DALYs) that would be avoided if all quintiles had the same age-standardised DALY rate as 
the least disadvantaged (1st) quintile. Range given in brackets is the estimated 95% confidence or uncertainty interval.
Source: AIHW: Mathers et al. 1999.
01 AH2000 body  Page 222  Thursday, June 1, 2000  3:06 PM
4 Health and determinants in population groups  223
TRIM SIZE 175 mm Wide x 250 mm Deep
Among all people aged 15 years and over, 17% rated their health as fair or poor, with
this percentage ranging from 12% in the least disadvantaged areas to 22% of those in
the most disadvantaged areas (ABS 1999f). 
Of the fifteen most common non-minor illnesses recorded in the survey, five were more
common in the most disadvantaged areas, including arthritis, asthma, bronchitis/
emphysema, ulcer and diabetes. As found in earlier studies, the more socio-
economically disadvantaged also made greater use of doctors and outpatient/casualty
services, but were less likely to use preventive health services (ABS 1999f). 
4.8 Rural and remote populations
The health of populations living in rural and remote areas of Australia is worse than of
those living in capital cities and other metropolitan areas (AIHW 1998). Mortality and
illness levels increase as the distance from metropolitan centres increases. Relatively
poor access to health services, lower socioeconomic status and employment levels,
exposure to comparatively harsher environments and occupational hazards contribute
to and may explain most of these inequalities. Also, a large proportion of the population
in the more remote parts of Australia are Aboriginal and Torres Strait Islander peoples,
who generally have poorer health status. 
Source: AIHW: Mathers et al. 1999.
Figure 4.27: Estimated burden of disease and injury (age-standardised DALYs per 
1,000 population) by quintile of area of socioeconomic disadvantage, by sex, 1996
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The geographical basis of reporting in this section is the Rural, Remote and
Metropolitan Areas (RRMA) classification which is outlined in Table 4.13. This
classification is based mainly on population numbers and an index of remoteness (DPIE
& DHSH 1994). 
Demographic and environmental factors
About 29% of the Australian population (including 64% of the Indigenous population)
live in rural and remote Australia. Although Aboriginal and Torres Strait Islander
peoples constitute about 2.1% of the total Australian population, they make up 1% of
the capital city population and 20% of the population of the remote zone. The remote
zone also has a low or negative population growth rate, higher fertility rates, more
children and fewer old people (AIHW 1998), and Year 12 high school completion rates
tend to be 10% lower than in capital cities (SCRCSSP 1997). The Index of Relative
Socioeconomic Disadvantage tends to increase with increasing remoteness
(AIHW 1998). 
Risk factors 
Personal health risk factors tend to be worse in remote areas than in metropolitan areas.
For example, a higher proportion of males in remote areas self-report high alcohol
consumption (8.0% compared with 4.4% in capital cities). Also, in remote areas a higher
proportion of people smoke (approximately 10 percentage points higher for both sexes)
and a lower proportion of men walk for exercise (AIHW 1998). Based on self-reported
measures of height and weight, a higher proportion of women from remote areas are
overweight. 
Table 4.13: Population distribution by Rural, Remote and Metropolitan Areas classification
RRMA category
Population (1998)
Population
growth
1991–96
(per cent)
Indigenous population 
(1996)(a)
Number Per cent Number Per cent
Metropolitan
Capital cities 11,952,545 63.8 1.2 117,103 1.0
Other metropolitan centres 1,421,040 7.6 1.8 22,880 1.7
Rural
Large rural centres 1,119,312 6.0 1.5 33,435 3.1
Small rural centres 1,218,495 6.5 1.2 34,009 2.8
Other rural areas 2,466,695 13.2 0.9 63,807 2.6
Remote
Remote centres 224,168 1.2 0.1 27,530 12.6
Other remote areas 345,549 1.8 –0.3 87,088 25.9
Total 18,747,804 100.0 1.2 385,852 2.1
(a) 1998 estimates of the Indigenous population by statistical local area (SLA) were not available.
Source: AIHW, derived from ABS SLA population estimates.
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Mortality and morbidity
Death rates show a graduated increase with increasing remoteness. Death rates vary
according to age and sex grouping, but overall the rates for the Indigenous population
are two to three times higher than those of the non-Indigenous population. The higher
death rates in remote areas for the population overall can be largely explained by the
high proportion of Indigenous peoples living in those areas (Table 4.14). 
The death rate for Indigenous people in the remote zone was about 10% higher than for
Indigenous people in the metropolitan zone. A major reason for this was the higher
rates of death from respiratory disease and injury in the remote zone. 
The death rates for non-Indigenous males and females in the remote zone were lower
than in the metropolitan zone, even though rates of injury-related death were higher in
the remote zone. 
Indigenous males in the rural zone have a similar death rate to their metropolitan
counterparts, and Indigenous females have a death rate 10% lower than their
metropolitan counterparts (Table 4.14). Death rates for non-Indigenous people were
similar or only slightly higher for the rural zone compared with the metropolitan zone. 
Recent data indicate that the health of those in remote areas is generally poorer in each
of the National Health Priority Areas:
¥ Mortality from heart, stroke and vascular disease is marginally higher in remote areas
than in metropolitan areas. Mortality from rheumatic heart disease is almost three
times higher in remote areas, reflecting the high rate in the Indigenous population.
The hospital admission rate for coronary heart disease is 1.4 times higher, and the
admission rates for stroke are 1.4 times higher for males and 1.6 times higher for
females in remote areas than in metropolitan areas (DHAC & AIHW 1999b).
¥ Whereas rural and metropolitan death rates from diabetes are similar, death rates in
remote areas are approximately twice as high, reflecting the high rate in Indigenous
people. Hospital admission rates for rural residents are a little higher, and admission
Table 4.14: Mortality rates for the Indigenous and non-Indigenous populations by 
geographic zone, 1994Ð98 (per 100,000 population)
Indigenous 
status
Death rate 1994–98
Metropolitan Rural Remote Total
Males Indigenous 1,763 1,721 1,916 1,825
Non-Indigenous 773 *800 746 778
Total males 779 *809 *948 805
Females Indigenous 1,215 1,097 1,361 1,286
Non-Indigenous 507 502 *454 505
Total females 511 509 *649 524
* Significantly different from the metropolitan zone at the 5% level.
Notes
1. Age standardised to the Australian population at 30 June 1991.
2. Based on data for South Australia, Western Australia and the Northern Territory.
Source: AIHW 1998a.
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rates for remote residents are more than 2.5 times higher than those for their
metropolitan counterparts (DHAC & AIHW 1999a). 
¥ Cancer mortality is similar in metropolitan, rural and remote areas. People living in
the remote zone show higher cervical cancer and slightly lower melanoma incidence
and death rates (AIHW 1998). 
¥ Death rates and hospital admissions due to injury are moderately higher in rural areas,
but two to three times higher in remote areas compared with capital cities (AIHW
1998a). In remote areas, approximately 30% of these extra injury deaths are attributable
to motor vehicle accidents, 20% to suicide and 10% to interpersonal violence. 
¥ There are few comparative data available on mental health; however, higher suicide
rates, particularly in young men from rural and remote areas, may indicate higher
levels of depression (DHAC & AIHW 1999c). In Ôother remote areasÕ, the male suicide
rate is one-and-a-half times the capital cities rate, and the suicide rate of males aged
15Ð24 years is almost twice that of their capital city counterparts.
¥ Asthma death rates are up to twice as high in more remote areas compared with
metropolitan centres (AIHW 1998). 
Children and youth
Death rates for children aged less than 15 years are higher with increasing remoteness.
Half of all deaths in this age group are due to injury, with smaller proportions due to
cancer and asthma. In the remote zone, where the death rate is almost double that for
metropolitan children, over 60% of these extra deaths were due to injury, and of these
half were as a result of motor vehicle accidents and a third were due to drowning (with
boys having higher rates than girls for all these causes). Death rates for all children
from the rural zone fall between the rates for metropolitan and remote zones (AIHW:
Moon et al. 1998). 
Death rates for Indigenous children in the metropolitan and remote zones were
approximately double those for non-Indigenous children in those zones. Indigenous
children from the remote zone had death rates double that of metropolitan and rural
zone Indigenous children. 
Hospital admission rates for girls and boys were higher in the remote zone (172 and
227 per 1,000 population respectively) than in the rural zone (113 and 156 per 1,000
population respectively) and in the metropolitan zone (113 and 156 per 1,000 population
respectively).
Death rates for young adults (those aged 15Ð24 years) increase with increasing
remoteness. The death rate for young adult males in Ôother remote areasÕ was twice that
for their capital city counterparts. Death from motor vehicle accidents was three times
more likely for young adults in remote areas compared with those living in capital
cities. Young males from remote areas are almost twice as likely to commit suicide
compared with young males from capital cities. Injury death rates for young adults fell
substantially in the last decade in all three zones, with rates for motor vehicle accident
deaths decreasing by about 40%. However, rates for suicide death increased by about
16% in the last decade. 
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Death rates for young Indigenous adults (15Ð24 years) are double the rate for all young
Australian adults in this age group across all three zones. The death rate for young
Indigenous males in the remote zone was twice that of their metropolitan zone
Indigenous counterparts, but for young Indigenous females there was no significant
difference between death rates in each zone. Almost 70% of these Indigenous deaths
were due to injury as for all young adults.
Hospital admission rates for young adults increase with increasing remoteness. Females
were admitted at twice the rate of males (though this difference was greater in more
remote areas). In Ôother remote areasÕ the hospital admission rate for males and females
respectively were one-and-a-half times and two-and-a-half times the admission rate of
their capital city counterparts. Of the leading causes for male admission, only injury
showed a clear and strong trend for significantly higher rates (three times higher) in
Ôother remote areasÕ compared with capital cities. Females in Ôother remote areasÕ were
admitted for pregnancy-related reasons at a rate 2.5 times higher and for injury at a rate
4 times higher than their capital city counterparts.
Oral health
Major differences in oral health exist between the metropolitan, rural and remote areas.
Variations in tooth loss indicate differing historical treatment patterns between urban,
rural and remote locations. 
Complete tooth loss increases with increasing age (Table 4.15). In total, less than 2% of
adults aged less than 45 years had lost all their natural teeth, but this increased to more
than one in five rural adults in the 45Ð64 age group. Adults aged 65 years and over from
rural areas had a higher rate of complete tooth loss than adults from remote or
metropolitan areas. 
See page 285 for information on the use of dental services by persons in urban, rural
and remote areas.
Health workforce 
The number of healthcare professionals in an area is an important factor in influencing
both health status and access to care. The availability of healthcare professionals across
the geographic areas is described in section 5.4 (page 260)
Table 4.15: Complete tooth loss among adults aged 18 years and over, 1994Ð96 (per cent)
Age group Metropolitan Rural Remote Australia
18–24 years 0.1 0.2 0.0 0.1
25–44 years 1.4 2.1 *2.2 1.8
45–64 years 11.7 21.5 *14.8 14.2
65+ years 36.6 50.0 43.2 40.3
Total 9.3 16.2 9.4 10.9
* Estimate has a relative standard error greater than 25%.
Source: National Dental Telephone Interview Surveys 1994, 1995, 1996.
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Expenditure and access
There are 65% more public hospital beds available per person in the rural zone
compared with capital cities. The per person amount spent on hospitalisation (as
measured by average cost weight and ignoring length of stay) is similar for residents of
metropolitan and rural zones (AIHW 1998). Hospital admission rates are 20Ð40% higher
for remote zone residents (due to higher rates of medical admission) compared with
residents of capital cities, but rates of admission for remote area residents requiring
specialist medical practitioners and equipment are lower, being 70Ð90% of capital city
rates (AIHW 1998). 
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5 Health resources and 
use of services
The focus of this chapter is on: 
¥ the resources or inputs (money, personnel, facilities) used in the delivery of health
services; and 
¥ use of these inputs to produce outputs (patients treated, health services delivered).
Resources provide the means by which health interventions are carried out, and these
interventions produce outputs and outcomes which may contribute to health and
wellbeing.
Clinical interventions can occur in a diverse range of settings such as large health
establishments (hospitals), other health establishments (nursing homes, hospices,
rehabilitation centres), community centres, small health clinics, ambulatory care services,
the private rooms of health professionals, and the patientÕs home or workplace.
Increasingly, telemedicine services and the Internet are being used to communicate
information about health services. At the personal level, individuals may also choose to
use information from reference material to self-manage minor medical conditions.
Public, occupational and environmental health interventions may be delivered in several
ways: through information in the media; regulation; improved water, sewerage, and
transport infrastructure; and infectious disease identification and containment programs.
5.1 Health services funding and expenditure
The health expenditure statistics examined here relate largely to expenditure on health
services provided to people who are ill and services provided within the health sector
aimed at health promotion and illness prevention. They do not include expenditures
that have a ÔhealthÕ outcome but which are undertaken outside the health sector, such as
expenditure on building safer transport systems.  
Box 5.1: Health services expenditure to GDP ratio
From November 1998, the Australian Bureau of Statistics (ABS) upgraded gross domestic
product (GDP) measures in line with the recommendations of the revised international
standard for the System of National Accounts 1993 (SNA93). This increased the estimate
of GDP by an average of 3.0%. In 1997Ð98, the GDP was revised upwards by $16.9 bil-
lion, of which $15.9 billion was due to the SNA93 recommendations. These changes have
resulted in a reduction of about 0.3% in the health services expenditure to GDP ratios for
all years.
For further details see the 1998 ABS publication Upgraded Australian National
Accounts, ABS Cat. No. 5253.0. 
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Health services expenditure is looked at in terms of total health expenditure,
expenditures on the different components of the health care system, and the sources of
funding for health services. Some factors contributing to changes in health services
expenditure are examined and a comparison is made of health services expenditure by
the State and Territory Governments. AustraliaÕs expenditure on health services is also
compared with that of other Organisation for Economic Co-operation and Development
(OECD) member countries. 
Funding health services in Australia
In 1997Ð98, total health services expenditure, including expenditure by both the
government and the non-government sectors, was $47,030 million. Health services
expenditure as a proportion of gross domestic product (GDP) almost doubled over the
last four decades of the twentieth century, from 4.3% in 1960Ð61 to 8.3% in 1997Ð98
(Table 5.1, page 234). The preliminary estimate for 1998Ð99 is $50,335 million. Most of
this increase was in the Ôpre-MedibankÕ period, from 1960Ð61 to 1974Ð75, and the first
year of Medibank, and was largely due to reclassification of expenditure by States as
they moved towards cost-sharing of hospitals with the Commonwealth. Since the
introduction of Medibank in 1975, health expenditure as a proportion of GDP has
increased from 6.3% to 8.3%.
More than two-thirds of the funding for health expenditure in 1997Ð98 was provided by
governments (68.6%). Of this, the Commonwealth Government provided 45.2% and
State and local governments 23.4%. The non-government sector provided the remaining
31.4% of the total funding (Table 5.2, page 235).   
The way health services are funded, particularly by the Commonwealth and the non-
government sector, was quite different in 1997Ð98 from what had prevailed in 1960Ð61.
Despite similarities in the overall proportions of expenditureÑthe Commonwealth
Government was responsible for 39.2% of total expenditure in 1960Ð61 and 45.2% in
1997Ð98Ñthere were major differences in the way that funding was provided. In
1960Ð61, tax expenditures accounted for 30.0% of Commonwealth Government
expenditure on health services. In 1997Ð98, tax expenditures made up only 1.6% of
Commonwealth health services expenditure. Similarly, tax expenditures by the
Commonwealth greatly reduced the net expenditure by non-government sources in
1960Ð61, but this was not the case in 1997Ð98.
Between 1960Ð61 and 1997Ð98, real expenditure by the Commonwealth Government
grew at an average of 6.4% per year (Table 5.3, page 236). At the same time, State and
local government real expenditure grew at an average of 4.7% per year, and the non-
government sector at 4.0% per year. The rapid rate of growth in the CommonwealthÕs
expenditure was largely due to the influence of Medibank in permanently changing the
distribution of responsibility for the funding of hospital and medical services. 
The relative share of responsibility for funding healthcare services in Australia over the
last quarter of the twentieth century was very largely influenced by the introduction of
Medibank and its modifications (1975 to 1984) and Medicare (from 1984). 
With the introduction of Medibank in 1975, the Commonwealth took over responsibility
for funding half the operating costs of the StatesÕ public hospitals and assumed most of
the responsibility for funding medical services. This increased the CommonwealthÕs
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share of total expenditure from 40.6% in 1974Ð75 to 49.0% in the next year. At the same
time, the State and local governmentsÕ share, which had risen rapidly in the period
immediately preceding Medibank, fell from 33.6% to 25.2%. The non-government
sourcesÕ share of expenditure was essentially unchanged. This was due mainly to a
large reduction in Commonwealth health-related tax expenditures associated with the
introduction of Medibank. 
The various changes to Medibank between 1975Ð76 and 1981Ð82 brought about
substantial changes in the relative shares of expenditure of the different funding
sources. Between 1975Ð76 and 1977Ð78, the CommonwealthÕs share fell from 49.0% to
36.2%Ñthis reduction impacted largely on the non-government sector as a source of
funding, which increased from 25.8% to 38.3%. State and local governmentsÕ share of
funding increased only marginally, from 25.2% to 25.5%.
Table 5.1: Total health expenditure and GDP (current prices), 1960Ð61 to 1997Ð98
Year
Total health expenditure
($ million) GDP ($ million)
Total health expenditure as
percentage of GDP
1960–61 692 15,946  4.3
1963–64 870  19,546  4.5
1966–67 1,139  24,941 4.6
1969–70  1,627  33,547 4.8
1974–75  4,233  67,138 6.3
1975–76  5,684  79,313 7.2
1976–77  6,557  91,276 7.2
1977–78  7,408  99,395 7.5
1978–79  8,166  112,815 7.2
1979–80  9,000  128,287 7.0
1980–81  10,130  145,665 7.0
1981–82  11,681  166,475 7.0
1982–83  13,026  179,649 7.3
1983–84  14,802  202,571 7.3
1984–85  16,371  224,857 7.3
1985–86  18,394  247,681 7.4
1986–87  20,881  271,672 7.7
1987–88  23,053  309,942 7.4
1988–89  25,795  350,753 7.4
1989–90  28,800  383,494 7.5
1990–91  31,270  396,236 7.9
1991–92  33,087  406,890 8.1
1992–93  34,993  427,772 8.2
1993–94  36,787  450,050 8.2
1994–95  38,967  474,646 8.2
1995–96  41,783  508,246 8.2
1996–97  44,482  533,709 8.3
1997–98  47,030  565,963 8.3
Sources: AIHW Health Expenditure Database; ABS Australian National Accounts—National Income, Expenditure and 
Product, June quarter, various years (Cat. No. 5206.0).
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The next significant event affecting the relativities between the different sectors was the
introduction of Medicare in February 1984. Medicare raised the CommonwealthÕs share of
expenditure from 38.0% in 1983Ð84 to 45.8% in 1984Ð85. This was almost completely offset
by the fall in the share met by the non-government sector, which dropped from 35.6% to
28.4%. Once again there was only a marginal impact on the share of expenditure met by
State and local governments, which fell slightly, from 26.4% to 25.8%.
Table 5.2: Government and non-government sector expenditure as a proportion of total health 
services expenditure, 1960Ð61 to 1997Ð98 (current prices) (per cent)
Year 
Government sector Non-government
sector(a) All sectors totalCommonwealth(a) State and local Total
1960–61 39.2 23.3 62.5 37.5 100.0
1963–64 40.6 22.1 62.7 37.3 100.0
1966–67 41.7 22.5 64.3 35.7 100.0
1969–70 41.3 28.6 69.9 30.1 100.0
1974–75 40.6 33.6 74.3 25.7 100.0
1975–76 49.0 25.2 74.2 25.8 100.0
1976–77 42.2 25.1 67.3 32.7 100.0
1977–78 36.2 25.5 61.7 38.3 100.0
1978–79 35.6 26.7 62.3 37.7 100.0
1979–80 34.9 26.6 61.5 38.5 100.0
1980–81 35.6 27.1 62.7 37.3 100.0
1981–82 38.9 27.3 66.1 33.9 100.0
1982–83 37.7 27.1 64.8 35.2 100.0
1983–84 38.0 26.4 64.4 35.6 100.0
1984–85 45.8 25.8 71.6 28.4 100.0
1985–86 45.5 25.9 71.4 28.6 100.0
1986–87 44.1 26.3 70.4 29.6 100.0
1987–88 43.8 25.9 69.7 30.3 100.0
1988–89 42.5 25.7 68.2 31.8 100.0
1989–90 42.2 26.1 68.3 31.7 100.0
1990–91 42.2 25.5 67.7 32.3 100.0
1991–92 42.8 24.6 67.4 32.6 100.0
1992–93 43.7 23.4 67.1 32.9 100.0
1993–94 45.3 21.4 66.7 33.3 100.0
1994–95 45.0 21.7 66.7 33.3 100.0
1995–96 45.6 22.2 67.7 32.3 100.0
1996–97 44.6 22.4 66.9 33.1 100.0
1997–98 45.2 23.4 68.6 31.4 100.0
(a) Proportions for Commonwealth Government and non-government sector expenditure are calculated after adjusting for 
tax expenditure (see Box 5.3, page 237).
Sources: 1960–61, 1963–64 and 1966–67: Senate Select Committee on Medical and Hospital Costs 1970; 
1974–75: WD Scott & Co. Pty Ltd 1978; 1975–76 to 1997–98: AIHW Health Expenditure Database.
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Box 5.2: Constant price estimates
In previous editions of AustraliaÕs Health, the Australian Institute of Health and Welfare
included estimates of expenditure at Ôconstant (average 1989Ð90) pricesÕ. These were, in
the main, calculated using implicit price deflators (IPDs) that were, in turn, based on
fixed-weighted indexes (1989Ð90 base). The ABS has now ceased calculating constant
price expenditure estimates based on such fixed-weighted indexes and has moved to annu-
ally reweighted chain volume measures. In the tables that follow, wherever Ôconstant priceÕ
estimates are shown they are intended to reflect changes in volume expressed in terms of
current prices in the reference yearÑ1997Ð98 in this publication. These estimates are cal-
culated using IPDs that are derived from the new series of annually reweighted chain
volume indexes produced by ABS. 
These new IPDs are considered to be superior to those used previously in that they lessen
the effect of compositional change. 
A full discussion of chain volume measures can be found in the 1997 ABS publication
Chain Volume Measures in the Australian National Accounts, ABS Cat. No. 5248.0.
Table 5.3: Total health services expenditure, constant prices(a), and annual growth rates, 
by source of funds, 1960Ð61 to 1997Ð98
Year
Government sector Non-government 
sector(b) All sectors totalCommonwealth(b)  State and local
Amount
($m)
Rate of
growth
(%)
Amount
($m)
Rate of
growth
(%)
Amount
($m)
Rate of
growth
(%)
Amount
($m)
Rate of
growth
(%)
1960–61 2,024 . . 1,952 . . 3,337 . . 7,313 . .
1963–64 2,466 6.8 2,127 3.1 3,902 5.4 8,505 5.2
1966–67 2,928 5.9 2,459 4.8 4,623 5.8 10,010 5.6
1969–70 3,482 6.0 3,482 14.1 5,078 3.2 12,275 7.0
1974–75 5,445 9.4 6,015 10.1 7,247 7.4 18,707 8.6
1975–76 9,943 82.6 5,214 –13.3 6,266 –13.5 21,423 14.5
1983–84 10,017 0.1 6,683 3.3 9,890 6.0 26,681 2.8
1984–85 12,406 3.8 6,690 0.1 8,334 –6.5 27,429 2.8
1988–89 14,020 3.1 8,269 5.4 10,829 6.8 33,118 4.8
1992–93 16,608 4.3 8,867 1.8 12,829 4.3 38,304 3.7
1997–98 21,411 5.2 10,990 7.8 14,628 2.7 47,030 4.9
Average annual growth rates
1960–61 to 1974–75 7.3 8.4 5.7 6.9
1975–76 to 1997–98 3.5 3.4 3.9 3.6
1984–95 to 1988–89 4.3 3.9 4.4 4.2
1960–61 to 1997–98 6.4 4.7 4.0 5.0
(a) See Box 5.2 for explanation of constant price estimating method.
(b) Commonwealth Government and non-government sector expenditure adjusted for tax expenditure (see Box 5.3).
Source: AIHW Health Expenditure Database.
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Under Medicare, the Commonwealth and each of the States and Territories entered into
health services financing agreements. This led to the CommonwealthÕs share of hospital
funding increasing and the StatesÕ share decreasing. However, the StatesÕ share of all
health funding decreased only marginally.
During the first set of Medicare agreements, 1984Ð85 to 1987Ð88, the CommonwealthÕs
share of health funding fell consistently each year (from 45.8% to 43.8%) while the
proportion met by State and local governments generally remained at just under 26.0%.
The share of funding borne by non-government sources increased from 28.4% to 30.3%
to make up for the fall in the CommonwealthÕs share of funding.
The introduction of Medicare also led to a major increase in Commonwealth funding
for private medical services provided out of hospitals. 
Health services expenditure 1960–61 to 1997–98
Between 1960Ð61 and 1997Ð98, real expenditure on health services more than doubled.
Measured in 1997Ð98 prices, health services expenditure grew from $7,313 million in
1960Ð61 to $47,030 million in 1997Ð98 (Table 5.3). This represented a real average annual
Box 5.3: Health-related tax expenditures
Tax expenditures refer to financial benefits that individuals and businesses derive from
taxation concessions of various kinds. These concessions are usually delivered by tax
exemptions, tax deductions, tax rebates or reduced tax rates. Tax expenditures lower the
tax burden by either reducing or delaying the collection of taxation revenue, and the bene-
fits provided by them could equally be delivered in the form of direct expenditures. Tax
expenditures are, therefore, regarded as an expenditure by the Commonwealth Government
and are offset against the non-government sectorÕs total funding of health services. Because
health-related tax expenditures can relate to the whole range of areas of expenditure, it is
not possible to adjust Commonwealth Government and non-government expenditure on
individual areas for tax expenditures.
In the area of health services expenditure the main tax expenditures have been:
Before 1975Ð76 Taxation deduction on medical expenses (including any part refunded
by private health insurance funds): 1960Ð61, $80m; 1963Ð64, $100m; 1966Ð67, $139m;
1969Ð70, $206m; 1974Ð75, $452m.
1975Ð76 to 1980Ð81 Taxation rebate on medical expenses (not including any part
refunded through private health insurance): 1975Ð76, $87m; 1976Ð77, $46m; 1977Ð78,
$7m; 1978Ð79, $11m; 1979Ð80, $13m; 1980Ð81, $17m.
1981Ð82 to 1982Ð83 Taxation rebate on medical expenses (not including any part
refunded through private health insurance) plus rebate on contributions to private health
insurance: 1981Ð82, $477m; 1982Ð83, $591m.
1983Ð84 to 1997Ð98 Taxation rebates on medical expenses: 1983Ð84, $21m; 1984Ð85,
$27m; 1985Ð86, $28m; 1986Ð87, $34m; 1987Ð88, $37m; 1988Ð89, $44m; 1989Ð90, $61m;
1990Ð91, $85m; 1991Ð92, $82m; 1992Ð93, $91m; 1993Ð94, $95m; 1994Ð95, $91m;
1995Ð96, $141m; 1996Ð97, $137m; 1997Ð98, $350m.
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increase of 5.0%. The population grew by 75.4%, at an average of 1.5% per year over the
period. Consequently, real per person health services expenditure increased at an
average rate of 3.6% per year (Table 5.5, page 241). This reflected the combined effects of
change in the intensity of use of health service resources by individuals and the quality
of the services provided.
Health services expenditure as a proportion of GDP increased from 4.3% in 1960Ð61 to
7.2% in 1975Ð76. Except for one year (1986Ð87) it fluctuated between 7.0% and 7.5%
until 1989Ð90. In 1990Ð91 it increased to 7.9% and then to 8.1% in 1991Ð92. From 1992Ð93
to 1997Ð98 it remained reasonably steady at between 8.2% and 8.3% (Table 5.1,
page 234).
The increases that occurred in the health services expenditure to GDP ratio in 1990Ð91
and 1991Ð92 were largely due to the recession in this period. Although growth in health
services expenditure was not significantly higher during that time, real GDP declined
between 1989Ð90 and 1990Ð91 and increased marginally (0.3%) between 1990Ð91 and
1991Ð92. As a consequence, the health services expenditure to GDP ratio increased over
those two years.
Between 1984Ð85, the first year of the first Medicare agreement, and 1988Ð89, the first
year of the second agreement, the CommonwealthÕs share of funding for institutional
health care fell from 46.0% to 40.9% (Table 5.4). This was partly taken up by the States
and Territories, whose share rose from 33.5% to 36.8% and partly by the non-
government sector, whose share increased from 20.5% to 22.4%. 
Expenditure during the period of the second Medicare agreement was influenced by
the 1990Ð91 recession. State and local governmentsÕ expenditure on health services
contracted, resulting in a fall in their share from 25.7% in 1988Ð89 to 23.4% in 1992Ð93
(Table 5.2, page 235). As a consequence, the shares of both the Commonwealth and non-
government sources of funding increased during this period.
Table 5.4: Shares of total recurrent expenditure on institutional health services, current prices, 
1960Ð61 to 1997Ð98 (per cent)
Year
Government Non-government
sector TotalCommonwealth State and local  Total
1960–61 26.6 46.0 72.6 27.4 100.0
1963–64 28.0 43.4 71.4 28.6 100.0
1966–67 24.9 42.6 67.4 32.6 100.0
1969–70 26.3 45.5 71.8 28.2 100.0
1974–75 21.8 51.4 73.2 26.8 100.0
1975–76 42.3 36.3 78.7 21.3 100.0
1983–84 38.7 35.5 74.2 25.8 100.0
1984–85 46.0 33.5 79.5 20.5 100.0
1988–89 40.9 36.8 77.6 22.4 100.0
1992–93 41.9 33.4 75.3 24.7 100.0
1997–98  43.2  32.9 76.0 24.0 100.0
Sources: 1960–61, 1963–64 and 1966–67: Senate Select Committee on Medical and Hospital Costs 1970; 
1974–75: WD Scott & Co. Pty Ltd 1978; 1969–70 and 1975–76 to 1997–98: AIHW Health Expenditure Database.
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Over the period of the third Medicare agreement, the Commonwealth GovernmentÕs
share of funding again increased, from 43.7% in 1992Ð93 to 45.2% in 1997Ð98 (Table 5.2,
page 235). The proportion met by State and local governments was the same in both years
at 23.4%, while the non-government sectorÕs share of funding fell from 32.9% to 31.4%.
Recurrent expenditure by area of health expenditure 
Recurrent expenditure on health services in 1997Ð98 (the latest year for which detailed
data are available) was $43,994 million. This represents 93.5% of the total expenditure
on health services in that year ($47,030 million). Expenditure on hospitals was
$16,900 million, made up of $12,852 million on public hospitals (recognised public
hospitals and repatriation hospitals), $3,658 million on private hospitals, and
$390 million on public psychiatric hospitals (Table S41, page 404). 
In 1997Ð98, expenditure on nursing home care totalled $3,320 million (7.5% of recurrent
health services expenditure), medical services $8,503 million (19.3%), pharmaceuticals
$5,335 million (12.1%) and dental services $2,591 million (5.9%). A further $1,653 million
(3.8%) was spent on other health professional services, such as physiotherapy,
chiropractic and podiatry. 
Source: AIHW Health Expenditure Database.
Figure 5.1: Proportional split of recurrent health expenditure by area of expenditure and 
source of funds (current prices), 1997Ð98
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The significance of each of the major sources of funding for health services varies
according to the type of service (Figure 5.1, page 239). The Commonwealth Government
provides most of the funds for nursing homes and medical services. Public hospitals
and community and public health services are funded jointly by the Commonwealth
and State Governments, while funding for pharmaceuticals is shared between the
Commonwealth and the non-government sector. Private hospitals are mostly funded
from the non-government sector, with a small contribution by the Commonwealth
Government in the form of payments made by the Department of VeteransÕ Affairs for
eligible veterans and their dependants using private hospitals. 
Between 1960Ð61 and 1975Ð76, the proportion of recurrent expenditure devoted to
hospital services increased from 37.9% to 46.1% (Table S40, page 403). From 1975Ð76 the
proportion steadily declined to 37.5% in 1995Ð96. By 1997Ð98, hospitals accounted for
38.4% of total recurrent health expenditure. Much of the decline since 1975Ð76 was
concentrated in the public hospitals. Expenditure on recognised public hospitals fell
from 34.8% of recurrent expenditure in 1975Ð76 to 29.2% in 1997Ð98. Expenditure on
repatriation hospitals, which accounted for 1.8% in 1975Ð76, had all but ceased in
1997Ð98, following the disposal by the Department of VeteransÕ Affairs of most of its
repatriation hospitals. 
Although expenditure on private hospitals continued to grow for much of the period,
its rate of growth was greater under Medicare than it had been under Medibank. No
data are available to allow a comparison with the earlier years. Expenditure on private
hospitals in 1975Ð76 represented 4.5% of recurrent expenditure and this had increased
to 5.6% in 1984Ð85. By 1997Ð98 it accounted for 8.3% of recurrent health expenditure.
There were increases in the proportions of most types of services in the non-
institutional area. Expenditure on medical services rose from 15.4% of recurrent
expenditure in 1960Ð61 to 18.2% in 1975Ð76. By 1992Ð93, it was 19.6% of recurrent
expenditure and remained at about that level until 1997Ð98. Expenditure on dental
services in 1960Ð61 is not available. Between 1974Ð75 and 1992Ð93 it increased from
4.3% to 5.9% and remained at that general level until 1997Ð98. In 1975Ð76, other
professional health services accounted for 1.8% of recurrent health expenditure. This
had risen to 4.0% by 1988Ð89 and remained at between 3.4% and 3.9% thereafter. 
Expenditure on pharmaceuticals decreased between 1960Ð61 and 1984Ð85, and since
1984Ð85 has grown each year. It was 12.1% of recurrent expenditure in 1997Ð98. 
The changes in proportions of recurrent expenditure are due to the different growth
rates for particular areas of expenditure over the period. Recognised public hospitals,
repatriation hospitals and public psychiatric hospitals all experienced low or negative
average growth between 1975Ð76 and 1997Ð98 (3.1%, Ð13.0% and Ð3.9%, respectively).
Expenditure on private hospitals, medical services and pharmaceuticals, on the other
hand, had relatively high rates of growth over the period (6.8%, 4.3% and 4.3%,
respectively) (Table S42, page 405).
Health services expenditure per person
In 1997Ð98, the average rate of per person expenditure was $2,523 (Table 5.5). The
average annual real rate of growth in per person health expenditure from 1960Ð61 to
1997Ð98 was 3.6%.  
01 AH2000 body  Page 240  Thursday, June 1, 2000  3:06 PM
5 Health resources and use of services  241
TRIM SIZE 175 mm Wide x 250 mm Deep
Aboriginal and Torres Strait Islander health services expenditure
The first comprehensive analysis of expenditure on health services for Aboriginal and
Torres Strait Islander peoples was released in July 1998 (DHFS 1998), following a study
conducted by the Australian Institute of Health and Welfare (AIHW) in conjunction
with the National Centre for Epidemiology and Population Health. The main focus was
on public sector expenditure in 1995Ð96, although preliminary estimates of total
expenditure were also made. In the next phase, 1998Ð99 data will be analysed, with a
report scheduled for release in November 2000. 
Total recurrent health services expenditure for Aboriginal and Torres Strait Islander
peoples for all services and from all sources of funds, government and private, in 1995Ð96
was estimated at $853 million (Table 5.6, page 242), or 2.2% of total Australian recurrent
health expenditure. Total spending for and by Aboriginal and Torres Strait Islander
peoples was $2,320 per person, about 8% higher than for non-Indigenous Australians. 
Expenditure on health services for Aboriginal and Torres Strait Islander peoples in
1995Ð96 through government-subsidised programs was estimated at $822 million,
mainly through State and local government programs. 
On a per person basis, gross expenditure on Aboriginal and Torres Strait Islander
peoples through government-subsidised programs was $2,235, 44% higher than the
amount for non-Indigenous Australians. State and local government spending per head
on Indigenous peoples was more than twice that for non-Indigenous Australians. On
the other hand, total gross expenditure through Commonwealth-subsidised programs
was significantly less per head for Indigenous peoples, mainly because the per person
Table 5.5: Health services expenditure per person, current and constant prices(a), and 
annual growth rates, 1960Ð61 to 1997Ð98
Year 
Amount ($) Average annual growth (%)
Current Constant Current Constant
1960–61 65 688 . . . .
1963–64 77 754 5.8 3.1
1966–67 95 838 7.3 3.6
1969–70 129 970 10.5 5.0
1974–75 306 1,354 19.0 6.9
1975–76 407 1,534 32.9 13.3
1983–84 956 1,723 11.3 1.5
1984–85 1,044 1,749 9.2 1.5
1988–89 1,546 1,914 10.3 2.3
1992–93 1,990 2,102 6.5 2.4
1997–98 2,523 2,523 4.9 3.7
Average annual growth rates
1960–61 to 1974–75 5.0
1975–76 to 1997–98 2.3
1984–95 to 1988–89 2.3
1960–61 to 1997–98 3.6
(a) See Box 5.2 (page 236) for explanation of constant price estimating method.
Source: AIHW Health Expenditure Database.
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Medicare and Pharmaceutical Benefits Scheme (PBS) expenditures were one-quarter of
expenditures through Medicare and PBS for non-Indigenous Australians. Government
expenditure per person on health services for Aboriginal and Torres Strait Islander
peoples appears to be similar to that for non-Indigenous Australians with similarly low
incomes, but their need for services is greater due to the poorer health of Indigenous
peoples.
For further information, see AustraliaÕs Health 1998, pages 38Ð40. 
Health services expenditure by States and Territories 
The largest single area of health services expenditure by State and Territory
Governments is public hospitals. In 1997Ð98, State and Territory Governments spent
$6,437 million or 58.6% of their total health expenditure in meeting the operating costs of
public hospitals. In addition, a large proportion of the State and Territory GovernmentsÕ
$1,400 million capital expenditure and $538 million capital consumption related to public
hospitals (Table S41, page 404). 
There was a 7.0% increase in real terms in total health services expenditure per person
by State and Territory Governments from $551 in 1996Ð97 to $590 in 1997Ð98. Tasmania
and the Australian Capital Territory recorded declines in real expenditure of Ð19.7%
and Ð8.3%, respectively, while New South Wales (1.2%), and the Northern Territory
Table 5.6: Gross expenditures(a) on health services for Indigenous and non-Indigenous people, 
by sector, 1995Ð96
Delivery
Total
expenditure
on Indigenous
peoples ($m)
Per person
expenditure on
Indigenous
peoples ($)
Per person
expenditure on
non-Indigenous
people ($)
Indigenous:
non-
Indigenous(b)
Through State and local 
governments(c) 649 1,763 806 2.19:1
Through Commonwealth 
programs 173 472 748 0.63:1
Through Medicare and the 
PBS(d) 47 128 535 0.24:1
Through Aboriginal health 
organisations and other 
Commonwealth programs 126 344 213 1.62:1
Total through government-
subsidised programs 822 2,235 1,554 1.44:1
Through private sector 
organisations 31 85 594 0.14:1
All sector total 853  2,320  2,148 1.08:1
(a) Gross expenditures include all private out-of-pocket payments and funding from non-government organisations. 
Services not covered are private hospitals, dentistry, optometry, private ancillary services (e.g. physiotherapy, 
chiropractic) and over-the-counter pharmaceuticals. 
(b) Ratio of per person Indigenous expenditures to expenditures for non-Indigenous Australians.
(c) Includes Commonwealth Government transfers and expenditure funded by patient contributions.
(d) Pharmaceutical Benefits Scheme.
Source: DHFS 1998.
01 AH2000 body  Page 242  Thursday, June 1, 2000  3:06 PM
5 Health resources and use of services  243
TRIM SIZE 175 mm Wide x 250 mm Deep
(0.8%) both had rates of growth that were below the national average. Western
Australia had the highest rate of growth (18.6%), followed by Queensland (17.0%),
Victoria (13.1%) and South Australia (12.3%) (Table 5.7, page 244).
In terms of the relative order of State and Territory GovernmentsÕ real expenditure per
person, Northern Territory was the by far the highest spender in both 1996Ð97 and
1997Ð98, with the Australian Capital Territory ranked second. The Victorian
Government was consistently the lowest spending jurisdiction over the period, just
below South Australia. Tasmania, which was the third highest spender in 1996Ð97,
exchanged places with Queensland, which went from being the third lowest spender to
the third highest in 1997Ð98. 
Box 5.4: State and Territory expenditure data sources
Statistics of health services expenditure by State and Territory Governments are available
from a variety of central agency sources, including the Australian Bureau of Statistics
(ABS) public finance database, State and Territory health authoritiesÕ annual reports,
State and Territory Budget papers, and the Commonwealth Grants Commission (CGC). In
addition, the AIHW Health Expenditure Database substitutes data from its own Aus-
tralian Hospital Statistics collection for expenditure on public acute hospitals and public
psychiatric hospitals in Australia.
The different bodies involved in collecting State and Territory health expenditure data have
adopted different practices for defining and measuring that expenditure and this has
resulted in differences in statistics reported at the State level. There is also a lack of detail
in the information collected. For example, the CGC database, one of the better databases on
State health services expenditure for recent years, includes Commonwealth grants to
States. Also, it reports only recurrent expenditure, excluding both capital expenditure and
capital consumption (depreciation).
At the individual State level there are some marked annual differences between the ABS
and CGC data. One way such differences occur is from the manner in which interstate
payments are treated. The aim of the CGC is to give each State Ôthe capacity to provide the
average standard of State-type public services, assuming it does so at an average level of
operational efficiency and makes an average effort to raise revenue from its own sourcesÕ
(CGC 1997:1). Its statistical collations are, therefore, geared to determining the level of
expenditure required by States to provide for the needs of their populations. The needs of
StatesÕ populations are assessed in terms of the expenditure involved in providing services
to them, irrespective of whether or not those services are provided within the State con-
cerned. The ABS, on the other hand, is responsible for recording expenditure incurred by
each State and Territory within its own jurisdiction. For example, services provided in
Victoria to a person who is a resident of New South Wales would be counted by the CGC
as New South Wales expenditure and by the ABS as Victorian expenditure.
In addition, the CGC and the ABS treat revenues differently, with the CGC including only
patient-related revenues.
State and Territory expenditure data used in this publication are derived from the AIHW
Health Expenditure Database.
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Medicare levy
Almost all Commonwealth government funding for health services comes from general
revenue sources. However, when Medicare was introduced in 1984 it replaced some
existing Commonwealth government programs and expanded eligibility to others. Its
introduction was also associated with the abolition of an existing tax rebate on
contributions to basic health insurance. A levy of 1.0% of taxable earnings was
introduced to help offset any additional costs to government of Medicare. In the first
full year of operation of Medicare, 1984Ð85, the levy raised $1,223 million or 2.3% of
total taxation revenue. The levy has been increased several times since 1984 and the
basic rate is currently set at 1.5% of taxable income. Total revenue collected by the
Commonwealth through the Medicare levy in 1998Ð99 was $4,100 million (Table 5.8).
Since October 1997, high-income earners who do not have private insurance cover for
hospitals paid an additional surcharge of 1.0% of taxable income. 
Table 5.7: State and Territory government acute hospital and total health services expenditure 
per person, 1996Ð97 to 1997Ð98, constant prices(a) ($ per person)
State/Territory 1996Ð97 1997–98
Change 1996–97
to 1997–98 (%)
Acute hospital services
NSW 350  390 11.6
Vic 294 310 5.6
Qld 265 269 1.4
WA 273 330 20.9
SA 206 256 24.3
Tas 201 150 –25.2
ACT 408 450 10.3
NT 301 296 –1.5
Australia 298 320 7.3
Total health services
NSW 572 579 1.2
Vic 459 519 13.1
Qld 536 627 17.0
WA 554 658 18.6
SA 473 531 12.3
Tas 714 574 –19.7
ACT 742 681 –8.3
NT 1,219 1,229 0.8
Australia 551  590 7.0
(a) See Box 5.2 (page 236) for explanation of constant price estimating method.
Source: AIHW Health Expenditure Database.
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Health services expenditure internationally
This section compares AustraliaÕs health services expenditure with that of other
members of the OECD. The countries included are Canada, France, Germany, Japan,
New Zealand, the United Kingdom and the United States of America. The comparison,
which looks at the period 1960 to 1997, provides an indication of the relative efforts
being undertaken to meet the need for health services in countries with similar economic
and social structures or with which Australia has important economic and social links.
Differences between countries in terms of what is included as Ôhealth servicesÕ
complicate the comparison to some extent, and caution is therefore necessary when
comparing the data presented here. Note that there is no definitive relationship between
what a country spends on health services and the health status of its population.
Health services expenditures of different countries can be compared as a proportion of
GDP. This measure gives an indication of the proportion of a nationÕs productive effort
that is spent on funding its health services. However, fluctuations in the health-to-GDP
ratio can be misleading because they may be as much indications of movements in GDP
as of changes in health services expenditure. For this reason it is also important to look
at what has happened in terms of per person expenditure on health. 
In looking at both the health expenditure to GDP ratio and per person expenditure on
health, it is useful to consider the weighted means for the group in order to see where
Australia fits vis-a-vis the Ôaverage of the groupÕ. Because of the size of both its
economy and population, the United States dominates the averages for the eight
countries. For this reason, weighted means, including and excluding the United States,
are used for comparisons. 
Between 1960 and 1997, the United States generally spent the most on health services,
measured as a proportion of GDP (Table S45, page 408, and Figure 5.2, page 246). Apart
from the early 1960s when its health expenditure was second only to Canada,
expenditure on health services by the United States was the highest in the group. It
spent 5.4% of its GDP on health in 1961, increasing to 14.2% by 1993, but then dropped
slightly to 13.9% in 1997. The United Kingdom, on the other hand, tended to have the
lowest health-to-GDP ratioÑ4.0% in 1961 rising to 6.8% in 1997. 
Table 5.8: Commonwealth government receipts from the Medicare levy and total taxation 
revenue, current prices, 1984Ð85 to 1998Ð99 ($ million)
Revenue type 1984–85 1991–92 1992–93 1993–94 1994–95 1995–96 1996–97 1997–98 1998–99
Medicare levy 1,223 2,385 2,415 2,870 3,030 3,350 3,664(a) 3,760 4,100
Total taxation 
revenue 53,208 87,970 89,435 94,024 105,687 116,386 125,815(b) 132,217 139,202
Medicare levy 
as a proportion 
of total taxation 2.3% 2.7% 2.7% 3.1% 2.9% 2.9% 2.9% 2.8% 2.9%
(a) Does not include an estimated $486 million in special surcharge levied for the purpose of buying back certain firearms 
from the public.
(b) Includes an estimated $486 million in special surcharge levied for the purpose of buying back certain firearms from the 
public.
Source: Commonwealth of Australia 1999.
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Australia was ranked fifth behind the United States, Canada, France and Germany for
much of the period. Australia spent 4.3% of its GDP on health in 1961, which was below
the average for the eight selected OECD nations and almost the same as France (4.5%).
It was around the average when the influence of the United States was removed.
AustraliaÕs health-to-GDP ratio was below the average for the whole group throughout
the period 1961 to 1997. 
Health spending for the group increased substantially. The average for the eight
countries, weighted according to GDP, rose from 4.9% in 1961 to 11.0% in 1997. This was
greatly influenced by the United States, which grew from 5.4% to 13.9%. Even without
the influence of the United States, the weighted average still almost doubled from 4.3%
to 8.4%. 
Expenditure on health per person is another way of comparing health expenditure of
countries. This method removes the complicating effect of GDP, which is inherent in
comparisons that are based on health expenditure to GDP ratios. It is calculated
allowing for different purchasing power per dollar in different countries.
Source: AIHW from OECD data.
Figure 5.2: Health expenditure as a proportion of GDP, Australia and selected OECD 
member countries, 1960 to 1997
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The rankings of most countries, in terms of per person health expenditure, were similar
to those based on expenditure as a share of GDP. The United States was again the
highest spending country. Its per person health spending in 1997 was 72% higher than
the next highest spending country, Japan, and more than double that of Australia
(Table 5.9). In 1997, Australia had the fifth highest per person expenditure on health
services. 
Factors contributing to the growth in health services expenditure are inflation (both
general inflation and excess health inflation), and change in the level of services used,
either from population growth or from more intensive per person use of services. The
general rate of inflation is an indication of price pressures that apply throughout the
economy, and the rate of excess health inflation indicates additional price rises specific
to the health services sector. The ability of a nationÕs health financing system to control
health prices is an important factor in controlling growth in total expenditure on health
services. 
Table 5.9: Total health services expenditure per person, Australia and other selected OECD 
member countries, current prices, 1960 to 1997(a) (A$)
Year(a) Australia Canada France Germany(b) Japan NZ UK USA
1960 66 109 50  80  12  65  48  132
1965 96 143 94 111 37 n.a. 67 188
1970 148 248 145 198 79 106 88 316
1975 407 394 343 362 192 220 174 460
1980 684 684 819 725 520 376 473 956
1985 1,157 1,605 1,144 1,776 1,074 515 675 2,571
1986 1,294 1,789 1,675 1,928 1,646 699 871 2,874
1987 1,406 1,901 1,933 1,946  1,896 926 1,017 2,949
1988 1,546 1,975 1,879 1,902 1,956 1,084 1,091 2,926
1989 1,700 2,214 1,891 1,900 1,858 1,063 1,087 3,202
1990 1,820 2,410 2,388 2,050 1,868 1,149 1,310 3,580
1991 1,902 2,633 2,448 2,049 2,138 1,172 1,446 3,886
1992 1,990 2,756 2,942 2,487 2,575 1,202 1,702 4,453
1993 2,071 2,830 3,128 2,702 3,324 1,337 1,634 5,115
1994 2,169 2,508 3,054 2,703 3,541 1,444 1,662 4,981
1995 2,296 2,468 3,483 2,939 3,965 1,624 1,772 5,096
1996 2,403 2,365 3,293 2,928 3,339 1,645 1,738 5,025
1997 2,502  2,471 3,085 3,191  3,209 1,771 2,000 5,527
(a) Australian data relate to the year ending 30 June; data for France and Germany relate to the calender year indicated; 
data for New Zealand before 1990 relate to the year commencing 1 April in the year indicated, and data for 1990 
onwards refer to the year ending 30 June; data for Canada, Japan and the United Kingdom relate to the year 
commencing 1 April in the year indicated; United States data relate to the year ending 30 September. 
(b) Data up to and including 1990 relate to West Germany only; data for 1991 onwards refer to the unified Germany.
Note: Expenditures converted to Australian dollar (A$) values using GDP purchasing power parities.
Sources: AIHW Health Expenditure Database; OECD unpublished data.
01 AH2000 body  Page 247  Thursday, June 1, 2000  3:06 PM
248  AustraliaÕs Health 2000
TRIM SIZE 175 mm Wide x 250 mm Deep
Even in countries with fairly similar approaches to health services provision, rates of
health inflation can vary markedly. At one end is New Zealand with a very high excess
health inflation rateÑaveraging 3.6% between 1968 and 1996. At the other extreme is
France, which had a negative excess health inflation rate of Ð0.5% (Table S46, page 408).
Australia had an excess health inflation rate of 0.5%, the third lowest for the group. 
In order to compare the level of expenditure without the complication of different rates
of population growth, it is useful to examine real growth in per person health services
expenditure. Australia and the United Kingdom (0.9%) had the second lowest average
real growth in per person expenditure between 1960 and 1997. Japan experienced the
highest growth of 5.3% per year, and New ZealandÕs per person health expenditure fell
dramaticallyÑa drop of 4.2% in real terms. 
5.2 Cost of diseases
This section describes the way total direct healthcare expenditure is distributed among
specific disease and injury groups, and by age groups and sex. The AIHW has analysed
direct health system costs of disease and injury in Australia for 1993Ð94, using disease
and injury groups defined according to the International Classification of Diseases,
9th Revision (see Box 5.7, page 274). The estimates were derived using a methodology
that ensures that they add across disease, age and sex groups to the total Australian
health system expenditure by health sector for 1993Ð94. They provide a description of
the utilisation and costs of health services in Australia, as well as a reference source for
planners and researchers interested in the costs and utilisation patterns for a particular
disease group.
The disease cost estimates allocate over 90% of the total recurrent health expenditure in
1993Ð94, or just over $31 billion in total. The main components of health expenditure
not yet included in the disease cost estimates are capital expenditure, community health
services (apart from specialised mental health services) and public health programs
(apart from four cancer public health programs). The estimates have been revised since
their inclusion in AustraliaÕs Health 1998.
The six disease groups that account for the most health expenditure in Australia, in
descending order, are:
¥ cardiovascular diseases $3.7 billion (11.8% of total health system costs)
¥ digestive system diseases $3.7 billion (11.8%)
¥ mental disorders $3.0 billion (9.6%)
¥ musculoskeletal problems $3.0 billion (9.6%)
¥ injury and poisoning $2.6 billion (8.3%)
¥ respiratory diseases $2.5 billion (8.0%).
Digestive system diseases are the second most expensive group in part because of the
large expenditure on dental services ($1.8 billion).
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The AIHW has published detailed estimates of costs for specific diseases and injuries
within four of the six national health priority areas: cardiovascular diseases, cancer,
injury and diabetes (AIHW: Mathers et al. 1998, 1999a, 1999b). 
Health system costs for mental disorders in 1993Ð94 are shown in Table 5.10. Including
specialised community mental health services, drug and alcohol residential centres and
public health expenditure under the National Campaign Against Drug Abuse, the total
health system costs of mental disorders are estimated at $3.0 billion or 9.6% of total
health expenditure. 
Asthma is the most recent addition to the list of national health priority areas.
Provisional analysis of health system costs for asthma in 1993Ð94 indicate that it cost
$478 million, of which $199 million was for pharmaceuticals. 
Table 5.10: Mental health: health system costs by health sector, 1993Ð94 ($ million)
Hospital(a) Medical(b)
Pharma-
ceuticals
Other
health
services(c) Other(d)
All
sectors
Per cent
of total
Dementia 110 11 2 9 582 714 23.6
Substance abuse disorders 136 46 12 18 136 348 11.5
Schizophrenia 275 26 8 106 40 454 15.0
Other non-drug psychoses 63 5 1 6 53 128 4.2
Affective disorders 217 141 68 70 148 644 21.3
Anxiety disorders 24 102 51 25 37 239 7.9
Personality disorders 24 7 1 12 9 53 1.8
Stress and adjustment 
disorders 28 27 7 31 19 112 3.7
Mental retardation 16 1 0 3 5 26 0.9
Disorders of psychological 
development 2 2 0 3 10 16 0.5
Eating disorders 14 3 0 1 4 22 0.7
Disorders of childhood and 
adolescence 10 9 1 19 16 55 1.8
Behavioural syndromes and 
other mental disorders 17 53 45 9 50 174 5.8
Unspecified mental 
disorders, prevention and 
screening 5 6 2 23 1 37 1.2
Total 941 438 199 334 1,110 3,022 100.0
(a) Public and private acute hospitals, repatriation hospitals and psychiatric hospitals. Excludes public hospital 
non-admitted services.
(b) Medical services for private patients in hospitals are included under Hospitals.
(c) Includes hospital non-inpatient services, specialised community mental health services, residential and non-residential 
treatment services run by non-government organisations, and allied health services.
(d) Includes National Drug Strategy funding for prevention, research expenditure and other institutional, non-institutional 
and administration expenditure. Does not include expenditure for other public health services, non-specialised 
community health services, ambulances, or medical aids and appliances.
Source: AIHW analysis of health expenditure data.
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Table 5.11: Diseases and injuries in NHPAs(a) and musculoskeletal disorders: health system 
costs(b) by health sector, 1993Ð94 ($ million)
Hospital(c) Medical(d)
Pharma-
ceuticals Other
All
sectors
Ischaemic heart disease 574 88 105 127 894
Hypertension(e) 55 217 476 84 831
Accidental falls 501 112 32 166 810
Dementia 119 11 2 582 714
Back problems 239 133 62 266 700
Diabetes mellitus(f) 201 98 136 247 681
Affective disorders 287 141 68 148 644
Stroke 283 31 13 303 630
Osteoarthritis 301 80 58 185 624
Disorders of muscles, tendons and soft tissue 165 127 60 167 519
Asthma 94 102 199 82 478
Schizophrenia 381 26 8 40 454
Heart failure 157 47 45 162 411
Adverse effects of medical treatment(g) 300 38 23 43 403
Road traffic accidents 232 56 16 68 372
Substance abuse disorders 154 46 12 136 348
Chronic obstructive pulmonary disease(h) 112 61 66 61 300
Skin cancers 141 112 5 41 298
Anxiety disorders 49 102 51 37 239
Cardiac dysrhythmias(i) 114 36 31 43 224
Peripheral arterial disease 134 17 9 49 209
Colorectal cancer 171 11 3 19 205
High serum cholesterol 6 42 135 16 199
Breast cancer 80 11 16 77 184
Neck problems 54 25 18 62 160
Lung cancer 81 7 3 17 107
Prostate cancer 66 14 8 13 101
All causes 14,062 5,640 4,042 7,653 31,397
(a) The six National Health Priority Areas are cardiovascular disease, cancer, mental health, injury, diabetes mellitus and 
asthma.
(b) Diseases and injuries with health system costs of less than $150 million not included in this table.
(c) Public and private acute hospitals, repatriation hospitals and psychiatric hospitals. Includes public hospital non-
admitted services. For mental health services, also includes specialised community mental health services and drug 
and alcohol residential treatment services.
(d) Medical services for private patients in hospitals are included under Hospitals.
(e) Hypertension comprises high blood pressure and hypertensive heart and renal disease.
(f) Includes health system costs of cardiovascular disease and complications due to diabetes.
(g) Part of the injury priority area; includes surgical and medical misadventure, and adverse effects of drugs in therapeutic 
use.
(h) Chronic bronchitis and emphysema.
(i) Inflammatory heart disease comprises cardiomyopathy, myocarditis, endocarditis, pericarditis and other diseases of the 
pericardium and endocardium.
Source: AIHW unpublished analysis of disease costs.
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Table 5.11 ranks the health system costs of diseases and injuries in the six National
Health Priority Areas, together with musculoskeletal disorders. Other diseases have not
been included in this table. Ischaemic heart disease and hypertension are the leading
causes of health system expenditure, together accounting for 5.5% of total health
expenditure. Following these are accidental falls, dementia and back problems, then
diabetes, affective disorders and stroke. The majority of health system costs for
dementia are for nursing home patients. Osteoarthritis costs the Australian health
system almost as much as stroke. 
Total health system costs for females are 32% higher than those for males: $17.9 billion
compared with $13.5 billion. Costs are higher for females than males for all disease
groups apart from injury and congenital anomalies. Total health system costs per
person in 1993Ð94 ranged from a minimum of around $800 for boys aged 5Ð14 years to
$7,500 for women aged 75 years and over. The maleÐfemale difference in per person
costs is greatest in the peak reproductive years, where average annual costs for women
aged 25Ð34 years were $1,716, almost double the average cost of $888 for men of the
same age.
It should be emphasised that this analysis does not attempt to estimate the total
economic impact of diseases in the Australian community and that, as well as the health
system costs described here, there are substantial costs relating to absenteeism, lost
productivity, the burden on carers and family, and lost quality and quantity of life. 
5.3 Private health insurance 
Funding of health services by health insurance funds
The introduction of the Private Health Insurance Incentives Scheme (PHIIS) and its
replacement by the 30% rebate on premiums substantially altered the role of the health
insurance funds in the funding of health services after 1996Ð97. Total recurrent health
expenditure in 1997Ð98 was $43,994 million. Of this, $4,685 million was directed
through private health insurance funds. However, the Commonwealth Government
subsidised $459 million of that expenditure through the PHIIS. 
The PHIIS was paid in two waysÑeither as a direct subsidy (in which case the private
health insurance fund would charge the contributor a reduced premium and claim the
subsidy from the Commonwealth) or as a rebate through the taxation system (in which
case the contributor would be charged the full premium and would be reimbursed when
he or she lodged a taxation return). A total of $252 million was paid through the direct
subsidy during 1997Ð98 and $207 million was claimed through the taxation system. 
As a result of the PHIIS, the amount paid from non-government sources through the
health insurance funds was $4,434 million. The $207 million claimed through the
taxation system meant that the net, unsubsidised amount paid by health insurance
funds was $4,226 million. This represented 9.6% of recurrent health expenditure in
1997Ð98. By 1998Ð99, total expenditure through private health insurers had increased to
$4,840 million. The net expenditure by the funds (after deduction of Commonwealth
subsidies) was $3,785 million (Table 5.12, page 253).
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Expenditure on hospitals, both public and private, during 1997Ð98 was $16,510 million.
Of this, $2,485 million was funded by the health insurance organisations. During
1998Ð99, the health insurance funds paid $2,200 million for hospital services from their
own resources.
The hospital expenditure funded through health insurance was largely concentrated in
private hospitals. In 1998Ð99, the benefits paid in respect of private hospital care
($2,524 million) represented 89.7% of all hospital-related benefits paid through health
insurance funds. Similarly, 84.1% of total hospital bed-days for which hospital benefits
were paid during 1998Ð99 were in respect of care in private hospitals.
Administration of health insurance funds accounted for $591 million in 1998Ð99. This
represented 14 cents for each dollar of benefit paid from the funds and accounted for
12% of contributions income receivable by the funds in that year. 
Trends in private health insurance coverage, 
membership and premiums 
The proportion of the population with private health insurance at the end of March
2000 was 32.7%, an increase on the 30.5% coverage at 30 June 1999. This was the same
level as at 30 June 1998. However, between the time of the introduction of Medicare
(February 1984) and 31 December 1998 the trend in private health insurance coverage
had been generally downwards. In June 1984 just over half of the total population
(50.2%) were covered by some level of private health insurance. At 31 December 1998
this had fallen to 30.1% (Figure 5.3, page 254). 
Box 5.5: Private health insurance arrangements
Since the introduction of Medicare in 1984, health insurance funds operated by Registered
Health Benefits Organisations1 have offered benefits to members for approved services pro-
vided in both public and private hospitals. They have also operated ancillary tables which
provide benefits for a wide range of non-hospital health and health-related services. 
There are four categories of health insurance membershipÑsingles, couples without chil-
dren, sole parents, and couples with childrenÑproviding a wide range of benefits cover.
These include Ôexclusionary tablesÕ under which funds are able to tailor the range of benefits
provided to meet particular needs of different groups of contributors. They can, for example,
offer tables that exclude benefits for obstetrics or hip replacements. The contribution rates
for such tables reflect the particular exclusion(s) and are lower than similar tables that do
not contain such exclusion(s). ÔFront-end deductibleÕ tables are also available, which allow
contributors to meet a set proportion of the charge for hospital care from their own pockets.
Changes to health insurance arrangements will be introduced from 1 July 2000, to
encourage people to take out and retain private health insurance cover. From that date,
people who join a health insurance fund early in life and maintain their hospital cover will
pay lower premiums throughout their life compared with someone who joins later in life.
1. A Registered Health Benefits Organisation is an organisation registered under the National Health Act 1953 for 
the purpose of conducting a health benefits fund.
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A number of incentives were introduced to help arrest the decline in membership and
coverage. These included:
¥ Introduction of Ôfront-end deductibleÕ (FED) tables in the late 1980s. These enabled
funds to offer tables that provided cover for that part of hospital charges that exceeded
a given amount (excess) in a year. Between 1995Ð96 and 1998Ð99, coverage by FEDs
grew by 0.8 million and coverage by non-FED tables fell by 1 million (Figure 5.4,
page 255).
¥ Introduction of ÔexclusionaryÕ and Ônon-exclusionaryÕ tables in 1995. Exclusionary
tables did not provide benefits for some types of treatment (e.g. obstetrics) and were
Table 5.12: Expenditure through the private health insurance funds, by area of expenditure 
and income, by type of income, current prices, 1996Ð97 to 1998Ð99 ($ million)
1996–97 1997–98 1998–99
Own
funds
PHIIS 
subsidy(a) Own
funds
PHIIS 
subsidy(a)
Subsidy on 
premiums(b) Own
fundsTax Direct Tax Direct Tax Direct
Expenditure
Institutional 2,890 126 153 2,586 125 79 41 396 2,295
Public hospitals(c) 360 14 17 297 12 8 4 39 226
Private hospitals 2,437 107 130 2,188 107 68 35 340 1,974
Ambulance(d) 93 5 6 101 5 3 2 17 95
Non-institutional(e) 1,279 58 70 1,154 56 35 18 177 1,028
Medical 229 12 14 206 11 7 4 34 198
Dental 596 26 32 542 26 16 8 81 472
Other professional 225 10 12 204 10 6 3 32 184
Home nursing 1 — — 1 — — — — 1
Pharmaceuticals 44 2 2 32 2 1 1 5 28
Aids and appliances 184 8 10 169 8 5 3 25 146
Total benefits 4,169 183 223 3,740 181 114 59 572 3,323
Administration 530 24 29 487 25 16 8 80 463
Total benefits plus 
administration 4,699 207 252 4,226 206 130 67 652 3,785
Revenue
Contributions 
receivable 4,404 207 252 4,254 206 130 67 652 3,872
Non-contributions 
income 240 n.a. n.a. 140 n.a. n.a. n.a. n.a. 149
Total income, all 
sources 4,644 207 252 4,394 206 130 67 652 4,021
(a) Commonwealth direct outlays and taxation expenditure on Private Health Insurance Subsidy Scheme is allocated by 
area of expenditure.
(b) Commonwealth direct outlays and taxation expenditure on the 30% rebate on premiums is allocated by area of 
expenditure.
(c) Public hospitals include both recognised public hospitals and repatriation hospitals.
(d) Ambulance includes levies imposed by some State and Territory Governments in respect of ambulance transport.
(e) Non-institutional excludes administration.
Source: PHIAC unpublished data.
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aimed at enabling funds to tailor their benefits cover and premiums to meet
particular groups of low-drawing members.
¥ Increasing the number of membership categories from 2 (single and family) to 4
(single, family, single parent and couples) in 1997. This was to enable funds to further
differentiate their premiums.
¥ Introduction of the PHIIS in 1997.
¥ Replacement of the PHIIS with a 30% rebate on private health insurance premiums in
1999. 
Despite these incentives, coverage by health insurance continued to decline until
December 1998. At the same time, expenditure by the funds in the form of benefits,
levies and administration continued to increase and the proportion of total health
expenditure that was met by health insurance funds from their own resources remained
relatively stable at between 10.6% and 11.5%. The introduction of the PHIIS and the
rebate on private health insurance premiums have both had an effect in slowing the
decline in coverage. After reaching 30.1% in December 1998, coverage increased in each
quarter of 1999 to reach 31.2% at the end of December 1999. 
Sources: PHIAC 1999 and unpublished data.
Figure 5.3: Proportion of population covered by basic health insurance, 1984 to 1999
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Growth in contributions income
Despite their falling coverage, health insurance funds have maintained their capacity to
generate income through premiums.
Between 1984Ð85 and 1998Ð99 real growth in contributions income averaged 5.2% per
year. Between 1989Ð90 and 1998Ð99 the rate of growth averaged 4.1% and since 1995Ð96
it has averaged 4.3% (Figure 5.5, page 256).
Growth in the total amount of benefits and levies payable by health insurance funds
was higher than that for contributions income between 1984Ð85 and 1998Ð99, averaging
7.4%. However, since 1995Ð96 the rate of growth in benefits and levies payable has been
much lower (1.7%) than that of contributions income. 
Ancillary benefits tables
In addition to their hospital tables, health insurance funds offer tables providing
ancillary benefits in respect of services such as dental, optical, therapeutic and other
(generally non-accommodation) non-medical services.
(a) Front-end deductable tables.
Source: PHIAC annual reports, various years.
Figure 5.4: Hospital insurance coverage by type of cover, 1995Ð96 to 1998Ð99
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About 6,049,000 persons (31.9% of the total resident population) had some form of
ancillary cover at 30 June 1999 (Table 5.13). Of these, 4,423,000 were covered for both
hospital and ancillary cover with the same organisation. A further 1,626,000 either had
ancillary cover only or had ancillary cover with one organisation and hospital insurance
with another organisation. 
Changes in the characteristics of the insured
The structure of the insured population changed substantially between 1983 and 1998.
The proportion of contributor units with hospital insurance cover more than halved
over the period, from 62.1% to 30.3%.
In all age groups below 60 years, the level of coverage by hospital insurance fell
markedly. Excluding the age groups 60 years and over, coverage ranged from 54.6% to
75.6% in 1983 and from 16.3% to 41.9% in 1998 (Table 5.14). The largest falls were in the
youngest age groups. In the case of contributor units headed by persons aged 60 years
and over, the fall-off in coverage was less dramatic. Coverage for contributor units
headed by persons aged 60Ð69 years fell from 45.3% to 39.6%, while those headed by
persons aged 70 years and over remained relatively constant at around 36%. 
Source: PHIAC annual reports, various years.
Figure 5.5: Health insurance funds contributions income, benefits and levies payable at 
constant (1997Ð98) prices, 1984Ð85 to 1998Ð99
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Table 5.13: Membership and persons covered by ancillary tables, by type of membership, 
States and Territories, 30 June 1999 (Õ000)
Membership type NSW(a) Vic Qld WA SA Tas NT Australia
Combined with hospital insurance(b)
Single 353 183 135 111 86 29 6 904
Family 232 118 105 85 54 19 6 618
Single parent 10 5 4 4 2 1 (d) 26
Couples 173 81 91 77 47 15 4 488
Total members 768 387 335 277 189 64 17 2,036
Persons covered 1,653 834 745 617 399 136 39 4,423
Without hospital insurance cover(c)
Single 127 32 39 106 35 8 1 349
Family 96 34 24 48 28 4 1 236
Single parent 6 3 2 12 2 (d) (d) 26
Couples 50 12 12 38 16 2 (d) 131
Total members 280 80 76 204 82 15 3 741
Persons covered 635 202 163 400 189 31 6 1,626
All ancillaries
Single 480 215 174 217 121 37 7 1,253
Family 328 152 129 133 82 23 7 854
Single parent 16 8 6 16 4 1 (d) 52
Couples 223 93 103 115 63 17 4 619
Total members 1,048 467 411 481 271 79 20 2,777
Persons covered 2,288 1,036 908 1,017 588 167 45 6,049
(a) New South Wales includes the Australian Capital Territory.
(b) Members and persons covered where both hospital insurance and ancillary cover are provided with the same fund.
(c) Members and persons covered by ancillary tables only (may include members who have hospital insurance cover with 
a fund other than the fund providing ancillary cover).
(d) Less than 500.
Source: PHIAC 1999.
Table 5.14: Private health insurance, proportion of contributor units(a) with hospital insurance 
cover by age group, 1983 to 1998
Age group of head of 
contributor unit (years) 1983 1986 1988 1990 1992 1995 1998
15–24 54.6 29.3 30.0 29.5 29.3 20.8 16.3
25–34 70.4 46.5 43.0 40.1 35.8 27.2 22.1
35–49 75.6 55.5 53.8 52.7 46.7 40.3 32.0
50–59 71.4 56.4 56.5 55.6 52.2 48.4 41.9
60–69 45.3 42.0 43.4 45.1 45.5 42.9 39.6
70 and over 36.0 31.5 34.9 36.8 36.4 39.0 36.4
All ages 62.1 44.2 43.6 43.1 40.5 35.1 30.3
(a) A contributor unit includes all persons within a family unit or a single person unit that would be coverable by a health 
insurance policy. For example, a ‘couple with dependants’ contributor unit includes the parents and all dependent 
children and is counted as one contributor unit. 
Sources: AIHW analysis of ABS Private Health Insurance Survey data.
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5.4 Health workforce
The health industry
The health industry is highly labour intensive. In 1997Ð98, total health services
expenditure in Australia was $47.03 billion. Based on the 1994Ð95 inputÐoutput tables of
the Australian national accounts constructed by the Australian Bureau of Statistics (ABS),
an estimated 65% of this expenditure can be attributed to the labour costs of wages and
salaries and employer contributions to workersÕ compensation and superannuation
(ABS 1999b). 
In 1998 there were 610,000 persons employed in the health industry, 7.1% of the total
civilian workforce in Australia. Of these, 378,000 or 62.0% were employed in hospitals
and nursing homes.
In the health industry workforce, 38.1% of persons worked part-time, i.e. less than
35 hours per week. Although 76.6% of persons employed were female, this proportion
was higher in hospitals and nursing homes in which 79.3% were female. 
Between 1993 and 1998, the health industry workforce increased by 9.7%, compared
with an 11.9% increase in the civilian workforce and a 6.1% increase in the population.
In both, growth in part-time employment was much stronger than growth in full-time
employment. In the health industry, male part-time employment growth of 13.6% was
similar to full-time growth of 13.4%, but female part-time employment increased by
14.0%, much faster than the full-time increase of 4.4% (Table 5.15). 
Table 5.15: Composition of the health industry and civilian population workforces, 
1993 and 1998
Full-time Part-time Total Per cent
Males Females Males Females Males Females Persons Part-time Female
Hospitals and nursing homes
1993 64,583 170,346 7,354 124,475 71,937 294,821 366,758 35.9 80.4
1998 69,755 167,249 8,445 132,599 78,200 299,848 378,048 37.3 79.3
Increase 8.0% –1.8% 14.8% 6.5% 8.7% 1.7% 3.1%
Other health industry
1993 47,322 70,282 6,838 65,121 54,160 135,403 189,563 38.0 71.4
1998 57,107 83,892 7,683 83,620 64,790 167,512 232,302 39.3 72.1
Increase 20.7% 19.4% 12.4% 28.4% 19.6% 23.7% 22.5%
Total health industry
1993 111,905 240,628 14,192 189,595 126,097 430,223 556,320 36.6 77.3
1998 126,862 251,141 16,127 216,218 142,989 467,359 610,348 38.1 76.6
Increase 13.4% 4.4% 13.6% 14.0% 13.4% 8.6% 9.7%
Total civilian workforce (’000s)
1993 3,958 1,889 438 1,359 4,396 3,248 7,644 23.5 42.5
1998 4,256 2,094 587 1,618 4,843 3,712 8,555 25.8 43.4
Increase 7.5% 10.9% 34.0% 19.1% 10.2% 14.3% 11.9%
Note: Quarterly survey statistics have been averaged for 1993 and 1998 to minimise volatility in estimates due to sampling.
Source: ABS Labour Force Survey.
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International health workforce trends
The OECD maintains a time series of selected health statistics for OECD countries. The
data need to be interpreted with care because of inconsistencies in the definitions used
among countries for enumerating doctors, dentists, pharmacists and nurses, and
because of differences in the health systems.
Nevertheless, Australia appears to be similar in a number of respects to other countries
in some key workforce trends. The medical workforce has increased at a much faster
rate than population growth and the proportion of doctors who are female has
increased from around 11% in 1960 to nearly 30% now (Table 5.16, page 260). 
In nursing, Australia and New Zealand with almost 10 nurses per 1,000 population in
1996 appear to have a relatively high level of nurse employment compared with
Canada (7.6), the United States (8.1) and the United Kingdom (4.5). In Australia, nurse
workforce numbers per 1,000 population have been declining during the 1990s because
of relatively stable total nurse employment numbers. According to the ABS labour force
survey, there were 197,700 employed nurses in 1998 compared with 197,100 in 1989.
Part-time employment increased from 39.2% to 44.0% during the period, so that the
numbers of full-time equivalent nurses fell by 1.6%, and numbers of full-time
equivalent nurses per 1,000 population fell by 11.8%. In Canada, there has been a
similar, but more pronounced, pattern. Employed nurses per 1,000 population climbed
from 5.3 in 1966 to 11.0 in 1986, and stayed at this level until 1992 after which there was
a sharp decline to 7.6 in 1997, the most recent year of data. 
Growth in the dentist and pharmacist workforces per 1,000 population has been much
slower than in medicine. Supply requirements for dentists are influenced by changes in
work practices, productivity and labour force participation on the one hand and
changes in patient demand on the other. Influences on demand include population
growth, oral health status, cost and propensity to visit a dentist for preventive health
reasons. Largely as a result of public health measures (such as water fluoridation and
childhood screening) and rising education and real income levels, there has been a
considerable improvement in the oral health of the population since the 1960s. This has
led to a change in both the nature and number of dental consultations, which have
increased in annual number per capita in Australia from 1.1 in 1979 to 1.5 in 1995. A
similar trend occurred overseas. In the United States dental consultations per capita
have increased from 1.6 in 1962 to 2.1 in 1989 and in the United Kingdom from 0.3 in
1960 to 0.7 in 1990 (OECD 1999). 
In pharmacy, there have been significant workforce productivity gains in Australia
through pre-packaging drugs and economies of scale achieved through restructuring
the community pharmacy industry to increase the average number of pharmacists per
pharmacy. The number of approved pharmacies fell from 5,606 in 1990 to 4,942 in 1999.
The number of community pharmacists increased by 13.3% from 8,713 to 9,870 between
1991 and 1996, with pharmacist registrations rising a further 4.9% between 1996 and
1998. In 1996, pharmacist numbers of 0.6 per 1,000 population in Australia were the
same as in New Zealand, Canada and the United Kingdom, and only just below the
0.7 per 1,000 population in the United States. 
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Distribution of the medical practitioner, dental and 
nursing workforces
Medical practitioners
In 1998, there were substantial differences in the supply of doctors among the States and
Territories and between metropolitan, rural and remote areas. Both Western Australia
and Queensland, with 236 medical practitioners per 100,000 population, were below the
national average of 260, whereas South Australia (293) and the Australian Capital
Territory (310 per 100,000 population) were well above this average. Supply in
metropolitan areas of 306 practitioners per 100,000 population was much higher than the
144 practitioners per 100,000 population in rural and remote areas. In the latter, there
were also large differencesÑ267 per 100,000 population in large rural centres compared
with 154 in small rural centres, 91 in other rural areas and 105 in remote areas.  
Reducing this imbalance has been a high priority of government and the medical
profession. Longer term strategies have included increasing the numbers of medical
students of rural origins and from the Aboriginal and Torres Strait Islander populations.
Table 5.16: Provision of doctors, dentists, pharmacists and nurses in selected countries, 
selected years
Medical practitioners Dentists Pharmacists Nurses
No.
No. per
1,000
popn
Per cent
female No.
No. per
1,000
popn No.
No. per
1,000
popn No.
No. per
1,000
popn
Australia
1961 10,881 1.1 11.0 3,315 0.3 8,351 0.8 63,821 5.9
1981 27,127 1.8 18.9 5,586 0.4 10,189 0.7 106,565 7.1
1996 45,416 2.5 27.4 7,601 0.4 12,310 0.6 174,770 9.5
New Zealand
1960 2,573 1.1 7.7 n.a. n.a. n.a. n.a. n.a. n.a.
1980 4,881 1.6 16.4 1,145 0.4 2,277 0.7 19,195 6.1
1996 7,634 2.2 29.4 1,364 0.4 2,401 0.6 36,303 9.8
Canada
1961 21,290 1.2 n.a. 5,708 0.3 n.a. n.a. n.a. n.a.
1981 45,542 1.8 17.1 11,484 0.5 13,034 0.5 235,606 9.7
1996 63,209 2.1 28.4 15,869 0.5 17,808 0.6 227,830 7.6
United States 
1960 259,400 1.4 6.0 90,120 0.5 101,000 0.6 527,000 2.9
1980 453,165 2.0 10.8 126,240 0.6 142,400 0.6 1,272,900 5.6
1996 701,249 2.6 21.2 166,100 0.6 185,000 0.7 2,161,700 8.1
United Kingdom
1960 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a.
1980 72,198 1.3 19.5 17,604 0.3 n.a. n.a. 197,900 3.5
1996 98,800 1.7 n.a. 22,200 0.4 34,418 0.6 264,744 4.5
Source: OECD 1999.
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Because undergraduate and postgraduate medical training takes 10 years or more, little
change will be seen in the characteristics of the workforce due to these strategies for
some years.
The medical colleges have greatly expanded rural outreach programs, including
telemedicine, to improve access to medical services by rural populations, and State
Governments have increased the numbers of temporary resident overseas-trained
doctors entering Australia from 667 in 1992Ð93 to 2,224 in 1998Ð99. There are also many
incentive schemes to attract doctors to rural areas and to reduce the level of attrition of
doctors from rural areas.
Table 5.17: Distribution of Medicare general practice providers, 1984Ð85 and 1998Ð99
Locality 1984–85 1998–99
Per cent change
1984–85 to 1998–99
Head count numbers
Capital city 12,135 16,512 36.1
Other metropolitan 1,024 1,709 66.9
Large rural centre 852 1,375 61.4
Small rural centre 948 1,374 44.9
Other rural 1,695 2,426 43.1
Remote centre 137 295 115.3
Other remote area 157 485 208.9
Total 16,948 24,176 42.6
Full-time workload equivalents(a)
Capital city 7,050 11,428 62.1
Other metropolitan 809 1,277 57.8
Large rural centre 596 939 57.6
Small rural centre 653 918 40.6
Other rural 1,116 1,458 30.6
Remote centre 87 115 32.2
Other remote area 98 133 35.7
Total 10,410 16,268 56.3
Population per full-time workload equivalent
Capital city 1,407 1,045 –25.7
Other metropolitan 1,353 1,115 –17.6
Large rural centre 1,517 1,190 –21.6
Small rural centre 1,491 1,328 –10.9
Other rural 1,906 1,690 –11.3
Remote centre 2,318 1,952 –15.8
Other remote area 3,421 2,674 –21.8
Total 1,494 1,153 –22.9
(a) The full-time workload equivalent (FWE) is defined by the Department of Health and Aged Care (DHAC) on the basis 
of income from fees charged for Medicare services rendered. The FWE for each doctor is calculated by dividing this 
income by the mean billing of doctors considered to be working full-time. The mean billing of full-time doctors was 
$183,332 in 1998–99.
Source: AIHW analysis of DHAC data.
01 AH2000 body  Page 261  Thursday, June 1, 2000  3:06 PM
262  AustraliaÕs Health 2000
TRIM SIZE 175 mm Wide x 250 mm Deep
There has been considerable improvement in the provision of general practitioners
(GPs) since the commencement of Medicare in 1984Ð85 (Table 5.17). Large rural centres
now have, on average, a similar supply of GPs per 100,000 population as non-capital
city metropolitan areas. Between 1984Ð85 and 1998Ð99, the GP workforce per 100,000
population for other rural and remote areas increased by about one-third, although
some areas are less well-off than others.
Dental workforce
The national dental workforce in clinical practice consists of dentists and dental
auxiliaries (dental therapists, dental prosthetists and dental hygienists). There are major
geographic differences in the distribution of both dentists and dental auxiliaries in
Australia.
In 1994, there were 43.0 dentists per 100,000 population in Australia, with the
Australian Capital Territory and South Australia having the highest rates (57.5 and 49.7
respectively) and Tasmania the lowest (25.2). Capital cities had 51.2 dentists per 100,000
population and the rest of Australia 28.7 per 100,000 population.
The number of practising clinical dental auxiliaries per 100,000 population varies
according to the type of auxiliary and the State and Territory of practice. Dental
therapists who worked in School Dental Services were the most numerous in 1997,
there being 7.1 per 100,000 population, which is equivalent to a full-time rate of 5.8.
Western Australia (17.8), Tasmania (14.6) and Queensland (12.3) had the highest
numbers of dental therapists per 100,000 population, and New South Wales (3.6) and
Victoria (2.7) had the lowest.
Dental prosthetists predominantly work in their own practices making removable
dentures. In 1998 there were 4.2 per 100,000 population in Australia. Tasmania had the
highest number with 11.2 per 100,000 population, and South Australia had the lowest
with 1.7 per 100,000 population. 
There were only 1.5 dental hygienists per 100,000 population in 1997. The Australian
Capital Territory (7.7) and South Australia (6.6) had the highest numbers per 100,000
population.
In contrast, in the early 1990s the United States had 60.8 dentists and 39.5 hygienists per
100,000 population, Canada 52.4 dentists and 22.8 hygienists per 100,000 population,
and the Netherlands 52.8 dentists and 6.7 hygienists per 100,000 population.
Nursing workforce
There are significant differences in the supply of nurses among the States and
Territories and between metropolitan and rural areas, but not to the same extent as for
medicine and dentistry.
In 1996, there were 1,064 full-time equivalent nurses per 100,000 population. Western
Australia with 1,236 nurses per 100,000 population, Victoria 1,178, the Australian
Capital Territory 1,142 and Tasmania 1,120 were above the national average.
Queensland with 962 nurses per 100,000 population and New South Wales with 984
were well below the national average. South Australia and the Northern Territory had
close to the national average.
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Nurse employment in rural areas was much higher than employment of other health
professions. In 1996, nurse employment per 100,000 population in large rural centres
(1,705), small rural centres (1,363) and remote centres (1,220) exceeded that of capital
cities (1,183). However, in small rural centres, other rural and remote areas, around 30%
of nurses were enrolled nurses whose minimum training involves 1 year of post-school
nursing education compared with 3 years for registered nurses. In capital cities, 17% of
nurses were enrolled nurses.
Tertiary education entrants to the health workforce
The number of Australian citizens and permanent residents who completed
undergraduate degrees in health fields at universities increased only slightly between
1992 and 1997, from 12,645 to 12,999. However, non-nursing course completions
increased by 35.2%, from 4,373 to 5,914. Basic nursing course commencements fell by
8.3% and post-basic commencements by just over two-thirds, mainly because of a fall in
school leavers applying to undertake nurse training. 
Table 5.18: Undergraduate course commencements in health fields, 1993 and 1998
Field of study
1993 1998
Total
Per cent
female Total
Per cent
female
Medicine 1,293 47.3 1,221 50.3
Dentistry 224 48.7 267 50.2
Pharmacy 465 61.1 699 62.8
Physiotherapy 624 60.6 713 59.0
Medical radiography 396 63.6 574 62.9
Occupational therapy 549 85.2 749 88.1
Speech pathology 285 94.7 410 95.6
Optometry 180 63.3 231 63.6
Podiatry 120 47.5 193 59.6
Nursing
Basic 8,543 85.2 7,830 86.3
Post-basic 3,441 91.8 1,105 92.3
Dental therapy 24 91.7 28 85.7
Rehabilitation 162 82.1 363 83.2
Nutrition and dietetics 73 87.7 160 90.6
Health administration 404 79.0 341 75.7
Medical science 454 60.1 550 63.6
Medical technology 357 65.8 384 67.2
Science and technology 250 68.4 795 71.2
Health surveying and environmental health 215 53.0 203 57.1
Health counselling 48 89.6 142 83.8
Other health(a) 351 77.2 807 81.2
Total 18,458 79.2 18,050 76.8
Total excluding nursing 6,474 64.7 9,115 66.7
(a) Mainly public health and Aboriginal health courses.
Note: Australian citizen or permanent resident students only.
Source: AIHW analysis of Department of Education, Training and Youth Affairs data.
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Statistics on undergraduate course commencements provide a guide to future
workforce supply. Between 1993 and 1998 there was a 40.8% increase in non-nursing
commencements, from 6,474 to 9,115, with the female proportion increasing from 64.7%
to 66.7%. In 1998, female medical and dentistry commencements exceeded the number
of male commencements for the first time. Overall, 76.8% of all those commencing
undergraduate health courses in 1998 were females (66.7% if nursing courses are
excluded) (Table 5.18), compared with 57.5% for undergraduate commencements in all
university courses in 1998. 
Table 5.19: Undergraduate course commencements by Aboriginal and Torres Strait Islander 
persons in health fields, 1993 and 1998
Field of study
1993 1998
Indigenous
Non-
Indigenous
Per cent
Indigenous Indigenous
Non-
Indigenous
Per cent
Indigenous
Medicine 7 1,286 0.54 10 1,211 0.83
Dentistry 1 223 0.45 0 267 0.00
Pharmacy 0 465 0.00 2 697 0.29
Physiotherapy 4 620 0.64 4 709 0.56
Medical radiography 3 393 0.76 3 571 0.53
Occupational therapy 2 547 0.36 1 748 0.13
Speech pathology 2 283 0.70 2 408 0.49
Optometry 0 180 0.00 1 230 0.43
Podiatry 0 120 0.00 2 191 1.05
Nursing
Basic 80 8,463 0.94 102 7,728 1.32
Post-basic 10 3,431 0.29 6 1,099 0.55
Dental therapy 0 24 0.00 1 27 3.70
Rehabilitation 1 161 0.62 1 362 0.28
Nutrition and dietetics 0 73 0.00 1 159 0.63
Health administration 2 402 0.50 2 339 0.59
Medical science 0 454 0.00 2 548 0.36
Medical technology 2 355 0.56 4 380 1.05
Science and 
technology 26 224 10.40 17 878 1.94
Health surveying and 
environmental health 1 214 0.47 1 202 0.50
Health counselling 1 47 2.08 0 142 0.00
Other health(a) 67 284 19.09 171 821 20.83
Total 209 18,249 1.13 333 17,717 1.88
(a) Mainly public health and Aboriginal health courses.
Note: Australian citizen or permanent resident students only.
Source: AIHW analysis of Department of Education, Training and Youth Affairs data.
01 AH2000 body  Page 264  Thursday, June 1, 2000  3:06 PM
5 Health resources and use of services  265
TRIM SIZE 175 mm Wide x 250 mm Deep
Aboriginal and Torres Strait Islanders peoples are underrepresented in all fields of
study except Aboriginal health and public health training. Excluding the latter,
79 Aboriginal and Torres Strait Islander persons completed undergraduate degrees in
health fields in 1997, with 62 of these in nursing. This is an increase on the
54 undergraduate degree completions in 1992, when there were 40 nursing graduates. 
Overall, there were 333 Aboriginal and Torres Strait Islander persons commencing
undergraduate courses in 1998, with 162 in fields other than Aboriginal and public
health, including 10 in medicine (Table 5.19). 
Immigration of health professionals
There are stringent immigration and professional registration board requirements for
health professionals trained in overseas countries who wish to migrate permanently or
work temporarily in Australia. New Zealand is an exception to this as Australian health
professional registration boards recognise the qualifications of New Zealand graduates
as equivalent to those gained in Australian universities, and trans-Tasman immigration
agreements facilitate migration between the two countries. 
During the 1990s, State health authorities have increasingly used temporary employment
of overseas-trained health professionals in an attempt to remedy shortages in the
Australian workforce, particularly in hospitals and in rural and remote areas. Between
1993Ð94 and 1998Ð99, the numbers of temporary resident health professionals increased
from 1,282 to 3,395 (Table 5.20). The most popular countries of origin in 1998Ð99 were the
United Kingdom and Ireland (1,867), New Zealand (632) and Asian countries (333).
During this period, the number of Australian health professionals travelling to overseas
countries for temporary employment of 12 months or more increased from 1,569 to
1,770, a 12.8% increase. 
Table 5.20: Health professionals arriving in Australia, 1993Ð94 and 1998Ð99
Field of study
Permanent migrants
Temporary residents for the 
purpose of employment
1993–94 1998–99
Per cent
change 1993–94 1998–99
Per cent
change
Medical practitioners 445 408 –8.3 893 2,224 149.0
Nurses and midwives 870 1,080 24.1 261 772 195.8
Dental practitioners 79 80 1.3 11 42 281.8
Pharmacists 72 120 66.7 27 89 229.6
Occupational therapists 27 29 7.4 12 18 50.0
Optometrists 15 98 553.3 23 101 339.1
Physiotherapists 77 90 16.9 10 32 220.0
Speech pathologists 20 16 –20.0 3 6 100.0
Chiropractors and osteopaths 5 9 80.0 9 18 100.0
Podiatrists 7 8 14.3 3 7 133.3
Medical imaging professionals 44 53 20.5 18 68 277.8
Other health occupations 54 39 –27.8 12 19 58.3
Total 1,715 2,030 18.4 1,282 3,395 164.8
Source: AIHW analysis of Department of Immigration and Multicultural Affairs data.
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5.5 Supply and use of health services
Acute care hospitals
In 1997Ð98, there were 1,051 acute care hospitals in Australia, 734 of which were public
hospitals and 317 private hospitals (Table 5.21). Acute care hospitals provide medical,
surgical and obstetric services on a 24-hour basis and are staffed by qualified medical,
nursing and allied health professionals. Due to advances in health care, drug treatments
and medical technology, lengths of stay in hospital care are decreasing. Although some
categories of patient are not admitted for acute care services, such as those requiring
rehabilitation, specialised mental health services or palliative care, most patients require
a relatively short stay in acute care. Alongside the increasing trend towards day surgery
and procedures, treatments that have previously required admission are frequently
being provided in outpatient clinics and day-care facilities or by community health
services. Thus, the role of the acute hospital is increasingly to provide services to those
patients where conditions require the high level of care and technology that can only be
provided within hospitals. 
Hospitals vary in size from small community facilities that may have as few as 10 beds
to large metropolitan hospital campuses that can have up to 1,000 beds. Changes and
differences in the number of hospitals reported by States and Territories are often due to
Table 5.21: Institutions and available beds, 1991Ð92 to 1997Ð98
1991–92 1992–93 1993–94 1994–95 1995–96 1996–97 1997–98
Institutions
Hospitals
Public acute(a) 713 699 702 727 704 704 734
Private acute(b) 319 323 329 328 323 319 317
Public psychiatric(c) 45 36 37 35 34 23 24
Available beds(d)(e)
Hospitals
Public acute(a) 57,053 54,116 56,140(e) 54,211 54,579 53,410 52,606
Private acute(b) 20,745 20,860 21,241 22,370 22,757 22,966 23,019
Public psychiatric 7,266 5,814 5,360(e) 4,685 3,992 3,426 3,112
Available beds (per 1,000 population)(d)(e)
Hospitals
Public acute(a) 3.3 3.1 3.2 3.0 3.0 2.9 2.8
Private acute(b) 1.2 1.2 1.2 1.2 1.3 1.2 1.2
Public psychiatric 0.4 0.4 0.3 0.2 0.3 0.2 0.2
(a) Includes Department of Veterans’ Affairs General and Auxiliary hospitals. 
(b) Private hospitals include private psychiatric hospitals and exclude freestanding day hospital facilities.
(c) Excludes institutions in New South Wales which are not predominantly psychiatric hospitals, but have psychiatric 
programs.  
(d) Average available beds where possible, otherwise available beds at 30 June.
(e) Available beds for New South Wales are estimated. 
Sources: AIHW National Public Hospital Establishments Database; AIHW National Survey of Mental Health Services; AIHW 
analysis of the DHFS Aged and Community Care Strategic Information System (ACCSIS); ABS 1999a.
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changes in administrative or reporting arrangements and not necessarily due to a
change in the number of hospital campuses or buildings. In addition, the service
delivery structure differs between jurisdictions, so the count of hospitals in States and
Territories is not useful for comparative purposes. 
A more reliable indicator of shifts in the availability of hospital services is the increases
or decreases in the number of available beds over time. Available beds are those that are
immediately available for use by admitted patients when required. Between 1991Ð92
and 1997Ð98, there was a 3% reduction in available acute care beds, resulting in a
decrease in the rate of available beds from 4.5 to 4.1 beds per 1,000 population
(Table 5.21). Decreased length of stay has led to a lower requirement for hospital beds.
The change in available beds was not evenly distributed between the public and private
sectors, with the number of private acute care beds increasing by 11% and public acute
beds decreasing by 8%. 
Psychiatric hospitals
Reforms in recent years in the provision of mental health services have led to a change
in the way people with a severe mental disorder are treated, with a move away from
segregated and custodial institutional care to a more balanced system that integrates
hospital services with continuing care in community settings. 
Between 1991Ð92 and 1997Ð98, there was a substantial reduction in the number of
public psychiatric hospitals, from 45 to 24 facilities. Over the same period, the number
of available beds in public psychiatric hospitals declined from 7,266 to 3,122 beds. There
has been a corresponding increase in the number of beds provided in community-based
residential services. The section on mental health services (page 282) contains
additional information on the changes that have occurred in the delivery of mental
health services over the past decade.
Regional variation in bed supply
The number of beds per 1,000 population in health care institutions is a useful indicator
of the comparative supply of healthcare services across States and Territories. For
hospitals, there is a different mix between public and private beds across the States and
Territories. The national average for all hospital beds is 4.0 beds per 1,000 population. In
1997Ð98, South Australia (4.7 beds per 1,000 population) and Queensland (4.4 beds)
were above the national average (Table 5.22, page 268).  
Other health services
In addition to the institutional care services provided in hospitals and residential aged
care facilities, there is a large range of community health services provided both
publicly and privately. These include services provided directly to individuals as well
as other public and environmental health services that aim to protect and promote the
health of communities as a whole (through activities such as food safety regulation,
monitoring of radiation levels and tobacco control measures). For services delivered
directly to individuals, care is largely delivered as ambulatory care, including services
provided in peopleÕs homes (e.g. home-based palliative care, domiciliary nursing) and
outreach services (e.g. mobile services to homeless people, health promotion in
schools). Some health services delivered in the community also provide residential care,
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i.e. in 24-hour-staffed residential units that provide specialised treatment, rehabilitation
or care. This includes residential mental health care services and residential alcohol and
drug treatment services. 
A large number of community-based services available to individuals are provided by
private healthcare practitioners. These include general practitioners, dentists, private
domiciliary nursing services and private allied health professionals. 
There are also a significant number of services available to individuals that are
provided publicly by governments, usually under the umbrella term Ôcommunity
health servicesÕ. These services are often provided within models of care that emphasise
the availability of multidisciplinary care, disease prevention and early intervention,
accessibility to those with high needs, and the provision of care in a way that reduces
the stigma that may be associated with some health issues (e.g. sexual health services,
mental health services). 
The services vary in terms of the extent to which they serve specific population groups
(e.g. womenÕs health services, child health centres) or specialise in treating specific
health problems (e.g. alcohol and other drug treatment services, dental services). Other
services may provide a broad range of services to a broad client base (e.g. a community
nursing service may be involved in many aspects of postnatal care and post-discharge
care following a hospital admission, and provide ongoing care to the aged or people
who need long-term care. Community health services may also deliver services in other
ways, such as services to groups (e.g. health education, support programs), and may
also undertake health promotion, public health and community development activities. 
Although comprehensive national data are lacking on many of the health services that
are provided in the community, data are available in some areas of community health
service. Two are described below. 
Family planning organisations 
Family planning organisations provide a range of services to promote the sexual and
reproductive health of Australians, particularly for people who choose not to, or are not
able to, access sexual and reproductive health services through other healthcare
Table 5.22: Available beds per 1,000 population(a), States and Territories, 1997Ð98
Institution type NSW Vic Qld WA SA Tas ACT NT Aust
Hospitals
Public acute(b) 2.9 2.6 2.9 2.7 3.2 2.3 2.5 3.1 2.8
Private acute(c) 1.0 1.3 1.5 1.3 1.5 1.7 (d) (e) 1.2
Public psychiatric 0.2 0.0 0.3 0.3 0.3 n.a. — — 0.2
Aged care facilities 87.7 83.5 91.7 89.4 88.8 85.8 87.2 98.3 87.5
(a) Rates per 1,000 population calculated using total population for hospitals and population aged 70 and 
over for aged care facilities.
(b) Includes Department of Veterans’ Affairs General and Auxiliary hospitals.
(c) Private hospitals include private psychiatric hospitals and exclude freestanding day hospital facilities.
(d) Included with New South Wales.
(e) Included with South Australia.
Sources: AIHW National Public Hospital Establishments Database; ABS 1999a.
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providers, such as general practitioners. The services provided include clinic services
for individual clients, community education programs, and education and training of
health professionals. The clinical services provided to individuals include contraceptive
services, counselling and information services, and the management of sexual and
reproductive health. 
In 1998Ð99, there were 151,338 client visits to family planning organisations, at which
275,521 services were provided (Table 5.23). This represented a 14% reduction on the
number of services provided in 1996Ð97, and a 13% reduction in the number of client
visits over the period.
Of these services, 40% were delivered to clients who were aged less than 25 years and
20% to clients aged 40 years or over. Males made 4% of client visits, although the
number of males who attended with their partners (i.e. as couples) is unknown.
Approximately 25% of client visits were made by people born outside Australia (Family
Planning Australia 2000). 
Aboriginal health services
Aboriginal health services provide healthcare services specifically to meet the needs of
Aboriginal and Torres Strait Islander peoples in urban, rural and remote regions across
Australia. These services are funded by the State/Territory and Commonwealth
Governments. The State/Territory Governments provide significant funding through
hospitals and community clinics. Most direct funding from the Commonwealth is
provided to Aboriginal Community Controlled Health Services (ACCHS).
The Commonwealth Government, through the Office for Aboriginal and Torres Strait
Islander Health (OATSIH), provides funding for a range of Indigenous-specific health
and substance misuse services, which are largely delivered in community-based
settings. In 1998Ð99, OATSIH provided $141 million for the provision of these services
from 210 primary service sites and 64 secondary service sites (including outreach
services) distributed throughout Australia (DHAC 1999a). 
Table 5.23: Client visits and services provided by family planning organisations(a), 
1996Ð97 to 1998Ð99
Type of service provided 1996–97 1997–98 1998–99
Contraceptive services 72,463 64,486 62,040
Reproductive and sexual health management(b) 31,159 26,592 23,868
Early intervention/health promotion services(c) 127,807 113,193 107,554
Reproductive health counselling and information services 89,975 82,742 82,059
Total services 321,404 287,013 275,521
Number of client visits 173,036 153,767 151,338
(a) Excludes South Australia.
(b) Includes antenatal checks, postnatal checks, post-termination checks and management of menstrual irregularity, 
sexually transmitted infections and menopause.
(c) Includes breast checks, Pap smears, pregnancy tests, investigation and care of sexually transmitted infections, rubella 
tests and hepatitis tests.
Source:  Family Planning Australia national database.
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The largest area of Commonwealth funding to Aboriginal health services is in the form
of ÔglobalÕ grants to ACCHS, for the provision of services that are Ôculturally
appropriate, autonomous primary health services, initiated, planned and governed by
local Aboriginal communities through their locally elected Aboriginal board of
directorsÕ (DHAC 2000a). They manage acute and chronic health conditions, conduct
preventive health and health promotion activities, provide transport services, and
provide advocacy and assistance to clients in obtaining other community and health
services. The services operate in different ways, with the emphasis being on the
provision of primary medical care within a multidisciplinary team framework.
Aboriginal health workers are an important part of these teams. In 1997Ð98, 106 ACCHS
provided reports on their service activity. These services reported that approximately
860,000 episodes of health care were provided to individual clients. Of clients who
received services, 90% were Aboriginal (DHAC 2000a).
In 1996, there were 703 employed Aboriginal and Torres Strait Islander health workers
(ABS 1997a). In 1998, there were 698 medical practitioners who worked full-time or
part-time in an Aboriginal health service; 63% worked in metropolitan areas (AIHW
2000). The Commonwealth has commissioned a National Workforce Modelling Project
to provide further data on the numbers and types of health professionals working in
Aboriginal health services.
Use of hospitals 
Admitted patients, patient-days and length of stay
There were 5,563,074 separations from public acute, public psychiatric and private
hospitals reported to the National Hospital Morbidity Database for 1997Ð98 (AIHW
1999c), representing 299 separations per 1,000 population (Table 5.24, page 273). There
were 3,747,532 (67%) separations from public acute hospitals, 22,566 (0.4%) separations
from public psychiatric hospitals and 1,792,976 (32%) separations from private
hospitals. These separations accounted for 22,555,130 patient-days, 67% in public
hospitals, 6% in public psychiatric hospitals and 27% in private hospitals.  
With public psychiatric hospitals excluded, average length of stay in 1997Ð98 was
3.8 days overall, 4.0 days in public acute hospitals and 3.3 days in private hospitals. The
difference between these two hospital sectors at least in part reflects the different range
of patients cared for and treatments undertaken (casemixes). For example, public acute
hospitals had more children under the age of 5 years as patients (7.3% of separations)
compared with private hospitals (2.7% of separations) and procedures were more
commonly reported for patients of private hospitals (87%) than for patients of public
acute hospitals (71%). 
If same-day separations are excluded (as is the practice in most OECD countries), the
average length of stay was 6.4 days in public acute hospitals and 6.0 days in private
hospitals. These figures are within the range of those reported for other OECD
countries (OECD 1999). 
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Box 5.6: Statistics and data sources relating to the use of hospitals
Admitted patient statistics
Statistics on admitted patients, although sometimes referred to as admission statistics, are
more correctly referred to as separation statistics. This is because most of the data on the
use of hospitals by admitted patients are based on information collected at the end of
patientsÕ episodes of care, rather than at the beginning. The reason for this is that the
actual length of stay and the procedures carried out are known and the diagnostic infor-
mation is more accurate.
Admitted patient means a patient who undergoes a hospitalÕs formal admission process.
Patient-day means the occupancy of a hospital bed (or chair in the case of some same-day
patients) by an admitted patient for all or part of a day.
Separation is the term used to refer to the episode of care, which can be a total hospital
stay (from admission to discharge, transfer or death), or a portion of a hospital stay begin-
ning or ending in a change of type of care (for example, from acute to rehabilitation). ÔSep-
arationÕ also means the process by which an admitted patient completes an episode of care
by being discharged, dying, transferring to another hospital or changing type of care.
For each separation, patients are assigned a principal diagnosis or the diagnosis estab-
lished after study to be chiefly responsible for occasioning the patientÕs episode of admitted
patient care. The principal diagnosis recorded for each separation is usually a disease,
injury or poisoning, but can also be specific treatment of an already diagnosed condition,
such as dialysis for renal disease, or other reasons for hospitalisation. 
If applicable, a principal procedure is also identified. This is the most significant proce-
dure performed for treatment of the principal diagnosis or, if no procedure was performed
for that, another therapeutic or diagnostic procedure. Diagnoses and procedures were
reported using the ICD-9-CM classification in 1997Ð98 and are now reported using the
ICD-10-AM classification (see Box 5.7, page 274).
The State and Territory health authorities compile information on separations and supply
it to the Australian Institute of Health and Welfare for collation into the National Hospital
Morbidity Database. This database comprises an electronic record for each separation from
almost all hospitals in Australia, including public acute and psychiatric hospitals (public
sector) and private hospitals, which include private psychiatric and private freestanding
day hospital facilities (private sector).
As indicators of community morbidity, hospital separation data have limitations. Sick
people who are not admitted to hospital are not counted and those who are admitted more
than once, or to more than one hospital, are counted on each occasion. Hospital separation
data also reflect differing admission practices and availability of and access to hospitals.
(continued)
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Between 1993Ð94 and 1997Ð98, there was a 10% increase in separations from public
acute hospitals and a 28% increase in separations from private hospitals. There was a
decrease of 5% in patient-days for public hospitals over this period but an increase of
14% for private hospitals. This is consistent with the larger increase in separations for
private hospitals over this period. 
In 1993Ð94, 72% of separations and 76% of patient days were in public acute hospitals,
whereas in 1997Ð98 these percentages had fallen to 68% and 73% respectively. Within
public acute hospitals, the proportion of patients admitted as public patients increased
from 78% in 1993Ð94 to 86% in 1997Ð98. 
Between 1993Ð94 and 1997Ð98, the crude separation rate per 1,000 population increased
by 15% and, after adjusting for changes in the age structure, there was still a 13%
increase in separations over the period. Age-standardised patient-days per 1,000
population fell by 1% over the 5-year period (Table 5.24). Thus, despite an increase in
the number of separations, total patient-days remained relatively stable. 
The increase in separations may be accounted for, at least in part, by the introduction of
episodes of care as the unit of reporting, rather than hospital stays (see Box 5.6). This
reporting change may also account for part of the decline in average length of stay over
the last few years. The increased numbers of separations may also reflect improved
reporting by hospitals. 
In 1997Ð98, there were 2,577,653 same-day separations, 1,622,339 from public acute
hospitals, 2,390 from public psychiatric hospitals and 952,924 from private hospitals.
There has been a marked upward trend over the period 1993Ð94 to 1997Ð98 in the
proportion of separations that were day-only separations, reflecting changing medical
practice and efforts to increase hospital productivity. In 1993Ð94, 37% of separations
were same-day separations, but by 1997Ð98 this had increased to 46% of all separations.
Box 5.6 (continued): Statistics and data sources relating to the use 
of hospitals
Non-admitted patients
Hospitals provide services to non-admitted patients through emergency departments, out-
patient clinics and a range of other specialised services. Summary information on these
services is collated nationally for public hospitals by the Australian Institute of Health and
Welfare and for private hospitals by the Australian Bureau of Statistics.
An occasion of service for a non-admitted patient is defined as any examination, consul-
tation, treatment or other service provided to a patient in each functional unit of a health
service establishment on each occasion such service is provided. National data are catego-
rised into broad clinic or service-based groupings.
Use of the national definition and categorisation for non-admitted patients is not com-
pletely uniform among the States and Territories and has varied over time, and this affects
data quality. Existing national systems for counting and classifying non-admitted patient
services are being revised.
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Table 5.24: Hospital use by admitted patients, 1993Ð94 to 1997Ð98(a)
1993–94(b) 1994–95(b) 1995–96(c) 1996–97 1997–98
Separations per 1,000 population(g) 
Public acute hospitals(d)(e) 185.6 190.5 196.4 196.6 201.2
Public patients 144.0 151.5 163.1 166.0 173.0
Private patients 30.7 27.2 24.1 21.3 19.1
Private hospitals 74.7 82.1 87.7 92.4 97.3
Total(f) 259.5 271.9 284.6 289.1 298.7
Total age-standardised rate 257.0 268.1 279.1 282.7 290.6
Patient-days per 1,000 population(g)
Public acute hospitals(d)(e) 895.6 867.2 859.1 824.1 813.6
Public patients 677.3 673.3 694.1 678.2 669.0
Private patients 142.4 121.0 103.4 88.0 76.2
Private hospitals 291.0 304.1 327.6 319.9 325.2
Total(f) 1,183.8 1,168.4 1,235.7 1,214.0 1,211.1
Total age-standardised rate 1,157.7 1,133.8 1,187.9 1,161.4 1,149.9
Same-day separations as a percentage of total
Public acute hospitals(d)(e) 34.2 37.7 39.8 42.0 43.3
Public patients 35.0 38.2 40.4 42.6 43.8
Private patients 33.2 36.5 38.4 40.9 42.7
Private hospitals 43.3 46.1 48.9 51.0 53.1
Total(f) 36.8 40.2 42.4 44.7 46.3
Average length of stay (days)
Public acute hospitals(d)(e) 4.8 4.6 4.4 4.2 4.0
Public patients 4.7 4.4 4.3 4.1 3.9
Private patients 4.6 4.4 4.3 4.1 4.0
Private hospitals 3.9 3.7 3.7 3.5 3.3
Total(f) 4.8 4.3 4.3 4.2 4.1
Average length of stay, excluding same-day separations (days)
Public acute hospitals(d)(e) 6.8 6.7 6.6 6.5 6.4
Public patients 6.7 6.6 6.5 6.4 6.1
Private patients 6.4 6.4 6.3 6.3 6.2
Private hospitals 6.1 6.0 6.4 6.0 6.0
Total(f) 6.6 6.5 6.8 6.8 6.7
(a) Some of these data have been updated since previously published.
(b) For 1993–94 and 1994–95, Victorian private hospital data are incomplete. About 81% of 1993–94 separations and 98% 
of 1994–95 separations were included.
(c) Statistical separations were introduced in 1995–96 and would have resulted in an increase in separations reported for 
that and subsequent years compared with previous years.
(d) Includes the Department of Veterans’ Affairs hospitals.
(e) Public and private patients account for the bulk of separations from these hospitals, but there are also 
separations for other categories of patients.
(f) Public psychiatric hospital data are included in totals from 1995–96. In 1995–96 Queensland was unable to report. 
Victoria was not able to provide patient-days data for all separations in 1995–96 and for 407 separations in 1996–97, 
as leave days could not be identified.
(g) Figures are crude rates per 1,000 population at 31 December of the relevant year or, if indicated as such, directly age 
standardised to the Australian population at 30 June 1991. For private hospitals, rates were derived using populations 
of the reporting States and Territories only, without adjustment for incomplete reporting.
Source: AIHW 1999c.
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This change has been accompanied by a substantial increase in the number of
freestanding day hospital facilities now operating in the private sector. In 1993Ð94 there
were 111 private freestanding day hospital facilities but by 1997Ð98 there were 175
(ABS 1999a). 
Box 5.7: Classification of diseases, procedures and episodes for 
admitted patients
Diseases and procedures
Hospital patient records contain a great deal of information about the patientÕs diagnosis
and about any procedures performed during the hospital stay. To allow efÞcient storage
and analysis of this information, detailed classiÞcation and coding systems are used to
describe and record diagnoses and procedures. The classiÞcation used in 1997Ð98 in Aus-
tralia was the second Australian version of the International ClassiÞcation of Diseases,
9th Revision, Clinical ModiÞcation (ICD-9-CM), developed by the National Coding
Centre (NCC 1996). It comprises classiÞcations of diseases and external causes of injuries
and poisoning, based on the World Health Organization version of ICD-9, and a classiÞca-
tion of procedures. These ICD-9-CM codes can be a source of information on the diseases
which are treated in hospitals and the operations which are performed, at very detailed
levels or aggregated into broad groupings such as the ICD-9-CM chapters.
The International Statistical ClassiÞcation of Diseases and Related Health Problems,
10th Revision, Australian ModiÞcation (ICD-10-AM) has now replaced ICD-9-CM. It
was developed by the National Centre for ClassiÞcation in Health (NCCH 1998) and
implemented on 1 July 1998 in four jurisdictions, and on 1 July 1999 in the other four
jurisdictions. National data for 1998Ð99 will be compiled and reported using this classiÞ-
cation, with data from four jurisdictions mapped from ICD-9-CM to ICD-10-AM.
Diagnosis related groups
Australian National Diagnosis Related Groups (AN-DRGs) is a classiÞcation system used
for acute admitted patient episodes. This classiÞcation provides a means of summarising
and relating the number and type of acute admitted patients treated in a hospital (i.e. its
casemix) and relating this information to the resources required by the hospital. This clas-
siÞcation groups episodes with similar clinical conditions and similar usage of hospital
resources using information in the hospital morbidity record such as diagnoses, proce-
dures, and age and sex of the patients. A new diagnosis related group classiÞcation, the
Australian ReÞned Diagnosis Related Group (AR-DRG) has been developed by the
Department of Health and Aged Care for implementation with ICD-10-AM.
Each AN-DRG or AR-DRG is associated with information on the average length of stay
and estimated average cost for patients in the group in the public and private sectors. This
classiÞcation, therefore, has use in measuring outputs and performance of hospitals and in
planning and funding hospital service provision.
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Diagnoses, procedures and diagnosis related groups for admitted patients
The conditions that hospitals treat are of interest to health service managers, planners,
funders and epidemiologists. These conditions, the procedures that patients undergo in
hospital and the consequent casemix of hospitals are detailed in the National Hospital
Morbidity Database using the classification systems described in Box 5.7. 
For patients with a disease, injury or poisoning recorded as a principal diagnosis, the
broad diagnosis groups (ICD-9-CM chapters) with the highest number of separations in
Australian hospitals (public acute, public psychiatric and private hospitals) in 1997Ð98
were diseases of the digestive system, followed by diagnoses within the obstetric
category (complications of pregnancy, childbirth and the puerperium, which includes
normal deliveries) and diseases of the circulatory system (Tables S34, page 397, and S35,
page 398).
At a more detailed level (3-digit ICD-9-CM categories), the most common disease or
injury principal diagnoses (excluding diagnoses described as symptoms) in public
hospitals were asthma (54,006 separations) and selected forms of acute and subacute
ischaemic heart disease, not including acute myocardial infarction (46,499 separations).
In private hospitals, the most common diagnoses were cataract (71,258 separations) and
diseases of the oesophagus (50,054 separations). 
Principal diagnoses within the six National Health Priority Areas accounted for 29% of
hospital separations (1,637,689) and 42% of patient-days (9,500,510) in Australian
hospitals. Cancer accounted for the largest number of these (477,927 separations),
followed by cardiovascular disease (434,748 separations). Mental disorders accounted
for the highest number of patient-days (3,145,162), followed by cardiovascular disease
(2,462,898 patient-days). Of the six priority areas, patients admitted with a principal
diagnosis of a mental disorder had the longest lengths of stay on average (Table 5.25,
page 276). 
A procedure was reported for 76% of separations in Australian hospitals in 1997Ð98. Of
these, 63% were in public hospitals, although public hospitals accounted for 68% of
separations overall. Similarly, although 73% of overall patient-days were in public
hospitals, only 70% of patient-days associated with procedures were in public hospitals
(10,999,725). This reflects the higher proportion of separations in the private sector that
were associated with a procedure compared with the public sector, 87% and 71%
respectively. 
At the broad group (ICD-9-CM chapter) level, if miscellaneous diagnostic and
therapeutic procedures are not included (i.e. procedures that are not ÔoperationsÕ or
obstetrical procedures), operations on the cardiovascular system were the principal
procedures associated with the largest proportion of public hospital separations for
which a principal procedure was reported (489,280 separations)(Table S36, page 399).
Haemodialysis was the principal procedure reported for 77% (378,466) of these
separations. The most commonly reported procedure group for the private sector was
operations on the digestive system (374,314 separations). Within that grouping,
endoscopies and other diagnostic procedures on the small and large intestines were
reported for 61% of the separations. 
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Table 5.25: Separations for National Health Priority Areas(a), all hospitals(b), 1997Ð98
National Health 
Priority Area Separations
Separations
per 1,000
population(c)
Patient-
days(d)
Patient-days
per 1,000
population(c)(d)
No. same
day
Average
length of
stay (days)
Cancer 477,927 25.7 1,732,144 93.0 309,606 3.6
Cardiovascular disease 434,748 23.3 2,462,898 132.3 83,209 5.7
Mental disorders 235,489 12.6 3,145,162 168.9 85,383 13.4
Diabetes 23,857 1.3 166,495 8.9 3,814 7.0
Injury or poisoning 405,388 21.8 1,783,573 95.8 109,882 4.4
Asthma 60,280 3.2 210,238 11.3 7,118 3.5
Total 1,637,689 87.9 9,500,510 510.1 599,012 5.8
(a) Only separations for which the principal diagnosis corresponds to one of the priority areas have been included. These 
conditions will also have been reported as additional diagnoses for separations with principal diagnoses not within 
these priority areas. Diabetes in particular is more often reported as an additional diagnosis than a principal diagnosis. 
The ICD-9-CM codes associated with the priority areas can be found in AIHW 1999c.
(b) Includes public psychiatric hospitals.
(c) Crude rates.
(d) Information on patient-days has been updated since it was published in AIHW 1999c.
Source: AIHW 1999c.
Table 5.26: Separations(a) for the top 12 AN-DRGs (version 3.1), all hospitals, 1997Ð98
AN-DRG Separations
Per cent
same-day
separations Patient-days(b)
Average
length of stay
(days)
572 Admit for renal dialysis 417,359 99.9 418,134 1.0
780 Chemotherapy 193,529 99.7 194,138 1.0
332 Other gastroscopy for non-
major digestive disease(c) 181,419 94.7 203,595 1.1
335 Other colonoscopy(c) 145,241 93.2 166,561 1.1
674 Vaginal delivery without 
complicating diagnosis 141,124 3.2 512,238 3.6
99 Lens procedure without 
vitrectomy(c) 97,405 73.4 106,265 1.1
128 Dental extractions and 
restorations 73,392 84.7 77,383 1.1
421 Knee procedures 69,325 60.4 97,470 1.4
484 Other skin, subcutaneous 
tissue and breast procedures 66,034 85.6 84,686 1.3
683 Abortion with D&C, 
aspiration curretage or 
hysterotomy 65,242 82.0 68,653 1.1
843 Major affective disorders 56,078 44.6 569,084 10.1
659 Conisation, vagina, cervix 
and vulva procedures 48,487 85.8 56,864 1.2
(a) Includes separations with acute or unspecified type of episode of care only. Includes public psychiatric hospitals.
(b) Information on patient-days has been updated since it was published in AIHW 1999c.
(c) Without complications and co-morbidities.
Source: AIHW 1999c.
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Procedures were reported for varying proportions of separations within the broad
groups of principal diagnoses. High proportions of separations for neoplasms (93%),
diseases of the blood and blood-forming organs (91%) and diseases of the genito-
urinary system (88%) had procedures reported. In contrast, there were fewer reported
for separations for mental disorders (33%), infectious and parasitic diseases (39%) and
diseases of the respiratory system (50%). 
The Australian National Diagnosis Related Groups (AN-DRGs) with the highest
numbers of separations in 1997Ð98 featured several for which same-day separations
dominated (Table 5.26). Among these were the top two groups in public hospitals,
admit for renal dialysis (372,965 public sector separations) and chemotherapy (133,062
public sector separations) and the top two groups in the private sector, gastroscopy
(107,914 private sector separations) and colonoscopy (95,483 private sector separations)
(AIHW 1999c). 
Vaginal delivery without complicating diagnosis was the most common AN-DRG that
was not usually a same-day hospitalisation. This group was the third most common in
public hospitals (109,246 separations) and the eighth most common in private hospitals
(31,878 separations). This category does not include deliveries by caesarean section or
complicated deliveries. 
Area of usual residence
Figures 5.6 (page 278) and 5.7 (page 279) show age-standardised separation rates per
1,000 population by statistical division of the usual residence of the patient, for public
and private hospitals. In the public sector, the highest rates were reported for residents
of the statistical divisions of the Kimberley in Western Australia, north-west
Queensland and northern South Australia. In the private sector, highest rates were
reported for the Queensland statistical divisions of Mackay and Darling Downs and for
the Victorian statistical division of Melbourne.  
Non-admitted patients 
Public hospitals provide about 95% of non-admitted patient services. In 1997Ð98, there
were 32,764,972 non-admitted patient occasions of service reported for public acute and
psychiatric hospitals, or about 1,760 per 1,000 population (AIHW 1999c). In 1997Ð98,
5,138,744 or 14.0% of these occasions of service were provided in accident and
emergency departments and 2,683,371 or 8.2% were provided as radiology or organ
imaging. Note that there is considerable variation among States and Territories in the
way data on non-admitted patient occasions of service are collected, and this may affect
the proportion of non-admitted patient occasions of service assigned to this category by
different jurisdictions.
Private hospitals also contribute to the provision of non-admitted patient services, with
a different mix of types compared with the public hospitals. In 1997Ð98, private
hospitals reported 1,670,300 occasions of service (90 per 1,000 population) (ABS 1999a).
The largest numbers were reported for allied health services (384,100 or 22.9%),
radiology and organ imaging (248,000 or 14.8%) and accident and emergency (408,300
or 24.4%). 
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Aged care services
As well as using those health services provided for the general population, such as
hospitals and community health services, older Australians use a number of health
services provided specifically for the older, frail segment of the population. The core
elements of the Australian aged care system are aged care assessment teams, home- and
community-based services provided through the Home and Community Care (HACC)
program, community aged care packages and residential aged care facilities. Current
policy directions include a continued emphasis on the role of assessment, containment
of the expansion of residential aged care facilities to the planning ratio of 90 places per
1,000 persons aged 70 and over, continuing expansion of home-based services provided
through both the HACC program and community aged care packages, the development
and implementation of quality appraisal and accreditation procedures for both home-
Note: Data for statistical divisions were combined for mapping purposes for both the Northern Territory and the 
Australian Capital Territory because of the difference in the relative sizes of the populations between statistical 
divisions within these jurisdictions.
Source: AIHW National Hospital Morbidity Database.
Figure 5.6: Separations per 1,000 population by statistical division of usual residence, 
public hospitals, 1997Ð98
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based and residential care, and an ongoing emphasis on providing support to carers
through a range of support services including respite care. For a more detailed account
of these policy directions, see AustraliaÕs Welfare 1999 (AIHW 1999b).
Aged care assessment teams
Aged care assessment teams play a central role in the Australian aged care system. They
determine eligibility for community aged care packages and for admission to
residential aged care facilities. They also function as a source of advice and referral for
a range of services including the HACC program, although they do not determine
eligibility for HACC services. Their aim is to Ôensure frail older people gain access to
available care services appropriate to their needs, and improve coordination of aged
care services with other health and community support agenciesÕ (DHAC 1999a:213).
In 1999, there were 123 assessment teams in Australia, 66 based in rural and remote
areas and 57 in metropolitan areas. 
Note: Data for statistical divisions were combined for mapping purposes for both the Northern Territory and the 
Australian Capital Territory because of the difference in the relative sizes of the populations between statistical 
divisions within these jurisdictions.
Source: AIHW National Hospital Morbidity Database.
Figure 5.7: Separations per 1,000 population by statistical division of usual residence, 
private hospitals, 1997Ð98
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In the 6 months from January to June 1999, 81,135 clients aged 65 and over were
assessed, an increase on the 55,746 clients assessed in the same period in 1994. The
proportion of the aged population assessed has also increased, from 2.6% in 1994 to
3.5% in 1999. Rates of assessment were higher among women than among men, and
substantially higher in the 80 and over age group (9.6%) than at younger ages (0.7% of
those aged 65Ð69) (Table 5.27). Expenditure on aged care assessment teams was
$36.1 million in 1997Ð98 (AIHW 1999b:200).
In 1998, 24% of persons assessed were recommended for nursing home accommodation,
21% for hostel accommodation, and 9% to receive assistance through community aged
care packages or through community options projects (AIHW 1999b:184). 
Home and Community Care program
The HACC program is funded jointly by the Commonwealth and State and Territory
Governments. The bulk of home- and community-based services are provided through
this program, many of them by not-for-profit agencies. The program includes home
nursing services, delivered meals, home help and home maintenance services, transport
and shopping assistance, paramedical services, home- and centre-based respite care, and
advice and assistance of various kinds. HACC also provides special case management
services for some clients through its community options or linkages projects. 
In 1997Ð98, HACC agencies provided 441 hours of home help per month per 1,000
people aged 70 and over. They also provided 506 hours of centre-based respite care and
697 delivered meals per 1,000 persons aged 70 and over. The levels of provision were
lower in the more intensive service typesÑfor home-based respite (196 hours), for
personal care (143 hours) and for home nursing (127 hours). There was a substantial
increase in the level of services delivered in 1997Ð98 compared with 1993Ð94 for
personal care, paramedical, respite care and centre day care. There was a substantial
reduction in the level of provision of home nursing (Table 5.28).
Expenditure on HACC increased from $620.9 million in 1993Ð94 to $855.3 million in
1998Ð99. 
Table 5.27: Assessments of aged care assessment team clients aged 65 years and over by age 
group and sex, January to June 1994 and January to June 1999
1994 1999
65–69 70–79 80+ Total 65–69 70–79 80+ Total
Males
Assessments 2,145 7,372 9,930 19,447 2,176 10,519 15,873 28,568
% population assessed 0.6 1.7 6.5 2.1 0.7 2.1 8.6 2.8
Females
Assessments 2,421 11,601 22,277 36,299 2,478 15,354 34,735 52,567
% population assessed 0.7 2.1 7.6 3.0 0.7 2.5 10.1 4.0
Persons
Assessments 4,566 18,973 32,207 55,746 4,654 25,873 50,608 81,135
% population assessed 0.7 2.0 7.2 2.6 0.7 2.3 9.6 3.5
Source: AIHW 1999b:184. 
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Community aged care packages
Community aged care packages were first implemented in 1993 and provide personal
care services for people living at home who would otherwise be eligible for what was
then referred to as Personal Care level admission to a hostel. Care packages provide a full
range of home-based care services, with care coordinated by the care package provider. 
The program has expanded rapidly in recent years, from 1,227 packages in 1994 to 6,124
in 1997, and then to 13,725 in 1999. The ratio of provision has thus changed from less
than 1 per 1,000 persons aged 70 and over in 1994 to 8 places per 1,000 persons aged 70
and over in 1999 (Table 5.29). Expenditure on community aged care packages increased
from $7.4 million in 1993Ð94 to $121.8 million in 1998Ð99. 
Table 5.28: HACC average hours of service provision per month(a) per 1,000 persons aged 70 
and over, 1993Ð94 and 1997Ð98
Service type 1993–94 1997–98 Per cent change
Home help (hours) 428 441 3.0
Personal care (hours) 109 143 31.2
Home nursing (hours)(b) 206 127 –38.3
Paramedical (hours) 20 23 15.0
Home respite care (hours) 155 196 26.5
Centre day care (hours) 421 506 20.2
Home meals (number) 746 697 –6.6
Centre meals (number) 101 100 –1.0
Home maintenance/modification (hours) 42 45 7.1
(a) Based on data collected for a sample month.
(b) Excludes the Northern Territory as home nursing is not HACC-funded in the Northern Territory.
Source: AIHW 1999b:186. 
Table 5.29: Community aged care packages and residential care places, 30 June 1994 and 
30 June 1999
Year Residential care type No. of places
Ratio of places per
1,000 population
aged 70 and over
1994 Care packages 1,227 0.9
Hostels 57,104 40.3
Nursing homes 74,247 52.3
Residential aged care(a) 131,351 92.6
Total residential aged care and care packages 132,578 93.5
1999 Care packages 13,725 8.3
Residential aged care(a) 140,651 85.6
Total residential aged care and care packages 154,376 93.9
(a) Residential aged care combines nursing homes and hostels; from 1 October 1997 nursing homes and hostels were 
combined into one residential aged care system.
Source: AIHW 1999b:192.
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Residential aged care facilities
From 1 October 1997, nursing homes and hostels were integrated into a single
residential aged care system. These changes were undertaken as part of the National
Aged Care Strategy, which was implemented during 1997Ð98. In addition to the
amalgamation of nursing homes and hostels into a single system of care, the new eight-
category Resident Classification Scale was introduced to determine the level of
payment to which facilities were entitled for each resident (based on residentsÕ levels of
dependency); income and asset-tested fees were introduced; and a pre-existing system
of contributions to the capital costs of aged care facilities was modified and expanded
to include all aged care facilities.
The number of residential aged care places has increased in recent years, from 131,351
in 1994 to 140,651 in 1998. However, taking into account the increasing size of the aged
population, this is equivalent to a decline in the number of places per 1,000 persons
aged 70 and over, from 92.6 places in 1994 to 85.6 places in 1998. When community aged
care packages are taken into account, there has been a slight increase in the total level of
provision (care packages plus residential aged care places) from 93.5 in 1994 to 93.9 in
1999. The average annual cost per bed has increased, from $22,784 in 1997Ð98 to $24,801
in 1998Ð99 (DHAC 1999a:228).
The number of respite bed-days provided in residential aged care facilities is increasing,
in line with the policy commitment to improve support for carers of frail older people
or those with disabilities. In 1998Ð99, there were 969,838 bed-days of respite care
provided, compared with 872,128 in 1996Ð97, an increase of 11%. 
Between 1993Ð94 and 1998Ð99, expenditure on residential aged care facilities increased
from $2,016.0 million to $2,963.3 million. 
Public hospitals also provide nursing-home-type care to some patients. In 1997Ð98,
there were 10,548 separations of nursing-home-type patients reported to the AIHWÕs
National Public Hospital Establishments Database, with an average length of stay of
109 days. 
Mental health services
Services for Australians with a mental illness are provided in a number of settings. In
the institutional setting, both psychiatric hospitals and designated wards or units in
acute hospitals (Ôco-located facilitiesÕ) provide specialised psychiatric care. In the
community sector, ambulatory care services provide mental health assessment,
treatment and rehabilitation programs, including mental health crisis teams and
outpatient clinic services. Residential facilities provide 24-hour care in the community.
Non-government organisations provide services such as supported accommodation
and advocacy programs. General practitioners also play a significant role in the
treatment of mental illness: in 1997, 77% of Australians with a mental disorder who use
health services consulted a general practitioner about their condition (ABS 1998). 
Over the last decade, the delivery of services to mental health patients has shifted from
predominantly institutional to a mix of institutional and community-based services such
as ambulatory and 24-hour residential care. This change in emphasis is demonstrated by
the shift in expenditure (Figure 5.8). Over the period 1992Ð93 to 1996Ð97, there has been
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a decrease in spending per person on stand-alone psychiatric hospitals (from $31 to
$23 per person) and a corresponding increase in spending in community areas,
particularly ambulatory care (from $15 to $24 per person). 
There have been marked decreases in the number of public psychiatric hospitals and
available beds since 1989Ð90 (Figure 5.9, page 284, and Table 5.21, page 266). In 1997Ð98,
there were 23 private and 24 public psychiatric hospitals in Australia, although public
psychiatric hospitals had over twice the number of available beds compared with
private psychiatric establishments (Table 5.30). 
The number of staff per 1,000 patient-days was similar in both public and private
psychiatric hospitals. However, the number of staff per 1,000 separations in public
psychiatric hospitals was 10 times that for private psychiatric hospitals. This is consistent
with the difference in the type of mental health disorders treated between the sectors,
with fewer separations and longer average lengths of stay in public psychiatric hospitals.
In the public sector, the major component of expenditure was for staff costs.
Expenditure on psychiatric hospitals was about $489 million in 1997Ð98, of which
around three-quarters was for public psychiatric hospitals. 
As well as the services provided in psychiatric hospitals, there are specialised psychiatric
units in acute hospitals. One hundred and four public acute hospitals and 20 private acute
hospitals had specialised psychiatric wards in 1997Ð98 (AIHW: Moore et al. 2000). 
Note: Co-located facilities are designated wards/units in acute hospitals.
Source: DHAC 1998.
Figure 5.8: Gross per person expenditure on mental health services, 1992Ð93 and 1996Ð97
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Notes
1. No data are available for 1990–91.
2. Average available beds where possible, otherwise available beds at 30 June.
Sources: 1989–90: AIHW: Gillett & Solon 1992; 1992–93 to 1996–97: National Survey of Mental Health Services; 
1997–98: AIHW National Public Hospitals Establishments Database.
Figure 5.9: Number of public psychiatric hospitals and available beds, 
1989Ð90 to 1997Ð98
Table 5.30: Psychiatric hospitals: number of hospitals, beds, staff, and total expenditure, 
1997Ð98
Public psychiatric hospitals Private psychiatric hospitals
Number of hospitals 24 23
Available beds 3,112 1,344
Full-time equivalent staff
Number 6,128 1,515
Per 1,000 separations 271 27
Per 1,000 patient-days 4.4 4.2
Recurrent expenditure ($’000)(a)
Staff 276,877 n.a.
Other 100,962 n.a.
Total 377,839 111,141
(a) Excludes Tasmanian public psychiatric hospitals as data not available.
Source: AIHW: Moore et al. 2000.
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Hospitalisations
Although patients with a mental health disorder as the principal diagnosis accounted
for only 4.2% of all hospital separations in 1997Ð98, they made up 13.9% of all patient-
days (AIHW: Moore et al. 2000). 
A patient with a mental health disorder as the principal diagnosis may or may not
receive specialised psychiatric treatment depending on the type and severity of the
illness and the availability of specialised services. Patients who received any care in a
specialised psychiatric unit or ward are classified as receiving specialised care, whereas
those who were not in specialised units are referred to as receiving general care. Nearly
all patients in psychiatric hospitals received some specialised care. In public acute
hospitals, 48% of all mental health disorder separations received some specialised care
(Table 5.31, page 286). However, approximately two-thirds of the 6,741 patients who
stayed 36 days or more in public acute hospitals received some specialised care. 
Community-based facilities
Currently there are only limited data available on the number and size of community
mental health care facilities. However, recent collection agreements have provided
means whereby these data will soon become available. Collection of information on
resources and other establishment characteristics commenced on 1 July 1998. This data
set, along with the patient-level community mental health care collection to be
introduced from 1 July 2000, will provide more information on this growing sector of
mental health service delivery.
Use of dental services
This section focuses on the use of dental services with a particular emphasis on use by
persons in rural and remote communities, persons born overseas, and AustraliaÕs
Aboriginal and Torres Strait Islander peoples. The data presented here were collected in
three national telephone interview surveys in the period 1994 to 1996. A further survey
was conducted in late 1999.
Rural and remote dwellers
The time since a person last visited a dental professional is an indication of the level of
contact with dental services.
In all age groups, 15.7% of dentate adults (those with some natural teeth) in remote
areas and 12.5% in rural areas had a period of 5 or more years since their last dental
visit compared with 9.4% of urban adults (Table 5.32, page 287). Differences between
urban and rural residents were most evident in the 45Ð64 and 65 years and over age
groups. The proportion of rural adults aged 45 years and over who had not visited a
dental professional for 5 or more years was almost double the urban rate. 
The percentage of dentate adults who made a visit to a dental professional in the
previous 12 months is highest in urban areas and declines across rural to remote areas.
Of urban persons who were not recipients of a government concession card, 58% had
made a recent dental visit, compared with 54% of rural dwellers and 47% of those living
in remote areas. The pattern for holders of government concession cards was quite
similar, although the overall percentage of cardholders who visited a dental
professional in the last year was lower than for non-cardholders (Figure 5.10, page 288). 
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The reason for seeking dental care influences the treatment likely to be received.
Visiting for a problem rather than a check-up may reflect the ability to access dental
services in terms of availability and affordability. The lack of oral health facilities and
the scarcity of dentists, as well as the greater distances involved, present a barrier to
regular dental care in rural and remote areas.
Table 5.31: Hospital separations and patient days for a mental health disorder principal 
diagnosis, type of care received, 1997Ð98
Public acute Private(a)
Public
psychiatric Total
Same-day separations with a mental health disorder principal diagnosis
General care 18,574 15,380 105 34,059
Specialised care 19,581 29,818 1,925 51,324
Total 38,155 45,198 2,030 85,383
Short-stay(b) separations with a mental health principal diagnosis
General care 51,736 14,367 1,753 67,856
Specialised care 43,634 11,813 13,670 69,117
Total 95,370 26,180 15,423 136,973
Long-stay(b) separations with a mental health disorder principal diagnosis
General care 2,302 1,032 16 3,350
Specialised care 4,439 2,011 3,331 9,781
Total 6,741 3,043 3,347 13,131
Total separations with a mental health 
principal diagnosis 140,266 74,421 20,800 235,487
Per cent receiving specialised care 48.2 58.6 91.0 55.3
Same-day patient-days with a mental health disorder principal diagnosis
General care 18,574 15,380 105 34,059
Specialised care 19,581 29,818 1,925 51,324
Total 38,155 45,198 2,030 85,383
Short-stay(b) patient-days with a mental health principal diagnosis
General care 346,374 153,216 8,584 508,174
Specialised care 412,314 151,449 147,002 710,765
Total 758688 304665 155586 1218939
Long-stay(b) patient-days with a mental health disorder principal diagnosis
General care 266,377 71,686 1,449 339,512
Specialised care 300,153 116,195 1,084,957 1,501,305
Total 566,530 187,881 1,086,406 1,840,817
Total patient-days with a mental health 
principal diagnosis 1,363,373 537,744 1,244,022 3,145,139
Per cent receiving specialised care 53.7 55.3 99.2 72.0
(a) Includes some separations from private freestanding day hospitals.
(b) Short-stay separations are those with less than 36 patient-days, excluding same-day separations. Long-stay 
separations are those with 36 patient-days or more.
Source: AIHW: Moore et al. 2000.
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A considerably higher proportion of adult non-cardholders in rural (55%) and remote
areas (58%) than in urban areas (45%) reported that their usual reason for making a
dental visit was for a dental problem (Figure 5.11, page 289). Cardholders in rural and
remote areas reported even higher levels of problem-related visits to a dental
professional, 65% and 69% respectively, compared with 56% of urban cardholders. 
Overseas-born
There is little difference between Australian-born persons and those born overseas in
the percentage who had visited a dental professional in the previous 12 months
(Figure 5.12, page 289). However, in each group there were some differences between
English-speakers and those who spoke a language other than English at home. Of those
born in Australia, a greater proportion of persons who spoke a language other than
English at home had visited than those who spoke English at home. Of those born
overseas, a higher percentage of those who spoke English at home had visited than of
those who spoke a language other than English at home. Among persons aged 18Ð24
years, the percentage who made a dental visit within the previous 2 years was 70.3% of
Australian-born persons, compared with 80.9% of overseas-born persons. The pattern
of dental visits was similar for other age groups. 
Table 5.32: Dentate adults: time since visit to a dental professional, 1994 to 1996 (per cent)
Urban Rural Remote Total
18–24 years
<12 months 54.7 50.2 47.6 53.6
1–4 years 35.5 37.3 36.3 35.9
5+ years 9.8 12.5 *16.1 10.5
25–44 years
<12 months 53.9 53.3 42.3 53.5
1–4 years 36.0 36.4 41.8 36.3
5+ years 10.0 10.3 15.8 10.2
45–64 years
<12 months 63.0 54.7 54.8 61.0
1–4 years 28.9 31.3 31.6 29.5
5+ years 8.1 14.0 *13.6 9.5
65+ years
<12 months 64.6 52.4 43.5 61.6
1–4 years 26.3 28.9 *37.2 27.0
5+ years 9.2 18.7 *19.3 11.4
Total
<12 months 57.6 53.2 45.8 56.3
1–4 years 33.0 34.3 38.5 33.5
5+ years 9.4 12.5 15.7 10.2
* Estimate has a relative standard error greater than 25%.
Source: National Dental Telephone Interview Surveys 1994, 1995, 1996.
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Overseas-born persons who spoke a language other than English at home were
generally the most likely to report that their last dental visit was for a problem
(Table 5.33, page 290). Overall, 61% of this group last visited for a problem, compared
with 56% of Australian-born persons. 
Among persons who received their dental care in the public system, there were
consistent differences between the Australian-born and the overseas-born in the type of
care received, with higher percentages of emergency treatment received by patients
born overseas (65%) compared with those born in Australia (50%). However, patterns of
oral health were not consistently better or worse for overseas-born patients.
Differences in public service provision by country of birth/language spoken persisted
after controlling for age, geographic location, type of care, Indigenous status, numbers
of decayed teeth, numbers of missing teeth, numbers of decayed tooth roots, and the
presence of periodontal pockets. These findings may indicate variations in the
availability of fluoridated water and cultural differences in accessing dental services. 
Source: National Dental Telephone Interview Surveys 1994, 1995, 1996.
Figure 5.10: Proportion of dentate adults who visited a dental professional in the 
last year, 1994 to 1996
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Source: National Dental Telephone Interview Surveys 1994, 1995, 1996.
Figure 5.11: Proportion of dentate adults who usually visit a dental professional for a 
dental problem, 1994 to 1996
Note: Non-English speakers are those who spoke a language other than English at home.
Source: National Dental Telephone Interview Surveys 1994, 1995, 1996.
Figure 5.12: Proportion of dentate adults who visited a dentist in the last year by 
place of birth, 1994 to 1996
Urban Rural Remote
0
20
40
60
80
100
Per cent
Non-cardholders
Cardholders
Australia Overseas
0
20
40
60
80
100
Per cent
English-speakers
Non-English-speakers
01 AH2000 body  Page 289  Thursday, June 1, 2000  3:06 PM
290  AustraliaÕs Health 2000
TRIM SIZE 175 mm Wide x 250 mm Deep
Indigenous Australians
An analysis by Indigenous status of the time since the last visit to a dental professional
indicates that Indigenous adults are slightly less likely than non-Indigenous adults to
have visited a dental professional in the last 12 months (Table 5.34). They were also
more likely than non-Indigenous adults to have reported a problem as their usual
reason for a dental visit (64% compared with 50%). Indigenous adults also had a lower
mean number of dental visits in a 12-month period (1.81 compared with 2.43 visits)
than non-Indigenous Australians. 
Table 5.33: Dentate adults whose last dental visit was less than 12 months ago: reason for last 
dental visit by country of birth, language spoken and age group, 1994 to 1996 (per cent)
Australian-born Overseas-born
English Non-English Total English Non-English Total
18–24 years
Problem 46.8 *22.3 44.8 38.1 50.6 45.2
Check-up 53.2 77.7 55.2 61.9 49.4 54.8
25–44 years
Problem 56.8 60.5 57.0 45.3 62.0 50.9
Check-up 43.2 39.5 43.0 54.7 38.0 49.1
45–64 years
Problem 61.5 76.7 61.8 58.9 64.5 60.7
Check-up 38.5 *23.3 38.2 41.1 35.5 39.3
65+ years
Problem 58.0 *55.1 58.0 61.6 64.6 62.5
Check-up 42.0 *44.9 42.0 38.4 35.4 37.5
Total
Problem 56.4 51.2 56.2 52.3 61.4 55.5
Check-up 43.6 48.8 43.8 47.7 38.6 44.5
* Estimate has a relative standard error greater than 25%.
Source: National Dental Telephone Interview Surveys 1994, 1995, 1996.
Table 5.34: Dentate adults: time since last dental visit by 
Indigenous status, 1994 to 1996 (per cent)
Indigenous
Non-
Indigenous Total
Total
<12 months 53.7 56.4 56.3
1–4 years 37.3 33.3 33.5
5+ years *9.0 10.2 10.2
* Estimate has a relative standard error greater than 25%.
Note: Estimates are based on small numbers of Indigenous persons who have a 
younger age distribution than non-Indigenous persons.
Source: National Dental Telephone Interview Surveys 1994, 1995, 1996.
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Use of allied health and other health services
Information on the number of people who consulted non-medical health professionals
is provided by the 1995 National Health Survey. This survey included questions about
occasions on which people had consulted an allied or other health professional for
treatment or discussion of a health-related matter. Occasions on which the person may
have attended an allied or other health professional only to obtain medical supplies or
aids (such as attending a chemist to fill a prescription) were not included (ABS 1997b).
Table 5.35 shows that 10% of people (8% of males and 12% of females) had consulted an
allied or other health professional within the previous 2 weeks. Only 1% had visited
more than one type of allied or other health professional within the previous 2 weeks.
The allied or other health professionals most frequently consulted were chemists (by
2.4% of the population), chiropractors (1.6%), physiotherapists/hydrotherapists (1.5%)
and nurses (1.3%). 
Table 5.35: Number and per cent of people who visited an allied or other health professional 
in previous 2 weeks, by sex and type of health professional visited, 1995
Males Females Total
Number
(’000) Per cent
Number
(’000) Per cent
Number
(’000) Per cent
Acupuncturist 15.2 0.2 39.0 0.4 54.2 0.3
Audiologist/audiometrist 13.1 0.1 6.3 0.1 19.4 0.1
Chiropractor 126.5 1.4 159.9 1.8 286.3 1.6
Chemist 159.0 1.8 265.5 2.9 424.5 2.4
Chiropodist/podiatrist 34.0 0.4 77.1 0.9 111.1 0.6
Dietician/nutritionist 15.2 0.2 39.5 0.4 54.7 0.3
Herbalist 12.5 0.1 28.9 0.3 41.3 0.2
Hypnotherapist *1.4 *0.0 3.4 0.0 4.8 0.0
Naturopath 32.7 0.4 80.2 0.9 112.9 0.6
Nurse 100.2 1.1 132.9 1.5 233.1 1.3
Optician/optometrist 71.4 0.8 81.4 0.9 152.8 0.8
Osteopath 11.6 0.1 20.5 0.2 32.1 0.2
Occupational therapist 13.0 0.1 8.5 0.1 21.4 0.1
Physiotherapist/hydrotherapist 136.9 1.5 139.8 1.5 276.6 1.5
Psychologist 25.4 0.3 35.5 0.4 60.9 0.3
Social worker/welfare officer 27.5 0.3 44.3 0.5 71.8 0.4
Speech therapist/pathologist 29.8 0.3 9.6 0.1 39.4 0.2
Not stated 5.2 0.1 8.1 0.1 13.3 0.1
Total(a) 751.4 8.4 1,041.2 11.5 1,792.6 9.9
(a) Totals do not add to the sum of components as people may have consulted with more than one allied or other health 
professional within the previous 2 weeks.
* Relative standard error greater than 25%.
Source: ABS National Health Survey, unpublished data.
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People aged 65 years or over were more likely to have visited at least one allied or other
health professional within the previous 2 weeks than people in younger age groups. In
this age group, the most frequently consulted health professionals were chiropodists/
podiatrists (by 2.8% of those aged 65 years or over), nurses (2.1%), physiotherapists/
hydrotherapists (1.7%) and opticians/optometrists (1.7%) (Table 5.36). For those aged
under 65, the most frequently consulted allied or other health professionals were
chemists, chiropractors, physiotherapists/hydrotherapists and nurses. 
People who had consulted a non-medical health professional were asked to provide up
to five reasons for their most recent consultation. The most frequently mentioned health
conditions or reasons for which people had sought treatment from an allied or other
health professional were Ôcheck-up/examinationÕ, Ôother diseases of the musculo-
skeletal system and connective tissueÕ, Ôunspecified back problemsÕ and Ôdislocations,
sprains and strainsÕ. Information on the treatments provided in these consultations was
not collected. 
Table 5.36: Percentage of people who visited an allied or other health professional in previous 
2 weeks, by age group and type of professional visited, 1995
Type of health professional 0–24 25–49 50–64 65+ Total
Acupuncturist 0.1 0.4 0.4 0.5 0.3
Audiologist/audiometrist 0.1 0.0 *0.1 0.4 0.1
Chiropractor 0.7 2.3 2.3 1.2 1.6
Chemist 2.8 2.6 1.7 1.0 2.4
Chiropodist/podiatrist 0.1 0.3 0.9 2.8 0.6
Dietician/nutritionist 0.2 0.3 0.5 0.3 0.3
Herbalist 0.2 0.3 0.2 *0.1 0.2
Hypnotherapist *0.0 0.0 n.p. *0.0 0.0
Naturopath 0.5 0.9 0.6 0.4 0.6
Nurse 1.8 0.8 0.6 2.1 1.3
Optician/optometrist 0.6 0.7 1.2 1.7 0.8
Osteopath 0.1 0.3 0.2 *0.1 0.2
Occupational therapist 0.1 0.1 0.1 0.2 0.1
Physiotherapist/hydrotherapist 1.0 1.8 2.1 1.7 1.5
Psychologist 0.3 0.5 0.2 *0.0 0.3
Social worker/welfare officer 0.5 0.4 0.2 0.3 0.4
Speech therapist/pathologist 0.5 *0.0 *0.0 *0.0 0.2
Not stated 0.0 0.1 0.1 *0.0 0.1
Total(a) 8.7 10.7 9.9 11.5 9.9
(a) Totals do not add to the sum of the components as people may have consulted with more than one allied or other 
health professional within the previous 2 weeks.
* Relative standard error greater than 25%.
Source:  ABS National Health Survey, unpublished data.
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Hearing services
Hearing problems or deafness are major problems for many Australians. In 1995, a total
of 2.25 million Australians reported that they suffered from diseases of the ear and
mastoid process (ABS 1997b). The 1998 ABS Survey of Disability, Ageing and Carers
estimated that there were 280,700 persons with a disability due to diseases of the ear
and mastoid process. Of these, 30,600 were severely or profoundly restricted in their
communication, and 73,100 were restricted in their ability to successfully participate in
schooling or employment (ABS 1999c). Permanent hearing impairment occurs in
approximately 3.5 children per 1,000 births and nearly 50% of people over the age of 60
years have a hearing impairment (Australian Hearing Services 1999).
The Commonwealth Government funds Australian Hearing Services to provide hearing
support services and to conduct research. In 1998Ð99, Australian Hearing Services
assisted 167,827 clients, including 43,866 children and 115,783 pensioners and veterans
(Table 5.37). Services provided included fitting 98,737 hearing aids. 
Morbidity and its management in general practice
Consulting a doctor is the second most common health-related action taken by
Australians, after the use of medications (ABS 1997b). The clinical activities of GPs are
now the subject of an ongoing national survey known as BEACH (Bettering the
Evaluation And Care of Health). The study is conducted by the General Practice Statistics
and Classification Unit (an AIHW collaborating unit within the Family Medicine Research
Centre, University of Sydney). BEACH began in April 1998 and involves a random
sample of approximately 1,000 GPs per year. This section provides a brief summary of the
first yearÕs results, covering the period April 1998 to March 1999 (AIHW GPSCU: Britt
et al. 1999a, 1999b).
The patients
The majority (57.7%) of patients were female. Approximately one in six encounters was
with a child aged less than 15 years (15.8%), one in ten with a young adult (9.8%), and
one in four with a patient in each of the following age groups: 25Ð44 years (26.0%),
45Ð64 years (24.4%), and 65 years and older (24.0%). 
Table 5.37: Australian Hearing Services: client statistics and hearing aids fitted, 
1996Ð97 to 1998Ð99
1996–97 1997–98 1998–99
Client programs
Pensioners and veterans 114,200 114,800 115,783
Children 41,500 43,700 43,866
Other services 6,400 8,300 8,178
Total clients 162,100 166,800 167,827
Hearing aids fitted
In the ear/in the ear canal 53,700 53,500 61,402
Behind the ear 41,600 34,300 36,708
Other 900 600 627
Total 96,200 88,400 98,737
Source: Australian Hearing Services 1999.
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Almost half the encounters (47.3%) were with patients who held a healthcare card and
3.4% were with persons who held a Department of VeteransÕ Affairs card. In 14.5% of
encounters the patient was from a non-English-speaking background, and in 1.0% the
patient identified as an Aboriginal and/or a Torres Strait Islander person (Table 5.38). 
Patients described an average 146.3 reasons for encounter (RFEs) per 100 encounters.
Almost half (48.6%) of all reasons were symptom descriptions and 23.0% were described
in terms of a diagnostic label (e.g. Ôabout my diabetesÕ). The 10 most commonly recorded
RFEs accounted for 35.4% of all RFEs and are listed in order of frequency in Table 5.39. 
The need for a check-up was by far the most common RFE (13.7 per 100 encounters)
and requests for medication were also frequent (8.2). It is notable that RFEs described as
ÔhypertensionÕ or Ôhigh blood pressureÕ were reported at a rate of 2.5 per 100 encounters
and these are likely to be closely associated with the need for a check-up and/or
request for medication. RFEs associated with immunisation or vaccination were the
fourth most often reported RFE (4.9 per 100). 
Table 5.38: GP consultations: patient characteristics, 1998Ð99
Patient characteristic Percentage of encounters
New patient to practice 9.2
Healthcare card 47.3
Veterans’ Affairs card 3.4
Non-English-speaking background 14.5
Aboriginal and Torres Strait Islander person 1.1
Note: Based on 96,901 encounters.
Source: AIHW GPSCU: Britt et al. 1999b.
Table 5.39: GP consultations: 10 most frequent patient reasons for encounter, 1998Ð99
Patient reason for encounter (RFE) Percentage of all reasons Rate per 100 encounters
Check-up 9.3 13.7
Prescription 5.6 8.2
Cough 4.3 6.2
Immunisation/vaccination 3.4 4.9
Throat complaint 2.6 3.8
Back complaint 2.4 3.6
Test results 2.3 3.4
Upper respiratory tract infection 2.0 2.9
Rash 1.8 2.6
Hypertension/high blood pressure 1.7 2.5
Subtotal 35.4 . .
Total RFEs 100.0 146.3
Note: Based on 141,766 reasons for encounter.
Source: AIHW GPSCU: Britt et al. 1999b.
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Problems managed
A total of 140,824 problems were managed at an average of 145.3 problems per 100
encounters. The number of problems managed increased steadily with age of patient
and ranged from 118 per 100 encounters for those aged 1Ð14 years to 170 per 100 for
those aged 65 years or more. 
Half the problems managed in general practice related to four major body systemsÑthe
respiratory (16.7%), musculoskeletal (11.7%), skin (11.3%) and circulatory (11.11%)
systems. The 20 most frequently managed problems accounted for 39.0% of all
problems managed. Hypertension was the most common (8.3 per 100 encounters)
followed by upper respiratory tract infection (6.8), immunisation/vaccination (5.2) and
depression (3.5) (Table 5.40). 
Table 5.40: GP consultations: 20 most frequently managed problems, 1998Ð99
Problem managed Percentage of all problems Rate per 100 encounters
Hypertension 5.7 8.3
Upper respiratory tract infection 4.7 6.8
Immunisation/vaccination 3.6 5.2
Depression 2.4 3.5
Acute bronchitis/bronchiolitis 2.3 3.3
Asthma 2.2 3.2
Back complaint 1.8 2.7
Diabetes 1.8 2.6
Lipid disorder 1.7 2.5
Osteoarthritis 1.5 2.2
Sprain/strain 1.3 1.9
Contact dermatitis 1.3 1.8
Acute otitis media/myringitis 1.2 1.8
Anxiety 1.2 1.7
Sleep disturbance 1.1 1.6
Urinary tract infection 1.1 1.6
Female genital check-up/Pap smear 1.1 1.6
Sinusitis acute/chronic 1.1 1.6
General check-up 1.1 1.6
Oesophageal disease 1.0 1.5
Subtotal 39.0 . .
Total problems 100.0 145.3
Note: Based on 140,824 problems managed.
Source: AIHW GPSCU: Britt et al. 1999b.
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Management
A total of 189,735 management activities were undertaken by GPs at rates of 196 per 100
encounters and 135 per 100 problems. The most common management activity was the
prescribing, advising (for purchase over the counter) or supply of medications
(109.7 per 100 encounters or 75.5 per 100 problems). Other treatments of a clinical or
procedural nature were provided at a rate of 43.2 per 100 encounters, and referral
(11.2 per 100), ordering of pathology (24.6) and imaging (7.1) were also significant
management activities (Table 5.41).
One or more medications were given for 59.1% of problems and at least one non-
pharmacological treatment was used for 26.8% of problems. A referral was made for
7.6% of problems and at least one investigation was ordered for 14.2%, more commonly
for pathology (10.0% of problems) than for imaging (4.5% of problems). 
Medicare services
Data on the operation of Medicare, AustraliaÕs universal system of health insurance,
provide an overview of the use of private medical services. These include services
provided outside hospital as well as medical services for private patients in public and
private hospitals. Note, however, that Medicare data do not provide a complete view of
the use of medical services (see Box 5.8, page 297).  
In 1998Ð99, Medicare provided benefits for 206.3 million services. This represents a
2-year increase of 3.8% over the 198.8 million services in 1996Ð97. The increase over this
period was in part due to the effects of population growth (2.4%), a rise in the number
of items per person and the inclusion of additional items in the Medical Benefits
Schedule (MBS). Medicare items cover a range of different services, from a single doctor
consultation to multiple pathology tests for a single patient episode, each of which is
Table 5.41: GP consultations: summary of management activities, 1998Ð99
Management type
Rate per
100 encounters
Rate per
100 problems
Percentage of
total problems(a)
Medications 109.7 75.5 59.1
Prescribed 93.6 64.4 51.3
Advised 8.8 6.1 5.5
GP supplied 7.3 5.0 4.0
Other treatments 43.2 29.7 26.8
Clinical 31.4 21.6 19.8
Procedural 11.8 8.1 7.7
Referrals 11.2 7.71 7.6
Specialist 7.4 5.1 5.0
Allied health 3.0 2.1 2.0
Hospital 0.7 0.5 0.5
Emergency department 0.1 0.0 0.0
Pathology 24.6 12.8 10.0
Imaging 7.1 3.7 4.5
(a) The percentage of total problems for which at least one of the specified management types was initiated by the GP.
Source: AIHW GPSCU: Britt et al. 1999b.
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Box 5.8: Medicare
Medicare, a universal system of health insurance, came into operation in 1984. Adminis-
ered by the Health Insurance Commission (HIC), the scheme covers everyone normally
resident in Australia, except foreign diplomats and their dependants. Short-term visitors,
except those from countries with which reciprocal health care agreements have been made,
are not eligible for Medicare beneÞts.
A schedule of fees has been established, and Medicare beneÞts for services provided by pri-
vate practitioners are based on those fees. BeneÞts are payable for services provided by
qualiÞed medical practitioners, consultations by participating optometrists and certain
services performed by eligible dental practitioners.
Some types of medical services do not qualify for Medicare beneÞts. These include services
provided to eligible veterans and their dependants under VeteransÕ Affairs arrangements.
Interim Medicare beneÞts may be paid for services for which claims may be lodged under
motor vehicle third-party insurance and workersÕ compensation schemes, but these beneÞts
are recovered by the HIC at the time claims are settled. Other services which do not qualify
for Medicare beneÞts include services provided by public authorities and most govern-
ment-funded community health services, as well as services not necessary for patient care
(for example, examinations for employment purposes). To attract beneÞts, services must be
Ôclinically relevantÕ, i.e. reasonably required for the treatment of the patientÕs condition.
Practitioners are not obliged to adhere to the schedule fees, except in the case of partici-
pating optometrists, but if they direct-bill the HIC for any service rather than issuing
patients with accounts, the amount payable is the Medicare benefit, and additional charges
must not be raised for the service.
For private admitted patients in hospitals (including day-hospital facilities), the Medicare
benefit is 75% of the schedule fee, but the gap between benefit and schedule fee is insurable
with private health insurance organisations. Insurance to cover amounts paid in excess of
the schedule fee is prohibited unless the services are the subject of a private health insur-
ance contract.
For non-hospital services, a benefit of up to 85% of the schedule fee is payable. The patient is
responsible for the gap between the benefit paid and the schedule fee, up to a maximum
amount, which is indexed annually. From 1 November 1999, that amount was set at $50.90.
Patients remain responsible for payments of amounts charged above the schedule fee.
For all beneficiaries (individuals and registered families), if the sum of the gaps between
benefits and schedule fees exceeds a specified amount in any year for non-hospital services,
an amount up to the level of the schedule fee is reimbursed for services during the
remainder of the year. The level of this Ôsafety netÕ threshold is linked to the Consumer
Price Index, and is adjusted each year.
(continued)
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counted as a separate item. Consequently, it is not possible to directly compare different
types of services on the basis of the number of Medicare claims. Also for this reason, the
terms ÔitemsÕ or Ôitems of serviceÕ are generally used when referring to Medicare claims.
In 1998Ð99, a total of $6,669 million was paid in Medicare benefits, of which $2,395 million
(35.9%) was for unreferred attendances, i.e. general practitioner services, emergency
attendances after hours, other prolonged attendances, group therapy and acupuncture. A
further $1,065 million (16.0%) was paid for diagnostic imaging, $1,008 million (15.1%) for
pathology tests and $941 million (14.1%) for specialist attendances (Figure 5.13).
The largest increases in items of service from 1996Ð97 to 1998Ð99 were in radiotherapy
and therapeutic nuclear medicine (39.1%), diagnostic imaging (21.5%) and pathology
(17.6%). 
Each person in Australia received, on average, 10.9 services under Medicare in 1998Ð99
(or 9.9 services if patient episode initiation items, which cover the administrative costs
associated with collection of specimens for pathology, are excluded). These services
included 5.4 unreferred attendances, 1.0 specialist attendance and 2.9 pathology items. 
Since 1996Ð97, the annual number of services per person (including pathology patient
episode initiation items) has increased from 10.7 to 10.9, or an average annual increase
of 0.7% (Table 5.42, page 300). The largest increase was in pathology, in part due to
privatisation of Commonwealth pathology laboratories and the inclusion of new items
in the MBS. The next largest increase was in diagnostic imaging, partly due to the
inclusion of magnetic resonance imaging in the MBS from 1 September 1998.
Although the average use was 10.9 services overall, the number per person varied
considerably. For example, in 1998Ð99, 2.7% of the population received 51 or more
services, accounting for 20.2% of total benefits paid, whereas 39.6% of the population
received between one and five services, accounting for only 7.4% of total benefits.
The average number of consultations with general practitioners and specialists per
person increased steadily from 1986Ð87, until levelling out from 1995Ð96 (Figure 5.14).
The data exclude obstetrics, pathology, radiology, anaesthetics, optometry and surgery.
Box 5.8 (continued): Medicare
Agreements between the Commonwealth Government and State and Territory Govern-
ments provide for all persons eligible for Medicare benefits to obtain inpatient and out-
patient care at public hospitals without charge. Doctors appointed by the hospitals provide
medical care for such ÔpublicÕ patients (at no cost to the patient). Inpatients in public hos-
pitals may choose to be private patients, in which case they are liable for accommodation
and nursing charges set at levels agreed by the Commonwealth and for medical fees
charged by private practitioners. Private health insurance can be purchased to cover hos-
pital charges for private patients of public hospitals and patients of private hospitals.
Uninsured patients can also elect to be treated as private patients, and pay the accommo-
dation and other fees charged themselves.
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Note: Based on the amount paid in benefits ($), not the number of services.
Source: DHAC 2000b.
Figure 5.13: Medicare benefits paid by broad type, 1998Ð99
Note: Rates are age-adjusted to the Australian population at 30 June 1991.
Source: AIHW, derived from Medicare claims data provided by the DHAC.
Figure 5.14: GP and specialist consultations per person, 1986Ð87 to 1998Ð99
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In 1986Ð87, males consulted a general practitioner or specialist on average 4.3 times per
year and females 6.2 times per year. In 1998Ð99, these rates were 5.5 and 7.5 respectively,
representing average annual increases of 2.3% and 1.7%, respectively. The increase in
consultation rates may be due in part to improved access to doctors, as there was a
20.6% increase in the number of full-time equivalent Medicare providers of general
practice services between 1986Ð87 and 1998Ð99 (DHAC 2000b).
Increased promotion and awareness of steps which individuals can take to maintain
their own health and that of their families, such as immunisation, Pap smears, blood
pressure measurements and general health check-ups, may have also contributed to the
increased consultation rates.  
Use of private medical services by State
Variations in the use of medical items occur across States. In 1998Ð99, the highest
number of services was in New South Wales with 11.7 services per person, followed by
Victoria (11.0), Queensland (10.8) and South Australia (10.3). The lowest per person use
occurred in the Northern Territory (5.7). The low rate in the Northern Territory is at
least partly due to services being provided to Aboriginal and Torres Strait Islander
peoples through programs other than Medicare, and these services are not included in
the data reported here.
Table 5.42: Medicare items processed per capita, by broad type, 1996Ð97 and 1998Ð99
Type of item 1996–97 1998–99
Total change
(per cent)
Annual change
(per cent)
Unreferred attendances(a) 5.53 5.41 –2.3 –1.2
Specialist attendances 0.98 0.98 0.1 0.1
Obstetrics 0.09 0.08 –6.8 –3.4
Anaesthetics 0.09 0.09 –0.0 –0.0
Pathology
PEI items(b) 0.91 0.97 6.3 3.2
Other 1.80 1.96 8.9 4.4
Total 2.71 2.93 8.0 4.0
Diagnostic imaging 0.56 0.60 7.2 3.6
Operations 0.29 0.29 –1.2 –0.6
Optometry 0.20 0.21 4.1 2.0
Other(c) 0.26 0.27 6.9 3.4
Total including PEI items 10.73 10.88 1.4 0.7
Total excluding PEI items 9.82 9.91 0.9 0.5
(a) Includes general practitioner attendances, emergency attendances, attendances after hours, other prolonged 
attendances, group therapy and acupuncture. 
(b) Patient episode initiation items. These items cover the administrative costs associated with the collection of specimens.
(c) Includes assistance at operations, radiotherapy and therapeutic nuclear medicine, and miscellaneous services.
Source: DHAC 2000b.
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5.6 Use of medications
Use of medications is the most common health-related action taken by Australians (ABS
1997b). Prescription medications are provided through community pharmacies and
hospitals, and non-prescription medicines and complementary and alternative
medicines are available from pharmacies and other retail outlets. 
The 1995 National Health Survey provides the most recent data on the overall use of
medicines in the total community. The survey estimated that 10.7 million Australians
(59.1% of the population) used some form of prescribed or non-prescribed orthodox
medication (medications other than homeopathic, herbal, nutritional and other
complementary and alternative medicines) in the 2 weeks before interview, 4.7 million
(25.8%) used vitamins or minerals and 1.7 million (9.4%) used herbal or natural
medications. In general, the use of medication as a health-related action increased with
age, with the lowest usage in the age group 5Ð14 years (48.9%) and the highest in the
age group 75 years and over (91.6%). More females reported medication use than males
(74.0% compared with 63.4%). 
Use of orthodox medicines was also more common in females (64.0%) than in males
(54.2%) and most common in persons aged 75 years or more (87.3%). Most types of
drugs were most commonly used by persons aged 65 years or more; however,
medications for coughs and colds were most commonly reported for children under the
age of 5 years (16.7%), asthma medications were most common in children in the age
group 5Ð14 years (9.6%) and use of medications for allergies and pain relievers was
most often reported by persons in the age group 35Ð44 years (4.3% and 31.3% of people
in that age group, respectively). 
Prescribed medicines
The 1995 National Health Survey estimated that 6.54 million Australians used
medications that had been prescribed by a medical practitioner in the 2 weeks prior to
interview. The types of drugs most commonly used were medications for fluid, heart,
blood pressure (1.93 million people), asthma medications (1.01 million people) and pain
relievers (752,000 people). 
Other information on the apparent use of prescription medicines in the community is
compiled from two sources (DHAC 1999b). The first is the Health Insurance
Commission records of prescriptions submitted for payment of a subsidy under the
Pharmaceutical Benefits Scheme or the Repatriation Pharmaceutical Benefits Scheme
(PBS and RPBS, see Box 5.9, page 302). The second is the Pharmacy Guild of AustraliaÕs
ongoing survey of a representative sample of about 250 community pharmacies, which
provides an estimate of the use of non-subsidised prescription medicines. These sources
do not cover use of medications in public hospitals and only cover use of some
medications in private hospitals. 
In 1998Ð99, there were 128.4 million community PBS prescriptions (19.3 million to
general patients, 109.1 million or 85.0% to concessional patients) and about 45 million
prescriptions which did not attract a subsidy (35 million below the copayment
threshold and about 10 million private prescriptions, i.e. prescriptions for drugs not
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listed on the PBS or RPBS) (DHAC 1999b). The number of prescriptions per person
remained fairly constant over the period 1995 to 1998, averaging around 6.7 PBS
prescriptions and 2.5 non-PBS prescriptions per year. 
Use of prescription medicine can be described using the defined daily dose per 1,000
population per day (DDD/1,000/day) as the unit of measurement. The DDD is based on
the assumed average dose per day of the drug, used for its main indication (reason for
use) by adults. It provides an estimate of how many people per 1,000 population are
taking the standard dose of the drug each day, on average, and allows for comparisons
independent of differences in quantities of drugs per prescription. In 1998, salbutamol
(a bronchodilator used for asthma) was the most commonly used drug using the DDD/
1,000/day measurement (Table 5.43), followed by frusemide (a diuretic) and simvastatin
(used for serum lipid reduction). In contrast, the top three drugs by prescription volume
were paracetamol (an analgesic; 4.6 million PBS/RPBS prescriptions and 0.1 million
Box 5.9: The Pharmaceutical Benefits Scheme
The Pharmaceutical BeneÞts Scheme (PBS) aims to provide timely, reliable and affordable
access for the Australian community to necessary and cost-effective medicines, subsidising
the cost of a wide range of prescription medications. As at 1 February 2000, 574 generic
drugs, available in 1,391 forms and strengths (items) marketed as 2,084 different drug
products (brands) were covered by the scheme. The items that attract beneÞts are reviewed
frequently, and the price of every item covered is negotiated with the supplier.
Australian residents and visitors from those countries with which Australia has a Recip-
rocal Health Care Agreement are eligible for PBS beneÞts. Patients are grouped into two
classes. General patients pay the Þrst $20.60 (from 1 January 2000) for each prescription
item. Concessional patients (people with low incomes and sickness beneÞciaries who hold a
healthcare card) make a copayment of $3.30 per item. 
Individuals and families are protected from large overall expenses for PBS-listed medicines
by safety nets. Once a general patient and/or their immediate family has spent $631.20 in
a calendar year, the patient copayment per item decreases from $20.60 to the concessional
rate of $3.30 per item. For concessional patients, the $3.30 copayment is not required once
their expenditure on PBS items exceeds $171.60 in a calendar year. These copayments and
safety net thresholds are indexed to movements in the Consumer Price Index from 1 Jan-
uary each year.
Patients may pay more than the standard copayment where a PBS item is priced above the
benchmark price for different brands of the same drug or the benchmark price for a particular
therapeutic group of drugs. These additional payments do not count towards safety nets.
The PBS also funds a range of miscellaneous services including highly specialised drugs,
IVF-centre hormones, growth hormones, emergency (DoctorÕs Bag) supplies and methadone. 
The Commonwealth also helps in the provision and purchase of drugs through the Repatri-
ation Pharmaceutical BeneÞts Scheme (RPBS), which provides assistance to speciÞc
groups of Australian war veterans and dependants. It is generally similar to the PBS for
concessional beneÞciaries. 
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other prescriptions), amoxycillin (an antibiotic; 2.3 million PBS/RPBS prescriptions and
2.3 million other prescriptions) and salbutamol (3.6 million PBS/RPBS prescriptions and
0.9 million other prescriptions). 
The BEACH survey of general practice activity collects information on drugs prescribed
by GPs. In 1998Ð99, antibiotics was the drug group most commonly prescribed by
general practitioners, accounting for 17.8% of all prescriptions. This was followed by
cardiovascular drugs (14.8%), central nervous system drugs (12.0%), psychological
drugs (8.3%), respiratory drugs (7.3%) and hormones (6.9%). 
The most frequently prescribed individual generic drugs are listed in Table 5.44
(page 304). Five of the top ten drugs are from the antibiotic group. Simple analgesics
were very frequently prescribed, probably reflecting their prescription for health care
cardholders for whom they are a cheaper option than over-the-counter purchase.
Influenza vaccine represented 1.8% of all prescriptions, presumably reflecting a
response by patients and GPs to public health campaigns to increase vaccination levels
in at-risk groups. 
Non-prescribed medicines
The 1995 National Health Survey estimated that 6.3 million people (34.6% of the
population) used orthodox medications that were not prescribed in the 2 weeks prior to
interview, and 178,900 Australians (1.0%) used medications provided by a doctor or
hospital (ABS 1997b). The most commonly used types of non-prescribed drugs were
pain relievers (used by 3.6 million people) and skin ointments and creams (1.1 million
people). Those drug types were also most commonly reported as provided by doctors
or hospitals (48,600 people and 14,500 people respectively). 
The BEACH survey collects information on drugs that GPs advise patients to purchase
over the counter, and those that the GPs supply directly. About 8.0% of drugs were
advised for over-the-counter purchase in 1998Ð99 and 6.7% were supplied by the GP,
with the remainder being prescribed. Extrapolated, this represented about 8 million
recommendations for purchase of drugs, and 6.7 million occasions at which at least one
Table 5.43: Top 10 drugs by defined daily dose per 1,000 population per day
Rank and drug name Action PBS/RPBS
Non-PBS/
RPBS
Total
community
use
1 Salbutamol Bronchodilator (used for asthma) 22.5 6.5 29.0
2 Frusemide Diuretic 20.3 2.2 22.6
3 Simvastatin Serum lipid reduction 21.9 0.1 22.0
4 Enalapril Anti-hypertensive 18.7 0.3 19.0
5 Ranitidine Peptic ulcer treatment 17.0 0.1 16.9
6 Ipratropium bromide Bronchodilator (used for asthma) 15.4 0.0 15.5
7 Amlodipine Anti-hypertensive 13.9 0.1 13.9
8 Budesonide Asthma preventative 13.5 0.0 13.6
9 Felodipine Anti-hypertensive 10.9 1.0 11.9
10 Thyroxine Thyroid hormone 7.1 4.6 11.7
Source: DHAC 1999b. 
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drug was supplied from the GPsÕ stocks or samples. The drugs most commonly advised
for over-the-counter purchase were paracetamol, chlorpheniramine/phenylephid (an
expectorant) and topical clotrimazole (an anti-infective). GPs most commonly supplied
influenza vaccine, triple antigen vaccine and oral polio vaccine. 
Complementary and alternative medicines
In addition to the prescribed pharmaceuticals and other orthodox drugs, some
Australians use a range of complementary and alternative medicines, including
homoeopathic, herbal and nutritional medications. The 1995 National Health Survey
estimated that 25.8% of Australians used vitamin or mineral supplements in the
2 weeks prior to interview, and 9.4% used herbal or natural medications (ABS 1997b).
Vitamin or mineral supplements were used more commonly by females (30.3%) than by
males (21.3%), as were herbal or natural medications (12.0% and 6.9% respectively).
Persons aged 45 to 54 years were most likely to have used vitamin and mineral
supplements (32.3%), and herbal or natural medications were most commonly used by
persons aged between 45 and 64 years (13.6%). 
Table 5.44: GP consultations: 20 most frequently prescribed drugs, 
1998Ð99
Generic drug 
Percentage of
prescriptions
Prescriptions per
100 encounters
Paracetamol 4.2 3.9
Amoxycillin 3.5 3.2
Paracetamol/codeine 2.8 2.7
Salbutamol 2.6 2.4
Cefaclor monohydrate 2.3 2.2
Cephalexin 2.3 2.1
Roxithromycin 1.9 1.8
Amoxycillin/potassium clavulanate 1.9 1.8
Influenza virus vaccine 1.8 1.7
Temazepam 1.5 1.4
Diclofenac sodium systemic 1.4 1.3
Levonorgestrel/ethinyloestradiol 1.3 1.2
Doxycycline HCl 1.2 1.2
Diazepam 1.2 1.1
Erythromycin 1.2 1.1
Ranitidine 1.1 1.0
Atenolol 1.1 1.0
Frusemide (furosemide) 1.0 1.0
Betamethasone topical 1.0 0.9
Simvastatin 1.0 0.9
Subtotal 36.2 . .
Total prescribed 100.0 93.6
Note: Based on 90,710 prescriptions.
Source:  AIHW GPSCU: Britt et al. 1999b.
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In a 1993 representative survey of South Australian residents, 48.5% of respondents
(54.8% of females and 33.8% of males) reported using at least one non-medically
prescribed alternative medicine in the past year (MacLennan et al. 1996). Non-prescribed
vitamins were most commonly reported (41.2% of females and 33.8% of males), followed
by herbal medicines (11.1% of females and 8.6% of males), mineral supplements (10.3%
of females and 8.1% of males) and evening primrose oil (12.7% of females and 2.7% of
males). Respondents reported spending between $1 and $500 each on alternative
medicines each month, with a median expenditure of $10. Extrapolated to the total
Australian population, this expenditure corresponded to an estimated $621 million spent
on complementary and alternative medicines in 1993. 
Expenditure on pharmaceuticals
Total expenditure on non-hospital pharmaceuticals was $5,335 million in 1997Ð98:
$3,377 million on benefit-paid pharmaceuticals and $1,958 million on other non-hospital
pharmaceuticals. The Commonwealth Government contributed $2,783 million to the
benefit-paid pharmaceuticals and individuals paid the remaining $593 million
(Table 5.45). Public hospital expenditure reported to the AIHW National Public Hospital
Establishments Database was about $611 million. 
The PBS was the largest single contributor to expenditure on pharmaceuticals. PBS
expenditure on prescriptions and other miscellaneous services was $2,785 million in
1997Ð98 and increased by 10% to $3,070 million in 1998Ð99 (Table 5.46, page 306) (DHAC
1999c). Costs of the scheme and patient copayments have both risen each year in recent
years, with the proportion met by the scheme remaining constant at about 82%.  
Table 5.45: Expenditure on pharmaceuticals(a) in Australia, 1997Ð98 ($ million)
Benefit-paid
pharmaceuticals
All other
pharmaceuticals
Total
pharmaceuticals
Public sector
Commonwealth Department of Veterans’ Affairs 205 . . 205
Commonwealth Department of Health and 
Aged Care 2,578 2 2,580
Public acute care and psychiatric hospitals . . 611 611
Other State, Territory and local government . . 16 16
Total public sector 2,783 629 3,412
Private sector
Health insurance funds . . 34 34
Individuals 593 1,869 2,463
Workers’ compensation insurance . . 27 27
Third party motor vehicle insurance . . 10 10
Private hospitals . . n.a. n.a.
Total private sector(b) 593 1,940 2,534
Total(b) 3,377 2,569 5,946
(a) Not including complementary and alternative medicines.
(b) Not including most expenditure in private hospitals.
Source: AIHW Health Expenditure Database. 
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5.7 Health promotion and prevention
Health promotion and prevention are part of the suite of activities generally referred to
as public health or population health. Health promotion and prevention activities have
traditionally included population screening (e.g. for breast cancer), mass immunisation,
water fluoridation, food inspection and quarantine, communicable disease control and
surveillance, and health promoting communications (including social marketing), to
name just a few. 
In the last couple of decades, the scope of population health interventions and
infrastructure has extended to include surveillance of disease risk factors, management
of healthy growth and development (including, for example, parenting effectiveness
training and support), mental health promotion, consumer product safety, and so on.
Population health interventions are characterised by a focus on:
¥ prevention, promotion and protection as opposed to treatment;
¥ population groups rather than the individual;
¥ the factors that affect health and causes of illness.
In its population health planning framework document, the National Public Health
Partnership (NPHP 2000) lists 10 types of public health interventions covering policy
and program areas (see Box 5.10). 
For a particular public health issue, a mixture of intervention types is typically
employed (constituting an intervention portfolio)Ñthis is another characteristic of
public health action, namely a comprehensive program of integrated activities to tackle
the health issue. This section presents a case study of an intervention portfolio in the
area of tobacco control.
Table 5.46: Cost of PBS items to the PBS and patients, 1994Ð95 to 1998Ð99 ($ million)
1994–95 1995–96 1996–97 1997–98 1998–99
Patient contributions for PBS prescription items (a) 445 478 530 570 601
General patients 230 252 278 294 318
Concessional patients 214 227 252 276 283
PBS payments for PBS prescription items (b) 1,882 2,191 2,333 2,527 2,782
General patients—no safety net 291 343 392 412 468
General patients—safety net 93 119 73 99 107
Total general patients 384 462 465 510 576
Concessional patients—no safety net 1,195 1,369 1,466 1,576 1,740
Concessional patients—safety net 303 360 402 440 467
Total concessional patients 1,497 1,730 1,867 2,016 2,207
Total cost of PBS prescription items (a) + (b) 2,326 2,669 2,863 3,097 3,384
Miscellaneous PBS service payments (c) 110 135 206 259 287
Total expenditure by the PBS (b) + (c) 1,991 2,327 2,538 2,785 3,070
Total cost of PBS items to the PBS and patients 
(a) + (b)  + (c) 2,436 2,805 3,068 3,356 3,671
Source: DHAC 1999c.
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Tobacco control—a case study in public health interventions
Over 18,000 deaths and 150,000 hospital separations each year in Australia are
attributable to tobacco smoking (AIHW 1999a). Smoking-related conditions account for
almost 10% of the total burden of disease (AIHW: Mathers et al. 1999c). Tobacco
smoking is the single largest preventable cause of death.
The main elements of public health action in tobacco control are:
¥ taxation;
¥ regulation of tobacco products;
¥ promotion of (and, in some cases, legislation for) smoke-free indoor areas;
¥ education campaigns and social marketing; and
¥ community development and partnership building.
Taxation is a mechanism by which governments can affect the price of tobacco
products; increasing the price of tobacco in turn reduces its accessibility. The
Commonwealth Government levies the industry through excise payments on locally
manufactured products and customs duty tariffs on imported products.
Tobacco products are regulated in a number of ways: legislation banning or limiting
tobacco advertising; regulations regarding health warnings on tobacco products;
minimum age restrictions on the sale of cigarettes; and legislation prohibiting the sale of
individual cigarettes.
Restrictions on the promotion of tobacco products have been introduced, with a
gradual phasing-in of bans on tobacco advertising in print, on television and radio, and
in cinemas, with the exception of point-of-sale advertising. Point-of-sale advertising is
Box 5.10: Types of public health interventions
1. Public policy development
2. Legislation and regulation
3. Resource allocation
4. Engineering and technical
5. Incentives (financial and non-financial)
6. Service development and delivery
7. Education (including in clinical care and skills development)
8. Communication (including social marketing)
9. Collaboration/partnership building (community and intersectoral)
10. Community and organisational development (including organisational policy)
Source: NPHP 2000.
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prohibited in two States and restrictions are imposed in several other jurisdictions.
There have been significant restrictions in the number of international sporting events
granted exemptions from the general ban on tobacco advertising in Australia.
In some jurisdictions, health promotion foundations have been established. These
foundations provide funding to arts and sporting bodies to replace tobacco sponsorship,
resources for health promotion and, in some jurisdictions, funding for research.
In 1994 regulations were enacted to ensure uniform labelling of tobacco products
throughout Australia and provision of appropriate product information to consumers.
This includes six rotating health warnings and related information on tobacco products
(see Box 5.11). 
In all jurisdictions the minimum age for purchasing tobacco products is 18 years (with
penalties imposed on those selling or, in some cases, supplying to minors). Most
jurisdictions also restrict the location of cigarette vending machines to limit access by
under-aged persons.
Policy change over the last decade has sought to reduce environmental tobacco smoke.
Industries have been encouraged to adopt non-smoking policies for enclosed public
places and in workplaces. More formal arrangements include the prohibition of
smoking in commercial and government buildings, and on public transport. Legislation
exists in some jurisdictions for smoke-free indoor areas in workplaces and other public
places such as restaurants, cafes, shops and theatres. All other jurisdictions are working
towards similar legislation.
Box 5.11: Health warnings on tobacco products
Under the system operating since 1994, tobacco products are required to display:
1. one of six rotating health warnings occupying 25% of the front of the pack:
SMOKING CAUSES LUNG CANCER
SMOKING IS ADDICTIVE
SMOKING KILLS
SMOKING CAUSES HEART DISEASE
SMOKING WHEN PREGNANT HARMS YOUR BABY
YOUR SMOKING CAN HARM OTHERS
2. detailed information (corresponding to the warning on the front of the pack) occupying
33% of the back of the pack
3. information about the tar, nicotine and carbon monoxide content of the cigarettes, occu-
pying one entire side of the pack.
Source: Trade Practices (Consumer Product Information Standards) (Tobacco) Regulations 1994 (Attachment W).
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The multi-tiered National Tobacco Campaign combines a series of explicit
advertisements on television and radio, in newspapers and on buses with a nationally
coordinated Quitline service for smokers. At the national level, Quitline call activity has
been closely correlated with the volume of television advertising (Figure 5.15). 
5.8 Health research in Australia
Health research focuses on understanding the influences on population health, and on
developing and testing health promotion and disease prevention strategies. Medical
research relates to understanding fundamental biological processes, disease and injury
mechanisms, and the development and testing of clinical interventions for disease and
injury prevention, treatment, rehabilitation and palliation. 
Research funding
Australia invested a total of $853 million in health research and development during
1996Ð97 (Table 5.47, page 310). General government sources provided 38.3% of this
funding ($328 million). A further $268 million came from institutes of higher education,
while businessesÑincluding government business enterprisesÑprovided $134 million
and private non-profit organisations and overseas sources funded the remaining
$123 million. 
Source: Ministerial Tobacco Advisory Group 1999.
Figure 5.15: National Tobacco Campaign: target audience rating points (TARPs) 
compared with calls to Quitline services, MayÐDecember 1997
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Institutes of higher education increased their share of the proportion of total funding
for health research and development from 24.9% in 1994Ð95 to 31.4% in 1996Ð97. The
share of funding by business enterprises also grew, from 10.6% in 1994Ð95 to 15.7% in
1996Ð97. General government funding of research and development fell as a proportion
of total expenditure from 49.9% in 1994Ð95 to 38.3% in 1996Ð97.
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6 Health service 
strategies, performance 
and monitoring
In view of the importance, high cost and complexity of maintaining health, it is
necessary to coordinate activities, set priorities and monitor the performance of the
health system. This is a very challenging task, given the large number of agencies, both
government and non-government, responsible for the delivery of health services, the
range of potential health interventions and the difficulty of measuring their
independent effects. This chapter describes the efforts being made at the national level
to deal with these problems.
Commonwealth, State and Territory Health Ministers meet regularly as the Australian
Health MinistersÕ Conference to coordinate health policy matters across jurisdictions.
Their high-level advisory body, the Australian Health MinistersÕ Advisory Council
(AHMAC), includes the heads of Commonwealth, State and Territory health authorities
and the Commonwealth Department of VeteransÕ Affairs. In recent years these bodies
have adopted a range of strategic plans for a national approach to deal with major
health issues. 
Performance indicators exist for Aboriginal and Torres Strait Islander health, the six
National Health Priority Areas (NHPAs) and hospital services. The National Public
Health Partnership and a new National Health Performance Committee, established by
Health Ministers in 1999, are coordinating the development of frameworks for public
health and for monitoring the performance of the overall health system.
Section 6.1 provides background on general issues associated with health services
planning, including the evidence base needed to support priority setting. Section 6.2
describes some emerging and contemporary issues that are influencing decisions on
health priorities. Section 6.3 describes the information frameworks that have been
developed for monitoring performance against the objectives of high-level national
health strategies. Section 6.4 reports on performance in some specific areas where
national information has been developed and collected.
6.1 Issues in health services planning
The type of evidence and information required to support informed priority setting in
health depends on the societal goals for health. Improving the overall health of the
population is a major goal of all societies. However, priority setting based on the potential
for health gain is not the only goal that Australians might value. Others might be:
¥ to give priority to those most disadvantaged, so that inequalities in health are
reduced; 
01 AH2000 body  Page 313  Thursday, June 1, 2000  3:06 PM
314  AustraliaÕs Health 2000
TRIM SIZE 175 mm Wide x 250 mm Deep
¥ to attach greater priority to large benefits than to the sum of many small ones, with
life-saving counting the most of all; 
¥ to attach greater importance to giving everyone some benefits as opposed to larger
benefits for a few; and 
¥ to attach less importance to life extension past a normal lifespan, thus attaching
greater moral weight to achieving a Ôfair inningsÕ (Williams 1999). 
The World Health Organization sees three goals for the health sector: health
improvement, responsiveness and fair financing (Murray 1999). Responsiveness refers
to the non-health aspects of the health sector which society values, and includes
attributes such as privacy, accountability, informed choice and consumer participation.
In principle, societies will generally be interested in improving both the level and the
distribution of health and of responsiveness. Fair financing relates to distribution only;
the level of health financing usually depends on broader social and political choices. 
The evidence base needed to support priority setting in relation to these goals requires
the following basic types of information (AIHW: Mathers et al. 1999):
¥ evidence based on scientific research on the nature and causes of health problems and
the efficacy of prevention and treatment interventions;
¥ a detailed assessment of the magnitude and impact of health problems in the
population, including information on the causes of loss of health (both in terms of
disease and injury, and risk factors or broader determinants);
¥ information on health expenditure and health infrastructure (a national system of
health accounts) detailing the availability of resources for health improvement, what
the resources are currently used for, and the sources and distribution of health
financing;
¥ information on the cost-effectiveness of available technologies and strategies for
improving health; and
¥ information on variations and inequalities in health status, health determinants, and
access to and use of health services (including both prevention and treatment services).
Australian and international health research aims to provide the first of these types of
information. The National Health and Medical Research Council is the principal adviser
to Government on health research matters. 
A wide range of health information is collected in Australia to attempt to improve the
second of these information needs. Health Ministers and administrators attach a high
priority to this national task, which is led by the Australian Institute of Health and
Welfare. 
The third type of information is obtained through a range of statistical activity to
monitor health expenditure, workforce numbers and infrastructure (see chapter 5). 
The fourth type of information is still largely unexplored territory and will remain so,
although there are increasing numbers of cost-effectiveness studies into particular
aspects of health. An example is presented in Box 6.1.
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Confronting a major health problem comprehensively may require a combination of
preventive and curative interventions and continuing care. Resource allocation
decisions are influenced by information, not always empirically derived, on the cost-
effectiveness of interventions across this continuum. Most ÔhealthÕ data in Australia still
relate mainly to the inputs and throughputs of the healthcare system rather than to
health outcomes and cost-effectiveness. 
Box 6.1: Pharmaceutical Benefits Scheme: 
evidence-based case study
The Commonwealth subsidises a wide range of prescription medications through the Phar-
maceutical Benefits Scheme (PBS). Before a new pharmaceutical is listed on the PBS, it is
evaluated for safety and effectiveness by the Pharmaceutical Benefits Advisory Committee
(PBAC). Since 1991Ð92, the PBAC has taken into consideration the costs as well as the
benefits of new pharmaceuticals.
The guidelines for the PBAC state: 
ÔA new drug entity may be recommended for listing if 
(a) it is needed for the prevention or treatment of significant medical conditions not
already covered, or inadequately covered, by drugs in the exiting list and is of accept-
able cost-effectiveness;
(b) it is more effective, less toxic (or both) than a drug already listed for the same indica-
tions and is of acceptable cost-effectiveness; or
(c) it is at least as effective as a drug already listed for the same indications and is of sim-
ilar or better cost-effectiveness.Õ
When pharmaceutical companies make submissions for listing their new products on the
PBS, they have to supply an economic analysis of the expected costs and benefits of the
pharmaceutical as well as information on the chemistry of the product, stability, quality
control, in vitro studies, animal studies and clinical trials. There are specific guidelines to
ensure that the economic analyses are undertaken in a way that enables the different phar-
maceuticals to be evaluated consistently. 
Analysis of the recommendations of the PBAC in the period November 1993 to March
1996 shows significant consistency in the decisions. Where the cost per additional life-year
gained due to the pharmaceutical was less than $37,000, then 10 of the 11 pharmaceuticals
in this category were recommended for listing on the PBS. All pharmaceuticals with a cost
effectiveness greater than $70,000 per life-year were rejected at that price, and for those
with a cost-effectiveness between $37,000 and $70,0000 per life-year some were accepted,
and some rejected (George et al. 1997).
A pharmaceutical that does not get listed on the PBS, but is considered safe, can still be
purchased in Australia. However, consumers have to pay the full cost.
A considerable number of pharmaceuticals approved before 1992Ð93 have not been consid-
ered for cost-effectiveness. In 1998Ð99, 34% of drugs listed on the PBS had been subjected
to a cost-effectiveness evaluation.
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Analyses of health information for population subgroups defined by a range of factors
(area, socioeconomic status, Indigenous status, country of birth, etc.) are a source of
information on variations and inequalities in health. Chapter 4 provides information of
this nature.
The evidence base needed to help society set priorities for health interventions should
allow assessment of the trade-offs between efficiency (maximising health outcomes)
and equity (providing health benefits to all groups and reducing inequalities in health
outcomes). Thus society needs information not only on the size of health problems and
the potential for cost-effective health gain, but also on measures of the distribution of
health in the population and the distributional impacts of health-related interventions.
Equity concerns can then be tackled explicitly in any priority-setting or resource-
allocation process, along with the potential to improve health.
6.2 Emerging and contemporary issues
There are a number of issues that are influencing decisions on health priorities to some
extent at present, but which are likely to take on greater significance in coming years.
These include demographic changes such as population ageing, changes in service
delivery models including a move to more emphasis on community care, and
coordinated care. A brief review of these emerging and contemporary issues follows.
Population ageing 
The Australian population, like that of most other industrialised countries, is ageing,
with an increasing proportion of men and women aged 65 and over. This is due to
increases in life expectancy and lower fertility rates. In 1999, 12.2% (2.3 million) of the
population were aged 65 and over; this is projected to rise to 18.0% (4.0 million) by 2021
(ABS 1998).
Turning to the older ages, some 2.0% of men were aged 80 and over in 1999; this is
projected to reach 3.2% in 2021. For women, the comparable figures are 3.6% and 4.9%.
This older age group (80 and over) is then projected to increase more rapidly, reaching
6.7% of men and 10.1% of women in 2051. 
Expenditure on health services in the future depends on the interaction between supply
and demand factors, each of which is difficult to predict. On the demand side, ageing
adds only 0.6% to expenditure per year, so does not have a major impact on costs.
However, changes in medical practice due to changes in technology add significantly to
health costs each year (1.9% per person per year in the last 22 years). On the supply
side, there has been an excess supply of general practitioners (GPs) in the metropolitan
areas and shortages in the rural GP workforce. Whether supply shortages occur in the
future will depend on workforce planning decisions now. In the nursing area, student
nurse entrants have dropped from a peak of 9,300 in 1991 to 7,900 in 1998. The
implications of this decline for the future, and the reasons for it, merit close attention. 
Shift to community care
A move away from institutional-based care has occurred in the areas of mental health,
disability and aged care, and there have been new models to replace some traditional
hospital treatment, such as birthing centres and day surgery.
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Between the early 1960s and 1992, the psychiatric bed ratio declined from 281 beds per
100,000 population to 40 beds per 100,000. As a consequence, thousands of people were
discharged from long-stay institutions into the community, as were somewhat smaller
numbers of people with physical or intellectual disabilities (Burdekin et al. 1993:166). In
line with policy driving the first National Mental Health Strategy from 1992Ð93 to
1996Ð97, this Ôde-institutionalisationÕ continued, with the proportion of State and
Territory mental health service expenditure going to psychiatric hospital services
reducing from 49% to 32%, and the proportion going to ambulatory services increasing
from 23% to 34% (DHAC 1999b).
Average lengths of stay in public acute hospitals have fallen from 5.1 days in 1993Ð94 to
4.0 days in 1997Ð98 and in private hospitals from 3.9 to 3.3 days over the same period.
A major contributor to this trend in recent years has been an increase in the number of
same-day patients, whose treatment does not require an overnight stay in hospital.
Same-day separations as a proportion of separations from all hospitals increased from
36.8% in 1993Ð94 to 46.3% in 1997Ð98.
Since 1985, the mix of aged care services has changed. There has been an increase in the
availability of community-based care and no increase in the ratio of residential places to
the population aged 70 and over. Similarly, in the last two decades there has been a
large increase in the number of people with a disability with ongoing support needs
living in the community, mainly with their families, and a relatively small decline in the
number living in institutions (AIHW 1999c).
The cumulative effect of these coinciding policy directions is one of increasing need for
and use of services that are home- and community-based.
Coordinated care
People with complex health service needs, such as those with chronic conditions,
multiple health issues or other complex health needs, present a particular challenge to
the health system. The number of people in this group is growing, in part due to the
ageing of the population. Their needs are a challenge when faced with a complex health
system and with care being needed from a number of different, and quite often separate,
service providers. To better meet the needs of such people, Commonwealth, State and
Territory governments have cooperated to establish coordinated care trials. There are
currently nine trials being conducted throughout Australia. They have involved
nomination of a formal care coordinator who undertakes multidisciplinary care planning
and service coordination, along with pooled funding arrangements to support access to
services needed for optimal patient care. These trials are in the final stages of data
collection, with interim evaluation results recently released (DHAC 1999a).
6.3 Performance indicators
Well-designed and clearly defined indicators enable the systematic analysis of trends in
health outcomes and factors affecting those outcomes. Indicators also enable
comparisons across populations, help identify problem areas and are used to establish
benchmarks. A number of high-level indicator frameworks have been established, or
are under development, to enable the objectives of particular national health strategies
to be monitored.
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Performance indicators for Aboriginal and 
Torres Strait Islander health
In early 1996, the AHMAC agreed to develop a set of performance indicators for
Aboriginal and Torres Strait Islander health. One of the intentions behind developing
these indicators was to allow jurisdictions to monitor their efforts and progress in
tackling the health disadvantages of Indigenous Australians, described in section 4.6.
Interim performance indicators, incorporating targets for selected indicators, were
endorsed by AHMAC in April 1997, and later endorsed by all Australian Health
Ministers and Ministers responsible for Aboriginal Affairs. 
The interim indicator set includes over 50 indicators in the areas of:
¥ health outcomes, such as various aspects of mortality (age-specific, age-standardised,
premature, by selected causes, stillbirths, etc.), childrenÕs hearing loss, low
birthweight, hospitalisation, infectious diseases and sexually transmitted diseases;
¥ access to services, such as travel time to primary healthcare services and to hospital,
per capita expenditure on health services, and measures of community control and
community participation;
¥ health service outputs, such as health promotion programs targeted at Indigenous
people, cervical cancer screening, childhood immunisation, protocols for effective
management of selected conditions, hospital inpatient and outpatient activity, and
primary care activity; 
¥ health workforce development, such as Indigenous people in training, availability of
an appropriate workforce in hospitals and primary care centres, number of identified
positions and cross-cultural awareness programs;
¥ risk factors, including smoking, obesity, and hazardous consumption of alcohol and
other substances; and
¥ intersectoral issues, such as household after-tax income relative to the poverty line
and the presence of functioning household utilities (water, sewerage, power).
A first report comparing selected indicators from different jurisdictions was published in
early 2000 (NHIMG 2000), but is characterised by much missing and poor-quality data.
All jurisdictions have experienced difficulty in reporting on a number of the indicators,
although the extent of such problems has varied. Reporting problems have generally
been due to inadequacies in the availability and quality of the necessary data, but some
difficulties have arisen because of shortcomings in some of the indicators themselves.
Refinement of the performance indicators is under way, taking into account the
experiences of jurisdictions in the reporting process to date. Among the issues to be
considered are the total number of indicators, the balance of measures of inputs,
outputs and outcomes, the relevance of individual indicators, and the feasibility of
collecting adequate data to allow for reporting on a regular basis.
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National Health Priority Area indicators
Sets of indicators have been developed or are under development to monitor health
interventions and outcomes in each of the National Health Priority Areas (NHPAs) of
cardiovascular health, cancer control, injury prevention and control, mental health,
diabetes mellitus and asthma (the last still under development). The indicators have
been designed as summary measures, rates and ratios, to monitor the results of
interventions at process, risk and primary outcome levels. A framework to guide the
development of these indicators was prepared by the National Health Information
Management Group in 1996 (see Box 6.2, page 320). 
Extensive information on NHPAs is included in other parts of this report. However, an
update of the indicator sets that have been adopted for NHPA reporting is provided in
Tables S52Ð57, pages 415Ð425.
As NHPA strategies are developed, strategic tracking indicators will be included to
enable more precise monitoring and evaluation. 
National public health performance indicators
Public health is characterised by planning and intervening for better health in
populations rather than focusing on the health of the individual. The activity of public
health is concerned with those factors that determine health and causes of illness rather
than responding to episodes of illness or injury, which is the major role of clinical health
services. Therefore, public health indicators must be able to monitor health determinants
as well as health status in populations. 
The National Public Health Partnership (NPHP) is currently developing a set of public
health performance indicators. It is working concurrently on a Planning Framework for
Public Health Practice, which will define the principles that characterise public health
action and the domains in which action takes place, and provide a framework for public
health performance indicators. An AIHW discussion paper on National Public Health
Indicators (AIHW 1999b) and recently developed overseas models, such as the United
StatesÕ Leading Indicators for Healthy People 2010 (Institute of Medicine 1999) and the
Canadian health indicators framework (Canadian Institute for Health Information
2000), are helping to shape the process. The NPHP is working in conjunction with the
National Health Performance Committee (NHPC) in this task.
National health performance indicators
In 1999, the Australian Health MinistersÕ Conference, on advice from AHMAC, agreed
to the establishment of the NHPC, whose terms of reference include developing and
maintaining a national performance measurement framework for the health system.
This framework will provide a basis for reporting to the Australian Health MinistersÕ
Conference and other national authorities with a comparative analysis and information
on national health system performance. The scope of the NHPCÕs brief is broad and so
will encompass reporting on the acute healthcare sector, as previously undertaken by
the National Health MinistersÕ Benchmarking Working Group (see Performance
indicators in the hospital sector, page 321), community health care and public health.
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Outside of the health sector, the performance of the national health system is monitored
in annual reports by the Steering Committee for the Review of Commonwealth/State
Service Provision. Health agencies, including the AIHW, are represented on the Steering
CommitteeÕs Health Working Group, which draws principally on data already available
across the health sector (SCRCSSP 2000).
Box 6.2: NHIMG health outcome indicator framework
In 1996, the National Health Information Management Group responded to a request from
AHMAC for development of a framework for health outcome indicators. The framework
was required to be applicable to generic and clinically specified measures and indicators of
health outcomes, including outcomes pertaining to the national goals and targets. The
NHPA initiative, which replaced previous activity under the banner ÔNational Health
Goals and TargetsÕ, adopted the framework to guide specification and development of indi-
cator sets.
The framework consists of a two-dimensional grid made up of four types of indicators: 
¥ primary outcome indicators
¥ risk indicators
¥ process and quality indicators
¥ system indicators 
and three intervention strategies:
¥ prevention
¥ management
¥ maintenance. 
The primary outcome indicators cover incidence, prevalence and sequelae ranging from
mortality to quality of life. Risk indicators provide information about characteristics, vari-
ables or hazards, which, if present in a given individual, make it more (or less) likely that
this individual will develop a health problem. The process and quality indicators refer to
the performance of interventions on health or risk. System indicators relate to policies,
resources and infrastructure for dealing with the health problem area.
The term ÔpreventionÕ is reserved for interventions that occur before the diagnosis of an
event is made. There are three different types of prevention targeted at populations or indi-
viduals with different risk levels: universal, selective and indicated. ÔManagementÕ refers
to interventions that are therapeutic in nature and are provided to individuals who meet
diagnostic criteria. Management involves case identification and standard treatment for
the known disorder, which includes interventions to reduce the likelihood of future associ-
ated disorders. ÔMaintenanceÕ interventions include the provision of support and after-care
services to the patient, including rehabilitation.
Further information is contained in the First Report on National Health Priority Areas
1996 (AIHW & DHFS 1997). 
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6.4 Service delivery monitoring
This section presents information illustrative of the current state of information that can
be reported on performance in health service delivery. It covers admitted patient
services in the hospital sector and palliative care services. Performance reporting for
services delivered in community and ambulatory settings remains developmental. A
case study in the preventive care field, breast cancer screening, is also included to
illustrate the kind of performance monitoring that is emerging for public health activity.
Performance indicators in the hospital sector
Advances in drug treatments and medical technology have led to substantial changes in
the hospital sector. Health care delivered in hospitals has become more and more the
domain of specialist services that provide a high level of medical and technical care for
patients with the most severe conditions. There have also been reductions in the length
of stay of patients and a shift towards the provision of care in community settings. 
Efficiency and effectiveness
The National Health MinistersÕ Benchmarking Working Group, which operated under the
auspices of the Australian Health MinistersÕ Conference from 1994 to 1999, has developed
a set of indicators to measure the efficiency and effectiveness of hospital performance
(Table 6.1, page 322). Data are not currently available to allow a comprehensive report on
all these indicators. Data are presented in this section on cost per casemix-adjusted
separation, the main indicator of efficiency of hospital operations, on elective surgery
waiting times and, to the extent possible with limited data, on quality of care in hospitals
and other healthcare delivery settings. Other indicators have been reported by the
National Health MinistersÕ Benchmarking Working Group (DHAC 1999c). 
Cost per casemix-adjusted separation
The cost per casemix-adjusted separation can be used to compare the average cost of
treating an admitted patient after adjusting for differences in the complexity of case types
(i.e. the overall casemix) treated by different hospitals. Table 6.2 (page 322) shows the cost
per casemix-adjusted separation for each jurisdiction. In 1997Ð98, the cost per casemix-
adjusted separation for acute hospital care for States and Territories ranged from $2,354 in
Queensland to $3,623 in the Australian Capital Territory. A major portion of these costs is
nursing and medical staff salaries, which nationally accounted for 45% (27% in nursing
salaries and 18% in medical salaries) of the cost per casemix-adjusted separation. 
In Victoria, psychiatric patients are included in the total separations used to calculate
the cost figures in Table 6.2. This follows the mainstreaming of specialised psychiatric
care into the public acute hospital system so that, for the period reported, these
separations cannot be separately identified. For other States, much of their specialised
psychiatric care is in public psychiatric hospitals which are not included in this
calculation. Separations and expenditure for rehabilitation and non-acute patients could
also not be excluded from the Victorian data. The Victorian Department of Human
Services has estimated that the combined effect of these differences is to inflate the cost
per casemix-adjusted separation for Victoria by approximately 10%. 
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Elective surgery waiting times 
Waiting lists for elective surgery, and the associated waiting times, are often used to
evaluate the status of health services within a community, particularly the ability of
public hospitals to provide access to their services, i.e. to provide appropriate,
affordable and timely care according to need. 
The National Elective Surgery Waiting Times Data Collection is maintained by the
AIHW (see Box 6.3 for definitions used). The focus of the national collection is waiting
times, rather than waiting lists, because, without knowledge of the rate of turnover of
Table 6.1: Performance indicators developed for benchmarking in the hospital sector
Category Indicator
Efficiency Cost per casemix-adjusted separation
Cost of treatment per outpatient
Average length of stay for top twenty Australian National Diagnosis Related Groups
(AN-DRGs)
User cost of capital (per casemix-adjusted separation)
Ratio of depreciated replacement value to total replacement value
Total replacement value per casemix-adjusted separation
Labour costs per casemix-adjusted separation
Effectiveness Rate of emergency patient readmission within 28 days of separation
Rate of hospital-acquired infection
Rate of unplanned return to theatre
Patient satisfaction
Proportion of beds accredited by Australian Council on Healthcare Standards
Waiting times for elective surgery
Accident and emergency waiting times
Outpatient waiting times
Variations in intervention rates
Separations per 1,000 population
Source: NHMBWG 1996.
Table 6.2: Cost per casemix-adjusted separation ($), selected public acute hospitals(a), 1997Ð98
Cost component NSW Vic Qld WA SA Tas ACT NT Aust
Medical labour(b) 542 440 376 484 472 453 685 481 471
Non-medical labour(c) 1,431 1,384 1,359 1,631 1,237 1,486 1,856 1,858 1,419
Non-salary costs(d) 664 638 619 851 749 800 1,082 1,024 685
Total 2,637 2,462 2,354 2,966 2,458 2,739 3,623 3,363 2,575
(a) Excludes psychiatric hospitals, drug and alcohol services, mothercraft hospitals, dental hospitals, hospices, community 
non-acute hospitals, rehabiliation facilities and multipurpose facilities. 
(b) Salaried/sessional staff, payments to Visiting Medical Officers and private patient costs.
(c) Salary costs for nursing, diagnostic/allied health staff, administrative staff, other personal care and domestic staff and 
superannuation payments.
(d) Non-salary costs for domestic services, repairs/maintenance, medical supplies, drug supplies, food supplies, 
administration, transport and insurance.
Source: AIHW 1999a.
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patients on a waiting list, its size is not a reliable indicator of access to the hospital
system or of the amount of time that a patient would be likely to have to wait, or to
have waited, for surgery. Two summary measures are used: 
¥ the proportion of patients admitted for elective surgery after extended waits on
waiting lists (throughput data); and
¥ the proportion of patients on waiting lists on a particular date who had already had
an extended wait (census data).
Waiting times for patients admitted during a certain period of time are generally used as
the main summary measure of elective surgery waiting times, although they provide
measures of waiting times only for patients who complete their wait and are admitted.
Most patients are admitted after waiting, but 10% to 20% of patients are removed from
waiting lists for other reasons (e.g. they were admitted as an emergency patient for the
awaited procedure; or they were not contactable, had died, had been treated elsewhere,
or had declined the surgery). In contrast, census data are collected on all patients on
waiting lists, not just those who actually receive elective surgery at the end of their wait. 
Box 6.3: Elective surgery waiting times: definitions
National Health Data Dictionary (AIHW 1998b) definitions are the basis of the
National Elective Surgery Waiting Times Data Collection, but the definitions used varied
slightly among the States and Territories in 1997Ð98 and compared with previous
reporting periods.  
Clinical urgency category
The patients waiting for elective surgery are classified according to their clinical urgency
into three categories. ÔExtended waitsÕ are waits longer than 30 days for clinical urgency
category 1, waits longer than 90 days for clinical urgency category 2 and waits longer
than 12 months for clinical urgency category 3.
Calculation of waiting times
Waiting times are generally calculated by comparing the date a patient was added to a
waiting list with the date the patient was admitted (for throughput data) or the census
date (for census data). In 1997Ð98, there was some variation in the method by which
waiting times were calculated by the States and Territories for patients who change clinical
urgency category while they are on the waiting list. 
Emergency admissions
Most States and Territories provided data separately for patients admitted for the awaited
procedure as an elective admission and for patients admitted as an emergency patient for
the awaited procedure. In that case, only the data on elective admissions were included,
because patients who were admitted as emergency patients for the awaited procedure can
no longer be regarded as having Ôelective surgeryÕ. However, small numbers of records for
emergency admissions were not able to be excluded from the patient-level admissions data
for some States and Territories. 
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National elective surgery waiting times data are for public acute care hospitals. Private
hospitals are not included, except for two hospitals in New South Wales that are funded
by the New South Wales Health Department to provide services for public patients. Some
public patients treated under contract in private hospitals in Victoria are also included. 
The most recent data available are for 1997Ð98 (AIHW 2000b). In that year all public
acute care hospitals in New South Wales, the Australian Capital Territory and the
Northern Territory were included in the data collection. In other States and Territories,
all public hospitals that perform elective surgery were generally included, although
data were not collected for some smaller public hospitals. 
Table 6.3 shows the proportion of patients admitted for elective surgery during 1997Ð98
after extended waits on waiting lists (throughput data). Nationally, 11% of patients
admitted for elective surgery from the two most urgent groups (clinical urgency
categories 1 and 2) had extended waits. In clinical urgency category 3, 4% of patients
had extended waits. 
The proportion of patients in clinical urgency category 1 admitted with extended waits
varied among the jurisdictions, from 6% in Queensland hospitals to 15% in Tasmanian
hospitals. There was more variation in the proportion with extended waits in clinical
urgency categories 2 (from 9% to 35%) and 3 (from 0% to 13%). Some of this variation
could be due to differences in coverage and use of definitions, or to differences in the
types of elective surgery performed in each jurisdiction. 
Quality
Frameworks for health sector performance measurement all incorporate quality as an
aspect of health care that should be monitored, but there is variation in the way in which
it is included. Some frameworks, such as that developed by the National Health
MinistersÕ Benchmarking Working Group for acute care hospitals, have viewed quality
as a component of effectiveness, monitored with indicators such as patient satisfaction,
Table 6.3: Proportion of patients admitted after extended waits, by State and Territory and 
clinical urgency, 1997Ð98 (per cent)
State or Territory Coverage 
Clinical urgency(a)
All patientsCategory 1 Category 2 Category 3
New South Wales 100 14.3 8.5 5.6 9.6
Victoria(b) 76 n.a. n.a. n.a. n.a.
Queensland 95 6.4 15.5 0.0 8.3
Western Australia 68 10.0 12.0 9.0 9.9
South Australia 73 8.6 8.9 2.7 5.2
Tasmania 88 15.3 35.3 13.2 20.4
Australian Capital Territory 100 7.7 25.7 10.7 16.9
Northern Territory 100 10.3 19.0 3.7 9.8
Total 11.2 11.2 4.0 8.2
(a) See Box 6.3, page 323.
(b) For the period 1 January to 30 June 1998 only.
Source: AIHW 2000b.
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rates of unplanned re-admissions, rates of hospital-acquired infection and the proportion
of hospital beds that are accredited. Other frameworks, such as that proposed by Boyce
et al. (1997), and frameworks currently under consideration by the National Health
Performance Committee to be applicable to the wider health sector, have included
quality not as a separate category but as encompassing effectiveness, appropriateness,
safety, consumer experience, acceptability, accessibility and equity, continuity, capability
and/or other aspects of service delivery. 
Considered together, the range of frameworks can be seen to summarise quality as
being assessable in two major ways. The first is whether the health service has achieved
what was intended, i.e. whether it has been effective in producing a desired outcome.
The second is whether it was safe, i.e. whether there were adverse effects or unintended
or undesired outcomes resulting from the intervention or the healthcare environment.
Reliable national information on these aspects of the quality of the health services is,
however, not readily available. Most data collection and indicator development have
focused on clinical care and, in particular, on the acute care hospital setting, with
progress in the areas of prevention and population health much more limited. Even
within clinical care and hospitals, the availability of information has been limited by
difficulties in specifying valid indicators and in generating reliable and consistent data.
Because desired and undesired outcomes can be difficult to assess (because they occur a
long time after the health service provision, for example), ÔprocessÕ indicators are
sometimes used instead of outcome indicators. Process indicators, which should be able
to predict outcomes, are often based on specialist and evidence-based opinion on
methods for managing particular conditions, for example, and can be more sensitive to
errors or deficiencies in healthcare provision than are outcome indicators.
Desired outcomes
National information on whether health services have achieved desired outcomes is
particularly scarce. In the hospital setting, a wide range of clinical indicators (including
health outcome indicators and process indicators) are being developed for the
Australian Council on Healthcare Standards (ACHS) Evaluation and Quality
Improvement Program by the ACHS itself and by medical colleges, associations and
special societies. Reports published for the Program summarise data from over 500
healthcare organisations and may provide directions for the development of national
health outcome indicators (ACHS 1998). 
The evaluation of some population health programs has included assessment of health
outcomes, but these outcomes are necessarily influenced by other factors, including
other health services, and non-health factors such as socioeconomic status.
Nevertheless, national programs such as those for controlling HIV/AIDS, for
improving immunisation against measles and for breast cancer screening have been
linked with reduced incidence, impact and/or mortality of the diseases that they
targeted. 
The effectiveness of healthcare services has also been indirectly assessed using process
indicators such as the proportion of hospitals that are accredited by the ACHS or other
bodies. The proportion of hospitals and hospital beds accredited by the ACHS is the
only data available on a national basis for this assessment for hospitals. In 1997Ð98, 47%
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of public hospitals, 49% of private freestanding day hospital facilities and 78% of other
private hospitals were accredited. Larger hospitals were more likely to be accredited
than smaller hospitals, such that 75% of beds in public hospitals, 52% of beds in private
freestanding day hospital facilities and 90% in other private hospitals were accredited.
Because accreditation is voluntary, can be relatively costly for small hospitals and can
be sought from other bodies, these data provide only indicative information about the
quality of care provided in Australian hospitals. 
Accreditation measures have also been reported as an indicator related to quality for
general practitioners (SCRCSSP 2000). In 1998Ð99, the proportion of full-time GPs with
vocational registration was 91% in 1998Ð99 and, at end of 1999, almost half of the general
practices were accredited with Australian General Practice Accreditation Limited. 
Patient perspectives on the quality of health care, gathered through patient satisfaction
surveys, can also potentially provide measures of whether health care has produced
desired outcomes. These surveys, which have included questions to assess aspects of
health care related to effectiveness, safety, accessibility and acceptability, have been
conducted on a population basis in some jurisdictions, and for hospital patients in
others. Methods and questionnaires used differ among the surveys so the data have not
been collated or reported on a national basis. However, State reports indicate high
levels of satisfaction with care provided in public acute care hospitals (SCRCSSP 2000).
Undesired outcomes
Information from the patientÕs perspective has also been used to assess the occurrence
of adverse events and other undesired outcomes of health care. Each State and Territory
has an independent health complaint body that investigates and conciliates complaints
made by consumers about health services, and compiles information about the
complaints. In 1996, the National Health Complaints Information Project was
established to work towards a national database of health complaint data. It was
anticipated that collation and analysis of the national database would lead to
information being available to improve health care services. The ProjectÕs main focus so
far has been on developing the reporting infrastructures and definitions to be used in
the national database, with national data yet to be reported.
In the hospital setting, the last large-scale assessment of the occurrence of adverse
events was in the Quality in Australian Health Care Study (Wilson et al. 1995), which
used information collected in a review of medical records for hospitalisations in New
South Wales and South Australia in 1992. Since then, potential hospital-level indicators
of undesired outcomes (unplanned re-admission to hospital, unexpected return to
operating theatre, and hospital-acquired infections) have been tested for validity and
reliability and for the ease of collection of the data required for their measurement.
However, a valid relationship between quality of care and the indicators tested could
not be demonstrated and the data to measure these outcomes could not be extracted
from the databases available of routinely collected data. 
The Australian and New Zealand College of Anaesthetists has been compiling and
publishing reports on anaesthesia-related mortality in Australia since 1985. In the 1994Ð96
triennium, there were 135 deaths that were definitely or probably attributable to
anaesthesia, or were attributable to anaesthesia in combination with other factors (about
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2.6 deaths per million population per year). Of these, 55 deaths (1.0 death per million
population per year) were considered to be definitely attributable to anaesthesia. It was
estimated that there was 1 death definitely, probably or jointly attributable to anaesthesia
for every 63,000 operative or diagnostic procedures performed in Australia in the
triennium, with 1 death definitely attributable to anaesthesia for every 150,000 procedures
(Davis 1999).
The Australian Incident Monitoring Scheme, run by the Australian Patient Safety
Foundation, compiles anonymously reported detailed data on incidents in hospitals
and other healthcare facilities, with incidents defined broadly as any event or
circumstance which could have harmed or did harm anyone or which could result in a
complaint. This type of incident reporting may be a source of national adverse-event
data in the future, but reporting is voluntary and, at present, only a minority of
hospitals and other facilities report. Some data on the occurrence of adverse events are
also collected in the routinely compiled hospital morbidity databases and in the
national mortality data. However, the sensitivity and specificity of these data sources
for adverse events are probably not high enough for them to be used to routinely
measure adverse outcomes.
The development of a national reporting system for errors that result in serious injury
and death of patients in the healthcare system has been identified as an area for
immediate action by the recently established Australian Council for Safety and Quality
in Health Care. The role of the Council, established in 2000 by the Commonwealth,
State and Territory Health Ministers, is to lead national efforts to promote systemic
improvements in the safety and quality of health care in Australia with a particular
focus on minimising the likelihood and effects of error. Its main aims include the
development of a national strategy to improve the safety and quality of health care in
hospitals and other health settings; the development of a national framework for
adverse-event monitoring, management and prevention including incident monitoring
and complaints; and effective reporting and measurement of performance, including
research and development of clinical and administrative information systems. 
Palliative care 
Palliative care is Ôthe active total care of people whose disease is not responsive to curative
treatmentÕ (DHFS 1998:2). Most palliative care is provided to patients with cancer,
although a significant amount of care is also provided to people with non-malignant
diseases such as heart failure, end-stage renal failure and motor neurone disease. 
In 1997Ð98, there were 17,824 hospital separations in Australia where the patient was
identified as receiving palliative care. The average length of stay was 13.3 days, and
84% of separations were from public hospitals. Over one-third of palliative care
separations were patients aged 75 years or over, and approximately two-thirds of all
palliative care separations were patients aged 65 years or over. Males accounted for 54%
of the palliative care separations, and 70% of palliative care separations had a principal
diagnosis of cancer.
To support the monitoring of the provision of palliative care, all States and Territories
are cooperating in the development of a National Minimum Data Set (NMDS) for
palliative care. 
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The NMDS for institutional palliative care will be used to collect data on palliative care
patients seen in public and private hospitals and hospices from 1 July 2000. The data set
will include demographic, clinical and administrative data on all admitted patients.
Patients who do not receive care from specialised palliative care staff, but where the
principal clinical intent is palliative, will be separately identified. Much of these data
are already collected as part of the National Hospital Morbidity Database, and existing
data relating to palliative-care patients has been summarised in Palliative Care
Information Development: Progress Report on the National Minimum Data Set for Palliative
Care (AIHW: Jellie & Shaw 1999).
An NMDS for community palliative care is currently being developed by all States and
Territories in collaboration with the AIHW and the Commonwealth Department of
Health and Aged Care. This data set will be used to collect information in all services
funded by governments which provide home- or community-based palliative care. 
These data will be used to underpin the derivation of a suite of national palliative care
performance indicators. This information will be used to monitor the current delivery of
palliative care and to provide a basis for future policy development relating to this area. 
Breast cancer screening
Following a review of international evidence and an evaluation of breast cancer
screening in Australia, AHMAC implemented, in 1991, the National Program for the
Early Detection of Breast Cancer (now called BreastScreen Australia). 
The key aims of BreastScreen Australia are:
¥ to ensure that the program is implemented in such a way that significant reductions
can be achieved in morbidity and mortality attributable to breast cancer;
¥ to maximise the early detection of breast cancer in the target population;
¥ to ensure that screening for breast cancer is provided in dedicated, accredited
screening and assessment services;
¥ to ensure equitable access for women aged 50Ð69 years to breast cancer screening;
and
¥ to ensure that services are acceptable and appropriate to the needs of the eligible
population.
Indicators have been developed in areas of participation, detection, sensitivity,
incidence and mortality to monitor the performance of the program (AIHW 1998a). 
In the two years 1996 and 1997, about 1.25 million Australian women were screened
through the program, including just over half of all women in the target group (aged
50Ð69 years, Table 6.4).
The rate of small cancer detection measures the number of women with small invasive
breast cancers of 10 mm or less in size. Early detection of small cancers gives a woman
a better chance for a good prognosis, as small tumours have a greater chance of being
removed with less extensive surgery, requiring less after-care. The greater the rate of
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detection of small cancers, the greater the likelihood of achieving reductions in
mortality and morbidity from breast cancer. The small-cancer detection rate for women
aged 50Ð69 years in 1997 was 13.2 cancers per 10,000 women screened (Table 6.4). 
Sensitivity refers to the effectiveness of screening mammography and/or the
BreastScreen Australia program at detecting the presence of breast cancer in well
women. There are two sensitivity measures. The first is the interval cancer rate, which
measures the sensitivity of the mammography screening test. The second is program
sensitivity, which takes into account the accuracy of the test, the processes of the
program and the length of the screening interval. The aim is for an interval cancer rate
as low as possible and high program sensitivity (AIHW 2000a).
Incidence is the rate of new cases of breast cancer. After peaking in the mid-1990s, the
incidence rate for women aged 50Ð69 years appears to have declined slightly. 
Reducing the death rate from breast cancer is the main objective of BreastScreen
Australia. The effect of the program on death rates may not be evident until several
years after the introduction of screening. However, the death rate for breast cancer
among women aged 50Ð69 years has fallen slightly in recent years from 65.0 per 100,000
in 1996 to 59.4 per 100,000 women in 1998 (Table 6.4). 
References
ABS 1998. Population projections 1997 to 2051. ABS Cat. No. 3222.0. Canberra: ABS.
ACHS (Australian Council on Healthcare Standards) 1998. Measurement of care in
Australian hospitals. Volume 5, November 1998. Quantitative and qualitative data for
1997. Sydney: ACHS.
AIHW 1998a. Breast and cervical cancer screening in Australia 1996Ð97. AIHW Cat. No.
CAN 3. Canberra: AIHW.
AIHW 1998b. National Health Data Dictionary, version 7.0. AIHW Cat. No. HWI 15.
Canberra: AIHW.
AIHW 1999a. Australian hospital statistics, 1997Ð98. AIHW Cat. No. HSE 6. Canberra:
AIHW.
Table 6.4: Summary indicators for breast cancer screening, women aged 50Ð69 years 
Indicator Year Proportion/rate
Per cent of women screened in 24-month period 1996–1997 52.2
Rate of small diameter (£ 10 mm) invasive cancers detected 
(per 10,000 women screened) 1997 14.4
Incidence rate of breast cancer cases (new cases per 100,000 women) 1996 270.2
1997 281.5
Death rate for breast cancer (per 100,000 women) 1996 65.0
1997 62.8
1998 59.4
Source: AIHW 1998a.
01 AH2000 body  Page 329  Thursday, June 1, 2000  3:06 PM
330  AustraliaÕs Health 2000
TRIM SIZE 175 mm Wide x 250 mm Deep
AIHW 1999b. Development of national public health indicators: discussion paper.
Canberra: AIHW.
AIHW 1999c. AustraliaÕs welfare 1999: services and assistance. Canberra: AIHW.
AIHW 2000a (forthcoming). BreastScreen Australia achievement report 1997Ð1998.
AIHW Cat. No. CAN 8. Canberra: AIHW.
AIHW 2000b (forthcoming). Waiting times for elective surgery, 1997Ð98. Canberra:
AIHW.
AIHW & DHFS 1997. First report on National Health Priority Areas 1996. AIHW Cat.
No. PHE 1. Canberra: AIHW & DHFS.
AIHW: Jellie C & Shaw J 1999. Palliative care information development: progress report
on the national minimum data set for palliative care. AIHW Cat. No. HSE 8.
Canberra: AIHW. 
AIHW: Mathers C, Vos T & Stevenson C 1999. The burden of disease and injury in
Australia. AIHW Cat. No. PHE 17. Canberra: AIHW.
Boyce N, McNeil J, Graves D & Dunt D 1997. Quality and outcome indicators for acute
healthcare services. Canberra: AGPS.
Burdekin B, Guilfoyle M & Hall D 1993. Human rights and mental illness: report of the
National Inquiry into the Human Rights of People with Mental Illness. Canberra:
AGPS. 
Canadian Institute for Health Information 2000. Roadmap initiativeÉlaunching the
process. Ottawa: Canadian Institute for Health Information. 
Davis NJ (ed.) 1999. Anaesthesia related mortality in Australia 1994Ð1996. Australian
and New Zealand College of Anaesthetists. 
DHAC 1999a. The Australian coordinated care trials: interim technical national
evaluation report. Canberra: DHAC. 
DHAC 1999b. Mental health information development: national information priorities
and strategies under the second national mental health plan 1998 to 2003. Canberra:
AGPS.
DHAC 1999c. Third national report on health sector performance indicators. Canberra:
AGPS.
DHFS 1998. A national strategy for palliative care in Australia 1998Ð2003. Canberra:
AGPS.
George B, Harris A & Mitchell A 1997. Reimbursement decisions and the implied value
of life: cost effectiveness analysis and decisions to reimburse pharmaceuticals in
Australia 1993Ð1996. Paper presented at the conference of the Australian Health
Economists Society, Melbourne, July 1997. 
Institute of Medicine 1999. Leading healthy indicators for healthy people 2010: final
report. Chrvala CA & Bulger RJ (eds). Washington DC: National Academy Press. 
01 AH2000 body  Page 330  Thursday, June 1, 2000  3:06 PM
6 Health service strategies, performance and monitoring  331
TRIM SIZE 175 mm Wide x 250 mm Deep
Murray CJL 1999. WHO framework for measuring health inequality. Second Meeting of
the International Burden of Disease Network, Lorne, Victoria, Australia, 15Ð17
November 1999.
NHIMG (National Health Information Management Group) 2000. National summary of
the 1998 jurisdictional reports against the Aboriginal and Torres Strait Islander health
performance indicators. Canberra: AIHW.
NHMBWG (National Health MinistersÕ Benchmarking Working Group) 1996. First
national report on health sector performance indicators: public hospitalsÑthe state of
play. Canberra: AIHW. 
SCRCSSP (Steering Committee for the Review of Commonwealth/State Service
Provision) 2000. Report on government services 2000. Melbourne: Commonwealth of
Australia.
Williams A 1999. Calculating the global burden of disease: time for a strategic
reappraisal? [editorial]. Health Economics 8(1):1Ð8.
Wilson RM, Runciman WB, Gibberd RW, Harrison BT, Newby L & Hamilton JD 1995.
The Quality in Australian Health Care Study. Medical Journal of Australia 163:458Ð71.
01 AH2000 body  Page 331  Thursday, June 1, 2000  3:06 PM
332  AustraliaÕs Health 2000
TRIM SIZE 175 mm Wide x 250 mm Deep
7 Challenges for national 
health information
The large amount of material presented in preceding chapters describes the current state
of health in Australia at the end of the twentieth century. Australia has a well-developed
statistical system, and is well served by institutions with a major commitment to national
health information. Among these, the Australian Institute of Health and Welfare (AIHW)
and the Australian Bureau of Statistics (ABS) play leading roles in the collection,
coordination and reporting of information on health and wellbeing. These two agencies,
together with the Commonwealth, State and Territory health departments and the
Health Insurance Commission, are responsible for implementing the National Health
Information Agreement (NHIA). The bulk of the information presented in this report is
sourced from one or more of the NHIA members.
The National Health Information Management Group (NHIMG), which oversees the
NHIA on behalf of the Australian Health MinistersÕ Advisory Council (AHMAC),
advises on health information priorities. Its National Health Information Development
Plan (AIHW & AHMAC 1995) identified priority directions for a projected 10-year
period. Since the release of the plan, progress has been achieved in each of its highest
priority areas. However, new information demands have emerged, and NHIMG
currently has the plan under review.
This chapter presents an overview of progress with the National Health Information
Development Plan and outlines the emerging information requirements of new national
health strategies. Information gaps that constrain reporting in the earlier chapters of
AustraliaÕs Health 2000 are also identified.
7.1 The National Health Information 
Development Plan
The objectives of the Plan are to Ôpromote the development of high priority health
information and to increase the cost-effectiveness of Australian national health
informationÕ. Highest priority development directions of the Plan are:
¥ work with Aboriginal and Torres Strait Islander peoples to develop a plan to improve
all aspects of information about their health and health services;
¥ develop a national health and welfare information model;
¥ in consultation with health service consumers and providers, undertake a
comprehensive examination of the feasibility and usefulness of potential approaches
to developing and enhancing the ability to link health records, and identify the
linkages that will result in the greatest community benefit;
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¥ develop a plan to improve health outcomes information by developing clinically
specific measures of health outcomes for major health problems and enhancing the
usefulness of clinical information systems for measuring the effectiveness and
outcomes of interventions;
¥ develop and collect standardised information on the incidence, prevalence,
consequences and outcomes of care of severe mental illness;
¥ develop and collect standardised information on primary and other non-institutional
healthcare encounter data;
¥ undertake a systematic review of current major health data collections and make
recommendations regarding rationalisation and improvements in the cost-
effectiveness of collections; and
¥ develop ongoing surveillance of potentially modifiable, major disease risk factors,
including biological measurements where necessary, ensuring adequate coverage of
small, priority populations.
Achievements since 1995
Progress has been made in each of the priority directions.
Aboriginal and Torres Strait Islander health
In 1998, AHMAC endorsed The Aboriginal and Torres Strait Islander Health Information
PlanÉThis Time LetÕs Make it Happen (ATSIHWIU 1997) and established a process for its
implementation, to be managed by NHIMG. The ABS accepted responsibility for
improving the quality of Indigenous identification in vital statistics collections. Good
progress has been made in Queensland, which was the last State to commence
Indigenous identification in birth and death records. Nevertheless, the quality of
identification in the other eastern States has not improved sufficiently to permit
publication of data on deaths. 
The joint ABS/AIHW Aboriginal and Torres Strait Islander Health and Welfare
Information Unit has taken the lead role in improving hospital morbidity data for the
Indigenous populations. A pilot study has provided indicative results on the extent of
coverage of Indigenous patients in hospitals (which ranged from 55% to 100%) and a
methodology for testing coverage in other hospitals. AIHW has accepted the lead role
in relation to cancer registries (where it is working with the Australasian Association of
Cancer Registries) and in perinatal statistics (where it is working through its National
Perinatal Statistics Unit to standardise and improve coverage in perinatal data
collections). 
National health and welfare information model
The National Health Information Model, version 1 (AIHW 1995), has been further
developed and replaced by a draft version 2. Version 2 has been constructed as a high-
level, conceptual model, quite different from version 1 which was constructed as an
entity-relationship model. Unlike version 1, version 2 does not attempt to describe
relationships between the entities in the model, as it is considered that these are more
appropriately described at enterprise or operational levels of information modelling.
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Version 2 provides an organising structure for the National Health Data Dictionary, which
is now structured to present data elements in accordance with their relationship to
Model entities (NHDC 1998).
Record linkage
The AIHW has built considerable record linkage experience using its National Death
Index and the National Cancer Statistics Clearing House. The AIHWÕs Health Ethics
Committee approved 41 projects involving linkage using these databases during
1998Ð99, a number that has increased markedly over 5 years. Studies have contributed to
knowledge about health patterns in occupational cohorts (e.g. Radium Hill workers),
specific population groups (e.g. older women, Vietnam veterans), selected communities
(Western Sydney Area Health Service) and for specific diseases (e.g. hepatitis C,
cardiovascular surgery outcomes). Other linkage projects have been undertaken to
examine the potential for creating person-based records from hospital separations to
examine the patterns of re-admission for cardio-revascularisation procedures.
Several States have established linked data sets with matched records from local hospital
morbidity, mortality and other health records. Western Australia, in particular, has used
health record linkage extensively in health studies, including prostate cancer survival
analysis (Holman et al. 1999), an examination of hospitalisation of the elderly during the
last year of life (Brameld et al. 1998), and estimation of the incidence of aortic aneurysm
(Semmens et al. 1998). A study into the linking of data from the Western Australian
linked data set with national data sets (e.g. Medicare data, data from the Pharmaceutical
Benefits Scheme and the National Death Index) for people with diabetes is in the
planning stages. Protocols for such studies are complicated by the need to meet privacy
protection requirements under various administrative and legislative regimes.
Identifying and resolving such issues is one of the objectives of the study.
Following a review of its household survey program, the ABS has announced that it
will pursue the linking of survey data to administrative records with consent. The
linkage would be done within the ABS under the protection of the secrecy provisions of
the Census and Statistics Act 1905.
Health outcomes
The NHIMG, in response to a specific request from AHMAC, has developed a health
outcomes indicator framework. The framework encompasses outcome and other
indicators spanning prevention, management and maintenance services. It has been
adopted for reporting under the National Health Priority Areas (NHPA) program.
NHPA reports on injury and diabetes and a forthcoming report on asthma have applied
the framework. The framework also provides a planning basis for data development for
future NHPA reporting.
A register to monitor new cases and prevalence of acute rheumatic fever and rheumatic
heart disease among the Indigenous populations has been established in the Top End of
the Northern Territory. Data in the register permits monitoring of rates of compliance
with treatment and provides data on the outcome of intervention. For cardiovascular
disease in general, the AIHW has reported on medical care of cardiovascular disease
and, in collaboration with the National Heart Foundation of Australia, on the use of
cardiac surgery and coronary angioplasty procedures. The feasibility of establishing a
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national cardiovascular procedures register is being investigated. This would provide
reliable, longitudinal, risk-adjusted data for monitoring national indicators of quality
and outcomes for cardiac procedures and cardiology interventions.
One of the indicator sets developed under the health outcomes indicator framework is
that for monitoring the performance of the BreastScreen Australia program. These
indicators seek to highlight progress towards the program objectives relating to
participation, cancer detection, program sensitivity, cancer incidence and mortality. The
mortality indicator is the ultimate test of the programÕs effectiveness, and between 1994
and 1998 there has been evidence of a reduction in mortality rates due to breast cancer
of 2.5% per annum (AIHW & AACR 1999). 
Severe mental illness
An ABS Survey of Mental Health and Wellbeing, conducted in 1995, reported on the
prevalence of mental illness among adults in the community (ABS 1998). A
complementary multijurisdiction study of people living with psychotic illness has
provided information on people attending mental health services for treatment of
psychotic disorders, including schizophrenia (Jablensky et al. 1999). New administrative
data in mental health services have become available through implementation of a new
National Minimum Data Set for Institutional Mental Health Services from 1997Ð98
(AIHW 2000). Progressive implementation of a National Minimum Data Set for
Community Mental Health Services is proceeding, following its adoption by NHIMG. 
Non-institutional healthcare data
Progress in this area has included the establishment in 1998 of a Survey of General
Practice Activity (BEACHÑBettering the Evaluation And Care of HealthÑsee chapter 5).
The survey commenced in April 1998 with funding from a consortium of private
pharmaceutical companies and several government agencies. A report on the first year of
the survey was published in 1999. 
A National Community Based Health Services Codeset, prepared by a consortium of
Commonwealth and State health agencies, has provided the basis for implementing
data collections that will fill a large gap in national health services information. 
Improving cost-effectiveness of collections
The ABS has conducted a wide-ranging review of its household survey system,
including the National Health Survey, and plans to introduce a new 3-yearly cycle of
health surveys. Sample supplementation for the Aboriginal and Torres Strait Islander
populations will be introduced over the first two surveys in the new program (2001 and
2004) and continue at 6-year intervals thereafter. Also included in the program is a
3-yearly General Social Survey that will permit analysis of the social determinants of
the health of the population. An Indigenous General Social Survey will be conducted in
conjunction with every second General Social Survey from 2002. 
Some rationalisation has occurred in national hospital statistics, with a withdrawal by
the Department of Heath and Aged Care from publication of its hospital casemix series.
Re-establishment of the AIHWÕs Australian Hospital Statistics series on a regular and
timely basis has permitted this rationalisation of publication activities. 
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Potentially modifiable disease risk factors
ABS National Health Surveys have provided information on disease risk factors,
including smoking, alcohol consumption, exercise and unhealthy weight, based on self-
report methods. National Drug Household Surveys, conducted by the Department of
Health and Aged Care and its predecessors, provide information about use of and
attitudes towards tobacco, alcohol and illicit drugs. Biomedical risk factor information,
of the kind collected by the National Heart Foundation in three surveys during the
1980s, has not been collected during the past decade. A one-off survey of diabetes
prevalence is being undertaken during 1999 and 2000 by the International Diabetes
Institute, Melbourne, but plans for ongoing national monitoring of biomedical risk
factors are still at the development stage. Options include a survey in conjunction with
the ABSÕs National Health Survey in 2004 or a stand-alone survey.
7.2 Newly emerging information challenges
Since the release of the National Health Information Development Plan, new issues
have raised unanticipated challenges for national health information. Major emerging
themes are:
¥ plans to incorporate new communications technology into health care;
¥ increased focus on the health of rural and remote populations;
¥ increased focus on factors affecting the health and wellbeing of children; and
¥ coordinated attention to public health, brought by the National Public Health
Partnership.
Plans Ôto provide a basis for a national strategic approach to using information in the
health systemÕ have been released in a report by the National Health Information
Management Advisory Council entitled Health Online (NHIMAC 1999). The PlanÕs
scope includes information collection, privacy and confidentiality, and access, but also
information transfer in interactive services and situations. Under the planÕs information
objectives, two strands of information development have been identified. One is
concerned with development and adoption of information technology standards, for
which much of the work occurs under the auspices of Standards Australia, its
committee processes and international connections. The other strand is concerned with
data standards, for which the NHIMGÕs management of the National Health Data
Dictionary (NHDD) provides a well-established basis for future development. 
Electronic health records offer an opportunity for expanded availability of statistical
data, including linked data sets. The challenge for national health information will arise
from the strict business requirements for an electronic health record that is transferable
across healthcare settings. This will require standard definitions for data elements that
are included in an electronic health record. The NHIMGÕs processes are well placed to
handle this expanded requirement. As well, classification and coding schemes are
required that are flexible enough to support the expected interchange of information
across settings while continuing to meet the different business requirements for specific
care settings. The World Health OrganizationÕs development of a Family of
International Health Classifications is pertinent. The AIHW is a WHO Collaborating
01 AH2000 body  Page 336  Thursday, June 1, 2000  3:06 PM
7 Challenges for national health information  337
TRIM SIZE 175 mm Wide x 250 mm Deep
Centre on health classifications (including the International Classification of Diseases
and the International Classification of Impairments, Disabilities and Handicaps) and is
actively participating in this work. 
Increased attention to rural and remote health and health services presents challenges
to improve the flexibility of geographic coding in major health data sets. Fixed regional
boundaries, whether administrative (such as postcodes or local government areas) or
statistical (such as statistical local area or statistical division), currently coded in most
data sets, limit the capacity to support the area-specific analysis that is increasingly
required to meet rural and remote health and environmental health management needs.
Remote health issues are confounded by the poorer health of Aboriginal and Torres
Strait Islander people who constitute a significant proportion of the population in
remote areas (see chapter 4). 
Demands for information about child and youth health and wellbeing are increasingly
concerned with the influence of early social development as a determinant. Existing
information systems are extensive, but are cross-sectional, not longitudinal.
Opportunities exist through linkage of data sets to create longitudinal views at low cost.
Public health information has a higher profile since the establishment in 1996 of the
National Public Health Partnership. Through its National Public Health Information
Working Group, the Partnership has developed a National Public Health Information
Development Plan (AIHW 1999). The challenges contained in this plan include
establishment of an infrastructure for monitoring health determinants, health and
causes of ill health of Aboriginal and Torres Strait Islander populations, socioeconomic
disadvantage and health, intersectoral information on the physical environment and
financial information on public health programs.
Across a number of health fields there is increasing demand for analytical work for the
specification and production of broad health indicators and of performance indicators,
either within specific program areas or more generally focused on the health system as
a whole. General health indicator requirements cover fields such as burden of disease
and health inequalities. Performance indicators include efficiency and effectiveness of
services, including quality and outcomes. 
The 1998 Australian Health Care Agreements include requirements for development of
performance indicators across the health sector. This work is being led by the National
Health Performance Committee.
7.3 Major gaps in this report
The requirement to report on AustraliaÕs health itself raises awareness of the gaps that
are unable to be filled. This section provides an alternative view, from a reporting
perspective, of the development required to augment information presented in the
preceding chapters of this report.
The health of Australians (chapter 2)
As reported in chapter 2, mental health is the third most important contributor to the
burden of disease. Although information available on mental health services continues
to improve (chapter 5), there is no provision in the work programs of relevant agencies
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for any ongoing data collection on population mental health. Information from the ABS
1997 Survey of Mental Health and Wellbeing was reported in AustraliaÕs Health 1998 and
some further information from that survey has been included in chapter 2. However,
ongoing coverage of population mental health is not included in a comprehensive
manner in the new ABS population survey program.
Chapter 2 is able to report in only a limited way on the oral health of Australians,
particularly of adults. As reported in AustraliaÕs Health 1998, fluoridation of water
supplies has reduced the prevalence of dental decay in cohorts that have lived all or
most of their lives with such protection. Some information on decayed, missing or filled
teeth (DMFT status) is available from self-report through telephone surveys conducted
by the AIHW Dental Statistics Research Unit. However, periodic surveys including an
oral examination are needed to verify reports on DMFT status and to measure other
aspects of oral health.
Determinants of health (chapter 3)
Chapter 3 is devoted to the environmental and individual factors that determine health.
This reflects the increasing attention being given to managing determinants through
public health practice, evident at the national level in the establishment in 1996 of the
National Public Health Partnership. However, only limited information could be
presented in many areas of chapter 3. In particular, biomedical risk factor information is
needed to monitor levels of modifiable risks to health from major disease categories,
especially cardiovascular disease, diabetes and some cancers. Better information is also
needed on environmental health risks, and on attitudinal and lifestyle factors, an area
where the National Public Health Partnership has begun efforts to coordinate existing
information activities.
Health and determinants in population groups (chapter 4)
The inability to report comprehensively on the health of Aboriginal and Torres Strait
Islander people has already been discussed, as has the lack of longitudinal data to
monitor child and youth health. Health of people with disabilities is another area where
data is almost non-existent (see AustraliaÕs Welfare 1999). A particularly difficult group to
monitor is homeless people. 
Health resources and use of services (chapter 5)
Chapter 5 presents only limited information about health services other than those
provided to admitted patients in hospitals and consultations with general practitioners.
Ambulatory services provided within hospitals (accident and emergency units and
hospital-based clinics) and in the community are important in their own right and as
contributors to integrated care regimes that are emerging. A Community Based Health
Services Codeset, developed by a consortium of jurisdictions, provides a basis for
development of community services information, but will require a major coordinated
effort to implement. 
Health service strategies, performance and monitoring (chapter 6)
A number of frameworks for health system performance monitoring are receiving
attention from national bodies such as the National Health Performance Committee.
Information systems are being developed to support these frameworks, but some
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components require prior work to develop concepts and specifications for indicators.
For instance, in line with many countries, Australia has not developed valid and
reliable indicators of the quality of health care.
Data systems for monitoring the performance of services and activities aimed at the
health of Aboriginal and Torres Strait Islander peoples are a priority, as are performance
information systems related to community-based health care.
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8 Changes in Australia’s 
disease profile: a view 
of the twentieth century
The twentieth century was a period of great social, economic and scientific development
in Australia. In health, these developments brought better nutrition and living
conditions from the start of the century, widespread immunisation and improvements in
medical treatment in the second half, and a growing awareness in more recent times of
the effect of lifestyle and socioeconomic factors on health. Such advances have resulted
in death rates that are now less than half what they were in 1900, an improvement in life
expectancy at birth of over 20 years, and a dramatic decline in perinatal mortality and
deaths from infectious diseases. But there has also been a greater prominence of the
chronic diseases (e.g. cardiovascular diseases and cancer) and the rise and partial fall of
two epidemics, coronary heart disease and lung cancer. 
This chapter examines these and other mortality trends in Australia over the past
100 years. Although mortality trends provide a limited picture of AustraliaÕs health,
they are one of the few statistical series that were collected with some consistency over
the whole century (AIHW: Taylor 1992). This chapter also highlights some critical
factors that have influenced patterns of deaths in Australia. 
8.1 General trends in health over the 
twentieth century
Mortality has shown a remarkably consistent decline during the century despite some
short-term impacts of specific diseases (Figure 8.1). This decline has been consistent in
both males and females, although there are differences in the timing and make-up in
the patterns of causes of death. Age-standardised mortality rates declined by 61% in
males and 71% in females between 1907 and 1998 (Knibbs 1909; ABS 1999). This is in
line with mortality reductions seen elsewhere in the developed world. The death rate in
males is consistently above that of females. 
As expected, these mortality declines are reflected in the substantial increases in life
expectancy that have occurred over the century (Figure 8.2, page 342). However, what is
not evident from these declines are the significant changes in the main causes of death
during the twentieth century. Also, these mortality declines may not have been equally
distributed among all population groups such as the immigrant and Indigenous
populations. For example, there is presently a substantial difference in life expectancy
between Indigenous and non-Indigenous Australians and death rates are higher for the
Indigenous populations for most causes of death. Indeed, the mortality patterns for
Australian Indigenous peoples are strikingly worse than their indigenous counterparts
in Canada, New Zealand and the United States, as shown by their lower life
expectancies at birth and higher age- and cause-specific death rates (Hogg 1992). It is
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not known whether Indigenous health has improved over the century or whether it has
maintained its relatively poor position. This is because Indigenous peoples have not
been identified in many administrative or health-specific data collections. It is known
that while the population of Australia has increased from around 4.4 million in 1899 to
about 18 million a century later (an approximate fourfold increase) the Indigenous
population has not yet doubled from its estimated level of 200,000 in 1898 (Coghlan
1900), and reached only 386,000 in 1996 (ABS 1998). However, it is not known what
effect these changes in the relative sizes of the Indigenous and total populations have
had on overall trends in mortality and life expectancy.
Many immigrant groups have proved to be healthier in some respects than the existing
Australian population (e.g. cardiovascular disease, cancer). Young (1986) speculated
that this healthy migrant effect is a result of immigrant selection, lifestyle and diet, and
tobacco and alcohol consumption patterns. Young indicated that immigrants from
Southern Europe, Lebanon and South East Asia had lower mortality rates than for
Australians generally for many causes of death. Giles, Jelfs and Kliewer (1995) showed
this pattern existed for many of the major migrant groups in Australia in relation to
cancer mortality, even showing that for some cancers these migrants fared better than
those remaining in their own country. It is important to recognise these differences in
mortality patterns when looking at long-term trends, as the impact of the large-scale
immigration from the 1940s onwards would have tended to reduce the overall mortality
rate from this point forward.
Note: Age standardised to the population at 30 June 1991.
Source: AIHW National Mortality Database.
Figure 8.1: Death rates for all causes combined, 1907 to 1998
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Increased life expectancy
For the overall population, life expectancy at birth rose from 55.2 and 58.8 years at the
beginning of the twentieth century to 75.9 and 81.5 years in the late 1990s for males and
females respectively (ABS 1999) (Figure 8.2). This rise in life expectancy was relatively
constant over the century, apart from a plateau during the 1960s that was related to an
increase in deaths from heart disease. 
However, in the late 1990s, the life expectancy of Indigenous Australians was estimated
to be 20 years less than the general population, at 56.9 years for males and 61.7 years for
females (ABS & AIHW 1999). So life expectancies for Indigenous Australians are
100 years behind those for non-Indigenous people, and show that the high standard of
health achieved by the general population over the last 100 years has not been shared
by all Australians. 
Reductions in infant mortality
Increases in life expectancy are largely related to the substantial decrease in perinatal
and infant mortality that occurred in the first half of the century (Figure 8.3). Infant
mortality rates were very high in the 1880s (130.5 deaths per 1,000 live births in males
and 114.1 in females) but had fallen to nearly half that by 1910Ð20 (Lancaster 1956). In
the first decade of the twentieth century, 1 in 10 children died before the age of 5, most
from infections such as diarrhoeal diseases and enteritis (Cumpston 1989:111). 
Source: AIHW unpublished data.
Figure 8.2: Life expectancy at birth, 1905 to 1998
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By 1926, the infant mortality rate had been reduced by half and there had been a
dramatic decline in deaths from gastrointestinal diseases. This followed the introduction
of improved sanitation, such as the systematic collection and removal of ÔnightsoilÕ
(Cumpston 1989:113). Improvements in the quality of water and milk supplies, an
increase in breast-feeding, better access to education and a decreasing number of births
per woman were also likely to have played a part in the dramatic declines in child
deaths through better infant health and increased resistance to infection (Gandevia 1978).
Infant mortality continued to decrease after the 1940s with the introduction of antibiotics
and improved perinatal care, and reached a low of between 5 and 7 deaths per 1,000 live
births in the late 1990s (AIHW 1998). Few infants (other than Indigenous infants) now
die from infection or from conditions in the perinatal period such as low birthweight or
birth trauma. Congenital anomalies, sudden infant death syndrome (SIDS) and accidents
have become the leading causes of death in young children (AIHW 1998). Indigenous
infant mortality was around 18 per 1,000 live births at the end of the twentieth century
(ABS & AIHW 1999). 
Reductions in maternal mortality
As well as improvements in infant mortality, there has been a dramatic decline in
mortality rates for women during childbirth in Australia. Childbirth was responsible for
the death of around 6 women in every 1,000 live births (Cumpston 1989:138) in 1900.
ÔPuerperal feverÕ, a condition now known as post-partum infection, was responsible for
about one-third of these deaths. In the 1920s and 1930s, doctors attributed maternal
death rates partly to the poor standards of obstetric care practised by some of their
Source: AIHW unpublished data.
Figure 8.3: Trends in infant mortality, 1901 to 1998
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peers, especially the use of unnecessary caesarean sections (Hughes 1939). Maternal
death rates remained relatively high until a dramatic decline in 1937, when antibacterial
drugs became available (Taylor et al. 1998). Improved nutrition, better general health,
the advent of medical interventions such as antiseptic procedures, a decrease in
pregnancies (from contraception and family planning), use of blood transfusions and
the professional training of those attending births have all contributed to a sustained
decrease in deaths of women following childbirth (Weil & Fernandez 1999). By the late
1990s, maternal mortality in Australia was rare and it remains among the lowest in the
world. In the early 1990s, maternal mortality was 10.9 per 100,000 confinements
(NHMRC 1998), around 2% of the rate in 1900.
The transition from infectious to chronic disease
As in many other developed nations, Australia has experienced a Ôhealth transitionÕ from
infectious to chronic diseases, with influenza and tuberculosis being replaced by
circulatory (cardiovascular) diseases and cancer as the major causes of death (Beaglehole
& Bonita 1997:6) (Figure 8.4). More specifically, there was a decrease in death rates from
infectious diseases, particularly from the early 1900s, and an increase in coronary heart
disease, stroke and lung cancer from the 1920s and 1930s. 
Note: Age standardised to the population at 30 June 1991.
Source: AIHW National Mortality Database.
Figure 8.4: Death rates by major causes, 1907 to 1998
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Better nutrition and public health measures such as improved sanitation and housing
made a major contribution to the decrease in deaths from infectious diseases. Lifestyle
factors such as changes in diet and smoking are considered responsible for the increase
(and partly for the subsequent decline) in deaths from circulatory diseases and some
cancers, and the increasing number of motor vehicles led to an increase in transport-
related deaths. 
Since the late 1960s, death rates from cardiovascular causes (in particular heart attack and
stroke) have declined steadily and more recently there has been a slight rise in death rates
from infectious disease in males. The reduction in cardiovascular death rates is related to
the success of prevention strategies and better treatment of cardiovascular conditions. The
rise in infectious disease death rates, although slight in Australia, has been seen around
the world with the emergence of infections such as the human immunodeficiency virus
(HIV) and hepatitis C. This has led to speculation that a further transition in the disease
profile of Western countries may occur (Beaglehole & Bonita 1997:7). 
8.2 Trends in the major causes of death in 
Australia
The following sections describe trends in the major causes of death for Australians over
the twentieth century. The disease categories are defined by the International
Classification of Diseases and include infectious diseases, cardiovascular disease
(circulatory system diseases), cancer (malignant neoplasms), respiratory diseases, and
deaths from external causes (injury and poisoning). Interpreting trends in death
statistics poses some difficulties as international definitions, classification frameworks
and diagnoses of disease have changed over time (AIHW: Taylor 1992; Taylor et al.
1998). In the early 1900s, causes of death were classified initially using a system devised
by Dr William Farr, and then according to the Bertillon Index. The International
Classification of Diseases, version 2 (ICD-2) was used in Australia from 1918, and ICD-
10 was introduced in 1999. Because of the different classifications used, the following
sections focus on broad trends in the data.
Infectious diseases
Infectious diseases were the main cause of death in Australia in the first 100 years after
European settlement. Dysentery, scurvy and typhus were the major infections, but
epidemics of smallpox, cholera, tuberculosis and other infections were also common
(Sax 1984:15). Children bore the brunt of infectious diseases as did the Indigenous
populations who, having not encountered these diseases before, had no resistance to
them and suffered very high death rates (Gordon 1976:182).
In the early 1800s, infectious diseases were of enormous public and political concern
around the industrialised world, and governments in many countries were called upon
to enact public health measures to reduce their spread. At the time, it was thought that
infections were the result of ÔmiasmasÕ or foul vapours that arose from decaying matter,
and sanitation was seen as an important way of arresting the spread of disease (Davis &
George 1988:166). During the late 1800s, a range of public health measures was
introduced in Australia including publicly financed water and sewerage schemes,
improved sanitation and better housing to reduce overcrowding (Davis & George
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1988:167). These measures were largely responsible for the decreases in infectious
diseases that were already under way at the beginning of the twentieth century
(Cumpston 1989:114).
Despite declines, infectious diseases remained a major cause of death in the early 1900s
(Figure 8.5) with tuberculosis and venereal diseases being the most common
(Sax 1984:16). Public health legislation had been enacted across Australia but was
beginning to extend beyond sanitation to the compulsory notification of infectious cases
and the isolation of infected individuals. In 1900, for example, when bubonic plague
arrived in Sydney, officials isolated infected individuals in the quarantine station at North
Head, closed their dwellings and coated their possessions in lime (Hickman 2000). An
Australian researcher, Ashburton Thompson, established the connection between rats,
fleas and the spread of the plague (and was the first in the world to do so) and public
health inspectors were despatched to find and destroy rats and their breeding grounds
(Hickman 2000). Despite a public outcry about the plague and its effects, only 463 people
died from the disease in Australia between 1900 and 1909 (Cumpston 1978). This small
number was undoubtedly due to the timely action of public health officials. The plague
outbreak was the trigger for the first Commonwealth action in quarantine. 
Note: Age standardised to the population at 30 June 1991.
Source: AIHW National Mortality Database.
Figure 8.5: Death rates from infectious and parasitic diseases, 1907 to 1998
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Influenza, although classified as a respiratory condition, has been responsible for a
large numbers of deaths over the twentieth century, none more significant than the 1919
pandemic (see Figure 8.11, page 358). In that year approximately 12,000 Australians
died, making influenza the most common cause of death, exceeding the number of
deaths attributed to circulatory disease (Cumpston 1989). This outbreak was also
responsible for the deaths of approximately 20 million people worldwide. A smaller but
significant influenza outbreak also occurred in 1907Ð1908 and was responsible for
around 700 deaths in each of those years, compared with an expected 200Ð300 deaths. 
There was a steady decline in deaths from infectious diseases over the century
(Figure 8.5). Mass vaccination occurred from the 1930s for diphtheria, from the 1950s for
pertussis (whooping cough), tetanus and poliomyelitis (for which no cases have been
reported since 1978), and from the 1960s for measles (Hall 1993). Widespread
immunisation continued in the 1980s and 1990s, as other vaccines became available, and
has been the focus of recent public health campaigns as immunisation levels have fallen.
Some declines have also been attributed to the introduction of antibiotics from 1937
onwards, the anti-tuberculosis campaign, and to continued improvements in
environmental health and socioeconomic conditions (Taylor et al. 1998). 
During the 1970s and 1980s a number of viral infections including hepatitis B, hepatitis C
and the human papilloma virus were newly described, although it is likely that these
diseases existed before this but had not been recognised. Viral conditions were largely
untreatable and became a significant concern, especially with the emergence of HIV in
the early 1980s. Acquired immunodeficiency syndrome (AIDS) (caused by HIV) has now
led to the deaths of 13.9 million people worldwide and is among the top four causes of
death globally (WHO 2000). The effect on overall life expectancy in many countries has
been dramatic. In Australia, the epidemic has been controlled by relatively rapid public
health interventions, and, although over 6,000 people have died in Australia from AIDS,
the epidemic appears to have been slowing since 1994 (WHO 2000). Further information
is contained in section 2.5 (page 112). Safe-sex and safe-injecting campaigns, blood
supply regulation, infection-control guidelines and the introduction of new treatments
have all contributed to the control of mortality from AIDS in this country. 
In Australia, a combination of improved living conditions and access to readily
available treatments over the twentieth century has resulted in many infectious diseases
becoming comparatively rare (the 1998 death rate from infectious diseases was less than
1% of that in the 1930s). However, the levels of infectious diseases remain relatively
high in the Indigenous populations. Diarrhoeal infections and infections that result in
pre-term birth are still major problems for some Indigenous communities, reflected in
their higher infant mortality rates (ABS & AIHW 1999). 
Cardiovascular diseases
Another striking trend in mortality in Australia in the first half of the twentieth century
was the significant increase in death rates from circulatory system diseases, followed by
an even greater fall beginning in the late 1960s (Figure 8.6). The main conditions
contributing to this pattern were heart attack and stroke. 
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The evolution of the epidemic of cardiovascular disease was paralleled by a rapid
increase in the understanding of how the heart functions and of the contribution of risk
factors to heart disease. It was also a time of significant development in methods to
diagnose and treat heart and other circulatory problems. The application of this
knowledge ultimately resulted in a decline in cardiovascular death rates. 
In the first years of the twentieth century, cardiovascular disease was already
recognised as a significant contributor to the mortality of Australians. It was the fourth
most common cause of death in Australia after pneumonia, tuberculosis, and diarrhoeal
disease, and it was much more common than cancer (Cumpston 1989:133). In 1916, the
Commonwealth Departmental Committee on Invalidity and Mortality, concerned at
possible declines in the Australian population and its health status, recognised the risks
of Ômiddle ageÕ thus:
It is commonly said that a man is as old as his arteries É about the age of 40, slow changes
begin, which tend to make the coats more rigid É But at the age of 40 É when these quiet
changes in the main arteries should be slowly beginning É more serious evil often sets in
É more rapid in evolution É the whole circulation is in a condition of strain. The persons
affected think themselves robust É But they often die suddenly É Men suffer in this way
far more than women, but even women are affected in large numbers. What are the causes
of this disastrous series of changes which cut off thousands of people in their full
maturity? 
Note: Age standardised to the population at 30 June 1991.
Source: AIHW National Mortality Database.
Figure 8.6: Death rates from circulatory system diseases, 1907 to 1998
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In the early 1900s, knowledge of the heart was limited to an understanding of its
anatomy, and relatively little was known about how it worked. There was only a
rudimentary appreciation of the relationship between the heart and other important
facets of the circulation such as blood pressure, and the function of the heart as an
Ôelectrically driven pumpÕ within the body was largely unknown. The introduction of a
portable instrument, the sphygmomanometer, and the interpretation of the sounds heard
via the stethoscope, enabled doctors to measure blood pressure for the first time, and
this became part of a routine physical examination. However, there were no effective
remedies for the treatment of elevated blood pressure once it had been diagnosed. The
recognition of disturbances in heart rhythm had developed as a clinical skill, but it was
difficult for doctors to predict which rhythms were harmful, and treatments were largely
unavailable, other than bed rest and the use of digitalis (derived from the foxglove
flower) which had been available since Roman times (Porter 1997). 
By 1910, circulatory system disease had become the most common cause of death in
Australia and, except for a brief period following the great influenza epidemic in 1919,
it has remained the leading cause of death. Over the first half of the century, the
percentage of deaths due to cardiovascular disease increased substantially in all age
groups and in both sexes, and by mid-century the disease accounted for more than half
of all deaths, not only in Australia but also in most of the industrialised world
(Braunwald 1997). The link between heart disease and infections such as rheumatic
fever and syphilis was well known, and by 1950 antibiotics were available to treat these
conditions, thereby preventing their cardiac consequences for the first time. However,
the major causes of death from heart diseaseÑsudden death and heart attackÑwere
still unexplained and continuing to rise. Lancaster (1990) observed that part of this
increase could be explained by better cause-of-death coding, with ill-defined causes of
death falling to near zero as the epidemic gathered momentum.
During the first half of the twentieth century, changes in death rates from heart disease
occurred in Western countries, with rises tending to follow increasing prosperity.
Increasing rates were noted, for example, in the United States among affluent men who
smoked (Keys et al. 1963), but in postwar Europe, cardiovascular disease rates
decreased sharply in the wake of reduced food supplies. Changes in incidence rates
seemed to reflect powerful socioeconomic and behavioural influences in newly rich
countries operating with a relatively short incubation period for the disease, perhaps as
short as a decade (Rose 1989). 
In 1941, new X-ray techniques allowed doctors to view the pumping action of the heart
(and, later, the health of the coronary arteries) using radio-opaque dye introduced
through a fine tube inserted into an arm or groin blood vessel in a conscious person
(cardiac catheterisation). 
With improved diagnosis, attention was directed at treatment. In 1945 Blalock
attempted surgical repair in a child with congenital heart disease, and this led to the
development of open-heart surgery within a decade, providing some relief for those
with congenital heart disease, disease of the heart valves and other conditions. In the
mid-1950s, the invention of the heartÐlung bypass machine (the pump-oxygenator),
taking over the function of the heart and lungs outside the body, allowed surgeons
enough time to undertake more complicated procedures. 
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From 1967 onwards, surgical techniques were used in Australia to bypass obstructions
in the coronary arteries and so relieve the debilitating pain suffered by those with
coronary artery disease. This operation, coronary artery bypass grafting, became one of
the most frequently performed surgical procedures around the world (Mueller et al.
1997). Initially undertaken to relieve symptoms, it was also found to decrease mortality
(Julian 1989). Other interventions followed including the use of specific drugs and anti-
clotting agents. In-hospital care improved through the setting up of coronary care units
with specifically trained nursing staff and intensive monitoring of patients. Other
advances, including drugs and devices for correcting abnormal heart rhythm
(pacemakers and defibrillators) and better training of emergency services personnel,
also assisted survival in those with established coronary heart disease. 
Attention was increasingly focused on the social and lifestyle factors that contribute to
the development of cardiovascular disease in the healthy population. From this
emerged the concept of risk factors for coronary heart disease and stroke. In 1961,
results were published from a research project in the United States, the Framingham
Heart Study, which became one of the cornerstones of cardiac epidemiology (Kannel
et al. 1961). High blood pressure, smoking, elevated cholesterol in the blood and dietary
factors (especially dietary saturated fat and salt) were identified as major contributors
to the epidemic of cardiovascular disease. The importance of other factors such as
socioeconomic status, obesity and physical inactivity was acknowledged (NHLBI 1994)
as well as the significance of social, cultural and environmental factors. 
Mortality rates from coronary heart disease increased dramatically after World War II,
peaked in Australia in 1968 and then decreased substantially by over 60% among males
and females (AIHW & HFA 1999) (Figure 8.7). Death rates for stroke remained constant
through the 1950s and 1960s and have fallen by more than two-thirds since 1968
(Figure 8.7). These improvements are considerable, particularly as mortality from non-
cardiovascular diseases decreased by about 20% only (AIHW & HFA 1999). The decline
in coronary heart disease occurred in all age groups and for both sexes, with greater
declines in the younger age groups and a greater rate of decrease for males than for
females (Beaglehole et al. 1989). This implied that broadly operating effects such as
market-led dietary change were responsible, more so than individual efforts to alter
lifestyle, and that those changes acted with only a short lag period (Rose 1989). One
suggested factor in Australia was the change in the balance and types of fats in the
national diet (Hetzel & McMichael 1987). 
Mortality rates from coronary heart disease in Australia declined by about 25% over the
1970s but the greatest declines were experienced by the professional occupations,
whereas lower socioeconomic groups had higher mortality rates at the beginning of the
period and experienced smaller declines. From a national survey in 1980, lower risk
levels of blood pressure, cigarette smoking, body weight and exercise were significantly
and consistently found among higher status occupation groups. This suggested that
there was a pattern of coronary prevention behaviour spanning multiple risk factors
that was associated with a reduction in coronary heart disease (Dobson et al. 1985). 
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The relative contributions of alterations in lifestyle and changed levels of risk factors in
the population, and of medical interventions to declines in mortality rates for
cardiovascular disease is still being assessed. The most important advances in medical
care for coronary heart disease and stroke may well have occurred after the beginning
of the decline in mortality (Hetzel & McMichael 1987). Recent Australian research has
found a decline in rates of coronary heart disease events as well as deaths, consistent
with reductions in risk-factor levels and improved acute medical treatment for the
period 1985 to 1993 (Dobson et al. 1999). 
Although a significant proportion of cardiovascular disease is preventable, the prevalence
of risk factors, such as tobacco smoking, high blood pressure, physical inactivity and poor
nutrition, that are amenable to change still remains high in the Australian population. It
has been estimated that 80% of all adult Australians have one modifiable cardiovascular
risk factor and 10% have three or more such factors (Tonkin et al. 1999). 
In Indigenous people, death rates from cardiovascular disease are about twice those of
non-Indigenous people. Among Indigenous Australians living in the Northern Territory
the occurrence of rheumatic heart disease is the highest recorded in the world; the
annual incidence of its precursor, acute rheumatic fever, for the years 1989 to 1993 was
between two and seven cases for every 1,000 children aged 5Ð14 years. In contrast, not
one non-Indigenous child suffered rheumatic fever over the same period (Carapetis &
Currie 1998).
Note: Age standardised to the population at 30 June 1991.
Source: AIHW National Mortality Database.
Figure 8.7: Death rates from cardiovascular causes, 1950 to 1998
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Cancer
Over the twentieth century, there has been an increase in the proportion of deaths in
Australia due to cancer. At the beginning of the century, cancer was the fifth leading
cause of death among Australians after deaths from infectious diseases, cardiovascular
disease, respiratory disease and injury (Cumpston 1989:133). Since then, cancer death
rates have increased as a proportion of all-cause mortality, and cancer is now second
only to cardiovascular disease as a major cause of death (AIHW 1998). Both the
incidence and mortality of cancer are higher among males than among females, and
there is also significant geographical and socioeconomic variation in cancer mortality
within the Australian population (Armstrong 1985).
Trends in cancer mortality are difficult to interpret because there are many different
types of cancer, each having different causes and some more amenable to treatment
than others. Identifying carcinogens (cancer-causing agents) has been controversial, but
it is now generally accepted that over 75% of cancers are associated with exposure to
environmental factors that interact with an individualÕs genetic make-up (Carroquino
et al. 1998). There is also a lag time of many years between contact with carcinogens and
the emergence of disease which makes it difficult to identify all the factors which may
have influenced the trends in death rates for cancer. 
Over the century, public health turned its attention to environmental factors such as
tobacco smoke, alcohol, air pollution, some industrial processes, manufactured
products, sun exposure, certain viruses and diet in order to understand their
relationship with cancer. Although some of these factors have proven amenable to
public health control measures, others have proved more difficult. Changes in
diagnosis, treatment and classification of cancers have also contributed to variations in
mortality patterns, particularly for certain types of cancer (Armstrong 1985).
The overall increases in mortality from cancer over the twentieth century reflect
changes in the age distribution of the population (due to increased life expectancy,
postwar baby booms and significant immigration) and in exposure to various
carcinogens, particularly tobacco. 
Analyses of trends in death rates over the century (Figure 8.8) have indicated that
overall cancer death rates among females increased between 1907 and 1920, plateaued
until approximately 1942, then declined through to the 1960s. Female cancer death rates
were stable in the 1960s and 1970s before increasing slightly in the 1980s through to the
mid-1990s. In males, there was an increase in cancer death rates during the period
1907Ð30 and then a significant increase after 1945, largely the result of a substantial rise
in lung cancer (Armstrong 1985). 
Tobacco consumption is by far the largest contributor to the increase in total cancer
deaths in the twentieth century, having its greatest effect on lung and oral cancers. By
the 1950s, Australia was in the grip of a smoking epidemic with 92 different types of
cigarettes on the market (Office of Prices, Victoria 1990). A rise in lung cancer deaths
followed as a direct result of increased tobacco consumption (Giles, Hill & Silver 1991).
Smoking rates have declined substantially in males over the last several decades
(AIHW 1996) and male deaths from lung cancer have subsequently declined since the
1970s (Figure 8.9, page 354). Smoking rates in females were much lower than in males
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until recent times, and consequently females have lower lung cancer rates. The decline
in smoking in females was less than in males and began much later. Due to the timelag
of about 20 years between exposure to carcinogens in tobacco smoke and the diagnosis
of cancer, lung cancer rates in females are expected to increase in the early 2000s.
Further information on trends in tobacco smoking can be found in section 3.4, page 148.
At the end of the twentieth century, tobacco smoking continued to be by far the most
important cause of cancer of the lung and is estimated to be responsible for
approximately 80% of lung cancer and 20% of all cancer deaths (English et al. 1995).
Reductions in the lung cancer death rate in the 1980s and 1990s was influenced by
changes in prices of tobacco products, decreases in tar content, tobacco advertising
reforms, and behavioural changes, resulting in smoking cessation (Giles, Hill & Silver
1991). However, although there have been overall reductions in smoking by Australians
over the last three decades, the gap in smoking prevalence between groups is widening;
individuals of higher socioeconomic status are more likely to avoid smoking, whereas
those who are socioeconomically disadvantaged continue to smoke at higher rates (Hill
et al. 1998). 
Note: Age standardised to the population at 30 June 1991.
Source: AIHW National Mortality Database.
Figure 8.8: Trends in death rates from all cancers in Australia, 1907 to 1998
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Occupational exposures, including exposure to asbestos, are estimated to be responsible
for 15% of lung cancers in males and air pollution is perhaps responsible for 5% of all
cases of lung cancer (Giles et al. 1988). Asbestos was used widely throughout Australia
by the 1950s and could be found in most homes, cars and workplaces. A substantial
mining industry also existed, exposing thousands of workers to large doses of asbestos
dust. In 1955, it was demonstrated that asbestos caused lung cancer. 
In women, breast cancer is currently the major cause of cancer deaths (AIHW 1998) with
deaths from colorectal (bowel) cancer and lung cancer in second and third places
respectively. Breast cancer mortality rose steadily from the early decades of the twentieth
century to peak in the early 1940s, decreased to the 1960s and 1970s before rising again
in the late 1980s (Smith et al. 1998). It is thought that the increase to the mid-1940s was
caused mainly by rapidly falling fertility in the late nineteenth century and the early
twentieth century. The increase in mortality of women born in the first 30 years of the
twentieth century is probably related to larger body size due to changes in nutrition
resulting in an earlier age of menarche and, therefore, greater oestrogen exposure (Smith
et al. 1998). Subsequent increases in fertility and earlier diagnosis may have contributed
to the fall in mortality between the 1940s and early 1960s. However, it is also likely that
improvements in survival have resulted from earlier detection through screening and
newer medical treatments for breast cancer (Hermon & Beral 1996).
Note: Death rates are age standardised to the population at 30 June 1991.
Source: ABS Yearbooks, various years; AIHW National Mortality Database.
Figure 8.9: Per capita consumption of tobacco products in Australia and death rates for 
lung cancer, 1903 to 1998
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Alcohol consumption has been associated with cancers of the upper gastrointestinal
tract and the liver and there is some evidence of changes in alcohol consumption
paralleling a trend in death rates from these cancers (Armstrong 1985). Sun exposure is
the main cause of skin cancers, and malignant melanoma of the skin is more common in
Australia than anywhere else in the world. Increases in deaths from other types of
cancer have been associated with a variety of carcinogens in the Australian
environment. During the twentieth century, an array of potentially carcinogenic
substances emerged as new industries and products were developed. These included
radiation, pesticides, mining dusts, benzene (in petrol, paints and printing inks),
chemicals used in the production of plastics and pharmaceuticals, and environmental
pollutants. The contribution of many of these substances to the trends in cancer
mortality remains to be measured. 
Not all cancers have shown an increase in death rates. Mortality rates for cancers of the
stomach, cervix, bowel (in females) and testes have all shown significant declines in the
adult population. Mortality rates in children have fallen substantially for leukaemia and
cancers of the brain and nervous system, due to an improvement in survival rates. 
Patterns of exposure to risk factors differ according to occupation, socioeconomic
groupings such as education and income, sex, race and ethnicity, and geographical
location, and some of these patterns have changed over the twentieth century. In general,
there is evidence of an inverse socioeconomic gradient for cancer mortality among both
males and females in Australia (Glover et al. 1999). The persisting socioeconomic
differences in cancer mortality at the end of the twentieth century are a reminder that
there is much in the social environment that contributes to malignant disease.
Injury
Over the twentieth century, although the contribution of injury to overall deaths in
Australia has remained relatively stable at around 6Ð7% of all deaths, there has been a
steady decline in death rates from this cause (AIHW 1998). Injury rates have been
consistently higher in males than in females in all categories for the entire period
(AIHW: dÕEspaignet et al. 1991) and there have been some substantial changes within
the injury categories (Figure 8.10, page 356). Most change has occurred in the accidental
death category with the emergence of motor vehicle accident deaths offset by a large
decrease in deaths from all other accidental causes (AIHW NISU 1999). The
contributions made by both suicide and homicide have remained relatively stable. In
the 1990s, injury was the fourth leading cause of death in Australia and is a major cause
of premature death. 
Accidental deaths
Accidental deaths were relatively common in the early part of the twentieth century
with drowning, burns, falls, work-related injuries and accidents with horses the most
significant contributors to mortality rates (Gordon 1976:217). Deaths from accidents
have always tended to have a greater impact on the younger age groups. In 1925,
deaths from external causes were the leading cause of death (26%) for those aged 15 to
24 years (Cumpston 1989:132). This pattern still applies today, particularly to deaths
from motor vehicle accidents. Drowning also remains a significant cause of injury
deaths for children aged 1 to 4 years, many of whom drown in swimming pools. 
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The advent of motor vehicles in the early years of the twentieth century brought with it
not only the advantages of more rapid transport and the ability to travel larger distances,
but also a significant burden of mortality and morbidity for the population. For much of
the century, road deaths accounted for a significant proportion of injury deaths in
Australia. Fatality rates rose steeply in the 1950s and 1960s, peaking in 1970. Since then,
the road accident death rates have decreased significantly despite an increase in the
average amount of road travel per person (AIHW NISU: OÕConnor 1995). This
improvement can be attributed to a number of interventions, including better vehicle,
road and traffic flow design; compulsory use of seat belts, child restraints and helmets for
cyclists and motorcyclists; lower speed limits; restrictions on the use of alcohol and other
drugs while driving; and public education campaigns (AIHW NISU: OÕConnor 1995).
Work-related fatalities have also made up a significant proportion of accidental deaths
through the century. Working conditions in the earlier part of the century were often
dangerous, involving substantial exposure to a range of toxic substances or immediate
physical risks. Occupational health and safety have only relatively recently become
matters of legislative concern in Australia, with some employers and unions previously
focusing more on agreed extra payments (Ôdanger moneyÕ) for working in risky or
hazardous environments (Deery & Plowman 1985:415). Occupational health hazards are
still present for many workers, with the complexity of modern work processes bringing
new problems as well as some improvements. 
Note: Age standardised to the population at 30 June 1991.
Source: AIHW National Mortality Database.
Figure 8.10: Death rates from accident or injury, 1907 to 1998
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Suicide
An analysis of trends in suicide over the past 100 years shows that the overall suicide
rate has remained relatively stable, fluctuating within a range between about
10Ð14 deaths per 100,000 population (DHAC 1998). The highest rates were recorded
during the Depression of the 1930s, and in the 1960s and into the 1990s (Hassan 1996).
The higher rates in the 1960s are likely to be related to the availability of medications
such as barbiturates that were then restricted in subsequent years (Oliver & Hetzel 1972). 
However, this relative stability hides some significant internal differences in the rates of
suicide of males and females in Australian society. The most striking feature over the
last 100 years is the change that has occurred in the age groups affected. Until the mid-
1960s, suicide was a problem mainly among the older age groups but since then there
has been a dramatic shift to the young. This increase in the suicide rate for the younger
age groups has been largely offset by significant reductions in suicide in middle-aged
and older Australians (Goldney & Harrison 1998). 
Suicide rates for males are significantly greater than those for females. The rate of
suicide among males aged 15Ð29 years has been increasing gradually over the last
30 years, although this upward trend may be levelling off (Glover et al. 1999). The rate
of suicide among males aged 15Ð24 years has trebled since 1960. There has been no
equivalent rise in the rate of suicide among young females. However, there is evidence
to suggest a higher rate of attempted suicide among females than males, particularly for
women under the age of 25 years (Ruzicka & Choi 1999; AIHW: Moon et al. 1999).
There is some evidence that risks for suicide increase significantly with decreasing
socioeconomic status in males, but this is not the case in females. It has been noted that
the fluctuations in male suicide rates over the century have coincided with periods of
high unemployment, whereas the rates for females have remained fairly stable at those
times (Morrell et al. 1993). Studies of the recent increase in suicides among the young
have suggested a number of contributing factors, including unemployment, changing
family structure, increasing violence and loss of autonomy (Hassan 1996). Suicide arises
from a complex interaction of psychological, social and environmental factors. Social
issues are important and there are also substantial data indicating the presence of
psychiatric illness in the majority of those who commit suicide (Goldney 1993).
Prevention efforts are now focusing on earlier detection of symptoms of illness and a
range of other interventions.
Deaths from interpersonal violence
Death rates from interpersonal violence have remained fairly constant during the
twentieth century and homicide remains a rare event relative to other forms of violent
death in Australia, such as suicide and road traffic accidents (James & Carcach 1997).
Between 1915 and 1997, the average homicide rate per year was 1.6 per 100,000
population (AIC 1999). The present rates of homicide are similar to those prevailing
from 1915 to 1925 (James & Carcach 1997). The homicide rate in Australia fell during the
period between 1930 and 1950 but then increased to a plateau of about 1.5 per 100,000
population in the 1960s and 1970s. An upward trend then once again became apparent,
reaching a level of around 2.0 per 100,000 population in the late 1980s and 1990s (James
& Carcach 1997). The lowest homicide rate this century was recorded in 1941, 0.8 per
100,000 population (AIC 1999). 
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Respiratory diseases
The death rate from respiratory diseases has decreased significantly over the twentieth
century (Figure 8.11) to a rate now less than half of that in the early decades (AIHW
1998). The dramatic spike in death rates from respiratory disease in 1919Ð20 reflects the
influenza pandemic. In 1921, the death rate from respiratory disease was 207 per
100,000 population. By 1941, the rate had fallen to 104 per 100,000 population. Between
1950 and 1996, the standardised death rate for diseases of the respiratory system fell for
males from 107 to 61 per 100,000 and for females from 63 to 38 per 100,000 population
(AIHW 1998). The causes of these respiratory deaths have also altered over the century.
For example, the contribution of occupational exposure to substances that cause
respiratory disease is thought to have decreased in importance. Early in the twentieth
century, mining activity was responsible for various lung diseases and became the
subject of government inquiries and trade union action, leading to major reforms
throughout mining and related industries (Cumpston 1989:166). In contrast, tobacco
smoking increased steadily throughout the century (with the exception of a fall in
1931Ð32) with substantial reductions in tobacco consumption occurring only since the
1970s. Pollution has also been associated with deaths from respiratory disease (Giles
et al. 1988), and it is likely that levels of different pollutants have been significant
contributors to deaths from respiratory disease over the twentieth century. 
Note: Age standardised to the population at 30 June 1991.
Source: AIHW National Mortality Database.
Figure 8.11: Death rates from respiratory diseases, 1907 to 1998
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Chronic obstructive pulmonary disease is the fourth leading cause of death in Australia
(AIHW 1998). There was a marked increase in death rates for this condition in the
postwar years with the death rate from chronic bronchitis in males doubling between
1950 and 1964 (Gordon 1976:222). This upward trend, like the rise in lung cancer, was
associated with increased tobacco consumption over the century. Male age-
standardised death rates for chronic obstructive pulmonary disease increased 160%
between 1964 and 1970, followed by a decline (Crockett et al. 1994). By 1990, the death
rate was 5% less than in 1964. Female age-standardised mortality, on the other hand,
showed a 260% increase from 1964 to 1990 (Crockett et al. 1994). These trends in
mortality from chronic obstructive pulmonary disease for males and females reflect
significant differences in their smoking habits over time (Hill et al. 1998). 
Deaths from pneumonia have fallen markedly with the availability of antibiotics in the
1940s. However, an even greater fall occurred in the three decades before this, probably
as a result of improvements in living conditions (Gordon 1976:233). The proportion of
deaths from pneumonia dropped from 47% of all male deaths from diseases of the
respiratory system in 1950 to 14% in 1986, and a similar trend occurred for females.
Death from pneumonia is now seen mainly in people at the extremes of the lifespan and
in those whose immunity is impaired. However, death from pneumonia is still
relatively frequent among Indigenous peoples.
Rates of death from asthma have risen in Australia, as they have worldwide from the
middle of the century onwards (Meza & Gershwin 1997), although asthma is still a
relatively infrequent cause of death. Asthma is a disease that is exacerbated by a wide
range of factors including infection, allergens, tobacco smoke and some environmental
pollutants (Landrigan et al. 1998). Early Australian studies found that the mortality rate
for asthma remained stable between 1900 and 1948. There was then an upward trend
with some peaking of death rates in the 1960s (AIH 1988). The evidence for an upward
trend in asthma deaths since the late 1940s appears to be real, despite changes in
classifications and differences in medical treatments (Bauman & Lee 1990). Death rates
for asthma peaked again in 1989 but have since declined. This may be partly due to
public health campaigns aimed at improving the awareness and management of the
disease (AIHW: Abraham et al. 1995).
Conclusion
The decline in mortality over the twentieth century in Australia has been dramatic.
Growth in income, increased educational levels and consequent improvements in food
intake, water quality and sanitation have accounted for much of the decline. Access to
new knowledge, medical treatments and vaccines has also been important. There have
been far-reaching consequences for every aspect of life: populations have aged, fertility
rates have decreased and better health has, in turn, contributed to social and economic
wellbeing. This has led to a major shift in causes of death from infectious diseases to
non-communicable diseases. 
As the twenty-first century unfolds, there will be a number of challenges. Ironically, one
of these challenges results from the success of the twentieth centuryÑas a consequence
of ageing and the effects of an affluent lifestyle, epidemics of non-communicable
diseases may persist, driving the demand for health resources for some years to come.
There is also the possibility of an emergence of new infectious diseases and the
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re-emergence of others. Finally, not everyone has shared equally in the benefits of better
health over the last 100 years. In the year 2000, although life expectancy for most
Australians has increased significantly, that of Indigenous peoples is at levels not seen
in the rest of the population since 1900. Large inequalities in death rates from many
causes also persist for disadvantaged populations in Australia, in spite of the long list of
achievements in health during the twentieth century. Reducing the inequalities will also
be a priority for the twenty-first century.
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Statistical tables
 
1.1 Population
Table S1: Estimated resident population by sex and age group, selected years, 1901 to 1999 
(number)
Age group 1901 1921 1941 1961 1981 1991 1999(a)
Males
0–4 172,957 307,300 299,900 573,700 583,218 652,302 653,209
5–14 450,067 570,800 575,300 1,056,600 1,321,340 1,290,729 1,357,900
15–24 366,146 457,900 627,900 776,100 1,320,618 1,405,897 1,378,722
25–34 320,455 451,800 593,900 728,000 1,244,663 1,416,512 1,447,687
35–44 279,558 369,500 496,000 737,900 931,360 1,319,366 1,460,891
45–54 156,674 281,300 432,400 627,800 772,879 960,260 1,277,628
55–64 99,170 208,400 307,600 427,800 661,984 734,081 845,044
65–74 64,716 90,900 173,100 266,300 426,174 548,636 621,531
75–84 18,731 29,300 70,900 102,300 158,247 243,406 323,697
85+ 2,207 4,700 7,500 15,800 27,784 44,220 74,189
All ages 1,977,928 2,771,900 3,584,500 5,312,300 7,448,267 8,615,409 9,440,498
Females
0–4 168,836 296,300 288,700 546,400 556,400 619,401 619,341
5–14 441,003 557,300 556,000 1,008,300 1,264,582 1,223,098 1,291,639
15–24 365,792 462,800 614,900 729,300 1,278,293 1,354,941 1,316,396
25–34 293,424 458,400 573,300 664,400 1,212,261 1,408,886 1,444,118
35–44 216,135 353,200 471,900 706,100 891,517 1,303,292 1,466,414
45–54 118,574 257,400 436,400 595,700 737,394 915,819 1,256,014
55–64 80,302 179,300 307,600 435,500 691,752 728,737 829,803
65–74 48,935 82,000 186,400 333,100 511,502 633,509 675,403
75–84 14,757 31,000 79,700 149,200 256,487 370,917 460,358
85+ 2,038 5,500 10,500 27,900 74,805 110,027 166,804
All ages 1,795,873 2,683,200 3,525,400 5,195,900 7,474,993 8,668,627 9,526,290
(a) Preliminary data.
Note: Population estimates are for 30 June of each year.
Sources: Commonwealth Statistician 1925; ABS Cat. No. 3201.0; AIHW National Population Database.
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Fertility and pregnancy
Table S2: Age-specific birth rates(a) and total fertility rates(b), 1921 to 1998 (live births per 
1,000 females)
Age group of mother (years) Total
fertility
rate
Less
than 20 20–24 25–29 30–34 35–39 40–44
45 and
over
Annual averages
1921–1925 27.3 133.7 167.0 137.0 96.9 40.4 4.2 3,032
1941–1945 23.9 126.9 152.8 114.3 66.3 21.1 1.7 2,535
1961–1965 46.5 204.0 207.2 122.4 59.2 17.5 1.2 3,289
1981–1985 25.7 100.8 144.5 82.0 25.4 4.4 0.3 1,915
1991–1995 21.2 71.6 128.3 104.2 39.3 6.4 0.3 1,857
Annual rates
1996 20.1 65.2 117.1 105.7 43.7 7.5 0.3 1,797
1997 19.5 62.3 113.8 106.7 44.9 7.5 0.3 1,775
1998 18.5 60.0 111.2 107.2 45.7 8.0 0.3 1,755
(a) Age-specific birth rates are the live births registered during the calendar year, according to age of mother, per 1,000 of 
the female resident population of the same age as estimated for 30 June.
(b) Total fertility rate is obtained by summing the 5-year age-specific birth rates and multiplying by 5. It represents the 
number of children 1,000 women would bear during their lifetimes if they experienced the rates of the year shown.
Sources: ABS 1977; ABS Cat. No. 3301.0.
Table S3: Age-specific birth rates(a) and total fertility rates(b), States and Territories, 1998 
(live births per 1,000 females)
State/ 
Territory
Age group of mother (years) Total
fertility
rate
Less
than 20 20–24 25–29 30–34 35–39 40–44
45 and
over
NSW 18.5 63.3 113.4 107.6 46.8 8.7 0.3 1,793
Vic 12.4 46.9 104.7 113.2 49.4 8.3 0.3 1,676
Qld 23.3 70.2 115.0 101.9 40.8 6.7 0.3 1,791
WA 20.9 61.1 113.5 105.5 44.0 7.3 0.4 1,764
SA 15.3 55.1 109.4 107.1 44.8 8.6 0.4 1,704
Tas 24.2 75.9 121.2 96.7 37.4 6.1 0.4 1,810
ACT 11.9 40.2 100.3 102.9 46.9 8.6 0.2 1,555
NT 68.7 105.0 118.7 93.6 44.9 7.6 0.7 2,196
Australia 18.5 60.0 111.2 107.2 45.7 8.0 0.3 1,755
(a) Age-specific birth rates are the live births registered during the calendar year, according to age of mother, per 1,000 of 
the female resident population of the same age as estimated for 30 June.
(b) Total fertility rate is obtained by summing the 5-year age-specific birth rates and multiplying by 5. It represents the 
number of children 1,000 women would bear during their lifetimes if they experienced the rates of the year shown.
Source: ABS 1999a.
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Table S4: Total fertility rates(a), crude birth rates(b) and male:female birth ratio, selected 
countries (latest available year)
Country
Total fertility rate Crude birth rate M:F birth ratio
Year Rate Year Rate Year ratio
Australia 1998 1,755 1998 13.3 1998 1.05
Australia 1996 1,797 1997 13.6 1996 1.06
Canada 1995 1,638 1997 12.1 1995 1.05
China 1990–95 1,918 1995–2000 16.2 1994 1.12
Denmark 1995 1,807 1997 12.8 1995 1.06
France 1996 1,721 1996 12.6 1994 1.05
Germany 1996 1,316 1997 9.6 1996 1.06
Greece 1995 1,319 1996 9.7 1995 1.08
Ireland 1996 1,879 1997 14.3 1996 1.09
Israel 1995 2,881 1996 21.3 1995 1.05
Italy 1995 1,187 1997 9.4 1995 1.06
Japan 1996 1,425 1997 9.5 1996 1.06
Korea, Republic of 1995 1,658 1995 15.6 1995 1.13
Malaysia 1990–95 3,620 1997 25.8 1996 1.06
Netherlands 1996 1,529 1997 12.3 1996 1.06
New Zealand 1994 2,040 1997 15.4 1993 1.07
Norway 1996 1,889 1997 13.6 1996 1.07
Philippines 1994 3,522 1995–2000 28.4 1993 1.09
Poland 1996 1,580 1997 10.7 1996 1.06
Russian Federation 1995 1,344 1995 9.2 1995 1.06
Singapore 1997 1,637 1997 12.7 1997 1.08
Spain 1995 1,170 1996 9.0 1995 1.06
Sweden 1996 1,606 1997 10.1 1996 1.04
Switzerland 1996 1,500 1997 11.2 1996 1.06
United Kingdom 1996 1,725 1996 12.5 1996 1.05
United States 1995 2,019 1996 14.8 1994 1.05
(a) Total fertility rate is obtained by summing the 5-year age-specific birth rates and multiplying by 5. It represents the 
number of children 1,000 women would bear during their lifetimes if they experienced the rates of the year shown.
(b) Live births per 1,000 mid-year population.
Sources: UN 1999; WHO 1998; ABS 1999a.
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Table S5: Birthweight distribution of total births(a), States and Territories, 1997
Births/birthweight NSW Vic Qld WA SA Tas ACT NT Australia
Births (Number)
Less than 2,500 g 5,414 4,056 3,310 1,675 1,307 320 360 358 16,800
All births 88,133 62,307 48,038 25,253 18,674 5,447 4,785 3,561 256,198
Birthweight (g) (Per cent)
Less than 500 0.2 0.3 0.3 0.3 0.4 0.4 0.2 0.4 0.3
500 to 999 0.5 0.5 0.6 0.5 0.6 0.4 0.7 0.7 0.5
1,000 to 1,499 0.5 0.6 0.7 0.7 0.7 0.5 1.1 0.8 0.6
1,500 to 1,999 1.2 1.2 1.4 1.3 1.3 1.1 1.5 2.0 1.3
2,000 to 2,499 3.8 3.8 3.9 3.9 4.1 3.5 4.0 6.3 3.9
Less than 2,500 6.1 6.5 6.9 6.6 7.0 5.9 7.5 10.2 6.6
2,500 to 2,999 15.3 15.5 14.6 16.3 14.7 13.4 13.4 18.2 15.2
3,000 to 3,499 36.2 36.3 35.6 36.4 35.5 33.3 35.1 35.5 36.0
3,500 to 3,999 30.6 30.2 30.7 30.0 31.0 33.9 32.0 27.1 30.5
4,000 to 4,499 10.0 9.7 10.4 9.3 10.0 11.3 10.0 7.6 9.9
4,500+ 1.7 1.8 1.8 1.4 1.8 2.2 1.9 1.3 1.7
(a) Includes live births and foetal deaths (stillbirths) with known birthweight. Totals include births with unstated 
birthweights.
Source: AIHW NPSU 1999.
Table S6: Infant mortality rates, States and Territories, selected years, 1901 to 1998 (per 1,000 
live births)
Year NSW Vic Qld WA SA Tas ACT NT Australia
1901 103.7 102.9 101.9 128.9 100.1 89.0 (a) 62.5 103.6
1921 62.6 72.5 54.2 78.3 65.5 78.0 74.1 63.3 65.7
1941 43.8 36.2 39.1 35.3 32.5 49.0 16.4 83.3 39.7
1961 20.8 17.8 20.0 19.7 20.0 16.8 15.6 23.9 19.5
1981 10.2 9.3 10.4 8.9 8.0 12.3 8.9 23.5 10.0
1991 7.2 6.5 7.6 7.2 5.5 9.0 7.6 14.2 7.1
1992 7.4 5.6 7.9 7.0 6.1 6.6 6.3 15.5 7.0
1993 6.2 5.4 7.0 5.9 5.2 5.9 4.3 15.3 6.1
1994 6.3 5.1 6.2 5.6 4.7 7.5 4.7 11.3 5.9
1995 5.7 4.9 6.3 5.1 5.8 5.8 4.8 13.3 5.7
1996 5.8 5.0 6.4 6.5 4.9 4.5 5.7 11.5 5.8
1997 5.2 4.9 5.8 5.3 4.7 6.5 3.8 12.5 5.3
1998 4.3 4.7 6.4 5.0 4.0 5.7 6.0 12.4 5.0
(a) Part of New South Wales prior to 1911.
Source: ABS Cat. No. 3101.0.
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Table S7: Perinatal mortality rates(a), by age group of mother, 1989 to 1998 (per 1,000 live births 
plus foetal deaths)
Year
Age group of mother (years)
Less
than 20 20–24 25–29 30–34 35–39
40 and
over Aust
1989 14.6 11.4 9.3 10.5 12.3 19.5 11.0
1990 15.3 11.4 10.0 10.9 13.2 20.0 11.3
1991 15.2 11.0 9.0 10.3 11.3 20.8 10.6
1992 14.1 11.1 9.2 9.8 11.6 18.0 10.7
1993 12.7 9.6 8.1 8.1 10.4 13.1 9.2
1994 12.0 9.3 7.6 8.4 10.8 14.8 9.1
1995 14.2 10.2 8.0 7.9 9.5 13.4 9.4
1996 14.0 10.9 8.4 8.9 9.9 17.3 10.0
1997 15.0 9.6 8.0 7.6 10.7 12.1 9.2
1998 13.0 8.9 7.4 6.9 9.6 12.6 8.3
(a) Perinatal deaths consist of foetal deaths (stillbirths) and neonatal deaths (within 28 days of birth). The perinatal 
mortality rate is defined as the number of deaths per 1,000 live births and foetal deaths combined.
Note: Data are based on year of registration and use the ABS definition for perinatal deaths of at least 400 grams 
birthweight or, where birthweight is unknown, at least 20 weeks gestation. Previous editions of Australia’s Health used the 
WHO definition of 500 grams birthweight and 22 weeks gestation.
Source: ABS Cat. No. 3303.0.
Table S8: Perinatal mortality rates(a), States and Territories, 1989 to 1998 (per 1,000 live births 
plus foetal deaths)
Year NSW Vic Qld WA SA Tas ACT NT Aust
1989 11.5 10.1 10.8 9.6 11.8 11.4 9.8 23.6 11.0
1990 11.7 11.6 10.2 10.4 11.0 10.6 13.8 18.1 11.3
1991 11.0 9.8 11.1 10.3 9.0 11.9 12.5 18.2 10.6
1992 11.8 9.4 10.6 9.8 9.9 9.1 9.4 19.3 10.7
1993 9.5 8.5 9.4 8.3 8.8 10.0 7.7 21.1 9.2
1994 9.2 9.3 8.9 8.3 8.5 8.4 6.9 16.9 9.1
1995 8.9 9.2 9.8 9.3 9.9 9.7 9.2 16.3 9.4
1996 11.0 8.8 10.0 10.2 8.6 9.5 8.8 12.6 10.0
1997 9.8 8.5 9.1 8.1 8.2 11.6 6.6 15.5 9.2
1998 8.1 7.7 9.6 7.5 7.2 9.8 12.2 13.1 8.3
(a) Perinatal deaths consist of foetal deaths (stillbirths) and neonatal deaths (within 28 days of birth). The perinatal 
mortality rate is defined as the number of deaths per 1,000 live births and foetal deaths combined.
Note: Data are based on year of registration and use the ABS definition for perinatal deaths of at least 400 grams 
birthweight or, where birthweight is unknown, at least 20 weeks gestation. Previous editions of Australia’s Health used the 
WHO definition of 500 grams birthweight and 22 weeks gestation.
Source: ABS Cat. No. 3303.0.
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Table S9: Neonatal, postneonatal and infant mortality rates(a), selected countries 
(latest available year) (per 1,000 live births)
Males Females
Neonatal
Post-
neonatal Infant Neonatal
Post-
neonatal Infant
Australia (1998) 3.7 1.8 5.5 3.0 1.5 4.5
Australia (1996) 4.2 2.3 6.5 3.4 1.6 5.0
Canada (1995) 4.5 2.2 6.7 3.8 1.7 5.5
China—rural (1994) n.a. n.a. 22.8 n.a. n.a. 22.2
China—urban (1994) n.a. n.a. 14.0 n.a. n.a. 12.1
Denmark (1995) 4.1 1.5 5.6 3.4 1.1 4.5
France (1995) 3.2 2.2 5.4 2.6 1.7 4.3
Germany (1996) 3.4 2.2 5.6 2.7 1.7 4.4
Greece (1995) 6.4 2.6 9.0 5.2 2.1 7.3
Ireland (1996) 4.3 1.6 5.9 3.5 1.6 5.1
Israel (1995) 5.1 2.4 7.5 4.0 2.2 6.2
Italy (1994) 5.3 1.9 7.2 4.3 1.5 5.8
Japan (1996) 2.2 1.9 4.1 1.8 1.6 3.4
Korea, Republic of (1995) n.a. n.a. 2.9 n.a. n.a. 2.4
Malaysia (1996) 6.7 3.3 10.0 5.3 2.8 8.1
Netherlands (1996) 4.6 1.7 6.3 3.8 1.3 5.1
New Zealand (1993) 3.8 3.9 7.7 3.6 3.1 6.7
Norway (1996) 2.8 1.7 4.5 2.2 1.4 3.6
Philippines (1993) 11.3 11.7 23.0 8.6 9.4 18.0
Poland (1996) 9.9 3.5 13.4 7.8 3.1 10.9
Russian Federation (1995) 12.8 7.9 20.7 9.1 6.5 15.6
Singapore (1996) 2.4 1.4 3.8 2.2 1.5 3.6
Spain (1995) 3.9 2.0 5.9 3.2 1.9 5.1
Sweden (1996) 2.5 1.7 4.2 2.5 1.2 3.7
Switzerland (1996) 3.7 1.6 5.3 2.8 1.2 4.0
United Kingdom (1996) 4.5 2.3 6.8 3.6 1.8 5.3
United States (1995) 5.3 3.0 8.3 4.4 2.4 6.8
(a) Neonatal: less than 28 days. Postneonatal: 28 to 364 days. Infant: less than 1 year.
Sources: ABS 1999b; UN 1999.
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Mortality  
 
Table S10: Life expectancy at selected ages by sex, 1901 to 1996Ð98 (years)
Year
At birth At age 15 At age 65
Males Females Males Females Males Females
Annual averages
1901–10 55.2 58.8 49.0 51.9 11.3 12.9
1920–22 59.2 63.3 51.4 54.6 12.0 13.6
1946–48 66.1 70.6 54.3 58.3 12.3 14.4
1960–62 67.9 74.2 55.1 61.0 12.5 15.7
1980–82 71.2 78.3 57.4 64.3 13.8 18.0
Annual rates
1990 73.9 80.1 59.8 65.8 15.2 19.0
1991 74.4 80.4 60.2 66.0 15.4 19.1
1992 74.5 80.4 60.3 66.1 15.4 19.2
1993 75.0 80.9 60.8 66.5 15.7 19.5
1994 75.0 80.9 60.8 67.0 15.7 19.7
1994–96(a) 75.2 81.1 60.9 66.7 15.8 19.6
1995–97(a) 75.6 81.3 61.3 66.9 16.1 19.8
1996–98(a) 75.9 81.5 61.5 67.1 16.3 20.0
(a) The methodology used to calculate this table has changed since 1995. Data on population and deaths averaged over 
3 years are now used to minimise year-to-year statistical variations.
Sources: ABS Cat. No. 3302.0; ABS unpublished data.
Table S11: Life expectancy at selected ages by sex, States and Territories, 1996Ð98 (years)
State/Territory
At birth At age 15 At age 65
Males Females Males Females Males Females
New South Wales 75.8 81.6 61.4 67.1 16.3 20.0
Victoria 76.3 81.7 61.9 67.2 16.4 20.0
Queensland 75.6 81.5 61.4 67.2 16.5 20.2
Western Australia 76.1 81.9 61.8 67.4 16.6 20.3
South Australia 76.0 81.6 61.6 67.1 16.3 20.0
Tasmania 75.1 80.4 60.9 66.0 15.7 19.3
Australian Capital Territory 77.5 81.6 63.0 67.2 17.1 20.0
Northern Territory 70.6 75.0 56.8 61.2 15.0 16.9
Australia 75.9 81.5 61.5 67.1 16.3 20.0
Note: The methodology used to calculate this table has changed since 1995. Data on population and deaths averaged over 
3 years are now used to minimise year-to-year statistical variations.
Sources: ABS Cat. No. 3302.0; ABS unpublished data.
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Table S12: Life expectancy at selected ages, selected countries, latest year (years)
Country/year
At birth At age 15 At age 65
Males Females Males Females Males Females
Australia (1996–98) 75.9 81.5 61.5 67.1 16.3 20.0
Australia (1995–97) 75.6 81.3 61.3 66.9 16.1 19.8
Canada (1995) 75.2 81.2 61.0 66.9 16.1 20.1
China (1990) 66.9 70.5 55.4 59.2 12.2 14.7
Denmark (1995) 72.8 77.9 58.5 63.4 14.1 17.6
France (1995) 73.9 81.9 59.5 67.4 16.1 20.6
Germany (1995) 73.3 79.8 58.9 65.4 14.7 18.6
Greece (1995) 75.0 80.2 60.9 66.0 16.1 18.4
Ireland (1993) 72.5 78.1 58.3 63.7 13.4 17.0
Israel (1995) 75.3 79.3 61.1 65.0 15.8 17.8
Italy (1994) 74.3 80.7 60.1 66.4 15.4 19.2
Japan (1996) 77.0 83.6 62.6 69.1 16.9 21.5
Korea, Republic of (1991) 67.7 75.7 53.9 61.9 12.3 16.1
Malaysia (1996) 69.3 74.1 55.7 60.2 12.7 14.7
Netherlands (1995) 74.6 80.4 60.3 66.0 14.7 19.1
New Zealand (1992–94) 73.4 79.1 59.3 64.9 15.0 18.8
Norway (1996) 75.4 81.1 60.9 66.5 15.5 19.5
Philippines (1991) 63.1 66.7 53.5 56.3 12.3 13.7
Poland (1995) 67.6 76.4 53.9 62.5 12.9 16.5
Russian Federation (1995) 58.3 71.7 45.1 58.4 10.8 14.9
Singapore (1997) 75.0 79.2 60.5 64.6 15.2 17.6
Spain (1994) 74.2 81.5 60.0 67.2 16.0 19.9
Sweden (1996) 76.5 81.5 62.0 66.9 16.1 19.7
Switzerland (1995–96) 75.7 81.9 61.3 67.4 16.3 20.3
United Kingdom (1996) 74.3 79.5 60.0 65.1 14.8 18.3
United States (1995) 72.5 78.9 58.4 64.7 15.6 18.9
Sources: UN 1999; ABS 1999b.
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Table S13: Age-specific, crude and age-standardised death rates, all causes by sex, selected 
years, 1921 to 1998 (per 100,000 population)
Sex/age group (years) 1921 1941 1961 1981 1991 1998
Males
0–4 2,213 1,289 564 281 191 137
5–9 200 139 49 34 20 15
10–14 172 108 52 29 22 19
15–19 219 159 123 124 88 75
20–24 321 205 161 153 128 125
25–29 373 199 146 133 127 134
30–34 442 232 169 123 133 151
35–39 584 339 229 165 161 152
40–44 730 461 380 261 198 188
45–49 994 737 588 455 313 248
50–54 1,299 1,161 992 790 517 398
55–59 1,895 1,775 1,614 1,294 885 684
60–64 2,878 2,774 2,619 1,983 1,543 1,180
65–69 4,199 4,251 4,117 3,231 2,489 2,002
70–74 6,199 6,479 6,252 5,195 3,927 3,359
75–79 10,076 10,054 9,312 8,018 6,547 5,351
80–84 15,368 15,264 14,084 12,112 10,548 9,292
85+ 26,213 29,453 23,772 20,814 17,571 16,484
Crude rate 1,106 1,099 946 815 744 719
ASR(a) 1,733 1,578 1,358 1,109 885 758
Females
0–4 1,771 1,022 443 216 151 111
5–9 192 103 38 18 14 9
10–14 128 73 30 20 15 14
15–19 205 104 47 45 37 37
20–24 290 155 61 48 45 39
25–29 377 202 74 51 54 42
30–34 426 234 92 57 54 53
35–39 535 311 146 87 77 77
40–44 563 374 209 143 111 108
45–49 690 565 347 265 187 163
50–54 943 780 542 378 307 264
55–59 1,289 1,103 785 617 484 398
60–64 1,915 1,805 1,298 971 797 654
65–69 3,112 2,884 2,178 1,568 1,305 1,043
70–74 5,041 4,789 3,652 2,552 2,187 1,819
75–79 8,295 8,275 6,271 4,426 3,797 3,145
80–84 13,136 12,704 10,241 7,597 6,487 5,994
85+ 22,345 25,457 20,670 16,035 14,351 13,414
Crude rate 873 901 745 646 635 638
ASR(a) 1,394 1,225 875 633 537 468
(a) Age standardised to the total Australian population at 30 June 1991.
Source: AIHW National Mortality Database.
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Table S14: Age-specific, crude and age-standardised death rates, all causes by sex, State or 
Territory of usual residence, 1998 (per 100,000 population)
Sex/age group (years) NSW Vic Qld WA SA Tas ACT NT Aust
Males
0–4 124 127 178 131 111 150 130 253 137
5–9 13 13 23 10 16 6 9 45 15
10–14 23 18 17 17 10 6 9 50 19
15–19 70 76 71 83 73 91 47 228 75
20–24 134 102 117 154 141 91 126 221 125
25–29 136 119 119 162 143 156 137 280 134
30–34 155 137 152 160 158 134 75 347 151
35–39 170 111 165 156 144 154 130 360 152
40–44 186 167 197 188 205 153 163 545 188
45–49 256 227 270 215 262 182 198 618 248
50–54 394 374 416 345 442 520 272 861 398
55–59 700 624 755 602 693 811 593 921 684
60–64 1,214 1,098 1,230 1,149 1,138 1,204 1,267 1,987 1,180
65–69 1,958 1,965 2,053 2,034 2,110 2,054 1,723 3,235 2,002
70–74 3,349 3,288 3,589 3,126 3,331 3,501 3,262 3,668 3,359
75–79 5,290 5,214 5,533 5,166 5,433 6,090 5,916 7,851 5,351
80–84 9,419 9,179 9,368 8,897 9,391 9,436 7,715 10,870 9,292
85+ 16,593 16,310 16,398 16,273 16,710 17,493 18,695 6,707 16,484
Crude rate 742 711 713 624 830 806 473 526 719
ASR(a) 761 730 781 737 768 795 733 997 758
Females
0–4 97 113 135 99 93 90 183 232 111
5–9 8 10 11 6 12 6 9 49 9
10–14 11 12 17 11 18 17 0 53 14
15–19 28 33 50 45 48 24 9 132 37
20–24 40 39 36 43 18 33 38 126 39
25–29 41 37 42 52 48 36 23 63 42
30–34 51 50 51 60 48 42 49 178 53
35–39 75 64 75 86 92 111 62 202 77
40–44 95 110 117 100 108 117 105 428 108
45–49 169 144 168 141 171 194 213 346 163
50–54 261 261 260 246 284 343 200 495 264
55–59 413 380 386 379 401 403 492 606 398
60–64 647 630 728 529 692 682 503 1,710 654
65–69 1,020 1,005 1,157 1,013 989 1,035 1,216 2,311 1,043
70–74 1,880 1,711 1,822 1,814 1,743 1,981 2,377 3,090 1,819
75–79 3,241 3,070 3,064 3,048 3,032 3,470 3,127 7,828 3,145
80–84 5,957 6,189 5,771 5,812 6,235 5,930 5,794 4,063 5,994
85+ 13,256 13,813 13,202 12,773 13,513 13,860 15,440 13,200 13,414
Crude rate 661 661 588 541 750 713 449 378 638
ASR(a) 467 464 472 450 469 489 503 783 468
(a) Age standardised to the total Australian population at 30 June 1991.
Source: AIHW National Mortality Database.
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Table S15: Age-specific, crude and age-standardised death rates, all causes, by sex, selected 
countries, latest year (per 100,000 population)
Country/year
Age group (years)
0(a) 1–4 5–14 15–24 25–34 35–44
Males
Australia (1998) 551 37 17 101 143 170
Australia (1995) 614 39 18 102 133 176
Canada (1995) 673 30 20 93 122 194
China—selected rural areas (1994) 2,275 158 69 95 164 289
China—selected urban areas (1994) 1,404 59 39 52 94 201
Denmark (1995) 557 37 19 74 127 239
France (1994) 671 33 21 102 175 290
Germany (1995) 592 35 17 89 113 241
Greece (1995) 896 23 21 98 124 191
Ireland (1993) 666 34 25 85 117 164
Israel (1995) 748 42 19 80 92 146
Italy (1993) 765 37 23 90 141 180
Japan (1994) 471 45 19 63 76 153
Korea, Republic of (1995) 289 67 42 111 172 354
Malaysia (1991) 1,350 95 59 142 182 293
Netherlands (1995) 625 38 19 61 77 158
New Zealand (1993) 784 47 19 159 134 210
Norway (1994) 579 22 18 73 97 175
Philippines (1990) 2,714 379 101 185 338 497
Poland (1995) 1,471 47 28 111 199 473
Russian Federation (1995) 2,067 122 69 334 649 1,195
Singapore (1995) 455 40 26 92 131 198
Spain (1994) 670 42 22 87 206 250
Sweden (1995) 453 20 13 56 81 160
Switzerland (1994) 573 41 25 112 160 200
United Kingdom (1995) 692 28 18 77 99 170
United States (1994) 881 47 27 146 209 333
(continued)
(a) Infant mortality per 100,000 births.
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Table S15 (continued): Age-specific, crude and age-standardised death rates, all causes, by sex, 
selected countries, latest year (per 100,000 population)
Country/year
Age group (years) Crude
rate ASR(b)45–54 55–64 65–74 75+
Males
Australia (1998) 320 909 2,622 8,550 720 742
Australia (1995) 349 1,025 2,889 9,135 737 802
Canada (1995) 402 1,112 2,933 9,184 760 853
China—selected rural areas (1994) 642 1,644 4,469 11,047 691 1,212
China—selected urban areas (1994) 422 1,238 3,898 11,483 628 1,099
Denmark (1995) 505 1,477 3,965 11,691 1,204 1,073
France (1994) 570 1,297 2,803 9,684 960 878
Germany (1995) 565 1,380 3,481 11,662 1,034 1,013
Greece (1995) 423 1,126 2,800 9,922 1,024 846
Ireland (1993) 447 1,489 4,317 12,456 959 1,133
Israel (1995) 376 1,124 3,014 10,153 657 859
Italy (1993) 433 1,228 3,106 10,050 1,029 907
Japan (1994) 380 1,039 2,387 8,895 783 768
Korea, Republic of (1995) 821 1,771 4,330 11,218 588 1,230
Malaysia (1991) 721 1,879 4,239 10,967 520 1,166
Netherlands (1995) 381 1,173 3,413 11,250 893 955
New Zealand (1993) 445 1,296 3,368 10,307 831 970
Norway (1994) 396 1,157 3,325 10,385 1,043 912
Philippines (1990) 922 1,822 3,765 10,832 610 1,247
Poland (1995) 1,052 2,395 4,810 12,831 1,095 1,423
Russian Federation (1995) 2,228 3,885 6,479 14,154 1,693 2,171
Singapore (1995) 493 1,489 3,772 9,192 589 975
Spain (1994) 500 1,194 2,876 9,544 939 893
Sweden (1995) 370 986 2,835 10,075 1,088 826
Switzerland (1994) 407 988 2,833 9,868 914 847
United Kingdom (1995) 422 1,267 3,669 11,016 1,082 974
United States (1994) 599 1,444 3,332 9,431 915 990
(continued)
(b) Age-standardised rate. Reference population is the European standard population (WHO 1995). Standard death rates 
in this table are different from standard rates in other tables because of the use of a different reference population.
02 AH2000 stat tables  Page 376  Thursday, June 1, 2000  2:18 PM
Statistical tables  377
TRIM SIZE 175 mm Wide x 250 mm Deep
Table S15 (continued): Age-specific, crude and age-standardised death rates, all causes, by sex, 
selected countries, latest year (per 100,000 population)
Country/year
Age group (years)
0(a) 1–4 5–14 15–24 25–34 35–44
Females
Australia (1998) 449 29 12 38 47 92
Australia (1995) 515 30 16 38 50 89
Canada (1995) 553 25 16 33 47 96
China—selected rural areas (1994) 2,216 145 46 80 125 189
China—selected urban areas (1994) 1,208 50 25 33 55 116
Denmark (1995) 452 24 13 30 50 149
France (1994) 504 25 15 35 62 117
Germany (1995) 464 26 14 34 47 117
Greece (1995) 728 21 14 28 44 88
Ireland (1993) 555 28 13 25 44 106
Israel (1995) 615 39 13 30 35 94
Italy (1993) 645 35 17 29 51 94
Japan (1994) 376 36 12 25 38 84
Korea, Republic of (1995) 244 60 28 53 68 123
Malaysia (1991) 1,160 80 38 57 88 171
Netherlands (1995) 464 28 14 28 45 110
New Zealand (1993) 677 48 20 53 64 116
Norway (1994) 463 30 16 30 39 91
Philippines (1990) 2,122 340 81 90 146 240
Poland (1995) 1,243 38 17 34 56 157
Russian Federation (1995) 1,562 96 39 95 155 317
Singapore (1995) 330 28 21 39 50 109
Spain (1994) 536 32 17 28 65 96
Sweden (1995) 349 14 9 26 40 86
Switzerland (1994) 446 30 13 39 62 99
United Kingdom (1995) 541 24 13 29 46 107
United States (1994) 720 38 18 48 78 146
(continued)
(a) Infant mortality per 100,000 births.
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Table S15 (continued): Age-specific, crude and age-standardised death rates, all causes, by sex, 
selected countries, latest year (per 100,000 population)
Country/year
Age group (years) Crude
rate ASR(b)45–54 55–64 65–74 75+
Females
Australia (1998) 210 516 1419 6697 639 489
Australia (1995) 216 567 1,563 7,078 649 522
Canada (1995) 248 639 1,622 6,797 665 522
China—selected rural areas (1994) 445 1,074 2,750 8,437 586 845
China—selected urban areas (1994) 279 851 2,577 9,230 544 776
Denmark (1995) 368 970 2,430 9,023 1,199 707
France (1994) 237 502 1,211 7,406 839 454
Germany (1995) 284 628 1,831 8,980 1,130 596
Greece (1995) 187 491 1,540 8,872 894 571
Ireland (1993) 279 809 2,353 9,477 842 709
Israel (1995) 196 697 2,040 8,704 618 631
Italy (1993) 222 548 1,510 7,787 911 535
Japan (1994) 192 440 1,133 6,025 632 423
Korea, Republic of (1995) 289 684 2,106 8,463 456 667
Malaysia (1991) 427 1,176 3,192 9,087 402 850
Netherlands (1995) 257 638 1,668 8,101 863 565
New Zealand (1993) 307 838 1,977 7,685 743 625
Norway (1994) 253 621 1,663 7,828 991 551
Philippines (1990) 452 963 2,373 9,307 425 837
Poland (1995) 379 911 2,453 10,485 911 791
Russian Federation (1995) 684 1,390 3,189 11,574 1,330 1,058
Singapore (1995) 278 839 2,308 7,092 452 634
Spain (1994) 206 473 1,300 7,417 792 501
Sweden (1995) 233 570 1,502 7,634 1,035 512
Switzerland (1994) 217 516 1,338 7,405 860 486
United Kingdom (1995) 279 750 2,180 8,601 1,121 624
United States (1994) 330 842 1,990 7,449 838 612
(b) Age-standardised rate. Reference population is the European standard population (WHO 1995). Standard death rates 
in this table are different from standard rates in other tables because of the use of a different reference population.
Sources: WHO 1998; AIHW National Mortality Database.
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Table S16: Age-standardised death rates(a), by sex and ICD-9 chapter, selected years, 1921 to 
1998 (per 100,000 population)
ICD-9 chapter or disease 1921 1941 1961 1971 1981 1991 1996 1997 1998
Males
Infectious and parasitic(b) 210 93 17 10 5 6 12 10 8
Neoplasms 157 179 197 222 242 237 234 223 220
Endocrine, nutritional(c) 16 24 16 23 18 24 24 22 22
Blood diseases 10 6 4 3 3 3 2 2 2
Mental disorders 7 4 5 9 9 13 19 17 18
Nervous system diseases 47 26 15 12 13 16 19 15 16
Circulatory diseases 387 635 759 763 565 381 326 305 284
Respiratory diseases 207 149 108 124 98 78 71 84 77
Digestive diseases 59 57 39 31 36 29 24 23 22
Genito-urinary diseases 126 138 44 24 16 14 13 13 13
Skin diseases 5 3 2 1 1 1 1 1 1
Musculoskeletal diseases 7 5 4 4 3 3 3 2 2
Congenital diseases 9 10 10 8 7 5 4 5 4
Perinatal diseases 54 43 20 17 7 5 4 4 4
Ill-defined conditions 315 103 15 7 6 5 3 3 4
Injury and poisoning 117 104 104 105 81 65 61 60 61
All causes 1,733 1,577 1,358 1,361 1,109 885 820 790 758
Females
Infectious and parasitic(b) 158 58 9 6 4 4 5 5 5
Neoplasms 159 163 139 138 136 144 141 137 133
Endocrine, nutritional(c) 26 40 20 22 15 15 16 16 15
Blood diseases 13 6 5 3 3 2 2 2 2
Mental disorders 3 3 2 6 6 9 15 12 12
Nervous system diseases 36 22 9 9 8 12 13 12 11
Circulatory diseases 345 523 514 509 347 246 211 200 187
Respiratory diseases 160 115 45 43 32 34 38 48 43
Digestive diseases 58 40 23 18 20 19 15 15 15
Genito-urinary diseases 67 76 20 17 12 10 10 10 10
Complications of pregnancy 24 14 2 1 — — — — —
Skin diseases 5 3 2 1 — 1 1 1 1
Musculoskeletal diseases 9 6 4 5 4 5 5 4 4
Congenital diseases 7 9 8 8 6 4 3 4 3
Perinatal diseases 40 33 15 13 5 4 4 3 3
Ill-defined conditions 250 74 14 6 4 3 2 2 2
Injury and poisoning 34 40 42 46 30 25 21 22 22
All causes 1,394 1,225 875 848 633 537 501 494 468
(a) Age standardised to the total Australian population at 30 June 1991.
(b) From 1996, includes AIDS and AIDS-related deaths.
(c) Prior to 1996, includes AIDS and AIDS-related deaths.
Source: AIHW National Mortality Database.
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Table S17: Age-standardised death rates(a), by sex and ICD-9 chapter, States and Territories, 
1998 (per 100,000 population)
ICD-9 chapter or disease NSW Vic Qld WA SA Tas ACT NT Aust
Males
Infectious and parasitic(b) 10 7 8 6 9 5 8 20 8
Neoplasms 217 222 229 215 212 225 232 201 220
Endocrine, nutritional 18 27 22 19 25 15 9 43 22
Blood diseases 3 2 2 1 3 2 6 — 2
Mental disorders 21 20 13 14 17 13 9 19 18
Nervous system diseases 16 15 14 18 14 20 16 25 16
Circulatory diseases 291 265 296 265 291 312 270 327 284
Respiratory diseases 77 71 80 73 83 85 69 126 77
Digestive diseases 22 21 21 21 26 20 28 43 22
Genito-urinary diseases 12 14 12 15 13 14 15 14 13
Skin diseases 1 1 1 2 1 1 — 1 1
Musculoskeletal diseases 2 3 2 2 2 1 2 — 2
Congenital diseases 3 4 5 4 3 3 3 3 4
Perinatal diseases 3 4 5 3 3 5 4 10 4
Ill-defined conditions 2 3 5 11 4 13 2 14 4
Injury and poisoning 62 50 65 72 62 61 60 151 61
All causes 761 730 781 737 768 795 733 997 758
Females
Infectious and parasitic(b) 5 4 3 5 5 5 4 17 5
Neoplasms 131 135 132 129 134 136 157 156 133
Endocrine, nutritional 12 19 16 16 14 10 15 66 15
Blood diseases 1 2 2 1 2 1 2 4 2
Mental disorders 12 14 11 13 10 10 12 15 12
Nervous system diseases 11 12 10 13 10 14 13 13 11
Circulatory diseases 193 177 193 172 189 199 183 257 187
Respiratory diseases 44 42 40 40 47 49 47 114 43
Digestive diseases 15 15 16 16 15 16 20 26 15
Genito-urinary diseases 11 11 10 8 9 9 14 35 10
Complications of pregnancy — — — — — — — — —
Skin diseases 1 1 1 1 1 1 — — 1
Musculoskeletal diseases 3 4 4 3 3 4 6 5 4
Congenital diseases 2 3 3 2 3 3 5 6 3
Perinatal diseases 3 3 4 2 3 2 5 7 3
Ill-defined conditions 2 2 3 5 2 7 3 3 2
Injury and poisoning 20 20 25 25 21 22 16 58 22
All causes 467 464 472 450 469 489 503 783 468
(a) Age standardised to the total Australian population at 30 June 1991.
(b) Includes AIDS and AIDS-related deaths.
Source: AIHW National Mortality Database.
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Table S18: Age-standardised death rates(a), by selected ICD-9 chapters and sex, selected 
countries, latest year (per 100,000 population)
ICD-9 chapter
Infectious
& parasitic Neoplasms Circulatory Respiratory
Injury &
poisoning All causes
Males
Australia (1998) 8 221 273 72 59 742
Australia (1995) 7 235 320 66 57 802
Canada (1995) 6 238 307 79 63 841
China—selected rural 
areas (1994) 40 206 371 326 106 1,212
China—selected urban 
areas (1994) 18 234 428 203 58 1,099
Denmark (1995) 14 275 408 94 75 1,073
France (1994) 12 285 240 60 92 878
Germany (1995) 7 263 443 72 60 1,013
Greece (1995) 6 221 381 48 61 846
Ireland (1993) 6 274 515 159 55 1,133
Israel (1995) 14 197 366 37 52 859
Italy (1993) 4 276 350 62 59 907
Japan (1994) 14 228 233 117 64 768
Korea, Republic of (1995) 31 276 316 73 131 1,230
Netherlands (1995) 7 282 358 100 40 955
New Zealand (1993) 5 261 421 100 71 970
Norway (1994) 7 229 390 83 61 912
Poland (1995) 11 301 687 59 123 1,423
Russian Federation 
(1995) 38 307 1,052 142 395 2,171
Singapore (1995) 23 257 338 208 60 975
Spain (1994) 11 261 292 93 59 893
Sweden (1995) 6 191 393 60 58 826
Switzerland (1994) 20 248 322 64 82 847
United Kingdom (1995) 6 258 411 144 41 974
United States (1994) 14 244 389 90 85 990
(continued)
(a) Reference population is the European standard population (WHO 1998). Standard death rates in this table are different 
from the rates in other tables because of the use of a different reference population.
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Table S18 (continued): Age-standardised death rates(a), by selected ICD-9 chapters and sex, 
selected countries, latest year (per 100,000 population)
ICD-9 chapter
Infectious
& parasitic Neoplasms Circulatory Respiratory
Injury &
poisoning All causes
Females
Australia (1998) 5 139 194 45 22 489
Australia (1995) 4 146 222 36 23 522
Canada (1995) 5 156 185 42 25 515
China—selected rural 
areas (1994) 22 115 267 241 71 845
China—selected urban 
areas (1994) 8 126 319 142 38 776
Denmark (1995) 6 209 247 62 38 707
France (1994) 7 127 140 27 39 454
Germany (1995) 4 156 278 29 24 596
Greece (1995) 4 115 303 31 19 571
Ireland (1993) 4 181 308 95 22 709
Israel (1995) 10 160 268 26 26 631
Italy (1993) 2 144 235 23 24 535
Japan (1994) 7 111 154 48 25 423
Korea, Republic of (1995) 9 109 212 32 48 667
Netherlands (1995) 6 159 205 43 20 565
New Zealand (1993) 3 179 267 59 27 625
Norway (1994) 5 154 219 52 26 551
Poland (1995) 4 156 421 21 34 791
Russian Federation 
(1995) 8 140 633 38 94 1,058
Singapore (1995) 15 146 254 125 20 634
Spain (1994) 6 119 206 34 17 501
Sweden (1995) 5 142 221 36 24 512
Switzerland (1994) 8 139 198 29 36 486
United Kingdom (1995) 4 174 245 90 17 624
United States (1994) 10 162 245 55 29 612
(a) Reference population is the European standard population (WHO 1998). Standard death rates in this table are 
different from the rates in other tables because of the use of a different reference population.
Sources: WHO 1996, 1998.
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Table S19: Age-standardised death rates(a), States and Territories, by major causes of death, 
1994Ð98 and changes from 1989Ð93 to 1994Ð98
Cause of death NSW Vic Qld WA SA Tas ACT NT
Ischaemic heart disease
Males 195.3 182.4 203.2 181.3 196.2 207.7 170.6 184.4
% change 89–93 to 94–98 –17.9 –20.6 –16.9 –19.8 –21.0 –16.7 –8.7 –16.5
Females 111.2 100.7 113.0 98.3 105.9 110.2 85.2 97.5
% change 89–93 to 94–98 –21.7 –20.0 –17.0 –18.0 –21.3 –22.5 –12.9 –18.8
Cerebrovascular disease (stroke)
Males 67.1 59.1 62.0 60.7 64.3 70.8 60.8 81.7
% change 89–93 to 94–98 –11.9 –8.6 –14.4 –10.4 –14.9 –2.9 4.7 20.0
Females 60.4 52.6 56.6 52.7 57.4 61.3 53.1 68.5
% change 89–93 to 94–98 –21.4 –19.0 –14.2 –8.7 –9.4 –16.6 5.8 42.8
Lung cancer
Males 53.8 55.9 56.2 55.0 52.9 61.2 40.1 88.2
% change 89–93 to 94–98 –8.6 –7.6 –4.9 –6.6 –8.5 –8.5 –23.0 28.4
Females 18.3 19.8 17.3 19.8 16.7 21.4 16.9 34.8
% change 89–93 to 94–98 14.9 22.4 35.4 8.7 14.5 12.3 –9.3 49.5
Chronic obstructive pulmonary disease
Males 44.7 45.5 43.9 39.7 39.3 55.6 38.7 86.8
% change 89–93 to 94–98 –15.9 –19.0 –19.4 –19.8 –24.2 –15.1 –25.7 –26.6
Females 19.0 18.8 15.9 15.7 15.0 25.0 18.2 58.6
% change 89–93 to 94–98 13.2 13.6 19.4 20.1 28.2 26.2 –9.3 –0.9
Colorectal cancer
Males 27.6 30.9 28.5 28.8 28.0 33.7 32.9 20.7
% change 89–93 to 94–98 –5.1 –4.9 –2.2 6.6 –1.9 9.2 –4.2 –8.2
Females 17.7 20.7 18.3 18.4 18.9 23.8 22.3 22.3
% change 89–93 to 94–98 –7.6 –7.4 –5.1 –6.7 –0.3 2.1 –11.2 47.6
All causes
Males 816.3 793.5 807.0 784.9 805.4 885.1 729.2 1,107.2
% change 89–93 to 94–98 –8.6 –10.8 –9.7 –7.4 –9.9 –9.1 –8.0 –14.7
Females 499.0 492.2 484.5 474.6 489.0 548.8 456.0 764.1
% change 89–93 to 94–98 –10.3 –8.5 –5.3 –2.0 –4.9 –7.7 –4.2 –3.1
(a) Age standardised to the total Australian population at 30 June 1991.
Source: AIHW National Mortality Database.
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Infectious diseases 
Table S20: Selected notifiable diseases, 1995 to 1998
Disease
Notifications Rate per 100,000 population
1995 1996 1997 1998 1995 1996 1997 1998
Arbovirus infection, nec 67 52 18 81 0.4 0.3 0.1 0.4
Barmah Forest virus infection 756 837 704 558 4.7 4.6 3.8 3.0
Brucellosis 29 38 41 45 0.2 0.2 0.2 0.2
Campylobacteriosis 10,933 12,158 11,848 13,439 91.6 100.4 96.7 108.3
Chancroid 2 3 1 1 — — — —
Chlamydial infection(a) 6,411 8,420 9,126 11,405 53.7 69.6 74.5 87.7
Cholera 5 4 3 4 — — — —
Dengue fever 34 43 210 557 0.2 0.2 1.1 3.0
Donovanosis(a) 85 50 45 31 0.8 0.5 0.4 0.3
Gonococcal infection 3,259 4,173 4,689 5,428 18.1 22.8 25.3 29.0
Haemophilus influenzae type b 74 51 53 35 0.4 0.3 0.3 0.2
Hepatitis A 1,601 2,150 3,076 2,503 8.9 11.7 16.6 13.4
Hepatitis B—incident 321 225 247 261 1.8 1.2 1.3 1.4
Hepatitis B—unspecified npr npr 7,114 6,682 npr npr 38.4 35.6
Hepatitis C—incident 69 72 81 343 0.8 0.8 0.5 2.2
Hepatitis C—unspecified(b) 9,601 9,489 19,689 19,261 91.8 89.3 106.3 102.7
Hepatitis, nec 55 36 29 19 0.3 0.2 0.2 0.1
Hydatid infection 46 45 61 46 0.3 0.2 0.3 0.4
Legionellosis 160 192 161 271 0.9 1.0 0.9 1.4
Leprosy 7 10 14 3 — 0.1 0.1 —
Leptospirosis 148 227 126 197 0.8 1.2 0.7 1.1
Listeriosis 58 70 71 58 0.3 0.4 0.4 0.3
Malaria 625 849 746 705 3.5 4.6 4.0 3.8
Measles 1,324 498 852 306 7.3 2.7 4.6 1.6
Meningococcal infection 382 426 499 455 2.1 2.3 2.7 2.4
Mumps 153 128 191 183 1.0 0.9 1.0 1.0
Ornithosis 176 85 46 56 1.5 0.7 0.4 0.6
Pertussis 4,297 4,031 10,668 6,432 23.8 22.0 57.6 34.3
Q fever 473 555 593 571 2.6 3.0 3.2 3.0
Ross River virus infection 2,602 7,823 6,683 3,094 14.4 42.7 36.1 16.5
Rubella 4,380 2,845 1,446 772 24.3 15.5 7.8 4.1
Salmonellosis, nec 5,895 5,819 7,004 7,700 32.7 31.8 37.8 41.1
Shigellosis 734 676 799 615 6.1 5.6 6.5 5.0
Syphilis 1,854 1,523 1,304 1,689 10.3 8.3 7.0 9.0
Tetanus 7 2 8 7 — — — —
Tuberculosis 1,073 1,067 1,008 982 5.9 5.8 5.4 5.2
Typhoid(c) 69 84 77 69 0.4 0.5 0.4 0.4
Yersiniosis, nec 306 268 245 207 2.6 2.2 2.0 1.7
(a) New South Wales not included in the calculation rates for 1998 as only notifiable since September 1998.
(b) Data for South Australia and New South Wales were included for the first time in 1997.
(c) Includes paratyphoid in New South Wales and Victoria, and Queensland from July 1996.
Note: In the period 1995–98 there were no reported cases of the following notifiable diseases: diphtheria, plague, 
poliomyelitis, rabies, viral haemorrhagic fever, yellow fever. There was 1 case of lymphogranuloma venereum in 1995. There 
was 1 case of botulism in 1998.
Source: DHAC 1999a.
02 AH2000 stat tables  Page 384  Thursday, June 1, 2000  2:18 PM
Statistical tables  385
TRIM SIZE 175 mm Wide x 250 mm Deep
Table S21: Characteristics of AIDS cases, by age, sex, State/Territory, exposure category and 
defining condition, 1987 to 1998
Description 1987–89 1990 1991 1992 1993 1994 1995 1996 1997 1998
Total cases 1,947 674 802 787 844 950 798 653 351 265
Median age (years)
Males 36 37 37 38 37 37 37 37 39 39
Females 35 33 32 32 38 31 34 34 31 35
Per cent males 96.6 97.2 96.4 95.2 94.4 94.8 95.5 95.0 92.3 94.0
State/Territory (per cent)
NSW 62.4 62.9 55.1 54.5 57.0 57.8 58.0 54.8 51.9 57.4
Vic 20.2 18.2 23.0 21.1 21.3 20.0 20.2 20.7 20.8 19.2
Qld 7.5 8.5 10.5 11.4 10.8 10.3 12.6 11.5 16.2 12.5
WA 4.7 4.2 4.7 5.8 3.8 4.3 3.8 5.8 4.0 4.2
SA 3.4 3.7 4.7 4.2 5.3 5.3 3.8 4.6 5.7 3.0
Tas 0.5 0.6 0.4 1.3 0.1 0.5 0.2 1.1 0.6 0.7
NT 0.1 0.4 0.6 0.6 0.6 0.3 0.4 0.1 0.8 1.1
ACT 1.1 1.5 1.0 1.0 1.1 1.5 1.0 1.4 — 1.9
Exposure category (per cent)
Male homosexual/bisexual 
contact 88.1 87.3 83.5 82.1 81.0 83.3 81.7 79.9 75.5 69.7
Male homosexual/bisexual 
contact and ID use 3.2 2.9 3.9 5.0 6.9 5.0 5.2 5.8 3.3 3.3
ID use (female and 
heterosexual male) 1.6 2.3 3.9 2.1 3.3 3.2 3.5 3.9 4.9 6.6
Heterosexual contact 1.3 3.1 4.9 6.6 6.4 5.8 6.4 8.3 14.5 18.0
Haemophilia/coagulation 
disorder 1.8 1.8 1.4 1.7 1.4 1.1 2.0 1.0 1.2 0.4
Receipt of blood/tissue 3.9 2.1 2.0 2.0 1.0 1.0 0.7 1.1 0.3 1.2
Mother with/at risk for 
HIV infection 0.1 0.5 0.4 0.5 — 0.6 0.5 — 0.3 0.8
Other/undetermined 1.8 2.7 3.1 3.2 3.8 3.6 4.4 5.5 6.0 7.9
AIDS-defining condition (per cent)
Pneumocystis carinii 
pneumonia (PCP) 38.8 29.8 31.3 26.9 22.1 22.4 19.8 22.5 25.9 23.8
Kaposi’s sarcoma (KS) 15.8 10.7 12.1 12.3 11.0 10.0 10.9 11.5 10.0 9.4
PCP and other (not KS) 6.6 8.5 6.0 6.3 3.8 2.5 4.1 4.4 7.4 8.3
Oesophageal candidiasis 5.1 7.5 7.7 8.8 11.7 14.4 16.4 14.7 8.8 8.7
Other(a) 33.7 47.5 42.8 45.7 51.4 50.7 48.8 46.9 47.8 49.8
(a) Includes Mycobacterium avium and HIV wasting disease.
Source: NCHECR 1999.
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Table S22: Leading cancers(a), new cases and deaths by type and sex, 1996
Cancer
New cases Deaths
Number Per cent ASR(b)
Lifetime
risk(c) Number Per cent ASR(b) PYLL(d)
Males
Prostate 10,055 23.5 117.4 1 in 10 2,644 13.8 33.0 6,228
Colorectal 6,067 14.2 69.2 1 in 17 2,474 12.9 28.8 17,788
Lung 5,228 12.2 60.1 1 in 19 4,743 24.7 55.0 31,038
Melanoma 4,313 10.1 48.0 1 in 25 580 3.0 6.7 6,955
Bladder 1,921 4.5 22.4 1 in 56 543 2.8 6.6 2,108
NHL(e) 1,718 4.0 19.4 1 in 63 707 3.7 8.2 6,750
Unknown primary 1,625 3.8 19.0 1 in 72 1,189 6.2 14.1 7,663
Kidney 1,209 2.8 13.7 1 in 84 460 2.4 5.4 3,583
Stomach 1,190 2.8 13.8 1 in 91 752 3.9 8.8 5,373
Lip 826 1.9 9.2 1 in 131 5 0.0 0.1 63
All cancers 42,733 100.0 489.1 1 in 3 19,196 100.0 225.5 140,070
Females
Breast 9,621 27.5 95.5 1 in 12 2,619 17.6 24.9 30,955
Colorectal 4,931 14.1 46.0 1 in 26 2,132 14.3 19.0 13,115
Melanoma 3,448 9.9 35.0 1 in 34 323 2.2 3.0 3,820
Lung 2,393 6.9 23.0 1 in 47 2,021 13.6 19.1 14,983
Unknown primary 1,406 4.0 12.5 1 in 109 1,142 7.7 10.0 6,015
NHL(e) 1,387 4.0 13.3 1 in 85 681 4.6 6.2 5,135
Uterus 1,316 3.8 12.9 1 in 83 273 1.8 2.5 1,468
Ovary 1,166 3.3 11.4 1 in 98 797 5.4 7.6 7,290
Cervix 923 2.6 9.4 1 in 130 301 2.0 2.9 4,253
Pancreas 801 2.3 7.2 1 in 201 822 5.5 7.2 3,413
All cancers 34,933 100.0 338.8 1 in 4 14,893 100.0 136.9 121,228
(a) Rankings are based on the number of new cases; excludes non-melanocytic skin cancers.
(b) Per 100,000 population, age standardised to the Australian population at 30 June 1991.
(c) Lifetime risk—a measure which approximates the risk of contracting a particular cancer in a lifetime if the risks at the 
year of estimation remained throughout a person’s life. For the purposes of this table, ‘lifetime’ is defined as ages 
0–74.
(d) Potential years of life lost between the ages of 0 and 74 years.
(e) Non-Hodgkin’s lymphoma.
Sources: AIHW & AACR 1999; AIHW National Mortality Database.
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Table S23: Major cancers, age-standardised incidence rates(a), by sex, 1988 to 1996 (per 100,000 
population)
Cancer 1988 1989 1990 1991 1992 1993 1994 1995 1996
Males
Prostate 70.6 75.5 85.3 92.4 104.2 140.9 158.3 144.0 117.4
Colorectal 62.1 63.8 64.3 67.4 66.0 66.3 67.4 68.1 69.2
Lung 66.9 67.0 68.5 66.0 64.9 62.7 64.8 60.6 60.1
Melanoma 40.9 38.7 39.0 39.1 42.4 43.8 43.7 46.4 48.0
Bladder 23.6 22.4 21.9 20.5 22.1 22.4 23.9 23.7 22.4
NHL(b) 15.8 16.0 17.3 18.2 19.0 18.7 17.7 17.6 19.4
Stomach 16.5 15.3 16.4 15.3 15.2 15.3 14.7 15.1 13.8
Kidney 10.9 11.4 12.0 13.3 13.0 12.8 13.1 13.7 13.7
Pancreas 9.4 9.7 10.0 9.6 9.7 9.5 10.2 9.3 9.4
Testis 4.3 4.6 4.8 5.2 5.6 5.5 6.0 5.7 6.0
All cancers 427.7 431.6 448.4 457.9 476.5 507.5 530.6 510.4 489.1
Females
Breast 79.1 81.9 83.2 88.2 85.7 92.7 100.3 101.1 95.5
Colorectal 43.4 44.3 44.5 47.2 47.3 46.0 47.5 46.1 46.0
Melanoma 33.4 29.6 30.5 30.7 32.5 32.7 32.6 34.4 35.0
Lung 19.5 20.0 21.0 21.5 21.3 22.4 22.5 22.7 23.0
NHL(b) 10.8 11.2 11.1 12.2 12.6 12.3 12.7 13.4 13.3
Uterus 12.3 11.8 12.0 12.6 13.2 13.1 13.9 13.6 12.9
Cervix 12.8 12.3 12.3 12.4 11.2 11.0 11.9 9.9 9.4
Kidney 6.6 6.3 6.8 7.4 8.1 7.4 7.2 7.3 7.6
Pancreas 6.9 6.5 6.8 7.1 7.3 7.2 7.0 7.2 7.2
Stomach 6.8 6.7 6.5 6.8 6.4 6.1 5.9 6.4 6.0
Bladder 6.9 6.1 5.9 5.3 5.3 5.9 6.1 6.1 5.7
All cancer 309.8 308.0 314.2 327.0 327.9 332.2 342.1 345.7 338.8
(a) Age standardised to the Australian population at 30 June 1991.
(b) Non-Hodgkin’s lymphoma.
Source: AIHW & AACR 1999.
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Table S24: Major cancers, average annual age-standardised incidence rates(a), by sex, States 
and Territories 1992Ð96 and Australia 1996 (per 100,000 population)
Cancer NSW Vic Qld WA SA Tas ACT NT Aust(b)
Males
Prostate 135.2 124.0 127.0 150.5 142.8 156.7 149.0 74.7 117.4
Colorectal 66.5 68.8 69.7 64.1 67.0 67.8 65.9 50.5 69.2
Lung 61.2 62.0 66.0 64.7 61.8 68.2 46.4 85.5 60.1
Melanoma 45.8 33.3 63.2 49.5 39.4 34.7 37.4 32.8 48.0
Bladder 18.3 30.0 28.9 15.1 17.0 28.5 17.6 11.5 22.4
NHL(c) 19.2 19.3 18.0 16.1 18.0 16.5 20.5 10.7 19.4
Stomach 14.3 15.5 14.2 16.0 14.6 16.0 14.7 10.2 13.8
Kidney 13.9 12.1 15.0 10.3 13.5 14.3 11.9 10.1 13.7
Pancreas 9.6 9.5 9.8 9.7 9.8 10.7 9.4 11.0 9.4
Testis 5.7 5.8 6.0 5.5 6.0 5.9 5.6 4.5 6.0
Females
Breast 94.4 96.6 93.5 98.2 96.3 93.8 95.2 65.2 95.5
Colorectal 44.3 47.6 50.3 43.5 48.2 50.9 44.3 42.7 46.0
Melanoma 30.8 28.3 45.6 36.1 34.5 30.5 28.4 18.9 35.0
Lung 56.1 57.8 58.0 57.4 55.3 60.7 46.4 92.8 23.0
NHL(c) 12.9 13.4 12.7 11.8 13.0 12.3 14.8 9.5 13.3
Uterus 12.3 14.9 14.0 11.8 14.6 12.4 11.8 12.7 12.9
Cervix 10.8 10.5 12.0 11.1 7.8 11.5 9.0 21.8 9.4
Kidney 8.2 6.7 8.7 6.2 7.1 5.8 5.5 6.0 7.6
Pancreas 7.7 6.8 6.9 6.9 7.3 6.9 5.7 5.6 7.2
Stomach 5.7 6.6 6.3 6.5 6.3 6.7 5.5 4.9 6.0
Bladder 4.6 7.5 8.2 3.2 4.0 6.7 3.7 4.6 5.7
(a) Age standardised to the Australian population at 30 June 1991.
(b) State and Territory averages for 1992–96 do not equate to a single-year average for Australia.
(c) Non-Hodgkin’s lymphoma.
Source: AIHW & AACR 1999.
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Table S25: Major cancers, age-standardised incidence rates(a), by sex, selected countries 
1988Ð92 and Australia 1992 and 1996 (per 100,000 population)
Males Colorectal Lung Melanoma Prostate Stomach All cancers(b)
Australia 1992 46.6 44.3 32.4 63.4 10.4 327.2
Australia 1996 49.5 41.9 37.3 79.1 9.3 351.6
Canada 43.0 65.4 7.7 64.7 10.6 322.1
England and Wales(c) 33.9 62.4 4.6 28.0 16.1 261.1
Italy (Venice) 35.4 81.9 6.1 26.8 19.9 355.9
Japan (Osaka) 34.2 43.5 0.2 6.8 65.0 272.8
Netherlands 36.4 73.0 6.9 39.6 15.4 288.4
New Zealand (non-Maori) 51.3 46.5 25.0 37.8 11.0 290.3
United States (black) 46.4 99.1 0.7 137.0 14.5 454.5
United States (white) 42.4 61.3 13.1 100.8 7.5 370.9
Females Colorectal Lung Melanoma Breast Stomach All cancers(b)
Australia 1992 32.6 15.0 26.3 69.4 4.1 247.2
Australia 1996 33.0 16.9 29.0 78.4 4.1 263.5
Canada 30.5 28.0 6.9 76.8 4.5 252.8
England and Wales(c) 23.7 22.8 6.6 68.8 6.3 225.5
Italy (Venice) 24.3 13.9 7.0 72.6 8.8 230.6
Japan (Osaka) 19.9 12.4 0.2 24.3 27.3 154.8
Netherlands 27.8 13.0 9.8 79.6 6.1 225.0
New Zealand (non-Maori) 40.8 18.2 29.8 77.2 4.8 274.6
United States (black) 35.3 38.5 0.5 79.3 5.9 271.6
United States (white) 29.5 33.8 10.2 90.7 3.1 280.9
(a) Age standardised to the World Standard Population.
(b) Excludes non-melanocytic skin cancer.
(c) 1988–90.
Source: Parkin et al. 1997.
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Table S26: Primary teeth with caries experience(a), 5- to 10-year-old school children, 
1989 to 1996 (mean number of teeth)
Age (years)
5 6 7 8 9 10
1989 2.07 2.15 2.38 2.31 2.26 1.88
1990 1.85 2.06 2.20 2.31 2.28 1.78
1991 1.78 1.94 2.13 2.24 2.22 1.81
1992 1.80 1.95 1.93 2.21 2.11 1.74
1993 1.76 1.90 2.01 2.15 2.13 1.73
1994 1.56 1.79 1.95 2.13 2.01 1.71
1995 1.49 1.73 1.87 2.05 1.97 1.61
1996 1.26 1.45 1.66 1.68 1.72 1.47
(a) As measured by dmft index (number of decayed, missing and filled primary teeth).
Source: AIHW Dental Statistics and Research Unit Child Dental Health Survey.
Table S27: Permanent teeth with caries experience(a), 6- to 12-year-old school children, 
1989 to 1996 (mean number of teeth)
Age (years)
6 7 8 9 10 11 12
1989 0.09 0.26 0.46 0.65 0.83 1.37 1.56
1990 0.10 0.24 0.42 0.63 0.76 1.00 1.44
1991 0.09 0.24 0.40 0.56 0.83 0.91 1.29
1992 0.09 0.21 0.38 0.53 0.69 0.90 1.22
1993 0.08 0.22 0.36 0.51 0.66 0.90 1.10
1994 0.11 0.23 0.37 0.47 0.65 0.88 1.09
1995 0.10 0.20 0.36 0.46 0.57 0.79 1.01
1996 0.07 0.18 0.30 0.38 0.49 0.66 0.90
(a) As measured by DMFT index (number of decayed, missing and filled permanent teeth).
Source: AIHW Dental Statistics and Research Unit Child Dental Health Survey.
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Table S28: Dental caries experience(a) of 6-year-old and 12-year-old school children, 
States and Territories, 1989 to 1996 (mean number of teeth)
NSW Vic Qld WA SA Tas ACT NT Aust
6-year-olds (dmft)
1989 2.21 2.16 2.34 1.62 2.21 1.70 1.17 2.04 2.15
1990 2.20 2.10 2.43 1.54 1.88 1.59 1.15 2.08 2.06
1991 2.05 2.04 2.48 1.29 1.98 1.57 1.14 1.96 1.94
1992 2.00 2.05 2.37 1.32 1.53 1.48 1.09 1.99 1.95
1993 2.04 1.81 2.18 1.48 1.38 1.35 1.33 1.81 1.90
1994 1.93 1.67 2.27 1.37 1.17 (c) 1.17 1.99 1.79
1995 1.75 1.78 1.99 1.39 1.47 1.48 1.39 1.99 1.73
1996 0.94 1.61 2.25 1.30 1.17 1.37 0.89 1.79 1.45
12-year-olds (DMFT)
1989 1.32 1.54 1.65 2.04 1.52 1.06 1.14 1.08 1.56
1990 1.32 (b) 1.69 1.75 1.26 1.11 1.03 1.18 1.44
1991 1.18 1.38 1.54 1.43 1.06 1.18 0.91 1.26 1.29
1992 1.19 1.77 1.50 1.22 1.04 0.98 0.76 0.91 1.22
1993 1.04 1.52 1.44 1.20 0.64 0.96 0.77 0.85 1.10
1994 1.11 1.28 1.37 1.07 0.59 (c) 0.69 0.81 1.09
1995 0.93 1.02 1.37 1.04 0.64 0.86 0.61 0.82 1.01
1996 0.64 1.09 1.30 0.99 0.47 0.96 0.56 0.71 0.90
(a) As measured by dmft or DMFT index (number of decayed, missing and filled primary or permanent teeth).
(b) Insufficient numbers examined to provide an estimate.
(c) Data not available for Tasmania in 1994.
Source: AIHW Dental Statistics and Research Unit unpublished data.
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Cardiovascular risk factors
Table S29: Cardiovascular disease risk factors by age, 1995 (per cent)
Risk factor Sex
Age group
18–24 25–34 35–44 45–54 55–64 65–74 75+ 18+(a)
Diabetes type 2 Male 0.0(b) 0.1* 0.8 2.7 5.3* 8.7 8.7* 1.9(c)
Female 0.2(b)* 0.4* 0.6 2.2 4.1 6.6* 6.8 1.5(c)
High blood cholesterol(d) Male 18.1(e) 32.4 52.7 66.7 60.5 61.7(f) — 46.6(g)
Female 17.2(e) 32.2 30.9 52.3 66.7 97.0(f) — 38.6(g)
High blood pressure(h) Male 2.5* 3.7 9.6 20.2 34.3* 45.3* 49.0* 17.3
Female 0.6 0.9* 4.3 15.1 32.2* 46.8 60.8* 15.0
Overweight(i) Male 35.6 58.1 66.0 75.6 75.6 70.5 60.1 63.1
Female 25.9 33.9 44.4 56.4 66.5 62.1 53.1 47.8
Physical inactivity(j) Male 24.1 30.7 35.9 38.6 38.4 35.7 45.5 33.5
Female 27.4 30.0 34.2 34.7 36.9 43.6 54.1 33.8
Smoking(k) Male 29.7 34.4 29.7 25.6 21.6* 16.4 10.0 27.1
Female 26.8 ** 21.3 18.2 16.0 10.6 6.1 20.3
* Should be interpreted with caution as the relative standard error is between 25% and 50%.
** Not included as the relative standard error is greater than 50%.
(a) Age standardised to the Australian population at 30 June 1991.
(b) Persons aged 15–24 years.
(c) Persons aged 15 years and over.
(d) Most recent data are for 1989. High blood cholesterol is defined as above 5.5 mmol/L.
(e) Persons aged 20–24 years.
(f) Persons aged 65–69 years.
(g) Persons aged 20–69 years.
(h) High blood pressure is defined as systolic blood pressure ‡  160 mm Hg and/or diastolic blood pressure ‡  95 mm Hg 
and/or receiving treatment for high blood pressure.
(i) Overweight is defined as Body Mass Index (BMI) ‡  25.
(j) Physical inactivity is defined as no leisure-time physical activity for recreation or exercise in the previous two weeks.
(k) The daily smoking of tobacco products, including packet cigarettes, roll-your-own cigarettes, pipes and cigars.
Sources: AIHW analysis of the 1995 National Health Survey and 1995 National Nutrition Survey; Risk Factor Prevalence 
Study Management Committee 1990. 
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Table S30: Separations from public hospitals, by age group and sex, States and Territories,
1997Ð98
Age group NSW Vic Qld WA SA Tas ACT NT Total
Males
Under 1 25,586 16,342 12,608 5,916 6,380 964 919 1,619 70,334
1–4 32,779 19,738 17,849 8,768 8,758 1,453 1,303 1,586 92,234
5–14 39,815 22,865 21,397 10,276 9,687 1,915 1,548 1,340 108,843
15–24 41,599 27,943 29,460 11,190 10,458 2,569 2,436 1,652 127,307
25–34 50,372 37,465 33,919 18,172 14,884 3,946 2,457 2,731 163,946
35–44 56,557 43,170 38,479 18,871 17,101 4,221 3,871 4,625 186,895
45–54 66,933 50,877 41,854 19,821 19,037 4,687 4,245 3,838 211,292
55–64 77,202 65,174 46,375 21,060 20,839 5,814 4,445 3,221 244,130
65–74 108,680 85,736 51,233 27,299 28,261 7,444 4,530 2,191 315,374
75+ 92,155 62,257 36,702 20,212 26,593 5,965 2,273 636 246,793
Total 591,679 431,569 329,876 161,585 161,998 38,978 28,027 23,441 1,767,153
Females
Under 1 18,213 11,210 9,797 4,006 4,380 711 724 1,377 50,418
1–4 21,387 12,580 12,529 6,213 5,937 1,151 1,009 1,182 61,988
5–14 25,636 16,128 15,136 7,590 7,287 1,537 1,093 959 75,366
15–24 69,650 51,273 46,758 21,280 21,431 4,892 3,147 4,146 222,577
25–34 118,654 96,493 66,422 34,182 34,059 7,506 5,670 6,224 369,210
35–44 79,017 62,602 44,954 25,112 22,272 5,196 4,121 4,920 248,194
45–54 66,257 53,800 39,136 20,109 18,854 5,015 3,328 4,234 210,733
55–64 69,614 52,939 35,537 18,793 17,960 4,038 3,566 3,758 206,205
65–74 94,701 64,557 40,894 22,535 23,865 5,620 3,718 1,465 257,355
75+ 117,988 75,691 44,306 24,955 28,739 5,737 2,772 672 300,860
Total 681,118 497,277 355,469 184,775 184,784 41,403 29,148 28,940 2,002,914
Total 
separations 1,272,797 928,847 685,345 346,363 346,782 80,389 57,175 52,400 3,770,098
Note: Totals include separations for which age and/or sex was not reported.
Source: AIHW 1999.
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Table S31: Separations from private hospitals, by age group and sex, States and Territories,
1997Ð98
Age group NSW Vic Qld WA SA Tas ACT NT Total
Males
Under 1 3,332 3,150 2,360 1,274 626 626 738 n.a. 12,106
1–4 5,176 3,846 4,168 1,976 1,479 628 215 n.a. 17,488
5–14 7,049 6,026 5,599 2,712 1,899 1,032 341 n.a. 24,658
15–24 14,500 13,340 9,048 5,155 4,404 1,197 671 n.a. 48,315
25–34 18,993 15,986 10,508 6,109 5,020 1,481 537 n.a. 58,634
35–44 27,074 22,613 15,991 7,631 6,984 2,241 764 n.a. 83,298
45–54 39,216 31,723 26,578 11,209 10,520 3,508 1,083 n.a. 123,837
55–64 38,737 34,090 28,016 10,483 9,709 3,008 1,087 n.a. 125,130
65–74 47,368 42,850 36,541 12,040 12,637 4,044 1,241 n.a. 156,721
75+ 38,852 36,610 36,444 12,524 10,819 3,563 958 n.a. 139,770
Total 240,297 210,234 175,253 71,113 64,097 21,328 7,635 n.a. 789,957
Females
Under 1 2,156 2,007 1,559 896 387 495 660 n.a. 8,160
1–4 3,052 2,348 2,787 1,368 1,000 390 130 n.a. 11,075
5–14 5,956 5,232 4,524 2,260 1,685 808 235 n.a. 20,700
15–24 24,133 17,774 12,912 8,546 5,096 2,403 744 n.a. 71,608
25–34 50,411 41,951 32,397 16,535 10,575 5,103 1,879 n.a. 158,851
35–44 46,437 39,458 29,959 14,268 10,968 4,326 1,743 n.a. 147,159
45–54 46,297 42,309 32,110 13,822 13,287 4,495 1,499 n.a. 153,819
55–64 37,908 34,441 26,810 10,518 10,512 3,244 1,098 n.a. 124,531
65–74 43,493 40,785 33,505 9,999 12,728 3,833 1,039 n.a. 145,382
75+ 44,140 47,660 36,262 11,030 17,085 4,572 908 n.a. 161,657
Total 303,999 273,965 212,825 89,242 83,323 29,669 9,935 n.a. 1,002,958
Total 
separations 544,351 484,201 388,078 160,358 147,420 50,997 17,571 n.a. 1,792,976
Note: Totals include separations for which age and/or sex was not reported.
Source: AIHW 1999.
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Table S32: Patient-days in public hospitals, by age group and sex, States and Territories,
1997Ð98(a)
Age 
group NSW Vic Qld WA SA Tas ACT NT Total
Males
Under 1 128,242 90,705 61,661 31,832 30,319 4,343 7,198 11,240 365,540
1–4 64,392 35,590 33,394 18,188 15,540 2,732 2,933 7,097 179,866
5–14 79,855 45,036 72,626 24,774 19,951 4,205 3,673 5,057 255,177
15–24 175,560 91,404 174,292 45,563 38,061 8,416 10,034 7,160 550,490
25–34 252,224 120,330 173,207 65,306 49,661 17,982 7,904 10,214 696,828
35–44 213,862 138,006 163,151 62,007 53,917 32,993 13,974 13,731 691,641
45–54 274,117 165,420 173,645 75,563 65,338 16,116 12,425 11,253 793,877
55–64 374,446 216,218 196,317 81,876 76,905 20,912 15,430 10,874 992,978
65–74 580,883 360,979 250,083 115,074 137,215 41,719 23,002 9,877 1,518,832
75+ 687,921 437,745 270,916 149,148 203,419 49,039 17,940 4,814 1,820,942
Total 2,831,520 1,701,448 1,569,292 669,331 690,326 198,457 114,513 91,337 7,866,224
Females
Under 1 99,416 69,192 51,977 23,621 25,612 4,164 5,291 10,171 289,444
1–4 43,970 22,906 23,877 13,426 11,410 2,004 2,018 5,994 125,605
5–14 57,807 34,959 33,126 19,369 15,502 3,327 2,636 4,023 170,749
15–24 208,225 134,380 125,873 67,323 53,860 14,922 9,487 14,111 628,181
25–34 399,124 276,274 201,875 111,361 97,726 23,042 18,105 18,653 1,146,160
35–44 268,074 177,174 156,034 80,009 67,457 16,120 12,751 13,056 790,675
45–54 234,674 157,255 143,471 69,931 58,613 15,499 11,619 10,496 701,558
55–64 267,807 180,426 170,199 65,272 61,007 19,139 18,341 8,339 790,530
65–74 489,553 311,301 216,353 111,184 118,870 38,967 18,987 5,432 1,310,647
75+ 1,066,911 662,837 398,002 229,838 286,489 61,347 29,496 5,350 2,740,270
Total 3,135,563 2,027,013 1,520,787 791,334 796,546 198,531 128,731 95,643 8,694,148
Total 
patient- 
days 5,967,083 3,728,462 3,090,079 1,460,677 1,486,872 396,996 243,244 187,016 16,560,429
(a) Information on patient-days has been updated since it was published in AIHW 1999.
Note: Totals include separations for which age and/or sex was not reported.
Source: AIHW 1999.
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Table S33: Patient-days in private hospitals, by age group and sex, States and Territories,
1997Ð98(a)
Age 
group NSW Vic Qld WA SA Tas ACT NT Total
Males
Under 1 16,227 12,744 11,956 5,968 2,301 2,552 4,085 n.a. 55,838
1–4 7,121 4,558 5,525 2,496 1,619 790 223 n.a. 22,427
5–14 12,153 12,092 8,242 3,487 2,479 1,674 390 n.a. 40,518
15–24 24,687 27,799 17,129 8,473 8,529 2,415 1,035 n.a. 90,066
25–34 35,724 40,608 20,570 11,532 9,651 3,099 931 n.a. 122,115
35–44 51,222 47,539 34,022 15,183 15,464 5,234 1,564 n.a. 170,228
45–54 85,271 72,523 65,285 24,984 25,182 9,122 2,696 n.a. 285,063
55–64 97,530 86,823 73,195 28,127 27,455 8,893 3,592 n.a. 325,615
65–74 154,371 148,791 137,983 46,498 43,550 15,740 4,807 n.a. 551,740
75+ 183,413 203,856 212,840 70,775 56,528 19,590 5,992 n.a. 752,994
Total 667,719 657,333 586,747 217,523 192,758 69,109 25,315 n.a. 2,416,504
Females
Under 1 12,750 9,825 9,904 5,121 1,879 2,294 3,783 n.a. 45,556
1–4 4,219 2,792 3,895 1,705 1,115 558 131 n.a. 14,415
5–14 11,130 9,281 6,717 2,983 2,272 1,365 290 n.a. 34,038
15–24 45,095 40,088 29,166 16,056 11,224 5,637 1,523 n.a. 148,789
25–34 144,649 137,542 102,216 54,310 36,474 16,206 7,632 n.a. 499,029
35–44 113,474 108,977 80,662 39,831 34,193 12,746 5,945 n.a. 395,828
45–54 111,235 110,534 81,080 36,393 38,942 13,086 4,642 n.a. 395,912
55–64 102,074 101,145 73,914 31,002 34,690 11,214 3,845 n.a. 357,884
65–74 152,754 159,594 129,529 41,773 56,478 18,053 5,029 n.a. 563,210
75+ 265,661 347,064 270,531 75,935 126,734 30,716 6,726 n.a. 1,123,369
Total 963,076 1,026,842 787,614 305,109 344,001 111,875 39,546 n.a. 3,578,063
Total 
patient- 
days 1,630,910 1,684,185 1,374,361 522,636 536,759 180,984 64,866 n.a. 5,994,701
(a)  Information on patient-days has been updated since it was published in AIHW 1999.
Note: Totals include separations for which age and/or sex was not reported.
Source: AIHW 1999.
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Table S34: Separations, same-day separations, patient-days and average length of stay by 
principal diagnosis, grouped into ICD-9-CM chapters, public hospitals, 1997Ð98
Principal diagnosis Separations
Per cent
same-day
separations
Patient-
days(a)
ALOS
(days)
ALOS
(days)
excluding
same-day
001–139 Infectious and parasitic 67,861 21.4 259,010 3.8 4.6
140–239 Neoplasms 221,538 40.4 1,181,853 5.3 8.3
240–279 Endocrine, nutritional 53,892 32.6 280,775 5.2 7.2
280–289 Blood diseases 53,060 59.3 129,169 2.4 4.5
290–319 Mental disorders 160,651 25.0 2,652,540 16.5 21.7
320–389 Nervous system diseases 152,063 54.5 470,354 3.1 5.6
390–459 Circulatory diseases 313,282 17.6 1,828,424 5.8 6.9
460–519 Respiratory diseases 260,595 12.0 1,173,208 4.5 5.0
520–579 Digestive diseases 351,952 46.6 1,023,890 2.9 4.6
580–629 Genito-urinary diseases 218,135 48.2 612,599 2.8 4.5
630–677 Complications of pregnancy 330,624 22.0 1,039,342 3.1 3.7
680–709 Skin disorders 68,104 36.6 319,765 4.7 6.8
710–739 Musculoskeletal diseases 142,081 37.3 628,340 4.4 6.5
740–759 Congenital anomalies 25,067 42.5 96,161 3.8 5.9
760–779 Perinatal diseases 39,033 8.9 378,955 9.7 10.6
780–799 Ill-defined conditions 228,293 36.5 593,884 2.6 3.5
800–999 Injuries and poisoning 328,652 28.1 1,372,673 4.2 5.4
V01–V82 Other 754,186 86.5 2,462,850 3.3 17.8
Not reported 1,029 18.2 56,637 55.0 67.0
Total 3,770,098 43.1 16,560,429 4.4 7.0
(a) Information on patient-days has been updated since it was published in AIHW 1999.
Note: ALOS = average length of stay.
Source: AIHW 1999.
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Table S35: Separations, same-day separations, patient-days and average length of stay by 
principal diagnosis, grouped into ICD-9-CM chapters, private hospitals, 1997Ð98
Principal diagnosis Separations
Per cent
same-day
separations
Patient-
days(a)
ALOS
(days)
ALOS
(days)
excluding
same-day
001–139 Infectious and parasitic 11,313 28.3 48,587 4.3 5.6
140–239 Neoplasms 156,532 52.9 595,599 3.8 7.0
240–279 Endocrine, nutritional 14,713 26.6 73,948 5.0 6.5
280–289 Blood diseases 14,612 53.3 37,633 2.6 4.4
290–319 Mental disorders 74,306 60.8 535,559 7.2 16.8
320–389 Nervous system diseases 143,573 67.1 240,088 1.7 3.0
390–459 Circulatory diseases 120,300 22.9 631,892 5.3 6.5
460–519 Respiratory diseases 70,899 10.8 329,843 4.7 5.1
520–579 Digestive diseases 311,589 70.3 575,739 1.8 3.9
580–629 Genito-urinary diseases 145,205 58.2 340,524 2.3 4.2
630–677 Complications of pregnancy 103,510 30.6 428,610 4.1 5.5
680–709 Skin disorders 29,874 57.6 107,438 3.6 7.1
710–739 Musculoskeletal diseases 170,302 37.2 662,923 3.9 5.6
740–759 Congenital anomalies 9,546 48.8 21,451 2.2 3.4
760–779 Perinatal diseases 9,066 6.0 66,046 7.3 7.7
780–799 Ill-defined conditions 89,795 49.4 195,062 2.2 3.3
800–999 Injuries and poisoning 74,734 22.6 392,803 5.3 6.5
V01–V82 Other 242,601 80.7 706,880 2.9 10.9
Not reported 506 54.9 4,076 8.1 16.7
Total 1,792,976 53.1 5,994,701 3.3 6.0
(a) Information on patient-days has been updated since it was published in AIHW 1999.
Note: ALOS = average length of stay.
Source: AIHW 1999.
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Table S36: Separations, same-day separations, patient-days and average length of stay by 
principal procedure, grouped into ICD-9-CM chapters, public hospitals, 1997Ð98
Principal procedure Separations
Per cent
same-day
separations
Patient-
days(a)
ALOS
(days)
ALOS
(days)
excluding
same-day
010–059 Operations on the nervous 
system 51,577 41.3 238,030 4.6 7.9
060–079 Operations on the endocrine 
system 5,433 2.9 23,177 4.3 4.4
080–169 Operations on the eye 63,053 67.1 99,620 1.6 4.8
180–209 Operations on the ear 27,566 70.9 36,600 1.3 4.6
210–299 Operations on the nose, 
mouth and pharynx 86,410 48.0 170,908 2.0 3.8
300–349 Operations on the 
respiratory system 33,901 36.4 251,046 7.4 11.6
350–399 Operations on the 
cardiovascular system 489,280 81.9 1,000,362 2.0 11.3
400–419 Operations on the haemic 
and lymphatic system 15,669 45.7 98,384 6.3 11.6
420–549 Operations on the digestive 
system 379,546 54.7 1,284,139 3.4 7.5
550–599 Operations on the urinary 
system 67,328 48.6 242,519 3.6 7.0
600–649 Operations on the male 
genital organs 40,858 53.3 106,732 2.6 5.6
650–719 Operations on the female 
genital organs 165,188 64.5 322,108 1.9 5.5
720–759 Obstetrical procedures 167,728 6.2 703,431 4.2 4.5
760–849 Operations on the 
musculoskeletal system 189,156 28.6 935,857 4.9 6.9
850–869 Operations on the 
integumentary system(b) 123,586 51.6 489,428 4.0 8.2
870–999 Miscellaneous diagnostic 
and therapeutic proceudres 766,870 38.1 4,997,384 6.5 10.5
No principal procedure or 
not reported 1,096,949 26.5 5,560,704 5.1 6.9
Total 3,770,098 43.1 16,560,429 4.4 7.0
(a) Information on patient-days has been updated since it was published in AIHW 1999.
(b) Breast, skin and subcutaneous tissue.
Source: AIHW 1999.
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Table S37: Separations, same-day separations, patient-days and average length of stay by 
principal procedure, grouped into ICD-9-CM chapters, private hospitals, 1997Ð98
Principal procedure Separations
Per cent
same-day
separations
Patient-
days(a)
ALOS
(days)
ALOS
(days)
excluding
same-day
010–059 Operations on the nervous 
system 37,473 54.5 115,362 3.1 6.8
060–079 Operations on the endocrine 
system 3,414 1.6 12,987 3.8 3.9
080–169 Operations on the eye 100,754 70.5 117,474 1.2 4.0
180–209 Operations on the ear 27,389 78.1 31,602 1.2 5.3
210–299 Operations on the nose, 
mouth and pharynx 108,904 57.0 132,946 1.2 2.8
300–349 Operations on the 
respiratory system 10,499 45.6 58,713 5.6 10.3
350–399 Operations on the 
cardiovascular system 108,220 52.2 332,797 3.1 6.4
400–419 Operations on the haemic 
and lymphatic system 5,868 48.0 23,887 4.1 7.8
420–549 Operations on the digestive 
system 374,314 75.1 758,067 2.0 8.1
550–599 Operations on the urinary 
system 54,688 59.8 134,678 2.5 6.1
600–649 Operations on the male 
genital organs 31,832 47.5 89,328 2.8 5.3
650–719 Operations on the female 
genital organs 123,006 72.5 242,038 2.0 7.2
720–759 Obstetrical procedures 54,826 1.1 332,636 6.1 6.1
760–849 Operations on the 
musculoskeletal system 178,671 36.4 684,907 3.8 6.0
850–869 Operations on the 
integumentary system(b) 90,922 58.3 224,992 2.5 5.9
870–999 Miscellaneous diagnostic 
and therapeutic proceudres 257,579 47.2 1,468,021 5.7 10.8
No principal procedure or 
not reported 224,617 24.7 1,234,266 5.5 7.3
Total 1,792,976 53.1 5,994,701 3.3 6.0
(a) Information on patient-days has been updated since it was published in AIHW 1999.
(b) Breast, skin and subcutaneous tissue.
Source: AIHW 1999.
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Table S38: Separations(a), same-day separations, patient-days, average length of stay and cost 
by major diagnostic category, public hospitals, 1997Ð98
Major diagnostic category Separations
Per cent
same-day
separations
Patient-
days(b)
ALOS
(days)
ALOS
(days)
excluding
same-day
Estimated
cost
($’000)(c)
01 Nervous system 183,343 27.7 1,198,714 6.5 8.7 615,799
02 Eye diseases, disorders 69,294 63.7 110,275 1.6 2.6 130,727
03 Ear, nose, mouth, throat 174,061 42.3 310,673 1.8 2.4 257,713
04 Respiratory system 240,621 12.9 1,218,736 5.1 5.7 683,977
05 Circulatory system 308,450 19.3 1,432,227 4.6 5.5 1,129,699
06 Digestive system 406,414 46.8 1,125,655 2.8 4.3 791,455
07 Hepatobiliary, pancreas 72,901 16.8 327,891 4.5 5.2 248,051
08 Musculoskeletal system 
and connective tissue 288,386 31.8 1,324,235 4.6 6.3 969,782
09 Skin, subcutaneous 
tissue and breast 146,834 49.7 472,976 3.2 5.4 308,455
10 Endocrine, nutritional and 
metabolic 42,378 20.6 212,371 5.0 6.1 131,623
11 Kidney and urinary tract 495,962 84.1 803,407 1.6 4.9 467,688
12 Male reproductive 48,910 50.5 126,436 2.6 4.2 96,400
13 Female reproductive 142,340 60.6 311,225 2.2 4.0 260,776
14 Pregnancy, childbirth and 
puerperium 336,086 21.9 1,054,020 3.1 3.7 706,489
15 Newborns, neonates 54,175 11.7 449,520 8.3 9.3 278,540
16 Blood, blood forming 
organs, immunological 63,556 64.8 143,440 2.3 4.6 92,580
17 Neoplastic disorders 167,765 89.6 291,203 1.7 2.9 190,727
18 Infectious and parasitic 
diseases 45,532 18.0 220,688 4.8 5.7 139,488
19 Mental diseases and 
disorders 120,315 26.8 1,391,271 11.6 15.4 446,657
20 Alcohol/drug use and 
disorders 24,459 18.8 113,814 4.7 5.5 44,728
21 Injury, poison, toxic 
effects of drugs 104,822 34.9 308,102 2.9 4.0 231,558
22 Burns 5,963 22.1 37,033 6.2 7.7 31,653
23 Factors influencing health 
status, other contacts 95,740 68.5 321,608 3.4 8.5 136,065
ED Edit DRG(d) 8,975 27.4 97,606 10.9 14.6 52,964
PR pre-MDC(d) 9,165 2.7 259,128 28.2 29.0 405,540
Total 3,656,447 43.4 13,662,254 3.7 5.7 8,849,132
(a) Separations for acute and unspecified episode of care only.
(b) Information on patient-days has been updated since it was published in AIHW 1999.
(c) The estimated total hospital cost is the sum of the estimated costs for each AN-DRG within the major diagnostic 
category, calculated using the estimated average cost for all public hospital separations ($2,422) and relative cost 
weights for each AN-DRG. 
(d) Major diagnostic categories (MDCs) are groupings of AN-DRGs within the AN-DRG (casemix) classification. ‘Pre-
MDC’ is a group of particularly resource-intensive AN-DRGs such as transplants. Separations in the ‘Edit DRG’ 
grouping did not have a valid AN-DRG.
Note: Abbreviations: ALOS = average length of stay; MDC = major diagnostic category; DRG = diagnosis related group.
Source: AIHW 1999.
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Table S39: Separations(a), same-day separations, patient-days, average length of stay and cost 
by major diagnostic category, private hospitals, 1997Ð98
Major diagnostic category Separations
Per cent
same-day
separations
Patient-
days(b)
ALOS
(days)
ALOS
(days)
excluding
same-day
Estimated
cost
($’000)(c)
01 Nervous system 50,183 32.0 288,551 5.7 8.0 131,580
02 Eye diseases, disorders 99,322 70.0 116,934 1.2 1.6 153,078
03 Ear, nose, mouth, throat 132,418 56.3 180,016 1.4 1.8 137,690
04 Respiratory system 57,141 10.6 342,916 6.0 6.6 138,129
05 Circulatory system 103,869 16.4 507,523 4.9 5.6 342,606
06 Digestive system 330,718 72.8 667,651 2.0 4.8 414,598
07 Hepatobiliary, pancreas 25,525 8.9 111,923 4.4 4.7 70,263
08 Musculoskeletal system 
and connective tissue 222,701 35.5 928,272 4.2 5.9 646,710
09 Skin, subcutaneous 
tissue and breast 106,747 59.8 266,263 2.5 4.7 182,664
10 Endocrine, nutritional and 
metabolic 13,382 17.5 65,043 4.9 5.7 34,554
11 Kidney and urinary tract 99,647 70.7 198,825 2.0 4.4 100,107
12 Male reproductive 34,543 48.7 95,573 2.8 4.4 57,309
13 Female reproductive 101,670 64.1 235,105 2.3 4.7 168,830
14 Pregnancy, childbirth and 
puerperium 106,843 29.7 444,960 4.2 5.5 220,110
15 Newborns, neonates 13,243 11.9 84,086 6.3 7.1 29,524
16 Blood, blood forming 
organs, immunological 17,255 57.8 41,453 2.4 4.3 19,921
17 Neoplastic disorders 74,210 89.8 117,840 1.6 6.8 49,957
18 Infectious and parasitic 
diseases 9,023 10.5 55,079 6.1 6.7 25,819
19 Mental diseases and 
disorders 55,407 63.8 357,168 6.4 16.0 101,142
20 Alcohol/drug use and 
disorders 6,721 43.1 46,536 6.9 11.4 14,984
21 Injury, poison, toxic 
effects of drugs 15,475 24.8 62,091 4.0 5.0 30,870
22 Burns 429 19.3 2,894 6.7 8.1 1,889
23 Factors influencing health 
status, other contacts 63,702 79.5 148,897 2.3 7.5 95,171
ED Edit DRG(d) 9,527 60.2 41,200 4.3 9.3 33,888
PR Pre-MDC(d) 943 1.6 28,305 30.0 30.5 29,244
Total 1,750,644 53.3 5,435,104 3.1 5.5 3,230,637
(a) Separations for acute and unspecified episode of care only.
(b) Information on patient-days has been updated since it was published in AIHW 1999.
(c) The estimated total hospital cost is the sum of the estimated costs for each AN-DRG within the major diagnostic 
category, calculated using the estimated average cost for all private hospital separations ($1,932) and relative cost 
weights for each AN-DRG. 
(d) Major diagnostic categories (MDCs) are groupings of AN-DRGs within the AN-DRG (casemix) classification. Pre-
MDC’ is a group of particularly resource-intensive AN-DRGs such as transplants. Separations in the ‘Edit DRG’ 
grouping did not have a valid AN-DRG.
Note: Abbreviations: ALOS = average length of stay; MDC = major diagnostic category; DRG = diagnosis related group.
Source: AIHW 1999.
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Health expenditure  
Table S40: Proportion of recurrent expenditure on health services (current prices), by area of 
expenditure, 1960Ð61 to 1997Ð98 (per cent)
Area of expenditure
1960–
61
1975–
76
1984–
85
1988–
89
1992–
93
1993–
94
1994–
95
1995–
96
1996–
97
1997–
98
Total hospitals 37.9 46.1 43.9 41.8 38.6 37.7 37.6 37.5 37.9 38.4
Recognised public 
hospitals (a) 34.8 32.7 31.5 28.2 27.8 27.8 28.3 28.5 29.2
Repatriation 
hospitals (a) 1.8 1.6 1.7 1.5 1.0 0.6 — — —
Private hospitals (a) 4.5 5.6 5.6 7.3 7.5 7.8 8.1 8.4 8.3
Public psychiatric 
hospitals 5.5 5.0 4.0 3.0 1.6 1.4 1.3 1.1 1.0 0.9
Nursing homes 4.3 7.5 9.2 8.7 8.1 7.8 7.5 7.5 7.5 7.5
Ambulance 0.9 1.3 1.7 1.4 1.4 1.4 1.2 1.3 1.2 1.5
Other institutional (nec) n.a. 0.1 0.2 0.2 0.2 0.3 0.3 0.4 — —
Total institutional 43.2 54.9 55.0 52.1 48.3 47.2 46.6 46.7 46.6 47.4
Medical services 15.4 18.2 17.6 18.1 19.6 20.0 20.2 20.0 19.6 19.3
Other professional services 0.1 (b) 1.8 3.2 4.0 3.7 3.6 3.6 3.4 3.9 3.8
Total pharmaceuticals 22.2 11.1 8.7 9.0 10.4 11.0 11.6 11.8 12.1 12.1
Benefit-paid 
pharmaceuticals (c) 8.1 5.6 5.3 6.0 6.6 7.0 7.6 7.8 7.7
All other 
pharmaceuticals (c) 3.0 3.1 3.7 4.5 4.4 4.6 4.2 4.3 4.5
Aids and appliances 2.2 1.4 2.0 2.1 2.2 2.2 2.1 2.0 2.0 1.9
Community and public 
health(d) 4.2 3.5 3.9 4.4 4.9 5.2 4.7 5.1 5.0 4.8
Dental services 7.5 (b) 4.2 4.7 5.2 5.9 6.0 5.9 6.0 6.1 5.9
Administration 3.3 4.2 3.5 3.6 3.6 3.2 3.6 3.3 3.0 3.3
Research 1.7 0.7 1.4 1.4 1.5 1.6 1.6 1.6 1.6 1.5
Total non-institutional 56.8 45.1 45.0 47.9 51.7 52.8 53.4 53.3 53.4 52.6
Total recurrent 
expenditure 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
(a) Separate estimates not available, included in total hospitals.
(b) Some other professional services were included with dental services in 1960–61 data.
(c) Separate estimates not available, included in total pharmaceuticals.
(d) Includes expenditure classified as ‘Other non-institutional’.
Source: AIHW Health Expenditure Database.
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Table S41: Total health services expenditure (current prices), by area of expenditure and source 
of funds, 1997Ð98(a) ($ million)
Area of expenditure
Government sector Non-government sector
Total all
sectors
Common-
wealth
State
and
local Total
Health
insurance
funds
Indi-
viduals Other(b) Total
Total hospitals 6,343 6,437 12,780 2,607 418 1,095 4,120 16,900
Recognised 
public hospitals 5,771 6,080 11,851 311 79 595 986 12,836
Private hospitals 550 — 550 2,295 321 493 3,109 3,658
Repatriation 
hospitals 15 — 15 — — — — 15
Public psychiatric 
hospitals 7 357 365 — 18 7 25 390
Nursing homes 2,575 137 2,712 — 608 — 608 3,320
Ambulance 90 281 370 106 129 38 273 643
Total institutional 9,007 6,855 15,862 2,712 1,155 1,133 5,000 20,863
Medical services 6,970 — 6,970 217 897 419 1,533 8,503
Other professional 
services 219 — 219 214 1,046 173 1,434 1,653
Total pharmaceuticals 2,785 16 2,801 34 2,463 37 2,534 5,335
Benefit paid 
pharmaceuticals 2,783 — 2,783 — 593 — 593 3,377
All other 
pharmaceuticals 2 16 18 34 1,869 37 1,941 1,959
Aids and appliances 174 — 174 177 435 38 649 823
Other non-
institutional services 1,380 2,086 3,466 1,080 1,611 8 2,699 6,165
Community and 
public health(c) 775 1,357 2,132 1 — — 1 2,133
Dental services 76 328 404 568 1,611 8 2,187 2,591
Administration 529 401 930 511 — — 511 1,441
Research 427 96 523 — — 129 129 652
Total non-institutional 11,956 2,197 14,154 1,721 6,452 805 8,978 23,132
Total recurrent 
expenditure 20,964 9,053 30,016 4,434 7,606 1,938 13,978 43,994
Capital expenditure 70 1,400 1,470 n.a. n.a. n.a. 994 (d) 2,464
Capital consumption 34 538 572 .. .. .. .. (e) 572
Total health 
expenditure 21,068 10,990 32,058 n.a. n.a. n.a. 14,972 47,030
(a) This table shows the amounts provided by the Commonwealth Government, State and Territory Governments, local 
government authorities and by the non-government sector to fund expenditure on health services. It does not show 
gross outlays on health services by the different levels of government or by the non-government sector.
(b) ‘Other’ includes expenditure on health services by providers of Workers’ Compensation and Compulsory Motor Vehicle 
Third Party insurance cover.
(c) Includes expenditure classified as ‘Other non-institutional’.
(d) Capital outlays for the non-government sector cannot be allocated according to ‘source of funds’.
(e) Private capital consumption (depreciation) expenditure is included as part of recurrent expenditure.
Source: AIHW Health Expenditure Database.
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Table S43: Total recurrent expenditure on health services, constant prices(a), by area of 
expenditure, selected years ($ million)
Area of expenditure 1960–61 1974–75 1975–76 1984–85 1988–89 1992–93 1997–98
Total hospitals 3,191 7,573 8,644 10,740 12,571 13,747 16,900
Recognised public hospitals (b) 5,765 6,522 7,996 9,476 10,063 12,836
Repatriation hospitals (b) 324 334 390 516 541 15
Private hospitals (b) 557 853 1,375 1,678 2,587 3,658
Public psychiatric hospitals 463 928 935 979 902 556 390
Nursing homes 366 1,269 1,403 2,250 2,612 2,874 3,320
Ambulance 78 233 245 405 429 513 643
Other institutional (nec) n.a. 13 15 41 73 77 —
Total institutional 3,635 9,087 10,307 13,436 15,684 17,211 20,863
Medical services 942 2,659 3,390 4,427 5,668 6,897 8,503
Other professional services 460 1,278 1,366 1,758 1,991 2,395 2,591
Total pharmaceuticals 1,354 2,263 2,110 2,600 3,001 3,986 5,335
Benefit-paid pharmaceuticals (c) 1,442 1,541 1,675 1,765 2,277 3,377
All other pharmaceuticals (c) 821 569 926 1,236 1,709 1,959
Aids and appliances 137 302 264 593 687 836 823
Other non-institutional services 1,091 2,452 2,736 3,568 4,395 5,396 6,165
Community and public health 350 509 586 948 1,335 1,733 2,133
Dental services 460 1,278 1,366 1,758 1,991 2,395 2,591
Administration 281 665 783 862 1,069 1,268 1,441
Research 146 52 122 351 422 517 652
Total non-institutional 3,678 8,114 9,044 12,357 15,441 18,943 23,132
Total recurrent expenditure 7,313 17,201 19,350 25,793 31,124 36,154 43,994
(a) See Box 5.2, page 236, for explanation of constant price estimating method. 
(b) Separate estimates not available, included in total hospitals.
(c) Separate estimates not available, included in total pharmaceuticals.
Source: AIHW Health Expenditure Database.
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Table S44: Total health expenditure, current and constant prices (a) and average annual growth 
rates, 1960Ð61 to 1997Ð98
Year
Amount ($ million) Average annual growth rates (%)
Current Constant Current Constant
1960–61 692 7,313 . . . .
1963–64 870 8,505 7.9 5.2
1966–67 1,139 10,010 9.4 5.6
1969–70 1,627 12,275 12.6 7.0
1974–75 4,233 18,707 21.1 8.8
1975–76 5,684 21,423 34.3 14.5
1983–84 14,802 26,681 12.7 2.8
1984–85 16,371 27,429 10.6 2.8
1988–89 25,795 33,118 12.0 4.8
1992–93 34,993 38,304 7.9 3.7
1993–94 36,787 39,798 5.1 3.9
1994–95 38,967 41,324 5.9 3.8
1995–96 41,783 43,392 7.2 5.0
1996–97 44,482 45,330 6.5 4.5
1997–98 47,030 47,030 6.1 4.2
1960–61 to 1974–75 13.8 6.9
1975–76 to 1997–98 10.1 3.6
1960–61 to 1997–98 11.7 5.0
(a) See Box 5.2, page 236, for explanation of constant price estimating method.
Source: AIHW Health Expenditure Database.
02 AH2000 stat tables  Page 407  Thursday, June 1, 2000  2:18 PM
408  AustraliaÕs Health 2000
TRIM SIZE 175 mm Wide x 250 mm Deep
Table S45: Total health expenditure as a proportion of GDP, Australia and selected OECD 
countries, 1961 to 1997 (per cent)
Year Aust Can Fra Ger Jpn NZ UK USA
Seven-
country
mean(a)
Eight-
country
mean(b)
1961 4.3 5.8 4.5 4.8 3.4 n.a. 4.0 5.4 4.3 4.9
1964 4.5 5.9 5.0 4.9 3.5 n.a. 4.1 5.8 4.5 5.2
1967 4.6 6.3 5.6 5.7 4.7 n.a. 4.4 6.3 5.2 5.8
1970 4.8 7.0 5.8 6.3 4.6 5.2 4.5 7.3 5.4 6.3
1975 6.3 7.2 7.0 8.8 5.6 6.7 5.5 8.2 6.7 7.5
1976 7.2 7.1 7.0 8.7 5.6 6.3 5.5 8.5 6.7 7.6
1984 7.3 8.3 8.5 9.1 6.6 5.7 5.9 10.3 7.5 8.9
1985 7.3 8.3 8.5 9.3 6.7 5.3 5.9 10.6 7.5 9.0
1989 7.4 8.7 8.7 8.8 6.2 6.6 5.8 11.9 7.3 9.5
1993 8.2 10.1 9.8 9.9 6.6 7.2 6.9 14.2 8.2 11.0
1994 8.2 9.8 9.7 10.0 6.9 7.3 6.9 14.1 8.3 11.0
1995 8.2 9.4 9.8 10.4 7.2 7.3 6.9 14.1 8.5 11.1
1996 8.2 9.3 9.8 10.8 7.1 7.3 6.9 14.1 8.5 11.1
1997 8.3 9.2 9.6 10.7 7.2 7.6 6.8 13.9 8.4 11.0
(a) Weighted mean, excludes United States.
(b) Weighted mean.
Sources: AIHW Health Expenditure Database; OECD 1999.
Table S46: Components of growth in health services expenditure, Australia and other selected 
OECD member countries, 1961 to 1997 (per cent)
Aust Can(a) Fra Ger(a) Jpn(b) NZ(c) UK(a) USA
Nominal growth in health 
services expenditure 12.1 10.2 10.2 10.6 7.9 9.2 8.8 10.5
Health services inflation 6.6 5.8 5.4 4.5 2.0 12.8 7.5 5.8
General inflation 6.1 5.0 5.9 3.8 1.4 8.9 7.3 4.5
Excess health inflation(d) 0.5 0.8 –0.5 0.7 0.6 3.6 0.2 1.3
Real growth in health 
services expenditure 5.2 4.1 4.6 5.8 5.8 –3.2 1.2 4.4
Population growth 1.6 1.4 0.7 1.1 0.5 1.1 0.3 1.1
Per person real growth 3.5 2.7 3.9 4.7 5.3 –4.2 0.9 3.3
(a) Canada, Germany and the United Kingdom from 1961 to 1996.
(b) Japan from 1980 to 1997.
(c) New Zealand from 1968 to 1996.
(d) Excess health inflation rate is the rate by which changes in the prices of health services exceed changes in prices 
throughout the general community. A positive excess health inflation rate indicates that health prices are rising faster 
than the general rate of inflation; a negative rate indicates that health prices are falling or not rising as fast as the 
general rate of inflation.
Sources: AIHW Health Expenditure Database; OECD unpublished data.
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Health labour force
Table S47: Employment in the health industry, August 1981 to August 1999
Year
Employed in
health industry
(’000)
All employed
persons (’000)
Proportion of
all employed
persons (%)
Civilian labour
force(a) (’000)
Proportion of
civilian labour
force(a) (%)
1981 406.1 6,393.7 6.4 6,774.3 6.0
1982 424.5 6,379.3 6.7 6,840.7 6.2
1983 440.6 6,241.1 7.1 6,927.9 6.4
1984 453.6 6,466.1 7.0 7,070.1 6.4
1985 461.6 6,675.6 6.9 7,248.3 6.4
1986 489.2 6,918.6 7.1 7,516.2 6.5
1987 510.5 7,092.3 7.2 7,694.4 6.6
1988 530.7 7,353.4 7.2 7,892.1 6.7
1989 520.3 7,727.6 6.7 8,197.0 6.3
1990 557.9 7,825.0 7.1 8,412.5 6.6
1991 580.0 7,669.2 7.6 8,475.2 6.8
1992 575.3 7,679.3 7.5 8,585.7 6.7
1993 561.4 7,621.0 7.4 8,537.0 6.6
1994 547.2 7,885.7 6.9 8,683.5 6.3
1995 591.9 8,217.7 7.2 8,939.6 6.6
1996 590.2 8,319.7 7.1 9,090.8 6.5
1997 610.2 8,315.5 7.3 9,080.1 6.7
1998 598.7 8,535.9 7.0 9,261.5 6.5
1999 600.4 8,731.6 6.9 9,384.4 6.4
1989 to 1999 
increase (%) 15.4 13.0 14.5
(a) Includes unemployed persons looking for work.
Sources: ABS Cat No. 6203.0; Labour Force Survey estimates on microfiche.
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Use of professional services 
Table S48: Medical and optometrical services, fees and benefits under Medicare, 1992Ð93 to 
1998Ð99
Year
 Number of
services (million)
Fees charged
($ million)
 Schedule fees
($ million)
Benefits paid
($ million)
GP attendances
1992–93  93.2  2,166.2  2,353.4  1,997.8
1993–94  96.7  2,288.7  2,503.1  2,126.1
1994–95  98.4  2,361.5  2,582.7  2,195.6
1995–96  102.1  2,484.4  2,722.3  2,314.4
1996–97  102.5  2,517.8  2,752.6  2,339.7
1997–98  103.1  2,564.5  2,786.6  2,367.8
1998–99  102.6  2,605.0  2,818.6  2,395.4
Special attendances
1992–93  16.3  930.9  908.0  763.3
1993–94  16.8  977.4  957.4  806.2
1994–95  17.5  1,031.2  1,005.7  847.3
1995–96  18.1  1,084.0  1,053.5  887.8
1996–97  18.2  1,109.3  1,066.6  897.7
1997–98  18.2  1,133.1  1,078.9  907.5
1998–99  18.6  1,183.3  1,119.2  941.3
Obstetrics
1992–93  0.7  93.7  71.8  55.3
1993–94  0.7  92.0  70.0  54.1
1994–95  0.7  93.9  70.8  55.0
1995–96  1.3  100.7  74.1  58.7
1996–97  1.6  98.9  70.7  56.8
1997–98  1.6  97.4  68.2  54.9
1998–99  1.6  101.3  71.9  57.7
Anaesthetics
1992–93  1.6  165.4  137.9  104.4
1993–94  1.6  171.2  142.4  107.7
1994–95  1.7  184.0  152.1  115.0
1995–96  1.7  201.6  160.6  121.6
1996–97  1.7  218.6  166.0  125.7
1997–98  1.7  225.2  168.9  127.9
1998–99  1.8  235.2  175.5  132.9
Pathology(a)
1992–93  39.7  734.5  757.0  634.0
1993–94  42.9  795.5  837.8  703.1
1994–95  47.0  869.9  926.3  778.3
1995–96  48.6  901.4  966.7  812.8
1996–97  50.3  945.3  1,020.2  857.8
1997–98  52.4  1,014.5  1,099.6  924.2
1998–99  55.6  1,096.3  1,199.0  1,008.4
 (continued)
(a) In February 1992, a patient episode initiation item was introduced artificially inflating the number of pathology services. 
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Table S48 (continued): Medical and optometrical services, fees and benefits under Medicare, 
1992Ð93 to 1998Ð99
Year
 Number of
services (million)
Fees charged
($million)
 Schedule fees
($million)
Benefits paid
($million)
Diagnostic imaging
1992–93  9.1  762.7  765.7  655.2
1993–94  9.5  833.7  848.4  728.7
1994–95  9.9  904.2  925.9  797.1
1995–96  10.5  983.7  1,016.1  875.9
1996–97  10.4  992.2  1,029.9  880.1
1997–98  10.8  1,063.8  1,105.6  938.2
1998–99  11.4  1,199.9  1,250.9  1,064.7
Operations
1992–93  4.9  718.4  643.4  509.3
1993–94  5.0  727.6  652.6  515.8
1994–95  5.2  761.6  679.6  537.2
1995–96  5.3  799.6  708.6  560.7
1996–97  5.4  841.2  736.2  682.1
1997–98  5.4  861.4  744.7  587.2
1998–99  5.5  898.0  770.6  607.8
Optometry
1992–93  3.0  119.1  137.6  117.0
1993–94  3.2  125.7  145.6  123.9
1994–95  3.3  131.5  152.7  129.8
1995–96  3.6  143.2  166.9  141.9
1996–97  3.7  147.3  172.0  146.2
1997–98  3.8  144.2  167.8  142.7
1998–99  3.9  147.9  171.7  146.1
All other services(b)
1992–93  3.8  197.0  193.4  165.1
1993–94  4.2  227.9  225.0  191.2
1994–95  4.4  257.9  255.0  216.4
1995–96  4.5  283.3  280.9  238.2
1996–97  4.7  301.2  292.9  247.6
1997–98  4.8  321.0  309.8  260.7
1998–99  5.5  394.8  377.7  314.9
Total services
1992–93  172.3  5,922.1  5,998.5  5,023.7
1993–94  180.6  6,275.2  6,414.0  5,380.1
1994–95  188.1  6,633.3  6,784.2  5,696.4
1995–96  196.0  7,022.4  7,185.0  6,038.4
1996–97  198.8  7,209.1  7,339.5  6,158.0
1997–98  202.2  7,460.7  7,560.1  6,333.5
1998–99  206.3  7,861.8  7,955.2  6,669.1
(a) In February 1992, a patient episode initiation item was introduced artificially inflating the number of pathology services. 
(b) Includes radiotherapy and nuclear medicine therapy, assistance at operations and other miscellaneous services. 
Source: DHAC 1999b.
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Table S49: Medicare services, age-specific rates, by sex, 1991Ð92 to 1998Ð99 
(services per person)
Sex/age group 1991–92 1992–93 1993–94 1994–95 1995–96 1996–97 1997–98 1998–99
Males
0–4 8.90 9.73 9.85 9.60 9.80 9.60 9.47 9.27
5–9 5.00 5.39 5.43 5.24 5.30 5.31 5.25 5.12
10–14 4.22 4.50 4.60 4.50 4.54 4.48 4.53 4.44
15–19 4.37 4.68 4.68 4.67 4.86 4.83 4.77 4.73
20–24 4.57 4.90 5.00 5.02 5.32 5.26 5.12 5.02
25–34 5.14 5.49 5.58 5.77 5.97 5.93 5.84 5.75
35–44 6.00 6.39 6.60 6.91 7.11 7.07 7.05 7.08
45–54 7.66 8.22 8.82 9.23 9.48 9.45 9.54 9.61
55–64 11.70 12.72 13.35 14.01 14.41 14.42 14.59 14.74
65–74 12.55 14.18 15.82 17.11 18.35 19.07 20.11 21.09
75+ 17.35 18.85 19.85 20.38 20.69 20.54 20.66 20.26
Crude rate 7.11 7.73 8.07 8.35 8.68 8.71 8.81 8.87
ASR(a) 7.24 7.85 8.20 8.45 9.01 9.01 8.79 8.81
Females
0–4 8.10 8.88 9.01 8.80 8.98 8.82 8.67 8.52
5–9 4.99 5.39 5.44 5.23 5.26 5.21 5.23 5.15
10–14 4.39 4.68 4.79 4.67 4.66 4.60 4.64 4.62
15–19 7.63 8.18 8.27 8.37 8.64 8.43 8.26 8.28
20–24 10.20 11.13 11.43 11.64 12.12 11.72 11.35 11.16
25–34 11.38 12.40 12.62 13.05 13.57 13.51 13.36 13.30
35–44 10.36 11.27 11.61 12.11 12.23 12.17 12.13 12.21
45–54 11.71 12.77 13.52 14.00 14.06 14.02 14.04 14.19
55–64 13.85 15.03 15.54 16.20 16.67 16.87 17.19 17.56
65–74 16.46 17.73 18.57 19.21 20.08 20.45 20.97 21.60
75+ 20.41 21.94 22.87 23.43 24.10 24.36 24.63 24.88
Crude rate 10.81 11.75 12.14 12.49 12.84 12.85 12.89 13.01
ASR(a) 10.61 11.51 11.88 12.19 12.28 12.24 12.46 12.53
(a) Age standardised to the Australian population at 30 June 1991.
Sources: HIC 1992, 1993, 1994, 1995, 1996, 1997, 1998, 1999.
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Table S50: Medicare services, age-specific rates, by sex, States and Territories, 1998Ð99 
(services per person)
Sex/age group NSW Vic Qld WA SA Tas ACT NT Aust
Males
0–4 9.88 9.34 9.41 7.85 9.25 7.77 8.32 5.36 9.27
5–9 5.54 5.29 5.01 4.27 4.98 4.23 4.74 2.63 5.12
10–14 4.68 4.43 4.61 3.96 4.28 3.78 4.24 2.17 4.44
15–19 5.05 4.67 4.88 4.16 4.59 4.07 4.25 2.27 4.73
20–24 5.47 5.18 4.95 4.11 4.90 4.49 4.01 2.29 5.02
25–34 6.31 5.93 5.52 4.76 5.48 5.10 4.87 3.07 5.75
35–44 7.83 7.11 6.95 5.99 6.49 5.92 5.92 4.59 7.08
45–54 10.56 9.45 9.63 8.49 8.58 8.39 8.02 6.67 9.61
55–64 16.22 14.56 14.63 12.99 12.84 12.87 12.44 9.95 14.74
65–74 22.75 21.19 20.64 19.02 18.80 17.78 18.51 12.86 21.09
75+ 21.00 21.26 19.25 19.41 19.27 15.09 18.85 11.90 20.26
Crude rate 9.70 8.98 8.66 7.52 8.46 7.67 7.08 4.47 8.87
ASR(a) 9.54 8.88 8.69 7.71 8.16 7.46 7.65 5.28 8.81
Females
0–4 9.15 8.40 8.69 7.27 8.56 7.18 7.90 4.84 8.52
5–9 5.52 5.32 5.06 4.34 4.99 4.37 4.86 2.62 5.15
10–14 4.81 4.63 4.79 4.14 4.56 4.07 4.38 2.47 4.62
15–19 8.52 7.89 8.99 7.99 7.64 8.22 7.66 5.08 8.28
20–24 11.78 10.95 11.67 10.34 10.05 11.36 9.35 7.33 11.16
25–34 13.86 13.63 13.21 12.64 12.08 12.53 11.74 8.73 13.30
35–44 12.97 12.29 12.24 11.36 11.02 10.97 10.69 8.49 12.21
45–54 15.12 14.02 14.48 13.10 12.73 13.21 12.21 10.06 14.19
55–64 18.79 17.37 17.94 15.76 15.49 15.92 15.61 11.11 17.56
65–74 22.90 21.44 22.06 19.73 19.16 19.09 19.05 12.86 21.60
75+ 25.27 25.70 25.38 22.92 23.22 21.90 23.11 15.39 24.88
Crude rate 13.79 13.15 13.04 11.69 12.19 11.96 10.98 7.28 13.01
ASR(a) 13.20 12.54 12.75 11.53 11.42 11.48 11.13 8.03 12.53
(a) Age standardised to the Australian population at 30 June 1991.
Source: HIC 1999.
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Table S51: Medicare services, percentage of enrolled persons by number of items, 
by age group and sex, 1998Ð99
Sex/age group
Number of services
0 1 2 3 4 5 or more
Males
0–4 8.60 5.93 6.70 7.00 6.98 64.79
5–9 12.83 11.85 11.32 10.05 8.65 45.30
10–14 18.28 14.95 12.77 10.52 8.46 35.02
15–19 19.52 14.93 12.19 9.84 7.84 35.68
20–24 21.20 14.02 11.15 8.88 7.22 37.53
25–34 23.74 13.81 10.56 8.26 6.73 36.90
35–44 21.30 12.66 9.65 7.58 6.30 42.51
45–54 16.34 10.79 8.20 6.55 5.72 52.40
55–64 11.98 7.10 5.63 4.81 4.49 65.99
65–74 10.79 3.94 3.48 3.15 3.15 75.49
75+ 24.87 3.81 3.10 2.49 2.53 63.20
All ages 17.94 11.00 8.92 7.33 6.24 48.57
Females
0–4 9.17 6.72 7.46 7.70 7.61 61.34
5–9 13.26 12.31 11.50 10.14 8.68 44.11
10–14 18.12 15.14 12.90 10.47 8.39 34.98
15–19 13.97 12.18 10.84 8.99 7.51 46.51
20–24 7.87 6.31 6.44 6.30 6.07 67.01
25–34 9.28 5.56 5.33 5.39 5.30 69.14
35–44 9.99 6.64 5.78 5.95 5.71 65.93
45–54 8.21 5.95 5.09 5.10 5.04 70.61
55–64 7.09 4.26 3.96 3.96 4.02 76.71
65–74 8.23 2.97 2.86 2.86 3.01 80.07
75+ 15.84 2.04 2.10 2.09 2.24 75.69
All ages 10.57 6.84 6.28 5.95 5.56 64.80
Source: HIC 1999.
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National Health Priority Areas 
Table S52: Indicators for cardiovascular health
Descriptor
Baseline Most recent data
Year Value Year Value
Incidence rate for myocardial infarction, ages 30–79(a) (events per 100,000 population)
Males 1993–94 441 1997–98 377
Females 1993–94 144 1997–98 119
Hospital separation rate for principal diagnosis of unstable angina pectoris, ages 0–79 
(per 100,000 population)
Males 1993–94 178 1997–98 333
Females 1993–94 100 1997–98 166
Hospital separation rate for principal diagnosis of congestive heart failure, ages 0–79 
(per 100,000 population)
Males 1993–94 102 1997–98 98
Females 1993–94 63 1997–98 56
Death rate for coronary heart disease, ages 0–79 (deaths per 100,000 population)
Males 1986 200.8 1998 103.3
Females 1986 87.9 1998 41.6
Death rate for coronary heart disease among rural and remote area residents, ages 0–79 
(deaths per 100,000 population)
Males, remote 1988–90 199.9 1996–98 143.8
Males, rural 1988–90 182.3 1996–98 118.7
Males, urban 1988–90 174.3 1996–98 106.6
Females, remote 1988–90 100.3 1996–98 63.6
Females, rural 1988–90 81.5 1996–98 47.8
Females, urban 1988–90 73.6 1996–98 43.9
Proportion of people whose main/underlying disabling condition is stroke, ages 25 or more(b) 
(per 100,000 population)
Males 1993 297 1998 474
Females 1993 268 1998 490
Death rate for stroke, ages 0–79 (deaths per 100,000 population)
Males 1986 47.4 1998 26.4
Females 1986 36.4 1998 19.5
Death rate for stroke among rural and remote area residents, ages 0–79 
(deaths per 100,000 population)
Males, remote 1988–90 49.7 1996–98 31.3
Males, rural 1988–90 42.0 1996–98 29.8
Males, urban 1988–90 41.0 1996–98 27.9
Females, remote 1988–90 37.7 1996–98 27.0
Females, rural 1988–90 31.6 1996–98 21.8
Females, urban 1988–90 30.9 1996–98 20.5
(continued)
(a) Currently data are available only for ages 35–69. Rates are standardised to the 1993 Australian population.
(b) Although the prevalence of stroke may have increased between 1993 and 1998, a change in the data collection method 
may also have contributed to the increased reported rate. In 1993, it was based on the underlying cause of the main 
disabling condition, whereas in 1998, survey participants were asked directly whether they had had a stroke.
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Table S52 (continued): Indicators for cardiovascular health
Descriptor
Baseline Most recent data
Year Value Year Value
Hospital separation rate for major amputation for peripheral vascular disease, ages 0–79 
(per 100,000 population)
Males 1993–94 0.8 1997–98 3.6
Females 1993–94 0.3 1997–98 1.5
Hospital separation rate for emergency and elective surgery for abdominal aortic aneurysm, 
ages 0–79 (per 100,000 population)
Males 1993–94 19.0 1997–98 17.8
Females 1993–94 3.4 1997–98 3.3
(a) Currently data are available only for ages 35–69. Rates are standardised to the 1993 Australian population.
(b) Although the prevalence of stroke may have increased between 1993 and 1998, a change in the data collection
methods may also have contributed to the increased rate reported. In 1993, it was based on the underlying cause of
the main disabling condition, whereas in 1998, survey participants were asked directly whether they had had a stroke.
Note: Except for the incidence of myocardial infarction, rates have been age standardised to the 1991 Australian population.
Sources: AIHW National Mortality Database; AIHW National Hospital Morbidity Database; DHAC & AIHW 1999a.
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Table S53: Indicators for health risk factors
Descriptor
Baseline Most recent data
Year Value Year Value
Proportion of adults who smoke regularly, ages 18 or more (per cent)
Males 1989–90 31.6 1995 27.1
Females 1989–90 25.1 1995 20.8
Proportion of secondary school students who smoke, age 15 (per cent)(a)
Males 1984 29 1996 24
Females 1984 34 1996 29
Proportion of adults not engaged in regular physical activity, ages 18 or more (per cent)
Males 1989–90 35.6 1995 33.5
Females 1989–90 36.0 1995 33.8
Proportion of adults who are overweight, ages 18 or more (per cent)
Males 1989–90 44.4 1995 51.0
Females 1989–90 30.9 1995 36.1
Proportion of adults with high blood pressure and/or on antihypertensive treatment, ages 20–69 
(per cent)
Males 1989 19.5 1995 17.1
Females 1989 12.6 1995 10.1
Mean blood pressure levels, ages 20–69 (mm Hg)
Males, systolic BP 1989 129 1995 128
Males, diastolic BP 1989 82 1995 78
Females, systolic BP 1989 122 1995 122
Females, diastolic BP 1989 76 1995 74
Proportion of adults with high blood cholesterol, ages 20–69 (per cent)
Males 1989 46.6 n.a. n.a.
Females 1989 38.6 n.a. n.a.
Contribution of saturated fat as a proportion of total energy intake, ages 25–64 (per cent)
Males 1983 15.9 1995 12.7
Females 1983 16.3 1995 12.8
(a) Age-specific smoking rate among 15-year-olds.
Note: Age standardised to the 1991 Australian population.
Source: DHAC & AIHW 1999a.
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Table S54: Indicators for cancer control
Descriptor
Baseline Most recent data
Year Value Year Value
Incidence of cancer of the trachea, bronchus and lung (new cases per 100,000 population)
Males 1983 74.8 1996 60.1
Females 1983 17.1 1996 23.0
Death rate for cancer of the trachea, bronchus and lung (deaths per 100,000 population)
Males 1986 64.4 1998 53.1
Females 1986 16.1 1998 18.6
Incidence of melanoma of the skin (new cases per 100,000 population)
Males 1988 40.1 1996 48.0
Females 1988 32.9 1996 35.0
Death rate for melanoma of the skin (deaths per 100,000 population)
Males 1991 6.5 1998 6.9
Females 1991 3.2 1998 3.0
Incidence of (treated) non-melanocytic skin cancer (new cases per 100,000 population)
Males 1990 1,187 n.a. n.a.
Females 1990 769 n.a. n.a.
Death rate for non-melanocytic skin cancer (deaths per 100,000 population)
Males 1991 2.8 1998 2.5
Females 1991 0.6 1998 0.8
Incidence of cervical cancer among women aged 20–74 years (new cases per 100,000 population)
Females 1988 17.6 1996 13.0
Death rate for cervical cancer among women aged 20–74 years (deaths per 100,000 population)
Females 1991 4.3 1998 2.9
Incidence of breast cancer among women aged 50–74 years (new cases per 100,000 population)
Females 1988 202.4 1997 286.0
Death rate for breast cancer among women aged 50–74 years (deaths per 100,000 population)
Females 1992 68.7 1998 62.6
Incidence of colorectal cancer (new cases per 100,000 population)
Males 1988 60.2 1996 69.2
Females 1988 42.0 1996 46.0
Death rate for colorectal cancer (deaths per 100,000 population)
Males 1992 29.7 1998 27.3
Females 1992 19.7 1998 18.6
Incidence of prostate cancer (new cases per 100,000 population)
Males 1988 68.4 1996 117.4
Death rate for prostate cancer (deaths per 100,000 population)
Males 1992 33.7 1998 29.2
Proportion of females aged 50–69 years screened for breast cancer (per cent)
Females 1996–97 52.2 n.a. n.a.
Proportion of females aged 20–69 years screened within specified intervals for cervical cancer 
(per cent)
Females 1996–97 62.4 n.a. n.a.
Five-year survival rate for breast cancer (per cent)
Females 1982–94 76.8 n.a. n.a.
Note: Age standardised to the Australian population at 30 June 1991.
Sources: AIHW National Mortality Database; AIHW National Hospital Morbidity Database; DHFS & AIHW 1998a.
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Table S55: Indicators for diabetes mellitus
Descriptor
Baseline
Year Value
Prevalence rates for Type 1 and Type 2 diabetes in the general population, in the Indigenous 
population, and among people from culturally and linguistically diverse backgrounds (C&LDB)
(per 100,000 population)
Males, Type 1 diabetes, general population 1995 223
Males, Type 2 diabetes, general population 1995 1,846
Females, Type 1 diabetes, general population 1995 210
Females, Type 2 diabetes, general population 1995 1,508
Males, Type 1 diabetes, C&LDB 1995 146
Males, Type 2 diabetes, C&LDB 1995 2,627
Females, Type 1 diabetes, C&LDB 1995 158
Females, Type 2 diabetes, C&LDB 1995 3,609
Males, Indigenous population 1994 7,597
Females, Indigenous population 1994 9,763
Prevalence rates for obesity and overweight (as measured by BMI) in the general population, and 
among persons with Type 2 diabetes (per 1,000 population)
Males, Type 2 diabetes, overweight 1995 445
Males, Type 2 diabetes, obese 1995 317
Females, Type 2 diabetes, overweight 1995 313
Females, Type 2 diabetes, obese 1995 428
Males, general population, overweight 1995 430
Males, general population, obese 1995 129
Females, general population, overweight 1995 274
Females, general population, obese 1995 139
Rates for non-participation in regular, sustained, moderate aerobic exercise in the general 
population, and among persons with Type 2 diabetes (per 1,000 persons aged 30 years and over)
Males, Type 2 diabetes, low 1995 259
Males, Type 2 diabetes, sedentary 1995 496
Females, Type 2 diabetes, low 1995 323
Females, Type 2 diabetes, sedentary 1995 418
Males, general population, low 1995 307
Males, general population, sedentary 1995 373
Females, general population, low 1995 377
Females, general population, sedentary 1995 370
Prevalence rates for high blood pressure among persons with Type 2 diabetes, aged less than 
60 years and 60 years and over (per 1,000 persons)
Males, aged less than 60 years 1999 261
Males, aged 60 years and over 1999 220
Females, aged less than 60 years 1999 266
Females, aged 60 years and over 1999 341
(continued)
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Table S55 (continued): Indicators for diabetes mellitus
Descriptor
Baseline
Year Value
Prevalence rates for high levels of lipoproteins among persons with Type 1 and Type 2 diabetes 
(per 1,000 persons aged 20 years and over)
Males, Type 1 diabetes 1999 208
Males, Type 2 diabetes 1999 328
Females, Type 1 diabetes 1999 260
Females, Type 2 diabetes 1999 355
Prevalence rates for fasting hypertriglyceridaemia among persons with Type 1 and Type 2 diabetes 
(per 1,000 persons aged 20 years and over)
Males, Type 1 diabetes 1999 14.8
Males, Type 2 diabetes 1999 107
Females, Type 1 diabetes 1999 13.3
Females, Type 2 diabetes 1999 114
Proportion of persons with end-stage renal disease with diabetic nephropathy as a causal factor 
(per 1,000 persons aged 25–84 years)
Type 1 1997 68.0
Type 2, non-insulin-requiring 1997 64.5
Type 2, insulin-requiring 1997 83.5
Prevalence rate for foot problems among clinically diagnosed persons with diabetes 
(per 1,000 persons aged 20 years and over)
Current foot ulcers 1999 20.4
Previous foot ulcers 1999 40.3
Incidence rates for myocardial infarction and stroke among clinically diagnosed persons 
with diabetes (per 1,000 persons aged 35–69 years)
Myocardial infarction 1999 18.6
Stroke 1999 12.6
Hospital separations for end-stage renal disease (ICD 584–585) as the principal diagnosis 
with diabetes (ICD 250) as an associated diagnosis (per 1,000 persons)
Males 1997–98 0.15
Females 1997–98 0.13
Hospital separations for coronary heart disease (ICD 410-414) or stroke (ICD 430-438) as the principal 
diagnosis with diabetes as an associated diagnosis (per 1,000 persons)
Males 1997–98 2.39
Females 1997–98 1.32
Hospital separations for diabetes both as a principal diagnosis and as an associated diagnosis with 
conditions other than end-stage renal disease and coronary heart disease/stroke (per 1,000 persons)
Males 1997–98 14.87
Females 1997–98 12.01
(continued)
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Table S55 (continued): Indicators for diabetes mellitus
Descriptor
Baseline
Year Value
Death rates for diabetes in the general population, in the Indigenous population, and among people 
from culturally and linguistically diverse backgrounds (C&LDB) (per 100,000 population)
Males, Indigenous population 1998 102.26
Females, Indigenous population 1998 108.69
Males, C&LDB 1998 19.84
Females, C&LDB 1998 15.32
Males, general population 1998 16.05
Females, general population 1998 10.62
Self-assessed health status of persons with and without diabetes 
(per 1,000 persons aged 30 years and over)
Good, very good or excellent
Males, with diabetes 1995 543
Males, without diabetes 1995 827
Females, with diabetes 1995 626
Females, without diabetes 1995 834
Fair or poor
Males, with diabetes 1995 457
Males, without diabetes 1995 173
Females, with diabetes 1995 374
Females, without diabetes 1995 166
Sources: AIHW National Mortality Database; AIHW National Hospital Morbidity Database; DHAC & AIHW 1999b; NADC 
1999 Australian National Diabetes Information Audit and Benchmarking Survey unpublished data; Disney et al. 1998.
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Table S56: Indicators for injury prevention and control
Descriptor
Baseline Most recent data
Year Value Year Value
Death rate for injury and poisoning (per 100,000 population)
Persons 1992 42.0 1998 40.8
Hospital separation rate for injury and poisoning in the total population (per 100,000 population)
Persons 1991–92 1,714 1997–98 1,932
Death rate ratio comparing the injury status of Indigenous and non-Indigenous populations
Males 1991–92 3.7 1996–98 3.0
Females 1991–92 4.2 1996–98 3.3
Death rate ratio comparing the injury status of males and females
Male:female 1992 2.6 1998 2.9
Death rate ratio comparing the injury status among people living in rural and remote areas 
with the general population
Males, capital cities 1991–95 0.89 1994–98 0.88
Males, other metropolitan centres 1991–95 0.98 1994–98 1.00
Males, large rural centres 1991–95 1.10 1994–98 1.12
Males, small rural centres 1991–95 1.08 1994–98 1.13
Males, other rural areas 1991–95 1.28 1994–98 1.30
Males, remote centres 1991–95 1.51 1994–98 1.63
Males, other remote areas 1991–95 1.90 1994–98 1.84
Females, capital cities 1991–95 0.94 1994–98 0.92
Females, other metropolitan centres 1991–95 0.98 1994–98 1.04
Females, large rural centres 1991–95 0.98 1994–98 1.00
Females, small rural centres 1991–95 1.03 1994–98 1.02
Females, other rural areas 1991–95 1.19 1994–98 1.19
Females, remote centres 1991–95 1.33 1994–98 1.74
Females, other remote areas 1991–95 1.96 1994–98 1.87
Death rate for road transport-related injury in the total population, 
and among males aged 15–24 years (per 100,000 population)
Total population 1992 12.0 1998 9.4
Males aged 15–24 years 1992 31.5 1998 27.0
Hospital separation rate for road transport-related injury in the total population, 
and among males aged 15–24 years (per 100,000 population)
Total population 1990 232 1997–98 234
Males aged 15–24 years 1990 858 1997–98 596
Death rate due to falls among people aged 65 years and over (per 100,000 population)
Persons aged 65 years and over 1992 39.9 1998 38.9
Hospital separation rate due to falls among people aged 65 years and over (per 100,000 population)
Males aged 65–74 years 1991–92 668 1997–98 851
Males aged 75 years and over 1991–92 2,242 1997–98 3,198
Females aged 65–74 years 1991–92 1,225 1997–98 1,408
Females aged 75 years and over 1991–92 4,554 1997–98 5,519
(continued)
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Table S56 (continued): Indicators for injury prevention and control
Descriptor
Baseline Most recent data
Year Value Year Value
Hospital separation rate due to falls among children aged 0–4 and 5–9 years 
(per 100,000 population)
Children aged 0–4 years 1991–92 502 1997–98 571
Children aged 5–9 years 1991–92 868 1997–98 778
Death rate for homicide among people aged 20–39 years 
(per 100,000 population)
Males 1992 3.4 1998 3.7
Females 1992 2.4 1998 1.5
Death rate for homicide among children aged 0–9 years 
(per 100,000 population)
Children aged 0–9 years 1992 0.6 1998 1.0
Death rate for injury resulting from fire, burns and scalds among people aged 55 years and over 
(per 100,000 population)
Persons aged 55 years and over 1992 2.4 1998 1.4
Hospital separation rate for injury resulting from fire, burns and scalds among children aged 
0–4 years (per 100,000 population)
Boys 1991–92 167 1997–98 106
Girls 1991–92 127 1997–98 79
Hospital separation rate due to poisoning among children aged 0–4 years 
(per 100,000 population)
Children aged 0–4 years 1991–92 302 1997–98 288
Death rate for drowning in the total population and among children aged 0–4 years 
(per 100,000 population)
Total population 1992 1.7 1998 1.3
Children aged 0–4 years 1992 5.9 1998 3.7
Hospital separation rate for near drowning among children aged 0–4 years 
(per 100,000 population)
Children aged 0–4 years 1991–92 29.5 1997–98 23.0
Incidence rate for persistent spinal cord injury from traumatic causes 
(per 100,000 population)
Persons 1995–96 1.34 1998–99 1.45
Sources: AIHW National Mortality Database; AIHW National Morbidity Database; AIHW NISU unpublished data; DHFS & 
AIHW 1998b.
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Table S57: Indicators for mental health, focusing on depression
Descriptor
Baseline Most recent data
Year Value Year Value
Prevalence rates for depressive disorders (per 100,000 population)
Males 1997 4.2 n.a. n.a.
Females 1997 7.4 n.a. n.a.
Prevalence rates for anxiety disorders (per 100,000 population)
Males 1997 7.1 n.a. n.a.
Females 1997 12.1 n.a. n.a.
Hospital separations for suicide and self-inflicted injury among young adults aged 15–24 years, and 
older people aged 65 years and over (per 100,000 population)
Males, aged 15–24 years 1993–94 142.4 1997–98 164.0
Females, aged 15–24 years 1993–94 235.6 1997–98 280.8
Males, aged 65 years and over 1993–94 38.0 1997–98 42.5
Females, aged 65 years and over 1993–94 30.4 1997–98 33.1
Death rates for suicide among young adults aged 15–24 years and older people aged 65 years and 
over (per 100,000 population)
Males, aged 15–24 years 1986 21.3 1998 26.6
Females, aged 15–24 years 1986 5.4 1998 6.3
Males, aged 65 years and over 1986 30.7 1998 23.7
Females, aged 65 years and over 1986 7.0 1998 6.2
Death rates for suicide in urban, rural and remote areas among young adults aged 15–24 years 
(per 100,000 population)
Males, 15–24 years, capital cities 1986–96 22.7 1988–98 23.2
Males, 15–24 years, other metropolitan 1986–96 24.9 1988–98 26.0
Males, 15–24 years, large rural centres 1986–96 27.9 1988–98 29.8
Males, 15–24 years, small rural centres 1986–96 31.5 1988–98 30.6
Males, 15–24 years, other rural areas 1986–96 34.4 1988–98 37.6
Males, 15–24 years, remote centres 1986–96 31.0 1988–98 35.3
Males, 15–24 years, other remote areas 1986–96 42.5 1988–98 51.3
Females, 15–24 years, capital cities 1986–96 5.2 1988–98 5.2
Females, 15–24 years, other metropolitan 1986–96 4.1 1988–98 4.1
Females, 15–24 years, large rural centres 1986–96 4.0 1988–98 5.1
Females, 15–24 years, small rural centres 1986–96 4.1 1988–98 4.8
Females, 15–24 years, other rural areas 1986–96 4.8 1988–98 5.3
Females, 15–24 years, remote centres 1986–96 5.5 1988–98 6.4
Females, 15–24 years, other remote areas 1986–96 6.1 1988–98 6.3
(continued)
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Table S57 (continued): Indicators for mental health, focusing on depression
Descriptor
Baseline Most recent data
Year Value Year Value
Death rates for suicide in urban, rural and remote areas among older people aged 65 years and over 
(per 100,000 population)
Males, 65+ years, capital cities 1986–96 26.7 1988–98 25.4
Males, 65+ years, other metropolitan 1986–96 30.7 1988–98 30.7
Males, 65+ years, large rural centres 1986–96 29.2 1988–98 27.3
Males, 65+ years, small rural centres 1986–96 31.1 1988–98 28.7
Males, 65+ years, other rural areas 1986–96 34.4 1988–98 33.2
Males, 65+ years, remote centres 1986–96 51.1 1988–98 53.3
Males, 65+ years, other remote areas 1986–96 40.4 1988–98 36.5
Females, 65+ years, capital cities 1986–96 8.2 1988–98 7.8
Females, 65+ years, other metropolitan 1986–96 5.5 1988–98 5.9
Females, 65+ years, large rural centres 1986–96 6.9 1988–98 6.0
Females, 65+ years, small rural centres 1986–96 4.9 1988–98 5.0
Females, 65+ years, other rural areas 1986–96 4.6 1988–98 5.0
Females, 65+ years, remote centres 1986–96 0.0 1988–98 0.0
Females, 65+ years, other remote areas 1986–96 6.8 1988–98 7.5
Sources: AIHW National Mortality Database; AIHW National Morbidity Database; DHAC & AIHW 1999c.
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Methods and 
conventions
Methods
Details of methods used in particular sections of the report are included in the text and
boxes, and in footnotes to figures and tables. Entries in columns of tables may not add
to the totals shown, due to rounding.
Age standardisation has been used to facilitate the comparison of populations with
differing age compositions, either different populations at one time or the same
population at different times. The 1991 Australian population (ABS 1993) has been used
as the standard population for all intra-Australia comparisons. The 1988 Australian
population was used for these comparisons in editions of AustraliaÕs Health prior to the
1996 edition; some statistics may thus differ slightly from those in previous editions.
The European and the World Standard Populations have been used for some
international comparisons. Details of these standard populations are provided. 
Table A1: Age composition of the Australian population at 30 June 1991, and of European and 
World Standard Populations
Age group (years) Australia, 30 June 1991 European Std World Std
0 259,085 1,600 2,400
1–4 1,012,618 6,400 9,600
5–9 1,272,208 7,000 10,000
10–14 1,241,619 7,000 9,000
15–19 1,364,074 7,000 9,000
20–24 1,396,764 7,000 8,000
25–29 1,399,663 7,000 8,000
30–34 1,425,735 7,000 6,000
35–39 1,328,387 7,000 6,000
40–44 1,294,271 7,000 6,000
45–49 1,029,145 7,000 6,000
50–54 846,934 7,000 5,000
55–59 725,950 6,000 4,000
60–64 736,868 5,000 4,000
65–69 671,390 4,000 3,000
70–74 510,755 3,000 2,000
75–79 384,495 2,000 1,000
80–84 229,828 1,000 500
85 and over 154,247 1,000 500
Total 17,284,036 100,000 100,000
Sources: ABS 1993; WHO 1996.
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Within Australia, most regional comparisons are among States and Territories. For
within-State comparisons, Australian Bureau of Statistics sources use capital city
statistical areas and the rest of each State. Definitions for regional comparisons from
other sources are not consistent, and are stated at appropriate places in the text.
Average annual rates of change or growth rates have been calculated as geometric rates:
Average rate of change = ((Pn/Po)1/N Ð 1) ·  100
where Pn = value in later time period
Po = value in earlier time period
N = number of years between the two time periods.
The classification of deaths follows the Ninth Revision of the International
Classification of Diseases (WHO 1977). Diseases treated in hospitals and the procedures
performed during a hospital stay are classified using the Australian version of the
International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM
(see Box 5.7, page 274).
Symbols
$ Australian dollars, unless otherwise specified
Ñ nil or rounded to zero
% per cent
g gram
kcal kilocalorie
kg kilogram
kJ kilojoule
km2 square kilometres
Õ000 thousands
m million
mm millimetre
mm Hg millimetres of mercury
mmol/L millimoles per litre
n.a. not available
. . not applicable
nec not elsewhere classified
n.p. not published by the data source
npr not previously reported
wk week
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> more than
< less than
³ more than or equal to
² less than or equal to
* value subject to sampling variability too high for most practical purposes
and/or the relative standard error is 25% to 50%.
** value subject to sampling variability too high for most practical purposes
and/or the relative standard error is more than 50%.
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Abbreviations
 
AACR Australian Association of Cancer Registries
ABS Australian Bureau of Statistics
ACCHS Aboriginal Community Controlled Health Services
ACCSIS Aged and Community Care Strategic Information System
ACCV Anti-Cancer Council of Victoria
ACHS Australian Council on Healthcare Standards
ACIR Australian Childhood Immunisation Register
AGPS Australian Government Publishing Service
AHMAC Australian Health MinistersÕ Advisory Council
AIC Australian Institute of Criminology
AIDS Acquired immune deficiency syndrome
AIH Australian Institute of Health
AIHW Australian Institute of Health and Welfare
ALOS Average length of stay
AN-DRG Australian National Diagnosis Related Group
ANZDATA Australian and New Zealand Dialysis and Transplant Registry
APA American Psychiatric Association
APSU Australian Paediatric Surveillance Unit
AR-DRG Australian Refined Diagnosis Related Group
ARI Acute respiratory infections
ASCCSS Australian Standard Classification of Countries for Social Statistics
ASR Age-standardised rate
ASVS Australian Standard Vaccination Schedule
ATSIHWIU Aboriginal and Torres Strait Islander Health and Welfare Information Unit
BEACH Bettering the Evaluation And Care of Health
BMI Body mass index
CABG Coronary artery bypass grafting
CATI Computer-assisted telephone interview
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CBCS Commonwealth Bureau of Census and Statistics
CFCs Chlorofluorocarbons
CGC Commonwealth Grants Commission
CHD Coronary heart disease
CNS Central nervous system
COAG Council of Australian Governments
COPD Chronic obstructive pulmonary disease
CSIRO Commonwealth Scientific and Industrial Research Organisation
CT Computerised tomographic (scan)
CVD Cardiovascular disease
DALY Disability-adjusted life year
DASET Department of Art, Sport, the Environment and Territories
DBP Diastolic blood pressure
DDD Defined daily dose
DEETYA Department of Employment, Education, Training and Youth Affairs
DHAC Department of Health and Aged Care
DHCS Department of Health and Community Services
DHFS Department of Health and Family Services
DHHST Department of Health and Human Services, Tasmania
DHSH Department of Human Services and Health
DMFT Decayed, missing or filled permanent teeth
dmft Decayed, missing or filled primary teeth
DNA Deoxyribonucleic acid
DPIE Department of Primary Industries and Energy
DRG Diagnosis related group
DSRU Dental Statistics and Research Unit
DTP Diphtheria, tetanus, pertussis (triple antigen vaccine)
FECCA Federation of Ethnic CommunitiesÕ Councils of Australia
FED Front-end deductible
FORS Federal Office of Road Safety
FWE Full-time workload equivalent
GBD Global Burden of Disease Study
GDM Gestational diabetes mellitus
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GDP Gross domestic product
GIFT Gamete intra-fallopian transfer
GP General practitioner
GPSCU General Practice Statistics and Classification Unit
HACC Home and Community Care
HCV Hepatitis C virus
HFA Heart Foundation of Australia
HGP Human Genome Project
Hib Haemophilus influenzae type b
HIC Health Insurance Commission
HIV Human immunodeficiency virus
HLA Human leukocyte antigen
HUS Haemolytic uraemic syndrome
ICD International Classification of Diseases
ICD-10 International Classification of Diseases, 10th Revision
ICD-10-AM International Classification of Diseases, 10th Revision, 
Australian Modification
ICD-9 International Classification of Diseases, 9th Revision
ICD-9-CM International Classification of Diseases, 9th Revision, Clinical Modification
ICIDH International Classification of Impairments, Disabilities and Handicaps
ICPEMC International Commission for Protection against Environmental Mutagens
and Carcinogens
IHD Ischaemic heart disease
IPD Implicit price deflator
IRSD Index of relative socioeconomic disadvantage
IUD Intra-uterine device
IVF In-vitro fertilisation
KS KaposiÕs sarcoma
LIPID Long-term Intervention with Pravastatin in Ischaemic Disease
MBS Medicare Benefits Schedule
MCC Measles Control Campaign
MCS Mental component summary (of the SF-36)
MDBS MurrayÐDarling Basin Commission
MDC Major diagnostic category
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MEAC Measles Elimination Advisory Committee
MMR Measles, mumps and rubella (vaccine)
MRI Magnetic resonance imaging
MS Multiple sclerosis
NADC National Association of Diabetes Centres
NCATSIS National Centre for Aboriginal and Torres Strait Islander Statistics
NCC National Coding Centre
NCCH National Centre for Classification in Health
NCEPH National Centre for Epidemiology and Population Health
NCHECR National Centre in HIV Epidemiology and Clinical Research
NDR National Diabetes Register
NHDC National Health Data Committee
NHDD National Health Data Dictionary
NHF National Heart Foundation
NHIA National Health Information Agreement
NHIMAC National Health Information Management Advisory Committee
NHIMG National Health Information Management Group
NHL Non-HodgkinÕs lymphoma
NHLBI National Heart, Lung and Blood Institute
NHMBWG National Health MinistersÕ Benchmarking Working Group
NHMRC National Health and Medical Research Council
NHPA National Health Priority Area
NHPC National Health Performance Committee
NHS National Health Survey
NISAD Neuroscience Institute of Schizophrenia and Allied Disorders
NISU National Injury Surveillance Unit
NMDS National minimum data set
NMSC Non-melanocytic skin cancer
NNDSS National Notifiable Diseases Surveillance System
NPHP National Public Health Partnership
NPSU National Perinatal Statistics Unit
NTD Neural tube defect
OATSIH Office for Aboriginal and Torres Strait Islander Health 
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OECD Organisation for Economic Co-operation and Development
OGIT Oral glucose tolerance test
Pap Papanicolaou
PBAC Pharmaceutical Benefits Advisory Committee
PBS Pharmaceutical Benefits Scheme
PCP Pneumocystis carinii pneumonia
PCS Physical component score (of the SF-36)
PEI Patient episode initiation
PHIAC Private Health Insurance Advisory Council
PHIIS Private Health Insurance Incentives Scheme
PSA Prostate-specific antigen
PSD Post-traumatic stress disorder
PYLL Potential years of life lost
RDI Recommended Dietary Intake
RFE Reason for encounter
RNA Ribonucleic acid
RPBS Repatriation Pharmaceutical Benefits Scheme
RRMA Rural, Remote and Metropolitan Areas classification
RRV Ross River virus
SAAP Supported Accommodation Assistance Program
SBP Systolic blood pressure
SCRCSSP Steering Committee for the Review of 
Commonwealth/State Service Provision
SEIFA Socio-Economic Indexes for Areas
SF-12 Medical Outcomes Study Short-Form 12
SF-36 Medical Outcomes Study Short-Form 36
SIDS Sudden infant death syndrome
SIGNAL Strategic Intergovernmental Nutrition Alliance
SLA Statistical local area
SMR Standardised mortality ratio
SSPE Subacute sclerosing panencephalitis
STD Sexually transmitted disease
TFR Total fertility rate
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UN United Nations
UNEP United Nations Environment Program
UNICEF United Nations ChildrenÕs Fund
WHO World Health Organization
WHR Waist-to-hip-ratio
YLD Years lost due to disability
YLL Years of life lost (due to mortality)
Abbreviations of places
ACT Australian Capital Territory
Aust Australia
Can Canada
Fra France
Ger Germany
Jpn Japan
NSW New South Wales
NT Northern Territory
NZ New Zealand
Qld Queensland
SA South Australia
Tas Tasmania
UK United Kingdom
USA United States of America
USSR Former Union of Soviet Socialist Republics
Vic Victoria
WA Western Australia
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Glossary
 
Aboriginal: A person of Aboriginal descent who identifies as an Aboriginal and is
accepted as such by the community in which he or she lives.
accommodation (of eye): How the eye automatically adjusts so it can focus at various
distances, mainly by changing the shape of its lens.
acute: Coming on sharply to a crisis and often brief, intense and severe.
acute hospitals: Public, Department of VeteransÕ Affairs (repatriation) and private
hospitals which provide services primarily to admitted patients with acute or
temporary ailments. The average length of stay is relatively short.
admission: Admission to hospital. In this report, the number of separations has been
taken as the number of admissions. Hence an admission rate is the same as a separation
rate.
admitted patient: A patient who undergoes a hospitalÕs formal admission process.
See Box 5.6, page 271.
affective disorders: Mood disorders such as depression, mania and bipolar affective
disorder. (Do not include anxiety disorders, which are classified as a separate group.)
age-specific death rate: See Box 2.6, page 39.
age-specific rate: A rate for a specific age group. The numerator and denominator relate
to the same age group.
age standardisation: A method of removing the influence of age when comparing
populations with different age structures.
age-standardised death rate: See Box 2.6, page 39.
agoraphobia: Fear of being in public places from which it may be difficult to escape.
AlzheimerÕs disease: A disease (named after a German physician) in which there is
progressive loss of brainpower shown by worsening short-term memory, confusion and
disorientation.
ambulatory care: Care provided to hospital patients who are not admitted to the
hospital, such as patients of emergency departments and outpatients clinics. The term is
also used to refer to care provided to patients of community-based (non-hospital) health
care services.
AN-DRGs: See DRGs.
angina: Temporary chest pain or discomfort when the heartÕs own blood supply is
inadequate to meet extra needs, as in exercise. See also cardiovascular disease.
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angioplasty: A method of reducing a blockage in an artery by opening out a balloon
placed inside the artery at the point of narrowing.
anxiety disorders: A group of mental disorders marked by excessive feelings of
apprehension, worry, nervousness and stress. Includes panic disorder, various phobias,
generalised anxiety disorder, obsessiveÐcompulsive disorder and post-traumatic stress
disorder.
arrhythmia: A disturbed rhythm of the heart beatÑeither too fast, too slow or irregular.
arthritis: A group of disorders in which there is inflammation of the joints, which can
become stiff, painful, swollen or deformed. The two main types of arthritis are
osteoarthritis and rheumatoid arthritis.
asthma: An inflammatory disease of the air passages that makes them prone to narrow
too easily and too much in response to ÔtriggersÕ, causing episodes of shortness of
breath and wheezing or coughing. The triggers include exercise, pollens, the house dust
mite, cold weather, throat and chest infections, tobacco smoke and other factors.
atherosclerosis: A process that gradually clogs arteries, through fatty and fibre-like
deposits that build up on the inner walls of the arteries.
available beds: Beds immediately available for use by admitted patients.
average length of stay (ALOS): The average of the length of stay for admitted patient
episodes.
benchmark: A standard or point of reference for measuring quality or performance. See
also benchmarking.
benchmarking: A continuous process of measuring quality or performance against the
highest standards. See also benchmark.
bipolar affective disorder: A mental disorder where the person may be depressed at one
time and manic at another. Formerly known as manic depression.
blood cholesterol: Fatty substance produced by the liver and carried by the blood to
supply the rest of the body.
body mass index (BMI): The most commonly used method of assessing whether a
person is normal weight, underweight, overweight or obese. Calculated by dividing the
personÕs weight (in kilograms) by their height (in metres) squared, i.e. kg ‚  m2. Also
known as QueteletÕs Index. For both men and women, underweight is a BMI below 18.5,
acceptable weight is from 18.5 to less than 25, overweight is 25 and above but less
than 30, and obese is 30 and over.
campylobacteriosis: A disease usually marked by diarrhoea, abdominal pain, fever,
nausea and vomiting for a few days, caused by some types of Campylobacter bacteria
and often food-borne.
cancer: A range of diseases where some of the bodyÕs cells begin to multiply out of
control, can invade and damage the area around them, and can also spread to other
parts of the body to cause further damage.
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cardiovascular disease: Any disease of the heart or blood vessels, including heart attack,
angina, stroke and peripheral vascular disease. Also known as circulatory disease. 
capital expenditure: Expenditure on large-scale fixed assets (for example, new buildings
and equipment with a useful life extending over a number of years).
casemix: The range and types of patients (the mix of cases) treated by a hospital or other
health service. This provides a way of describing and comparing hospitals and other
services for planning and managing health care. Casemix classifications put patients into
manageable numbers of groups with similar conditions that use similar healthcare
resources, so that the activity and cost-efficiency of different hospitals can be compared.
cause of death: From information reported on the medical certificate of cause of death,
each death is classified by the underlying cause of death according to rules and
conventions of the 9th revision of the International Classification of Diseases. The
underlying cause is defined as the disease which initiated the train of events leading
directly to death. Deaths from injury or poisoning are classified according to the
circumstances of the violence which produced the fatal injury, rather than to the nature
of the injury.
cerebrovascular disease: See stroke.
chemotherapy: The use of drugs (chemicals) to prevent or treat disease, with the term
usually being applied to treatment for cancer rather than for other conditions.
chronic: Persisting over a long period.
chronic bronchitis: Long-term lung condition with inflammation of the main air
passages causing frequent coughing attacks and coughing up of mucus. 
chronic obstructive pulmonary disease: A combination of emphysema and chronic
bronchitis-related conditions, where damage to the lungs tends to obstruct their oxygen
intake.
cohort: A group of individuals being studied who have experienced the same event at a
specified period in time, e.g. Ôbirth cohortÕ refers to people born in the same year.
colonoscopy: A procedure whereby the inside of the large bowel (colon) is viewed
using a long flexible tube inserted through the anus.
colorectal cancer: Cancer of the colon (the lower 1.5 to 2 metres of the intestine) or of
the rectum (the final 15 cm at the end of the colon, ending with the anus).
co-morbidity: When a person has two or more health problems at the same time.
confidence interval: A statistical term describing a range (interval) of values within
which we can be ÔconfidentÕ that the true value lies, usually because it has a 95% or
higher chance of doing so.
congenital: A condition that is recognised at birth, or that is believed to have been
present since birth, including conditions which are inherited or caused by
environmental factors.
coronary heart disease: See ischaemic heart disease.
crude death rate: See Box 2.6, page 39.
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cryptosporidiosis: A disease usually marked by diarrhoea with cramping abdominal
pain and other symptoms, caused by Cryptosporidiosis parvum, a protozoan parasite and
transmitted directly from person to person, or food-borne.
dementia: A general and worsening loss of brain power such as memory,
understanding and reasoning.
dentate: Having one or more natural teeth.
depression: A mood disorder with prolonged feelings of being sad, hopeless, low and
inadequate, with a loss of interest or pleasure in activities and often with suicidal
thoughts or self-blame.
diphtheria: A bacterial infection that usually starts with soreness of the throat and
tonsils but which can also affect other parts of the body and become severe enough to
block breathing. Preventable by vaccine.
direct bill: The process by which a medical practitioner or optometrist sends the bill for
services direct to Medicare, often referred to as bulk billing.
disability: The presence of one or more of seventeen limitations, restrictions or
impairments (see Box 2.7, page 49).
disability-adjusted life year (DALY): Years of healthy life lost through premature death
or living with disability due to illness or injury.
DRGs (diagnosis related groups): A widely used type of casemix classification system.
In the case of Australian acute hospitals, AN-DRGs (Australian National Diagnosis
Related Groups) classify admissions into groups with similar clinical conditions (related
diagnoses) and similar resource usage. This allows the activity and performance of
hospitals to be compared on a common basis. See Box 5.7, page 274. See also casemix.
dysthymia: A disorder characterised by constant or constantly recurring chronic
depression of mood, lasting at least 2 years.
emphysema: A long-term lung disease where over expansion or destruction of the lung
tissue blocks oxygen intake, leading to shortness of breath and other problems.
endoscopy: The viewing of internal parts of the body, such as the inside of the lower
bowel (the colon) with a colonoscope.
encephalitis: Inflammation of the brain.
enterohaemorrhagic E. coli infection: A disease marked by diarrhoea that can be mild or
severe and bloody, and sometimes also the haemolytic-uraemic syndrome (sudden
kidney failure and anaemia in children) and other symptoms. It is caused by some
types of E. coli bacteria and is usually food-borne.
epidemiology: The study of the patterns and causes of health and disease in
populations, and the application of this study to improve health.
expectation of life: See life expectancy.
external cause: Environmental event, circumstance and/or condition as the cause of
injury, poisoning and/or other adverse effect. Used in disease classification.
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foetal death: Birth of a foetus weighing at least 400 grams (or, where birthweight is
unavailable, of at least 20 weeks gestation), which shows no signs of life. Commonly
referred to as stillbirth.
foetal death rate: Number of foetal deaths per 1,000 total births (foetal deaths plus live
births).
freestanding day hospital facility: A private hospital where only minor operations and
other procedures not requiring overnight stay are performed, not forming part of any
private hospital providing overnight care.
gastroscopy: A procedure whereby the inside of the stomach is viewed using a flexible
tube passed down into it via the mouth.
generalised anxiety disorder: A mental disorder where a person is overly and
unrealistically anxious and worried about many things over a long period. One of the
group of anxiety disorders.
gestational diabetes: Diabetes which is first diagnosed during pregnancy (gestation). It
may disappear after pregnancy but signals a high risk of diabetes occurring later on.
gross domestic product (GDP): A statistic commonly used to indicate national wealth. It
is the total market value of goods and services produced within a given period after
deducting the cost of goods and services used up in the process of production but
before deducting allowances for the consumption of fixed capital.
haemodyalisis/dialysis: Process used to treat kidney failure with a machine that is
connected to the patientÕs bloodstream so it can take on the role of the kidneys by
removing excess substances from the blood.
handicap: A disadvantage resulting from impairment or disability that limits or
prevents the fulfilment of a role that is normal (see Box 2.7, page 49).
health indicator: See indicator.
health outcome: A change in the health of an individual or population due to a
preventive or clinical intervention.
health promotion: Activities to improve health and prevent disease.
health status: An individualÕs or populationÕs overall level of health, taking account of
various aspects such as life expectancy, amount of disability, levels of disease risk
factors and so forth.
heart attack: Emergency illness that occurs when a vessel supplying blood to the heart
muscle is suddenly blocked completely by a blood clot. The medical term commonly
used for a heart attack is myocardial infarction. See also cardiovascular disease.
heart failure: When the heart cannot pump strongly enough to keep the blood
circulating around the body at  adequate rate.
hepatitis: Inflammation of the liver, which can be due to certain viral infections, alcohol
excess or a range of other causes.
Hib (Haemophilus influenzae type b): A bacterial infection of infants and children that
can cause meningitis, pneumonia and other serious effects. Preventable by vaccine.
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HodgkinÕs disease (HodgkinÕs lymphoma): A cancer marked by progressive painless
enlargement of lymph nodes throughout the body. A form of lymphoma. Named after
the English physician who described it.
hostels: Establishments providing board, lodging or accommodation for the aged,
distressed, or disabled who cannot live independently but who do not need nursing care
in a hospital or nursing home. Residents are generally responsible for their own
provisions, but may be provided with domestic assistance (meals, laundry, personal care). 
hypertensive disease: Occurs when blood pressure is high long term, especially when
this leads to damage of the heart, brain or kidneys.
hypomania: A lesser degree of mania characterised by a persistent mild abnormal
elevation of mood and increased activity lasting at least 4 days.
immunisation: Inducing immunity against infection by the use of antigen to stimulate
the body to produce its own antibodies. See vaccination.
impairment: Any loss or abnormality of psychological, physiological or anatomical
structure or function. 
incidence: The number of new cases (of an illness or event etc.) occurring during a given
period. Compare with prevalence.
indicator (health indicator): A key statistic that indicates an aspect of population health
status, health determinants, interventions, services or outcomes. Indicators are designed
to help assess progress and performance, as a guide to decision making. They may have
an indirect meaning as well as a direct one; for example, AustraliaÕs overall death rate is
a direct measure of mortality but is often used as a major indicator of population health.
Indigenous: A person of Aboriginal and/or Torres Strait Islander descent who identifies
as an Aboriginal and/or Torres Strait Islander and is accepted as such by the
community with which he or she is associated.
inflammation: Local response to injury or infection, marked by local redness, heat,
swelling and pain. Can also occur when there is no clear external cause and the body
reacts against itself, as in the auto-immune disorders.
International Classification of Diseases: The World Health OrganizationÕs
internationally accepted classification of death and disease. The 9th Revision (ICD-9) is
currently in use. In this report, causes of death classified before 1979 under previous
revisions have been reclassified to ICD-9 by the AIHW.
intervention (for health):  Any action taken by society or an individual which Ôsteps inÕ
(intervenes) to improve health, such as medical treatment and preventive campaigns.
ischaemia: Reduced or blocked blood supply. See also ischaemic heart disease.
ischaemic heart disease: Heart attack and angina (chest pain). Also known as coronary
heart disease.
length of stay: Duration of hospital stay, calculated by subtracting the date the patient is
admitted from the day of separation. All leave days, including the day the patient went
on leave, are excluded. A same-day patient is allocated a length of stay of 1 day.
03 AH2000 end matter  Page 442  Thursday, June 1, 2000  2:31 PM
Glossary  443
TRIM SIZE 175 mm Wide x 250 mm Deep
life expectancy: An indication of how long a person can expect to live. Technically it
is the number of years of life remaining to a person at a particular age if death rates do
not change.
listeriosis: A disease which normally appears in otherwise healthy people as an acute,
mild fever, sometimes with influenza-like symptoms, caused by the bacteria Listeria
monocytogenes and usually food-borne. It can cause more severe symptoms in
newborns, the elderly, people with poor immunity and pregnant women (in whom it
can also cause abortion).
low birthweight: Birth of a baby weighing less than 2,500 grams.
lymphoma: A cancer of the lymphatic system, which includes the lymph nodes and the
channels linking them. Lymphomas are divided into two broad types, HodgkinÕs disease/
lymphoma and non-HodgkinÕs lymphoma (NHL).
major diagnostic categories (MDCs): A high level of groupings of patients used in the
AN-DRG classification.
malignancy: See cancer.
mammogram: X-ray of the breast. May be used to assess a breast lump or as a screening
test in women with no evidence of cancer.
mania: A mental disorder where the person is overexcited, overactive and excessively
and unrealistically happy and expansive. It is the opposite of depression and can
alternate with it in the same person in what is known as bipolar affective disorder
(formerly known as manic depression). 
manic depression; manic depressive disorder: See bipolar affective disorder; mania; and
depression.
measles: A highly contagious infection, usually of children, that causes flu-like
symptoms, fever, a typical rash and sometimes serious secondary problems such as
brain damage. Preventable by vaccine. 
median: The midpoint of a list of observations ranked from the smallest to the largest.
Medicare: A national, government-funded scheme that subsidises the cost of personal
medical services, and that covers all Australians to help them afford medical care.
melanoma: A cancer of the bodyÕs cells that contain pigment (melanin), mainly affecting
the skin.
meningitis: Inflammation of the brainÕs covering (the meninges), as can occur with
some viral or bacterial infections.
mental disorder: A disturbance of mood or thought that can affect behaviour and
distress the person or those around them, so the person cannot function normally.
Includes anxiety disorders, depression and schizophrenia.
metastasis: The spread of a cancer from its original site to other parts of the body.
morbidity: Refers to ill health in an individual and to levels of ill health in a population
or group.
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motor neurone disease: A disease of the nervous system with progressive wasting of
muscles, weakness and paralysis.
multiple sclerosis: One of the most common nervous system disorders, with varied
symptoms such as loss of control of limbs, sudden vision problems and disturbed
sensations.
mumps: A contagious viral disease marked by acute and painful swelling of the saliva-
producing glands, often similarly affecting the testicles and sometimes other parts.
myocardial infarction: Term still commonly used to mean a heart attack, but more
correctly refers only to those heart attacks which have caused some death of heart muscle.
neonatal death: Death of an infant within 28 days of birth.
neonatal mortality rate: Number of neonatal deaths per 1,000 live births.
neural tube defects: Defects such as spina bifida and anencephalus that have arisen in
the neural tube, the part of the embryo that develops into the brain and spinal cord.
neurosis/neurotic disorders: A broad category of mental disorders with anxiety as their
main feature and whose symptoms are mostly exaggerations of normal emotions or
behaviour. Includes anxiety disorders, obsessiveÐcompulsive disorder, stress reactions
and other problems.
non-HodgkinÕs lymphoma: A range of cancers of the lymphatic system (lymph glands
and the channels they are linked to) which are not of the HodgkinÕs variety.
non-admitted patient: A patient who receives care from a recognised non-admitted
patient service/clinic of a hospital.
nursing homes: Establishments which provide long-term care involving regular basic
nursing care to chronically ill, frail, disabled or convalescent people or senile inpatients.
obesity: Marked degree of overweight defined as body mass index 30 and over. See also
overweight.
obsessiveÐcompulsive disorder: A form of anxiety disorder where repeated and
unwanted thoughts and impulses disturb and dominate a person. Often involves rituals
such as excessive-hand washing, checking and counting, which in turn cause anxiety if
they are prevented or out of control. 
occasion of service: Occurs when a patient receives some form of service from a
functional unit of the hospital, but is not admitted.
ophthalmology: A medical specialty dealing with eye diseases.
Organisation for Economic Co-operation and Development (OECD): An organisation
of 24 developed countries, including Australia.
outcome (health outcome): A health-related change due to a preventive or clinical
intervention or service. (The intervention may be single or multiple and the outcome
may relate to a person, group or population or be partly or wholly due to the
intervention.)
overweight: Defined as a body mass index 25 and over but less than 30. See also obesity.
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panic disorder: Marked by panic attacks (episodes of intense fear or discomfort) that
occur suddenly and unpredictably.
Pap smear: Papanicolaou smear, a procedure to detect cancer and pre-cancerous
conditions of the female genital tract.
parasuicide: The deliberate or ambivalent act of self-damage which is potentially life-
threatening, but not resulting in death.
pathology: General term for the study of disease, but often used more specifically for
diagnostic services which examine specimens, such as samples of blood or tissue.
patient-days: The number of full or partial days of stay for patients who were admitted
for an episode of care and who underwent separation during the reporting period. A
patient who is admitted and separated on the same day is allocated 1 patient-day.
performance indicators: Measures of the efficiency and effectiveness of health services
(hospitals, health centres, etc.) in providing  health care.
perinatal: Pertaining to or occurring in the period shortly before or (usually 28 days)
after birth.
perinatal death: Foetal or neonatal death.
perinatal mortality rate: Number of perinatal deaths per 1,000 total births (foetal
deaths plus live births).
peripheral vascular disease: Pain in the legs due to an inadequate blood supply to
them.
pertussis (whooping cough): A highly infectious bacterial disease of the air passages
marked by explosive fits of coughing and often a whooping sound on breathing in.
Preventable by vaccine.
Pharmaceutical Benefits Scheme (PBS): A national, government-funded scheme that
subsidises the cost of a wide range of pharmaceutical drugs, and that covers all
Australians to help them afford standard medications.
phobia: A form of anxiety disorder in which there is persistent, unrealistic fear of an
object or situation and which interferes with the personÕs life as they seek to avoid the
object of their fear. Different phobias include fear of heights, flying, open spaces, social
gatherings, animals such as spiders and snakes, etc.
poliomyelitis (polio): Muscle paralysis, wasting and deformity of limbs after infection
by a common virus (poliovirus) that can damage the so-called motor nerves in the
spinal cord. Preventable by vaccine.
post-traumatic stress disorder (PSD): A form of anxiety disorder in which a person has
a delayed and prolonged reaction after being in an extremely threatening or
catastrophic situation such as a war, natural disaster, terrorist attack, serious accident or
witnessing violent deaths.
potential years of life lost (PYLL): Number of potential years of life lost in a population
as a result of premature death.
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prescription drugs: Pharmaceutical drugs available only on the prescription of a
registered medical practitioner and available only from pharmacies.
prevalence: The number or proportion (of cases, instances, etc.) present in a population
at a given time. Compare with incidence.
prevention (of disease): Action to reduce or eliminate the onset, causes, complications or
recurrence of disease.
principal diagnosis: The diagnosis describing the problem that was chiefly responsible
for the patientÕs episode of care in hospital.
principal procedure: The most significant procedure that was performed for treatment
of the principal diagnosis.
private health insurance: See Box 5.5, page 252.
private hospital: A privately owned and operated institution, catering for patients who
are treated by a doctor of their own choice. Patients are charged fees for
accommodation and other services provided by the hospital and relevant medical and
paramedical practitioners. Includes private freestanding day hospital facilities.
private patients: Persons admitted to a private hospital; or persons admitted to a public
hospital who decide to choose the doctor(s) who will treat them and to have private
ward accommodation. This means they will be charged for medical services, food and
accommodation. 
prostate cancer: Cancer of the prostate, the male organ that sits next to the urinary
bladder and contributes to the semen (sperm fluid).
psychiatric hospitals: Establishments devoted primarily to the treatment and care of
inpatients with psychiatric disorders.
public health: Health activities which aim to benefit a population. Prevention,
protection and promotion of health are emphasised, as distinct from treatment tailored
to individuals with symptoms. Examples include provision of a clean water supply and
good sewerage, conduct of anti-smoking education campaigns and screening for
diseases such as cancer of the breast and cervix.
public hospital: A hospital controlled by a State or Territory health authority. In
Australia public hospitals offer free diagnostic services, treatment, care and
accommodation to all who need it. 
public patient: A patient admitted to a public hospital who has agreed to be treated by
doctors of the hospitalÕs choice and to accept shared ward accommodation. This means
the patient is not charged. 
quintile: A group derived by ranking the population according to specified criteria and
dividing it into five equal parts.
radiology: The use or study of X-rays and other rays to help view internal parts of the
body as a guide to diagnosis as well as to treatment and its progress.
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real expenditure: Expenditure expressed in terms which have been adjusted for inflation
(for example, in 1989Ð90 dollars). This enables comparisons to be made between
expenditures in different years.
recurrent expenditure: Expenditure on goods and services which are used up during the
year, for example, salaries. It may be contrasted with capital expenditure, such as
expenditure on hospital buildings and large-scale diagnostic equipment, the useful life
of which extends over a number of years.
refraction: The eyeÕs ability to bend light rays that enter it, to form an image at the back
of the eye.
renal dialysis: A treatment for kidney failure where the patient is connected to a
machine which does the kidneysÕ work by filtering the blood to control its contents.
rheumatic heart disease: Disease from damaged heart valves caused by childhood
attack of rheumatic fever.
risk factor: Any factor which represents a greater risk of a health disorder or other
unwanted condition. Some risk factors are regarded as causes of disease, others are not
necessarily so.
rubella (German measles): A contagious viral disease of children and young adults
which has mild symptoms but which often causes serious birth defects if it occurs in a
mother during the first 3 months of pregnancy. Preventable by vaccine.
salmonellosis: a disease commonly marked by sudden onset of headache, abdominal
pain, fever, diarrhoea, nausea and sometimes vomiting, caused by some types of
Salmonella bacteria and often food-borne.
same-day patients: Admitted patients who are admitted and separated on the same
day.
schizophrenia: A group of serious mental disorders where imagined and disordered
thoughts are key features, often with problems of behaviour, mood and motivation, and
a retreat from social life.
separation: The formal process by which a hospital records the completion of treatment
and/or care for an admitted patient. See Box 5.6, page 271.
SF-36: Short Form 36Ñwidely used questionnaire to measure general health and
wellbeing.
shigellosis: A disease characterised by acute diarrhoea with fever, nausea and
sometimes other symptoms, usually transmitted directly from person to person via the
faecalÐoral route. It is caused by Shigella species bacteria, including Shigella dysenteriae 1,
the cause of dysentery.
sign (clinical): An indication of a disorder that is apparent to a clinician or other
observer and not necessarily to the person affected. Compare with symptom.
social phobia: A persistent, irrational fear of being the focus of attention, or fear of
behaving in a way that will be embarrassing or humiliating.
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statistical significance: An indication from a statistical test that the result of a
comparison, suggesting a difference or change, may be significant or meaningful
because it is unlikely to be due just to chance. A statistical result is usually said to be
ÔsignificantÕ if it would occur by chance only once in twenty times or less.
stillbirth: See foetal death.
stroke: When an artery supplying blood to the brain suddenly becomes blocked or
bleeds, often causing paralysis of parts of the body or speech problems.
substance use disorders: Result from harmful use and/or dependence on illicit or licit
drugs, including alcohol, tobacco and prescription drugs. 
suicide: Deliberately ending oneÕs own life.
symptom: Any indication of a disorder that is apparent to the person affected. Compare
with sign. 
tetanus: A serious infection with a bacterial nerve poison causing spasm of the jaw
muscles (lockjaw) and body muscles generally, from a bacterium entering through a
wound. The disease is preventable by vaccine.
thrombolysis: Emergency Ôclot-bustingÕ drug treatment for a heart attack.
Torres Strait Islander: A person of Torres Strait Islander descent who identifies as a
Torres Strait Islander and is accepted as such by the community in which he or she lives.
tuberculosis: A bacterial disease that affects the lungs especially, with serious fever-like
symptoms and destruction of tissue. It can spread to other parts of the body, causing
secondary problems and often death if not treated.
underweight: Defined as a body mass index less than 18.5.
vaccination: The process of administering a vaccine to a person to produce immunity
against infection. See immunisation.
whooping cough: See pertussis.
yersiniosis: a disease typically involving acute diarrhoea, fever, and other abdominal
symptoms, caused by the bacteria Yersinia pseudotuberculosis and Yersinia enterocolitica
and often food-borne.
03 AH2000 end matter  Page 448  Thursday, June 1, 2000  2:31 PM
Index  449
TRIM SIZE 175 mm Wide x 250 mm Deep
Index
Aboriginal and Torres Strait Islander 
Health and Welfare Information Unit, 
333
Aboriginal Australians, see Indigenous 
Australians
Aboriginal Community Controlled 
Health Services, 269Ð70
abortion, 162, 181, 276
abuse, see violence
accident (emergency) departments, 92, 
277, 296
accidents, see injuries and poisonings; 
road traffic accidents
accredited hospitals, 325Ð6
ACIR, 35Ð6, 158Ð9
Active Australia, 155
acupuncturists, consultations with, 291, 
292
acute bronchitis/bronchiolitis, 213, 295
acute care hospitals, 266Ð7, 268, 270Ð3
expenditure on, 244
length of stay, 317
performance indicators, 321Ð7
psychiatric wards, 283
see also public hospitals
acute encephalitis, 160
acute otitis media/myringitis, 213, 295
acute respiratory infections, see 
respiratory diseases/infections
administration, 403Ð6
health insurance funds costs, 252, 253
undergraduate course 
commencements, 263, 264
admissions, see hospitalisation
adolescents
mental problems and disorders, 76
pregnancy terminations, 181
smokers, 150Ð1
see also age; young people
adverse events, 250, 326Ð7
aerobic capacity, 18
aerobics, 155
affective disorders, 78, 82, 84, 249, 250, 
276
age, 4, 142, 179Ð203, 365, 428
acute respiratory infections (ARI), 111, 
112
allied health service patients, 292
asthma, 90, 91, 92, 214
attitudes and beliefs, 143
blood cholesterol, 170, 392
blood pressure, 167, 392
body weight, 164Ð5, 392
cancer, 66: survival following, 67
cardiovascular diseases, 58, 392
contraception use, 163
dental (oral) health, 227, 285, 287, 290
diabetes, 86, 215, 392
epilepsy risk factors, 104
family planning clients, 269
general practitioner patients, 293
health system costs, 251
hepatitis B, 114
hepatitis C, 115
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hospital use, 393Ð6
Indigenous Australians, 214Ð15, 217
Medicare services, 412Ð14
medication use, 301
mental problems and disorders, 76, 
77, 84
mothers, 28, 179, 366, 369
musculoskeletal disorders, 100, 101, 
102, 103
physical activity, 154Ð5, 392
private health insurance coverage, 257
self-assessed health, 14Ð15
sun protection measures, 156, 157
tetanus, 120
waist-to-hip ratio (WHR), 166
see also children; life expectancy; older 
people; young people
age, at death, 39Ð40, 373Ð8
asthma, 93
cancer, 66, 67Ð8
cardiovascular diseases, 61Ð2
Indigenous Australians, 208Ð9, 210
socioeconomic status, 221
suicide, 79Ð80
tuberculosis, 119
aged care assessment teams, 279Ð80
aged care residents, oral health of, 23Ð6
aged care services, 239, 278Ð82, 403Ð6
aged people, see older people
ageing, 316
AIDS, see HIV/AIDS
aids and appliances, 253, 293, 403Ð6
alcohol consumption, 146Ð8, 355
attitudes to, 144
Indigenous Australians, 217
rural and remote Australians, 224
alcohol dependence and abuse, 46, 47, 
52, 55, 78, 194
young people, 189, 190
allergies, 36Ð7, 90, 301
allied health services, 263, 264, 277, 
291Ð2, 296
alternative medicines, 304Ð5
Alzheimer's disease, 103Ð4, 194, 199
see also dementia
ambulance services, 8, 253, 403Ð6
amlodipine, 303
amoxycillin, 303, 304
amphetamines, 143, 144, 152, 153
AN-DRGs, 274, 276, 277
anaemia, 46
anaesthetics, 299, 300, 410
mortality related to, 326Ð7
analgesic nephropathy, 106
analgesics/pain killers, 144, 152, 153, 
301, 302, 303
ancillary benefits tables, 255Ð6
anencephalus, 183Ð4
angina pectoris, 46, 47, 202
angioplasty, 59, 60, 334
antibiotics, 123, 303
anxiety disorders, 46, 47, 82, 84, 197, 199
general practitioner consultations, 295
health system costs, 249, 250
arbovirus infection, 384
arthritis, 37Ð8, 45, 98, 100Ð3, 201
see also musculoskeletal disorders; 
osteoarthritis
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asbestos, 354
assisted conception, 27, 180Ð1
asthma, 36Ð7, 45, 46, 47, 90Ð4, 359
burden of disease, 54, 93Ð4, 199
drugs, 91, 92, 94, 301, 303
general practitioner consultations, 
213, 295
health outcomes indicator framework, 
334
health system costs, 94, 250
hospitalisation, 92, 187Ð8, 276
Indigenous Australians, 213, 214
medications, 92, 94, 301: 
can trigger, 91
overseas-born Australians, 207
rural and remote Australians, 226
atenolol, 304
atmosphere, 136Ð7
atresia, 184
attention-deficit disorder, 46
attitudes and beliefs, 143Ð4
audiologists/audiometrists, 
consultations with, 291, 292
Australian Burden of Disease and Injury 
Study, 48Ð55
Australian Bureau of Statistics, 6, 332, 
334, 335, 336
constant price estimates, 236
health services expenditure to GDP 
ratio, 232
Australian Capital Territory, see States 
and Territories
Australian Childhood Immunisation 
Register (ACIR), 35Ð6, 158Ð9
Australian Council for Safety and 
Quality in Health Care, 327
Australian Council on Healthcare 
Standards, 325
Australian Health Care Agreements, 337
Australian Health MinistersÕ 
Benchmarking Working Group, 319, 
321
Australian Health Ministers' 
Conference, 313
Australian Hearing Services, 293
Australian Incident Monitoring Scheme, 
327
Australian Institute of Health and 
Welfare, 6, 86, 328, 332, 335
Health Ethics Committee, 334
Australian National Diagnosis Related 
Groups (AN-DRGs), 274, 276, 277
Australian Patient Safety Foundation, 
327
Australian Standard Vaccination 
Schedule, 158
auto-immunity, 37Ð8
autosomal deletion, 141
babies, see births
back complaints/problems, 46, 47, 98, 
99, 100
depression and, 84
general practitioner consultations, 
294, 295
health system costs, 99, 250
barbiturates, 144, 152, 153
Barmah Forest virus, 118, 384
bed accreditation, 325Ð6
bed availability, 228, 266Ð7, 268, 284
beer consumption, 148
behaviour (lifestyle), 3, 144Ð64, 169, 
350Ð1
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beliefs and attitudes, 143Ð4
benign prostatic hypertrophy, 46, 47
betamethasone topical, 304
Bettering the Evaluation And Care of 
Health (BEACH), 293, 335
biomedical risk factors, 164Ð70
bipolar affective disorder, 46
birth defects, 39, 53, 122, 138Ð40, 183Ð4, 
397Ð8
birthplace, 86, 135, 204Ð7, 265
births, 27Ð9, 179Ð84, 366Ð70, 342Ð4, 410
family planning organisations, 268Ð9
hospital separations, 276
Indigenous children, 209Ð10, 212
Medicare benefits paid, 299, 300
pregnancy complications, 397Ð8
birthweight, 182, 209Ð10, 368
bladder cancer, 65, 66, 67, 386Ð8
blindness, and diabetes and, 87, 88
blood-borne diseases, 112Ð15, 384
see also HIV/AIDS
blood cholesterol, 169Ð70, 250, 392, 417
blood diseases, 277, 379Ð80, 397Ð8
blood lead levels, 137Ð8
blood pressure, 167Ð9, 294, 392, 417
blood vessel diseases, 44
body weight, 164Ð7, 189, 216Ð17, 392, 
417
brain cancer, 66, 67
breast cancer, 65, 67, 68Ð9, 386Ð9
burden of disease, 54, 196, 197, 199
health system costs, 250
overseas-born Australians, 207
physical activity and, 154
screening, 328Ð9, 335
breast cancer: mortality, 40, 42, 43, 65, 67, 
68Ð9, 329, 354Ð5, 386
burden of premature (YLL), 51
overseas-born Australians, 205, 206
breastfeeding, 188
BreastScreen Australia, 328Ð9, 335
bronchitis/bronchiolitis, 213, 295
see also chronic obstructive pulmonary 
disease
bronchopneumonia, 160
brucellosis, 384
bubonic plague, 346
budesonide, 303
burden of disease, 38Ð55, 192Ð9
acute respiratory infections (ARI), 112
alcohol consumption, 146
asthma, 54, 93Ð4, 199
chronic obstructive pulmonary 
disease, 97, 194, 199
communicable diseases, 122, 193
diabetes, 53, 54, 89, 194
illicit drug use, 151
mental illness, 82, 193
musculoskeletal disorders, 52, 53, 98, 
101, 193, 195Ð9
nervous system disorders, 103, 193, 
195Ð8
socioeconomic status, 221Ð3
tobacco smoking, 148
unsafe sex, 162
burns/scalds, 46, 401Ð2
bypass operations, 59, 60, 350
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campylobacteriosis, 115Ð16, 384
cancer, 47, 63Ð71, 140Ð1, 386Ð9
burden of disease, 53, 193Ð9
health system costs, 250
hospital separations, 276, 397Ð8: 
procedures reported, 277
overseas-born Australians, 207
ozone depletion and, 137
palliative care, 327
physical activity and, 154
status of indicators, 418
see also breast cancer; colorectal 
cancer; lung cancer; prostate cancer
cancer mortality, 40, 52, 63, 64, 65, 67Ð8, 
344, 352Ð5, 379Ð83, 386
associated with ischaemic heart 
disease, 44
burden of disease, 54, 195, 197, 199
burden of premature mortality (YLL), 
51
health system costs, 250
caused by smoking, 149
Indigenous Australians, 211
melanoma, 70Ð1, 386
older people, 201, 202, 203
overseas-born Australians, 205, 206
record linkage, 334
rural and remote Australians, 226
cannabis/marijuana use, 151Ð2, 153
attitudes to, 143, 144
dependence/abuse, 46
young people, 190
carbon dioxide, 136
cardiac check-ups, 57
cardiac dysrhythmias, 57, 202, 250
cardiorespiratory fitness, 18Ð19
cardiovascular (circulatory) diseases, 45, 
55Ð63, 303
burden of disease, 52, 53, 193Ð9
health system costs, 248, 250
hospitalisation, 57Ð60, 225, 276, 
397Ð402
Indigenous Australians, 56Ð7, 58, 211, 
334Ð5, 351
overseas-born Australians, 207
predictors, 154, 166, 168, 392
rural and remote Australian, 225
status of indicators, 415Ð16
see also coronary hear disease; stroke
cardiovascular diseases: mortality, 60Ð3, 
201, 202, 203, 344, 347Ð51, 379Ð382
caused by smoking, 149
Indigenous Australians, 211
overseas-born Australians, 205Ð6
rural and remote Australian, 225
caries, see oral health
casearean sections, 183
casemix, 274, 276, 277, 335, 321Ð2
cataracts, 46, 87, 201, 202
causes of death, 39Ð44, 342Ð59, 379Ð82
AIDS, 114, 205
alcohol, 146
anaesthesia, 326Ð7
asthma, 90, 93, 359
auto-immune diseases and conditions, 
37
burden of premature mortality (YLL), 
51Ð2
children, 39Ð40, 185Ð7, 189, 209Ð10, 
226, 342Ð3, 347, 355
03 AH2000 end matter  Page 453  Thursday, June 1, 2000  2:31 PM
454  AustraliaÕs Health 2000
TRIM SIZE 175 mm Wide x 250 mm Deep
chronic obstructive pulmonary 
disease, 40, 41, 42, 43Ð4, 95, 96, 359, 
383
diabetes, 37, 40, 44, 89, 205, 225
digestive system diseases, 205, 211, 
379Ð80
diphtheria, 120
drug dependence and, 190
drugs, 51, 52, 73Ð4, 81, 152, 191
Haemophilus influenzae type b (Hib), 
120
hepatitis B, 114, 115
Indigenous Australians, 209, 211, 218
infectious and parasitic diseases, 
379Ð82, 345Ð7
injecting drug users, 152
injuries, 72Ð4, 75, 79Ð82, 379Ð82, 190, 
205, 211, 226, 344, 355Ð7
kidney diseases, 89, 107, 108
liver, cirrhosis of, 108Ð9
malaria, 118
measles, 121, 160
mental problems and disorders, 
79Ð82, 211
mothers, 181, 343Ð4
mumps, 121
musculoskeletal disorders, 98, 379Ð80
nervous system disorders, 103, 379Ð80
older people, 201Ð3
overseas-born Australians, 205Ð6
pertussis, 120
respiratory diseases, 39, 111, 205, 206, 
211, 344, 358Ð9
rubella, 122
rural and remote Australia, 225Ð6
subacute sclerosing panencephalitis 
(SSPE), 121
tetanus, 120
tuberculosis, 119
vaccine-preventable diseases, 120Ð2, 
160, 211
violence, 205, 218, 357
young people, 190
see also cancer mortality; 
cardiovascular diseases; road traffic 
fatalities; suicide
cefaclor monohydrate, 304
central nervous system drugs, 303
cephalexin, 304
cereal consumption, 191
cerebrovascular disease, see stroke
cervical cancer, 66, 67, 162, 386Ð8
overseas-born Australians, 205, 206, 
207
CFCs, 136Ð7
chancroid, 384
check-ups
general practitioner consultations, 28, 
294, 295
allied health consultations, 292
dental consultations, 290
chemists, see pharmacists
chemotherapy, 276
children, 185Ð9, 337
blood lead levels, 137Ð8
dental (oral) health, 19, 20Ð2, 390Ð1
diabetes, 86
diet, 145
epilepsy risk factors, 104
fitness, 18
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haemolytic uraemic syndrome (HUS), 
116
hearing impairment, 293
hospital separations, 270
Indigenous, 57, 226, 347
injury prevention, 75
mental problems and disorders, 76
mortality, 39Ð40, 185Ð7, 189, 209Ð10, 
226, 342Ð3, 347, 355
rural and remote Australians, 226
vaccination, 33, 36, 143, 158Ð61
see also age; births
chiropodists/podiatrists, 265, 291, 292
chiropractors and osteopaths, 265, 291, 
292
chlamydia, 29Ð30, 190, 384
chlorpheniramine/phenylephid, 304
cholera, 384
cholesterol, 169Ð70, 250, 392, 417
chromosomal abnormalities, 138Ð40, 141
chronic back pain, 46, 47, 99, 100
chronic obstructive pulmonary disease 
(COPD), 46, 95Ð7
burden of disease, 51, 52, 54, 194, 199
health system costs, 250
mortality, 40, 41, 42, 43Ð4, 359, 383: 
burden of premature (YLL), 51, 52
chronic respiratory diseases, 52, 53, 
193Ð9
cigarette smoking, see tobacco smoking
circulatory diseases, see cardiovascular 
diseases
cirrhosis of liver, 108Ð9
cleft lip/palate, 184
climate, 136
clothing (sun protection measure), 156, 
157
clotrimazole, 304
co-morbidity, 44, 86Ð9, 78, 84, 92
cocaine, 143, 144, 152, 153
colon cancer, 154
colonoscopy, 276
colorectal cancer, 40, 41, 42, 43, 65, 66, 67, 
383, 386Ð9
burden of disease, 54, 195, 197, 199
burden of premature mortality (YLL), 
51
health system costs, 250
Commonwealth Department of Health 
and Aged Care, 328, 335, 336
Commonwealth Department of 
VeteransÕ Affairs, 240
Commonwealth Government 
expenditure, 7, 8, 233Ð40
Indigenous health services, 241Ð2, 
269Ð70
pharmaceuticals, 305Ð6
private health insurance, 251
research and development, 310
Commonwealth Government receipts, 
244Ð5
communicable (infectious/parasitic) 
diseases, 109Ð23, 344, 345Ð7, 379Ð82, 
384Ð5, 397Ð8, 401Ð2
burden of disease, 53, 193
Indigenous Australians, 211
international comparisons, 185
overseas-born Australians, 205, 207
procedures reported, 277
sexually transmitted, 29Ð31, 116Ð17, 
162, 190, 384
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vaccination status, 157Ð61
community aged care packages, 281
community-based health care 
organisations, 7Ð8
community health services, 267Ð70, 
280Ð1, 316Ð17
mental health, 282Ð3, 285, 316Ð17
community palliative care, 328
complementary medicines, 304Ð5
computers and computing, 336
conception (assisted), 27, 180Ð1
condoms, 28, 31, 163
congenital anomalies/malformations, 
39, 53, 122, 138Ð40, 183Ð4, 379Ð80, 
397Ð8
constant price estimates, 236, 241, 407
consultations with health professionals, 
45, 285Ð300, 410Ð14
contact dermatitis, 295
contagious diseases, see communicable 
diseases
contraception, 28, 31, 162Ð4, 269
coordinated care, 317
coronary angiograms, 59, 60
coronary angioplasty, 59, 60, 334
coronary artery bypass grafting, 59, 60, 
350
coronary heart disease, 56, 57Ð63, 347Ð51
pravastatin, 170
rural and remote Australia, 225
coronary stenting, 59, 60
cost of diseases, see health system costs
cost per casemix-adjusted separation, 
321Ð2
coughs and colds, 294, 301
country of birth, 86, 135, 204Ð7, 265
CT brain scans, 59, 60
cultural health determinants, 135
DALYs, see disability-adjusted life years
day hospital facilities, 274
de-institutionalisation, 316Ð17
deafness (hearing loss), 46, 47, 52, 54, 
194, 293
death, see causes of death; mortality
definitions
disability, 49
elective surgery waiting times, 323
genetic terms, 139
health, 2Ð3
high blood pressure, 169
delivery monitoring, 321Ð9, 338Ð9
delivery method (births), 183, 276
dementia, 52, 78, 103, 194, 199, 201
health system costs, 249, 250
mortality, 40, 103Ð4: burden of 
premature (YLL), 51
dengue fever, 118, 384
dental (oral) health, 19Ð26, 45, 46, 47, 338
burden of disease, 53, 198
expenditure on, 239, 240, 248, 403Ð6: 
private health insurance funds, 253
hospital separations, 276
rural and remote Australians, 227, 
285Ð7
use of dental services, 285Ð90
dental workforce, 259, 260, 262, 263, 264, 
265
Department of Health and Aged Care, 
328, 335, 336
03 AH2000 end matter  Page 456  Thursday, June 1, 2000  2:31 PM
Index  457
TRIM SIZE 175 mm Wide x 250 mm Deep
Department of VeteransÕ Affairs, 240
depression, 46, 47, 78, 83Ð4
burden of disease, 54, 55, 82, 193, 194, 
197, 199
diabetes and, 88
general practitioner consultations, 295
status of indicators, 424Ð5
young people, 192
see also suicide
dermatitis, 295
designer drug use, attitudes to, 144
determinants of health, 2Ð4, 133Ð78, 338
children, 188Ð9
young people, 191
diabetes, 37Ð8, 46, 84Ð9, 336, 392
burden of disease, 52, 53, 54, 55, 89, 
194Ð9
general practitioner consultations, 
213, 295
health outcomes indicator framework, 
334
health system costs, 89, 250
hospital separations, 37, 276
Indigenous Australians, 213, 215
mortality, 37, 40, 44, 89, 205, 225; 
burden of premature (YLL), 51
overseas-born Australians, 205, 206, 
207
rural and remote Australia, 225Ð6
status of indicators, 419Ð21
diabetic nephropathy, 106, 108
diagnosis related groups (casemix), 274, 
276, 277, 335
diagnostic imaging, 265, 296, 298, 299, 
300, 411
dialysis, 106Ð7, 108, 202, 212Ð13, 276
diaphragmatic hernia, 184
diarrhoeal diseases/infections, 47, 48, 
342, 347
diastolic blood pressure, 168
diazepam, 304
diclofenac sodium systemic, 304
diet and nutrition, 63, 68, 142, 144Ð6
consultations with dietitians/
nutritionists, 291, 292
eating disorders, 82, 84, 249
Indigenous Australians, 216Ð17
undergraduate course 
commencements, 263, 264
young people, 191
digestive system diseases, 45, 276, 
379Ð80, 397Ð402
burden of disease, 53, 193, 195Ð8
health system costs, 248
Indigenous Australians, 211
overseas-born Australians, 205, 206, 
207
diphtheria, 120, 159, 347
disability, 48Ð55
asthma, 93
chronic obstructive pulmonary 
disease, 95
community care, 316Ð17
musculoskeletal disorders, 98
older people, 200Ð1
psychiatric, 78
socioeconomic status, 222
young people, 189
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disability-adjusted life years (DALYs), 
48Ð55, 192Ð9
mental illness, 82
respiratory diseases, 97
socioeconomic status, 222Ð3
unsafe sex, 162
disability burden (YLDs), 52Ð4, 193, 195, 
196
diabetes, 53, 54, 89
respiratory diseases, 97
socioeconomic status, 222Ð3
unsafe sex, 162
disadvantage, see Indigenous 
Australians; socioeconomic status
disease risk factors, see risk factors
diseases, 2Ð4, 19Ð26, 29Ð123
classification, 274Ð7
cost of, 248Ð51
ear diseases/disorders, 46, 47, 52, 54, 
194, 293
eye diseases/disorders, 45, 46, 87, 88, 
201, 202
genito-urinary diseases, 53, 195Ð9, 211, 
277, 379Ð80
Indigenous Australians, 210Ð15
rural and remote Australians, 225Ð7
see also cancer; cardiovascular 
diseases; causes of death; 
communicable diseases; digestive 
system diseases; disability; 
hospitalisation; injuries and 
poisonings; mental health/disorders; 
respiratory diseases/infections
dislocations, strains and sprains, 74, 295
diverticulitis, 47
doctors, see medical practitioners
donovanosis, 384
Down syndrome, 141
doxycycline HCI, 304
drinking water, fluoride in, 20, 22
drowning, 75, 187, 355
drug deaths, 51, 52, 73Ð4, 81, 152, 191
drugs and drug use, 146Ð54, 301Ð6, 
401Ð2
asthma and, 91, 92, 94, 301, 303
attitudes to, 143, 144
cardiovascular disease, 57, 170
dependence/drug use disorders, 78
general practitioner prescribed/
advised/supplied, 296
Indigenous Australians, 217
rural and remote Australians, 224
see also pharmaceutical services
ear diseases/disorders, 46, 47, 52, 54, 
194, 293, 399Ð402
eating disorders, 82, 84, 249
economic health determinants, 135
ecstasy, use of, 144, 152, 153
edentulism, 19Ð20, 23, 25, 46, 227
education and training, 215
health and medical, 263Ð5
see also socioeconomic status
EdwardÕs syndrome, 141
elective surgery waiting times, 322Ð4
electronic health records, 336
emergency departments, 92, 277, 296
emotional stress, 36
see also depression
emphysema, see chronic obstructive 
pulmonary disease
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employment, 191, 215
see also health workforce; 
socioeconomic status
enalapril, 303
encephalitis, 118, 160
encephalocele, 183Ð4
end-stage renal disease, 88, 105Ð9, 212
endocrine disorders, 196, 211, 379Ð80, 
397Ð402
energy intake, 145Ð6, 417
environmental determinants of health, 
133Ð8
epilepsy, 103, 104
erythromycin, 304
evening primrose oil, 305
evidence base to support priority 
setting, 313Ð16
exercise, see physical activity
expenditure, see health expenditure; 
health system costs
extrinsic aleolitis, see chronic obstructive 
pulmonary disease
eye diseases/disorders, 45, 46, 87, 88, 
201, 202, 399Ð402
falls, 47, 74, 75, 187, 250
family planning, 28, 162Ð4, 268Ð9
far-sightedness, 45
fat intakes, 145Ð6, 169, 417
fatalities, see mortality
felodipine, 303
females, see women
fertility, see births
finance, see health expenditure; health 
system costs
firearms, suicide by, 81
fires/burns/scalds, 46, 401Ð2
fitness, 17Ð19
flexibility and muscle strength, 18Ð19
fluoridated drinking water, 20, 22
foetal deaths (stillbirths), 27, 182, 209
folic acid, 183Ð4
food, see diet and nutrition
forceps delivery, 183
fractures, 74
fruit and vegetable consumption, 145, 
191
frusemide, 303, 304
full-time employment, 258, 259
funding, see health expenditure; health 
system costs
gall bladder and bile duct disease, 47
gamete intra-fallopian transfer (GIFT), 
181
gas emissions, 136
gastrointestinal infections, 115Ð16, 384
general practitioners (GPs), 7, 158, 316
general practitioners, consultations 
with, 293Ð6, 299, 300, 410
blood pressure, 168
cardiovascular diseases, 57
depression, 84
diabetes and complications, 88, 213, 
295
drugs prescribed/supplied during, 
303Ð4
Indigenous Australians, 213Ð14
mental problems and disorders, 76Ð7
musculoskeletal disorders, 98, 100
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generalised anxiety disorder, 46, 199
genetic diseases, 39, 53, 122, 138Ð40, 
183Ð4, 379Ð80, 397Ð8
genitals, 28Ð9, 183, 295, 399Ð402
genito-urinary diseases, 53, 195Ð9, 211, 
277, 379Ð80, 399Ð402
gestational diabetes, 85, 86
GIFT, 181
Gini coefficient, 220, 221, 222
glaucoma, 87
Global Burden of Disease Study, 48
global warming, 136
glomerulonephritis, 105, 106
golf, 155
gonococcal infection, 30, 117, 190, 384
gout, 102Ð3
government concession cardholders
Australian Hearing Service clients, 
293
dental (oral) health, 24, 285, 288, 289
general practitioner consultations, 294
government expenditure, 7, 233Ð40, 
241Ð4, 305, 309Ð10
see also Commonwealth Government 
expenditure
greenhouse gases, 136
gross domestic product (GDP), 2
health services expenditure ratio, 232, 
233, 234, 238, 245Ð7, 408
gum-related diseases, 22
HACC program, 279, 280Ð1
haemodialysis, 106Ð7, 108, 202, 212Ð13, 
276
haemolytic uraemic syndrome (HUS), 
116
Haemophilus influenzae type b (Hib), 
120, 159, 384
haemorrhoids, 57
hallucinogens, 144, 152, 153
hanging, suicide by, 81
hats, 156, 157
hay fever, 36, 45
headaches, 45
health administration, 403Ð6
undergraduate course 
commencements, 263, 264
health counselling undergraduate 
course commencements, 263, 264
health determinants, see determinants of 
health
health expenditure, 7, 232Ð53, 403Ð8
aged care, 239, 280, 281, 282, 403Ð6
ageing and, 316
Indigenous Australians, services for, 
218, 219
medications/pharmaceuticals, 305Ð6
mental health services, 282Ð3, 284
private health insurance funds, 251Ð2
research and development, 309Ð10, 
403Ð6
rural zone, 228
see also health system costs
health information, see statistical 
developments, gaps and deficiencies
Health Information Agreement, 6Ð7
health insurance, 8, 251Ð7
see also Medicare
Health Insurance Commission, 7, 297, 
332
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health outcomes indicator framework, 
320, 334
health planning issues, 313Ð17
health promotion and prevention, 306Ð9
health research, 94, 309Ð10, 314, 403Ð6
health resources, 232Ð312, 338
health risk factors, see risk factors
health services supply and use, 266Ð300, 
393Ð402, 410Ð14
Indigenous Australians, 218
see also general practitioners, 
consultations with; hospitalisation
health status, 10Ð132, 337Ð8
health system, 7Ð8
health system costs, 248Ð51
asthma, 94, 250
diabetes, 89, 250
mental disorders, 83, 248, 249, 250
musculoskeletal disorders, 99, 248, 
250
health workforce, 258Ð65, 316, 409
Indigenous, 264Ð5, 270
psychiatric hospitals, 283, 284
public hospital labour costs, 322
healthcare cards, see government 
concession cardholders
hearing loss, 46, 47, 52, 54, 194, 293
hearing services, 293
heart attack risk, 84
heart diseases
diabetes and, 87
older people, 201
rural and remote Australians, 225
rheumatic, 37Ð8, 56Ð7, 58, 61, 334Ð5, 
351
see also coronary heart disease; 
ischaemic heart disease
heart failure, 57, 58, 60, 61
diabetes and, 88
health system costs, 250
ischaemic heart disease and, 44
older people, 202
hepatitis A, 384
hepatitis B, 114, 115, 162, 384
hepatitis C, 114Ð15, 162, 384
hepatitis D, 115
hepatitis, nec, 384
herbal medications, 91, 304, 305
herbalists, consultations with, 291, 292
herd immunity, 33Ð6
heroin, 51, 52, 143, 144, 152, 153
Hib, 120, 159, 384
high blood cholesterol, 169Ð70, 250, 392, 
417
high blood pressure, 167Ð9, 294, 417
higher education, 263Ð5, 310
hip, congenital dislocation of, 184
histamines, 36
HIV/AIDS, 112Ð14, 162, 164, 347, 385
burden of disease, 52, 194
injecting drug users, 153Ð4
overseas-born Australians, 205
young people, 31, 189
Home and Community Care program, 
279, 280Ð1
home nursing services, 253
home tenure, 216
homicide, 205, 357
homosexual men, 154, 164, 385
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hormones, 303
hospitalisation, 270Ð8, 393Ð402
acute respiratory infections (ARI), 111
auto-immune diseases and conditions, 
37
alcohol caused, 146
asthma, 92, 94, 187Ð8
cardiovascular disease, 57Ð60, 225, 276
children, 187Ð8, 226
chronic obstructive pulmonary 
disease, 95, 96
dengue fever, 118
diabetes, 37, 88Ð9, 225Ð6
dialysis procedures, 107
haemolytic uraemic syndrome (HUS), 
116
Haemophilus influenzae type b (Hib), 
120
hepatitis B, 114
hepatitis C, 115
HIV/AIDS, 113Ð14
illicit drug users, 152
Indigenous Australians, 210Ð13, 217, 
218, 333
infectious and parasitic diseases, 110
injuries, 74, 75, 187, 218, 226, 227
liver, cirrhosis of, 108
malaria, 118
measles, 121
meningitis, 110
mental problems and disorders, 77Ð8, 
285, 286
multiple sclerosis, 105
mumps, 121
musculoskeletal disorders, 98, 99, 100, 
101, 102, 103
nervous system disorders, 103, 105
older people, 201, 202
overseas-born Australians, 206Ð7
palliative care, 327
pertussis, 119
pneumonia and influenza, 110
reproduction and reproductive 
organs, 28Ð9
rubella, 122
rural and remote Australian, 225Ð6, 
227, 228
smoking as cause, 149
subacute sclerosing panencephalitis 
(SSPE), 121
suicide and self-harm attempts, 81, 
192
tetanus, 120
tuberculosis, 118
vaccine-preventable diseases, 119Ð22, 
185
young people, 192
hospitals, 7, 8, 270Ð8, 335
bed availability, 228, 266Ð7, 268, 284
expenditure on, 237, 249, 250, 403Ð6: 
private health insurance funds, 252, 
253
general practitioner referrals to, 296
performance indicators, 321Ð7
see also public hospitals
hostels, 281, 282
housing, 216
Human Genome Project, 140
HUS, 116
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hydatid infection, 384
hydrocephalus, 184
hydrotherapists, see physiotherapists
hynotherapists, consultations with, 291, 
292
hypertension/hypertensive disease, 45, 
57, 58, 61
cause of renal failure, 106
diabetes and, 87, 88, 89
depression and, 84
general practitioner consultations, 
213, 294, 295
health system costs, 250
ischaemic heart disease and, 44
Indigenous Australians, 213
hypospadias, 184
illicit drugs, see drugs
illness, see diseases
imaging, 265, 296, 298, 299, 300, 411
immigrants, 86, 118, 204Ð7, 265, 287Ð90, 
294, 341
immunisation, see vaccination
Immunise Australia program, 158
immunodeficiency, 38
immunological health, 31Ð8
in-vitro fertilisation (IVF), 181
inactivity, 154Ð5, 205Ð6, 417
income
Commonwealth Government receipts, 
244Ð5
Indigenous Australians, 215Ð16
private health insurance funds, 253, 
255, 256
see also socioeconomic status
incontinence, 46
Index of Relative Socioeconomic 
Disadvantage, 220, 221, 224
Indigenous Australians, 7, 207Ð19, 224, 
333, 335
birthweight, 182, 209Ð10
cardiovascular diseases, 56Ð7, 58, 211, 
334Ð5, 351
dental (oral) health, 22, 290
general practitioner patients, 294
health education and training, 264Ð5
health performance indicators, 318
health services, 241Ð2, 269Ð70
kidney disease, 108, 212
life expectancy, 12, 208
Indigenous Australians: mortality, 
208Ð9, 211, 340Ð1
children, 209Ð10, 226, 347
kidney disease, 108
metropolitan/rural, 225
rheumatic heart disease, 61
young people, 192
industrial lead, 137Ð8
infants, 401Ð2
mortality, 39, 182, 189, 185Ð6, 342Ð3, 
379Ð80: Indigenous, 209Ð10, 347
epilepsy risk factors, 104
immunisation, 159
infectious agents, 63
infectious diseases, see communicable 
diseases
influenza, 347
vaccine, 303, 304
information technology, 336
inhalants, 144, 152, 153
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injected drugs, 152, 153Ð4
injuries and poisonings, 47, 71Ð5, 176, 
344, 355Ð7, 379Ð82, 397Ð8, 401Ð2
burden of disease, 53, 193Ð8
children, 75, 187, 355
health outcomes indicator framework, 
334
health system costs, 248
Indigenous Australians, 211, 212, 227
overseas-born Australians, 205, 207
rural and remote Australians, 226, 227
status of indicators, 422Ð3
young people, 189, 190, 192, 227
see also suicide
institutional care, 238, 316Ð17
aged people, 239, 281Ð2: oral health of 
residents, 23Ð6
see also hospitals
intentional injuries, 74, 193, 197
see also suicide
international comparisons, 428
alcohol consumption, 148
asthma mortality, among young 
people, 90
cancer incidence, 389
childrenÕs health, 185
death rates, 375Ð8: cardiovascular 
diseases, 62Ð3
fertility and pregnancy, 367, 370
health expenditure, 245Ð8, 408
health workforce, 259Ð60, 262
hospital length of stay, 270
Indigenous peoplesÕ mortality 
patterns, 340Ð1
life expectancy, 12, 13, 372
melanoma, 70
International Diabetes Institute, 336
interpersonal violence, see violence
intracranial injuries, 74
intra-uterine devices (IUDs), 28, 29, 163
ipratropium bromide, 303
iron-deficiency anaemia, 46
ischaemic heart disease, 54, 194, 197, 
199, 202
diabetes and, 88, 89
health system costs, 250
overseas-born Australians, 205, 207
ischaemic heart disease: mortality, 40, 
41Ð2, 89, 205, 383
additional causes of death associated 
with, 44
burden of premature mortality (YLL), 
51
IUDs, 28, 29, 163
IVF, 181
Japanese encephalitis, 118
juvenile chronic arthritis, 102
kidney diseases, 105Ð9
cancer, 65, 66, 67, 386Ð8
diabetes and, 87, 88, 89
dialysis, 106Ð7, 108, 202, 212Ð13, 276
haemolytic uraemic syndrome (HUS), 
116
Indigenous Australians, 108, 212Ð13
KlinefelterÕs syndrome, 141
knee procedures, 276
knowledge, about sexual health, 31
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labour force, see health workforce
language spoken at home, use of dental 
services and, 287Ð8, 289Ð90
larynx, cancer of, 66, 67
lead, health effects of, 137Ð8
legionellosis, 384
length of hospital stay, 270, 272, 273, 276, 
317, 397Ð402
acute respiratory infections (ARI), 111
cardiovascular diseases, 58Ð9
chronic obstructive pulmonary 
disease, 95
diabetes, 89
liver, cirrhosis of, 108
reproductive organs, 28Ð9
injuries, 74
musculoskeletal disorders, 98
palliative care, 327
leprosy, 384
leptospirosis
leukaemia, 66, 67
levonorgestrel/ethinyloestradiol, 304
life expectancy, 11Ð12, 13, 200, 208, 342, 
371Ð2
disability-free, 48
see also disability-adjusted life years
lifestyle, 3, 144Ð64, 169, 350Ð1
lip cancer, 65, 386
lipid disorder, 57, 88, 295
listeriosis, 384
liver diseases, 108Ð9
living conditions, 216
see also socioeconomic status
local government, 8, 233Ð40, 241Ð2
longevity, see life expectancy
lower respiratory tract infections, 47, 
110Ð12
LSD, 144
lung cancer, 65, 66, 67, 69Ð70, 386Ð9
burden of disease, 54, 194, 195, 197, 
199
health system costs, 250
overseas-born Australians, 206, 207
lung cancer mortality, 40, 41, 42Ð3, 65, 
67, 69Ð70, 352Ð4, 383, 386
burden of premature (YLL), 51, 52
overseas-born Australians, 205, 206
lung function, 18Ð19
lymphatic system, operations on, 
399Ð400
lymphatic tissue, cancer of, 40
malaria, 118, 384
males, see sex of population groups
male homosexuals, 164, 154, 385
marijuana, see cannabis
maternal mortality, 181, 343Ð4
MCS (mental health component 
summary) scores, 12Ð17
meal services, for older people, 280, 281
measles, 33, 121, 159, 160Ð1, 185, 347, 384
Measles Control Campaign (MCC), 161
Medibank, 233Ð4, 240
medical imaging, 265, 296, 298, 299, 300, 
411
medical practitioners, 7, 8, 259, 260Ð2
in Aboriginal health services, 270
consultations with, 293Ð6, 298Ð300
overseas trained, 265
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undergraduate course 
commencements, 263, 264
see also general practitioners
medical radiography, 263, 264
medical science, 263, 264
medical services, expenditure on, 239, 
240, 249, 403Ð6
private health insurance funds, 253
medical technology, 263, 264, 336
medical treatment, adverse effects of, 
250, 326Ð7
Medicare, 7, 8, 296Ð300, 410Ð14
Australian Health Care 
Agreements 1998, 337
distribution of general practice 
providers, 261, 262
expenditure and, 235, 237, 238Ð9, 240, 
242
Medicare levy, 244Ð5
medications, see drugs; pharmaceutical 
services
medicine (field of study), 263, 264
melanoma, 65, 67, 70Ð1, 206, 386Ð9
men, see sex of population groups
men who have sex with men, 164, 154, 
385
meningitis, 110, 120, 384
menopausal complaints, 28, 84
menstrual problems, 47
mental health/disorders, 46, 47, 76Ð84, 
335, 337Ð8, 379Ð80
burden of disease, 52, 53, 55, 192Ð9
health system costs, 83, 248, 249, 250
Indigenous Australians, 211
mental component summary (MCS) 
scores, 12Ð17
older people, 201
overseas-born Australians, 207
psychiatric hospitals, 240, 267, 268, 
283Ð5, 317
psychiatric patients, 77Ð8, 82, 285, 286, 
277, 397Ð8, 401Ð2
rural and remote Australians, 226
status of indicators, 424Ð5
young people, 76, 77, 189
mental health services, 240, 267, 282Ð5, 
316Ð7
mental retardation, 249
metabolic and endocrine disorders, 196, 
379Ð80
methadone, 144, 153
methods and conventions, 428Ð9
migrants, 86, 118, 204Ð7, 265, 287Ð90, 
294, 341
mineral supplements, 304, 305
monitoring service delivery, 321Ð9, 
338Ð9
morbidity, see diseases
mortality, 39Ð44, 135, 340Ð64, 368Ð83
children, 39Ð40, 185Ð7, 209Ð10, 226, 
342Ð3, 347, 355
Indigenous Australians, 192, 208Ð10, 
225, 226, 227, 347
infants, 39, 182, 189, 185Ð6, 209Ð10, 
342Ð3, 347, 379Ð80
maternal, 181
overseas-born Australians, 204Ð6, 341
palliative care, 327Ð8
rural and remote Australians, 225Ð7
socioeconomic status, 221Ð2
young people, 189, 190, 191, 192, 226
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see also causes of death; life 
expectancy
mortality (premature), burden of (YLLs), 
50, 51Ð4, 193, 195, 196
diabetes, 53, 54, 89
respiratory diseases, 97
socioeconomic status, 221, 222, 223
unsafe sex, 162
mothers, 28, 179, 181, 343Ð4, 366, 369
motor vehicle accidents, see road traffic 
accidents
motor vehicle exhaust gas suicides, 81
multiple births, 180Ð1
multiple sclerosis (MS), 37Ð8, 103, 105
mumps, 121, 159, 384
muscle strength and flexibility, 18Ð19
musculoskeletal disorders, 97Ð103, 
379Ð80, 397Ð8, 401Ð2
burden of disease, 52, 53, 98, 101, 193, 
195Ð9
congenital malformations, 183
health system costs, 99, 248, 250
older people, 100, 101, 102, 201
see also arthritis
myringitis/otitis media, 213, 295
National Cancer Statistics Clearing 
House, 64, 334
National Community Based Health 
Services Codeset, 335
National Death Index, 334
National Diabetes Register, 87
National Elective Surgery Waiting Times 
Data Collection, 322Ð4
National Health and Medical Research 
Council, 314
National Health Information 
Agreement, 6Ð7
National Health Information 
Development Plan, 332Ð6
National Health Information 
Management Advisory Council, 336
National Health Information 
Management Group (NHIMG), 320, 
332, 334
National Health Information Model, 
333Ð4
National Health Priority Areas 
(NHPAs), 55Ð94, 276, 319, 334
status of indicators, 415Ð25
see also asthma; cancer; cardiovascular 
diseases; diabetes; injuries and 
poisonings; mental health
National Heart Foundation, 334, 336
National Minimum Data Sets, 327Ð8, 335
National Program for the Early 
Detection of Breast Cancer 
(BreastScreen Australia), 328Ð9, 335
National Public Health Partnership, 319, 
337
National Tobacco Campaign, 309
natural medications, 304
naturopaths, consultations with, 291, 
292
neck problems, 250
neonatal conditions, 53
neonates, see infants
neoplasm, see cancer
nephritis, 44
nephropathy, 106, 108
nervous system disorders, 52, 53, 103Ð5, 
193, 195Ð8, 379Ð80, 397Ð402
drugs, 303
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Indigenous Australians, 211
see also dementia
neural tube defects, 183Ð4
neurotic disorders, 78
New South Wales, see States and 
Territories
NHPAs, see National Health Priority 
Areas
non-admitted patients, 92, 277, 296
non-Hodginkin's lymphoma, 65, 66, 67, 
386Ð8
non-prescribed medicines, 303Ð5
Northern Territory, see States and 
Territories
notifiable diseases, see cancer; 
communicable diseases
nurses and nursing, 259, 262Ð3, 264, 265, 
316
consultations, 291, 292
nursing homes, 94, 239, 281, 282, 403Ð6
oral health of residents, 23Ð6
nutrition, see diet and nutrition
obesity, 164Ð7, 189, 216Ð17, 417
obstetrics, see births
occupation, see health workforce; 
socioeconomic status
occupational asthma, 91
occupational fatalities, 357
occupational therapists/therapy, 263, 
264, 265, 291, 291
oesophagus, 67, 184, 202, 295
Office for Aboriginal and Torres Strait 
Islander Health, 269
older people, 200Ð3
aged care services, 239, 278Ð82, 403Ð6
epilepsy risk factors, 104
private health insurance, 254
online information, 336Ð7
open wounds, 74
operations, 299, 300, 399Ð400, 411
elective surgery waiting times, 322Ð4
oral surgery, 22
waiting times for elective surgery, 
322Ð4
see also procedures
opiate-related deaths, 51, 52, 73Ð4, 81, 
191
optometrists, opticians and optometry, 
263, 264, 265
consultations with, 291, 292, 411
Medicare benefits paid, 299, 300
oral contraceptive pill, 28, 31, 163
oral health, see dental health
ornithosis, 384
osteoarthritis, 46, 98, 100Ð1
burden of disease, 52, 54, 101, 199
diabetes and, 88
general practitioner consultations, 295
health system costs, 99, 250
osteopaths and chiropractors, 265, 291, 
292
osteoporosis, 46, 99, 100, 101
otitis media, 47, 160, 213, 295
outcomes indicator framework, 320, 334
overseas-born Australians, 86, 118, 
204Ð7, 265, 287Ð90, 294, 341
overseas-trained health professionals, 
265
overweight, 164Ð7, 189, 216Ð17, 392, 417
ozone layer, 136Ð7
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pain killers/relievers (analgesics), 144, 
152, 153, 301, 302, 303
palliative care, 327Ð8
pancreas, cancer of, 66, 67, 386Ð8
Pap smears, 28, 295
paracetamol, 302Ð3, 304
paranoid states, 78
parasitic diseases, see communicable 
diseases
Parkinson's disease, 103, 104Ð5, 199
part-time employment, 258, 259
Patau's syndrome, 141
pathology, 57, 296, 298, 299, 300, 410
patient-days, 74, 270, 271, 272, 276, 285, 
286, 395Ð402
PCS (physical component summary) 
scores, 12Ð17
pedestrian deaths, 187
pensioners, see government concession 
cardholders
peptic ulcer disease, 46, 47, 303
per person expenditure, 228, 240Ð4, 
246Ð8
performance indicators, 317Ð29, 337, 
338Ð9
perinatal mortality, 182, 210, 212, 369Ð70, 
379Ð80, 397Ð8
periodontal disease, 46, 47
peripheral vascular disease, 57, 58, 60, 
61, 88, 250
personality disorders, 78, 82, 249
pertussis, 119Ð20, 159, 185, 347, 384
Pharmaceutical Benefits Advisory 
Committee, 315
Pharmaceutical Benefits Scheme, 242, 
301Ð2, 305Ð6, 315, 403Ð6
pharmaceutical services, expenditure 
on, 239, 240, 249, 250, 305Ð6, 403Ð6
private health insurance funds, 253
see also drugs
pharmacists (chemists), 259, 260
consultations with, 291, 291
undergraduate course 
commencements, 263, 264
overseas-trained, 265
physical activity/inactivity, 19, 154Ð5, 
205Ð6
overseas-born Australians, 205Ð6
rural and remote Australians, 224
status of indicators, 417
young people, 191
physical component summary (PCS) 
scores, 12Ð17
physical environmental health 
determinants, 135Ð8
physical fitness, 17Ð19
physical stress, 36
physicians, see medical practitioners
physiotherapists/hydrotherapists, 263, 
264, 265
consultations with, 291, 292
plague, 346
planning issues, 313Ð17
pneumonia, 40, 44, 110, 111, 202, 359
podiatrists/chiropodists, 263, 264, 265
consultations with, 291, 292
poisoning, 74, 75
poliomyelitis, 120, 159, 347
population ageing, 316
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population groups, 179Ð231, 338, 365, 
428
overseas-born Australians, 204Ð7, 265, 
287Ð90, 294, 341
private health insurance coverage, 
252Ð5, 256Ð7
see also age; Indigenous Australians; 
sex of population groups; 
socioeconomic status
pravastatin, 170
pregnancy, see births
prescribed medicines, 294, 296, 301Ð3
prevention and promotion, 306Ð9
priority setting, 313Ð16
private acute care hospitals, 266, 268, 
283
private health insurance, 8, 251Ð7
private health research and 
development, 309Ð10
private hospitals, 8, 270Ð3, 286, 394, 396, 
398, 400, 402
Australian Council on Healthcare 
Standards (ACHS) accreditation, 327
dialysis procedures, 107
expenditure on, 239, 240, 403Ð6: 
private health insurance funds, 252, 
253
freestanding day facilities, 274
non-admitted patients, 277
private patients, 8, 273, 297
private psychiatric hospitals, 283, 284
procedures, 271, 274, 275Ð7
cardiovascular, 59Ð60, 334Ð5, 349Ð50
dialysis, 106Ð7, 108, 202, 212Ð13, 276
older people, 201, 202
promotion and prevention, 306Ð9
prostate cancer, 40, 41, 43, 64Ð5, 66, 
386Ð9
burden of disease, 195
burden of premature mortality (YLL), 
51
health system costs, 250
overseas-born Australians, 205, 206, 
207
survival rate, 67
prostatic hypertrophy, 46, 47
PSA tests, 64Ð5
psychiatric hospitals, 240, 267, 268, 
283Ð5, 317, 403Ð6
psychiatric patients, 77Ð8, 82, 285, 286, 
277
psychological development, disorders 
of, 249
psychological drugs, 303
psychologists, consultations with, 291, 
291
psychotic disorders, 78, 84, 249
public attitudes, 143Ð4
public health, 6Ð8, 319, 337
interventions, 306Ð9
public (acute care) hospitals, 7, 8, 228, 
233, 266Ð7, 268
dialysis procedures, 107
expenditure on, 239, 240, 244, 403Ð6: 
private health insurance funds, 253
length of stay, 317, 397, 399, 401
non-admitted patients, 277
palliative care, 327
patient days, 395, 397, 399, 401
performance indicators, 321Ð7
psychiatric wards, 283
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separations, 270Ð3, 393, 397, 399, 401: 
mental health disorder, 286
public psychiatric hospitals, 240, 267, 
268, 270Ð3, 283, 284, 286, 403Ð6
pulmonary diseases, see chronic 
obstructive pulmonary disease
Q disease, 384
qualifications, 215
health and medical, 263Ð5
see also socioeconomic status
quality of health services, 324Ð7
quarantine, 346
Queensland, see States and Territories
radiation, 63, 71, 136Ð7
radiography, 263, 264
rainfall, 136
ranitidine, 303, 304
rashes, 294
record linkage, 334
recreational activity, participation in, 
155, 191
recurrent expenditure, 238, 239Ð40, 241, 
403Ð6
referrals, by general practitioners, 296
regulatory framework, 8
rehabilitation undergraduate course 
commencements, 263, 264
remote Australia, see rural and remote 
Australians
renal agenesis and dysgenesis, 184
renal dialysis, 106Ð7, 108, 202, 212Ð13, 
276
renal diseases, see kidney diseases
repatriation hospitals, 240, 403Ð6
Repatriation Pharmaceutical Benefits 
Scheme, 302
reproduction, see births; genitals
research and development, 94, 309Ð10, 
314, 403Ð6
residential aged care, 239, 281Ð2, 403Ð6
oral health of residents, 23Ð6
resources, 232Ð312, 338
respiratory diseases/infections, 45, 47, 
110Ð12, 379Ð82, 397Ð402
burden of disease, 52, 53, 97, 193Ð9
drugs, 303
general practitioner consultations, 
213, 294, 295
health system costs, 248
Indigenous Australians, 211, 212, 213
mortality, 39, 111, 205, 206, 211, 344, 
358Ð9
older people, 201, 202, 203
overseas-born Australians, 205, 206, 
207
procedures reported, 277
see also chronic obstructive pulmonary 
disease
respite aged care, 280, 282
rheumatic fever/heart disease, 37Ð8, 
56Ð7, 58, 61, 334Ð5, 351
rheumatoid arthritis, 37Ð8, 99, 101Ð2
risk factors, 133Ð78, 336, 338
asthma, 90Ð2
cancers, 63, 68, 69Ð70, 71
cardiovascular diseases, 392
children, 188
diabetes, 85, 86Ð7
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epilepsy, 104
Indigenous Australians, 215Ð18
rural and remote Australians, 224
road traffic accidents, 47, 52, 54, 193, 194
health system costs, 250
young people, 189
road traffic fatalities, 72, 73, 356
burden of premature mortality (YLL), 
51
children, 187
overseas-born Australians, 205
rural and remote Australians, 226
young people, 189
Ross River virus, 117, 384
roxithromycin, 304
rubella, 121Ð2, 159, 384
rural and remote Australians, 223Ð8, 
285Ð7, 337
health workers, 260Ð2, 263
safer sex practices, 31
salbutamol, 303, 304
salmonellosis, 384
salt consumption, 146
same-day patients, 272Ð4, 276, 286, 317, 
397Ð402
saturated fat intake, 145Ð6, 169, 417
scalds/burns, 46, 401Ð2
schizophrenia, 78, 82, 84, 249, 250
School Dental Services, 262
science undergraduate course 
commencements, 263, 264
self-reported health, 12Ð17
young people, 189, 191
separation anxiety disorder, 47
service delivery monitoring, 321Ð9, 
338Ð9
sex of population groups, 4, 192Ð9, 365, 
393Ð6
acute respiratory infections (ARI), 
111Ð12
aged care assessments, 280
aged 80 and over, 316
alcohol consumption, 147, 148
allied health service use, 291
asthma, 90
attitudes and beliefs, 143Ð4
auto-immune diseases and conditions, 
37Ð8
birth ratios, 367
blood cholesterol, 170, 392
blood pressure, 168, 392
body weight, 164Ð7, 392
burden of disease, 52
cancer, 63Ð71, 386Ð9
cardiovascular diseases, 56, 57Ð9, 350, 
392
chronic obstructive pulmonary 
disease, 95Ð7
dengue fever, 118
diabetes, 87, 88, 392
disability, 48, 78
family planning clients, 269
general practitioner patients, 293
health system costs, 251
health workforce, 258, 259, 260, 263
hepatitis B, 114
hepatitis C, 115
HIV/AIDS, 112, 114, 153Ð4, 385
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illicit drug use, 152, 153Ð4
Indigenous Australians, 208, 215, 
216Ð17, 218
injuries, 75
kidney diseases, 105, 107
life expectancy, 11, 12, 13, 20, 208, 342, 
371Ð2
malaria, 118
medical practitioner consultations, 
300
Medicare services, 412Ð14
medication use, 301, 304Ð5
mental problems and disorders, 76, 
78, 82, 84
morbidity, 45Ð7, 52
multiple sclerosis, 105
musculoskeletal disorders, 98, 100, 
101, 102, 103
older people, 200Ð3: oral health, 25
palliative care, 327
Parkinson's disease, 105
physical activity, 154Ð5, 392
rubella, 121, 122
rural and remote Australians, 224, 227
saturated fat intakes, 145
self-assessed health status, 14Ð17
socioeconomic status, 222Ð3
sexual health, 28Ð9
sexually transmitted diseases, 29Ð30
subacute sclerosing panencephalitis, 
121
tetanus, 120
tobacco smoking, 148Ð51, 392
tuberculosis, 118
young people, 192
sex of population groups, and mortality, 
39Ð44, 51, 52, 54, 340, 341, 371Ð83
auto-immune diseases and conditions, 
37
cancer, 63Ð71, 352Ð5, 386
cardiovascular diseases, 60Ð3, 211
children, 75, 185, 186, 187, 210
chronic obstructive pulmonary 
disease, 95, 96
coronary heart disease, 350Ð1
dementia, 104
diabetes, 89
Indigenous Australians, 208Ð9, 210, 
211, 218, 225, 227
infectious and parasitic diseases, 346
injuries, 72Ð4, 75, 226, 227, 379Ð82
kidney disease, 107, 108
liver, cirrhosis of, 108Ð9
mental problems and disorders, 
79Ð82, 211
musculoskeletal disorders, 98
overseas-born Australians, 205Ð6
respiratory diseases, 111, 358
road traffic accidents, 189, 226
rural and remote Australians, 225, 226
socioeconomic status, 221Ð2
suicide, 79Ð82, 191, 226, 357
young people, 190, 191, 192
sex chromosome anomalies, 141
sexual deviations and disorders, 78
sexual health/practice, 26Ð31, 162Ð4, 
268Ð9
see also births
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sexually transmitted diseases, 29Ð31, 
116Ð17, 162, 190, 384
see also HIV/AIDS
SF-12 questionnaire, 14
shigellosis, 384
shooting, suicide by, 81
sickness, see diseases
SIDS, 185, 186
sight, see eye diseases/disorders
simvastatin, 303, 304
sinusitis, 295
skin cancers, 47, 137, 155Ð7, 250
melanoma, 65, 67, 70Ð1, 206
older people, 202
overseas-born Australians, 205, 206, 
207
skin diseases/disorders, 379Ð80, 397Ð8
skin ointments and creams, 303
skin procedures, 276
sleep disturbance, 84, 295
slipped disc, 46, 47, 99, 100
smoking, see tobacco smoking
social health determinants, 135
social phobia, 46
social workers/welfare officers, 
consultations with, 291, 291
socioeconomic status, 5, 135, 142, 218Ð23
children, 188, 189
coronary heart disease mortality rates, 
350
Indigenous Australians, 215Ð16
life expectancy, 11
oral health, 22, 24
self-reported health status, 16Ð17
suicide, 357
young people, 191, 192
see also government concession 
cardholders
South Australia, see States and 
Territories
specialist medical attendances, 298, 299, 
300, 410
referrals, 296
speech therapists/pathologists, 263, 264, 
291, 292
spina bifida, 183Ð4
sports, participation in, 155, 191
sports injuries, 47
sprains, strains and dislocations, 74, 295
SSPE, 121, 160
States and Territories, 8
acute care hospital beds, 268
AIDS cases, 385
asthma prevalence, 90
births, 183, 212, 366, 368, 369
cancer incidence, 388
child dental health, 20, 22, 391
children immunised, 159
cost per casemix-adjusted separation, 
321Ð2
death rates, 374
elective surgery waiting times, 324
health expenditure, 7, 233Ð40, 241Ð4, 
310
health workforce, 260, 262
hospital costs, 322
hospital use, 277, 278, 279, 393Ð6
Indigenous Australians, 22, 108, 212, 
218
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kidney failure deaths, 108
life expectancy, 12, 371
multiple sclerosis, 105
perinatal deaths, 212, 369
private health insurance coverage, 257
private medical service use, 300
statistical developments, gaps and 
deficiencies, 6Ð7, 313Ð39
cancer surveillance and monitoring, 
64
constant price estimates, 236
diabetes, 86
health services expenditure to GDP 
ratio, 232
HIV/AIDS hospital separations, 113
hospital use, 271Ð2
immunisation levels, 35Ð6
Indigenous Australians, 207Ð8, 333
National Diabetes Register, 87
SF-12 questionnaire, 14
State and Territory expenditure 
sources, 243
sun protection estimates, 157
statistical methods and conventions, 
428Ð30
STDs, 29Ð31, 116Ð17, 162, 190, 384
see also HIV/AIDS
stenosis, 184
stenting, 59, 60
sterilisation, 28, 163
steroids, 144, 152, 153
stillbirths (foetal deaths), 27, 182, 209
stomach cancer, 52, 65, 66, 386Ð9
strains, sprains and dislocations, 74, 295
stratospheric ozone, 136Ð7
stress, 36, 249
stroke (cerebrovascular disease), 47, 56, 
57Ð8
burden of disease, 54, 194, 197, 199
CT brain scans, 59, 60
diabetes and, 88, 89
health system costs, 250
overseas-born Australians, 207
rural and remote Australians, 225
stroke: mortality, 40, 41, 42, 44, 60Ð3, 89, 
351, 383
burden of premature (YLL), 51
overseas-born Australians, 205
rural and remote Australians, 225
subacute sclerosing panencephalitis 
(SSPE), 121, 160
substance abuse, 82, 84, 192Ð3
health system costs, 249, 250
Indigenous Australians, 217
young people, 190
sudden infant death syndrome (SIDS), 
185, 186
suicide, 40, 72, 73Ð4, 79Ð82, 357
burden of disease, 54, 193, 194
burden of premature mortality (YLL), 
51
overseas-born Australians, 205, 206
rural and remote Australians, 226
schizophrenia sufferers, 84
young people, 190, 191, 192, 226
see also depression
sun exposure, 155Ð7
sunglasses, 156, 157
sunscreen, 156Ð7
supply of health services, 266Ð300
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surgery, see operations
survival, following cancer, 67, 68
swimming, 155
syphilis, 30, 190, 384
systemic lupus erythmatosus, 37
systolic blood pressure, 168
Tasmania, see States and Territories
tax expenditures, 233, 251, 237
technology undergraduate course 
commencements, 263, 264
teenagers, see adolescents; young people
teeth, see dental health
temazepam, 304
temperatures (climate), 136
tennis, 155
tenure of housing, 216
termination of pregnancy, 162, 181, 276
tertiary education entrants to workforce, 
263Ð5
test results, consultations about, 294
testis, cancer of, 66, 387Ð8
tetanus, 120, 159, 347, 384
throat complaints, 294
thyroxine, 303
tobacco smoking, 43, 63, 69, 148Ð51, 
352Ð4
asthma and, 91
attitudes to, 143, 144
Indigenous Australians, 217
public health interventions, 307Ð9
status of indicators, 417
young people, 190
see also chronic obstructive pulmonary 
disease; lung cancer
Torres Strait Islanders, see Indigenous 
Australians
toxic effects, 74
tracheo-oesophageal fistula, 184
traffic accidents, see road traffic 
accidents
tranquillisers, 152, 153
transplants, 106Ð7, 108
transposition of great vessels, 184
Trisomy, 141
tubal ligation, 29
tuberculosis, 118Ð19, 206, 207, 384
Turner's syndrome, 141
twins, 180Ð1
Type 1 diabetes, 37Ð8, 85, 86
Type 2 diabetes, 46, 85, 86, 87, 392
typhoid, 384
ultraviolet (UV) radiation, 136Ð7
umbrellas, 157
undergraduate course commencements, 
263Ð5
underweight, 164, 189
unemployment, 191, 215
see also socioeconomic status
unintentional injuries, 74, 193, 196, 197, 
198, 355Ð6
see also road traffic accidents
university course entrants, 263Ð5
unknown primary cancers, 65, 66, 67, 
386
unsafe sex, 162, 164
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upper respiratory tract infections, 47, 
110Ð12, 213, 294, 295
urinary incontinence, 46
urinary tract infection, 295
use of health services, 266Ð300
uterus, cancer of, 65, 66, 67, 386Ð8
vaccination (immunisation), 33Ð6, 
119Ð22, 185, 347, 157Ð61
attitudes to, 143
influenza vaccine, 303
general practitioner consultations, 
294, 295
vacuum extraction deliveries, 183
vaginal breech deliveries, 183
varicose veins, 57
vasectomies, 29
vector-borne diseases, 117Ð18, 384
vegetable consumption, 145
ventricular septal defect, 184
Veterans Affairs cardholders, see 
government concession cardholders
Victoria, see States and Territories
violence, 47, 74, 217Ð18
alcohol caused, 147
deaths from, 205, 218, 357
vision, see eye diseases/disorders
vitamin and mineral supplements, 304, 
305
waist-to-hip ratio (WHR), 166Ð7
waiting times for elective surgery, 322Ð4
walking, 155, 224
water fluoridation, 20, 22
weather, 136
weight, 164Ð7, 189, 216Ð17, 392, 417
welfare officers/social workers, 
consultations with, 291, 291
wellbeing, 2Ð4, 12Ð17
Western Australia, see States and 
Territories
whooping cough (pertussis), 119Ð20, 
159, 185, 347, 384
wine consumption, 148
women, 196Ð9
contraception used by, 163
mothers, 28, 179, 181, 343Ð4, 366, 369
see also sex of population groups
work-related fatalities, 357
workforce, see health workforce
World Health Organization, 2Ð3, 49, 314, 
336Ð7
wounds, 74
yersiniosis, 384
YLDs, see disability burden
YLLs, see mortality (premature), burden 
of
young people, 189Ð92, 337
asthma, 90
epilepsy risk factors, 104
Indigenous, 192, 227
mortality, 40, 189Ð90, 191, 192, 226Ð7, 
355
oral health, 22Ð3
rural and remote Australians, 226Ð7
sexual practices and knowledge, 31, 
190
smoking, 150Ð1
suicide, 79Ð80
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AustraliaÕs Welfare is the most comprehensive and
authoritative source of national information on welfare
services in Australia. 
Topics include welfare services expenditure, childrenÕs and
family services, child protection, housing assistance, crisis
accommodation and support services, aged care services
and disability services. 
AustraliaÕs Welfare 1999 features a special chapter on the
interactions between changing work patterns and demand
for, and supply of, welfare services. Both formal and
informal care services are explored, as well as changes in
the nature of the welfare labour force. 
Australia’s Health 1999
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